LABORATORY REPORT - Charleston Water

LABORATORY REPORT

This report may not be reproduced, except in full, without written approval from EEA.

If you have any questions concerning this report, please do not hesitate to call us at (800) 332-4345 or (574) 233-4777.

Page 1 of 201

Revision date: 09/29/2020

STATE CERTIFICATION LIST

State Certification State Certification Alabama 40700 Missouri 880 Alaska IN00035 Montana CERT0026 Arizona AZ0432 Nebraska NE-OS-05-04

Arkansas IN00035 Nevada IN00035 California 2920 New Hampshire* 2124 Colorado IN00035 New Jersey* IN598

Colorado Radiochemistry IN00035 New Mexico IN00035 Connecticut PH-0132 New York* 11398 Delaware IN035 North Carolina 18700

Florida(Primary AB)* E87775 North Dakota R-035 Georgia 929 Ohio 87775 Hawaii IN035 Oklahoma D9508 Idaho IN00035 Oregon* 4156

Illinois* 200001 Pennsylvania* 68-00466 Illinois Microbiology 17767 Puerto Rico IN00035

Illinois Radiochemistry IN00035 Rhode Island LAO00343 Indiana Chemistry C-71-01 South Carolina 95005

Indiana Microbiology M-76-07 South Dakota IN00035 Iowa 098 Tennessee TN02973

Kansas* E-10233 Texas* T104704187 Kentucky 90056 Texas/TCEQ TX207

Louisiana* LA014 Utah* IN00035 Maine IN00035 Vermont VT-8775

Maryland 209 Virginia* 460275 Massachusetts M-IN035 Washington C837

Michigan 9926 West Virginia 9927 C Minnesota* 018-999-338 Wisconsin 999766900 Mississippi IN035 Wyoming IN035

EPA IN00035 *NELAP/TNI Recognized Accreditation Bodies

Page 2 of 201

Laboratory Report

Client:

Attn:

Report:

Priority:

Status:

PWS ID:

Charleston Water System

Becky Thames

1104 Hanahan Road

500223

SC1010001

Standard Written

Final

95005Lab ID #:

Hanahan, SC 29410

110 South Hill StreetSouth Bend, IN 46617Tel: (574) 233-4777Fax: (574) 233-82071 800 332 4345

*NR = The chlorine demand was not performed for this analytical sample, at the request of the client.

EEA ID #

Client ID Method CollectedDate / Time

CollectedBy:

ReceivedDate / Time

4743528 1-22-15 AB38467 521 10/05/20 11:49 Client 10/07/20 09:15

4743529 Finished 521 10/06/20 09:44 Client 10/07/20 09:15

4743530 Finished 8330A 10/06/20 09:49 Client 10/07/20 09:15

4743531 Finished 544 10/06/20 09:53 Client 10/07/20 09:15

4743532 Finished 545 10/06/20 09:57 Client 10/07/20 09:15

4743533 Finished L520 10/06/20 09:59 Client 10/07/20 09:15

4743534 Finished 556 10/06/20 10:00 Client 10/07/20 09:15

4743536 Finished 525.2 10/06/20 10:15 Client 10/07/20 09:15

4743537 Finished 1613 10/06/20 10:21 Client 10/07/20 09:15

4743538 Finished 522 10/06/20 10:33 Client 10/07/20 09:15

4743539 Finished 549.2 10/06/20 10:29 Client 10/07/20 09:15


4743541 Finished 515.3 10/06/20 10:41 Client 10/07/20 09:15

4743542 Finished 331.0 10/06/20 11:17 Client 10/07/20 09:15

4743543 Finished 218.6 10/06/20 11:09 Client 10/07/20 09:15

4743544 Finished LC/MS/MS 10/06/20 10:47 Client 10/07/20 09:15

4743545 Finished 531.2 LL 10/06/20 10:46 Client 10/07/20 09:15


4743547 Finished SRL 524M-TCP 10/06/20 10:50 Client 10/07/20 09:15

4743548 Finished 524.2 10/06/20 10:54 Client 10/07/20 09:15

4743549 Finished 200.8 10/06/20 10:36 Client 10/07/20 09:15

Sample Information

Report Summary

Note: Nitroaromatics/Nitramines analysis was performed by Lancaster Laboratories, Lancaster, PA.

Note: Dioxin analysis was performed by Pace Analytical Services, Minneapolis, MN.

Note: EDC/PPCP/Homrones analysis was perfromed by EEA, Monrovia, CA.

Note: Please see attached QC Summary Report for recoveries that fall outside acceptance criteria.

Page 1 of 16

Page 3 of 201

Client Name: Report #: 500223Charleston Water System

Detailed quantitative results are presented on the following pages. The results presented relate only to the samples provided for analysis.

We appreciate the opportunity to provide you with this analysis. If you have any questions concerning this report, please do not hesitate to call Pat Muff at (574) 233-4777.

Note: This report may not be reproduced, except in full, without written approval from EEA.

Client Name:

Report #:

Charleston Water System

500223

Authorized Signature Title Date

11/11/2020

Page 2 of 16Page 4 of 201


Sampling Point: PWS ID:1-22-15 AB38467 SC1010001

Semi-volatile Organic Chemicals

AnalyteID #

Analyte Method RegLimit

MRL† Result Units PreparationDate

Analyzed EEAID #

474352810/13/20 01:0310/09/20 07:55ng/L< 2.02.0---521N-Nitrosodi-N-butylamine (NDBA)924-16-3

474352810/13/20 01:0310/09/20 07:55ng/L< 2.02.0---521N-Nitrosodi-N-propylamine (NDPA)2316

474352810/13/20 01:0310/09/20 07:55ng/L< 2.02.0---521N-Nitrosodiethylamine (NDEA)55-18-5

474352810/13/20 01:0310/09/20 07:55ng/L7.72.0---521N-Nitrosodimethylamine (NDMA)2314

474352810/13/20 01:0310/09/20 07:55ng/L< 2020---521N-Nitrosodiphenylamine (NDPhA)86-30-6

474352810/13/20 01:0310/09/20 07:55ng/L< 2.02.0---521N-Nitrosomethylethylamine (NMEA)10595-95-6

474352810/13/20 01:0310/09/20 07:55ng/L< 2.02.0---521N-Nitrosomorpholine (NMOR)59-89-2

474352810/13/20 01:0310/09/20 07:55ng/L< 2.02.0---521N-Nitrosopiperidine (NPIP)100-75-4

474352810/13/20 01:0310/09/20 07:55ng/L< 2.02.0---521N-Nitrosopyrrolidine (NPYR)930-55-2



Sampling Point: PWS ID:Finished SC1010001

General Chemistry

AnalyteID #



AnalyzedDate

EEAID #

1080 Chromium, Hexavalent 218.6 --- 0.02 0.33 ug/L --- 10/09/20 00:54 4743543

1039 Perchlorate 331.0 --- 0.05 < 0.05 ug/L --- 10/10/20 00:56 4743542

Metals

AnalyteID #



AnalyzedDate

EEAID #

1002 474354910/13/20 13:15---ug/L702.050 ^200.8Aluminum

1074 474354910/13/20 13:15---ug/L< 1.01.06 *200.8Antimony

1005 474354910/13/20 13:15---ug/L< 1.01.010 *200.8Arsenic

1010 474354910/13/20 13:15---ug/L142.02000 *200.8Barium

1075 474354910/13/20 13:15---ug/L< 0.30.34 *200.8Beryllium

1079 474354910/13/20 13:15---ug/L285.0---200.8Boron

1015 474354910/13/20 13:15---ug/L< 1.01.05 *200.8Cadmium

1020 474354910/13/20 13:15---ug/L< 0.90.9100 *200.8Chromium

1081 474354910/13/20 13:15---ug/L< 2.02.0---200.8Cobalt

1022 474354910/13/20 13:15---ug/L< 1.01.01300 !200.8Copper

1030 474354910/13/20 13:15---ug/L< 1.01.015 !200.8Lead

1083 474354910/13/20 13:15---ug/L< 2.02.0---200.8Lithium

1032 474354910/13/20 13:15---ug/L8.52.050 ^200.8Manganese

1084 474354910/13/20 13:15---ug/L< 2.02.0---200.8Molybdenum

1036 474354910/13/20 13:15---ug/L< 1.01.0---200.8Nickel

1045 474354910/13/20 13:15---ug/L< 2.02.050 *200.8Selenium

1050 474354910/13/20 13:15---ug/L< 2.02.0100 ^200.8Silver

1051 474354910/13/20 13:15---ug/L462.0---200.8Strontium

1085 474354910/13/20 13:15---ug/L< 0.30.32 *200.8Thallium

7440-29-1 474354910/13/20 13:15---ug/L< 5.05.0---200.8Thorium

1086 474354910/13/20 13:15---ug/L< 2.02.0---200.8Tin

1087 474354910/13/20 13:15---ug/L< 5.05.0---200.8Titanium

4006 474354910/13/20 13:15---ug/L< 1.01.030 *200.8Uranium

1088 474354910/13/20 13:15---ug/L< 2.02.0---200.8Vanadium

1095 474354910/13/20 13:15---ug/L< 5.05.05000 ^200.8Zinc

Semi-volatile Organic Chemicals

AnalyteID #



Analyzed EEAID #

474354110/21/20 03:1810/15/20 08:30ug/L< 1.01.0---515.3Acifluorfen2108

474354110/21/20 03:1810/15/20 08:30ug/L< 0.50.5---515.3Bentazon2625

474354110/21/20 03:1810/15/20 08:30ug/L< 2.02.0---515.3Chloramben2205

474354110/21/20 03:1810/15/20 08:30ug/L< 0.10.170 *515.32,4-D2105

474354110/21/20 03:1810/15/20 08:30ug/L< 1.01.0200 *515.3Dalapon2031

474354110/21/20 03:1810/15/20 08:30ug/L< 2.02.0---515.32,4-DB2106

474354110/21/20 03:1810/15/20 08:30ug/L< 0.50.5---515.3DCPA acid metabolites2108

474354110/21/20 03:1810/15/20 08:30ug/L< 0.10.1---515.3Dicamba2440

474354110/21/20 03:1810/15/20 08:30ug/L< 0.50.5---515.33,5-Dichlorobenzoic acid51-36-5

474354110/21/20 03:1810/15/20 08:30ug/L< 2.02.0---515.3Dichlorprop2206

474354110/21/20 03:1810/15/20 08:30ug/L< 0.10.17 *515.3Dinoseb2041



474354110/21/20 18:2310/15/20 08:30ug/L< 0.50.5---515.3MCPA2113

474354110/21/20 18:2310/15/20 08:30ug/L< 0.50.5---515.3Mecoprop2112

474354110/21/20 03:1810/15/20 08:30ug/L< 0.040.041 *515.3Pentachlorophenol2326

474354110/21/20 03:1810/15/20 08:30ug/L< 0.10.1500 *515.3Picloram2040

474354110/21/20 03:1810/15/20 08:30ug/L< 0.50.5---515.32,4,5-T2111

474354110/21/20 03:1810/15/20 08:30ug/L< 0.10.150 *515.32,4,5-TP (Silvex)2110

474354110/21/20 03:1810/15/20 08:30ug/L< 0.50.5---515.3Triclopyr2107

474352910/13/20 02:0710/09/20 07:55ng/L< 2.02.0---521N-Nitrosodi-N-butylamine (NDBA)924-16-3

474352910/13/20 02:0710/09/20 07:55ng/L< 2.02.0---521N-Nitrosodi-N-propylamine (NDPA)2316

474352910/13/20 02:0710/09/20 07:55ng/L< 2.02.0---521N-Nitrosodiethylamine (NDEA)55-18-5

474352910/13/20 02:0710/09/20 07:55ng/L5.62.0---521N-Nitrosodimethylamine (NDMA)2314

474352910/13/20 02:0710/09/20 07:55ng/L< 2020---521N-Nitrosodiphenylamine (NDPhA)86-30-6

474352910/13/20 02:0710/09/20 07:55ng/L< 2.02.0---521N-Nitrosomethylethylamine (NMEA)10595-95-6

474352910/13/20 02:0710/09/20 07:55ng/L< 2.02.0---521N-Nitrosomorpholine (NMOR)59-89-2

474352910/13/20 02:0710/09/20 07:55ng/L< 2.02.0---521N-Nitrosopiperidine (NPIP)100-75-4

474352910/13/20 02:0710/09/20 07:55ng/L< 2.02.0---521N-Nitrosopyrrolidine (NPYR)930-55-2

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Acenaphthene2261

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Acenaphthylene2260

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Acetochlor2027

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.12 *525.2Alachlor2051

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Aldrin2356

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Ametryn834-12-8

474353610/14/20 16:4010/13/20 08:06ug/L< 1.01.0---525.2Anilazine101-05-3

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Anthracene2280

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Aspon3244-90-4

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Atraton1610-17-9

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.13 *525.2Atrazine2050

474353610/14/20 16:4010/13/20 08:06ug/L< 0.50.5---525.2Azinphos-ethyl2642-71-9

474353610/14/20 16:4010/13/20 08:06ug/L< 0.50.5---525.2Azinphos-methyl2059

474353610/14/20 16:4010/13/20 08:06ug/L< 0.50.5---525.2Bendiocarb22781-23-3

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Benfluralin2207

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Benzo(a)anthracene2300

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Benzo(b)fluoranthene2302

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Benzo(k)fluoranthene2304

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Benzo(g,h,i)perylene2312

474353610/14/20 16:4010/13/20 08:06ug/L< 0.020.020.2 *525.2Benzo(a)pyrene2306

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2alpha-Hexachlorocyclohexane2348

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2beta-BHC2350

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2delta-BHC2354

474353610/14/20 16:4010/13/20 08:06ug/L< 0.020.020.2 *525.2gamma-BHC (Lindane)2010

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Bolstar2635

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Bromacil2098

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Butachlor2076

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Butylate2053

474353610/14/20 16:4010/13/20 08:06ug/L< 1.01.0---525.2Butylbenzylphthalate2294

474353610/14/20 16:4010/13/20 08:06ug/L< 0.50.5---525.2Carbophenothion2061

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Carboxin5234-68-4

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2alpha-Chlordane5103-71-9

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2gamma-Chlordane5103-74-2

474353610/14/20 16:4010/13/20 08:06ug/L< 5.05.0---525.2Chlorfenvinphos470-90-6

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Chlorobenzilate510-15-6

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.22-Chlorobiphenyl2051-60-7

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Chloroneb2675-77-6



474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Chloropropylate5836-10-2

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Chlorothalonil2213

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Chlorpropham101-21-3

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Chlorpyrifos2057

474353610/14/20 16:4010/13/20 08:06ug/L< 0.50.5---525.2Chlorpyrifos methyl5598-13-0

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Chrysene2296

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Clomazone81777-89-1

474353610/14/20 16:4010/13/20 08:06ug/L< 1010---525.2Clopyralid1702-17-6

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Coumaphos56-72-4

474353610/14/20 16:4010/13/20 08:06ug/L< 0.50.5---525.2Crotoxyphos7700-17-6

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Cyanazine2054

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Cycloate1134-23-2

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2DCPA2099

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.24,4'-DDD2071

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.24,4'-DDE2009

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.24,4'-DDT2075

474353610/14/20 16:4010/13/20 08:06ug/L< 0.50.5---525.2Demeton O298-03-3

474353610/14/20 16:4010/13/20 08:06ug/L< 0.50.5---525.2Demeton S126-75-0

474353610/14/20 16:4010/13/20 08:06ug/L< 1.01.0---525.2Desethylatrazine2006

474353610/14/20 16:4010/13/20 08:06ug/L< 1.01.0---525.2Desisopropylatrazine2007

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Diazinon2056

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Dibenzo(a,h)anthracene2310

474353610/14/20 16:4010/13/20 08:06ug/L< 2.02.0---525.2Di-n-butylphthalate2290

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Dichlobenil1194-65-6

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Dichlofenthion97-17-6

474353610/14/20 16:4010/13/20 08:06ug/L< 0.50.5---525.2Dichloran2933

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.22,3-Dichlorobiphenyl16605-91-7

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Dichlorvos62-73-7

474353610/14/20 16:4010/13/20 08:06ug/L< 0.50.5---525.2Dicrotophos141-66-2

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Dieldrin2070

474353610/14/20 16:4010/13/20 08:06ug/L< 0.60.6400 *525.2Di(2-ethylhexyl)adipate2035

474353610/14/20 16:4010/13/20 08:06ug/L< 0.60.66 *525.2Di(2-ethylhexyl)phthalate2039

474353610/14/20 16:4010/13/20 08:06ug/L< 1.01.0---525.2Diethylphthalate2284

474353610/14/20 16:4010/13/20 08:06ug/L< 0.50.5---525.2Dimethoate2221

474353610/14/20 16:4010/13/20 08:06ug/L< 1.01.0---525.2Dimethylphthalate2282

474353610/14/20 16:4010/13/20 08:06ug/L< 0.50.5---525.22,4-Dinitrotoluene2270

474353610/14/20 16:4010/13/20 08:06ug/L< 0.50.5---525.22,6-Dinitrotoluene2266

474353610/14/20 16:4010/13/20 08:06ug/L< 2.02.0---525.2Di-n-octylphthalate2223

474353610/14/20 16:4010/13/20 08:06ug/L< 0.50.5---525.2Dioxathion A78-34-2

474353610/14/20 16:4010/13/20 08:06ug/L< 0.50.5---525.2Dioxathion B78-34-2

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Diphenamid957-51-7

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Disulfoton2102

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Disulfoton sulfone2497-06-5

474353610/14/20 16:4010/13/20 08:06ug/L< 1010---525.2Disulfoton sulfoxide2497-07-6

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Endosulfan I2068

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Endosulfan II2072

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Endosulfan sulfate2074

474353610/14/20 16:4010/13/20 08:06ug/L< 0.010.012 *525.2Endrin2005

474353610/14/20 16:4010/13/20 08:06ug/L< 0.50.5---525.2Endrin aldehyde2372

474353610/14/20 16:4010/13/20 08:06ug/L< 0.50.5---525.2EPN2104-64-5

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2EPTC2052

474353610/14/20 16:4010/13/20 08:06ug/L< 5.05.0---525.2Erucylamide112-84-5

474353610/14/20 16:4010/13/20 08:06ug/L< 0.50.5---525.2Esfenvalerate66230-04-4



474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Ethalfluralin2252

474353610/14/20 16:4010/13/20 08:06ug/L< 5.05.0---525.2Ethion2062

474353610/14/20 16:4010/13/20 08:06ug/L< 0.50.5---525.2Ethofumesate26225-79-6

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Ethoprop2267

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Etridiazole2593-15-9

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Famphur52-85-7

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Fenamiphos22224-92-6

474353610/14/20 16:4010/13/20 08:06ug/L< 1.01.0---525.2Fenarimol60168-88-9

474353610/14/20 16:4010/13/20 08:06ug/L< 0.50.5---525.2Fenitrothion122-14-5

474353610/14/20 16:4010/13/20 08:06ug/L< 1.01.0---525.2Fenoxaprop-ethyl66441-23-4

474353610/14/20 16:4010/13/20 08:06ug/L< 0.50.5---525.2Fensulfothion115-90-2

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Fenthion55-38-9

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Fluazifop-butyl69806-50-4

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Fluchloralin33245-39-5

474353610/14/20 16:4010/13/20 08:06ug/L< 0.50.5---525.2Fluometuron2164-17-2

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Fluoranthene2286

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Fluorene2264

474353610/14/20 16:4010/13/20 08:06ug/L< 1.01.0---525.2Fluridone59756-60-4

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Fonofos2104

474353610/14/20 16:4010/13/20 08:06ug/L< 0.040.040.4 *525.2Heptachlor2065

474353610/14/20 16:4010/13/20 08:06ug/L< 0.020.020.2 *525.2Heptachlor epoxide2067

474353610/14/20 16:4010/13/20 08:06ug/L< 0.50.5---525.22,2',3,3',4,4',6-Heptachlorobiphenyl52663-71-5

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.11 *525.2Hexachlorobenzene2274

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.22,2',4,4',5,6'-Hexachlorobiphenyl60145-22-4

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.150 *525.2Hexachlorocyclopentadiene2042

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Hexazinone51235-04-2

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Indeno(1,2,3-cd)pyrene2308

474353610/14/20 16:4010/13/20 08:06ug/L< 0.50.5---525.2Iprodione36734-19-7

474353610/14/20 16:4010/13/20 08:06ug/L< 0.50.5---525.2Isofenphos2060

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Isophorone2262

474353610/14/20 16:4010/13/20 08:06ug/L< 0.50.5---525.2Leptophos21609-90-5

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Malathion2058

474353610/14/20 16:4010/13/20 08:06ug/L< 0.50.5---525.2Metalaxyl57837-19-1

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.140 *525.2Methoxychlor2015

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.21-Methylnaphthalene90-12-0

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.22-Methylnaphthalene2241

474353610/14/20 16:4010/13/20 08:06ug/L< 0.50.5---525.2Methyl paraoxon950-35-6

474353610/14/20 16:4010/13/20 08:06ug/L< 0.50.5---525.2Methyl parathion298-00-0

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Metolachlor2045

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Metribuzin2595

474353610/14/20 16:4010/13/20 08:06ug/L< 1010---525.2Metsulfuron-methyl74223-64-6

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Mevinphos2073

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2MGK 264 isomer a113-48-4

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2MGK 264 isomer b113-48-4

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2MGK 326136-45-8

474353610/14/20 16:4010/13/20 08:06ug/L< 0.50.5---525.2Mirex2932

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Molinate2626

474353610/14/20 16:4010/13/20 08:06ug/L< 0.50.5---525.2Monocrotophos6923-22-4

474353610/14/20 16:4010/13/20 08:06ug/L< 0.50.5---525.2Naled300-76-5

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Naphthalene2248

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Napropamide15299-99-7

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2cis-Nonachlor5103-73-1

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2trans-Nonachlor2273



474353610/14/20 16:4010/13/20 08:06ug/L< 1.01.0---525.2Norflurazon27314-13-2

474353610/14/20 16:4010/13/20 08:06ug/L< 0.50.5---525.22,2',3,3',4,5',6,6'-Octachlorobiphenyl40186-71-8

474353610/14/20 16:4010/13/20 08:06ug/L< 1010---525.2Oryzalin19044-88-3

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Oxadiazon19666-30-9

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Oxychlordane27304-13-8

474353610/14/20 16:4010/13/20 08:06ug/L< 0.50.5---525.2Oxyfluorfen42874-03-3

474353610/14/20 16:4010/13/20 08:06ug/L< 0.50.5---525.2Parathion2064

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Pebulate1114-71-2

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Pendimethalin2255

474353610/14/20 16:4010/13/20 08:06ug/L< 0.50.5---525.2Pentachlorobenzene608-93-5

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.22,2',3',4,6-Pentachlorobiphenyl60233-25-2

474353610/14/20 16:4010/13/20 08:06ug/L< 0.50.5---525.2Pentachloronitrobenzene2934

474353610/15/20 10:5110/13/20 08:06ug/L< 1.01.0---525.2Pentachlorophenol2326

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Permethrin, cis & trans2114

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Phenanthrene2278

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Phorate2605

474353610/14/20 16:4010/13/20 08:06ug/L< 0.50.5---525.2Phosmet732-11-6

474353610/14/20 16:4010/13/20 08:06ug/L< 0.50.5---525.2E-Phosphamidon297-99-4

474353610/14/20 16:4010/13/20 08:06ug/L< 0.50.5---525.2Z-Phosphamidon23783-98-4

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Profluralin26399-36-0

474353610/14/20 16:4010/13/20 08:06ug/L< 1.01.0---525.2Prometon2029

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Prometryn7287-19-6

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Pronamide23950-58-5

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Propachlor2077

474353610/14/20 16:4010/13/20 08:06ug/L< 0.50.5---525.2Propanil2289

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Propazine2256

474353610/14/20 16:4010/13/20 08:06ug/L< 5.05.0---525.2Propiconazole isomer a60207-90-1

474353610/14/20 16:4010/13/20 08:06ug/L< 5.05.0---525.2Propiconazole isomer b60207-90-1

474353610/14/20 16:4010/13/20 08:06ug/L< 0.50.5---525.2Prothiofos34643-46-4

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Pyrene2288

474353610/14/20 16:4010/13/20 08:06ug/L< 0.070.074 *525.2Simazine2037

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Simetryn1014-70-6

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Stirofos22248-79-9

474353610/14/20 16:4010/13/20 08:06ug/L< 0.50.5---525.2Sulfotep3689-24-5

474353610/14/20 16:4010/13/20 08:06ug/L< 1010---525.2Tebuthiuron2271

474353610/14/20 16:4010/13/20 08:06ug/L< 1.01.0---525.2TEPP107-49-3

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Terbacil2272

474353610/14/20 16:4010/13/20 08:06ug/L< 0.50.5---525.2Terbufos2545

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Terbutryn886-50-0

474353610/14/20 16:4010/13/20 08:06ug/L< 0.50.5---525.21,2,4,5-Tetrachlorobenzene95-94-3

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.22,2',4,4'-Tetrachlorobiphenyl2437-79-8

474353610/14/20 16:4010/13/20 08:06ug/L< 1010---525.2Thiabendazole148-79-8

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Thiobencarb2627

474353610/14/20 16:4010/13/20 08:06ug/L< 0.50.5---525.2Thionazin297-97-2

474353610/14/20 16:4010/13/20 08:06ug/L< 0.50.5---525.2Triadimefon43121-43-3

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Tribufos78-48-8

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.22,4,5-Trichlorobiphenyl15862-07-4

474353610/14/20 16:4010/13/20 08:06ug/L< 0.50.5---525.2Trichloronate327-98-0

474353610/14/20 16:4010/13/20 08:06ug/L< 1.01.0---525.2Tricyclazole41814-78-2

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Trifluralin2055

474353610/14/20 16:4010/13/20 08:06ug/L< 0.10.1---525.2Vernolate1929-77-7

474353610/14/20 16:4010/13/20 08:06ug/L< 0.50.5---525.2Vinclozolin50471-44-8

474354510/23/20 16:5410/22/20 09:10ug/L< 0.10.1---531.2 LLAldicarb2047



474354510/23/20 16:5410/22/20 09:10ug/L< 0.10.1---531.2 LLAldicarb sulfone2044

474354510/23/20 16:5410/22/20 09:10ug/L< 0.10.1---531.2 LLAldicarb sulfoxide2043

474354510/23/20 16:5410/22/20 09:10ug/L< 0.10.1---531.2 LLBaygon2023

474354510/23/20 16:5410/22/20 09:10ug/L< 0.10.1---531.2 LLCarbaryl2021

474354510/23/20 16:5410/22/20 09:10ug/L< 0.10.1---531.2 LLCarbofuran2046

474354510/23/20 16:5410/22/20 09:10ug/L< 0.10.1---531.2 LL3-Hydroxycarbofuran2066

474354510/23/20 16:5410/22/20 09:10ug/L< 1.01.0---531.2 LLMethiocarb2024

474354510/23/20 16:5410/22/20 09:10ug/L< 0.10.1---531.2 LLMethomyl2022

474354510/23/20 16:5410/22/20 09:10ug/L< 1.01.0---531.2 LL1-Naphthol2259

474354510/23/20 16:5410/22/20 09:10ug/L< 0.10.1---531.2 LLOxamyl2036

474353110/16/20 19:1610/16/20 07:30ug/L< 0.0080.008---544Microcystin-LA96180-79-9

474353110/16/20 19:1610/16/20 07:30ug/L< 0.0060.006---544Microcystin-LF154037-70-4

474353110/16/20 19:1610/16/20 07:30ug/L< 0.0200.020---544Microcystin-LR101043-37-2

474353110/16/20 19:1610/16/20 07:30ug/L< 0.0090.009---544Microcystin-LY123304-10-9

474353110/16/20 19:1610/16/20 07:30ug/L< 0.0060.006---544Microcystin-RR111755-37-4

474353110/16/20 19:1610/16/20 07:30ug/L< 0.0200.020---544Microcystin-YR101064-48-6

474353110/16/20 19:1610/16/20 07:30ug/L< 0.0050.005---544Nodularin118399-22-7

474353210/09/20 05:1010/08/20 14:25ug/L< 0.030.03---545Anatoxin-a64285-06-9

474353210/09/20 05:1010/08/20 14:25ug/L< 0.090.09---545Cylindrospermopsin143545-90-8

474353910/13/20 17:0010/13/20 08:20ug/L< 0.40.420 *549.2Diquat2032

474353910/13/20 17:0010/13/20 08:20ug/L< 0.40.4---549.2Paraquat2028

474353410/16/20 02:3410/13/20 08:38ug/L< 5.05.0---556Acetaldehyde2470

474353410/16/20 02:3410/13/20 08:38ug/L< 5.05.0---556Benzaldehyde2479

474353410/16/20 02:3410/13/20 08:38ug/L< 5.05.0---556Butanal2472

474353410/16/20 02:3410/13/20 08:38ug/L< 5.05.0---556Crotonaldehyde123-73-9

474353410/16/20 02:3410/13/20 08:38ug/L< 5.05.0---556Cyclohexanone108-94-1

474353410/16/20 02:3410/13/20 08:38ug/L< 5.05.0---556Decanal2481

474353410/16/20 02:3410/13/20 08:38ug/L7.35.0---556Formaldehyde2961

474353410/16/20 02:3410/13/20 08:38ug/L< 5.05.0---556Glyoxal2474

474353410/16/20 02:3410/13/20 08:38ug/L< 5.05.0---556Heptanal2477

474353410/16/20 02:3410/13/20 08:38ug/L< 5.05.0---556Hexanal2476

474353410/16/20 02:3410/13/20 08:38ug/L< 5.05.0---556Methyl glyoxal2475

474353410/16/20 02:3410/13/20 08:38ug/L< 5.05.0---556Nonanal2480

474353410/16/20 02:3410/13/20 08:38ug/L< 5.05.0---556Octanal2478

474353410/16/20 02:3410/13/20 08:38ug/L< 5.05.0---556Pentanal2473

474353410/16/20 02:3410/13/20 08:38ug/L< 5.05.0---556Propanal2471

Volatile Organic Chemicals

AnalyteID #


MRL† Result Units Preparation Date

AnalyzedDate

EEAID #

474354810/16/20 17:36---ug/L< 5.05.0---524.2Acetone2243

474354810/19/20 14:38---ug/L< 1.01.0---524.2Acrylonitrile2240

474354810/19/20 14:38---ug/L< 5.05.0---524.2Allyl chloride2402

474354810/13/20 16:11---ug/L< 3.03.0---524.2tert-Amyl Methyl ether994-05-8

474354810/19/20 14:38---ug/L< 0.50.55 *524.2Benzene2990

474354810/13/20 16:11---ug/L< 0.50.5---524.2Benzyl chloride100-44-7

474354810/19/20 14:38---ug/L< 0.50.5---524.2Bromobenzene2993

474354810/19/20 14:38---ug/L< 0.50.5---524.2Bromochloromethane2430

474354810/19/20 14:38---ug/L5.20.5---524.2Bromodichloromethane2943

474354810/19/20 14:38---ug/L< 0.50.5---524.2Bromoform2942

474354810/19/20 14:38---ug/L< 0.50.5---524.2Bromomethane2214

474354810/13/20 16:11---ug/L< 5.05.0---524.21,3-Butadiene2486

474354810/19/20 14:38---ug/L< 5.05.0---524.22-Butanone (MEK)2247



474354810/13/20 16:11---ug/L< 1.01.0---524.2n-Butyl acrylate141-32-2

474354810/19/20 14:38---ug/L< 0.50.5---524.2n-Butylbenzene2422

474354810/19/20 14:38---ug/L< 0.50.5---524.2sec-Butylbenzene2428

474354810/19/20 14:38---ug/L< 0.50.5---524.2tert-Butylbenzene2426

474354810/19/20 14:38---ug/L< 5.05.0---524.2Carbon disulfide1902

474354810/19/20 14:38---ug/L< 0.50.55 *524.2Carbon tetrachloride2982

474354810/19/20 14:38---ug/L< 5.05.0---524.2Chloroacetonitrile2466

474354810/19/20 14:38---ug/L< 0.50.5100 *524.2Chlorobenzene2989

474354810/19/20 14:38---ug/L< 5.05.0---524.21-Chlorobutane2086

474354810/19/20 14:38---ug/L< 0.50.5---524.2Chloroethane2216

474354810/19/20 14:38---ug/L7.10.5---524.2Chloroform2941

474354810/19/20 14:38---ug/L< 0.50.5---524.2Chloromethane2210

474354810/13/20 16:11---ug/L< 5.05.0---524.2Chloroprene126-99-8

474354810/19/20 14:38---ug/L< 0.50.5---524.22-Chlorotoluene2965

474354810/19/20 14:38---ug/L< 0.50.5---524.24-Chlorotoluene2966

474354810/13/20 16:11---ug/L< 5.05.0---524.2Cyclohexanone108-94-1

474354810/19/20 14:38---ug/L1.90.5---524.2Dibromochloromethane2944

474354810/19/20 14:38---ug/L14.20.580 *524.2Total Trihalomethanes2950

474354810/19/20 14:38---ug/L< 0.20.2---524.21,2-Dibromo-3-chloropropane (DBCP)2931

474354810/19/20 14:38---ug/L< 0.20.2---524.21,2-Dibromoethane (EDB)2946

474354810/19/20 14:38---ug/L< 0.50.5---524.2Dibromomethane2408

474354810/19/20 14:38---ug/L< 0.50.5600 *524.21,2-Dichlorobenzene2968

474354810/19/20 14:38---ug/L< 0.50.5---524.21,3-Dichlorobenzene2967

474354810/19/20 14:38---ug/L< 0.50.575 *524.21,4-Dichlorobenzene2969

474354810/19/20 14:38---ug/L< 0.50.5---524.2Total Dichlorobenzene2401

474354810/19/20 14:38---ug/L< 5.05.0---524.2trans-1,4-Dichloro-2-butylene2970

474354810/19/20 14:38---ug/L< 0.50.5---524.2Dichlorodifluoromethane2212

474354810/19/20 14:38---ug/L< 0.50.5---524.21,1-Dichloroethane2978

474354810/19/20 14:38---ug/L< 0.50.55 *524.21,2-Dichloroethane2980

474354810/19/20 14:38---ug/L< 0.50.57 *524.21,1-Dichloroethylene2977

474354810/19/20 14:38---ug/L< 0.50.570 *524.2cis-1,2-Dichloroethylene2380

474354810/19/20 14:38---ug/L< 0.50.5100 *524.2trans-1,2-Dichloroethylene2979

474354810/13/20 16:11---ug/L< 2.02.0---524.2Di(2-chloroethyl)ether2222

474354810/19/20 14:38---ug/L< 0.50.55 *524.2Dichloromethane2964

474354810/19/20 14:38---ug/L< 0.50.55 *524.21,2-Dichloropropane2983

474354810/19/20 14:38---ug/L< 0.50.5---524.21,3-Dichloropropane2412

474354810/19/20 14:38---ug/L< 5.05.0---524.21,1-Dichloropropanone2463

474354810/19/20 14:38---ug/L< 0.50.5---524.22,2-Dichloropropane2416

474354810/19/20 14:38---ug/L< 0.50.5---524.21,1-Dichloropropylene2410

474354810/19/20 14:38---ug/L< 0.50.5---524.2cis-1,3-Dichloropropylene2228

474354810/19/20 14:38---ug/L< 0.50.5---524.2trans-1,3-Dichloropropylene2224

474354810/19/20 14:38---ug/L< 0.50.5---524.21,3-Dichloropropylene, cis & trans2413

474354810/13/20 16:11---ug/L< 0.50.5---524.2Diisopropyl ether108-20-3

474354810/13/20 16:11---ug/L< 5.05.0---524.21,4-Dioxane2049

474354810/13/20 16:11---ug/L< 1.01.0---524.2Epichlorohydrin2257

474354810/13/20 16:11---ug/L< 1.01.0---524.2Ethyl acrylate140-88-5

474354810/19/20 14:38---ug/L< 2.02.0---524.2Ethyl Ether2090

474354810/19/20 14:38---ug/L< 1.01.0---524.2Ethyl methacrylate2293

474354810/19/20 14:38---ug/L< 0.50.5700 *524.2Ethylbenzene2992

474354810/13/20 16:11---ug/L< 3.03.0---524.2Ethyl tert-butyl ether637-92-3

474354810/19/20 14:38---ug/L< 0.50.5---524.2Hexachlorobutadiene2246

474354810/19/20 14:38---ug/L< 2.02.0---524.2Hexachloroethane2225



474354810/19/20 14:38---ug/L< 5.05.0---524.22-Hexanone2269

474354810/19/20 14:38---ug/L< 0.50.5---524.2Isopropylbenzene2994

474354810/19/20 14:38---ug/L< 0.50.5---524.24-Isopropyltoluene2030

474354810/19/20 14:38---ug/L< 5.05.0---524.2Methacrylonitrile2467

474354810/19/20 14:38---ug/L< 1.01.0---524.2Methylacrylate2297

474354810/19/20 14:38---ug/L< 2.02.0---524.2Methyl iodide2458

474354810/19/20 14:38---ug/L< 1.01.0---524.2Methylmethacrylate2295

474354810/19/20 14:38---ug/L< 2.02.0---524.24-Methyl-2-pentanone (MIBK)2249

474354810/13/20 16:11---ug/L< 2.02.0---524.2tert-Butyl alcohol75-65-0

474354810/19/20 14:38---ug/L< 0.50.5---524.2Methyl-t-butyl ether (MTBE)2251

474354810/19/20 14:38---ug/L< 0.50.5---524.2Naphthalene2248

474354810/19/20 14:38---ug/L< 5.05.0---524.2Nitrobenzene2254

474354810/19/20 14:38---ug/L< 2.02.0---524.22-Nitropropane2469

474354810/19/20 14:38---ug/L< 2.02.0---524.2Pentachloroethane2327

474354810/19/20 14:38---ug/L< 5.05.0---524.2Propionitrile2468

474354810/19/20 14:38---ug/L< 0.50.5---524.2n-Propylbenzene2998

474354810/19/20 14:38---ug/L< 0.50.5100 *524.2Styrene2996

474354810/19/20 14:38---ug/L< 0.50.5---524.21,1,1,2-Tetrachloroethane2986

474354810/19/20 14:38---ug/L< 0.50.5---524.21,1,2,2-Tetrachloroethane2988

474354810/19/20 14:38---ug/L< 0.50.55 *524.2Tetrachloroethylene2987

474354810/19/20 14:38---ug/L< 5.05.0---524.2Tetrahydrofuran2263

474354810/19/20 14:38---ug/L< 0.50.51000 *524.2Toluene2991

474354810/19/20 14:38---ug/L< 0.50.5---524.21,2,3-Trichlorobenzene2420

474354810/19/20 14:38---ug/L< 0.50.570 *524.21,2,4-Trichlorobenzene2378

474354810/19/20 14:38---ug/L< 0.50.5200 *524.21,1,1-Trichloroethane2981

474354810/19/20 14:38---ug/L< 0.50.55 *524.21,1,2-Trichloroethane2985

474354810/19/20 14:38---ug/L< 0.50.55 *524.2Trichloroethylene2984

474354810/19/20 14:38---ug/L< 0.50.5---524.2Trichlorofluoromethane2218

474354810/19/20 14:38---ug/L< 0.50.5---524.21,2,3-Trichloropropane2414

474354810/19/20 14:38---ug/L< 0.50.5---524.21,1,2-Trichloro-1,2,2-trifluoroethane2904

474354810/19/20 14:38---ug/L< 0.50.5---524.21,2,3-Trimethylbenzene2419



474354810/13/20 16:11---ug/L< 5.05.0---524.2Vinyl acetate2447

474354810/19/20 14:38---ug/L< 0.20.22 *524.2Vinyl chloride2976

474354810/19/20 14:38---ug/L< 0.50.5---524.21,2-Xylene2997

474354810/19/20 14:38---ug/L< 0.50.5---524.21,3 + 1,4-Xylene2963

474354810/19/20 14:38---ug/L< 0.50.510000 *524.2Xylenes, Total2955

474353810/15/20 14:0810/12/20 09:00ug/L0.110.07---5221,4-Dioxane2049

474354710/15/20 23:06---ng/L< 5.05.0---SRL 524M-TCP1,2,3-Trichloropropane2414

Compliance monitoring for 1,2-Dibromo-3-chloropropane (DBCP) must be done using EPA method 504.1.

Compliance monitoring for 1,2-Dibromoethane (EDB) must be done using EPA method 504.1.

EEA Methods

AnalyteID #


MRL† Result Units Preparation Date

AnalyzedDate

EEAID #

474354610/09/20 18:22---ug/L< 0.50.5---L306Aldicarb sulfone2044

474354610/09/20 18:22---ug/L< 0.50.5---L306Aldicarb sulfoxide2043

474354610/09/20 18:22---ug/L< 0.50.5---L306Azoxystrobin131860-33-8

474354610/09/20 18:22---ug/L< 0.050.05---L306Baygon2023

474354610/09/20 18:22---ug/L< 0.050.05---L306Bendiocarb22781-23-3

474354610/09/20 18:22---ug/L< 0.050.05---L306Bensulide741-58-2



474354610/09/20 18:22---ug/L< 0.050.05---L306Carbaryl2021

474354610/09/20 18:22---ug/L< 0.050.05---L306Carbofuran2046

474354610/09/20 18:22---ug/L< 0.050.05---L306Clomazone81777-89-1

474354610/09/20 18:22---ug/L< 0.050.05---L306Diflubenzuron2291

474354610/09/20 18:22---ug/L0.070.05---L306Diuron2103

474354610/09/20 18:22---ug/L< 0.050.05---L306Fenuron101-42-8

474354610/09/20 18:22---ug/L< 0.050.05---L306Fluometuron2164-17-2

474354610/09/20 18:22---ug/L< 0.050.05---L306Halofenozide112226-61-6

474354610/09/20 18:22---ug/L< 0.050.05---L306Halosulfuron methyl100784-20-1

474354610/09/20 18:22---ug/L< 0.050.05---L306Imidacloprid138261-41-3

474354610/09/20 18:22---ug/L< 0.50.5---L306Linuron2283

474354610/09/20 18:22---ug/L< 0.050.05---L306Metalaxyl/Metalaxyl-M (Mefenoxam)---

474354610/09/20 18:22---ug/L< 0.050.05---L306Methiocarb2024

474354610/09/20 18:22---ug/L< 0.050.05---L306Methomyl2022

474354610/09/20 18:22---ug/L< 0.050.05---L306MonuronMONU

474354610/09/20 18:22---ug/L< 0.050.05---L306Neburon555-37-3

474354610/09/20 18:22---ug/L< 0.50.5---L306Oryzalin19044-88-3

474354610/09/20 18:22---ug/L< 0.050.05---L306Oxadiazon19666-30-9

474354610/09/20 18:22---ug/L< 0.50.5---L306Oxamyl2036

474354610/09/20 18:22---ug/L< 0.050.05---L306Paclobutrazol76738-62-0

474354610/09/20 18:22---ug/L< 0.050.05---L306Propanil2289

474354610/09/20 18:22---ug/L< 0.050.05---L306Propargite2312-35-8

474354610/09/20 18:22---ug/L< 0.050.05---L306Siduron, Total2301

474354610/09/20 18:22---ug/L< 0.050.05---L306Tebuthiuron2271

474354610/09/20 18:22---ug/L< 0.050.05---L306Thidiazuron2303

474354610/09/20 18:22---ug/L< 0.050.05---L306Triadimefon43121-43-3

474354610/09/20 18:22---ug/L< 0.050.05---L306Triadimenol55219-65-3

474354610/09/20 18:22---ug/L< 0.050.05---L3063-Hydroxycarbofuran2066

474353310/09/20 20:19---ug/L< 0.50.5---L520Acrylamide2265

474353310/09/20 20:19---ug/L< 0.50.5---L520Aniline62-53-3

474353310/09/20 20:19---ug/L< 1.01.0---L520Urethane51-79-6

474354010/14/20 06:3210/13/20 06:30ng/L< 2.02.0---L40210:2 Fluorotelomer sulfonic acid (10:2 FTS)120226-60-0

474354010/14/20 06:3210/13/20 06:30ng/L< 2.02.0---L4024:2 Fluorotelomer sulfonic acid (4:2 FTS)2821



474354010/14/20 06:3210/13/20 06:30ng/L< 2.02.0---L402ADONA2815

474354010/14/20 06:3210/13/20 06:30ng/L< 2.02.0---L4029Cl-PF3ONS/F-53B Major2814

474354010/14/20 06:3210/13/20 06:30ng/L< 2.02.0---L40211Cl-PF3OUdS/F-53B Minor2813

474354010/14/20 06:3210/13/20 06:30ng/L< 5.05.0---L402HFPO-DA/GenX2816

474354010/14/20 06:3210/13/20 06:30ng/L< 2.02.0---L402N-ethylperfluorooctane sulfonamide (NEtFOSA)4151-50-2

474354010/14/20 06:3210/13/20 06:30ng/L< 2.02.0---L402N-ethylperfluorooctane sulfonamidoethanol1691-99-2

474354010/14/20 06:3210/13/20 06:30ng/L< 2.02.0---L402N-methylperfluorooctane sulfonamide (NMeFOSA)31506-32-8

474354010/14/20 06:3210/13/20 06:30ng/L< 2.02.0---L402N-methylperfluorooctane sulfonamidoethanol24448-09-7

474354010/14/20 06:3210/13/20 06:30ng/L2.92.0---L402Perfluorobutanesulfonic acid (PFBS)2801

474354010/14/20 06:3210/13/20 06:30ng/L8.05.0---L402Perfluorobutanoic acid (PFBA)2819

474354010/14/20 06:3210/13/20 06:30ng/L< 2.02.0---L402Perfluorodecanoic acid (PFDA)2807

474354010/14/20 06:3210/13/20 06:30ng/L2.62.0---L402Perfluoroheptanoic acid (PFHpA)2802

474354010/14/20 06:3210/13/20 06:30ng/L2.72.0---L402Perfluorohexanesulfonic acid (PFHxS)2803

474354010/14/20 06:3210/13/20 06:30ng/L4.92.0---L402Perfluorohexanoic acid (PFHxA)2809

474354010/14/20 06:3210/13/20 06:30ng/L< 2.02.0---L402Perfluorododecanoic acid (PFDoA)2808

474354010/14/20 06:3210/13/20 06:30ng/L< 2.02.0---L402Perfluorononanoic acid (PFNA)2804

474354010/14/20 06:3210/13/20 06:30ng/L7.52.0---L402Perfluorooctanesulfonic acid (PFOS)6909

474354010/14/20 06:3210/13/20 06:30ng/L< 2.02.0---L402N-ethyl Perfluorooctanesulfonamidoacetic acid2817

474354010/14/20 06:3210/13/20 06:30ng/L< 2.02.0---L402N-methyl Perfluorooctanesulfonamidoacetic acid2818



474354010/14/20 06:3210/13/20 06:30ng/L4.32.0---L402Perfluorooctanoic acid (PFOA)6912

474354010/14/20 06:3210/13/20 06:30ng/L< 2.02.0---L402Perfluorotridecanoic acid (PFTrDA)2811

474354010/14/20 06:3210/13/20 06:30ng/L< 2.02.0---L402Perfluoroundecanoic acid (PFUnA)2812

474354010/14/20 06:3210/13/20 06:30ng/L< 2.02.0---L402Perfluorododecanesulfonic acid (PFDoS)79780-39-5

474354010/14/20 06:3210/13/20 06:30ng/L< 2.02.0---L402Perfluorodecanesulfonic acid (PFDS)335-77-3

474354010/14/20 06:3210/13/20 06:30ng/L< 2.02.0---L402Perfluoroheptanesulfonic acid (PFHpS)2829

474354010/14/20 06:3210/13/20 06:30ng/L< 2.02.0---L402Perfluorohexadecanoic acid (PFHxDA)67905-19-5

474354010/14/20 06:3210/13/20 06:30ng/L< 5.05.0---L402Nonafluoro-3,6-dioxaheptanoic acid (NFDHA)2827

474354010/14/20 06:3210/13/20 06:30ng/L< 5.05.0---L402Perfluoro-4-isopropoxybutanoic acid801212-59-9

474354010/14/20 06:3210/13/20 06:30ng/L< 5.05.0---L402Perfluoro-4-methoxybutanoic acid (PFMBA)2825

474354010/14/20 06:3210/13/20 06:30ng/L< 5.05.0---L402Perfluoro-3-methoxypropanoic acid (PFMPA)2823

474354010/14/20 06:3210/13/20 06:30ng/L< 2.02.0---L402Perfluorononanesulfonic acid (PFNS)68259-12-1

474354010/14/20 06:3210/13/20 06:30ng/L< 2.02.0---L402Perfluorooctane sulfonamide (PFOSA)754-91-6

474354010/14/20 06:3210/13/20 06:30ng/L5.52.0---L402Perfluoropentanoic acid (PFPeA)2824

474354010/14/20 06:3210/13/20 06:30ng/L< 2.02.0---L402Perfluoropentanesulfonic acid (PFPeS)2828

474354010/14/20 06:3210/13/20 06:30ng/L< 2.02.0---L402Perfluorotetradecanoic acid (PFTeDA)2810

Reference Lab Tests

AnalyteID #



Analyzed EEAID #

2063 Dioxin 1613 30 * 5.0 < 5.0 pg/L 10/13/20 00:00 10/15/20 19:50 4743537

55589-62-3 Acesulfame-K LC/MS/MS --- 20 ng/L --- 11/03/20 21:51 4743544

103-90-2 Acetaminophen LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

18559-94-9 Albuterol LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

26787-78-0 Amoxicillin LC/MS/MS --- 20 ng/L --- 11/03/20 21:51 4743544

2705 4-Androstene-3,17-dione LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

29122-68-7 Atenolol LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

2050 Atrazine LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

74-48-3 Bendroflumethiazide LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

41859-67-0 Bezafibrate LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

80-05-7 Bisphenol A LC/MS/MS --- 10 ng/L --- 11/03/20 21:51 4743544

2098 Bromacil LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

77-26-9 Butalbital LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

94-26-8 Butylparaben LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

58-08-2 Caffeine LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

6804-07-5 Carbadox LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

298-46-4 Carbamazepine LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

78-44-4 Carisoprodol LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

56-75-7 Chloramphenicol LC/MS/MS --- 10 ng/L --- 11/03/20 21:51 4743544

1698-60-8 Chloridazon LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

15545-48-9 Chlorotoluron LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

51481-61-9 Cimetidine LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

882-09-7 Clofibric acid LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

486-56-6 Cotinine LC/MS/MS --- 10 ng/L --- 11/03/20 21:51 4743544

2054 Cyanazine LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

2105 2,4-D LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

134-62-3 DEET LC/MS/MS --- 10 ng/L --- 11/03/20 21:51 4743544

67035-22-7 Dehydronifedipine LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

2006 Desethylatrazine LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

2007 Desisopropylatrazine LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

3397-62-4 Diaminochlorotriazine LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

439-14-5 Diazepam LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

15307-86-5 Diclofenac LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

57-41-0 Dilantin LC/MS/MS --- 20 ng/L --- 11/03/20 21:51 4743544



42399-41-7 Diltiazem LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

611-59-6 1,7-Dimethylxanthine LC/MS/MS --- 10 ng/L --- 11/03/20 21:51 4743544

2103 Diuron LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

114-07-8 Erythromycin LC/MS/MS --- 10 ng/L --- 11/03/20 21:51 4743544

2701 17beta-Estradiol LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

2707 Estrone LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

120-47-8 Ethylparaben LC/MS/MS --- 20 ng/L --- 11/03/20 21:51 4743544

2702 17alpha-Ethynyl estradiol LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

42835-25-6 Flumequine LC/MS/MS --- 10 ng/L --- 11/03/20 21:51 4743544

59333-67-4 Fluoxetine (Prozac) LC/MS/MS --- 10 ng/L --- 11/03/20 21:51 4743544

25812-30-0 Gemfibrozil LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

15687-27-1 Ibuprofen LC/MS/MS --- 10 ng/L --- 11/03/20 21:51 4743544

66108-95-0 Iohexal LC/MS/MS --- 10 ng/L --- 11/03/20 21:51 4743544

73334-07-3 Iopromide LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

4247-02-3 Isobutylparaben LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

34123-59-6 Isoproturon LC/MS/MS --- 100 ng/L --- 11/03/20 21:51 4743544

22074-15-4 Ketoprofen LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

74103-06-3 Ketorolac LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

137-58-6 Lidocaine LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

154-21-2 Lincomycin LC/MS/MS --- 10 ng/L --- 11/03/20 21:51 4743544

2283 Linuron LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

51384-51-1 Lopressor LC/MS/MS --- 20 ng/L --- 11/03/20 21:51 4743544

644-62-2 Meclofenamic acid LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

57-53-4 Meprobamate LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

67129-08-2 Metazochlor LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

99-76-3 Methylparaben LC/MS/MS --- 20 ng/L --- 11/03/20 21:51 4743544

2045 Metolachlor LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

22204-53-1 Naproxen LC/MS/MS --- 10 ng/L --- 11/03/20 21:51 4743544

21829-25-4 Nifedipine LC/MS/MS --- 20 ng/L --- 11/03/20 21:51 4743544

104-40-5 4-Nonylphenol LC/MS/MS --- 100 ng/L --- 11/03/20 21:51 4743544

68-22-4 Norethisterone LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

140-66-9 4-tert-Octylphenol LC/MS/MS --- 50 ng/L --- 11/03/20 21:51 4743544

14698-29-4 Oxolinic acid LC/MS/MS --- 10 ng/L --- 11/03/20 21:51 4743544

6493-05-6 Pentoxifylline LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

125-33-7 Primidone LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

57-83-0 Progesterone LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

2256 Propazine LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

94-13-3 Propylparaben LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

91-22-5 Quinoline LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

2037 Simazine LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

56038-13-2 Sucralose LC/MS/MS --- 100 ng/L --- 11/03/20 21:51 4743544

80-32-0 Sulfachloropyridazine LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

68-35-9 Sulfadiazine LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

122-11-2 Sulfadimethoxine LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

127-79-7 Sulfamerazine LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

57-68-1 Sulfamethazine LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

144-82-1 Sulfamethizole LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

723-46-6 Sulfamethoxazole LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

72-14-0 Sulfathiazole LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

2706 Testosterone LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

83-67-0 Theobromine LC/MS/MS --- 10 ng/L --- 11/03/20 21:51 4743544

58-55-9 Theophylline LC/MS/MS --- 20 ng/L --- 11/03/20 21:51 4743544

148-79-8 Thiabendazole LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

101-20-2 Triclocarban LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544



3380-34-5 Triclosan LC/MS/MS --- 10 ng/L --- 11/03/20 21:51 4743544

738-70-5 Trimethoprim LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

13674-87-8 Tris(1,3-dichloro-2-propyl) phosphateLC/MS/MS --- 100 ng/L --- 11/03/20 21:51 4743544

81-81-2 Warfarin LC/MS/MS --- 5.0 ng/L --- 11/03/20 21:51 4743544

1115-70-4 Metformin LC/MS/MS --- 5.00 ng/L --- 11/03/20 21:51 4743544

35572-78-2 2-Amino-4,6-dinitrotoluene 8330A --- 0.6 ug/L --- 10/24/20 17:27 4743530

35572-78-2 4-Amino-2,6-dinitrotoluene 8330A --- 0.6 ug/L --- 10/24/20 17:27 4743530

99-65-0 1,3-Dinitrobenzene 8330A --- 0.6 ug/L --- 10/24/20 17:27 4743530

2270 2,4-Dinitrotoluene 8330A --- 2.0 ug/L --- 10/24/20 17:27 4743530

2266 2,6-Dinitrotoluene 8330A --- 1.3 ug/L --- 10/24/20 17:27 4743530

2691-41-0 HMX (Octahydro-1,3,5,7-tetranitro-1,3,5,7-tetrazocine)8330A --- 2.0 ug/L --- 10/24/20 17:27 4743530

2254 Nitrobenzene 8330A --- 0.6 ug/L --- 10/24/20 17:27 4743530

55-63-0 Nitroglycerin 8330A --- 15 ug/L --- 10/24/20 17:27 4743530

88-72-2 2-Nitrotoluene 8330A --- 0.75 ug/L --- 10/24/20 17:27 4743530



78-11-5 PETN (Pentaerythritol tetranitrate) 8330A --- 18 ug/L --- 10/24/20 17:27 4743530

2096 RDX (Hexahydro-1,3,5-trinitro-1,3,5-triazine)8330A --- 0.5 ug/L --- 10/24/20 17:27 4743530

479-45-8 Tetryl (2,4,6-Trinitrophenylmethylnitramine)8330A --- 0.8 ug/L --- 10/24/20 17:27 4743530

99-35-4 1,3,5-Trinitrobenzene 8330A --- 0.6 ug/L --- 10/24/20 17:27 4743530

118-96-7 2,4,6-Trinitrotoluene 8330A --- 0.6 ug/L --- 10/24/20 17:27 4743530

Reg Limit Type:

Symbol:

MCL SMCL AL

* ^ !

† EEA has demonstrated it can achieve these report limits in reagent water, but can not document them in all sample matrices.



Lab Definitions

Continuing Calibration Check Standard (CCC) / Continuing Calibration Verification (CCV) / Initial Calibration Verification Standard (ICV) / Initial Performance Check (IPC) - is a standard containing one or more of the target analytes that is prepared from the same standards used to calibrate the instrument. This standard is used to verify the calibration curve at the beginning of each analytical sequence, and may also be analyzed throughout and at the end of the sequence. The concentration of continuing standards may be varied, when prescribed by the reference method, so that the range of the calibration curve is verified on a regular basis. CCL, CCM, and CCH are the CCC standards at low, mid, and high concentration levels, respectively.

Internal Standards (IS) - are pure compounds with properties similar to the analytes of interest, which are added to field samples or extracts, calibration standards, and quality control standards at a known concentration. They are used to measure the relative responses of the analytes of interest and surrogates in the sample, calibration standard or quality control standard.

Laboratory Duplicate (LD) - is a field sample aliquot taken from the same sample container in the laboratory and analyzed separately using identical procedures. Analysis of laboratory duplicates provides a measure of the precision of the laboratory procedures.

Laboratory Fortified Blank (LFB) / Laboratory Control Sample (LCS) - is an aliquot of reagent water to which known concentrations of the analytes of interest are added. The LFB is analyzed exactly the same as the field samples. LFBs are used to determine whether the method is in control. FBL, FBM, and FBH are the LFB samples at low, mid, and high concentration levels, respectively.

Laboratory Method Blank (LMB) / Laboratory Reagent Blank (LRB) - is a sample of reagent water included in the sample batch analyzed in the same way as the associated field samples. The LMB is used to determine if method analytes or other background contamination have been introduced during the preparation or analytical procedure. The LMB is analyzed exactly the same as the field samples.

Laboratory Trip Blank (LTB) / Field Reagent Blank (FRB) - is a sample of laboratory reagent water placed in a sample container in the laboratory and treated as a field sample, including storage, preservation, and all analytical procedures. The FRB/LTB container follows the collection bottles to and from the collection site, but the FRB/LTB is not opened at any time during the trip. The FRB/LTB is primarily a travel blank used to verify that the samples were not contaminated during shipment.

If applicable, the calculation of the matrix spike (MS) or matrix spike duplicate (MSD) percent recovery is as follows: (MS or MSD value - Sample value) * 100 / spike target / dilution factor = Recovery %

Matrix Spike Duplicate Sample (MSD) / Laboratory Fortified Sample Matrix Duplicate (LFSMD) - is a sample aliquot taken from the same field sample source as the Matrix Spike Sample to which known quantities of the analytes of interest are added in the laboratory. The MSD is analyzed exactly the same as the field samples. Analysis of the MSD provides a measure of the precision of the laboratory procedures in a specific matrix. SDL, SDM, and SDH / LFSMDL, LFSMDM, and LFSMDH are the MSD or LFSMD at low, mid, and high concentration levels, respectively.

Matrix Spike Sample (MS) / Laboratory Fortified Sample Matrix (LFSM) - is a sample aliquot taken from field sample source to which known quantities of the analytes of interest are added in the laboratory. The MS is analyzed exactly the same as the field samples. The purpose is to demonstrate recovery of the analytes from a sample matrix to determine if the specific matrix contributes bias to the analytical results. MSL, MSM, and MSH / LFSML, LFSMM, and LFSMH are the MS or LFSM at low, mid, and high concentration levels, respectively.

Quality Control Standard (QCS) / Second Source Calibration Verification (SSCV) - is a solution containing known concentrations of the analytes of interest prepared from a source different from the source of the calibration standards. The solution is obtained from a second manufacturer or lot if the lot can be demonstrated by the manufacturer as prepared independently from other lots. The QCS sample is analyzed using the same procedures as field samples. The QCS is used as a check on the calibration standards used in the method on a routine basis.

Reporting Limit Check (RLC) / Initial Calibration Check Standard (ICCS) - is a procedural standard that is analyzed each day to evaluate instrument performance at or below the minimum reporting limit (MRL).

Surrogate Standard (SS) / Surrogate Analyte (SUR) - is a pure compound with properties similar to the analytes of interest, which is highly unlikely to be found in any field sample, that is added to the field samples, calibration standards, blanks and quality control standards before sample preparation. The SS is used to evaluate the efficiency of the sample preparation process.


Laboratory Report

for

Eurofins Eaton Analytical

110 South Hill Street

South Bend, IN 46617-2702

Attention: Karen Fullmer

Fax: 574-233-8207

Project Manager

Date of Issue

11/10/2020

EUROFINS EATON

ANALYTICAL, LLC

TRG6: Shea Greiner

897460

SUBCONTRACT

PPCP

Report:

Project:

Group:

750 Royal Oaks Drive, Suite 100

Monrovia, California 91016-3629

Tel: (626) 386-1100

Fax: (866) 988-3757

1 800 566 LABS (1 800 566 5227)

* Accredited in accordance with TNI 2016 and ISO/IEC 17025:2017.

* Laboratory certifies that the test results meet all TNI 2016 and ISO/IEC 17025:2017 requirements unless noted under the individual analysis.

* Following the cover page are State Certification List, ISO 17025 Accredited Method List, Acknowledgement of Samples Received, Comments, Hits Report,

Data Report, QC Summary, QC Report and Regulatory Forms, as applicable.

* Test results relate only to the sample(s) tested.

* Test results apply to the sample(s) as received, unless otherwise noted in the comments report (ISO/IEC 17025:2017).

* This report shall not be reproduced except in full, without the written approval of the laboratory.

* This report includes ISO/IEC 17025 and non-ISO 17025 accredited methods.

Page 1 of 30 pagesPage 19 of 201

STATE CERTIFICATION LIST

* NELAP/TNI Recognized Accreditation Bodies

State Certification Number State Certification Number

Alabama 41060 Montana Cert 0035

Arizona AZ0778 Nebraska Certified

Arkansas Certified Nevada CA000062018

California 2813 New Hampshire * 2959

Colorado Certified New Jersey * CA 008

Connecticut PH-0107 New Mexico Certified

Delaware CA 006 New York * 11320

Florida * E871024 North Carolina 06701

Georgia 947 North Dakota R-009

Guam 18-005R Oregon * CA200003-005

Hawaii Certified Pennsylvania * 68-565

Idaho Certified Puerto Rico Certified

Illinois * 200033 Rhode Island LAO00326

Indiana C-CA-01 South Carolina 87016

Iowa - Asbestos 413 South Dakota Certified

Kansas * E-10268 Tennessee TN02839

Kentucky 90107 Texas * T104704230-18-15

Louisiana * LA180000 Utah (Primary AB) * CA00006

Maine CA0006 Vermont VT0114

Maryland 224 Virginia * 460260

Commonwealth of Northern Marianas Is.

MP0004 Washington C838

Massachusetts M-CA006 EPA Region 5 Certified

Michigan 9906 Los Angeles County Sanitation Districts

10264

Mississippi Certified


ISO/IEC 17025 Accredited Method List

SPECIFIC TESTS METHOD OR

TECHNIQUE USED

Environ-

mental

(Drinking

Water)

Environ-

mental

(Waste

Water)

Water as a

Component of Food

and Bev/Bev/

Bottled Water

SPECIFIC TESTS METHOD OR

TECHNIQUE USED

Environ-

mental

(Drinking

Water)

Environ-

mental

(Waste

Water)

Water as a

Component of Food

and Bev/Bev/

Bottled Water

1,2,3-TCP (5 PPT & 0.5

PPT)CA SRL 524M-TCP x x Hexavalent Chromium EPA 218.7 x x

1,4-Dioxane EPA 522 x x Hexavalent Chromium SM 3500-Cr B x

2,3,7,8-TCDD Modified EPA 1613B x x Hormones EPA 539 x x

Acrylamide In House Method (2440) x x Hydroxide as OH Calc. SM 2330B x x

Algal Toxins/Microcystin In House Method (3570) Kjeldahl Nitrogen EPA 351.2 x

Alkalinity SM 2320B x x x Legionella Legiolert x x

Ammonia EPA 350.1 x x Mercury EPA 200.8 x x

Ammonia SM 4500-NH3 H x x Metals EPA 200.7 / 200.8 x x x

Anions and DBPs by IC EPA 300.0 x x x Microcystin LR ELISA (2360) x x

Anions and DBPs by IC EPA 300.1 x x Microcystin, Total EPA 546 x x

Asbestos EPA 100.2 x x NDMAEEA/Agilent 521.1

In house method (2425)x x

BOD / CBOD SM 5210B x x Nitrate/Nitrite Nitrogen EPA 353.2 x x x

Bromate In House Method (2447) x x OCL, Pesticides/PCB EPA 505 x x

Carbamates EPA 531.2 x x Ortho Phosphate EPA 365.1 x x x

Carbonate as CO3 SM 2330B x x x Ortho Phosphorous SM 4500P E x x

Carbonyls EPA 556 x xOxyhalides Disinfection

ByproductsEPA 317.0 x x

COD EPA 410.4 / SM 5220D x Perchlorate EPA 331.0 x x

Chloramines SM 4500-CL G x x x Perchlorate (low and high) EPA 314.0 x x

Chlorinated Acids EPA 515.4 x x Perfluorinated Alkyl Acids EPA 537 x x

Chlorinated Acids EPA 555 x x Perfluorinated Polutant In house Method (2434) x x

Chlorine DioxideSM 4500-CLO2 D

Palin Testx x pH EPA 150.1 x

Chlorine -Total/Free/

Combined ResidualSM 4500-Cl G x x x pH SM 4500-H+B x x x

Conductivity EPA 120.1 xPhenylurea Pesticides/

Herbicides

In House Method, based on EPA

532 (2448)x x

Conductivity SM 2510B x x x Pseudomonas IDEXX Pseudalert (2461) x x

Corrosivity (Langelier Index) SM 2330B x x Radium-226 GA Institute of Tech x x

Cyanide, Amenable SM 4500-CN G x x Radium-228 GA Institute of Tech x x

Cyanide, Free SM 4500CN F x x x Radon-222 SM 7500RN x x

Cyanide, Total EPA 335.4 x x x Residue, Filterable SM 2540C x x x

Cyanogen Chloride

(screen)In House Method (2470) x x Residue, Non-filterable SM 2540D x

Diquat and Paraquat EPA 549.2 x x Residue, Total SM 2540B x x

DBP/HAA SM 6251B x x Residue, Volatile EPA 160.4 x

Dissolved Oxygen SM 4500-O G x x Semi-VOC EPA 525.2 x x

DOC SM 5310C x x Silica SM 4500-Si D x x

E. Coli (MTF/EC+MUG) x x Silica SM 4500-SiO2 C x x

E. Coli CFR 141.21(f)(6)(i) x x Sulfide SM 4500-S= D x

E. Coli SM 9223 x Sulfite SM 4500-SO3B x x x

E. Coli (Enumeration) SM 9221B.1/ SM 9221F x x Surfactants SM 5540C x x x

E. Coli (Enumeration) SM 9223B x x Taste and Odor Analytes SM 6040E x x

EDB/DCBP EPA 504.1 x Total Coliform (P/A) SM 9221 A, B x x

EDB/DBCP and DBP EPA 551.1 x xTotal Coliform

(Enumeration)SM 9221 A, B, C x x

EDTA and NTA In House Method (2454) x x Total Coliform / E. coli Colisure SM 9223 x x

Endothall EPA 548.1 x x Total Coliform SM 9221B x

Endothall In-house Method (2445) x x

Total Coliform with Chlorine

PresentSM 9221B x

Enterococci SM 9230B x xTotal Coliform / E.coli (P/A

and Enumeration)SM 9223 x x

Fecal Coliform SM 9221 E (MTF/EC) x TOC SM 5310C x x x

Fecal Coliform SM 9221C, E (MTF/EC) x TOX SM 5320B x

Fecal Coliform

(Enumeration)SM 9221E (MTF/EC) x x Total Phenols EPA 420.1 x

Fecal Coliform with

Chlorine PresentSM 9221E x Total Phenols EPA 420.4 x x x

Fecal Streptococci SM 9230B x x Total Phosphorous SM 4500 P E x

Fluoride SM 4500-F C x x xTriazine Pesticides &

DegradatesIn House (3617) x x

Glyphosate EPA 547 x x Turbidity EPA 180.1 x x x

Glyphosate + AMPA In House Method (3618) x x Turbidity SM 2130B x x

Gross Alpha/Beta EPA 900.0 x x x Uranium by ICP/MS EPA 200.8 x x

Gross Alpha Coprecipitation SM 7110 C x x x UV 254 SM 5910B x

Hardness SM 2340B x x x VOC EPA 524.2 x x

Heterotrophic Bacteria In House Method (2439) x x VOC In House Method (2411) x x

Heterotrophic Bacteria SM 9215 B x x Yeast and Mold SM 9610 x x

Hexavalent Chromium EPA 218.6 x x x Field Sampling N/A

The tests listed below are accredited and meet the requirements of ISO/IEC 17025 as verified by the ANSI-ASQ National Accreditation Board/A2LA.

Refer to Certificate and scope of accreditation (5890) found at: https://www.eurofinsus.com/Eaton

750 Royal Oaks Dr., Ste 100, Monrovia, CA 91016 Tel (626) 386-1100 Fax (866) 988-3757 https://www.eurofinsus.com/Eaton Version 006 Issued: 05/04/20


Acknowledgement of Samples Received

EEA-SOUTHBEND

897460

SUBCONTRACT

PPCP

Client ID:

Folder #:

Project:

Sample Group:

Addr: Eurofins Eaton Analytical



Project Manager:

Phone:

Shea Greiner

(720) 491-1749

Attn:

Phone:

Karen Fullmer

800-332-4345

The following samples were received from you on October 09, 2020 at 1224. They have been scheduled for the tests

listed below each sample. If this information is incorrect, please contact your service representative. Thank you for

using Eurofins Eaton Analytical, LLC.

Sample # Sample ID Sample Date

202010090419 10/06/2020 10474743544

@DX_ABI_NEG @DX_ABI_POS

@DX_ABI_NEG -- Endocrine Disruptors Negative Mode - SPE

@DX_ABI_POS -- Endocrine Disruptors Positive Mode - SPE

Test Description

Reported: 11/10/2020 Page 1 of 1

750 Royal Oaks Drive, Suite 100, Monrovia, CA 91016 Tel (626) 386-1100 Fax (866) 988-3757 www.EurofinsUS.com/Eaton




Laboratory Comments


Karen Fullmer



Tel: (626) 386-1100

Fax: (866) 988-3757

1 800 566 LABS (1 800 566 5227)

897460

SUBCONTRACT

PPCP

Report:

Project:

Group:

Due to instrument issues the analysis was performed outside of the laboratory established

holding time for this in house method. Analytes have been shown to be stable for up to 90

days.

S. Greiner

11/09/2020

Folder Comments

Flags Legend:

EH - Only qualitative identification of the analyte is possible to due to analyte instability thus not meeting QA

acceptance limits. Analyte result is reported as an estimated concentration.

H1 - Sample analysis performed past holding time.

R7 - LFB/LFBD RPD exceeded the laboratory acceptance limit. Recovery met acceptance criteria.

Comments - Page 1 of 1The Comments Report may be blank if there are no comments for this report.


Laboratory Hits

Samples Received on:

10/09/2020 1224


Karen Fullmer



Tel: (626) 386-1100

Fax: (866) 988-3757

1 800 566 LABS (1 800 566 5227)

897460

SUBCONTRACT

PPCP

Report:

Project:

Group:

Analyzed Analyte Result Units MRLFederal MCLSample ID

202010090419 4743544

11/05/2020 17:40 Acesulfame-K ng/L46 20

11/03/2020 21:51 Atrazine ng/L24 5.0

11/03/2020 21:51 DEA ng/L6.2 5.0

11/03/2020 21:51 DEET ng/L21 10

11/03/2020 21:51 Diuron ng/L82 5.0

11/05/2020 17:40 Iohexol ng/L21 20

11/05/2020 17:40 Sucralose ng/L430 100

Hits Report - Page 1 of 1SUMMARY OF POSITIVE DATA ONLY


Laboratory Data


Karen Fullmer



Tel: (626) 386-1100

Fax: (866) 988-3757

1 800 566 LABS (1 800 566 5227)


10/09/2020 1224

897460

SUBCONTRACT

PPCP

Report:

Project:

Group:

Prepped Analyzed Analytical Batch Method Analyte Result Units MRL DilutionPrep Batch

4743544 (202010090419) Sampled on 10/06/2020 1047

LC-MS-MS - Endocrine Disruptors Positive Mode - SPE

1285365 1,7-Dimethylxanthine ng/L(LC-MS-MS) 5.0 1ND (H1)11/03/20 21:51

1285365 Acetaminophen ng/L(LC-MS-MS) 10 1ND (H1)11/03/20 21:51

1285365 Albuterol ng/L(LC-MS-MS) 5.0 1ND (H1)11/03/20 21:51

1285365 Amoxicillin (semi-quantitative) ng/L(LC-MS-MS) 20 1ND (H1)11/03/20 21:51

1285365 Andorostenedione ng/L(LC-MS-MS) 10 1ND (H1)11/03/20 21:51

1285365 Atenolol ng/L(LC-MS-MS) 5.0 1ND (H1)11/03/20 21:51

1285365 Atrazine ng/L(LC-MS-MS) 5.0 124 (H1)11/03/20 21:51

1285365 Bezafibrate ng/L(LC-MS-MS) 5.0 1ND (H1)11/03/20 21:51

1285365 Bromacil ng/L(LC-MS-MS) 5.0 1ND (H1)11/03/20 21:51

1285365 Caffeine ng/L(LC-MS-MS) 10 1ND (H1)11/03/20 21:51

1285365 Carbadox ng/L(LC-MS-MS) 5.0 1ND (H1)11/03/20 21:51

1285365 Carbamazepine ng/L(LC-MS-MS) 5.0 1ND (H1)11/03/20 21:51

1285365 Carisoprodol ng/L(LC-MS-MS) 5.0 1ND (H1)11/03/20 21:51

1285365 Chloridazon ng/L(LC-MS-MS) 5.0 1ND (H1)11/03/20 21:51

1285365 Chlorotoluron ng/L(LC-MS-MS) 5.0 1ND (H1)11/03/20 21:51

1285660 Cimetidine (semi quantitative) ng/L(LC-MS-MS) 50 10ND (H1)11/04/20 08:32

1285365 Cotinine ng/L(LC-MS-MS) 10 1ND (H1)11/03/20 21:51

1285365 DACT ng/L(LC-MS-MS) 20 1ND (H1)11/03/20 21:51

1285365 DEA ng/L(LC-MS-MS) 5.0 16.2 (H1)11/03/20 21:51

1285365 DEET ng/L(LC-MS-MS) 10 121 (H1)11/03/20 21:51

1285365 Dehydronifedipine ng/L(LC-MS-MS) 5.0 1ND (H1)11/03/20 21:51

1285365 DIA ng/L(LC-MS-MS) 5.0 1ND (H1)11/03/20 21:51

1285365 Diazepam ng/L(LC-MS-MS) 5.0 1ND (H1)11/03/20 21:51

1285365 Dilantin ng/L(LC-MS-MS) 20 1ND (H1)11/03/20 21:51

1285365 Diltiazem ng/L(LC-MS-MS) 5.0 1ND (H1)11/03/20 21:51

1285365 Diuron ng/L(LC-MS-MS) 5.0 182 (H1)11/03/20 21:51

1285365 Erythromycin ng/L(LC-MS-MS) 10 1ND (EH,H1)11/03/20 21:51

1285365 Flumeqine ng/L(LC-MS-MS) 20 1ND (H1)11/03/20 21:51

1285365 Fluoxetine ng/L(LC-MS-MS) 10 1ND (H1)11/03/20 21:51

1285365 Isoproturon ng/L(LC-MS-MS) 20 1ND (H1)11/03/20 21:51

1285365 Ketoprofen ng/L(LC-MS-MS) 5.0 1ND (H1)11/03/20 21:51

1285365 Ketorolac ng/L(LC-MS-MS) 5.0 1ND (H1)11/03/20 21:51

1285365 Lidocaine ng/L(LC-MS-MS) 5.0 1ND (H1,R7)11/03/20 21:51

1285365 Lincomycin ng/L(LC-MS-MS) 10 1ND (H1)11/03/20 21:51

Data Report - Page 1 of 3

Rounding on totals after summation.

(c) - indicates calculated results. Analysis is a calculated result. Reported results are not rounded until the

final step before reporting. Therefore methods that use a test result with further calculation may have slight

differences in final result than the component analyses.


Laboratory Data


Karen Fullmer



Tel: (626) 386-1100

Fax: (866) 988-3757

1 800 566 LABS (1 800 566 5227)


10/09/2020 1224

897460

SUBCONTRACT

PPCP

Report:

Project:

Group:


1285365 Linuron ng/L(LC-MS-MS) 5.0 1ND (H1)11/03/20 21:51

1285365 Lopressor ng/L(LC-MS-MS) 20 1ND (H1)11/03/20 21:51

1285365 Meclofenamic Acid ng/L(LC-MS-MS) 20 1ND (H1)11/03/20 21:51

1285365 Meprobamate ng/L(LC-MS-MS) 5.0 1ND (H1)11/03/20 21:51

1285365 Metazachlor ng/L(LC-MS-MS) 5.0 1ND (H1)11/03/20 21:51

1285365 Metformin ng/L(LC-MS-MS) 20 1ND (H1)11/03/20 21:51

1285365 Metolachlor ng/L(LC-MS-MS) 5.0 1ND (H1)11/03/20 21:51

1285365 Nifedipine (semi quantitative) ng/L(LC-MS-MS) 20 1ND (H1)11/03/20 21:51

1285365 Norethisterone ng/L(LC-MS-MS) 10 1ND (H1)11/03/20 21:51

1285365 OUST (Sulfometuron,methyl) ng/L(LC-MS-MS) 5.0 1ND (H1)11/03/20 21:51

1285365 Oxolinic acid ng/L(LC-MS-MS) 10 1ND (H1)11/03/20 21:51

1285365 Pentoxifylline ng/L(LC-MS-MS) 5.0 1ND (H1)11/03/20 21:51

1285365 Phenazone ng/L(LC-MS-MS) 5.0 1ND (H1)11/03/20 21:51

1285365 Primidone ng/L(LC-MS-MS) 5.0 1ND (H1)11/03/20 21:51

1285365 Progesterone ng/L(LC-MS-MS) 10 1ND (H1)11/03/20 21:51

1285365 Propazine ng/L(LC-MS-MS) 5.0 1ND (H1)11/03/20 21:51

1285365 Quinoline ng/L(LC-MS-MS) 20 1ND (H1)11/03/20 21:51

1285365 Simazine ng/L(LC-MS-MS) 5.0 1ND (H1)11/03/20 21:51

1285365 Sulfachloropyridazine ng/L(LC-MS-MS) 5.0 1ND (H1)11/03/20 21:51

1285365 Sulfadiazine ng/L(LC-MS-MS) 5.0 1ND (H1)11/03/20 21:51

1285365 Sulfadimethoxine ng/L(LC-MS-MS) 5.0 1ND (H1)11/03/20 21:51

1285365 Sulfamerazine ng/L(LC-MS-MS) 5.0 1ND (H1)11/03/20 21:51

1285365 Sulfamethazine ng/L(LC-MS-MS) 5.0 1ND (H1)11/03/20 21:51

1285365 Sulfamethizole ng/L(LC-MS-MS) 5.0 1ND (H1)11/03/20 21:51

1285365 Sulfamethoxazole ng/L(LC-MS-MS) 5.0 1ND (H1)11/03/20 21:51

1285365 Sulfathiazole ng/L(LC-MS-MS) 5.0 1ND (H1)11/03/20 21:51

1285365 TCEP ng/L(LC-MS-MS) 10 1ND (H1)11/03/20 21:51

1285365 TCPP ng/L(LC-MS-MS) 200 1ND (H1)11/03/20 21:51

1285365 TDCPP ng/L(LC-MS-MS) 100 1ND (H1)11/03/20 21:51

1285365 Testosterone ng/L(LC-MS-MS) 10 1ND (H1)11/03/20 21:51

1285365 Theobromine ng/L(LC-MS-MS) 50 1ND (H1)11/03/20 21:51

1285365 Theophylline (semi-quantitative) ng/L(LC-MS-MS) 10 1ND (H1)11/03/20 21:51

1285365 Thiabendazole ng/L(LC-MS-MS) 5.0 1ND (H1)11/03/20 21:51

1285365 Trimethoprim ng/L(LC-MS-MS) 5.0 1ND (H1)11/03/20 21:51

LC-MS-MS - Endocrine Disruptors Negative Mode - SPE

1285998 2,4-D ng/L(LC-MS-MS) 50 1ND (H1)11/05/20 17:40

1285998 4-nonylphenol - semi quantitative ng/L(LC-MS-MS) 400 1ND (H1)11/05/20 17:40







Laboratory Data


Karen Fullmer



Tel: (626) 386-1100

Fax: (866) 988-3757

1 800 566 LABS (1 800 566 5227)


10/09/2020 1224

897460

SUBCONTRACT

PPCP

Report:

Project:

Group:


1285998 4-tert-Octylphenol ng/L(LC-MS-MS) 25 1ND (H1)11/05/20 17:40

1285998 Acesulfame-K ng/L(LC-MS-MS) 20 146 (H1)11/05/20 17:40

1285998 Bendroflumethiazide ng/L(LC-MS-MS) 10 1ND (H1)11/05/20 17:40

1285998 BPA ng/L(LC-MS-MS) 10 1ND (H1)11/05/20 17:40

1285998 Butalbital ng/L(LC-MS-MS) 10 1ND (H1)11/05/20 17:40

1285998 Butylparaben ng/L(LC-MS-MS) 5.0 1ND (H1)11/05/20 17:40

1285998 Chloramphenicol ng/L(LC-MS-MS) 10 1ND (H1)11/05/20 17:40

1285998 Clofibric Acid ng/L(LC-MS-MS) 5.0 1ND (H1)11/05/20 17:40

1285998 Diclofenac ng/L(LC-MS-MS) 5.0 1ND (H1)11/05/20 17:40

1285998 Estradiol ng/L(LC-MS-MS) 10 1ND (H1)11/05/20 17:40

1285998 Estriol ng/L(LC-MS-MS) 10 1ND (H1)11/05/20 17:40

1285998 Estrone ng/L(LC-MS-MS) 10 1ND (H1)11/05/20 17:40

1285998 Ethinyl Estradiol - 17 alpha ng/L(LC-MS-MS) 10 1ND (H1)11/05/20 17:40

1285998 Ethylparaben ng/L(LC-MS-MS) 20 1ND (H1)11/05/20 17:40

1285998 Gemfibrozil ng/L(LC-MS-MS) 5.0 1ND (H1)11/05/20 17:40

1285998 Ibuprofen ng/L(LC-MS-MS) 25 1ND (H1)11/05/20 17:40

1285998 Iohexol ng/L(LC-MS-MS) 20 121 (H1)11/05/20 17:40

1285998 Iopromide ng/L(LC-MS-MS) 10 1ND (H1)11/05/20 17:40

1285998 Isobutylparaben ng/L(LC-MS-MS) 10 1ND (H1)11/05/20 17:40

1285998 Methylparaben ng/L(LC-MS-MS) 20 1ND (H1)11/05/20 17:40

1285998 Naproxen ng/L(LC-MS-MS) 20 1ND (H1)11/05/20 17:40

1285998 Propylparaben ng/L(LC-MS-MS) 5.0 1ND (H1)11/05/20 17:40

1285998 Salicylic Acid ng/L(LC-MS-MS) 200 1ND (H1)11/05/20 17:40

1285998 Sucralose ng/L(LC-MS-MS) 100 1430 (H1)11/05/20 17:40

1285998 Triclocarban ng/L(LC-MS-MS) 50 1ND (EH,H1)11/05/20 17:40

1285998 Triclosan ng/L(LC-MS-MS) 25 1ND (H1)11/05/20 17:40

1285998 Warfarin ng/L(LC-MS-MS) 5.0 1ND (H1)11/05/20 17:40







Laboratory QC Summary


Tel: (626) 386-1100

Fax: (866) 988-3757

1 800 566 LABS (1 800 566 5227)

897460

SUBCONTRACT

PPCP

Report:

Project:

Group:

Endocrine Disruptors Positive Mode - SPE

Analysis Date: 11/03/2020Analytical Batch: 1285365

4743544202010090419 Analyzed by: GG8Y

Endocrine Disruptors Positive Mode - SPE


4743544202010090419 Analyzed by: GG8Y

Endocrine Disruptors Negative Mode - SPE


4743544202010090419 Analyzed by: GG8Y

QC Summary - Page 1 of 1


Laboratory QC


QC Type Analyte Spiked Limits (%)Recovered Units Yield(%)NativeRPD

Limit(%) RPD%

Tel: (626) 386-1100

Fax: (866) 988-3757

1 800 566 LABS (1 800 566 5227)

897460

SUBCONTRACT

PPCP

Report:

Project:

Group:

Endocrine Disruptors Positive Mode - SPE by LC-MS-MS


LCS1 1,7-Dimethylxanthine 100 97.1 ng/L 97 (60-140)

LCS2 1,7-Dimethylxanthine 100 118 ng/L 119 (60-140) 2030

MBLK 1,7-Dimethylxanthine <5 ng/L

MRL_CHK 1,7-Dimethylxanthine 5 3.99 ng/L 80 (50-150)

MS_202010070501 1,7-Dimethylxanthine 100 106 ng/L 106 (60-140)ND

MSD_202010070501 1,7-Dimethylxanthine 100 120 ng/L 120 (60-140) 13ND 40

LCS1 Acetaminophen 100 116 ng/L 116 (60-140)

LCS2 Acetaminophen 100 108 ng/L 109 (60-140) 6.230

MBLK Acetaminophen <10 ng/L

MRL_CHK Acetaminophen 5 5.43 ng/L 109 (50-150)

MS_202010070501 Acetaminophen 100 99.0 ng/L 99 (60-140)ND

MSD_202010070501 Acetaminophen 100 158 ng/L 158 (60-140) 46ND 40

LCS1 Albuterol 100 124 ng/L 124 (60-140)

LCS2 Albuterol 100 110 ng/L 110 (60-140) 1230

MBLK Albuterol <5 ng/L

MRL_CHK Albuterol 5 6.38 ng/L 128 (50-150)

MS_202010070501 Albuterol 100 110 ng/L 110 (60-140)ND

MSD_202010070501 Albuterol 100 109 ng/L 109 (60-140) 1.2ND 40

LCS1 Amoxicillin (semi-quantitative) 400 430 ng/L 107 (60-140)

LCS2 Amoxicillin (semi-quantitative) 400 406 ng/L 102 (60-140) 5.730

MBLK Amoxicillin (semi-quantitative) <20 ng/L

MRL_CHK Amoxicillin (semi-quantitative) 20 22.1 ng/L 111 (50-150)

MS_202010070501 Amoxicillin (semi-quantitative) 400 420 ng/L 105 (60-140)ND

MSD_202010070501 Amoxicillin (semi-quantitative) 400 489 ng/L 122 (60-140) 15ND 40

LCS1 Andorostenedione 100 84.0 ng/L 84 (60-140)

LCS2 Andorostenedione 100 95.2 ng/L 95 (60-140) 1330

MBLK Andorostenedione <5 ng/L

MRL_CHK Andorostenedione 5 5.48 ng/L 110 (50-150)

MS_202010070501 Andorostenedione 100 89.8 ng/L 90 (60-140)ND

MSD_202010070501 Andorostenedione 100 80.6 ng/L 81 (60-140) 11ND 40

LCS1 Atenolol 100 99.0 ng/L 99 (60-140)

LCS2 Atenolol 100 93.6 ng/L 94 (60-140) 5.630

MBLK Atenolol <5 ng/L

MRL_CHK Atenolol 5 5.98 ng/L 120 (50-150)

MS_202010070501 Atenolol 100 136 ng/L 136 (60-140)ND

QC Report - Page 1 of 18

Spike recovery is already corrected for native results.

Spikes which exceed Limits and Method Blanks with positive results are highlighted by Underlining.

Criteria for MS and Dup are advisory only, batch control is based on LCS. Criteria for duplicates are advisory only, unless otherwise specified in the method.

RPD not calculated for LCS2 when different a concentration than LCS1 is used.

RPD not calculated for Duplicates when the result is not five times the MRL (Minimum Reporting Level).

(S) - Indicates surrogate compound.

(I) - Indicates internal standard compound.


Laboratory QC



Limit(%) RPD%

Tel: (626) 386-1100

Fax: (866) 988-3757

1 800 566 LABS (1 800 566 5227)

897460

SUBCONTRACT

PPCP

Report:

Project:

Group:

MSD_202010070501 Atenolol 100 111 ng/L 111 (60-140) 20ND 40

LCS1 Atrazine 100 109 ng/L 109 (60-140)

LCS2 Atrazine 100 107 ng/L 107 (60-140) 1.930

MBLK Atrazine <5 ng/L

MRL_CHK Atrazine 5 4.54 ng/L 91 (50-150)

MS_202010070501 Atrazine 100 105 ng/L 105 (60-140)ND

MSD_202010070501 Atrazine 100 99.8 ng/L 100 (60-140) 5.1ND 40

LCS1 Bezafibrate 100 97.8 ng/L 98 (60-140)

LCS2 Bezafibrate 100 98.2 ng/L 98 (60-140) 0.4130

MBLK Bezafibrate <5 ng/L

MRL_CHK Bezafibrate 5 5.31 ng/L 106 (50-150)

MS_202010070501 Bezafibrate 100 89.8 ng/L 90 (60-140)ND

MSD_202010070501 Bezafibrate 100 86.9 ng/L 87 (60-140) 3.3ND 40

LCS1 Bromacil 100 100 ng/L 101 (60-140)

LCS2 Bromacil 100 78.2 ng/L 78 (60-140) 2530

MBLK Bromacil <5 ng/L

MRL_CHK Bromacil 5 4.82 ng/L 96 (50-150)

MS_202010070501 Bromacil 100 82.8 ng/L 72 (60-140)11

MSD_202010070501 Bromacil 100 90.2 ng/L 80 (60-140) 8.511 40

LCS1 Caffeine 100 105 ng/L 105 (60-140)

LCS2 Caffeine 100 115 ng/L 115 (60-140) 9.130

MBLK Caffeine <10 ng/L

MRL_CHK Caffeine 5 5.02 ng/L 100 (50-150)

MS_202010070501 Caffeine 100 125 ng/L 106 (60-140)20

MSD_202010070501 Caffeine 100 104 ng/L 85 (60-140) 1720 40

LCS1 Carbadox 100 100 ng/L 100 (60-140)

LCS2 Carbadox 100 90.8 ng/L 91 (60-140) 9.630

MBLK Carbadox <5 ng/L

MRL_CHK Carbadox 5 4.70 ng/L 94 (50-150)

MS_202010070501 Carbadox 100 62.6 ng/L 63 (60-140)ND

MSD_202010070501 Carbadox 100 114 ng/L 114 (60-140) 58ND 40

LCS1 Carbamazepine 100 100 ng/L 100 (60-140)

LCS2 Carbamazepine 100 95.9 ng/L 96 (60-140) 4.230

MBLK Carbamazepine <5 ng/L

MRL_CHK Carbamazepine 5 5.55 ng/L 111 (50-150)

MS_202010070501 Carbamazepine 100 98.2 ng/L 98 (60-140)ND

MSD_202010070501 Carbamazepine 100 90.0 ng/L 90 (60-140) 8.8ND 40

LCS1 Carisoprodol 100 69.6 ng/L 70 (60-140)










Laboratory QC



Limit(%) RPD%

Tel: (626) 386-1100

Fax: (866) 988-3757

1 800 566 LABS (1 800 566 5227)

897460

SUBCONTRACT

PPCP

Report:

Project:

Group:

LCS2 Carisoprodol 100 75.2 ng/L 75 (60-140) 7.730

MBLK Carisoprodol <5 ng/L

MRL_CHK Carisoprodol 5 5.06 ng/L 101 (50-150)

MS_202010070501 Carisoprodol 100 87.9 ng/L 88 (60-140)ND

MSD_202010070501 Carisoprodol 100 103 ng/L 103 (60-140) 16ND 40

LCS1 Chloridazon 100 90.9 ng/L 91 (60-140)

LCS2 Chloridazon 100 91.6 ng/L 92 (60-140) 0.7730

MBLK Chloridazon <5 ng/L

MRL_CHK Chloridazon 5 5.36 ng/L 107 (50-150)

MS_202010070501 Chloridazon 100 69.2 ng/L 69 (60-140)ND

MSD_202010070501 Chloridazon 100 71.7 ng/L 72 (60-140) 3.5ND 40

LCS1 Chlorotoluron 100 80.9 ng/L 81 (60-140)

LCS2 Chlorotoluron 100 85.2 ng/L 85 (60-140) 5.230

MBLK Chlorotoluron <5 ng/L

MRL_CHK Chlorotoluron 5 5.23 ng/L 105 (50-150)

MS_202010070501 Chlorotoluron 100 91.2 ng/L 91 (60-140)ND

MSD_202010070501 Chlorotoluron 100 90.7 ng/L 91 (60-140) 0.55ND 40

LCS1 Cimetidine 100 116 ng/L 116 (60-140)

LCS2 Cimetidine 100 108 ng/L 108 (60-140) 7.130

MBLK Cimetidine <5 ng/L

MRL_CHK Cimetidine 5 3.54 ng/L 71 (50-150)

MS_202010070501 Cimetidine 100 116 ng/L 116 (60-140)ND

MSD_202010070501 Cimetidine 100 127 ng/L 127 (60-140) 9.2ND 40

LCS1 Cotinine 100 95.6 ng/L 96 (60-140)

LCS2 Cotinine 100 118 ng/L 119 (60-140) 2230

MBLK Cotinine <10 ng/L

MRL_CHK Cotinine 5 5.62 ng/L 112 (50-150)

MS_202010070501 Cotinine 100 84.7 ng/L 70 (60-140)15

MSD_202010070501 Cotinine 100 105 ng/L 90 (60-140) 2115 40

LCS1 DACT 100 126 ng/L 126 (60-140)

LCS2 DACT 100 110 ng/L 111 (60-140) 1330

MBLK DACT <20 ng/L

MRL_CHK DACT 5 6.78 ng/L 136 (50-150)

MS_202010070501 DACT 100 44.5 ng/L 45 (60-140)ND

MSD_202010070501 DACT 100 27.8 ng/L 28 (60-140) 46ND 40

LCS1 DEA 100 99.6 ng/L 100 (60-140)

LCS2 DEA 100 105 ng/L 105 (60-140) 5.330

MBLK DEA <50 ng/L










Laboratory QC



Limit(%) RPD%

Tel: (626) 386-1100

Fax: (866) 988-3757

1 800 566 LABS (1 800 566 5227)

897460

SUBCONTRACT

PPCP

Report:

Project:

Group:

MRL_CHK DEA 5 7.11 ng/L 142 (50-150)

MS_202010070501 DEA 100 75.4 ng/L 75 (60-140)ND

MSD_202010070501 DEA 100 112 ng/L 112 (60-140) 39ND 40

LCS1 DEET 40 42.8 ng/L 107 (60-140)

LCS2 DEET 40 41.7 ng/L 104 (60-140) 2.630

MBLK DEET <10 ng/L

MRL_CHK DEET 8 8.39 ng/L 105 (50-150)

MS_202010070501 DEET 40 107 ng/L 58 (60-140)84

MSD_202010070501 DEET 40 115 ng/L 78 (60-140) 7.584 40

LCS1 Dehydronifedipine 100 96.4 ng/L 96 (60-140)

LCS2 Dehydronifedipine 100 95.1 ng/L 95 (60-140) 1.430

MBLK Dehydronifedipine <5 ng/L

MRL_CHK Dehydronifedipine 5 5.89 ng/L 118 (50-150)

MS_202010070501 Dehydronifedipine 100 150 ng/L 150 (60-140)ND

MSD_202010070501 Dehydronifedipine 100 139 ng/L 139 (60-140) 7.7ND 40

LCS1 DIA 100 106 ng/L 106 (60-140)

LCS2 DIA 100 108 ng/L 108 (60-140) 1.930

MBLK DIA <5 ng/L

MRL_CHK DIA 5 3.76 ng/L 75 (50-150)

MS_202010070501 DIA 100 104 ng/L 104 (60-140)ND

MSD_202010070501 DIA 100 146 ng/L 146 (60-140) 34ND 40

LCS1 Diazepam 100 95.4 ng/L 95 (60-140)

LCS2 Diazepam 100 85.3 ng/L 85 (60-140) 1130

MBLK Diazepam <5 ng/L

MRL_CHK Diazepam 5 5.63 ng/L 113 (50-150)

MS_202010070501 Diazepam 100 96.0 ng/L 96 (60-140)ND

MSD_202010070501 Diazepam 100 96.0 ng/L 96 (60-140) 0.062ND 40

LCS1 Dilantin 400 403 ng/L 101 (60-140)

LCS2 Dilantin 400 405 ng/L 101 (60-140) 0.5030

MBLK Dilantin <20 ng/L

MRL_CHK Dilantin 20 25.9 ng/L 129 (50-150)

MS_202010070501 Dilantin 400 295 ng/L 74 (60-140)ND

MSD_202010070501 Dilantin 400 278 ng/L 69 (60-140) 6.0ND 40

LCS1 Diltiazem 100 90.3 ng/L 90 (60-140)

LCS2 Diltiazem 100 86.1 ng/L 86 (60-140) 4.830

MBLK Diltiazem <5 ng/L

MRL_CHK Diltiazem 5 6.67 ng/L 133 (50-150)

MS_202010070501 Diltiazem 100 77.4 ng/L 77 (60-140)ND










Laboratory QC



Limit(%) RPD%

Tel: (626) 386-1100

Fax: (866) 988-3757

1 800 566 LABS (1 800 566 5227)

897460

SUBCONTRACT

PPCP

Report:

Project:

Group:

MSD_202010070501 Diltiazem 100 95.1 ng/L 95 (60-140) 21ND 40

LCS1 Diuron 100 96.0 ng/L 96 (60-140)

LCS2 Diuron 100 106 ng/L 106 (60-140) 9.930

MBLK Diuron <5 ng/L

MRL_CHK Diuron 5 5.04 ng/L 101 (50-150)

MS_202010070501 Diuron 100 107 ng/L 99 (60-140)8.5

MSD_202010070501 Diuron 100 91.6 ng/L 83 (60-140) 168.5 40

LCS1 Erythromycin 200 263 ng/L 132 (60-140)

LCS2 Erythromycin 200 218 ng/L 109 (60-140) 1930

MBLK Erythromycin <10 ng/L

MRL_CHK Erythromycin 10 14.5 ng/L 145 (50-150)

MS_202010070501 Erythromycin 200 176 ng/L 88 (60-140)ND

MSD_202010070501 Erythromycin 200 178 ng/L 89 (60-140) 1.0ND 40

LCS1 Flumeqine 200 181 ng/L 90 (60-140)

LCS2 Flumeqine 200 186 ng/L 93 (60-140) 2.730

MBLK Flumeqine <10 ng/L

MRL_CHK Flumeqine 10 13.0 ng/L 130 (50-150)

MS_202010070501 Flumeqine 200 185 ng/L 93 (60-140)ND

MSD_202010070501 Flumeqine 200 186 ng/L 93 (60-140) 0.54ND 40

LCS1 Fluoxetine 100 112 ng/L 112 (60-140)

LCS2 Fluoxetine 100 110 ng/L 110 (60-140) 1.830

MBLK Fluoxetine <10 ng/L

MRL_CHK Fluoxetine 5 6.74 ng/L 135 (50-150)

MS_202010070501 Fluoxetine 100 98.4 ng/L 98 (60-140)ND

MSD_202010070501 Fluoxetine 100 97.2 ng/L 97 (60-140) 1.3ND 40

LCS1 Isoproturon 400 398 ng/L 100 (60-140)

LCS2 Isoproturon 400 425 ng/L 106 (60-140) 6.630

MBLK Isoproturon <20 ng/L

MRL_CHK Isoproturon 20 23.8 ng/L 119 (50-150)

MS_202010070501 Isoproturon 400 382 ng/L 96 (60-140)ND

MSD_202010070501 Isoproturon 400 347 ng/L 87 (60-140) 9.6ND 40

LCS1 Ketoprofen 100 100 ng/L 100 (60-140)

LCS2 Ketoprofen 100 108 ng/L 108 (60-140) 7.730

MBLK Ketoprofen <5 ng/L

MRL_CHK Ketoprofen 5 5.70 ng/L 114 (50-150)

MS_202010070501 Ketoprofen 100 77.5 ng/L 78 (60-140)ND

MSD_202010070501 Ketoprofen 100 89.4 ng/L 89 (60-140) 14ND 40

LCS1 Ketorolac 100 108 ng/L 108 (60-140)










Laboratory QC



Limit(%) RPD%

Tel: (626) 386-1100

Fax: (866) 988-3757

1 800 566 LABS (1 800 566 5227)

897460

SUBCONTRACT

PPCP

Report:

Project:

Group:

LCS2 Ketorolac 100 101 ng/L 101 (60-140) 6.730

MBLK Ketorolac <5 ng/L

MRL_CHK Ketorolac 5 7.06 ng/L 141 (50-150)

MS_202010070501 Ketorolac 100 94.8 ng/L 95 (60-140)ND

MSD_202010070501 Ketorolac 100 93.3 ng/L 93 (60-140) 1.6ND 40

LCS1 Lidocaine 100 137 ng/L 137 (60-140)

LCS2 Lidocaine 100 86.5 ng/L 87 (60-140) 4530

MBLK Lidocaine <5 ng/L

MRL_CHK Lidocaine 5 5.04 ng/L 101 (50-150)

MS_202010070501 Lidocaine 100 99.4 ng/L 99 (60-140)ND

MSD_202010070501 Lidocaine 100 86.7 ng/L 87 (60-140) 14ND 40

LCS1 Lincomycin 200 168 ng/L 84 (60-140)

LCS2 Lincomycin 200 220 ng/L 110 (60-140) 2730

MBLK Lincomycin <10 ng/L

MRL_CHK Lincomycin 10 12.5 ng/L 125 (50-150)

MS_202010070501 Lincomycin 200 212 ng/L 106 (60-140)ND

MSD_202010070501 Lincomycin 200 237 ng/L 119 (60-140) 11ND 40

LCS1 Linuron 100 114 ng/L 114 (60-140)

LCS2 Linuron 100 99.5 ng/L 100 (60-140) 1430

MBLK Linuron <5 ng/L

MRL_CHK Linuron 5 5.51 ng/L 110 (50-150)

MS_202010070501 Linuron 100 115 ng/L 115 (60-140)ND

MSD_202010070501 Linuron 100 95.4 ng/L 95 (60-140) 19ND 40

LCS1 Lopressor 400 468 ng/L 117 (60-140)

LCS2 Lopressor 400 417 ng/L 104 (60-140) 1230

MBLK Lopressor <20 ng/L

MRL_CHK Lopressor 20 27.0 ng/L 135 (50-150)

MS_202010070501 Lopressor 400 502 ng/L 126 (60-140)ND

MSD_202010070501 Lopressor 400 393 ng/L 98 (60-140) 25ND 40

LCS1 Meclofenamic Acid 100 85.8 ng/L 86 (60-140)

LCS2 Meclofenamic Acid 100 109 ng/L 109 (60-140) 2430

MBLK Meclofenamic Acid <20 ng/L

MRL_CHK Meclofenamic Acid 5 7.36 ng/L 147 (50-150)

MS_202010070501 Meclofenamic Acid 100 81.3 ng/L 81 (60-140)ND

MSD_202010070501 Meclofenamic Acid 100 79.4 ng/L 79 (60-140) 2.3ND 40

LCS1 Meprobamate 100 84.5 ng/L 85 (60-140)

LCS2 Meprobamate 100 92.9 ng/L 93 (60-140) 9.530

MBLK Meprobamate <5 ng/L










Laboratory QC



Limit(%) RPD%

Tel: (626) 386-1100

Fax: (866) 988-3757

1 800 566 LABS (1 800 566 5227)

897460

SUBCONTRACT

PPCP

Report:

Project:

Group:

MRL_CHK Meprobamate 5 5.81 ng/L 116 (50-150)

MS_202010070501 Meprobamate 100 76.4 ng/L 76 (60-140)ND

MSD_202010070501 Meprobamate 100 84.9 ng/L 85 (60-140) 11ND 40

LCS1 Metazachlor 100 98.6 ng/L 99 (60-140)

LCS2 Metazachlor 100 103 ng/L 103 (60-140) 4.330

MBLK Metazachlor <5 ng/L

MRL_CHK Metazachlor 5 6.25 ng/L 125 (50-150)

MS_202010070501 Metazachlor 100 94.6 ng/L 95 (60-140)ND

MSD_202010070501 Metazachlor 100 83.3 ng/L 83 (60-140) 13ND 40

LCS1 Metformin 100 98.9 ng/L 99 (60-140)

LCS2 Metformin 100 98.6 ng/L 99 (60-140) 0.3030

MBLK Metformin <20 ng/L

MRL_CHK Metformin 20 19.7 ng/L 98 (50-150)

MS_202010070501 Metformin 100 103 ng/L 84 (60-140)ND

MSD_202010070501 Metformin 100 86.5 ng/L 67 (60-140) 18ND 40

LCS1 Metolachlor 100 103 ng/L 103 (60-140)

LCS2 Metolachlor 100 102 ng/L 102 (60-140) 0.9830

MBLK Metolachlor <5 ng/L

MRL_CHK Metolachlor 5 6.13 ng/L 123 (50-150)

MS_202010070501 Metolachlor 100 90.3 ng/L 90 (60-140)ND

MSD_202010070501 Metolachlor 100 92.8 ng/L 93 (60-140) 2.7ND 40

LCS1 Nifedipine 400 450 ng/L 112 (60-140)

LCS2 Nifedipine 400 504 ng/L 126 (60-140) 1130

MBLK Nifedipine <20 ng/L

MRL_CHK Nifedipine 20 20.8 ng/L 104 (50-150)

MS_202010070501 Nifedipine 400 453 ng/L 113 (60-140)ND

MSD_202010070501 Nifedipine 400 405 ng/L 101 (60-140) 11ND 40

LCS1 Norethisterone 100 88.9 ng/L 89 (60-140)

LCS2 Norethisterone 100 91.1 ng/L 91 (60-140) 2.430

MBLK Norethisterone <10 ng/L

MRL_CHK Norethisterone 5 4.59 ng/L 92 (50-150)

MS_202010070501 Norethisterone 100 85.8 ng/L 86 (60-140)ND

MSD_202010070501 Norethisterone 100 95.5 ng/L 96 (60-140) 11ND 40

LCS1 OUST (Sulfameturon,methyl) 100 98.7 ng/L 99 (60-140)

LCS2 OUST (Sulfameturon,methyl) 100 99.0 ng/L 99 (60-140) 0.3030

MBLK OUST (Sulfameturon,methyl) <5 ng/L

MRL_CHK OUST (Sulfameturon,methyl) 5 5.20 ng/L 104 (50-150)

MS_202010070501 OUST (Sulfameturon,methyl) 100 104 ng/L 102 (60-140)ND










Laboratory QC



Limit(%) RPD%

Tel: (626) 386-1100

Fax: (866) 988-3757

1 800 566 LABS (1 800 566 5227)

897460

SUBCONTRACT

PPCP

Report:

Project:

Group:

MSD_202010070501 OUST (Sulfameturon,methyl) 100 106 ng/L 105 (60-140) 2.0ND 40

LCS1 Oxolinic acid 100 91.6 ng/L 92 (60-140)

LCS2 Oxolinic acid 100 92.9 ng/L 93 (60-140) 1.430

MBLK Oxolinic acid <10 ng/L

MRL_CHK Oxolinic acid 5 5.52 ng/L 110 (50-150)

MS_202010070501 Oxolinic acid 100 86.0 ng/L 86 (60-140)ND

MSD_202010070501 Oxolinic acid 100 110 ng/L 111 (60-140) 25ND 40

LCS1 Pentoxifylline 100 91.5 ng/L 92 (60-140)

LCS2 Pentoxifylline 100 91.4 ng/L 91 (60-140) 0.1130

MBLK Pentoxifylline <5 ng/L

MRL_CHK Pentoxifylline 5 5.44 ng/L 109 (50-150)

MS_202010070501 Pentoxifylline 100 80.5 ng/L 81 (60-140)ND

MSD_202010070501 Pentoxifylline 100 98.3 ng/L 98 (60-140) 20ND 40

LCS1 Phenazone 100 99.0 ng/L 99 (60-140)

LCS2 Phenazone 100 101 ng/L 101 (60-140) 2.030

MBLK Phenazone <5 ng/L

MRL_CHK Phenazone 5 4.18 ng/L 84 (50-150)

MS_202010070501 Phenazone 100 79.1 ng/L 79 (60-140)ND

MSD_202010070501 Phenazone 100 82.0 ng/L 82 (60-140) 3.6ND 40

LCS1 Primidone 100 88.1 ng/L 88 (60-140)

LCS2 Primidone 100 99.4 ng/L 99 (60-140) 1230

MBLK Primidone <5 ng/L

MRL_CHK Primidone 5 5.70 ng/L 114 (50-150)

MS_202010070501 Primidone 100 113 ng/L 113 (60-140)ND

MSD_202010070501 Primidone 100 99.2 ng/L 99 (60-140) 13ND 40

LCS1 Progesterone 100 108 ng/L 108 (60-140)

LCS2 Progesterone 100 103 ng/L 103 (60-140) 4.730

MBLK Progesterone <10 ng/L

MRL_CHK Progesterone 5 7.48 ng/L 150 (50-150)

MS_202010070501 Progesterone 100 106 ng/L 106 (60-140)ND

MSD_202010070501 Progesterone 100 113 ng/L 113 (60-140) 6.2ND 40

LCS1 Propazine 100 107 ng/L 107 (60-140)

LCS2 Propazine 100 113 ng/L 113 (60-140) 5.530

MBLK Propazine <5 ng/L

MRL_CHK Propazine 5 5.77 ng/L 115 (50-150)

MS_202010070501 Propazine 100 103 ng/L 103 (60-140)ND

MSD_202010070501 Propazine 100 90.8 ng/L 91 (60-140) 12ND 40

LCS1 Quinoline 100 98.1 ng/L 98 (60-140)










Laboratory QC



Limit(%) RPD%

Tel: (626) 386-1100

Fax: (866) 988-3757

1 800 566 LABS (1 800 566 5227)

897460

SUBCONTRACT

PPCP

Report:

Project:

Group:

LCS2 Quinoline 100 116 ng/L 116 (60-140) 1730

MBLK Quinoline <20 ng/L

MRL_CHK Quinoline 20 16.3 ng/L 82 (50-150)

MS_202010070501 Quinoline 100 125 ng/L 103 (60-140)21

MSD_202010070501 Quinoline 100 107 ng/L 85 (60-140) 1521 40

LCS1 Simazine 100 124 ng/L 124 (60-140)

LCS2 Simazine 100 127 ng/L 127 (60-140) 2.430

MBLK Simazine <5 ng/L

MRL_CHK Simazine 5 3.44 ng/L 69 (50-150)

MS_202010070501 Simazine 100 117 ng/L 113 (60-140)ND

MSD_202010070501 Simazine 100 113 ng/L 109 (60-140) 3.4ND 40

LCS1 Sulfachloropyridazine 100 108 ng/L 108 (60-140)

LCS2 Sulfachloropyridazine 100 112 ng/L 112 (60-140) 3.630

MBLK Sulfachloropyridazine <5 ng/L

MRL_CHK Sulfachloropyridazine 5 6.29 ng/L 126 (50-150)

MS_202010070501 Sulfachloropyridazine 100 99.7 ng/L 100 (60-140)ND

MSD_202010070501 Sulfachloropyridazine 100 92.6 ng/L 93 (60-140) 7.4ND 40

LCS1 Sulfadiazine 100 119 ng/L 119 (60-140)

LCS2 Sulfadiazine 100 116 ng/L 116 (60-140) 2.530

MBLK Sulfadiazine <5 ng/L

MRL_CHK Sulfadiazine 5 5.93 ng/L 119 (50-150)

MS_202010070501 Sulfadiazine 100 129 ng/L 129 (60-140)ND

MSD_202010070501 Sulfadiazine 100 83.2 ng/L 83 (60-140) 43ND 40

LCS1 Sulfadimethoxine 100 111 ng/L 111 (60-140)

LCS2 Sulfadimethoxine 100 104 ng/L 104 (60-140) 6.530

MBLK Sulfadimethoxine <5 ng/L

MRL_CHK Sulfadimethoxine 5 4.51 ng/L 90 (50-150)

MS_202010070501 Sulfadimethoxine 100 89.4 ng/L 89 (60-140)ND

MSD_202010070501 Sulfadimethoxine 100 101 ng/L 101 (60-140) 12ND 40

LCS1 Sulfamerazine 100 117 ng/L 117 (60-140)

LCS2 Sulfamerazine 100 125 ng/L 125 (60-140) 6.630

MBLK Sulfamerazine <5 ng/L

MRL_CHK Sulfamerazine 5 3.96 ng/L 79 (50-150)

MS_202010070501 Sulfamerazine 100 107 ng/L 107 (60-140)ND

MSD_202010070501 Sulfamerazine 100 99.1 ng/L 99 (60-140) 7.8ND 40

LCS1 Sulfamethazine 100 118 ng/L 118 (60-140)

LCS2 Sulfamethazine 100 93.1 ng/L 93 (60-140) 2430

MBLK Sulfamethazine <5 ng/L










Laboratory QC



Limit(%) RPD%

Tel: (626) 386-1100

Fax: (866) 988-3757

1 800 566 LABS (1 800 566 5227)

897460

SUBCONTRACT

PPCP

Report:

Project:

Group:

MRL_CHK Sulfamethazine 5 5.93 ng/L 119 (50-150)

MS_202010070501 Sulfamethazine 100 91.7 ng/L 92 (60-140)ND

MSD_202010070501 Sulfamethazine 100 98.2 ng/L 98 (60-140) 7.0ND 40

LCS1 Sulfamethizole 100 93.5 ng/L 94 (60-140)

LCS2 Sulfamethizole 100 110 ng/L 110 (60-140) 1630

MBLK Sulfamethizole <20 ng/L

MRL_CHK Sulfamethizole 5 4.71 ng/L 94 (50-150)

MS_202010070501 Sulfamethizole 100 92.3 ng/L 92 (60-140)ND

MSD_202010070501 Sulfamethizole 100 83.3 ng/L 83 (60-140) 10ND 40

LCS1 Sulfamethoxazole 100 105 ng/L 105 (60-140)

LCS2 Sulfamethoxazole 100 95.3 ng/L 95 (60-140) 9.730

MBLK Sulfamethoxazole <5 ng/L

MRL_CHK Sulfamethoxazole 5 5.68 ng/L 114 (50-150)

MS_202010070501 Sulfamethoxazole 100 86.1 ng/L 83 (60-140)ND

MSD_202010070501 Sulfamethoxazole 100 96.4 ng/L 94 (60-140) 11ND 40

LCS1 Sulfathiazole 100 109 ng/L 109 (60-140)

LCS2 Sulfathiazole 100 106 ng/L 106 (60-140) 2.830

MBLK Sulfathiazole <5 ng/L

MRL_CHK Sulfathiazole 5 5.42 ng/L 108 (50-150)

MS_202010070501 Sulfathiazole 100 97.0 ng/L 97 (60-140)ND

MSD_202010070501 Sulfathiazole 100 101 ng/L 101 (60-140) 4.0ND 40

LCS1 TCEP 100 96.9 ng/L 97 (60-140)

LCS2 TCEP 100 109 ng/L 109 (60-140) 1230

MBLK TCEP <10 ng/L

MRL_CHK TCEP 5 7.08 ng/L 142 (50-150)

MS_202010070501 TCEP 100 113 ng/L 104 (60-140)ND

MSD_202010070501 TCEP 100 98.0 ng/L 88 (60-140) 15ND 40

LCS1 TCPP 1000 942 ng/L 94 (40-160)

LCS2 TCPP 1000 1060 ng/L 107 (40-160) 1330

MBLK TCPP <200 ng/L

MRL_CHK TCPP 200 141 ng/L 71 (40-160)

MS_202010070501 TCPP 1000 969 ng/L 97 (40-160)ND

MSD_202010070501 TCPP 1000 823 ng/L 82 (40-160) 16ND 60

LCS1 TDCPP 1000 978 ng/L 98 (40-160)

LCS2 TDCPP 1000 1000 ng/L 100 (40-160) 2.230

MBLK TDCPP <100 ng/L

MRL_CHK TDCPP 50 64.1 ng/L 128 (40-160)

MS_202010070501 TDCPP 1000 815 ng/L 82 (40-160)ND










Laboratory QC



Limit(%) RPD%

Tel: (626) 386-1100

Fax: (866) 988-3757

1 800 566 LABS (1 800 566 5227)

897460

SUBCONTRACT

PPCP

Report:

Project:

Group:

MSD_202010070501 TDCPP 1000 823 ng/L 82 (40-160) 0.92ND 60

LCS1 Testosterone 100 105 ng/L 105 (60-140)

LCS2 Testosterone 100 84.9 ng/L 85 (60-140) 2130

MBLK Testosterone <5 ng/L

MRL_CHK Testosterone 5 6.10 ng/L 122 (50-150)

MS_202010070501 Testosterone 100 98.2 ng/L 98 (60-140)ND

MSD_202010070501 Testosterone 100 112 ng/L 112 (60-140) 13ND 40

LCS1 Theobromine 400 380 ng/L 95 (60-140)

LCS2 Theobromine 400 408 ng/L 102 (60-140) 7.130

MBLK Theobromine <50 ng/L

MRL_CHK Theobromine 20 24.0 ng/L 120 (50-150)

MS_202010070501 Theobromine 400 429 ng/L 107 (60-140)ND

MSD_202010070501 Theobromine 400 374 ng/L 94 (60-140) 14ND 40

LCS1 Theophylline 200 196 ng/L 98 (60-140)

LCS2 Theophylline 200 223 ng/L 111 (60-140) 1330

MBLK Theophylline <10 ng/L

MRL_CHK Theophylline 10 13.1 ng/L 131 (50-150)

MS_202010070501 Theophylline 200 183 ng/L 87 (60-140)ND

MSD_202010070501 Theophylline 200 190 ng/L 91 (60-140) 3.5ND 40

LCS1 Thiabendazole 100 105 ng/L 105 (60-140)

LCS2 Thiabendazole 100 125 ng/L 125 (60-140) 1730

MBLK Thiabendazole <5 ng/L

MRL_CHK Thiabendazole 5 4.72 ng/L 95 (50-150)

MS_202010070501 Thiabendazole 100 120 ng/L 120 (60-140)ND

MSD_202010070501 Thiabendazole 100 117 ng/L 117 (60-140) 2.6ND 40

LCS1 Trimethoprim 100 89.1 ng/L 89 (60-140)

LCS2 Trimethoprim 100 115 ng/L 115 (60-140) 2530

MBLK Trimethoprim <5 ng/L

MRL_CHK Trimethoprim 5 5.30 ng/L 106 (50-150)

MS_202010070501 Trimethoprim 100 80.0 ng/L 80 (60-140)ND

MSD_202010070501 Trimethoprim 100 107 ng/L 107 (60-140) 29ND 40

Endocrine Disruptors Positive Mode - SPE by LC-MS-MS


LCS1 1,7-Dimethylxanthine 100 77.1 ng/L 77 (60-140)

LCS2 1,7-Dimethylxanthine 100 99.2 ng/L 99 (60-140) 2530

MBLK 1,7-Dimethylxanthine <5 ng/L

MRL_CHK 1,7-Dimethylxanthine 5 3.80 ng/L 76 (50-150)










Laboratory QC



Limit(%) RPD%

Tel: (626) 386-1100

Fax: (866) 988-3757

1 800 566 LABS (1 800 566 5227)

897460

SUBCONTRACT

PPCP

Report:

Project:

Group:

MS_202011040078 1,7-Dimethylxanthine 100 97.1 ng/L 97 (60-140)ND

MSD_202011040078 1,7-Dimethylxanthine 100 105 ng/L 105 (60-140) 7.8ND 40

LCS1 Acetaminophen 100 101 ng/L 101 (60-140)

LCS2 Acetaminophen 100 94.9 ng/L 95 (60-140) 6.230

MBLK Acetaminophen <10 ng/L

MRL_CHK Acetaminophen 5 5.14 ng/L 103 (50-150)

MS_202011040078 Acetaminophen 100 102 ng/L 103 (60-140)ND

MSD_202011040078 Acetaminophen 100 96.2 ng/L 96 (60-140) 6.4ND 40

LCS1 Amoxicillin (semi-quantitative) 400 574 ng/L 144 (60-140)

LCS2 Amoxicillin (semi-quantitative) 400 493 ng/L 123 (60-140) 1530

MBLK Amoxicillin (semi-quantitative) <20 ng/L

MRL_CHK Amoxicillin (semi-quantitative) 20 33.5 ng/L 167 (50-150)

MS_202011040078 Amoxicillin (semi-quantitative) 400 979 ng/L 245 (60-140)ND

MSD_202011040078 Amoxicillin (semi-quantitative) 400 1050 ng/L 262 (60-140) 7.0ND 40

LCS1 Atenolol 100 120 ng/L 121 (60-140)

LCS2 Atenolol 100 107 ng/L 107 (60-140) 1230

MBLK Atenolol <5 ng/L

MRL_CHK Atenolol 5 5.02 ng/L 100 (50-150)

MS_202011040078 Atenolol 100 112 ng/L 112 (60-140)ND

MSD_202011040078 Atenolol 100 110 ng/L 110 (60-140) 1.7ND 40

LCS1 Caffeine 100 106 ng/L 106 (60-140)

LCS2 Caffeine 100 99.9 ng/L 100 (60-140) 5.930

MBLK Caffeine <10 ng/L

MRL_CHK Caffeine 5 5.97 ng/L 119 (50-150)

MS_202011040078 Caffeine 100 103 ng/L 95 (60-140)ND

MSD_202011040078 Caffeine 100 124 ng/L 116 (60-140) 19ND 40

LCS1 Carbamazepine 100 107 ng/L 107 (60-140)

LCS2 Carbamazepine 100 90.3 ng/L 90 (60-140) 1730

MBLK Carbamazepine <5 ng/L

MRL_CHK Carbamazepine 5 5.74 ng/L 115 (50-150)

MS_202011040078 Carbamazepine 100 103 ng/L 103 (60-140)ND

MSD_202011040078 Carbamazepine 100 77.7 ng/L 78 (60-140) 28ND 40

LCS1 Cimetidine 100 104 ng/L 104 (60-140)

LCS2 Cimetidine 100 97.7 ng/L 98 (60-140) 6.330

MBLK Cimetidine <5 ng/L

MRL_CHK Cimetidine 5 4.43 ng/L 89 (50-150)

MS_202011040078 Cimetidine 100 89.5 ng/L 90 (60-140)ND

MSD_202011040078 Cimetidine 100 120 ng/L 120 (60-140) 29ND 40










Laboratory QC



Limit(%) RPD%

Tel: (626) 386-1100

Fax: (866) 988-3757

1 800 566 LABS (1 800 566 5227)

897460

SUBCONTRACT

PPCP

Report:

Project:

Group:

LCS1 Lidocaine 100 120 ng/L 121 (60-140)

LCS2 Lidocaine 100 105 ng/L 105 (60-140) 1430

MBLK Lidocaine <5 ng/L

MRL_CHK Lidocaine 5 5.51 ng/L 110 (50-150)

MS_202011040078 Lidocaine 100 108 ng/L 108 (60-140)ND

MSD_202011040078 Lidocaine 100 114 ng/L 114 (60-140) 5.7ND 40

LCS1 Sulfamethoxazole 100 93.8 ng/L 94 (60-140)

LCS2 Sulfamethoxazole 100 100 ng/L 100 (60-140) 6.430

MBLK Sulfamethoxazole <5 ng/L

MRL_CHK Sulfamethoxazole 5 6.04 ng/L 121 (50-150)

MS_202011040078 Sulfamethoxazole 100 90.1 ng/L 84 (60-140)6.5

MSD_202011040078 Sulfamethoxazole 100 92.6 ng/L 86 (60-140) 2.76.5 40

LCS1 Theobromine 400 489 ng/L 122 (60-140)

LCS2 Theobromine 400 495 ng/L 124 (60-140) 1.230

MBLK Theobromine <50 ng/L

MRL_CHK Theobromine 20 19.2 ng/L 96 (50-150)

MS_202011040078 Theobromine 400 529 ng/L 132 (60-140)ND

MSD_202011040078 Theobromine 400 470 ng/L 117 (60-140) 12ND 40

LCS1 Theophylline 200 227 ng/L 114 (60-140)

LCS2 Theophylline 200 188 ng/L 94 (60-140) 1830

MBLK Theophylline <10 ng/L

MRL_CHK Theophylline 10 9.87 ng/L 99 (50-150)

MS_202011040078 Theophylline 200 194 ng/L 97 (60-140)ND

MSD_202011040078 Theophylline 200 200 ng/L 100 (60-140) 2.9ND 40

LCS1 Trimethoprim 100 79.5 ng/L 80 (60-140)

LCS2 Trimethoprim 100 66.8 ng/L 67 (60-140) 1730

MBLK Trimethoprim <5 ng/L

MRL_CHK Trimethoprim 5 2.96 ng/L 59 (50-150)

MS_202011040078 Trimethoprim 100 79.2 ng/L 79 (60-140)ND

MSD_202011040078 Trimethoprim 100 82.8 ng/L 83 (60-140) 4.4ND 40

Endocrine Disruptors Negative Mode - SPE by LC-MS-MS


LCS1 2,4-D 100 78.3 ng/L 78 (60-140)

LCS2 2,4-D 100 99.2 ng/L 99 (60-140) 2440

MBLK 2,4-D <50 ng/L

MRL_CHK 2,4-D 5 4.93 ng/L 99 (50-150)

MS_202010070501 2,4-D 100 98.2 ng/L 98 (60-140)ND










Laboratory QC



Limit(%) RPD%

Tel: (626) 386-1100

Fax: (866) 988-3757

1 800 566 LABS (1 800 566 5227)

897460

SUBCONTRACT

PPCP

Report:

Project:

Group:

MSD_202010070501 2,4-D 100 107 ng/L 107 (60-140) 8.6ND 40

LCS1 4-nonylphenol - semi quantitative 2000 1860 ng/L 93 (60-140)

LCS2 4-nonylphenol - semi quantitative 2000 1890 ng/L 95 (60-140) 1.640

MBLK 4-nonylphenol - semi quantitative <200 ng/L

MRL_CHK 4-nonylphenol - semi quantitative 100 126 ng/L 126 (50-150)

MS_202010070501 4-nonylphenol - semi quantitative 2000 1800 ng/L 90 (60-140)ND

MSD_202010070501 4-nonylphenol - semi quantitative 2000 1720 ng/L 86 (60-140) 4.7ND 40

LCS1 4-tert-octylphenol 500 385 ng/L 77 (60-140)

LCS2 4-tert-octylphenol 500 410 ng/L 82 (60-140) 6.340

MBLK 4-tert-octylphenol <50 ng/L

MRL_CHK 4-tert-octylphenol 25 29.6 ng/L 119 (50-150)

MS_202010070501 4-tert-octylphenol 500 423 ng/L 85 (60-140)ND

MSD_202010070501 4-tert-octylphenol 500 416 ng/L 83 (60-140) 1.6ND 40

LCS1 Acesulfame-K 400 400 ng/L 100 (60-140)

LCS2 Acesulfame-K 400 389 ng/L 97 (60-140) 3.040

MBLK Acesulfame-K <20 ng/L

MRL_CHK Acesulfame-K 20 20.4 ng/L 102 (50-150)

MS_202010070501 Acesulfame-K 400 499 ng/L 84 (60-140)160

MSD_202010070501 Acesulfame-K 400 496 ng/L 83 (60-140) 0.70160 40

LCS1 Bendroflumethiazide 100 75.6 ng/L 76 (60-140)

LCS2 Bendroflumethiazide 100 105 ng/L 105 (60-140) 3340

MBLK Bendroflumethiazide <10 ng/L

MRL_CHK Bendroflumethiazide 5 4.37 ng/L 87 (50-150)

MS_202010070501 Bendroflumethiazide 100 98.8 ng/L 99 (60-140)ND

MSD_202010070501 Bendroflumethiazide 100 106 ng/L 106 (60-140) 7.1ND 40

LCS1 BPA 100 86.3 ng/L 86 (60-140)

LCS2 BPA 100 89.4 ng/L 89 (60-140) 3.540

MBLK BPA <10 ng/L

MRL_CHK BPA 5 6.24 ng/L 125 (50-150)

MS_202010070501 BPA 100 125 ng/L 125 (60-140)ND

MSD_202010070501 BPA 100 99.5 ng/L 100 (60-140) 23ND 40

LCS1 Butalbital 100 85.6 ng/L 86 (60-140)

LCS2 Butalbital 100 86.8 ng/L 87 (60-140) 1.440

MBLK Butalbital <10 ng/L

MRL_CHK Butalbital 5 3.64 ng/L 73 (50-150)

MS_202010070501 Butalbital 100 84.0 ng/L 84 (60-140)ND

MSD_202010070501 Butalbital 100 75.3 ng/L 75 (60-140) 11ND 40

LCS1 Butylparben 100 91.6 ng/L 92 (60-140)










Laboratory QC



Limit(%) RPD%

Tel: (626) 386-1100

Fax: (866) 988-3757

1 800 566 LABS (1 800 566 5227)

897460

SUBCONTRACT

PPCP

Report:

Project:

Group:

LCS2 Butylparben 100 99.4 ng/L 99 (60-140) 8.240

MBLK Butylparben <5 ng/L

MRL_CHK Butylparben 5 5.33 ng/L 107 (50-150)

MS_202010070501 Butylparben 100 101 ng/L 101 (60-140)ND

MSD_202010070501 Butylparben 100 104 ng/L 105 (60-140) 4.3ND 40

LCS1 Chloramphenicol 100 94.2 ng/L 94 (60-140)

LCS2 Chloramphenicol 100 123 ng/L 123 (60-140) 2740

MBLK Chloramphenicol <10 ng/L

MRL_CHK Chloramphenicol 10 6.91 ng/L 69 (50-150)

MS_202010070501 Chloramphenicol 100 103 ng/L 103 (60-140)ND

MSD_202010070501 Chloramphenicol 100 102 ng/L 102 (60-140) 0.86ND 40

LCS1 Clofibric Acid 100 79.4 ng/L 79 (60-140)

LCS2 Clofibric Acid 100 96.3 ng/L 96 (60-140) 1940

MBLK Clofibric Acid <5 ng/L

MRL_CHK Clofibric Acid 5 5.78 ng/L 116 (50-150)

MS_202010070501 Clofibric Acid 100 96.2 ng/L 96 (60-140)ND

MSD_202010070501 Clofibric Acid 100 99.9 ng/L 100 (60-140) 3.8ND 40

LCS1 Diclofenac 100 105 ng/L 105 (60-140)

LCS2 Diclofenac 100 137 ng/L 137 (60-140) 2640

MBLK Diclofenac <5 ng/L

MRL_CHK Diclofenac 5 6.83 ng/L 137 (50-150)

MS_202010070501 Diclofenac 100 98.0 ng/L 98 (60-140)ND

MSD_202010070501 Diclofenac 100 83.4 ng/L 83 (60-140) 16ND 40

LCS1 Estradiol 100 87.3 ng/L 87 (60-140)

LCS2 Estradiol 100 105 ng/L 105 (60-140) 1840

MBLK Estradiol <5 ng/L

MRL_CHK Estradiol 5 5.06 ng/L 101 (50-150)

MS_202010070501 Estradiol 100 102 ng/L 103 (60-140)ND

MSD_202010070501 Estradiol 100 101 ng/L 101 (60-140) 1.5ND 40

LCS1 Estriol 100 86.8 ng/L 87 (60-140)

LCS2 Estriol 100 116 ng/L 116 (60-140) 2940

MBLK Estriol <5 ng/L

MRL_CHK Estriol 5 3.18 ng/L 64 (50-150)

MS_202010070501 Estriol 100 80.6 ng/L 81 (60-140)ND

MSD_202010070501 Estriol 100 60.3 ng/L 60 (60-140) 29ND 40

LCS1 Estrone 100 115 ng/L 115 (60-140)

LCS2 Estrone 100 113 ng/L 113 (60-140) 1.840

MBLK Estrone <5 ng/L










Laboratory QC



Limit(%) RPD%

Tel: (626) 386-1100

Fax: (866) 988-3757

1 800 566 LABS (1 800 566 5227)

897460

SUBCONTRACT

PPCP

Report:

Project:

Group:

MRL_CHK Estrone 5 4.70 ng/L 94 (50-150)

MS_202010070501 Estrone 100 107 ng/L 107 (60-140)ND

MSD_202010070501 Estrone 100 90.5 ng/L 91 (60-140) 17ND 40

LCS1 Ethinyl Estradiol - 17 alpha 100 89.2 ng/L 89 (60-140)

LCS2 Ethinyl Estradiol - 17 alpha 100 120 ng/L 120 (60-140) 2940

MBLK Ethinyl Estradiol - 17 alpha <5 ng/L

MRL_CHK Ethinyl Estradiol - 17 alpha 5 5.74 ng/L 115 (50-150)

MS_202010070501 Ethinyl Estradiol - 17 alpha 100 103 ng/L 103 (60-140)ND

MSD_202010070501 Ethinyl Estradiol - 17 alpha 100 117 ng/L 117 (60-140) 13ND 40

LCS1 Ethylparaben 400 394 ng/L 98 (60-140)

LCS2 Ethylparaben 400 482 ng/L 120 (60-140) 2040

MBLK Ethylparaben <20 ng/L

MRL_CHK Ethylparaben 20 18.8 ng/L 94 (50-150)

MS_202010070501 Ethylparaben 400 337 ng/L 84 (60-140)ND

MSD_202010070501 Ethylparaben 400 342 ng/L 86 (60-140) 1.5ND 40

LCS1 Gemfibrozil 100 89.6 ng/L 90 (60-140)

LCS2 Gemfibrozil 100 93.6 ng/L 94 (60-140) 4.440

MBLK Gemfibrozil <5 ng/L

MRL_CHK Gemfibrozil 5 6.79 ng/L 136 (50-150)

MS_202010070501 Gemfibrozil 100 103 ng/L 103 (60-140)ND

MSD_202010070501 Gemfibrozil 100 110 ng/L 110 (60-140) 6.3ND 40

LCS1 Ibuprofen 200 163 ng/L 81 (60-140)

LCS2 Ibuprofen 200 232 ng/L 116 (60-140) 3540

MBLK Ibuprofen <25 ng/L

MRL_CHK Ibuprofen 10 9.37 ng/L 94 (50-150)

MS_202010070501 Ibuprofen 200 260 ng/L 130 (60-140)ND

MSD_202010070501 Ibuprofen 200 249 ng/L 125 (60-140) 4.4ND 40

LCS1 Iohexol 200 176 ng/L 88 (60-140)

LCS2 Iohexol 200 214 ng/L 107 (60-140) 2040

MBLK Iohexol <20 ng/L

MRL_CHK Iohexol 10 5.29 ng/L 53 (50-150)

MS_202010070501 Iohexol 200 223 ng/L 106 (50-150)ND

MSD_202010070501 Iohexol 200 206 ng/L 97 (50-150) 8.2ND 50

LCS1 Iopromide 100 73.3 ng/L 73 (60-140)

LCS2 Iopromide 100 109 ng/L 109 (60-140) 3940

MBLK Iopromide <10 ng/L

MRL_CHK Iopromide 5 4.39 ng/L 88 (50-150)

MS_202010070501 Iopromide 100 101 ng/L 101 (50-150)ND










Laboratory QC



Limit(%) RPD%

Tel: (626) 386-1100

Fax: (866) 988-3757

1 800 566 LABS (1 800 566 5227)

897460

SUBCONTRACT

PPCP

Report:

Project:

Group:

MSD_202010070501 Iopromide 100 104 ng/L 104 (50-150) 2.8ND 50

LCS1 Isobutylparaben 100 85.5 ng/L 86 (60-140)

LCS2 Isobutylparaben 100 101 ng/L 101 (60-140) 1740

MBLK Isobutylparaben <5 ng/L

MRL_CHK Isobutylparaben 5 4.98 ng/L 100 (50-150)

MS_202010070501 Isobutylparaben 100 102 ng/L 102 (60-140)ND

MSD_202010070501 Isobutylparaben 100 105 ng/L 105 (60-140) 3.3ND 40

LCS1 Methylparaben 400 400 ng/L 100 (60-140)

LCS2 Methylparaben 400 445 ng/L 111 (60-140) 1140

MBLK Methylparaben <20 ng/L

MRL_CHK Methylparaben 20 14.1 ng/L 70 (50-150)

MS_202010070501 Methylparaben 400 512 ng/L 128 (60-140)ND

MSD_202010070501 Methylparaben 400 539 ng/L 135 (60-140) 5.1ND 40

LCS1 Naproxen 200 204 ng/L 102 (60-140)

LCS2 Naproxen 200 277 ng/L 139 (60-140) 3040

MBLK Naproxen <20 ng/L

MRL_CHK Naproxen 10 11.4 ng/L 114 (50-150)

MS_202010070501 Naproxen 200 156 ng/L 78 (60-140)ND

MSD_202010070501 Naproxen 200 157 ng/L 79 (60-140) 0.82ND 40

LCS1 Propylparaben 100 99.8 ng/L 100 (60-140)

LCS2 Propylparaben 100 103 ng/L 103 (60-140) 3.240

MBLK Propylparaben <5 ng/L

MRL_CHK Propylparaben 5 3.99 ng/L 80 (50-150)

MS_202010070501 Propylparaben 100 187 ng/L 187 (60-140)ND

MSD_202010070501 Propylparaben 100 173 ng/L 173 (60-140) 7.7ND 40

LCS1 Salicylic Acid 2000 2010 ng/L 101 (60-140)

LCS2 Salicylic Acid 2000 1970 ng/L 99 (60-140) 2.040

MBLK Salicylic Acid <200 ng/L

MRL_CHK Salicylic Acid 100 88.8 ng/L 89 (50-150)

MS_202010070501 Salicylic Acid 2000 2710 ng/L 136 (60-140)ND

MSD_202010070501 Salicylic Acid 2000 2610 ng/L 131 (60-140) 3.9ND 40

LCS1 Sucralose 2000 1580 ng/L 79 (60-140)

LCS2 Sucralose 2000 1750 ng/L 88 (60-140) 1040

MBLK Sucralose <100 ng/L

MRL_CHK Sucralose 100 99.9 ng/L 100 (50-150)

MS_202010070501 Sucralose 2000 2580 ng/L 86 (60-140)860

MSD_202010070501 Sucralose 2000 2740 ng/L 94 (60-140) 6.1860 40

LCS1 Triclocarban 400 202 ng/L 51 (60-140)










Laboratory QC



Limit(%) RPD%

Tel: (626) 386-1100

Fax: (866) 988-3757

1 800 566 LABS (1 800 566 5227)

897460

SUBCONTRACT

PPCP

Report:

Project:

Group:

LCS2 Triclocarban 400 276 ng/L 69 (60-140) 3140

MBLK Triclocarban <50 ng/L

MRL_CHK Triclocarban 20 17.1 ng/L 86 (50-150)

MS_202010070501 Triclocarban 400 190 ng/L 48 (60-140)ND

MSD_202010070501 Triclocarban 400 210 ng/L 53 (60-140) 9.8ND 40

LCS1 Triclosan 400 352 ng/L 88 (60-140)

LCS2 Triclosan 400 390 ng/L 98 (60-140) 1040

MBLK Triclosan <25 ng/L

MRL_CHK Triclosan 20 25.5 ng/L 127 (50-150)

MS_202010070501 Triclosan 400 311 ng/L 78 (60-140)ND

MSD_202010070501 Triclosan 400 445 ng/L 111 (60-140) 36ND 40

LCS1 Warfarin 100 82.4 ng/L 82 (60-140)

LCS2 Warfarin 100 90.4 ng/L 90 (60-140) 9.340

MBLK Warfarin <5 ng/L

MRL_CHK Warfarin 5 4.81 ng/L 96 (50-150)

MS_202010070501 Warfarin 100 117 ng/L 117 (60-140)ND

MSD_202010070501 Warfarin 100 111 ng/L 111 (60-140) 5.2ND 40










ANALYTICAL REPORTEurofins Lancaster Laboratories Env, LLC2425 New Holland PikeLancaster, PA 17601Tel: (717)656-2300

Laboratory Job ID: 410-16718-1Client Project/Site: Nitroaromatics/Nitroamines

For:Eurofins Eaton Analytical110 S Hill StreetSouth Bend, Indiana 46617

Attn: South Bend Reports

Authorized for release by:10/27/2020 9:57:21 AM

Barbara Weyandt, Project Manager(717)[email protected]

The test results in this report meet all 2003 NELAC, 2009 TNI, and 2016 TNI requirements foraccredited parameters, exceptions are noted in this report. This report may not be reproducedexcept in full, and with written approval from the laboratory. For questions please contact theProject Manager at the e-mail address or telephone number listed on this page.

This report has been electronically signed and authorized by the signatory. Electronic signature isintended to be the legally binding equivalent of a traditionally handwritten signature.

Results relate only to the items tested and the sample(s) as received by the laboratory.

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

Page 49 of 201

https://secure.testamericainc.com/TotalAccess/login.aspx

http://www.testamericainc.com/services-we-offer/ask-the-expert

http://www.eurofinsus.com/Env

mailto:[email protected]

Analytical test results meet all requirements of the associated regulatory program (e.g., NELAC (TNI), DoD,and ISO 17025) unless otherwise noted under the individual analysis. Data qualifiers are applied to noteexceptions. Noncompliant quality control (QC) is further explained in narrative comments. * QC recoveries that exceed the upper limits and are associated with non-detect samples are qualified butno further narration is needed since the bias is high and does not change a non-detect result. * Matrix QC may not be reported if insufficient sample or site-specific QC samples were not submitted. Inthese situations, to demonstrate precision and accuracy at a batch level, a LCS/LCSD is performed, unlessotherwise specified in the method. * Surrogate recoveries (if applicable) which are outside of the QC window are confirmed unless attributedto a dilution or otherwise noted in the narrative.Regulated compliance samples (e.g. SDWA, NPDES) must comply with the associated agencyrequirements/permits.

Measurement uncertainty values, as applicable, are available upon request.

Test results relate only to the sample tested. Clients should be aware that a critical step in a chemical ormicrobiological analysis is the collection of the sample. Unless the sample analyzed is truly representative ofthe bulk of material involved, the test results will be meaningless. If you have questions regarding the propertechniques of collecting samples, please contact us. We cannot be held responsible for sample integrity,however, unless sampling has been performed by a member of our staff. Times are local to the area of activity.Parameters listed in the 40 CFR Part 136 Table II as "analyze immediately" and tested in the laboratory are notperformed within 15 minutes of collection.

This report shall not be reproduced except in full, without the written approval of the laboratory.

WARRANTY AND LIMITS OF LIABILITY - In accepting analytical work, we warrant the accuracy of test resultsfor the sample as submitted. THE FOREGOING EXPRESS WARRANTY IS EXCLUSIVE AND IS GIVEN INLIEU OF ALL OTHER WARRANTIES, EXPRESSED OR IMPLIED. WE DISCLAIM ANY OTHERWARRANTIES, EXPRESSED OR IMPLIED, INCLUDING A WARRANTY OF FITNESS FOR PARTICULARPURPOSE AND WARRANTY OF MERCHANTABILITY. IN NO EVENT SHALL EUROFINS LANCASTERLABORATORIES ENVIRONMENTAL, LLC BE LIABLE FOR INDIRECT, SPECIAL, CONSEQUENTIAL, ORINCIDENTAL DAMAGES INCLUDING, BUT NOT LIMITED TO, DAMAGES FOR LOSS OF PROFIT ORGOODWILL REGARDLESS OF (A) THE NEGLIGENCE (EITHER SOLE OR CONCURRENT) OF EUROFINSLANACASTER LABORATORIES ENVIRONMENTAL AND (B) WHETHER EUROFINS LANCASTERLABORATORIES ENVIRONMENTAL HAS BEEN INFORMED OF THE POSSIBILITY OF SUCH DAMAGES.We accept no legal responsibility for the purposes for which the client uses the test results. No purchase orderor other order for work shall be accepted by Eurofins Lancaster Laboratories Environmental which includes anyconditions that vary from the Standard Terms and Conditions, and Eurofins Lancaster LaboratoriesEnvironmental hereby objects to any conflicting terms contained in any acceptance or order submitted byclient.

Barbara WeyandtProject Manager10/27/2020 9:57:21 AM

Client: Eurofins Eaton AnalyticalProject/Site: Nitroaromatics/Nitroamines

Laboratory Job ID: 410-16718-1

Page 2 of 17 10/27/2020

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

Page 50 of 201

Table of Contents

Client: Eurofins Eaton AnalyticalProject/Site: Nitroaromatics/Nitroamines

Laboratory Job ID: 410-16718-1

Page 3 of 17Eurofins Lancaster Laboratories Env, LLC

10/27/2020

Cover Page . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

Table of Contents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3

Definitions/Glossary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4

Case Narrative . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5

Detection Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6

Client Sample Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7

Surrogate Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8

QC Sample Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9

QC Association Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11

Lab Chronicle . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12

Certification Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13

Method Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14

Sample Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15

Chain of Custody . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16

Receipt Checklists . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

Page 51 of 201

Definitions/GlossaryJob ID: 410-16718-1Client: Eurofins Eaton Analytical

Project/Site: Nitroaromatics/Nitroamines

Qualifiers

HPLC/ICQualifier Description

*1 LCS/LCSD RPD exceeds control limits.

Qualifier

Glossary

These commonly used abbreviations may or may not be present in this report.

¤ Listed under the "D" column to designate that the result is reported on a dry weight basis

Abbreviation

%R Percent Recovery

1C Result is from the primary column on a dual-column method.

2C Result is from the confirmation column on a dual-column method.

CFL Contains Free Liquid

CFU Colony Forming Unit

CNF Contains No Free Liquid

DER Duplicate Error Ratio (normalized absolute difference)

Dil Fac Dilution Factor

DL Detection Limit (DoD/DOE)

DL, RA, RE, IN Indicates a Dilution, Re-analysis, Re-extraction, or additional Initial metals/anion analysis of the sample

DLC Decision Level Concentration (Radiochemistry)

EDL Estimated Detection Limit (Dioxin)

LOD Limit of Detection (DoD/DOE)

LOQ Limit of Quantitation (DoD/DOE)

MCL EPA recommended "Maximum Contaminant Level"

MDA Minimum Detectable Activity (Radiochemistry)

MDC Minimum Detectable Concentration (Radiochemistry)

MDL Method Detection Limit

ML Minimum Level (Dioxin)

MPN Most Probable Number

MQL Method Quantitation Limit

NC Not Calculated

ND Not Detected at the reporting limit (or MDL or EDL if shown)

NEG Negative / Absent

POS Positive / Present

PQL Practical Quantitation Limit

PRES Presumptive

QC Quality Control

RER Relative Error Ratio (Radiochemistry)

RL Reporting Limit or Requested Limit (Radiochemistry)

RPD Relative Percent Difference, a measure of the relative difference between two points

TEF Toxicity Equivalent Factor (Dioxin)

TEQ Toxicity Equivalent Quotient (Dioxin)

TNTC Too Numerous To Count

Eurofins Lancaster Laboratories Env, LLC

Page 4 of 17 10/27/2020

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

Page 52 of 201

Case NarrativeClient: Eurofins Eaton Analytical Job ID: 410-16718-1


Job ID: 410-16718-1

Laboratory: Eurofins Lancaster Laboratories Env, LLC

Narrative

Job Narrative

410-16718-1

Receipt

The sample was received on 10/9/2020 10:30 AM; the sample arrived in good condition, and, where required, properly preserved and on

ice. The temperature of the cooler at receipt time was -0.1°C

HPLC/IC

No additional analytical or quality issues were noted, other than those described above or in the Definitions/ Glossary page.

Eurofins Lancaster Laboratories Env, LLCPage 5 of 17 10/27/2020

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

Page 53 of 201

Detection SummaryJob ID: 410-16718-1Client: Eurofins Eaton Analytical


Client Sample ID: 4743530 Lab Sample ID: 410-16718-1

No Detections.


This Detection Summary does not include radiochemical test results.

Page 6 of 17 10/27/2020

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

Page 54 of 201

Client Sample ResultsJob ID: 410-16718-1Client: Eurofins Eaton Analytical


Lab Sample ID: 410-16718-1Client Sample ID: 4743530Matrix: Drinking WaterDate Collected: 10/06/20 09:49

Date Received: 10/09/20 10:30

Method: 8330B - Nitroaromatics and Nitramines (HPLC)RL MDL

1,3,5-Trinitrobenzene (1C) ND 0.60 0.20 ug/L 10/21/20 10:15 10/24/20 05:27 1

Analyte Dil FacAnalyzedPreparedUnit DResult Qualifier

0.60 0.11 ug/L 10/21/20 10:15 10/24/20 05:27 11,3-Dinitrobenzene (1C) ND

0.80 0.14 ug/L 10/21/20 10:15 10/24/20 05:27 12,4,6-Trinitrotoluene (1C) ND

0.60 0.24 ug/L 10/21/20 10:15 10/24/20 05:27 12,4-Dinitrotoluene (1C) ND

0.60 0.15 ug/L 10/21/20 10:15 10/24/20 05:27 12,6-Dinitrotoluene (1C) ND

0.85 0.42 ug/L 10/21/20 10:15 10/24/20 05:27 12-Amino-4,6-dinitrotoluene (1C) ND

0.90 0.31 ug/L 10/21/20 10:15 10/24/20 05:27 12-Nitrotoluene (1C) ND


0.60 0.25 ug/L 10/21/20 10:15 10/24/20 05:27 14-Amino-2,6-dinitrotoluene (1C) ND


0.60 0.20 ug/L 10/21/20 10:15 10/24/20 05:27 1HMX (1C) ND

0.90 0.20 ug/L 10/21/20 10:15 10/24/20 05:27 1Nitrobenzene (1C) ND

20 8.5 ug/L 10/21/20 10:15 10/24/20 05:27 1Nitroglycerin (1C) ND *1

23 11 ug/L 10/21/20 10:15 10/24/20 05:27 1PETN (1C) ND

0.80 0.35 ug/L 10/21/20 10:15 10/24/20 05:27 1RDX (1C) ND

2.0 0.93 ug/L 10/21/20 10:15 10/24/20 05:27 1Tetryl (1C) ND

2-Nitro-m-xylene (1C) 86 68 - 122 10/21/20 10:15 10/24/20 05:27 1

Surrogate Dil FacAnalyzedPreparedQualifier Limits%Recovery

2-Nitro-m-xylene (2C) 84 10/21/20 10:15 10/24/20 05:27 168 - 122


Page 7 of 17 10/27/2020

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

Page 55 of 201

Surrogate SummaryJob ID: 410-16718-1Client: Eurofins Eaton Analytical


Method: 8330B - Nitroaromatics and Nitramines (HPLC)Prep Type: Total/NAMatrix: Drinking Water

Lab Sample ID Client Sample ID (68-122) (68-122)

2NMX1 2NMX2

86 84410-16718-1

Percent Surrogate Recovery (Acceptance Limits)

4743530

86 84LCS 410-56812/2-A Lab Control Sample

84 82LCS 410-56812/6-A Lab Control Sample

86 86LCSD 410-56812/3-A Lab Control Sample Dup

87 85LCSD 410-56812/7-A Lab Control Sample Dup

81 79MB 410-56812/1-A Method Blank

Surrogate Legend

2NMX = 2-Nitro-m-xylene


Page 8 of 17 10/27/2020

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

Page 56 of 201

QC Sample ResultsJob ID: 410-16718-1Client: Eurofins Eaton Analytical


Method: 8330B - Nitroaromatics and Nitramines (HPLC)

Client Sample ID: Method BlankLab Sample ID: MB 410-56812/1-A

Matrix: Drinking Water Prep Type: Total/NA

Analysis Batch: 58743 Prep Batch: 56812

RL MDL

1,3,5-Trinitrobenzene (1C) ND 0.60 0.20 ug/L 10/21/20 10:15 10/24/20 00:33 1

MB MB

Analyte Dil FacAnalyzedPreparedDUnitResult Qualifier

ND 0.110.60 ug/L 10/21/20 10:15 10/24/20 00:33 11,3-Dinitrobenzene (1C)

ND 0.140.80 ug/L 10/21/20 10:15 10/24/20 00:33 12,4,6-Trinitrotoluene (1C)

ND 0.240.60 ug/L 10/21/20 10:15 10/24/20 00:33 12,4-Dinitrotoluene (1C)

ND 0.150.60 ug/L 10/21/20 10:15 10/24/20 00:33 12,6-Dinitrotoluene (1C)

ND 0.420.85 ug/L 10/21/20 10:15 10/24/20 00:33 12-Amino-4,6-dinitrotoluene (1C)

ND 0.310.90 ug/L 10/21/20 10:15 10/24/20 00:33 12-Nitrotoluene (1C)


ND 0.250.60 ug/L 10/21/20 10:15 10/24/20 00:33 14-Amino-2,6-dinitrotoluene (1C)


ND 0.200.60 ug/L 10/21/20 10:15 10/24/20 00:33 1HMX (1C)

ND 0.200.90 ug/L 10/21/20 10:15 10/24/20 00:33 1Nitrobenzene (1C)

ND 8.520 ug/L 10/21/20 10:15 10/24/20 00:33 1Nitroglycerin (2C)

ND 1123 ug/L 10/21/20 10:15 10/24/20 00:33 1PETN (1C)

ND 0.350.80 ug/L 10/21/20 10:15 10/24/20 00:33 1RDX (1C)

ND 0.932.0 ug/L 10/21/20 10:15 10/24/20 00:33 1Tetryl (1C)

2-Nitro-m-xylene (1C) 81 68 - 122 10/24/20 00:33 1

MB MB

Surrogate

10/21/20 10:15

Dil FacPrepared AnalyzedQualifier Limits%Recovery

79 10/21/20 10:15 10/24/20 00:33 12-Nitro-m-xylene (2C) 68 - 122

Client Sample ID: Lab Control SampleLab Sample ID: LCS 410-56812/2-A



1,3,5-Trinitrobenzene (1C) 10.0 9.83 ug/L 98 55 - 122

Analyte

LCS LCS

DUnitResult Qualifier %Rec

Spike

Added

%Rec.

Limits

1,3-Dinitrobenzene (1C) 10.0 9.20 ug/L 92 85 - 120

2,4,6-Trinitrotoluene (1C) 10.0 9.56 ug/L 96 83 - 128

2,4-Dinitrotoluene (1C) 10.1 9.89 ug/L 98 84 - 122

2,6-Dinitrotoluene (1C) 10.0 9.62 ug/L 96 85 - 122

2-Amino-4,6-dinitrotoluene (1C) 10.0 9.33 ug/L 93 85 - 115

2-Nitrotoluene (1C) 10.1 9.10 ug/L 90 85 - 115


4-Amino-2,6-dinitrotoluene (1C) 10.1 9.06 ug/L 90 84 - 119


HMX (1C) 10.1 8.61 ug/L 86 85 - 115

Nitrobenzene (1C) 10.1 9.87 ug/L 98 85 - 115

Nitroglycerin (2C) 110 113 ug/L 103 51 - 115

PETN (1C) 110 108 ug/L 98 85 - 115

RDX (1C) 10.1 9.81 ug/L 98 79 - 120

Tetryl (1C) 10.0 9.53 ug/L 95 10 - 115

2-Nitro-m-xylene (1C) 68 - 122

Surrogate

86

LCS LCS

Qualifier Limits%Recovery



Page 9 of 17 10/27/2020

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

Page 57 of 201

QC Sample ResultsJob ID: 410-16718-1Client: Eurofins Eaton Analytical


Method: 8330B - Nitroaromatics and Nitramines (HPLC) (Continued)

Client Sample ID: Lab Control SampleLab Sample ID: LCS 410-56812/6-A




Surrogate

84

LCS LCS



Client Sample ID: Lab Control Sample DupLab Sample ID: LCSD 410-56812/3-A



1,3,5-Trinitrobenzene (1C) 10.0 9.93 ug/L 99 55 - 122 1 30

Analyte

LCSD LCSD

DUnitResult Qualifier %Rec

Spike

Added

%Rec.

Limits LimitRPD

RPD

1,3-Dinitrobenzene (1C) 10.0 9.32 ug/L 93 85 - 120 5 30

2,4,6-Trinitrotoluene (1C) 10.0 9.69 ug/L 97 83 - 128 1 30

2,4-Dinitrotoluene (1C) 10.1 10.0 ug/L 100 84 - 122 2 30

2,6-Dinitrotoluene (1C) 10.0 9.78 ug/L 98 85 - 122 2 30

2-Amino-4,6-dinitrotoluene (1C) 10.0 9.50 ug/L 95 85 - 115 2 30

2-Nitrotoluene (1C) 10.1 9.31 ug/L 93 85 - 115 2 30


4-Amino-2,6-dinitrotoluene (1C) 10.1 9.29 ug/L 92 84 - 119 1 30


HMX (1C) 10.1 8.73 ug/L 87 85 - 115 8 30

Nitrobenzene (1C) 10.1 10.0 ug/L 99 85 - 115 2 30

Nitroglycerin (2C) 110 115 ug/L 104 51 - 115 40 30

PETN (1C) 110 113 ug/L 103 85 - 115 5 30

RDX (1C) 10.1 9.90 ug/L 98 79 - 120 2 30

Tetryl (1C) 10.0 9.76 ug/L 98 10 - 115 3 30


Surrogate

86

LCSD LCSD



Client Sample ID: Lab Control Sample DupLab Sample ID: LCSD 410-56812/7-A




Surrogate

87

LCSD LCSD




Page 10 of 17 10/27/2020

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

Page 58 of 201

QC Association SummaryJob ID: 410-16718-1Client: Eurofins Eaton Analytical


HPLC/IC

Prep Batch: 56812

Lab Sample ID Client Sample ID Prep Type Matrix Method Prep Batch

Drinking Water 8330-Prep410-16718-1 4743530 Total/NA

Drinking Water 8330-PrepMB 410-56812/1-A Method Blank Total/NA

Drinking Water 8330-PrepLCS 410-56812/2-A Lab Control Sample Total/NA

Drinking Water 8330-PrepLCS 410-56812/6-A Lab Control Sample Total/NA

Drinking Water 8330-PrepLCSD 410-56812/3-A Lab Control Sample Dup Total/NA

Drinking Water 8330-PrepLCSD 410-56812/7-A Lab Control Sample Dup Total/NA

Analysis Batch: 58743

Lab Sample ID Client Sample ID Prep Type Matrix Method Prep Batch

Drinking Water 8330B 56812410-16718-1 4743530 Total/NA

Drinking Water 8330B 56812MB 410-56812/1-A Method Blank Total/NA

Drinking Water 8330B 56812LCS 410-56812/2-A Lab Control Sample Total/NA

Drinking Water 8330B 56812LCS 410-56812/6-A Lab Control Sample Total/NA

Drinking Water 8330B 56812LCSD 410-56812/3-A Lab Control Sample Dup Total/NA

Drinking Water 8330B 56812LCSD 410-56812/7-A Lab Control Sample Dup Total/NA


Page 11 of 17 10/27/2020

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

Page 59 of 201

Lab ChronicleClient: Eurofins Eaton Analytical Job ID: 410-16718-1


Client Sample ID: 4743530 Lab Sample ID: 410-16718-1Matrix: Drinking WaterDate Collected: 10/06/20 09:49

Date Received: 10/09/20 10:30

Prep 8330-Prep 10/21/20 10:15 QTH756812 ELLE

Type

Batch Batch

MethodPrep Type LabAnalystRun

Prepared

or Analyzed

Batch

Number

Dilution

Factor

Total/NA

Analysis 8330B 1 58743 10/24/20 05:27 GM5C ELLETotal/NA

Laboratory References:

ELLE = Eurofins Lancaster Laboratories Env, LLC, 2425 New Holland Pike, Lancaster, PA 17601, TEL (717)656-2300


Page 12 of 17 10/27/2020

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

Page 60 of 201

Accreditation/Certification SummaryClient: Eurofins Eaton Analytical Job ID: 410-16718-1


Laboratory: Eurofins Lancaster Laboratories Env, LLCUnless otherwise noted, all analytes for this laboratory were covered under each accreditation/certification below.

Authority Program Identification Number Expiration Date

South Carolina 89002002State 01-31-21

The following analytes are included in this report, but the laboratory is not certified by the governing authority. This list may include analytes for which

the agency does not offer certification.

Analysis Method Prep Method Matrix Analyte

8330B 8330-Prep Drinking Water 1,3,5-Trinitrobenzene (1C)

8330B 8330-Prep Drinking Water 1,3-Dinitrobenzene (1C)

8330B 8330-Prep Drinking Water 2,4,6-Trinitrotoluene (1C)

8330B 8330-Prep Drinking Water 2,4-Dinitrotoluene (1C)

8330B 8330-Prep Drinking Water 2,6-Dinitrotoluene (1C)

8330B 8330-Prep Drinking Water 2-Amino-4,6-dinitrotoluene (1C)

8330B 8330-Prep Drinking Water 2-Nitrotoluene (1C)


8330B 8330-Prep Drinking Water 4-Amino-2,6-dinitrotoluene (1C)


8330B 8330-Prep Drinking Water HMX (1C)

8330B 8330-Prep Drinking Water Nitrobenzene (1C)

8330B 8330-Prep Drinking Water Nitroglycerin (1C)

8330B 8330-Prep Drinking Water PETN (1C)

8330B 8330-Prep Drinking Water RDX (1C)

8330B 8330-Prep Drinking Water Tetryl (1C)


Page 13 of 17 10/27/2020

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

Page 61 of 201

Method SummaryJob ID: 410-16718-1Client: Eurofins Eaton Analytical


Method Method Description LaboratoryProtocol

SW8468330B Nitroaromatics and Nitramines (HPLC) ELLE

SW8468330-Prep Solid-Phase Extraction (Explosives) ELLE

Protocol References:

SW846 = "Test Methods For Evaluating Solid Waste, Physical/Chemical Methods", Third Edition, November 1986 And Its Updates.

Laboratory References:

ELLE = Eurofins Lancaster Laboratories Env, LLC, 2425 New Holland Pike, Lancaster, PA 17601, TEL (717)656-2300


Page 14 of 17 10/27/2020

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

Page 62 of 201

Sample SummaryJob ID: 410-16718-1Client: Eurofins Eaton Analytical


Lab Sample ID Client Sample ID ReceivedCollectedMatrix Asset ID

410-16718-1 4743530 Drinking Water 10/06/20 09:49 10/09/20 10:30


Page 15 of 17 10/27/2020

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

Page 63 of 201

Pag

e 16

of 1

710

/27/

2020

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Page 64 of 201

Login Sample Receipt Checklist

Client: Eurofins Eaton Analytical Job Number: 410-16718-1

Login Number: 16718

Question Answer Comment

Creator: Rivera-Santa, Julissa

List Source: Eurofins Lancaster Laboratories Env

List Number: 1

N/ARadioactivity wasn't checked or is </= background as measured by a survey

meter.

N/AThe cooler's custody seal is intact.

TrueThe cooler or samples do not appear to have been compromised or

tampered with.

TrueSamples were received on ice.

TrueCooler Temperature is acceptable (</=6C, not frozen).

TrueCooler Temperature is recorded.

N/AWV: Container Temperature is acceptable (</=6C, not frozen).

N/AWV: Container Temperature is recorded.

TrueCOC is present.

TrueCOC is filled out in ink and legible.

TrueCOC is filled out with all pertinent information.

TrueThere are no discrepancies between the containers received and the COC.

TrueSamples are received within Holding Time (excluding tests with immediate

HTs)

TrueSample containers have legible labels.

TrueContainers are not broken or leaking.

TrueSample collection date/times are provided.

TrueAppropriate sample containers are used.

TrueSample bottles are completely filled.

TrueThere is sufficient vol. for all requested analyses.

TrueMultiphasic samples are not present.

N/ASamples do not require splitting or compositing.

FalseIs the Field Sampler's name present on COC? Received project as a subcontract.

N/ASample Preservation Verified.

N/AResidual Chlorine Checked.

N/ASample custody seals are intact.

Eurofins Lancaster Laboratories EnvPage 17 of 17 10/27/2020

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

Page 65 of 201

Page 66 of 201

Page 67 of 201

Eu

rofi

ns

Ea

ton

An

aly

tica

lR

un

Lo

gR

un ID

:281175

Meth

od:

1613

Sam

ple

Sit

eS

am

ple

Id

Typ

eIn

str

um

en

t ID

Cali

bra

tio

n F

ile

An

aly

sis

Date

Matr

ix

FS

47

43

53

7F

inis

he

dR

LR

ef

La

b D

ioxi

n1

0/1

5/2

02

0 1

9:5

0D

W

0.0

0

Page 1

of

2E

EA

Run I

D 2

81175 /

EE

A R

eport

# 5

00223

Page 68 of 201

QC

Su

mm

ary

Re

po

rt

EE

AID

#R

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

eth

od

An

aly

teS

am

ple

Typ

eD

ilF

ac

tor

RP

DL

imit

Re

co

ve

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

gM

RL

Ex

tra

cte

dA

na

lyze

d

Fals

e

2,3

,7,8

-Tetr

ach

loro

dib

enzo

-p-D

ioxi

n1613

5.0

FS

5.0

pg

/L1

.04

74

35

37

Fin

ishe

d--

---

---

---

-

<1

0/1

3/2

02

0 0

0:0

01

0/1

5/2

02

0 1

9:5

0

Page 2

of

2E

EA

Run I

D 2

81175 /

EE

A R

eport

# 5

00223

Page 69 of 201

Eu

rofi

ns

Ea

ton

An

aly

tica

lR

un

Lo

gR

un ID

:280839

Meth

od:

200.8

Sam

ple

Sit

eS

am

ple

Id

Typ

eIn

str

um

en

t ID

Cali

bra

tio

n F

ile

An

aly

sis

Date

Matr

ix

QC

S4

74

85

75

DS

10

/13

/20

20

12

:17

RW

ICV

47

46

79

7D

S1

0/1

3/2

02

0 1

2:2

0R

W

ICB

47

48

57

6D

S1

0/1

3/2

02

0 1

2:2

6R

W

LR

B4

74

85

77

DS

10

/13

/20

20

12

:33

RW

LF

B4

74

85

80

DS

10

/13

/20

20

12

:39

RW

FS

47

43

54

9F

inis

he

dD

S1

0/1

3/2

02

0 1

3:1

5D

W

CC

V4

74

85

81

DS

10

/13

/20

20

13

:18

RW

CC

B4

74

85

82

DS

10

/13

/20

20

13

:21

RW

CC

V4

74

85

84

DS

10

/13

/20

20

13

:46

RW

CC

B4

74

85

85

DS

10

/13

/20

20

13

:49

RW

0.0

0

Page 1

of

9E

EA

Run I

D 2

80839 /

EE

A R

eport

# 5

00223

Page 70 of 201

QC

Su

mm

ary

Re

po

rt

EE

AID

#R

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

eth

od

An

aly

teS

am

ple

Typ

eD

ilF

ac

tor

RP

DL

imit

Re

co

ve

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

gM

RL

Ex

tra

cte

dA

na

lyze

d

Fals

e

Alu

min

um

200.8

2.0

QC

S4

8.1

92

0ug

/L1

.04

74

85

75

---

---

---

90

- 1

10

96

50

.0

---

10

/13

/20

20

12

:17

Fals

e

Antim

ony

200.8

1.0

QC

S4

8.3

22

0ug

/L1

.04

74

85

75

---

---

---

90

- 1

10

97

50

.0

---

10

/13

/20

20

12

:17

Fals

e

Ars

enic

200.8

1.0

QC

S5

0.1

59

0ug

/L1

.04

74

85

75

---

---

---

90

- 1

10

10

05

0.0

--

-1

0/1

3/2

02

0 1

2:1

7F

als

e

Bari

um

200.8

2.0

QC

S4

7.8

99

0ug

/L1

.04

74

85

75

---

---

---

90

- 1

10

96

50

.0

---

10

/13

/20

20

12

:17

Fals

e

Bery

llium

200.8

0.3

QC

S4

8.0

44

0ug

/L1

.04

74

85

75

---

---

---

90

- 1

10

96

50

.0

---

10

/13

/20

20

12

:17

Fals

e

IS-B

ism

uth

200.8

N/A

QC

S0

.96

41

N/A

1.0

47

48

57

5--

---

---

-6

0 -

12

59

61

.0

---

10

/13

/20

20

12

:17

Fals

e

Boro

n200.8

5.0

QC

S4

9.6

42

0ug

/L1

.04

74

85

75

---

---

---

90

- 1

10

99

50

.0

---

10

/13

/20

20

12

:17

Fals

e

Cadm

ium

200.8

1.0

QC

S4

8.0

32

0ug

/L1

.04

74

85

75

---

---

---

90

- 1

10

96

50

.0

---

10

/13

/20

20

12

:17

Fals

e

Chro

miu

m200.8

0.9

QC

S4

9.0

48

0ug

/L1

.04

74

85

75

---

---

---

90

- 1

10

98

50

.0

---

10

/13

/20

20

12

:17

Fals

e

Cobalt

200.8

2.0

QC

S4

8.7

26

0ug

/L1

.04

74

85

75

---

---

---

90

- 1

10

97

50

.0

---

10

/13

/20

20

12

:17

Fals

e

Copper

200.8

1.0

QC

S4

8.5

15

0ug

/L1

.04

74

85

75

---

---

---

90

- 1

10

97

50

.0

---

10

/13

/20

20

12

:17

Fals

e

IS-I

ndiu

m200.8

N/A

QC

S0

.96

75

N/A

1.0

47

48

57

5--

---

---

-6

0 -

12

59

71

.0

---

10

/13

/20

20

12

:17

Fals

e

Lead

200.8

1.0

QC

S4

9.6

73

0ug

/L1

.04

74

85

75

---

---

---

90

- 1

10

99

50

.0

---

10

/13

/20

20

12

:17

Fals

e

Lithiu

m200.8

2.0

QC

S4

7.2

74

0ug

/L1

.04

74

85

75

---

---

---

90

- 1

10

95

50

.0

---

10

/13

/20

20

12

:17

Fals

e

Manganese

200.8

2.0

QC

S4

8.6

48

0ug

/L1

.04

74

85

75

---

---

---

90

- 1

10

97

50

.0

---

10

/13

/20

20

12

:17

Fals

e

Moly

bdenum

200.8

2.0

QC

S4

8.7

70

0ug

/L1

.04

74

85

75

---

---

---

90

- 1

10

98

50

.0

---

10

/13

/20

20

12

:17

Fals

e

Nic

kel

200.8

1.0

QC

S4

9.5

02

0ug

/L1

.04

74

85

75

---

---

---

90

- 1

10

99

50

.0

---

10

/13

/20

20

12

:17

Fals

e

IS-S

candiu

m200.8

N/A

QC

S0

.96

38

N/A

1.0

47

48

57

5--

---

---

-6

0 -

12

59

61

.0

---

10

/13

/20

20

12

:17

Fals

e

Sele

niu

m200.8

2.0

QC

S5

0.1

11

0ug

/L1

.04

74

85

75

---

---

---

90

- 1

10

10

05

0.0

--

-1

0/1

3/2

02

0 1

2:1

7F

als

e

Silv

er

200.8

2.0

QC

S5

1.2

58

0ug

/L1

.04

74

85

75

---

---

---

90

- 1

10

10

35

0.0

--

-1

0/1

3/2

02

0 1

2:1

7F

als

e

Str

ontium

200.8

2.0

QC

S4

9.7

85

0ug

/L1

.04

74

85

75

---

---

---

90

- 1

10

10

05

0.0

--

-1

0/1

3/2

02

0 1

2:1

7F

als

e

IS-T

erb

ium

200.8

N/A

QC

S0

.97

02

N/A

1.0

47

48

57

5--

---

---

-6

0 -

12

59

71

.0

---

10

/13

/20

20

12

:17

Fals

e

Thalli

um

200.8

0.3

QC

S4

9.7

93

0ug

/L1

.04

74

85

75

---

---

---

90

- 1

10

10

05

0.0

--

-1

0/1

3/2

02

0 1

2:1

7F

als

e

Thori

um

200.8

5.0

QC

S4

8.5

00

0ug

/L1

.04

74

85

75

---

---

---

90

- 1

10

97

50

.0

---

10

/13

/20

20

12

:17

Fals

e

Tin

200.8

2.0

QC

S4

8.2

45

0ug

/L1

.04

74

85

75

---

---

---

90

- 1

10

96

50

.0

---

10

/13

/20

20

12

:17

Fals

e

Titaniu

m200.8

5.0

QC

S4

8.8

19

0ug

/L1

.04

74

85

75

---

---

---

90

- 1

10

98

50

.0

---

10

/13

/20

20

12

:17

Fals

e

Ura

niu

m200.8

1.0

QC

S4

8.7

17

0ug

/L1

.04

74

85

75

---

---

---

90

- 1

10

97

50

.0

---

10

/13

/20

20

12

:17

Fals

e

Vanadiu

m200.8

2.0

QC

S4

9.1

60

0ug

/L1

.04

74

85

75

---

---

---

90

- 1

10

98

50

.0

---

10

/13

/20

20

12

:17

Fals

e

IS-Y

ttri

um

200.8

N/A

QC

S0

.94

94

N/A

1.0

47

48

57

5--

---

---

-6

0 -

12

59

51

.0

---

10

/13

/20

20

12

:17

Fals

e

Zin

c200.8

5.0

QC

S4

9.1

74

0ug

/L1

.04

74

85

75

---

---

---

90

- 1

10

98

50

.0

---

10

/13

/20

20

12

:17

Tru

e

Alu

min

um

200.8

2.0

ICV

47

.16

40

ug

/L1

.04

74

67

97

---

---

---

90

- 1

10

94

50

.0

---

10

/13

/20

20

12

:20

Tru

e

Antim

ony

200.8

1.0

ICV

47

.82

30

ug

/L1

.04

74

67

97

---

---

---

90

- 1

10

96

50

.0

---

10

/13

/20

20

12

:20

Tru

e

Ars

enic

200.8

1.0

ICV

48

.04

30

ug

/L1

.04

74

67

97

---

---

---

90

- 1

10

96

50

.0

---

10

/13

/20

20

12

:20

Tru

e

Bari

um

200.8

2.0

ICV

48

.32

40

ug

/L1

.04

74

67

97

---

---

---

90

- 1

10

97

50

.0

---

10

/13

/20

20

12

:20

Tru

e

Bery

llium

200.8

0.3

ICV

47

.50

70

ug

/L1

.04

74

67

97

---

---

---

90

- 1

10

95

50

.0

---

10

/13

/20

20

12

:20

Tru

e

IS-B

ism

uth

200.8

N/A

ICV

0.9

72

3N

/A1

.04

74

67

97

---

---

---

60

- 1

25

97

1.0

--

-1

0/1

3/2

02

0 1

2:2

0T

rue

Boro

n200.8

5.0

ICV

49

.66

60

ug

/L1

.04

74

67

97

---

---

---

90

- 1

10

99

50

.0

---

10

/13

/20

20

12

:20

Tru

e

Cadm

ium

200.8

1.0

ICV

48

.09

90

ug

/L1

.04

74

67

97

---

---

---

90

- 1

10

96

50

.0

---

10

/13

/20

20

12

:20

Tru

e

Chro

miu

m200.8

0.9

ICV

47

.83

00

ug

/L1

.04

74

67

97

---

---

---

90

- 1

10

96

50

.0

---

10

/13

/20

20

12

:20

Tru

e

Cobalt

200.8

2.0

ICV

47

.98

30

ug

/L1

.04

74

67

97

---

---

---

90

- 1

10

96

50

.0

---

10

/13

/20

20

12

:20

Page 2

of

9E

EA

Run I

D 2

80839 /

EE

A R

eport

# 5

00223

Page 71 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Tru

e

Copper

200.8

1.0

ICV

48

.01

60

ug

/L1

.04

74

67

97

---

---

---

90

- 1

10

96

50

.0

---

10

/13

/20

20

12

:20

Tru

e

IS-I

ndiu

m200.8

N/A

ICV

0.9

66

2N

/A1

.04

74

67

97

---

---

---

60

- 1

25

97

1.0

--

-1

0/1

3/2

02

0 1

2:2

0T

rue

Lead

200.8

1.0

ICV

48

.62

20

ug

/L1

.04

74

67

97

---

---

---

90

- 1

10

97

50

.0

---

10

/13

/20

20

12

:20

Tru

e

Lithiu

m200.8

2.0

ICV

46

.98

60

ug

/L1

.04

74

67

97

---

---

---

90

- 1

10

94

50

.0

---

10

/13

/20

20

12

:20

Tru

e

Manganese

200.8

2.0

ICV

48

.21

90

ug

/L1

.04

74

67

97

---

---

---

90

- 1

10

96

50

.0

---

10

/13

/20

20

12

:20

Tru

e

Moly

bdenum

200.8

2.0

ICV

48

.34

70

ug

/L1

.04

74

67

97

---

---

---

90

- 1

10

97

50

.0

---

10

/13

/20

20

12

:20

Tru

e

Nic

kel

200.8

1.0

ICV

48

.48

60

ug

/L1

.04

74

67

97

---

---

---

90

- 1

10

97

50

.0

---

10

/13

/20

20

12

:20

Tru

e

IS-S

candiu

m200.8

N/A

ICV

0.9

73

1N

/A1

.04

74

67

97

---

---

---

60

- 1

25

97

1.0

--

-1

0/1

3/2

02

0 1

2:2

0T

rue

Sele

niu

m200.8

2.0

ICV

48

.30

70

ug

/L1

.04

74

67

97

---

---

---

90

- 1

10

97

50

.0

---

10

/13

/20

20

12

:20

Tru

e

Silv

er

200.8

2.0

ICV

48

.63

50

ug

/L1

.04

74

67

97

---

---

---

90

- 1

10

97

50

.0

---

10

/13

/20

20

12

:20

Tru

e

Str

ontium

200.8

2.0

ICV

48

.92

30

ug

/L1

.04

74

67

97

---

---

---

90

- 1

10

98

50

.0

---

10

/13

/20

20

12

:20

Tru

e

IS-T

erb

ium

200.8

N/A

ICV

0.9

71

5N

/A1

.04

74

67

97

---

---

---

60

- 1

25

97

1.0

--

-1

0/1

3/2

02

0 1

2:2

0T

rue

Thalli

um

200.8

0.3

ICV

49

.00

90

ug

/L1

.04

74

67

97

---

---

---

90

- 1

10

98

50

.0

---

10

/13

/20

20

12

:20

Tru

e

Thori

um

200.8

5.0

ICV

47

.98

00

ug

/L1

.04

74

67

97

---

---

---

90

- 1

10

96

50

.0

---

10

/13

/20

20

12

:20

Tru

e

Tin

200.8

2.0

ICV

47

.90

00

ug

/L1

.04

74

67

97

---

---

---

90

- 1

10

96

50

.0

---

10

/13

/20

20

12

:20

Tru

e

Titaniu

m200.8

5.0

ICV

48

.40

70

ug

/L1

.04

74

67

97

---

---

---

90

- 1

10

97

50

.0

---

10

/13

/20

20

12

:20

Tru

e

Ura

niu

m200.8

1.0

ICV

48

.17

20

ug

/L1

.04

74

67

97

---

---

---

90

- 1

10

96

50

.0

---

10

/13

/20

20

12

:20

Tru

e

Vanadiu

m200.8

2.0

ICV

47

.66

10

ug

/L1

.04

74

67

97

---

---

---

90

- 1

10

95

50

.0

---

10

/13

/20

20

12

:20

Tru

e

IS-Y

ttri

um

200.8

N/A

ICV

0.9

62

5N

/A1

.04

74

67

97

---

---

---

60

- 1

25

96

1.0

--

-1

0/1

3/2

02

0 1

2:2

0T

rue

Zin

c200.8

5.0

ICV

48

.06

00

ug

/L1

.04

74

67

97

---

---

---

90

- 1

10

96

50

.0

---

10

/13

/20

20

12

:20

Fals

e

Alu

min

um

200.8

2.0

ICB

2.0

ug

/L1

.04

74

85

76

---

---

---

---

---

<

---

10

/13

/20

20

12

:26

Fals

e

Antim

ony

200.8

1.0

ICB

1.0

ug

/L1

.04

74

85

76

---

---

---

---

---

<

---

10

/13

/20

20

12

:26

Fals

e

Ars

enic

200.8

1.0

ICB

1.0

ug

/L1

.04

74

85

76

---

---

---

---

---

<

---

10

/13

/20

20

12

:26

Fals

e

Bari

um

200.8

2.0

ICB

2.0

ug

/L1

.04

74

85

76

---

---

---

---

---

<

---

10

/13

/20

20

12

:26

Fals

e

Bery

llium

200.8

0.3

ICB

0.3

ug

/L1

.04

74

85

76

---

---

---

---

---

<

---

10

/13

/20

20

12

:26

Fals

e

IS-B

ism

uth

200.8

N/A

ICB

0.9

58

2N

/A1

.04

74

85

76

---

---

---

60

- 1

25

96

1.0

--

-1

0/1

3/2

02

0 1

2:2

6F

als

e

Boro

n200.8

5.0

ICB

5.0

ug

/L1

.04

74

85

76

---

---

---

---

---

<

---

10

/13

/20

20

12

:26

Fals

e

Cadm

ium

200.8

1.0

ICB

1.0

ug

/L1

.04

74

85

76

---

---

---

---

---

<

---

10

/13

/20

20

12

:26

Fals

e

Chro

miu

m200.8

0.9

ICB

0.9

ug

/L1

.04

74

85

76

---

---

---

---

---

<

---

10

/13

/20

20

12

:26

Fals

e

Cobalt

200.8

2.0

ICB

2.0

ug

/L1

.04

74

85

76

---

---

---

---

---

<

---

10

/13

/20

20

12

:26

Fals

e

Copper

200.8

1.0

ICB

1.0

ug

/L1

.04

74

85

76

---

---

---

---

---

<

---

10

/13

/20

20

12

:26

Fals

e

IS-I

ndiu

m200.8

N/A

ICB

0.9

69

8N

/A1

.04

74

85

76

---

---

---

60

- 1

25

97

1.0

--

-1

0/1

3/2

02

0 1

2:2

6F

als

e

Lead

200.8

1.0

ICB

1.0

ug

/L1

.04

74

85

76

---

---

---

---

---

<

---

10

/13

/20

20

12

:26

Fals

e

Lithiu

m200.8

2.0

ICB

2.0

ug

/L1

.04

74

85

76

---

---

---

---

---

<

---

10

/13

/20

20

12

:26

Fals

e

Manganese

200.8

2.0

ICB

2.0

ug

/L1

.04

74

85

76

---

---

---

---

---

<

---

10

/13

/20

20

12

:26

Fals

e

Moly

bdenum

200.8

2.0

ICB

2.0

ug

/L1

.04

74

85

76

---

---

---

---

---

<

---

10

/13

/20

20

12

:26

Fals

e

Nic

kel

200.8

1.0

ICB

1.0

ug

/L1

.04

74

85

76

---

---

---

---

---

<

---

10

/13

/20

20

12

:26

Fals

e

IS-S

candiu

m200.8

N/A

ICB

0.9

83

2N

/A1

.04

74

85

76

---

---

---

60

- 1

25

98

1.0

--

-1

0/1

3/2

02

0 1

2:2

6F

als

e

Sele

niu

m200.8

2.0

ICB

2.0

ug

/L1

.04

74

85

76

---

---

---

---

---

<

---

10

/13

/20

20

12

:26

Fals

e

Silv

er

200.8

2.0

ICB

2.0

ug

/L1

.04

74

85

76

---

---

---

---

---

<

---

10

/13

/20

20

12

:26

Fals

e

Str

ontium

200.8

2.0

ICB

2.0

ug

/L1

.04

74

85

76

---

---

---

---

---

<

---

10

/13

/20

20

12

:26

Page 3

of

9E

EA

Run I

D 2

80839 /

EE

A R

eport

# 5

00223

Page 72 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Fals

e

IS-T

erb

ium

200.8

N/A

ICB

0.9

72

3N

/A1

.04

74

85

76

---

---

---

60

- 1

25

97

1.0

--

-1

0/1

3/2

02

0 1

2:2

6F

als

e

Thalli

um

200.8

0.3

ICB

0.3

ug

/L1

.04

74

85

76

---

---

---

---

---

<

---

10

/13

/20

20

12

:26

Fals

e

Thori

um

200.8

5.0

ICB

5.0

ug

/L1

.04

74

85

76

---

---

---

---

---

<

---

10

/13

/20

20

12

:26

Fals

e

Tin

200.8

2.0

ICB

2.0

ug

/L1

.04

74

85

76

---

---

---

---

---

<

---

10

/13

/20

20

12

:26

Fals

e

Titaniu

m200.8

5.0

ICB

5.0

ug

/L1

.04

74

85

76

---

---

---

---

---

<

---

10

/13

/20

20

12

:26

Fals

e

Ura

niu

m200.8

1.0

ICB

1.0

ug

/L1

.04

74

85

76

---

---

---

---

---

<

---

10

/13

/20

20

12

:26

Fals

e

Vanadiu

m200.8

2.0

ICB

2.0

ug

/L1

.04

74

85

76

---

---

---

---

---

<

---

10

/13

/20

20

12

:26

Fals

e

IS-Y

ttri

um

200.8

N/A

ICB

0.9

77

5N

/A1

.04

74

85

76

---

---

---

60

- 1

25

98

1.0

--

-1

0/1

3/2

02

0 1

2:2

6F

als

e

Zin

c200.8

5.0

ICB

5.0

ug

/L1

.04

74

85

76

---

---

---

---

---

<

---

10

/13

/20

20

12

:26

Tru

e

Alu

min

um

200.8

2.0

LR

B2

.0ug

/L1

.04

74

85

77

---

---

---

---

---

<

---

10

/13

/20

20

12

:33

Tru

e

Antim

ony

200.8

1.0

LR

B1

.0ug

/L1

.04

74

85

77

---

---

---

---

---

<

---

10

/13

/20

20

12

:33

Tru

e

Ars

enic

200.8

1.0

LR

B1

.0ug

/L1

.04

74

85

77

---

---

---

---

---

<

---

10

/13

/20

20

12

:33

Tru

e

Bari

um

200.8

2.0

LR

B2

.0ug

/L1

.04

74

85

77

---

---

---

---

---

<

---

10

/13

/20

20

12

:33

Tru

e

Bery

llium

200.8

0.3

LR

B0

.3ug

/L1

.04

74

85

77

---

---

---

---

---

<

---

10

/13

/20

20

12

:33

Tru

e

IS-B

ism

uth

200.8

N/A

LR

B0

.96

00

N/A

1.0

47

48

57

7--

---

---

-6

0 -

12

59

61

.0

---

10

/13

/20

20

12

:33

Tru

e

Boro

n200.8

5.0

LR

B5

.0ug

/L1

.04

74

85

77

---

---

---

---

---

<

---

10

/13

/20

20

12

:33

Tru

e

Cadm

ium

200.8

1.0

LR

B1

.0ug

/L1

.04

74

85

77

---

---

---

---

---

<

---

10

/13

/20

20

12

:33

Tru

e

Chro

miu

m200.8

0.9

LR

B0

.9ug

/L1

.04

74

85

77

---

---

---

---

---

<

---

10

/13

/20

20

12

:33

Tru

e

Cobalt

200.8

2.0

LR

B2

.0ug

/L1

.04

74

85

77

---

---

---

---

---

<

---

10

/13

/20

20

12

:33

Tru

e

Copper

200.8

1.0

LR

B1

.0ug

/L1

.04

74

85

77

---

---

---

---

---

<

---

10

/13

/20

20

12

:33

Tru

e

IS-I

ndiu

m200.8

N/A

LR

B0

.96

84

N/A

1.0

47

48

57

7--

---

---

-6

0 -

12

59

71

.0

---

10

/13

/20

20

12

:33

Tru

e

Lead

200.8

1.0

LR

B1

.0ug

/L1

.04

74

85

77

---

---

---

---

---

<

---

10

/13

/20

20

12

:33

Tru

e

Lithiu

m200.8

2.0

LR

B2

.0ug

/L1

.04

74

85

77

---

---

---

---

---

<

---

10

/13

/20

20

12

:33

Tru

e

Manganese

200.8

2.0

LR

B2

.0ug

/L1

.04

74

85

77

---

---

---

---

---

<

---

10

/13

/20

20

12

:33

Tru

e

Moly

bdenum

200.8

2.0

LR

B2

.0ug

/L1

.04

74

85

77

---

---

---

---

---

<

---

10

/13

/20

20

12

:33

Tru

e

Nic

kel

200.8

1.0

LR

B1

.0ug

/L1

.04

74

85

77

---

---

---

---

---

<

---

10

/13

/20

20

12

:33

Tru

e

IS-S

candiu

m200.8

N/A

LR

B0

.97

85

N/A

1.0

47

48

57

7--

---

---

-6

0 -

12

59

81

.0

---

10

/13

/20

20

12

:33

Tru

e

Sele

niu

m200.8

2.0

LR

B2

.0ug

/L1

.04

74

85

77

---

---

---

---

---

<

---

10

/13

/20

20

12

:33

Tru

e

Silv

er

200.8

2.0

LR

B2

.0ug

/L1

.04

74

85

77

---

---

---

---

---

<

---

10

/13

/20

20

12

:33

Tru

e

Str

ontium

200.8

2.0

LR

B2

.0ug

/L1

.04

74

85

77

---

---

---

---

---

<

---

10

/13

/20

20

12

:33

Tru

e

IS-T

erb

ium

200.8

N/A

LR

B0

.97

41

N/A

1.0

47

48

57

7--

---

---

-6

0 -

12

59

71

.0

---

10

/13

/20

20

12

:33

Tru

e

Thalli

um

200.8

0.3

LR

B0

.3ug

/L1

.04

74

85

77

---

---

---

---

---

<

---

10

/13

/20

20

12

:33

Tru

e

Thori

um

200.8

5.0

LR

B5

.0ug

/L1

.04

74

85

77

---

---

---

---

---

<

---

10

/13

/20

20

12

:33

Tru

e

Tin

200.8

2.0

LR

B2

.0ug

/L1

.04

74

85

77

---

---

---

---

---

<

---

10

/13

/20

20

12

:33

Tru

e

Titaniu

m200.8

5.0

LR

B5

.0ug

/L1

.04

74

85

77

---

---

---

---

---

<

---

10

/13

/20

20

12

:33

Tru

e

Ura

niu

m200.8

1.0

LR

B1

.0ug

/L1

.04

74

85

77

---

---

---

---

---

<

---

10

/13

/20

20

12

:33

Tru

e

Vanadiu

m200.8

2.0

LR

B2

.0ug

/L1

.04

74

85

77

---

---

---

---

---

<

---

10

/13

/20

20

12

:33

Tru

e

IS-Y

ttri

um

200.8

N/A

LR

B0

.97

16

N/A

1.0

47

48

57

7--

---

---

-6

0 -

12

59

71

.0

---

10

/13

/20

20

12

:33

Tru

e

Zin

c200.8

5.0

LR

B5

.0ug

/L1

.04

74

85

77

---

---

---

---

---

<

---

10

/13

/20

20

12

:33

Fals

e

Alu

min

um

200.8

2.0

LF

B5

2.8

16

0ug

/L1

.04

74

85

80

---

---

---

85

- 1

15

10

65

0.0

--

-1

0/1

3/2

02

0 1

2:3

9F

als

e

Antim

ony

200.8

1.0

LF

B4

9.7

34

0ug

/L1

.04

74

85

80

---

---

---

85

- 1

15

99

50

.0

---

10

/13

/20

20

12

:39

Page 4

of

9E

EA

Run I

D 2

80839 /

EE

A R

eport

# 5

00223

Page 73 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Fals

e

Ars

enic

200.8

1.0

LF

B5

1.3

58

0ug

/L1

.04

74

85

80

---

---

---

85

- 1

15

10

35

0.0

--

-1

0/1

3/2

02

0 1

2:3

9F

als

e

Bari

um

200.8

2.0

LF

B5

1.4

52

0ug

/L1

.04

74

85

80

---

---

---

85

- 1

15

10

35

0.0

--

-1

0/1

3/2

02

0 1

2:3

9F

als

e

Bery

llium

200.8

0.3

LF

B5

1.9

19

0ug

/L1

.04

74

85

80

---

---

---

85

- 1

15

10

45

0.0

--

-1

0/1

3/2

02

0 1

2:3

9F

als

e

IS-B

ism

uth

200.8

N/A

LF

B0

.95

52

N/A

1.0

47

48

58

0--

---

---

-6

0 -

12

59

61

.0

---

10

/13

/20

20

12

:39

Fals

e

Boro

n200.8

5.0

LF

B5

0.6

07

0ug

/L1

.04

74

85

80

---

---

---

85

- 1

15

10

15

0.0

--

-1

0/1

3/2

02

0 1

2:3

9F

als

e

Cadm

ium

200.8

1.0

LF

B5

1.0

50

0ug

/L1

.04

74

85

80

---

---

---

85

- 1

15

10

25

0.0

--

-1

0/1

3/2

02

0 1

2:3

9F

als

e

Chro

miu

m200.8

0.9

LF

B5

2.0

58

0ug

/L1

.04

74

85

80

---

---

---

85

- 1

15

10

45

0.0

--

-1

0/1

3/2

02

0 1

2:3

9F

als

e

Cobalt

200.8

2.0

LF

B5

1.8

37

0ug

/L1

.04

74

85

80

---

---

---

85

- 1

15

10

45

0.0

--

-1

0/1

3/2

02

0 1

2:3

9F

als

e

Copper

200.8

1.0

LF

B5

1.6

63

0ug

/L1

.04

74

85

80

---

---

---

85

- 1

15

10

35

0.0

--

-1

0/1

3/2

02

0 1

2:3

9F

als

e

IS-I

ndiu

m200.8

N/A

LF

B0

.96

99

N/A

1.0

47

48

58

0--

---

---

-6

0 -

12

59

71

.0

---

10

/13

/20

20

12

:39

Fals

e

Lead

200.8

1.0

LF

B5

2.0

31

0ug

/L1

.04

74

85

80

---

---

---

85

- 1

15

10

45

0.0

--

-1

0/1

3/2

02

0 1

2:3

9F

als

e

Lithiu

m200.8

2.0

LF

B5

0.0

15

0ug

/L1

.04

74

85

80

---

---

---

85

- 1

15

10

05

0.0

--

-1

0/1

3/2

02

0 1

2:3

9F

als

e

Manganese

200.8

2.0

LF

B5

2.1

09

0ug

/L1

.04

74

85

80

---

---

---

85

- 1

15

10

45

0.0

--

-1

0/1

3/2

02

0 1

2:3

9F

als

e

Moly

bdenum

200.8

2.0

LF

B5

0.3

09

0ug

/L1

.04

74

85

80

---

---

---

85

- 1

15

10

15

0.0

--

-1

0/1

3/2

02

0 1

2:3

9F

als

e

Nic

kel

200.8

1.0

LF

B5

1.6

82

0ug

/L1

.04

74

85

80

---

---

---

85

- 1

15

10

35

0.0

--

-1

0/1

3/2

02

0 1

2:3

9F

als

e

IS-S

candiu

m200.8

N/A

LF

B0

.97

35

N/A

1.0

47

48

58

0--

---

---

-6

0 -

12

59

71

.0

---

10

/13

/20

20

12

:39

Fals

e

Sele

niu

m200.8

2.0

LF

B5

1.6

89

0ug

/L1

.04

74

85

80

---

---

---

85

- 1

15

10

35

0.0

--

-1

0/1

3/2

02

0 1

2:3

9F

als

e

Silv

er

200.8

2.0

LF

B5

1.4

74

0ug

/L1

.04

74

85

80

---

---

---

85

- 1

15

10

35

0.0

--

-1

0/1

3/2

02

0 1

2:3

9F

als

e

Str

ontium

200.8

2.0

LF

B5

2.3

17

0ug

/L1

.04

74

85

80

---

---

---

85

- 1

15

10

55

0.0

--

-1

0/1

3/2

02

0 1

2:3

9F

als

e

IS-T

erb

ium

200.8

N/A

LF

B0

.95

60

N/A

1.0

47

48

58

0--

---

---

-6

0 -

12

59

61

.0

---

10

/13

/20

20

12

:39

Fals

e

Thalli

um

200.8

0.3

LF

B5

2.5

65

0ug

/L1

.04

74

85

80

---

---

---

85

- 1

15

10

55

0.0

--

-1

0/1

3/2

02

0 1

2:3

9F

als

e

Thori

um

200.8

5.0

LF

B5

1.1

77

0ug

/L1

.04

74

85

80

---

---

---

85

- 1

15

10

25

0.0

--

-1

0/1

3/2

02

0 1

2:3

9F

als

e

Tin

200.8

2.0

LF

B4

9.8

75

0ug

/L1

.04

74

85

80

---

---

---

85

- 1

15

10

05

0.0

--

-1

0/1

3/2

02

0 1

2:3

9F

als

e

Titaniu

m200.8

5.0

LF

B5

0.2

70

0ug

/L1

.04

74

85

80

---

---

---

85

- 1

15

10

15

0.0

--

-1

0/1

3/2

02

0 1

2:3

9F

als

e

Ura

niu

m200.8

1.0

LF

B5

1.9

59

0ug

/L1

.04

74

85

80

---

---

---

85

- 1

15

10

45

0.0

--

-1

0/1

3/2

02

0 1

2:3

9F

als

e

Vanadiu

m200.8

2.0

LF

B5

1.7

50

0ug

/L1

.04

74

85

80

---

---

---

85

- 1

15

10

45

0.0

--

-1

0/1

3/2

02

0 1

2:3

9F

als

e

IS-Y

ttri

um

200.8

N/A

LF

B0

.96

61

N/A

1.0

47

48

58

0--

---

---

-6

0 -

12

59

71

.0

---

10

/13

/20

20

12

:39

Fals

e

Zin

c200.8

5.0

LF

B5

1.8

40

0ug

/L1

.04

74

85

80

---

---

---

85

- 1

15

10

45

0.0

--

-1

0/1

3/2

02

0 1

2:3

9T

rue

Alu

min

um

200.8

2.0

FS

70

ug

/L1

.04

74

35

49

Fin

ishe

d--

---

---

---

-

--

-1

0/1

3/2

02

0 1

3:1

5T

rue

Antim

ony

200.8

1.0

FS

1.0

ug

/L1

.04

74

35

49

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

3/2

02

0 1

3:1

5T

rue

Ars

enic

200.8

1.0

FS

1.0

ug

/L1

.04

74

35

49

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

3/2

02

0 1

3:1

5T

rue

Bari

um

200.8

2.0

FS

14

ug

/L1

.04

74

35

49

Fin

ishe

d--

---

---

---

-

--

-1

0/1

3/2

02

0 1

3:1

5T

rue

Bery

llium

200.8

0.3

FS

0.3

ug

/L1

.04

74

35

49

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

3/2

02

0 1

3:1

5T

rue

IS-B

ism

uth

200.8

N/A

FS

0.9

47

0N

/A1

.04

74

35

49

Fin

ishe

d--

---

-6

0 -

12

59

51

.0

---

10

/13

/20

20

13

:15

Tru

e

Boro

n200.8

5.0

FS

28

ug

/L1

.04

74

35

49

Fin

ishe

d--

---

---

---

-

--

-1

0/1

3/2

02

0 1

3:1

5T

rue

Cadm

ium

200.8

1.0

FS

1.0

ug

/L1

.04

74

35

49

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

3/2

02

0 1

3:1

5T

rue

Chro

miu

m200.8

0.9

FS

0.9

ug

/L1

.04

74

35

49

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

3/2

02

0 1

3:1

5T

rue

Cobalt

200.8

2.0

FS

2.0

ug

/L1

.04

74

35

49

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

3/2

02

0 1

3:1

5T

rue

Copper

200.8

1.0

FS

1.0

ug

/L1

.04

74

35

49

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

3/2

02

0 1

3:1

5T

rue

IS-I

ndiu

m200.8

N/A

FS

0.9

44

3N

/A1

.04

74

35

49

Fin

ishe

d--

---

-6

0 -

12

59

41

.0

---

10

/13

/20

20

13

:15

Tru

e

Lead

200.8

1.0

FS

1.0

ug

/L1

.04

74

35

49

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

3/2

02

0 1

3:1

5

Page 5

of

9E

EA

Run I

D 2

80839 /

EE

A R

eport

# 5

00223

Page 74 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Tru

e

Lithiu

m200.8

2.0

FS

2.0

ug

/L1

.04

74

35

49

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

3/2

02

0 1

3:1

5T

rue

Manganese

200.8

2.0

FS

8.5

ug

/L1

.04

74

35

49

Fin

ishe

d--

---

---

---

-

--

-1

0/1

3/2

02

0 1

3:1

5T

rue

Moly

bdenum

200.8

2.0

FS

2.0

ug

/L1

.04

74

35

49

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

3/2

02

0 1

3:1

5T

rue

Nic

kel

200.8

1.0

FS

1.0

ug

/L1

.04

74

35

49

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

3/2

02

0 1

3:1

5T

rue

IS-S

candiu

m200.8

N/A

FS

0.9

57

6N

/A1

.04

74

35

49

Fin

ishe

d--

---

-6

0 -

12

59

61

.0

---

10

/13

/20

20

13

:15

Tru

e

Sele

niu

m200.8

2.0

FS

2.0

ug

/L1

.04

74

35

49

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

3/2

02

0 1

3:1

5T

rue

Silv

er

200.8

2.0

FS

2.0

ug

/L1

.04

74

35

49

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

3/2

02

0 1

3:1

5T

rue

Str

ontium

200.8

2.0

FS

46

ug

/L1

.04

74

35

49

Fin

ishe

d--

---

---

---

-

--

-1

0/1

3/2

02

0 1

3:1

5T

rue

IS-T

erb

ium

200.8

N/A

FS

0.9

53

5N

/A1

.04

74

35

49

Fin

ishe

d--

---

-6

0 -

12

59

51

.0

---

10

/13

/20

20

13

:15

Tru

e

Thalli

um

200.8

0.3

FS

0.3

ug

/L1

.04

74

35

49

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

3/2

02

0 1

3:1

5T

rue

Thori

um

200.8

5.0

FS

5.0

ug

/L1

.04

74

35

49

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

3/2

02

0 1

3:1

5T

rue

Tin

200.8

2.0

FS

2.0

ug

/L1

.04

74

35

49

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

3/2

02

0 1

3:1

5T

rue

Titaniu

m200.8

5.0

FS

5.0

ug

/L1

.04

74

35

49

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

3/2

02

0 1

3:1

5T

rue

Ura

niu

m200.8

1.0

FS

1.0

ug

/L1

.04

74

35

49

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

3/2

02

0 1

3:1

5T

rue

Vanadiu

m200.8

2.0

FS

2.0

ug

/L1

.04

74

35

49

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

3/2

02

0 1

3:1

5T

rue

IS-Y

ttri

um

200.8

N/A

FS

0.9

34

8N

/A1

.04

74

35

49

Fin

ishe

d--

---

-6

0 -

12

59

31

.0

---

10

/13

/20

20

13

:15

Tru

e

Zin

c200.8

5.0

FS

5.0

ug

/L1

.04

74

35

49

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

3/2

02

0 1

3:1

5F

als

e

Alu

min

um

200.8

2.0

CC

V4

8.0

02

0ug

/L1

.04

74

85

81

---

---

---

85

- 1

15

96

50

.0

---

10

/13

/20

20

13

:18

Fals

e

Antim

ony

200.8

1.0

CC

V4

7.1

56

0ug

/L1

.04

74

85

81

---

---

---

85

- 1

15

94

50

.0

---

10

/13

/20

20

13

:18

Fals

e

Ars

enic

200.8

1.0

CC

V4

7.4

03

0ug

/L1

.04

74

85

81

---

---

---

85

- 1

15

95

50

.0

---

10

/13

/20

20

13

:18

Fals

e

Bari

um

200.8

2.0

CC

V4

7.2

60

0ug

/L1

.04

74

85

81

---

---

---

85

- 1

15

95

50

.0

---

10

/13

/20

20

13

:18

Fals

e

Bery

llium

200.8

0.3

CC

V4

9.0

27

0ug

/L1

.04

74

85

81

---

---

---

85

- 1

15

98

50

.0

---

10

/13

/20

20

13

:18

Fals

e

IS-B

ism

uth

200.8

N/A

CC

V0

.93

99

N/A

1.0

47

48

58

1--

---

---

-6

0 -

12

59

41

.0

---

10

/13

/20

20

13

:18

Fals

e

Boro

n200.8

5.0

CC

V5

0.0

50

0ug

/L1

.04

74

85

81

---

---

---

85

- 1

15

10

05

0.0

--

-1

0/1

3/2

02

0 1

3:1

8F

als

e

Cadm

ium

200.8

1.0

CC

V4

6.5

94

0ug

/L1

.04

74

85

81

---

---

---

85

- 1

15

93

50

.0

---

10

/13

/20

20

13

:18

Fals

e

Chro

miu

m200.8

0.9

CC

V4

7.7

66

0ug

/L1

.04

74

85

81

---

---

---

85

- 1

15

96

50

.0

---

10

/13

/20

20

13

:18

Fals

e

Cobalt

200.8

2.0

CC

V4

7.9

92

0ug

/L1

.04

74

85

81

---

---

---

85

- 1

15

96

50

.0

---

10

/13

/20

20

13

:18

Fals

e

Copper

200.8

1.0

CC

V4

7.8

23

0ug

/L1

.04

74

85

81

---

---

---

85

- 1

15

96

50

.0

---

10

/13

/20

20

13

:18

Fals

e

IS-I

ndiu

m200.8

N/A

CC

V0

.94

06

N/A

1.0

47

48

58

1--

---

---

-6

0 -

12

59

41

.0

---

10

/13

/20

20

13

:18

Fals

e

Lead

200.8

1.0

CC

V4

8.3

18

0ug

/L1

.04

74

85

81

---

---

---

85

- 1

15

97

50

.0

---

10

/13

/20

20

13

:18

Fals

e

Lithiu

m200.8

2.0

CC

V4

9.0

45

0ug

/L1

.04

74

85

81

---

---

---

85

- 1

15

98

50

.0

---

10

/13

/20

20

13

:18

Fals

e

Manganese

200.8

2.0

CC

V4

8.2

94

0ug

/L1

.04

74

85

81

---

---

---

85

- 1

15

97

50

.0

---

10

/13

/20

20

13

:18

Fals

e

Moly

bdenum

200.8

2.0

CC

V4

7.1

81

0ug

/L1

.04

74

85

81

---

---

---

85

- 1

15

94

50

.0

---

10

/13

/20

20

13

:18

Fals

e

Nic

kel

200.8

1.0

CC

V4

8.2

89

0ug

/L1

.04

74

85

81

---

---

---

85

- 1

15

97

50

.0

---

10

/13

/20

20

13

:18

Fals

e

IS-S

candiu

m200.8

N/A

CC

V0

.94

55

N/A

1.0

47

48

58

1--

---

---

-6

0 -

12

59

51

.0

---

10

/13

/20

20

13

:18

Fals

e

Sele

niu

m200.8

2.0

CC

V4

6.4

53

0ug

/L1

.04

74

85

81

---

---

---

85

- 1

15

93

50

.0

---

10

/13

/20

20

13

:18

Fals

e

Silv

er

200.8

2.0

CC

V4

7.6

13

0ug

/L1

.04

74

85

81

---

---

---

85

- 1

15

95

50

.0

---

10

/13

/20

20

13

:18

Fals

e

Str

ontium

200.8

2.0

CC

V4

8.2

18

0ug

/L1

.04

74

85

81

---

---

---

85

- 1

15

96

50

.0

---

10

/13

/20

20

13

:18

Fals

e

IS-T

erb

ium

200.8

N/A

CC

V0

.94

40

N/A

1.0

47

48

58

1--

---

---

-6

0 -

12

59

41

.0

---

10

/13

/20

20

13

:18

Fals

e

Thalli

um

200.8

0.3

CC

V4

9.2

40

0ug

/L1

.04

74

85

81

---

---

---

85

- 1

15

98

50

.0

---

10

/13

/20

20

13

:18

Fals

e

Thori

um

200.8

5.0

CC

V4

8.2

16

0ug

/L1

.04

74

85

81

---

---

---

85

- 1

15

96

50

.0

---

10

/13

/20

20

13

:18

Page 6

of

9E

EA

Run I

D 2

80839 /

EE

A R

eport

# 5

00223

Page 75 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Fals

e

Tin

200.8

2.0

CC

V4

7.1

81

0ug

/L1

.04

74

85

81

---

---

---

85

- 1

15

94

50

.0

---

10

/13

/20

20

13

:18

Fals

e

Titaniu

m200.8

5.0

CC

V4

7.9

44

0ug

/L1

.04

74

85

81

---

---

---

85

- 1

15

96

50

.0

---

10

/13

/20

20

13

:18

Fals

e

Ura

niu

m200.8

1.0

CC

V4

8.6

86

0ug

/L1

.04

74

85

81

---

---

---

85

- 1

15

97

50

.0

---

10

/13

/20

20

13

:18

Fals

e

Vanadiu

m200.8

2.0

CC

V4

8.3

19

0ug

/L1

.04

74

85

81

---

---

---

85

- 1

15

97

50

.0

---

10

/13

/20

20

13

:18

Fals

e

IS-Y

ttri

um

200.8

N/A

CC

V0

.93

37

N/A

1.0

47

48

58

1--

---

---

-6

0 -

12

59

31

.0

---

10

/13

/20

20

13

:18

Fals

e

Zin

c200.8

5.0

CC

V4

7.6

08

0ug

/L1

.04

74

85

81

---

---

---

85

- 1

15

95

50

.0

---

10

/13

/20

20

13

:18

Tru

e

Alu

min

um

200.8

2.0

CC

B2

.0ug

/L1

.04

74

85

82

---

---

---

---

---

<

---

10

/13

/20

20

13

:21

Tru

e

Antim

ony

200.8

1.0

CC

B1

.0ug

/L1

.04

74

85

82

---

---

---

---

---

<

---

10

/13

/20

20

13

:21

Tru

e

Ars

enic

200.8

1.0

CC

B1

.0ug

/L1

.04

74

85

82

---

---

---

---

---

<

---

10

/13

/20

20

13

:21

Tru

e

Bari

um

200.8

2.0

CC

B2

.0ug

/L1

.04

74

85

82

---

---

---

---

---

<

---

10

/13

/20

20

13

:21

Tru

e

Bery

llium

200.8

0.3

CC

B0

.3ug

/L1

.04

74

85

82

---

---

---

---

---

<

---

10

/13

/20

20

13

:21

Tru

e

IS-B

ism

uth

200.8

N/A

CC

B0

.94

02

N/A

1.0

47

48

58

2--

---

---

-6

0 -

12

59

41

.0

---

10

/13

/20

20

13

:21

Tru

e

Boro

n200.8

5.0

CC

B5

.0ug

/L1

.04

74

85

82

---

---

---

---

---

<

---

10

/13

/20

20

13

:21

Tru

e

Cadm

ium

200.8

1.0

CC

B1

.0ug

/L1

.04

74

85

82

---

---

---

---

---

<

---

10

/13

/20

20

13

:21

Tru

e

Chro

miu

m200.8

0.9

CC

B0

.9ug

/L1

.04

74

85

82

---

---

---

---

---

<

---

10

/13

/20

20

13

:21

Tru

e

Cobalt

200.8

2.0

CC

B2

.0ug

/L1

.04

74

85

82

---

---

---

---

---

<

---

10

/13

/20

20

13

:21

Tru

e

Copper

200.8

1.0

CC

B1

.0ug

/L1

.04

74

85

82

---

---

---

---

---

<

---

10

/13

/20

20

13

:21

Tru

e

IS-I

ndiu

m200.8

N/A

CC

B0

.93

09

N/A

1.0

47

48

58

2--

---

---

-6

0 -

12

59

31

.0

---

10

/13

/20

20

13

:21

Tru

e

Lead

200.8

1.0

CC

B1

.0ug

/L1

.04

74

85

82

---

---

---

---

---

<

---

10

/13

/20

20

13

:21

Tru

e

Lithiu

m200.8

2.0

CC

B2

.0ug

/L1

.04

74

85

82

---

---

---

---

---

<

---

10

/13

/20

20

13

:21

Tru

e

Manganese

200.8

2.0

CC

B2

.0ug

/L1

.04

74

85

82

---

---

---

---

---

<

---

10

/13

/20

20

13

:21

Tru

e

Moly

bdenum

200.8

2.0

CC

B2

.0ug

/L1

.04

74

85

82

---

---

---

---

---

<

---

10

/13

/20

20

13

:21

Tru

e

Nic

kel

200.8

1.0

CC

B1

.0ug

/L1

.04

74

85

82

---

---

---

---

---

<

---

10

/13

/20

20

13

:21

Tru

e

IS-S

candiu

m200.8

N/A

CC

B0

.94

05

N/A

1.0

47

48

58

2--

---

---

-6

0 -

12

59

41

.0

---

10

/13

/20

20

13

:21

Tru

e

Sele

niu

m200.8

2.0

CC

B2

.0ug

/L1

.04

74

85

82

---

---

---

---

---

<

---

10

/13

/20

20

13

:21

Tru

e

Silv

er

200.8

2.0

CC

B2

.0ug

/L1

.04

74

85

82

---

---

---

---

---

<

---

10

/13

/20

20

13

:21

Tru

e

Str

ontium

200.8

2.0

CC

B2

.0ug

/L1

.04

74

85

82

---

---

---

---

---

<

---

10

/13

/20

20

13

:21

Tru

e

IS-T

erb

ium

200.8

N/A

CC

B0

.94

48

N/A

1.0

47

48

58

2--

---

---

-6

0 -

12

59

41

.0

---

10

/13

/20

20

13

:21

Tru

e

Thalli

um

200.8

0.3

CC

B0

.3ug

/L1

.04

74

85

82

---

---

---

---

---

<

---

10

/13

/20

20

13

:21

Tru

e

Thori

um

200.8

5.0

CC

B5

.0ug

/L1

.04

74

85

82

---

---

---

---

---

<

---

10

/13

/20

20

13

:21

Tru

e

Tin

200.8

2.0

CC

B2

.0ug

/L1

.04

74

85

82

---

---

---

---

---

<

---

10

/13

/20

20

13

:21

Tru

e

Titaniu

m200.8

5.0

CC

B5

.0ug

/L1

.04

74

85

82

---

---

---

---

---

<

---

10

/13

/20

20

13

:21

Tru

e

Ura

niu

m200.8

1.0

CC

B1

.0ug

/L1

.04

74

85

82

---

---

---

---

---

<

---

10

/13

/20

20

13

:21

Tru

e

Vanadiu

m200.8

2.0

CC

B2

.0ug

/L1

.04

74

85

82

---

---

---

---

---

<

---

10

/13

/20

20

13

:21

Tru

e

IS-Y

ttri

um

200.8

N/A

CC

B0

.93

46

N/A

1.0

47

48

58

2--

---

---

-6

0 -

12

59

31

.0

---

10

/13

/20

20

13

:21

Tru

e

Zin

c200.8

5.0

CC

B5

.0ug

/L1

.04

74

85

82

---

---

---

---

---

<

---

10

/13

/20

20

13

:21

Fals

e

Alu

min

um

200.8

2.0

CC

V4

6.7

46

0ug

/L1

.04

74

85

84

---

---

---

85

- 1

15

93

50

.0

---

10

/13

/20

20

13

:46

Fals

e

Antim

ony

200.8

1.0

CC

V4

6.5

19

0ug

/L1

.04

74

85

84

---

---

---

85

- 1

15

93

50

.0

---

10

/13

/20

20

13

:46

Fals

e

Ars

enic

200.8

1.0

CC

V4

6.5

05

0ug

/L1

.04

74

85

84

---

---

---

85

- 1

15

93

50

.0

---

10

/13

/20

20

13

:46

Fals

e

Bari

um

200.8

2.0

CC

V4

6.6

86

0ug

/L1

.04

74

85

84

---

---

---

85

- 1

15

93

50

.0

---

10

/13

/20

20

13

:46

Fals

e

Bery

llium

200.8

0.3

CC

V4

7.4

20

0ug

/L1

.04

74

85

84

---

---

---

85

- 1

15

95

50

.0

---

10

/13

/20

20

13

:46

Page 7

of

9E

EA

Run I

D 2

80839 /

EE

A R

eport

# 5

00223

Page 76 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Fals

e

IS-B

ism

uth

200.8

N/A

CC

V0

.99

08

N/A

1.0

47

48

58

4--

---

---

-6

0 -

12

59

91

.0

---

10

/13

/20

20

13

:46

Fals

e

Boro

n200.8

5.0

CC

V4

6.9

71

0ug

/L1

.04

74

85

84

---

---

---

85

- 1

15

94

50

.0

---

10

/13

/20

20

13

:46

Fals

e

Cadm

ium

200.8

1.0

CC

V4

6.2

34

0ug

/L1

.04

74

85

84

---

---

---

85

- 1

15

92

50

.0

---

10

/13

/20

20

13

:46

Fals

e

Chro

miu

m200.8

0.9

CC

V4

6.6

01

0ug

/L1

.04

74

85

84

---

---

---

85

- 1

15

93

50

.0

---

10

/13

/20

20

13

:46

Fals

e

Cobalt

200.8

2.0

CC

V4

7.0

40

0ug

/L1

.04

74

85

84

---

---

---

85

- 1

15

94

50

.0

---

10

/13

/20

20

13

:46

Fals

e

Copper

200.8

1.0

CC

V4

6.5

53

0ug

/L1

.04

74

85

84

---

---

---

85

- 1

15

93

50

.0

---

10

/13

/20

20

13

:46

Fals

e

IS-I

ndiu

m200.8

N/A

CC

V0

.97

18

N/A

1.0

47

48

58

4--

---

---

-6

0 -

12

59

71

.0

---

10

/13

/20

20

13

:46

Fals

e

Lead

200.8

1.0

CC

V4

7.2

07

0ug

/L1

.04

74

85

84

---

---

---

85

- 1

15

94

50

.0

---

10

/13

/20

20

13

:46

Fals

e

Lithiu

m200.8

2.0

CC

V4

7.5

80

0ug

/L1

.04

74

85

84

---

---

---

85

- 1

15

95

50

.0

---

10

/13

/20

20

13

:46

Fals

e

Manganese

200.8

2.0

CC

V4

7.4

92

0ug

/L1

.04

74

85

84

---

---

---

85

- 1

15

95

50

.0

---

10

/13

/20

20

13

:46

Fals

e

Moly

bdenum

200.8

2.0

CC

V4

6.4

43

0ug

/L1

.04

74

85

84

---

---

---

85

- 1

15

93

50

.0

---

10

/13

/20

20

13

:46

Fals

e

Nic

kel

200.8

1.0

CC

V4

7.0

39

0ug

/L1

.04

74

85

84

---

---

---

85

- 1

15

94

50

.0

---

10

/13

/20

20

13

:46

Fals

e

IS-S

candiu

m200.8

N/A

CC

V0

.97

37

N/A

1.0

47

48

58

4--

---

---

-6

0 -

12

59

71

.0

---

10

/13

/20

20

13

:46

Fals

e

Sele

niu

m200.8

2.0

CC

V4

6.2

65

0ug

/L1

.04

74

85

84

---

---

---

85

- 1

15

93

50

.0

---

10

/13

/20

20

13

:46

Fals

e

Silv

er

200.8

2.0

CC

V4

7.3

62

0ug

/L1

.04

74

85

84

---

---

---

85

- 1

15

95

50

.0

---

10

/13

/20

20

13

:46

Fals

e

Str

ontium

200.8

2.0

CC

V4

7.7

84

0ug

/L1

.04

74

85

84

---

---

---

85

- 1

15

96

50

.0

---

10

/13

/20

20

13

:46

Fals

e

IS-T

erb

ium

200.8

N/A

CC

V0

.99

09

N/A

1.0

47

48

58

4--

---

---

-6

0 -

12

59

91

.0

---

10

/13

/20

20

13

:46

Fals

e

Thalli

um

200.8

0.3

CC

V4

8.5

86

0ug

/L1

.04

74

85

84

---

---

---

85

- 1

15

97

50

.0

---

10

/13

/20

20

13

:46

Fals

e

Thori

um

200.8

5.0

CC

V4

6.8

52

0ug

/L1

.04

74

85

84

---

---

---

85

- 1

15

94

50

.0

---

10

/13

/20

20

13

:46

Fals

e

Tin

200.8

2.0

CC

V4

6.3

97

0ug

/L1

.04

74

85

84

---

---

---

85

- 1

15

93

50

.0

---

10

/13

/20

20

13

:46

Fals

e

Titaniu

m200.8

5.0

CC

V4

7.1

22

0ug

/L1

.04

74

85

84

---

---

---

85

- 1

15

94

50

.0

---

10

/13

/20

20

13

:46

Fals

e

Ura

niu

m200.8

1.0

CC

V4

7.0

40

0ug

/L1

.04

74

85

84

---

---

---

85

- 1

15

94

50

.0

---

10

/13

/20

20

13

:46

Fals

e

Vanadiu

m200.8

2.0

CC

V4

7.2

59

0ug

/L1

.04

74

85

84

---

---

---

85

- 1

15

95

50

.0

---

10

/13

/20

20

13

:46

Fals

e

IS-Y

ttri

um

200.8

N/A

CC

V0

.95

96

N/A

1.0

47

48

58

4--

---

---

-6

0 -

12

59

61

.0

---

10

/13

/20

20

13

:46

Fals

e

Zin

c200.8

5.0

CC

V4

6.8

47

0ug

/L1

.04

74

85

84

---

---

---

85

- 1

15

94

50

.0

---

10

/13

/20

20

13

:46

Tru

e

Alu

min

um

200.8

2.0

CC

B2

.0ug

/L1

.04

74

85

85

---

---

---

---

---

<

---

10

/13

/20

20

13

:49

Tru

e

Antim

ony

200.8

1.0

CC

B1

.0ug

/L1

.04

74

85

85

---

---

---

---

---

<

---

10

/13

/20

20

13

:49

Tru

e

Ars

enic

200.8

1.0

CC

B1

.0ug

/L1

.04

74

85

85

---

---

---

---

---

<

---

10

/13

/20

20

13

:49

Tru

e

Bari

um

200.8

2.0

CC

B2

.0ug

/L1

.04

74

85

85

---

---

---

---

---

<

---

10

/13

/20

20

13

:49

Tru

e

Bery

llium

200.8

0.3

CC

B0

.3ug

/L1

.04

74

85

85

---

---

---

---

---

<

---

10

/13

/20

20

13

:49

Tru

e

IS-B

ism

uth

200.8

N/A

CC

B0

.99

68

N/A

1.0

47

48

58

5--

---

---

-6

0 -

12

51

00

1.0

--

-1

0/1

3/2

02

0 1

3:4

9T

rue

Boro

n200.8

5.0

CC

B5

.0ug

/L1

.04

74

85

85

---

---

---

---

---

<

---

10

/13

/20

20

13

:49

Tru

e

Cadm

ium

200.8

1.0

CC

B1

.0ug

/L1

.04

74

85

85

---

---

---

---

---

<

---

10

/13

/20

20

13

:49

Tru

e

Chro

miu

m200.8

0.9

CC

B0

.9ug

/L1

.04

74

85

85

---

---

---

---

---

<

---

10

/13

/20

20

13

:49

Tru

e

Cobalt

200.8

2.0

CC

B2

.0ug

/L1

.04

74

85

85

---

---

---

---

---

<

---

10

/13

/20

20

13

:49

Tru

e

Copper

200.8

1.0

CC

B1

.0ug

/L1

.04

74

85

85

---

---

---

---

---

<

---

10

/13

/20

20

13

:49

Tru

e

IS-I

ndiu

m200.8

N/A

CC

B0

.97

20

N/A

1.0

47

48

58

5--

---

---

-6

0 -

12

59

71

.0

---

10

/13

/20

20

13

:49

Tru

e

Lead

200.8

1.0

CC

B1

.0ug

/L1

.04

74

85

85

---

---

---

---

---

<

---

10

/13

/20

20

13

:49

Tru

e

Lithiu

m200.8

2.0

CC

B2

.0ug

/L1

.04

74

85

85

---

---

---

---

---

<

---

10

/13

/20

20

13

:49

Tru

e

Manganese

200.8

2.0

CC

B2

.0ug

/L1

.04

74

85

85

---

---

---

---

---

<

---

10

/13

/20

20

13

:49

Tru

e

Moly

bdenum

200.8

2.0

CC

B2

.0ug

/L1

.04

74

85

85

---

---

---

---

---

<

---

10

/13

/20

20

13

:49

Page 8

of

9E

EA

Run I

D 2

80839 /

EE

A R

eport

# 5

00223

Page 77 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Tru

e

Nic

kel

200.8

1.0

CC

B1

.0ug

/L1

.04

74

85

85

---

---

---

---

---

<

---

10

/13

/20

20

13

:49

Tru

e

IS-S

candiu

m200.8

N/A

CC

B0

.97

31

N/A

1.0

47

48

58

5--

---

---

-6

0 -

12

59

71

.0

---

10

/13

/20

20

13

:49

Tru

e

Sele

niu

m200.8

2.0

CC

B2

.0ug

/L1

.04

74

85

85

---

---

---

---

---

<

---

10

/13

/20

20

13

:49

Tru

e

Silv

er

200.8

2.0

CC

B2

.0ug

/L1

.04

74

85

85

---

---

---

---

---

<

---

10

/13

/20

20

13

:49

Tru

e

Str

ontium

200.8

2.0

CC

B2

.0ug

/L1

.04

74

85

85

---

---

---

---

---

<

---

10

/13

/20

20

13

:49

Tru

e

IS-T

erb

ium

200.8

N/A

CC

B0

.99

84

N/A

1.0

47

48

58

5--

---

---

-6

0 -

12

51

00

1.0

--

-1

0/1

3/2

02

0 1

3:4

9T

rue

Thalli

um

200.8

0.3

CC

B0

.3ug

/L1

.04

74

85

85

---

---

---

---

---

<

---

10

/13

/20

20

13

:49

Tru

e

Thori

um

200.8

5.0

CC

B5

.0ug

/L1

.04

74

85

85

---

---

---

---

---

<

---

10

/13

/20

20

13

:49

Tru

e

Tin

200.8

2.0

CC

B2

.0ug

/L1

.04

74

85

85

---

---

---

---

---

<

---

10

/13

/20

20

13

:49

Tru

e

Titaniu

m200.8

5.0

CC

B5

.0ug

/L1

.04

74

85

85

---

---

---

---

---

<

---

10

/13

/20

20

13

:49

Tru

e

Ura

niu

m200.8

1.0

CC

B1

.0ug

/L1

.04

74

85

85

---

---

---

---

---

<

---

10

/13

/20

20

13

:49

Tru

e

Vanadiu

m200.8

2.0

CC

B2

.0ug

/L1

.04

74

85

85

---

---

---

---

---

<

---

10

/13

/20

20

13

:49

Tru

e

IS-Y

ttri

um

200.8

N/A

CC

B0

.96

30

N/A

1.0

47

48

58

5--

---

---

-6

0 -

12

59

61

.0

---

10

/13

/20

20

13

:49

Tru

e

Zin

c200.8

5.0

CC

B5

.0ug

/L1

.04

74

85

85

---

---

---

---

---

<

---

10

/13

/20

20

13

:49

Page 9

of

9E

EA

Run I

D 2

80839 /

EE

A R

eport

# 5

00223

Page 78 of 201

Eu

rofi

ns

Ea

ton

An

aly

tica

lR

un

Lo

gR

un ID

:280767

Meth

od:

218.6

Sam

ple

Sit

eS

am

ple

Id

Typ

eIn

str

um

en

t ID

Cali

bra

tio

n F

ile

An

aly

sis

Date

Matr

ix

LR

B4

74

77

12

DP

10

/08

/20

20

21

:26

RW

LF

B4

74

77

13

DP

10

/08

/20

20

21

:39

RW

IPC

47

47

71

6D

P1

0/0

9/2

02

0 0

0:2

8R

W

CC

B4

74

77

17

DP

10

/09

/20

20

00

:41

RW

FS

47

43

54

3F

inis

he

dD

P1

0/0

9/2

02

0 0

0:5

4D

W

MS

47

47

71

8F

inis

he

dD

P1

0/0

9/2

02

0 0

1:0

7D

W

MS

D4

74

77

19

Fin

ish

ed

DP

10

/09

/20

20

01

:20

DW

IPC

47

47

72

0D

P1

0/0

9/2

02

0 0

2:3

8R

W

CC

B4

74

77

21

DP

10

/09

/20

20

02

:51

RW

0.0

0

Page 1

of

2E

EA

Run I

D 2

80767 /

EE

A R

eport

# 5

00223

Page 79 of 201

QC

Su

mm

ary

Re

po

rt

EE

AID

#R

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

eth

od

An

aly

teS

am

ple

Typ

eD

ilF

ac

tor

RP

DL

imit

Re

co

ve

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

gM

RL

Ex

tra

cte

dA

na

lyze

d

Tru

e

Chro

miu

m, H

exa

vale

nt

218.6

0.0

2L

RB

0.0

2ug

/L1

.04

74

77

12

---

---

---

---

---

<

---

10

/08

/20

20

21

:26

Fals

e

Chro

miu

m, H

exa

vale

nt

218.6

0.0

2L

FB

0.9

97

0ug

/L1

.04

74

77

13

---

---

---

90

- 1

10

10

01

.0

---

10

/08

/20

20

21

:39

Tru

e

Chro

miu

m, H

exa

vale

nt

218.6

0.0

2IP

C0

.99

16

ug

/L1

.04

74

77

16

---

---

---

90

- 1

10

99

1.0

--

-1

0/0

9/2

02

0 0

0:2

8F

als

e

Chro

miu

m, H

exa

vale

nt

218.6

0.0

2C

CB

0.0

2ug

/L1

.04

74

77

17

---

---

---

---

---

<

---

10

/09

/20

20

00

:41

Tru

e

Chro

miu

m, H

exa

vale

nt

218.6

0.0

2F

S0

.33

ug

/L1

.04

74

35

43

Fin

ishe

d--

---

---

---

-

--

-1

0/0

9/2

02

0 0

0:5

4F

als

e

Chro

miu

m, H

exa

vale

nt

218.6

0.0

2M

S1

.40

01

ug

/L1

.04

74

77

18

Fin

ishe

d--

---

-9

0 -

11

01

07

1.3

31

89

9

---

10

/09

/20

20

01

:07

Tru

e

Chro

miu

m, H

exa

vale

nt

218.6

0.0

2M

SD

1.3

99

8ug

/L1

.04

74

77

19

Fin

ishe

d1

00

.09

0 -

11

01

07

1.3

31

89

9

---

10

/09

/20

20

01

:20

Fals

e

Chro

miu

m, H

exa

vale

nt

218.6

0.0

2IP

C1

.01

28

ug

/L1

.04

74

77

20

---

---

---

90

- 1

10

10

11

.0

---

10

/09

/20

20

02

:38

Tru

e

Chro

miu

m, H

exa

vale

nt

218.6

0.0

2C

CB

0.0

2ug

/L1

.04

74

77

21

---

---

---

---

---

<

---

10

/09

/20

20

02

:51

Page 2

of

2E

EA

Run I

D 2

80767 /

EE

A R

eport

# 5

00223

Page 80 of 201

Eu

rofi

ns

Ea

ton

An

aly

tica

lR

un

Lo

gR

un ID

:280763

Meth

od:

331.0

Sam

ple

Sit

eS

am

ple

Id

Typ

eIn

str

um

en

t ID

Cali

bra

tio

n F

ile

An

aly

sis

Date

Matr

ix

CC

L4

74

53

49

PW

61

00

92

0M

33

1a

.md

b1

0/0

9/2

02

0 1

8:2

4R

W

LM

B4

74

53

51

PW

61

00

92

0M

33

1a

.md

b1

0/0

9/2

02

0 1

9:0

7R

W

FB

L4

74

53

52

PW

61

00

92

0M

33

1a

.md

b1

0/0

9/2

02

0 1

9:2

9R

W

FB

M4

74

53

53

PW

61

00

92

0M

33

1a

.md

b1

0/0

9/2

02

0 1

9:5

1R

W

CC

H4

74

53

54

PW

61

00

92

0M

33

1a

.md

b1

0/0

9/2

02

0 2

3:5

0R

W

FS

47

43

54

2F

inis

he

dP

W6

10

09

20

M3

31

a.m

db

10

/10

/20

20

00

:56

DW

CC

M4

74

53

55

PW

61

00

92

0M

33

1a

.md

b1

0/1

0/2

02

0 0

3:2

8R

W

0.0

0

Page 1

of

2E

EA

Run I

D 2

80763 /

EE

A R

eport

# 5

00223

Page 81 of 201

QC

Su

mm

ary

Re

po

rt

EE

AID

#R

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

eth

od

An

aly

teS

am

ple

Typ

eD

ilF

ac

tor

RP

DL

imit

Re

co

ve

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

gM

RL

Ex

tra

cte

dA

na

lyze

d

Tru

e

Perc

hlo

rate

331.0

0.0

5C

CL

0.0

53

3ug

/L1

.04

74

53

49

---

---

---

50

- 1

50

10

70

.05

--

-1

0/0

9/2

02

0 1

8:2

4F

als

e

Perc

hlo

rate

331.0

0.0

5L

MB

0.0

5ug

/L1

.04

74

53

51

---

---

---

---

---

<

---

10

/09

/20

20

19

:07

Tru

e

Perc

hlo

rate

331.0

0.0

5F

BL

0.0

46

7ug

/L1

.04

74

53

52

---

---

---

50

- 1

50

93

0.0

5

---

10

/09

/20

20

19

:29

Fals

e

Perc

hlo

rate

331.0

0.0

5F

BM

4.9

77

3ug

/L1

.04

74

53

53

---

---

---

80

- 1

20

10

05

.0

---

10

/09

/20

20

19

:51

Tru

e

Perc

hlo

rate

331.0

0.0

5C

CH

10

.03

72

ug

/L1

.04

74

53

54

---

---

---

80

- 1

20

10

01

0.0

--

-1

0/0

9/2

02

0 2

3:5

0F

als

e

Perc

hlo

rate

331.0

0.0

5F

S0

.05

ug

/L1

.04

74

35

42

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

0/2

02

0 0

0:5

6T

rue

Perc

hlo

rate

331.0

0.0

5C

CM

4.8

96

0ug

/L1

.04

74

53

55

---

---

---

80

- 1

20

98

5.0

--

-1

0/1

0/2

02

0 0

3:2

8

Page 2

of

2E

EA

Run I

D 2

80763 /

EE

A R

eport

# 5

00223

Page 82 of 201

Eu

rofi

ns

Ea

ton

An

aly

tica

lR

un

Lo

gR

un ID

:281204

Meth

od:

515.3

Sam

ple

Sit

eS

am

ple

Id

Typ

eIn

str

um

en

t ID

Cali

bra

tio

n F

ile

An

aly

sis

Date

Matr

ix

CC

C4

75

10

45

GG

m 5

15

.3 1

00

92

0G

G1

0/2

0/2

02

0 1

4:1

7R

W

LM

B4

75

10

38

GG

m 5

15

.3 1

00

92

0G

G1

0/2

0/2

02

0 1

5:0

6R

W

CC

C4

75

10

46

GG

m 5

15

.3 1

00

92

0G

G1

0/2

1/2

02

0 0

1:4

0R

W

FS

47

43

54

1F

inis

he

dG

Gm

51

5.3

10

09

20

GG

10

/21

/20

20

03

:18

DW

CC

C4

75

10

47

GG

m 5

15

.3 1

00

92

0G

G1

0/2

1/2

02

0 1

2:1

4R

W

0.0

0

Page 1

of

4E

EA

Run I

D 2

81204 /

EE

A R

eport

# 5

00223

Page 83 of 201

QC

Su

mm

ary

Re

po

rt

EE

AID

#R

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

eth

od

An

aly

teS

am

ple

Typ

eD

ilF

ac

tor

RP

DL

imit

Re

co

ve

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

gM

RL

Ex

tra

cte

dA

na

lyze

d

Tru

e

IS-4

,4'-D

ibro

mooct

afluoro

bip

henyl

515.3

N/A

CC

C1

61

9ug

/L1

.04

75

10

45

---

---

---

70

- 1

30

98

16

52

1

0/1

5/2

02

0 0

8:3

01

0/2

0/2

02

0 1

4:1

7T

rue

SS

-2,4

-Dic

hlo

rophenyl

ace

tic

aci

d515.3

N/A

CC

C2

4.2

01

1ug

/L1

.04

75

10

45

---

---

---

70

- 1

30

97

25

.0

10

/15

/20

20

08

:30

10

/20

/20

20

14

:17

Tru

e

Aci

fluorf

en

515.3

1.0

CC

C0

.97

32

ug

/L1

.04

75

10

45

---

---

---

70

- 1

30

97

1.0

1

0/1

5/2

02

0 0

8:3

01

0/2

0/2

02

0 1

4:1

7T

rue

Benta

zon

515.3

0.5

CC

C1

.00

19

ug

/L1

.04

75

10

45

---

---

---

70

- 1

30

10

01

.0

10

/15

/20

20

08

:30

10

/20

/20

20

14

:17

Tru

e

Chlo

ram

ben

515.3

2.0

CC

C0

.85

75

ug

/L1

.04

75

10

45

---

---

---

70

- 1

30

86

1.0

1

0/1

5/2

02

0 0

8:3

01

0/2

0/2

02

0 1

4:1

7T

rue

2,4

-D515.3

0.1

CC

C1

.06

50

ug

/L1

.04

75

10

45

---

---

---

70

- 1

30

10

61

.0

10

/15

/20

20

08

:30

10

/20

/20

20

14

:17

Tru

e

Dala

pon

515.3

1.0

CC

C0

.96

55

ug

/L1

.04

75

10

45

---

---

---

70

- 1

30

97

1.0

1

0/1

5/2

02

0 0

8:3

01

0/2

0/2

02

0 1

4:1

7T

rue

2,4

-DB

515.3

2.0

CC

C0

.86

16

ug

/L1

.04

75

10

45

---

---

---

70

- 1

30

86

1.0

1

0/1

5/2

02

0 0

8:3

01

0/2

0/2

02

0 1

4:1

7T

rue

DC

PA

aci

d m

eta

bolit

es

515.3

0.5

CC

C0

.94

96

ug

/L1

.04

75

10

45

---

---

---

70

- 1

30

95

1.0

1

0/1

5/2

02

0 0

8:3

01

0/2

0/2

02

0 1

4:1

7T

rue

Dic

am

ba

515.3

0.1

CC

C1

.07

84

ug

/L1

.04

75

10

45

---

---

---

70

- 1

30

10

81

.0

10

/15

/20

20

08

:30

10

/20

/20

20

14

:17

Tru

e

3,5

-Dic

hlo

robenzo

ic a

cid

515.3

0.5

CC

C1

.02

85

ug

/L1

.04

75

10

45

---

---

---

70

- 1

30

10

31

.0

10

/15

/20

20

08

:30

10

/20

/20

20

14

:17

Tru

e

Dic

hlo

rpro

p515.3

2.0

CC

C0

.97

43

ug

/L1

.04

75

10

45

---

---

---

70

- 1

30

97

1.0

1

0/1

5/2

02

0 0

8:3

01

0/2

0/2

02

0 1

4:1

7T

rue

Din

ose

b515.3

0.1

CC

C0

.98

44

ug

/L1

.04

75

10

45

---

---

---

70

- 1

30

98

1.0

1

0/1

5/2

02

0 0

8:3

01

0/2

0/2

02

0 1

4:1

7T

rue

Penta

chlo

rophenol

515.3

0.0

4C

CC

0.1

90

8ug

/L1

.04

75

10

45

---

---

---

70

- 1

30

95

0.2

1

0/1

5/2

02

0 0

8:3

01

0/2

0/2

02

0 1

4:1

7T

rue

Pic

lora

m515.3

0.1

CC

C0

.43

99

ug

/L1

.04

75

10

45

---

---

---

70

- 1

30

88

0.5

1

0/1

5/2

02

0 0

8:3

01

0/2

0/2

02

0 1

4:1

7T

rue

2,4

,5-T

515.3

0.5

CC

C0

.96

03

ug

/L1

.04

75

10

45

---

---

---

70

- 1

30

96

1.0

1

0/1

5/2

02

0 0

8:3

01

0/2

0/2

02

0 1

4:1

7T

rue

2,4

,5-T

P (

Silv

ex)

515.3

0.1

CC

C0

.47

72

ug

/L1

.04

75

10

45

---

---

---

70

- 1

30

95

0.5

1

0/1

5/2

02

0 0

8:3

01

0/2

0/2

02

0 1

4:1

7T

rue

Tri

clopyr

515.3

0.5

CC

C0

.97

39

ug

/L1

.04

75

10

45

---

---

---

69

- 1

41

97

1.0

1

0/1

5/2

02

0 0

8:3

01

0/2

0/2

02

0 1

4:1

7F

als

e

IS-4

,4'-D

ibro

mooct

afluoro

bip

henyl

515.3

N/A

LM

B1

65

4ug

/L1

.04

75

10

38

---

---

---

70

- 1

30

10

01

65

2

10

/15

/20

20

08

:30

10

/20

/20

20

15

:06

Fals

e

SS

-2,4

-Dic

hlo

rophenyl

ace

tic

aci

d515.3

N/A

LM

B2

2.7

95

0ug

/L1

.04

75

10

38

---

---

---

70

- 1

30

91

25

.0

10

/15

/20

20

08

:30

10

/20

/20

20

15

:06

Fals

e

Aci

fluorf

en

515.3

1.0

LM

B1

.0ug

/L1

.04

75

10

38

---

---

---

---

---

<

10

/15

/20

20

08

:30

10

/20

/20

20

15

:06

Fals

e

Benta

zon

515.3

0.5

LM

B0

.5ug

/L1

.04

75

10

38

---

---

---

---

---

<

10

/15

/20

20

08

:30

10

/20

/20

20

15

:06

Fals

e

Chlo

ram

ben

515.3

2.0

LM

B2

.0ug

/L1

.04

75

10

38

---

---

---

---

---

<

10

/15

/20

20

08

:30

10

/20

/20

20

15

:06

Fals

e

2,4

-D515.3

0.1

LM

B0

.1ug

/L1

.04

75

10

38

---

---

---

---

---

<

10

/15

/20

20

08

:30

10

/20

/20

20

15

:06

Fals

e

Dala

pon

515.3

1.0

LM

B1

.0ug

/L1

.04

75

10

38

---

---

---

---

---

<

10

/15

/20

20

08

:30

10

/20

/20

20

15

:06

Fals

e

2,4

-DB

515.3

2.0

LM

B2

.0ug

/L1

.04

75

10

38

---

---

---

---

---

<

10

/15

/20

20

08

:30

10

/20

/20

20

15

:06

Fals

e

DC

PA

aci

d m

eta

bolit

es

515.3

0.5

LM

B0

.5ug

/L1

.04

75

10

38

---

---

---

---

---

<

10

/15

/20

20

08

:30

10

/20

/20

20

15

:06

Fals

e

Dic

am

ba

515.3

0.1

LM

B0

.1ug

/L1

.04

75

10

38

---

---

---

---

---

<

10

/15

/20

20

08

:30

10

/20

/20

20

15

:06

Fals

e

3,5

-Dic

hlo

robenzo

ic a

cid

515.3

0.5

LM

B0

.5ug

/L1

.04

75

10

38

---

---

---

---

---

<

10

/15

/20

20

08

:30

10

/20

/20

20

15

:06

Fals

e

Dic

hlo

rpro

p515.3

2.0

LM

B2

.0ug

/L1

.04

75

10

38

---

---

---

---

---

<

10

/15

/20

20

08

:30

10

/20

/20

20

15

:06

Fals

e

Din

ose

b515.3

0.1

LM

B0

.1ug

/L1

.04

75

10

38

---

---

---

---

---

<

10

/15

/20

20

08

:30

10

/20

/20

20

15

:06

Fals

e

Penta

chlo

rophenol

515.3

0.0

4L

MB

0.0

4ug

/L1

.04

75

10

38

---

---

---

---

---

<

10

/15

/20

20

08

:30

10

/20

/20

20

15

:06

Fals

e

Pic

lora

m515.3

0.1

LM

B0

.1ug

/L1

.04

75

10

38

---

---

---

---

---

<

10

/15

/20

20

08

:30

10

/20

/20

20

15

:06

Fals

e

2,4

,5-T

515.3

0.5

LM

B0

.5ug

/L1

.04

75

10

38

---

---

---

---

---

<

10

/15

/20

20

08

:30

10

/20

/20

20

15

:06

Fals

e

2,4

,5-T

P (

Silv

ex)

515.3

0.1

LM

B0

.1ug

/L1

.04

75

10

38

---

---

---

---

---

<

10

/15

/20

20

08

:30

10

/20

/20

20

15

:06

Fals

e

Tri

clopyr

515.3

0.5

LM

B0

.5ug

/L1

.04

75

10

38

---

---

---

---

---

<

10

/15

/20

20

08

:30

10

/20

/20

20

15

:06

Tru

e

IS-4

,4'-D

ibro

mooct

afluoro

bip

henyl

515.3

N/A

CC

C1

77

1ug

/L1

.04

75

10

46

---

---

---

70

- 1

30

10

71

65

2

10

/15

/20

20

08

:30

10

/21

/20

20

01

:40

Tru

e

SS

-2,4

-Dic

hlo

rophenyl

ace

tic

aci

d515.3

N/A

CC

C2

6.2

24

4ug

/L1

.04

75

10

46

---

---

---

70

- 1

30

10

52

5.0

1

0/1

5/2

02

0 0

8:3

01

0/2

1/2

02

0 0

1:4

0T

rue

Aci

fluorf

en

515.3

1.0

CC

C3

.69

17

ug

/L1

.04

75

10

46

---

---

---

70

- 1

30

12

33

.0

10

/15

/20

20

08

:30

10

/21

/20

20

01

:40

Tru

e

Benta

zon

515.3

0.5

CC

C3

.19

20

ug

/L1

.04

75

10

46

---

---

---

70

- 1

30

10

63

.0

10

/15

/20

20

08

:30

10

/21

/20

20

01

:40

Page 2

of

4E

EA

Run I

D 2

81204 /

EE

A R

eport

# 5

00223

Page 84 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Tru

e

Chlo

ram

ben

515.3

2.0

CC

C3

.09

75

ug

/L1

.04

75

10

46

---

---

---

70

- 1

30

10

33

.0

10

/15

/20

20

08

:30

10

/21

/20

20

01

:40

Tru

e

2,4

-D515.3

0.1

CC

C3

.26

16

ug

/L1

.04

75

10

46

---

---

---

70

- 1

30

10

93

.0

10

/15

/20

20

08

:30

10

/21

/20

20

01

:40

Tru

e

Dala

pon

515.3

1.0

CC

C3

.11

30

ug

/L1

.04

75

10

46

---

---

---

70

- 1

30

10

43

.0

10

/15

/20

20

08

:30

10

/21

/20

20

01

:40

Tru

e

2,4

-DB

515.3

2.0

CC

C2

.86

40

ug

/L1

.04

75

10

46

---

---

---

70

- 1

30

95

3.0

1

0/1

5/2

02

0 0

8:3

01

0/2

1/2

02

0 0

1:4

0T

rue

DC

PA

aci

d m

eta

bolit

es

515.3

0.5

CC

C3

.33

30

ug

/L1

.04

75

10

46

---

---

---

70

- 1

30

11

13

.0

10

/15

/20

20

08

:30

10

/21

/20

20

01

:40

Tru

e

Dic

am

ba

515.3

0.1

CC

C3

.31

01

ug

/L1

.04

75

10

46

---

---

---

70

- 1

30

11

03

.0

10

/15

/20

20

08

:30

10

/21

/20

20

01

:40

Tru

e

3,5

-Dic

hlo

robenzo

ic a

cid

515.3

0.5

CC

C3

.21

01

ug

/L1

.04

75

10

46

---

---

---

70

- 1

30

10

73

.0

10

/15

/20

20

08

:30

10

/21

/20

20

01

:40

Tru

e

Dic

hlo

rpro

p515.3

2.0

CC

C3

.07

30

ug

/L1

.04

75

10

46

---

---

---

70

- 1

30

10

23

.0

10

/15

/20

20

08

:30

10

/21

/20

20

01

:40

Tru

e

Din

ose

b515.3

0.1

CC

C3

.44

19

ug

/L1

.04

75

10

46

---

---

---

70

- 1

30

11

53

.0

10

/15

/20

20

08

:30

10

/21

/20

20

01

:40

Tru

e

Penta

chlo

rophenol

515.3

0.0

4C

CC

0.6

28

9ug

/L1

.04

75

10

46

---

---

---

70

- 1

30

10

50

.6

10

/15

/20

20

08

:30

10

/21

/20

20

01

:40

Tru

e

Pic

lora

m515.3

0.1

CC

C1

.54

04

ug

/L1

.04

75

10

46

---

---

---

70

- 1

30

10

31

.5

10

/15

/20

20

08

:30

10

/21

/20

20

01

:40

Tru

e

2,4

,5-T

515.3

0.5

CC

C3

.12

86

ug

/L1

.04

75

10

46

---

---

---

70

- 1

30

10

43

.0

10

/15

/20

20

08

:30

10

/21

/20

20

01

:40

Tru

e

2,4

,5-T

P (

Silv

ex)

515.3

0.1

CC

C1

.56

14

ug

/L1

.04

75

10

46

---

---

---

70

- 1

30

10

41

.5

10

/15

/20

20

08

:30

10

/21

/20

20

01

:40

Tru

e

Tri

clopyr

515.3

0.5

CC

C3

.08

48

ug

/L1

.04

75

10

46

---

---

---

69

- 1

41

10

33

.0

10

/15

/20

20

08

:30

10

/21

/20

20

01

:40

Fals

e

IS-4

,4'-D

ibro

mooct

afluoro

bip

henyl

515.3

N/A

FS

16

46

ug

/L1

.04

74

35

41

Fin

ishe

d--

---

-7

0 -

13

01

00

16

52

1

0/1

5/2

02

0 0

8:3

01

0/2

1/2

02

0 0

3:1

8F

als

e

SS

-2,4

-Dic

hlo

rophenyl

ace

tic

aci

d515.3

N/A

FS

20

.85

33

ug

/L1

.04

74

35

41

Fin

ishe

d--

---

-7

0 -

13

08

32

5.0

1

0/1

5/2

02

0 0

8:3

01

0/2

1/2

02

0 0

3:1

8F

als

e

Aci

fluorf

en

515.3

1.0

FS

1.0

ug

/L1

.04

74

35

41

Fin

ishe

d--

---

---

---

-

<1

0/1

5/2

02

0 0

8:3

01

0/2

1/2

02

0 0

3:1

8F

als

e

Benta

zon

515.3

0.5

FS

0.5

ug

/L1

.04

74

35

41

Fin

ishe

d--

---

---

---

-

<1

0/1

5/2

02

0 0

8:3

01

0/2

1/2

02

0 0

3:1

8F

als

e

Chlo

ram

ben

515.3

2.0

FS

2.0

ug

/L1

.04

74

35

41

Fin

ishe

d--

---

---

---

-

<1

0/1

5/2

02

0 0

8:3

01

0/2

1/2

02

0 0

3:1

8F

als

e

2,4

-D515.3

0.1

FS

0.1

ug

/L1

.04

74

35

41

Fin

ishe

d--

---

---

---

-

<1

0/1

5/2

02

0 0

8:3

01

0/2

1/2

02

0 0

3:1

8F

als

e

Dala

pon

515.3

1.0

FS

1.0

ug

/L1

.04

74

35

41

Fin

ishe

d--

---

---

---

-

<1

0/1

5/2

02

0 0

8:3

01

0/2

1/2

02

0 0

3:1

8F

als

e

2,4

-DB

515.3

2.0

FS

2.0

ug

/L1

.04

74

35

41

Fin

ishe

d--

---

---

---

-

<1

0/1

5/2

02

0 0

8:3

01

0/2

1/2

02

0 0

3:1

8F

als

e

DC

PA

aci

d m

eta

bolit

es

515.3

0.5

FS

0.5

ug

/L1

.04

74

35

41

Fin

ishe

d--

---

---

---

-

<1

0/1

5/2

02

0 0

8:3

01

0/2

1/2

02

0 0

3:1

8F

als

e

Dic

am

ba

515.3

0.1

FS

0.1

ug

/L1

.04

74

35

41

Fin

ishe

d--

---

---

---

-

<1

0/1

5/2

02

0 0

8:3

01

0/2

1/2

02

0 0

3:1

8F

als

e

3,5

-Dic

hlo

robenzo

ic a

cid

515.3

0.5

FS

0.5

ug

/L1

.04

74

35

41

Fin

ishe

d--

---

---

---

-

<1

0/1

5/2

02

0 0

8:3

01

0/2

1/2

02

0 0

3:1

8F

als

e

Dic

hlo

rpro

p515.3

2.0

FS

2.0

ug

/L1

.04

74

35

41

Fin

ishe

d--

---

---

---

-

<1

0/1

5/2

02

0 0

8:3

01

0/2

1/2

02

0 0

3:1

8F

als

e

Din

ose

b515.3

0.1

FS

0.1

ug

/L1

.04

74

35

41

Fin

ishe

d--

---

---

---

-

<1

0/1

5/2

02

0 0

8:3

01

0/2

1/2

02

0 0

3:1

8F

als

e

Penta

chlo

rophenol

515.3

0.0

4F

S0

.04

ug

/L1

.04

74

35

41

Fin

ishe

d--

---

---

---

-

<1

0/1

5/2

02

0 0

8:3

01

0/2

1/2

02

0 0

3:1

8F

als

e

Pic

lora

m515.3

0.1

FS

0.1

ug

/L1

.04

74

35

41

Fin

ishe

d--

---

---

---

-

<1

0/1

5/2

02

0 0

8:3

01

0/2

1/2

02

0 0

3:1

8F

als

e

2,4

,5-T

515.3

0.5

FS

0.5

ug

/L1

.04

74

35

41

Fin

ishe

d--

---

---

---

-

<1

0/1

5/2

02

0 0

8:3

01

0/2

1/2

02

0 0

3:1

8F

als

e

2,4

,5-T

P (

Silv

ex)

515.3

0.1

FS

0.1

ug

/L1

.04

74

35

41

Fin

ishe

d--

---

---

---

-

<1

0/1

5/2

02

0 0

8:3

01

0/2

1/2

02

0 0

3:1

8F

als

e

Tri

clopyr

515.3

0.5

FS

0.5

ug

/L1

.04

74

35

41

Fin

ishe

d--

---

---

---

-

<1

0/1

5/2

02

0 0

8:3

01

0/2

1/2

02

0 0

3:1

8T

rue

IS-4

,4'-D

ibro

mooct

afluoro

bip

henyl

515.3

N/A

CC

C1

72

6ug

/L1

.04

75

10

47

---

---

---

70

- 1

30

10

41

65

2

10

/15

/20

20

08

:30

10

/21

/20

20

12

:14

Tru

e

SS

-2,4

-Dic

hlo

rophenyl

ace

tic

aci

d515.3

N/A

CC

C2

6.2

98

2ug

/L1

.04

75

10

47

---

---

---

70

- 1

30

10

52

5.0

1

0/1

5/2

02

0 0

8:3

01

0/2

1/2

02

0 1

2:1

4T

rue

Aci

fluorf

en

515.3

1.0

CC

C3

.75

77

ug

/L1

.04

75

10

47

---

---

---

70

- 1

30

12

53

.0

10

/15

/20

20

08

:30

10

/21

/20

20

12

:14

Tru

e

Benta

zon

515.3

0.5

CC

C3

.22

86

ug

/L1

.04

75

10

47

---

---

---

70

- 1

30

10

83

.0

10

/15

/20

20

08

:30

10

/21

/20

20

12

:14

Tru

e

Chlo

ram

ben

515.3

2.0

CC

C3

.08

86

ug

/L1

.04

75

10

47

---

---

---

70

- 1

30

10

33

.0

10

/15

/20

20

08

:30

10

/21

/20

20

12

:14

Tru

e

2,4

-D515.3

0.1

CC

C3

.31

74

ug

/L1

.04

75

10

47

---

---

---

70

- 1

30

11

13

.0

10

/15

/20

20

08

:30

10

/21

/20

20

12

:14

Tru

e

Dala

pon

515.3

1.0

CC

C3

.11

65

ug

/L1

.04

75

10

47

---

---

---

70

- 1

30

10

43

.0

10

/15

/20

20

08

:30

10

/21

/20

20

12

:14

Tru

e

2,4

-DB

515.3

2.0

CC

C2

.89

43

ug

/L1

.04

75

10

47

---

---

---

70

- 1

30

96

3.0

1

0/1

5/2

02

0 0

8:3

01

0/2

1/2

02

0 1

2:1

4T

rue

DC

PA

aci

d m

eta

bolit

es

515.3

0.5

CC

C3

.34

23

ug

/L1

.04

75

10

47

---

---

---

70

- 1

30

11

13

.0

10

/15

/20

20

08

:30

10

/21

/20

20

12

:14

Page 3

of

4E

EA

Run I

D 2

81204 /

EE

A R

eport

# 5

00223

Page 85 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Tru

e

Dic

am

ba

515.3

0.1

CC

C3

.33

02

ug

/L1

.04

75

10

47

---

---

---

70

- 1

30

11

13

.0

10

/15

/20

20

08

:30

10

/21

/20

20

12

:14

Tru

e

3,5

-Dic

hlo

robenzo

ic a

cid

515.3

0.5

CC

C3

.18

19

ug

/L1

.04

75

10

47

---

---

---

70

- 1

30

10

63

.0

10

/15

/20

20

08

:30

10

/21

/20

20

12

:14

Tru

e

Dic

hlo

rpro

p515.3

2.0

CC

C3

.12

81

ug

/L1

.04

75

10

47

---

---

---

70

- 1

30

10

43

.0

10

/15

/20

20

08

:30

10

/21

/20

20

12

:14

Tru

e

Din

ose

b515.3

0.1

CC

C3

.45

51

ug

/L1

.04

75

10

47

---

---

---

70

- 1

30

11

53

.0

10

/15

/20

20

08

:30

10

/21

/20

20

12

:14

Tru

e

Penta

chlo

rophenol

515.3

0.0

4C

CC

0.6

36

8ug

/L1

.04

75

10

47

---

---

---

70

- 1

30

10

60

.6

10

/15

/20

20

08

:30

10

/21

/20

20

12

:14

Tru

e

Pic

lora

m515.3

0.1

CC

C1

.57

03

ug

/L1

.04

75

10

47

---

---

---

70

- 1

30

10

51

.5

10

/15

/20

20

08

:30

10

/21

/20

20

12

:14

Tru

e

2,4

,5-T

515.3

0.5

CC

C3

.16

89

ug

/L1

.04

75

10

47

---

---

---

70

- 1

30

10

63

.0

10

/15

/20

20

08

:30

10

/21

/20

20

12

:14

Tru

e

2,4

,5-T

P (

Silv

ex)

515.3

0.1

CC

C1

.58

37

ug

/L1

.04

75

10

47

---

---

---

70

- 1

30

10

61

.5

10

/15

/20

20

08

:30

10

/21

/20

20

12

:14

Tru

e

Tri

clopyr

515.3

0.5

CC

C3

.13

56

ug

/L1

.04

75

10

47

---

---

---

69

- 1

41

10

53

.0

10

/15

/20

20

08

:30

10

/21

/20

20

12

:14

Page 4

of

4E

EA

Run I

D 2

81204 /

EE

A R

eport

# 5

00223

Page 86 of 201

Eu

rofi

ns

Ea

ton

An

aly

tica

lR

un

Lo

gR

un ID

:281214

Meth

od:

515.3

Sam

ple

Sit

eS

am

ple

Id

Typ

eIn

str

um

en

t ID

Cali

bra

tio

n F

ile

An

aly

sis

Date

Matr

ix

CC

C4

75

10

45

GH

M 5

15

.3 1

02

02

02

01

0/2

1/2

02

0 1

5:4

1R

W

LM

B4

75

10

38

GH

M 5

15

.3 1

02

02

02

01

0/2

1/2

02

0 1

6:1

3R

W

FS

47

43

54

1F

inis

he

dG

HM

51

5.3

10

20

20

20

10

/21

/20

20

18

:23

DW

CC

C4

75

10

46

GH

M 5

15

.3 1

02

02

02

01

0/2

1/2

02

0 1

8:5

5R

W

0.0

0

Page 1

of

2E

EA

Run I

D 2

81214 /

EE

A R

eport

# 5

00223

Page 87 of 201

QC

Su

mm

ary

Re

po

rt

EE

AID

#R

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

eth

od

An

aly

teS

am

ple

Typ

eD

ilF

ac

tor

RP

DL

imit

Re

co

ve

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

gM

RL

Ex

tra

cte

dA

na

lyze

d

Tru

e

MC

PA

515.3

0.5

CC

C0

.81

66

ug

/L1

.04

75

10

45

---

---

---

60

- 1

52

82

1.0

1

0/1

5/2

02

0 0

8:3

01

0/2

1/2

02

0 1

5:4

1T

rue

Meco

pro

p515.3

0.5

CC

C0

.89

46

ug

/L1

.04

75

10

45

---

---

---

62

- 1

54

89

1.0

1

0/1

5/2

02

0 0

8:3

01

0/2

1/2

02

0 1

5:4

1F

als

e

IS-4

,4'-D

ibro

mooct

afluoro

bip

henyl

515.3

N/A

LM

B3

32

9ug

/L1

.04

75

10

38

---

---

---

70

- 1

30

87

38

43

1

0/1

5/2

02

0 0

8:3

01

0/2

1/2

02

0 1

6:1

3F

als

e

SS

-2,4

-Dic

hlo

rophenyl

ace

tic

aci

d515.3

N/A

LM

B2

5.0

33

5ug

/L1

.04

75

10

38

---

---

---

70

- 1

30

10

02

5.0

1

0/1

5/2

02

0 0

8:3

01

0/2

1/2

02

0 1

6:1

3F

als

e

MC

PA

515.3

0.5

LM

B0

.5ug

/L1

.04

75

10

38

---

---

---

---

---

<

10

/15

/20

20

08

:30

10

/21

/20

20

16

:13

Fals

e

Meco

pro

p515.3

0.5

LM

B0

.5ug

/L1

.04

75

10

38

---

---

---

---

---

<

10

/15

/20

20

08

:30

10

/21

/20

20

16

:13

Tru

e

MC

PA

515.3

0.5

FS

0.5

ug

/L1

.04

74

35

41

Fin

ishe

d--

---

---

---

-

<1

0/1

5/2

02

0 0

8:3

01

0/2

1/2

02

0 1

8:2

3T

rue

Meco

pro

p515.3

0.5

FS

0.5

ug

/L1

.04

74

35

41

Fin

ishe

d--

---

---

---

-

<1

0/1

5/2

02

0 0

8:3

01

0/2

1/2

02

0 1

8:2

3F

als

e

MC

PA

515.3

0.5

CC

C2

.20

89

ug

/L1

.04

75

10

46

---

---

---

60

- 1

52

74

3.0

1

0/1

5/2

02

0 0

8:3

01

0/2

1/2

02

0 1

8:5

5F

als

e

Meco

pro

p515.3

0.5

CC

C2

.22

14

ug

/L1

.04

75

10

46

---

---

---

62

- 1

54

74

3.0

1

0/1

5/2

02

0 0

8:3

01

0/2

1/2

02

0 1

8:5

5

Page 2

of

2E

EA

Run I

D 2

81214 /

EE

A R

eport

# 5

00223

Page 88 of 201

Eu

rofi

ns

Ea

ton

An

aly

tica

lR

un

Lo

gR

un ID

:280829

Meth

od:

521

Sam

ple

Sit

eS

am

ple

Id

Typ

eIn

str

um

en

t ID

Cali

bra

tio

n F

ile

An

aly

sis

Date

Matr

ix

CC

L4

74

62

39

GD

m 5

21

10

01

20

GD

10

/12

/20

20

11

:57

OS

FB

L4

74

62

32

GD

m 5

21

10

01

20

GD

10

/12

/20

20

16

:57

RW

LM

B4

74

62

84

GD

m 5

21

10

01

20

GD

10

/12

/20

20

17

:40

RW

CC

M4

74

62

41

GD

m 5

21

10

01

20

GD

10

/12

/20

20

21

:52

OS

FS

47

43

52

81

-22

-15

AB

38

46

7G

Dm

52

1 1

00

12

0G

D1

0/1

3/2

02

0 0

1:0

3D

W

MS

M4

74

62

78

1-2

2-1

5 A

B3

84

67

GD

m 5

21

10

01

20

GD

10

/13

/20

20

01

:24

DW

SD

M4

74

62

79

1-2

2-1

5 A

B3

84

67

GD

m 5

21

10

01

20

GD

10

/13

/20

20

01

:46

DW

FS

47

43

52

9F

inis

he

dG

Dm

52

1 1

00

12

0G

D1

0/1

3/2

02

0 0

2:0

7D

W

CC

H4

74

62

52

GD

m 5

21

10

01

20

GD

10

/13

/20

20

02

:50

OS

0.0

0

Page 1

of

4E

EA

Run I

D 2

80829 /

EE

A R

eport

# 5

00223

Page 89 of 201

QC

Su

mm

ary

Re

po

rt

EE

AID

#R

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

eth

od

An

aly

teS

am

ple

Typ

eD

ilF

ac

tor

RP

DL

imit

Re

co

ve

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

gM

RL

Ex

tra

cte

dA

na

lyze

d

Fals

e

IS-N

DP

A-d

14

521

N/A

CC

L4

40

59

ng

/L1

.04

74

62

39

---

---

---

50

- 1

50

95

46

45

6

10

/09

/20

20

07

:55

10

/12

/20

20

11

:57

Fals

e

SS

-ND

MA

-d6

521

N/A

CC

L1

.90

27

ng

/L1

.04

74

62

39

---

---

---

70

- 1

30

95

2.0

1

0/0

9/2

02

0 0

7:5

51

0/1

2/2

02

0 1

1:5

7F

als

e

N-N

itro

sopyr

rolid

ine (

NP

YR

)521

2.0

CC

L1

.90

90

ng

/L1

.04

74

62

39

---

---

---

50

- 1

50

95

2.0

1

0/0

9/2

02

0 0

7:5

51

0/1

2/2

02

0 1

1:5

7F

als

e

N-N

itro

sodi-

N-b

uty

lam

ine (

ND

BA

)521

2.0

CC

L2

.18

44

ng

/L1

.04

74

62

39

---

---

---

50

- 1

50

10

92

.0

10

/09

/20

20

07

:55

10

/12

/20

20

11

:57

Fals

e

N-N

itro

sodie

thyl

am

ine (

ND

EA

)521

2.0

CC

L1

.88

04

ng

/L1

.04

74

62

39

---

---

---

50

- 1

50

94

2.0

1

0/0

9/2

02

0 0

7:5

51

0/1

2/2

02

0 1

1:5

7F

als

e

N-N

itro

sodim

eth

ylam

ine (

ND

MA

)521

2.0

CC

L1

.99

62

ng

/L1

.04

74

62

39

---

---

---

50

- 1

50

10

02

.0

10

/09

/20

20

07

:55

10

/12

/20

20

11

:57

Fals

e

N-N

itro

sodi-

N-p

ropyl

am

ine (

ND

PA

)521

2.0

CC

L1

.95

22

ng

/L1

.04

74

62

39

---

---

---

50

- 1

50

98

2.0

1

0/0

9/2

02

0 0

7:5

51

0/1

2/2

02

0 1

1:5

7F

als

e

N-N

itro

sodip

henyl

am

ine (

ND

PhA

)521

20

CC

L1

0.8

92

7ng

/L1

.04

74

62

39

---

---

---

3 -

25

01

09

10

.0

10

/09

/20

20

07

:55

10

/12

/20

20

11

:57

Fals

e

N-N

itro

som

eth

yleth

ylam

ine (

NM

EA

)521

2.0

CC

L1

.84

43

ng

/L1

.04

74

62

39

---

---

---

50

- 1

50

92

2.0

1

0/0

9/2

02

0 0

7:5

51

0/1

2/2

02

0 1

1:5

7F

als

e

N-N

itro

som

orp

holin

e (

NM

OR

)521

2.0

CC

L1

.88

51

ng

/L1

.04

74

62

39

---

---

---

50

- 1

50

94

2.0

1

0/0

9/2

02

0 0

7:5

51

0/1

2/2

02

0 1

1:5

7F

als

e

N-N

itro

sopip

eri

din

e (

NP

IP)

521

2.0

CC

L2

.28

79

ng

/L1

.04

74

62

39

---

---

---

50

- 1

50

11

42

.0

10

/09

/20

20

07

:55

10

/12

/20

20

11

:57

Tru

e

IS-N

DP

A-d

14

521

N/A

FB

L4

11

96

ng

/L1

.04

74

62

32

---

---

---

50

- 1

50

94

44

05

9

10

/09

/20

20

07

:55

10

/12

/20

20

16

:57

Tru

e

SS

-ND

MA

-d6

521

N/A

FB

L1

8.5

45

8ng

/L1

.04

74

62

32

---

---

---

70

- 1

30

93

20

.0

10

/09

/20

20

07

:55

10

/12

/20

20

16

:57

Tru

e

N-N

itro

sopyr

rolid

ine (

NP

YR

)521

2.0

FB

L3

.80

83

ng

/L1

.04

74

62

32

---

---

---

50

- 1

50

95

4.0

1

0/0

9/2

02

0 0

7:5

51

0/1

2/2

02

0 1

6:5

7T

rue

N-N

itro

sodi-

N-b

uty

lam

ine (

ND

BA

)521

2.0

FB

L4

.10

41

ng

/L1

.04

74

62

32

---

---

---

50

- 1

50

10

34

.0

10

/09

/20

20

07

:55

10

/12

/20

20

16

:57

Tru

e

N-N

itro

sodie

thyl

am

ine (

ND

EA

)521

2.0

FB

L3

.56

30

ng

/L1

.04

74

62

32

---

---

---

50

- 1

50

89

4.0

1

0/0

9/2

02

0 0

7:5

51

0/1

2/2

02

0 1

6:5

7T

rue

N-N

itro

sodim

eth

ylam

ine (

ND

MA

)521

2.0

FB

L3

.58

65

ng

/L1

.04

74

62

32

---

---

---

50

- 1

50

90

4.0

1

0/0

9/2

02

0 0

7:5

51

0/1

2/2

02

0 1

6:5

7T

rue

N-N

itro

sodi-

N-p

ropyl

am

ine (

ND

PA

)521

2.0

FB

L3

.54

35

ng

/L1

.04

74

62

32

---

---

---

50

- 1

50

89

4.0

1

0/0

9/2

02

0 0

7:5

51

0/1

2/2

02

0 1

6:5

7T

rue

N-N

itro

sodip

henyl

am

ine (

ND

PhA

)521

20

FB

L8

.95

40

ng

/L1

.04

74

62

32

---

---

---

1 -

12

04

52

0.0

1

0/0

9/2

02

0 0

7:5

51

0/1

2/2

02

0 1

6:5

7T

rue

N-N

itro

som

eth

yleth

ylam

ine (

NM

EA

)521

2.0

FB

L3

.55

69

ng

/L1

.04

74

62

32

---

---

---

50

- 1

50

89

4.0

1

0/0

9/2

02

0 0

7:5

51

0/1

2/2

02

0 1

6:5

7T

rue

N-N

itro

som

orp

holin

e (

NM

OR

)521

2.0

FB

L3

.41

17

ng

/L1

.04

74

62

32

---

---

---

50

- 1

50

85

4.0

1

0/0

9/2

02

0 0

7:5

51

0/1

2/2

02

0 1

6:5

7T

rue

N-N

itro

sopip

eri

din

e (

NP

IP)

521

2.0

FB

L3

.81

74

ng

/L1

.04

74

62

32

---

---

---

50

- 1

50

95

4.0

1

0/0

9/2

02

0 0

7:5

51

0/1

2/2

02

0 1

6:5

7F

als

e

IS-N

DP

A-d

14

521

N/A

LM

B4

22

14

ng

/L1

.04

74

62

84

---

---

---

50

- 1

50

96

44

05

9

10

/09

/20

20

07

:55

10

/12

/20

20

17

:40

Fals

e

SS

-ND

MA

-d6

521

N/A

LM

B1

8.5

99

7ng

/L1

.04

74

62

84

---

---

---

70

- 1

30

93

20

.0

10

/09

/20

20

07

:55

10

/12

/20

20

17

:40

Fals

e

N-N

itro

sopyr

rolid

ine (

NP

YR

)521

2.0

LM

B2

.0ng

/L1

.04

74

62

84

---

---

---

---

---

<

10

/09

/20

20

07

:55

10

/12

/20

20

17

:40

Fals

e

N-N

itro

sodi-

N-b

uty

lam

ine (

ND

BA

)521

2.0

LM

B2

.0ng

/L1

.04

74

62

84

---

---

---

---

---

<

10

/09

/20

20

07

:55

10

/12

/20

20

17

:40

Fals

e

N-N

itro

sodie

thyl

am

ine (

ND

EA

)521

2.0

LM

B2

.0ng

/L1

.04

74

62

84

---

---

---

---

---

<

10

/09

/20

20

07

:55

10

/12

/20

20

17

:40

Fals

e

N-N

itro

sodim

eth

ylam

ine (

ND

MA

)521

2.0

LM

B2

.0ng

/L1

.04

74

62

84

---

---

---

---

---

<

10

/09

/20

20

07

:55

10

/12

/20

20

17

:40

Fals

e

N-N

itro

sodi-

N-p

ropyl

am

ine (

ND

PA

)521

2.0

LM

B2

.0ng

/L1

.04

74

62

84

---

---

---

---

---

<

10

/09

/20

20

07

:55

10

/12

/20

20

17

:40

Fals

e

N-N

itro

sodip

henyl

am

ine (

ND

PhA

)521

20

LM

B2

0ng

/L1

.04

74

62

84

---

---

---

---

---

<

10

/09

/20

20

07

:55

10

/12

/20

20

17

:40

Fals

e

N-N

itro

som

eth

yleth

ylam

ine (

NM

EA

)521

2.0

LM

B2

.0ng

/L1

.04

74

62

84

---

---

---

---

---

<

10

/09

/20

20

07

:55

10

/12

/20

20

17

:40

Fals

e

N-N

itro

som

orp

holin

e (

NM

OR

)521

2.0

LM

B2

.0ng

/L1

.04

74

62

84

---

---

---

---

---

<

10

/09

/20

20

07

:55

10

/12

/20

20

17

:40

Fals

e

N-N

itro

sopip

eri

din

e (

NP

IP)

521

2.0

LM

B2

.0ng

/L1

.04

74

62

84

---

---

---

---

---

<

10

/09

/20

20

07

:55

10

/12

/20

20

17

:40

Tru

e

IS-N

DP

A-d

14

521

N/A

CC

M4

65

75

ng

/L1

.04

74

62

41

---

---

---

50

- 1

50

10

04

65

75

1

0/0

9/2

02

0 0

7:5

51

0/1

2/2

02

0 2

1:5

2T

rue

SS

-ND

MA

-d6

521

N/A

CC

M1

9.2

33

4ng

/L1

.04

74

62

41

---

---

---

70

- 1

30

96

20

.0

10

/09

/20

20

07

:55

10

/12

/20

20

21

:52

Tru

e

N-N

itro

sopyr

rolid

ine (

NP

YR

)521

2.0

CC

M1

9.6

07

7ng

/L1

.04

74

62

41

---

---

---

70

- 1

30

98

20

.0

10

/09

/20

20

07

:55

10

/12

/20

20

21

:52

Tru

e

N-N

itro

sodi-

N-b

uty

lam

ine (

ND

BA

)521

2.0

CC

M2

0.6

26

6ng

/L1

.04

74

62

41

---

---

---

70

- 1

30

10

32

0.0

1

0/0

9/2

02

0 0

7:5

51

0/1

2/2

02

0 2

1:5

2T

rue

N-N

itro

sodie

thyl

am

ine (

ND

EA

)521

2.0

CC

M1

9.7

81

8ng

/L1

.04

74

62

41

---

---

---

70

- 1

30

99

20

.0

10

/09

/20

20

07

:55

10

/12

/20

20

21

:52

Tru

e

N-N

itro

sodim

eth

ylam

ine (

ND

MA

)521

2.0

CC

M1

9.1

83

9ng

/L1

.04

74

62

41

---

---

---

70

- 1

30

96

20

.0

10

/09

/20

20

07

:55

10

/12

/20

20

21

:52

Tru

e

N-N

itro

sodi-

N-p

ropyl

am

ine (

ND

PA

)521

2.0

CC

M2

0.9

96

4ng

/L1

.04

74

62

41

---

---

---

70

- 1

30

10

52

0.0

1

0/0

9/2

02

0 0

7:5

51

0/1

2/2

02

0 2

1:5

2

Page 2

of

4E

EA

Run I

D 2

80829 /

EE

A R

eport

# 5

00223

Page 90 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Tru

e

N-N

itro

sodip

henyl

am

ine (

ND

PhA

)521

20

CC

M1

05

.45

98

ng

/L1

.04

74

62

41

---

---

---

20

- 2

50

10

51

00

1

0/0

9/2

02

0 0

7:5

51

0/1

2/2

02

0 2

1:5

2T

rue

N-N

itro

som

eth

yleth

ylam

ine (

NM

EA

)521

2.0

CC

M1

9.1

94

2ng

/L1

.04

74

62

41

---

---

---

70

- 1

30

96

20

.0

10

/09

/20

20

07

:55

10

/12

/20

20

21

:52

Tru

e

N-N

itro

som

orp

holin

e (

NM

OR

)521

2.0

CC

M1

9.5

54

7ng

/L1

.04

74

62

41

---

---

---

70

- 1

30

98

20

.0

10

/09

/20

20

07

:55

10

/12

/20

20

21

:52

Tru

e

N-N

itro

sopip

eri

din

e (

NP

IP)

521

2.0

CC

M2

0.0

08

8ng

/L1

.04

74

62

41

---

---

---

70

- 1

30

10

02

0.0

1

0/0

9/2

02

0 0

7:5

51

0/1

2/2

02

0 2

1:5

2F

als

e

IS-N

DP

A-d

14

521

N/A

FS

56

81

8ng

/L1

.04

74

35

28

1-2

2-1

5 A

B3

84

67

---

---

50

- 1

50

12

24

65

75

1

0/0

9/2

02

0 0

7:5

51

0/1

3/2

02

0 0

1:0

3F

als

e

SS

-ND

MA

-d6

521

N/A

FS

14

.54

95

ng

/L1

.04

74

35

28

1-2

2-1

5 A

B3

84

67

---

---

70

- 1

30

73

20

.0

10

/09

/20

20

07

:55

10

/13

/20

20

01

:03

Fals

e

N-N

itro

sopyr

rolid

ine (

NP

YR

)521

2.0

FS

2.0

ng

/L1

.04

74

35

28

1-2

2-1

5 A

B3

84

67

---

---

---

---

<

10

/09

/20

20

07

:55

10

/13

/20

20

01

:03

Fals

e

N-N

itro

sodi-

N-b

uty

lam

ine (

ND

BA

)521

2.0

FS

2.0

ng

/L1

.04

74

35

28

1-2

2-1

5 A

B3

84

67

---

---

---

---

<

10

/09

/20

20

07

:55

10

/13

/20

20

01

:03

Fals

e

N-N

itro

sodie

thyl

am

ine (

ND

EA

)521

2.0

FS

2.0

ng

/L1

.04

74

35

28

1-2

2-1

5 A

B3

84

67

---

---

---

---

<

10

/09

/20

20

07

:55

10

/13

/20

20

01

:03

Fals

e

N-N

itro

sodim

eth

ylam

ine (

ND

MA

)521

2.0

FS

7.7

ng

/L1

.04

74

35

28

1-2

2-1

5 A

B3

84

67

---

---

---

---

10

/09

/20

20

07

:55

10

/13

/20

20

01

:03

Fals

e

N-N

itro

sodi-

N-p

ropyl

am

ine (

ND

PA

)521

2.0

FS

2.0

ng

/L1

.04

74

35

28

1-2

2-1

5 A

B3

84

67

---

---

---

---

<

10

/09

/20

20

07

:55

10

/13

/20

20

01

:03

Fals

e

N-N

itro

sodip

henyl

am

ine (

ND

PhA

)521

20

FS

20

ng

/L1

.04

74

35

28

1-2

2-1

5 A

B3

84

67

---

---

---

---

<

10

/09

/20

20

07

:55

10

/13

/20

20

01

:03

Fals

e

N-N

itro

som

eth

yleth

ylam

ine (

NM

EA

)521

2.0

FS

2.0

ng

/L1

.04

74

35

28

1-2

2-1

5 A

B3

84

67

---

---

---

---

<

10

/09

/20

20

07

:55

10

/13

/20

20

01

:03

Fals

e

N-N

itro

som

orp

holin

e (

NM

OR

)521

2.0

FS

2.0

ng

/L1

.04

74

35

28

1-2

2-1

5 A

B3

84

67

---

---

---

---

<

10

/09

/20

20

07

:55

10

/13

/20

20

01

:03

Fals

e

N-N

itro

sopip

eri

din

e (

NP

IP)

521

2.0

FS

2.0

ng

/L1

.04

74

35

28

1-2

2-1

5 A

B3

84

67

---

---

---

---

<

10

/09

/20

20

07

:55

10

/13

/20

20

01

:03

Tru

e

IS-N

DP

A-d

14

521

N/A

MS

M5

51

81

ng

/L1

.04

74

62

78

1-2

2-1

5 A

B3

84

67

---

---

50

- 1

50

11

84

65

75

1

0/0

9/2

02

0 0

7:5

51

0/1

3/2

02

0 0

1:2

4T

rue

SS

-ND

MA

-d6

521

N/A

MS

M1

4.9

02

3ng

/L1

.04

74

62

78

1-2

2-1

5 A

B3

84

67

---

---

70

- 1

30

75

20

.0

10

/09

/20

20

07

:55

10

/13

/20

20

01

:24

Tru

e

N-N

itro

sopyr

rolid

ine (

NP

YR

)521

2.0

MS

M2

0.9

79

7ng

/L1

.04

74

62

78

1-2

2-1

5 A

B3

84

67

---

---

70

- 1

30

10

52

0.0

1

0/0

9/2

02

0 0

7:5

51

0/1

3/2

02

0 0

1:2

4T

rue

N-N

itro

sodi-

N-b

uty

lam

ine (

ND

BA

)521

2.0

MS

M2

6.5

05

4ng

/L1

.04

74

62

78

1-2

2-1

5 A

B3

84

67

---

---

70

- 1

30

133

20

.0

10

/09

/20

20

07

:55

10

/13

/20

20

01

:24

Tru

e

N-N

itro

sodie

thyl

am

ine (

ND

EA

)521

2.0

MS

M1

8.3

10

4ng

/L1

.04

74

62

78

1-2

2-1

5 A

B3

84

67

---

---

70

- 1

30

92

20

.0

10

/09

/20

20

07

:55

10

/13

/20

20

01

:24

Tru

e

N-N

itro

sodim

eth

ylam

ine (

ND

MA

)521

2.0

MS

M2

2.2

18

6ng

/L1

.04

74

62

78

1-2

2-1

5 A

B3

84

67

---

---

70

- 1

30

73

27

.65

32

1

0/0

9/2

02

0 0

7:5

51

0/1

3/2

02

0 0

1:2

4T

rue

N-N

itro

sodi-

N-p

ropyl

am

ine (

ND

PA

)521

2.0

MS

M2

0.4

73

0ng

/L1

.04

74

62

78

1-2

2-1

5 A

B3

84

67

---

---

70

- 1

30

10

22

0.0

1

0/0

9/2

02

0 0

7:5

51

0/1

3/2

02

0 0

1:2

4T

rue

N-N

itro

sodip

henyl

am

ine (

ND

PhA

)521

20

MS

M2

9.8

63

3ng

/L1

.04

74

62

78

1-2

2-1

5 A

B3

84

67

---

---

1 -

12

03

01

00

1

0/0

9/2

02

0 0

7:5

51

0/1

3/2

02

0 0

1:2

4T

rue

N-N

itro

som

eth

yleth

ylam

ine (

NM

EA

)521

2.0

MS

M1

6.4

19

6ng

/L1

.04

74

62

78

1-2

2-1

5 A

B3

84

67

---

---

70

- 1

30

82

20

.0

10

/09

/20

20

07

:55

10

/13

/20

20

01

:24

Tru

e

N-N

itro

som

orp

holin

e (

NM

OR

)521

2.0

MS

M1

8.7

26

1ng

/L1

.04

74

62

78

1-2

2-1

5 A

B3

84

67

---

---

70

- 1

30

94

20

.0

10

/09

/20

20

07

:55

10

/13

/20

20

01

:24

Tru

e

N-N

itro

sopip

eri

din

e (

NP

IP)

521

2.0

MS

M0

.75

90

ng

/L1

.04

74

62

78

1-2

2-1

5 A

B3

84

67

---

---

70

- 1

30

42

0.0

1

0/0

9/2

02

0 0

7:5

51

0/1

3/2

02

0 0

1:2

4F

als

e

IS-N

DP

A-d

14

521

N/A

SD

M5

11

60

ng

/L1

.04

74

62

79

1-2

2-1

5 A

B3

84

67

---

---

50

- 1

50

11

04

65

75

1

0/0

9/2

02

0 0

7:5

51

0/1

3/2

02

0 0

1:4

6F

als

e

SS

-ND

MA

-d6

521

N/A

SD

M1

2.9

53

1ng

/L1

.04

74

62

79

1-2

2-1

5 A

B3

84

67

---

---

70

- 1

30

65

20

.0

10

/09

/20

20

07

:55

10

/13

/20

20

01

:46

Fals

e

N-N

itro

sopyr

rolid

ine (

NP

YR

)521

2.0

SD

M1

7.4

21

0ng

/L1

.04

74

62

79

1-2

2-1

5 A

B3

84

67

30

19

70

- 1

30

87

20

.0

10

/09

/20

20

07

:55

10

/13

/20

20

01

:46

Fals

e

N-N

itro

sodi-

N-b

uty

lam

ine (

ND

BA

)521

2.0

SD

M2

1.5

44

7ng

/L1

.04

74

62

79

1-2

2-1

5 A

B3

84

67

30

21

70

- 1

30

10

82

0.0

1

0/0

9/2

02

0 0

7:5

51

0/1

3/2

02

0 0

1:4

6F

als

e

N-N

itro

sodie

thyl

am

ine (

ND

EA

)521

2.0

SD

M1

5.2

09

5ng

/L1

.04

74

62

79

1-2

2-1

5 A

B3

84

67

30

19

70

- 1

30

76

20

.0

10

/09

/20

20

07

:55

10

/13

/20

20

01

:46

Fals

e

N-N

itro

sodim

eth

ylam

ine (

ND

MA

)521

2.0

SD

M1

9.0

31

5ng

/L1

.04

74

62

79

1-2

2-1

5 A

B3

84

67

30

15

70

- 1

30

57

27

.65

32

1

0/0

9/2

02

0 0

7:5

51

0/1

3/2

02

0 0

1:4

6F

als

e

N-N

itro

sodi-

N-p

ropyl

am

ine (

ND

PA

)521

2.0

SD

M1

7.1

34

4ng

/L1

.04

74

62

79

1-2

2-1

5 A

B3

84

67

30

18

70

- 1

30

86

20

.0

10

/09

/20

20

07

:55

10

/13

/20

20

01

:46

Fals

e

N-N

itro

sodip

henyl

am

ine (

ND

PhA

)521

20

SD

M3

0.3

92

1ng

/L1

.04

74

62

79

1-2

2-1

5 A

B3

84

67

30

1.8

1 -

12

03

01

00

1

0/0

9/2

02

0 0

7:5

51

0/1

3/2

02

0 0

1:4

6F

als

e

N-N

itro

som

eth

yleth

ylam

ine (

NM

EA

)521

2.0

SD

M1

3.9

89

9ng

/L1

.04

74

62

79

1-2

2-1

5 A

B3

84

67

30

16

70

- 1

30

70

20

.0

10

/09

/20

20

07

:55

10

/13

/20

20

01

:46

Fals

e

N-N

itro

som

orp

holin

e (

NM

OR

)521

2.0

SD

M1

5.4

66

3ng

/L1

.04

74

62

79

1-2

2-1

5 A

B3

84

67

30

19

70

- 1

30

77

20

.0

10

/09

/20

20

07

:55

10

/13

/20

20

01

:46

Fals

e

N-N

itro

sopip

eri

din

e (

NP

IP)

521

2.0

SD

M1

7.7

35

3ng

/L1

.04

74

62

79

1-2

2-1

5 A

B3

84

67

---

---

70

- 1

30

89

20

.0

10

/09

/20

20

07

:55

10

/13

/20

20

01

:46

Tru

e

IS-N

DP

A-d

14

521

N/A

FS

52

28

0ng

/L1

.04

74

35

29

Fin

ishe

d--

---

-5

0 -

15

01

12

46

57

5

10

/09

/20

20

07

:55

10

/13

/20

20

02

:07

Tru

e

SS

-ND

MA

-d6

521

N/A

FS

15

.58

65

ng

/L1

.04

74

35

29

Fin

ishe

d--

---

-7

0 -

13

07

82

0.0

1

0/0

9/2

02

0 0

7:5

51

0/1

3/2

02

0 0

2:0

7T

rue

N-N

itro

sopyr

rolid

ine (

NP

YR

)521

2.0

FS

2.0

ng

/L1

.04

74

35

29

Fin

ishe

d--

---

---

---

-

<1

0/0

9/2

02

0 0

7:5

51

0/1

3/2

02

0 0

2:0

7T

rue

N-N

itro

sodi-

N-b

uty

lam

ine (

ND

BA

)521

2.0

FS

2.0

ng

/L1

.04

74

35

29

Fin

ishe

d--

---

---

---

-

<1

0/0

9/2

02

0 0

7:5

51

0/1

3/2

02

0 0

2:0

7

Page 3

of

4E

EA

Run I

D 2

80829 /

EE

A R

eport

# 5

00223

Page 91 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Tru

e

N-N

itro

sodie

thyl

am

ine (

ND

EA

)521

2.0

FS

2.0

ng

/L1

.04

74

35

29

Fin

ishe

d--

---

---

---

-

<1

0/0

9/2

02

0 0

7:5

51

0/1

3/2

02

0 0

2:0

7T

rue

N-N

itro

sodim

eth

ylam

ine (

ND

MA

)521

2.0

FS

5.6

ng

/L1

.04

74

35

29

Fin

ishe

d--

---

---

---

-

1

0/0

9/2

02

0 0

7:5

51

0/1

3/2

02

0 0

2:0

7T

rue

N-N

itro

sodi-

N-p

ropyl

am

ine (

ND

PA

)521

2.0

FS

2.0

ng

/L1

.04

74

35

29

Fin

ishe

d--

---

---

---

-

<1

0/0

9/2

02

0 0

7:5

51

0/1

3/2

02

0 0

2:0

7T

rue

N-N

itro

sodip

henyl

am

ine (

ND

PhA

)521

20

FS

20

ng

/L1

.04

74

35

29

Fin

ishe

d--

---

---

---

-

<1

0/0

9/2

02

0 0

7:5

51

0/1

3/2

02

0 0

2:0

7T

rue

N-N

itro

som

eth

yleth

ylam

ine (

NM

EA

)521

2.0

FS

2.0

ng

/L1

.04

74

35

29

Fin

ishe

d--

---

---

---

-

<1

0/0

9/2

02

0 0

7:5

51

0/1

3/2

02

0 0

2:0

7T

rue

N-N

itro

som

orp

holin

e (

NM

OR

)521

2.0

FS

2.0

ng

/L1

.04

74

35

29

Fin

ishe

d--

---

---

---

-

<1

0/0

9/2

02

0 0

7:5

51

0/1

3/2

02

0 0

2:0

7T

rue

N-N

itro

sopip

eri

din

e (

NP

IP)

521

2.0

FS

2.0

ng

/L1

.04

74

35

29

Fin

ishe

d--

---

---

---

-

<1

0/0

9/2

02

0 0

7:5

51

0/1

3/2

02

0 0

2:0

7F

als

e

IS-N

DP

A-d

14

521

N/A

CC

H4

56

79

ng

/L1

.04

74

62

52

---

---

---

50

- 1

50

10

04

56

79

1

0/0

9/2

02

0 0

7:5

51

0/1

3/2

02

0 0

2:5

0F

als

e

SS

-ND

MA

-d6

521

N/A

CC

H3

7.1

29

3ng

/L1

.04

74

62

52

---

---

---

70

- 1

30

93

40

.0

10

/09

/20

20

07

:55

10

/13

/20

20

02

:50

Fals

e

N-N

itro

sopyr

rolid

ine (

NP

YR

)521

2.0

CC

H4

1.3

46

5ng

/L1

.04

74

62

52

---

---

---

70

- 1

30

10

34

0.0

1

0/0

9/2

02

0 0

7:5

51

0/1

3/2

02

0 0

2:5

0F

als

e

N-N

itro

sodi-

N-b

uty

lam

ine (

ND

BA

)521

2.0

CC

H4

4.8

24

6ng

/L1

.04

74

62

52

---

---

---

70

- 1

30

11

24

0.0

1

0/0

9/2

02

0 0

7:5

51

0/1

3/2

02

0 0

2:5

0F

als

e

N-N

itro

sodie

thyl

am

ine (

ND

EA

)521

2.0

CC

H4

0.7

23

2ng

/L1

.04

74

62

52

---

---

---

70

- 1

30

10

24

0.0

1

0/0

9/2

02

0 0

7:5

51

0/1

3/2

02

0 0

2:5

0F

als

e

N-N

itro

sodim

eth

ylam

ine (

ND

MA

)521

2.0

CC

H3

5.8

77

7ng

/L1

.04

74

62

52

---

---

---

70

- 1

30

90

40

.0

10

/09

/20

20

07

:55

10

/13

/20

20

02

:50

Fals

e

N-N

itro

sodi-

N-p

ropyl

am

ine (

ND

PA

)521

2.0

CC

H4

4.3

79

9ng

/L1

.04

74

62

52

---

---

---

70

- 1

30

11

14

0.0

1

0/0

9/2

02

0 0

7:5

51

0/1

3/2

02

0 0

2:5

0F

als

e

N-N

itro

sodip

henyl

am

ine (

ND

PhA

)521

20

CC

H2

15

.39

04

ng

/L1

.04

74

62

52

---

---

---

20

- 2

50

10

82

00

1

0/0

9/2

02

0 0

7:5

51

0/1

3/2

02

0 0

2:5

0F

als

e

N-N

itro

som

eth

yleth

ylam

ine (

NM

EA

)521

2.0

CC

H3

8.7

51

9ng

/L1

.04

74

62

52

---

---

---

70

- 1

30

97

40

.0

10

/09

/20

20

07

:55

10

/13

/20

20

02

:50

Fals

e

N-N

itro

som

orp

holin

e (

NM

OR

)521

2.0

CC

H3

9.5

46

3ng

/L1

.04

74

62

52

---

---

---

70

- 1

30

99

40

.0

10

/09

/20

20

07

:55

10

/13

/20

20

02

:50

Fals

e

N-N

itro

sopip

eri

din

e (

NP

IP)

521

2.0

CC

H4

1.9

14

7ng

/L1

.04

74

62

52

---

---

---

70

- 1

30

10

54

0.0

1

0/0

9/2

02

0 0

7:5

51

0/1

3/2

02

0 0

2:5

0

Page 4

of

4E

EA

Run I

D 2

80829 /

EE

A R

eport

# 5

00223

Page 92 of 201

Eu

rofi

ns

Ea

ton

An

aly

tica

lR

un

Lo

gR

un ID

:280886

Meth

od:

521

Sam

ple

Sit

eS

am

ple

Id

Typ

eIn

str

um

en

t ID

Cali

bra

tio

n F

ile

An

aly

sis

Date

Matr

ix

CC

L4

74

89

33

GD

m 5

21

10

01

20

GD

10

/14

/20

20

11

:17

OS

CC

H4

74

89

35

GD

m 5

21

10

01

20

GD

10

/14

/20

20

13

:26

OS

0.0

0

Page 1

of

2E

EA

Run I

D 2

80886 /

EE

A R

eport

# 5

00223

Page 93 of 201

QC

Su

mm

ary

Re

po

rt

EE

AID

#R

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

eth

od

An

aly

teS

am

ple

Typ

eD

ilF

ac

tor

RP

DL

imit

Re

co

ve

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

gM

RL

Ex

tra

cte

dA

na

lyze

d

Fals

e

IS-N

DP

A-d

14

521

N/A

CC

L4

88

93

ng

/L1

.04

74

89

33

---

---

---

50

- 1

50

10

54

64

56

1

0/0

9/2

02

0 0

7:5

51

0/1

4/2

02

0 1

1:1

7F

als

e

SS

-ND

MA

-d6

521

N/A

CC

L1

.57

51

ng

/L1

.04

74

89

33

---

---

---

70

- 1

30

79

2.0

1

0/0

9/2

02

0 0

7:5

51

0/1

4/2

02

0 1

1:1

7F

als

e

N-N

itro

sopyr

rolid

ine (

NP

YR

)521

2.0

CC

L2

.04

42

ng

/L1

.04

74

89

33

---

---

---

50

- 1

50

10

22

.0

10

/09

/20

20

07

:55

10

/14

/20

20

11

:17

Fals

e

N-N

itro

sodi-

N-b

uty

lam

ine (

ND

BA

)521

2.0

CC

L2

.16

90

ng

/L1

.04

74

89

33

---

---

---

50

- 1

50

10

82

.0

10

/09

/20

20

07

:55

10

/14

/20

20

11

:17

Fals

e

N-N

itro

sodie

thyl

am

ine (

ND

EA

)521

2.0

CC

L1

.92

56

ng

/L1

.04

74

89

33

---

---

---

50

- 1

50

96

2.0

1

0/0

9/2

02

0 0

7:5

51

0/1

4/2

02

0 1

1:1

7F

als

e

N-N

itro

sodim

eth

ylam

ine (

ND

MA

)521

2.0

CC

L1

.80

01

ng

/L1

.04

74

89

33

---

---

---

50

- 1

50

90

2.0

1

0/0

9/2

02

0 0

7:5

51

0/1

4/2

02

0 1

1:1

7F

als

e

N-N

itro

sodi-

N-p

ropyl

am

ine (

ND

PA

)521

2.0

CC

L2

.02

98

ng

/L1

.04

74

89

33

---

---

---

50

- 1

50

10

12

.0

10

/09

/20

20

07

:55

10

/14

/20

20

11

:17

Fals

e

N-N

itro

sodip

henyl

am

ine (

ND

PhA

)521

20

CC

L1

1.1

13

2ng

/L1

.04

74

89

33

---

---

---

3 -

25

01

11

10

.0

10

/09

/20

20

07

:55

10

/14

/20

20

11

:17

Fals

e

N-N

itro

som

eth

yleth

ylam

ine (

NM

EA

)521

2.0

CC

L1

.82

20

ng

/L1

.04

74

89

33

---

---

---

50

- 1

50

91

2.0

1

0/0

9/2

02

0 0

7:5

51

0/1

4/2

02

0 1

1:1

7F

als

e

N-N

itro

som

orp

holin

e (

NM

OR

)521

2.0

CC

L1

.81

49

ng

/L1

.04

74

89

33

---

---

---

50

- 1

50

91

2.0

1

0/0

9/2

02

0 0

7:5

51

0/1

4/2

02

0 1

1:1

7F

als

e

N-N

itro

sopip

eri

din

e (

NP

IP)

521

2.0

CC

L2

.35

64

ng

/L1

.04

74

89

33

---

---

---

50

- 1

50

11

82

.0

10

/09

/20

20

07

:55

10

/14

/20

20

11

:17

Tru

e

IS-N

DP

A-d

14

521

N/A

CC

H4

62

50

ng

/L1

.04

74

89

35

---

---

---

50

- 1

50

10

04

62

50

1

0/0

9/2

02

0 0

7:5

51

0/1

4/2

02

0 1

3:2

6T

rue

SS

-ND

MA

-d6

521

N/A

CC

H3

6.5

14

1ng

/L1

.04

74

89

35

---

---

---

70

- 1

30

91

40

.0

10

/09

/20

20

07

:55

10

/14

/20

20

13

:26

Tru

e

N-N

itro

sopyr

rolid

ine (

NP

YR

)521

2.0

CC

H3

8.9

48

1ng

/L1

.04

74

89

35

---

---

---

70

- 1

30

97

40

.0

10

/09

/20

20

07

:55

10

/14

/20

20

13

:26

Tru

e

N-N

itro

sodi-

N-b

uty

lam

ine (

ND

BA

)521

2.0

CC

H4

0.2

61

3ng

/L1

.04

74

89

35

---

---

---

70

- 1

30

10

14

0.0

1

0/0

9/2

02

0 0

7:5

51

0/1

4/2

02

0 1

3:2

6T

rue

N-N

itro

sodie

thyl

am

ine (

ND

EA

)521

2.0

CC

H3

8.7

39

1ng

/L1

.04

74

89

35

---

---

---

70

- 1

30

97

40

.0

10

/09

/20

20

07

:55

10

/14

/20

20

13

:26

Tru

e

N-N

itro

sodim

eth

ylam

ine (

ND

MA

)521

2.0

CC

H3

6.9

32

1ng

/L1

.04

74

89

35

---

---

---

70

- 1

30

92

40

.0

10

/09

/20

20

07

:55

10

/14

/20

20

13

:26

Tru

e

N-N

itro

sodi-

N-p

ropyl

am

ine (

ND

PA

)521

2.0

CC

H4

2.7

71

8ng

/L1

.04

74

89

35

---

---

---

70

- 1

30

10

74

0.0

1

0/0

9/2

02

0 0

7:5

51

0/1

4/2

02

0 1

3:2

6T

rue

N-N

itro

sodip

henyl

am

ine (

ND

PhA

)521

20

CC

H2

18

.75

66

ng

/L1

.04

74

89

35

---

---

---

20

- 2

50

10

92

00

1

0/0

9/2

02

0 0

7:5

51

0/1

4/2

02

0 1

3:2

6T

rue

N-N

itro

som

eth

yleth

ylam

ine (

NM

EA

)521

2.0

CC

H3

7.5

26

1ng

/L1

.04

74

89

35

---

---

---

70

- 1

30

94

40

.0

10

/09

/20

20

07

:55

10

/14

/20

20

13

:26

Tru

e

N-N

itro

som

orp

holin

e (

NM

OR

)521

2.0

CC

H3

8.6

30

1ng

/L1

.04

74

89

35

---

---

---

70

- 1

30

97

40

.0

10

/09

/20

20

07

:55

10

/14

/20

20

13

:26

Tru

e

N-N

itro

sopip

eri

din

e (

NP

IP)

521

2.0

CC

H3

9.4

76

2ng

/L1

.04

74

89

35

---

---

---

70

- 1

30

99

40

.0

10

/09

/20

20

07

:55

10

/14

/20

20

13

:26

Page 2

of

2E

EA

Run I

D 2

80886 /

EE

A R

eport

# 5

00223

Page 94 of 201

Eu

rofi

ns

Ea

ton

An

aly

tica

lR

un

Lo

gR

un ID

:281129

Meth

od:

521

Sam

ple

Sit

eS

am

ple

Id

Typ

eIn

str

um

en

t ID

Cali

bra

tio

n F

ile

An

aly

sis

Date

Matr

ix

CC

L4

75

04

17

GD

m 5

21

10

19

20

GD

10

/19

/20

20

22

:15

OS

FB

M4

75

04

16

GD

m 5

21

10

19

20

GD

10

/19

/20

20

22

:37

RW

CC

M4

75

04

18

GD

m 5

21

10

19

20

GD

10

/20

/20

20

04

:20

OS

CC

H4

75

04

19

GD

m 5

21

10

19

20

GD

10

/20

/20

20

05

:24

OS

0.0

0

Page 1

of

3E

EA

Run I

D 2

81129 /

EE

A R

eport

# 5

00223

Page 95 of 201

QC

Su

mm

ary

Re

po

rt

EE

AID

#R

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

eth

od

An

aly

teS

am

ple

Typ

eD

ilF

ac

tor

RP

DL

imit

Re

co

ve

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

gM

RL

Ex

tra

cte

dA

na

lyze

d

Tru

e

IS-N

DP

A-d

14

521

N/A

CC

L2

15

78

ng

/L1

.04

75

04

17

---

---

---

50

- 1

50

97

22

32

6

10

/15

/20

20

08

:05

10

/19

/20

20

22

:15

Tru

e

SS

-ND

MA

-d6

521

N/A

CC

L2

.11

46

ng

/L1

.04

75

04

17

---

---

---

70

- 1

30

10

62

.0

10

/15

/20

20

08

:05

10

/19

/20

20

22

:15

Tru

e

N-N

itro

sopyr

rolid

ine (

NP

YR

)521

2.0

CC

L2

.13

76

ng

/L1

.04

75

04

17

---

---

---

50

- 1

50

10

72

.0

10

/15

/20

20

08

:05

10

/19

/20

20

22

:15

Tru

e

N-N

itro

sodi-

N-b

uty

lam

ine (

ND

BA

)521

2.0

CC

L1

.67

14

ng

/L1

.04

75

04

17

---

---

---

50

- 1

50

84

2.0

1

0/1

5/2

02

0 0

8:0

51

0/1

9/2

02

0 2

2:1

5T

rue

N-N

itro

sodie

thyl

am

ine (

ND

EA

)521

2.0

CC

L1

.90

35

ng

/L1

.04

75

04

17

---

---

---

50

- 1

50

95

2.0

1

0/1

5/2

02

0 0

8:0

51

0/1

9/2

02

0 2

2:1

5T

rue

N-N

itro

sodim

eth

ylam

ine (

ND

MA

)521

2.0

CC

L1

.70

23

ng

/L1

.04

75

04

17

---

---

---

50

- 1

50

85

2.0

1

0/1

5/2

02

0 0

8:0

51

0/1

9/2

02

0 2

2:1

5T

rue

N-N

itro

sodi-

N-p

ropyl

am

ine (

ND

PA

)521

2.0

CC

L1

.61

88

ng

/L1

.04

75

04

17

---

---

---

50

- 1

50

81

2.0

1

0/1

5/2

02

0 0

8:0

51

0/1

9/2

02

0 2

2:1

5T

rue

N-N

itro

sodip

henyl

am

ine (

ND

PhA

)521

20

CC

L9

.34

28

ng

/L1

.04

75

04

17

---

---

---

3 -

25

09

31

0.0

1

0/1

5/2

02

0 0

8:0

51

0/1

9/2

02

0 2

2:1

5T

rue

N-N

itro

som

eth

yleth

ylam

ine (

NM

EA

)521

2.0

CC

L1

.85

35

ng

/L1

.04

75

04

17

---

---

---

50

- 1

50

93

2.0

1

0/1

5/2

02

0 0

8:0

51

0/1

9/2

02

0 2

2:1

5T

rue

N-N

itro

som

orp

holin

e (

NM

OR

)521

2.0

CC

L1

.88

53

ng

/L1

.04

75

04

17

---

---

---

50

- 1

50

94

2.0

1

0/1

5/2

02

0 0

8:0

51

0/1

9/2

02

0 2

2:1

5T

rue

N-N

itro

sopip

eri

din

e (

NP

IP)

521

2.0

CC

L2

.03

71

ng

/L1

.04

75

04

17

---

---

---

50

- 1

50

10

22

.0

10

/15

/20

20

08

:05

10

/19

/20

20

22

:15

Fals

e

IS-N

DP

A-d

14

521

N/A

FB

M2

31

35

ng

/L1

.04

75

04

16

---

---

---

50

- 1

50

10

72

15

78

1

0/1

5/2

02

0 0

8:0

51

0/1

9/2

02

0 2

2:3

7F

als

e

SS

-ND

MA

-d6

521

N/A

FB

M1

7.8

42

5ng

/L1

.04

75

04

16

---

---

---

70

- 1

30

89

20

.0

10

/15

/20

20

08

:05

10

/19

/20

20

22

:37

Fals

e

N-N

itro

sopyr

rolid

ine (

NP

YR

)521

2.0

FB

M1

8.1

62

2ng

/L1

.04

75

04

16

---

---

---

70

- 1

30

91

20

.0

10

/15

/20

20

08

:05

10

/19

/20

20

22

:37

Fals

e

N-N

itro

sodi-

N-b

uty

lam

ine (

ND

BA

)521

2.0

FB

M1

7.7

59

8ng

/L1

.04

75

04

16

---

---

---

70

- 1

30

89

20

.0

10

/15

/20

20

08

:05

10

/19

/20

20

22

:37

Fals

e

N-N

itro

sodie

thyl

am

ine (

ND

EA

)521

2.0

FB

M1

7.5

23

7ng

/L1

.04

75

04

16

---

---

---

70

- 1

30

88

20

.0

10

/15

/20

20

08

:05

10

/19

/20

20

22

:37

Fals

e

N-N

itro

sodim

eth

ylam

ine (

ND

MA

)521

2.0

FB

M1

7.8

76

1ng

/L1

.04

75

04

16

---

---

---

70

- 1

30

89

20

.0

10

/15

/20

20

08

:05

10

/19

/20

20

22

:37

Fals

e

N-N

itro

sodi-

N-p

ropyl

am

ine (

ND

PA

)521

2.0

FB

M1

7.6

85

3ng

/L1

.04

75

04

16

---

---

---

70

- 1

30

88

20

.0

10

/15

/20

20

08

:05

10

/19

/20

20

22

:37

Fals

e

N-N

itro

sodip

henyl

am

ine (

ND

PhA

)521

20

FB

M3

4.8

13

6ng

/L1

.04

75

04

16

---

---

---

1 -

12

03

51

00

1

0/1

5/2

02

0 0

8:0

51

0/1

9/2

02

0 2

2:3

7F

als

e

N-N

itro

som

eth

yleth

ylam

ine (

NM

EA

)521

2.0

FB

M1

7.8

92

7ng

/L1

.04

75

04

16

---

---

---

70

- 1

30

89

20

.0

10

/15

/20

20

08

:05

10

/19

/20

20

22

:37

Fals

e

N-N

itro

som

orp

holin

e (

NM

OR

)521

2.0

FB

M1

8.7

30

3ng

/L1

.04

75

04

16

---

---

---

70

- 1

30

94

20

.0

10

/15

/20

20

08

:05

10

/19

/20

20

22

:37

Fals

e

N-N

itro

sopip

eri

din

e (

NP

IP)

521

2.0

FB

M1

7.9

97

8ng

/L1

.04

75

04

16

---

---

---

70

- 1

30

90

20

.0

10

/15

/20

20

08

:05

10

/19

/20

20

22

:37

Tru

e

IS-N

DP

A-d

14

521

N/A

CC

M2

32

98

ng

/L1

.04

75

04

18

---

---

---

50

- 1

50

10

02

32

98

1

0/1

5/2

02

0 0

8:0

51

0/2

0/2

02

0 0

4:2

0T

rue

SS

-ND

MA

-d6

521

N/A

CC

M1

9.7

19

0ng

/L1

.04

75

04

18

---

---

---

70

- 1

30

99

20

.0

10

/15

/20

20

08

:05

10

/20

/20

20

04

:20

Tru

e

N-N

itro

sopyr

rolid

ine (

NP

YR

)521

2.0

CC

M1

9.9

31

6ng

/L1

.04

75

04

18

---

---

---

70

- 1

30

10

02

0.0

1

0/1

5/2

02

0 0

8:0

51

0/2

0/2

02

0 0

4:2

0T

rue

N-N

itro

sodi-

N-b

uty

lam

ine (

ND

BA

)521

2.0

CC

M2

0.3

39

4ng

/L1

.04

75

04

18

---

---

---

70

- 1

30

10

22

0.0

1

0/1

5/2

02

0 0

8:0

51

0/2

0/2

02

0 0

4:2

0T

rue

N-N

itro

sodie

thyl

am

ine (

ND

EA

)521

2.0

CC

M1

9.4

74

7ng

/L1

.04

75

04

18

---

---

---

70

- 1

30

97

20

.0

10

/15

/20

20

08

:05

10

/20

/20

20

04

:20

Tru

e

N-N

itro

sodim

eth

ylam

ine (

ND

MA

)521

2.0

CC

M2

0.2

03

1ng

/L1

.04

75

04

18

---

---

---

70

- 1

30

10

12

0.0

1

0/1

5/2

02

0 0

8:0

51

0/2

0/2

02

0 0

4:2

0T

rue

N-N

itro

sodi-

N-p

ropyl

am

ine (

ND

PA

)521

2.0

CC

M1

9.7

95

6ng

/L1

.04

75

04

18

---

---

---

70

- 1

30

99

20

.0

10

/15

/20

20

08

:05

10

/20

/20

20

04

:20

Tru

e

N-N

itro

sodip

henyl

am

ine (

ND

PhA

)521

20

CC

M9

5.7

67

2ng

/L1

.04

75

04

18

---

---

---

20

- 2

50

96

10

0

10

/15

/20

20

08

:05

10

/20

/20

20

04

:20

Tru

e

N-N

itro

som

eth

yleth

ylam

ine (

NM

EA

)521

2.0

CC

M1

9.6

85

6ng

/L1

.04

75

04

18

---

---

---

70

- 1

30

98

20

.0

10

/15

/20

20

08

:05

10

/20

/20

20

04

:20

Tru

e

N-N

itro

som

orp

holin

e (

NM

OR

)521

2.0

CC

M1

9.7

95

5ng

/L1

.04

75

04

18

---

---

---

70

- 1

30

99

20

.0

10

/15

/20

20

08

:05

10

/20

/20

20

04

:20

Tru

e

N-N

itro

sopip

eri

din

e (

NP

IP)

521

2.0

CC

M1

9.9

24

5ng

/L1

.04

75

04

18

---

---

---

70

- 1

30

10

02

0.0

1

0/1

5/2

02

0 0

8:0

51

0/2

0/2

02

0 0

4:2

0F

als

e

IS-N

DP

A-d

14

521

N/A

CC

H2

21

62

ng

/L1

.04

75

04

19

---

---

---

50

- 1

50

10

02

21

62

1

0/1

5/2

02

0 0

8:0

51

0/2

0/2

02

0 0

5:2

4F

als

e

SS

-ND

MA

-d6

521

N/A

CC

H3

9.9

80

9ng

/L1

.04

75

04

19

---

---

---

70

- 1

30

10

04

0.0

1

0/1

5/2

02

0 0

8:0

51

0/2

0/2

02

0 0

5:2

4F

als

e

N-N

itro

sopyr

rolid

ine (

NP

YR

)521

2.0

CC

H4

2.1

85

6ng

/L1

.04

75

04

19

---

---

---

70

- 1

30

10

54

0.0

1

0/1

5/2

02

0 0

8:0

51

0/2

0/2

02

0 0

5:2

4F

als

e

N-N

itro

sodi-

N-b

uty

lam

ine (

ND

BA

)521

2.0

CC

H4

4.6

08

1ng

/L1

.04

75

04

19

---

---

---

70

- 1

30

11

24

0.0

1

0/1

5/2

02

0 0

8:0

51

0/2

0/2

02

0 0

5:2

4F

als

e

N-N

itro

sodie

thyl

am

ine (

ND

EA

)521

2.0

CC

H4

1.0

94

7ng

/L1

.04

75

04

19

---

---

---

70

- 1

30

10

34

0.0

1

0/1

5/2

02

0 0

8:0

51

0/2

0/2

02

0 0

5:2

4F

als

e

N-N

itro

sodim

eth

ylam

ine (

ND

MA

)521

2.0

CC

H4

0.6

21

8ng

/L1

.04

75

04

19

---

---

---

70

- 1

30

10

24

0.0

1

0/1

5/2

02

0 0

8:0

51

0/2

0/2

02

0 0

5:2

4F

als

e

N-N

itro

sodi-

N-p

ropyl

am

ine (

ND

PA

)521

2.0

CC

H4

2.6

31

6ng

/L1

.04

75

04

19

---

---

---

70

- 1

30

10

74

0.0

1

0/1

5/2

02

0 0

8:0

51

0/2

0/2

02

0 0

5:2

4

Page 2

of

3E

EA

Run I

D 2

81129 /

EE

A R

eport

# 5

00223

Page 96 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Fals

e

N-N

itro

sodip

henyl

am

ine (

ND

PhA

)521

20

CC

H2

05

.51

23

ng

/L1

.04

75

04

19

---

---

---

20

- 2

50

10

32

00

1

0/1

5/2

02

0 0

8:0

51

0/2

0/2

02

0 0

5:2

4F

als

e

N-N

itro

som

eth

yleth

ylam

ine (

NM

EA

)521

2.0

CC

H4

0.9

68

7ng

/L1

.04

75

04

19

---

---

---

70

- 1

30

10

24

0.0

1

0/1

5/2

02

0 0

8:0

51

0/2

0/2

02

0 0

5:2

4F

als

e

N-N

itro

som

orp

holin

e (

NM

OR

)521

2.0

CC

H4

0.9

54

8ng

/L1

.04

75

04

19

---

---

---

70

- 1

30

10

24

0.0

1

0/1

5/2

02

0 0

8:0

51

0/2

0/2

02

0 0

5:2

4F

als

e

N-N

itro

sopip

eri

din

e (

NP

IP)

521

2.0

CC

H4

1.6

34

6ng

/L1

.04

75

04

19

---

---

---

70

- 1

30

10

44

0.0

1

0/1

5/2

02

0 0

8:0

51

0/2

0/2

02

0 0

5:2

4

Page 3

of

3E

EA

Run I

D 2

81129 /

EE

A R

eport

# 5

00223

Page 97 of 201

Eu

rofi

ns

Ea

ton

An

aly

tica

lR

un

Lo

gR

un ID

:281027

Meth

od:

522

Sam

ple

Sit

eS

am

ple

Id

Typ

eIn

str

um

en

t ID

Cali

bra

tio

n F

ile

An

aly

sis

Date

Matr

ix

CC

L4

74

76

57

DM

52

2-1

00

82

02

0-D

M.M

10

/15

/20

20

07

:49

OS

LR

B4

74

76

48

DM

52

2-1

00

82

02

0-D

M.M

10

/15

/20

20

08

:24

RW

FB

L4

74

76

50

DM

52

2-1

00

82

02

0-D

M.M

10

/15

/20

20

09

:01

RW

FB

M4

74

76

51

DM

52

2-1

00

82

02

0-D

M.M

10

/15

/20

20

09

:38

RW

FS

47

43

53

8F

inis

he

dD

M5

22

-10

08

20

20

-DM

.M1

0/1

5/2

02

0 1

4:0

8D

W

CC

M4

74

76

59

DM

52

2-1

00

82

02

0-D

M.M

10

/15

/20

20

16

:24

OS

0.0

0

Page 1

of

2E

EA

Run I

D 2

81027 /

EE

A R

eport

# 5

00223

Page 98 of 201

QC

Su

mm

ary

Re

po

rt

EE

AID

#R

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

eth

od

An

aly

teS

am

ple

Typ

eD

ilF

ac

tor

RP

DL

imit

Re

co

ve

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

gM

RL

Ex

tra

cte

dA

na

lyze

d

Fals

e

IS-T

etr

ahyd

rofu

ran-d

8522

N/A

CC

L8

79

87

ug

/L1

.04

74

76

57

---

---

---

50

- 1

50

10

08

79

87

1

0/1

2/2

02

0 1

1:3

01

0/1

5/2

02

0 0

7:4

9F

als

e

SS

-1,4

-Dio

xane-d

8522

N/A

CC

L9

.67

00

ug

/L1

.04

74

76

57

---

---

---

70

- 1

30

97

10

.0

10

/12

/20

20

11

:30

10

/15

/20

20

07

:49

Fals

e

1,4

-Dio

xane

522

0.0

7C

CL

0.0

84

0ug

/L1

.04

74

76

57

---

---

---

50

- 1

50

12

00

.07

1

0/1

2/2

02

0 1

1:3

01

0/1

5/2

02

0 0

7:4

9T

rue

IS-T

etr

ahyd

rofu

ran-d

8522

N/A

LR

B9

44

96

ug

/L1

.04

74

76

48

---

---

---

50

- 1

50

10

78

79

87

1

0/1

2/2

02

0 0

9:0

01

0/1

5/2

02

0 0

8:2

4T

rue

SS

-1,4

-Dio

xane-d

8522

N/A

LR

B8

.71

00

ug

/L1

.04

74

76

48

---

---

---

70

- 1

30

87

10

.0

10

/12

/20

20

09

:00

10

/15

/20

20

08

:24

Tru

e

1,4

-Dio

xane

522

0.0

7L

RB

0.0

7ug

/L1

.04

74

76

48

---

---

---

---

---

<

10

/12

/20

20

09

:00

10

/15

/20

20

08

:24

Fals

e

IS-T

etr

ahyd

rofu

ran-d

8522

N/A

FB

L9

24

29

ug

/L1

.04

74

76

50

---

---

---

50

- 1

50

10

58

79

87

1

0/1

2/2

02

0 0

9:0

01

0/1

5/2

02

0 0

9:0

1F

als

e

SS

-1,4

-Dio

xane-d

8522

N/A

FB

L8

.91

00

ug

/L1

.04

74

76

50

---

---

---

70

- 1

30

89

10

.0

10

/12

/20

20

09

:00

10

/15

/20

20

09

:01

Fals

e

1,4

-Dio

xane

522

0.0

7F

BL

0.0

78

0ug

/L1

.04

74

76

50

---

---

---

50

- 1

50

11

10

.07

1

0/1

2/2

02

0 0

9:0

01

0/1

5/2

02

0 0

9:0

1T

rue

IS-T

etr

ahyd

rofu

ran-d

8522

N/A

FB

M9

16

69

ug

/L1

.04

74

76

51

---

---

---

50

- 1

50

10

48

79

87

1

0/1

2/2

02

0 0

9:0

01

0/1

5/2

02

0 0

9:3

8T

rue

SS

-1,4

-Dio

xane-d

8522

N/A

FB

M9

.10

00

ug

/L1

.04

74

76

51

---

---

---

70

- 1

30

91

10

.0

10

/12

/20

20

09

:00

10

/15

/20

20

09

:38

Tru

e

1,4

-Dio

xane

522

0.0

7F

BM

0.9

11

0ug

/L1

.04

74

76

51

---

---

---

70

- 1

30

91

1.0

1

0/1

2/2

02

0 0

9:0

01

0/1

5/2

02

0 0

9:3

8F

als

e

IS-T

etr

ahyd

rofu

ran-d

8522

N/A

FS

90

40

9ug

/L1

.04

74

35

38

Fin

ishe

d--

---

-5

0 -

15

01

03

87

98

7

10

/12

/20

20

09

:00

10

/15

/20

20

14

:08

Fals

e

SS

-1,4

-Dio

xane-d

8522

N/A

FS

9.1

80

0ug

/L1

.04

74

35

38

Fin

ishe

d--

---

-7

0 -

13

09

21

0.0

1

0/1

2/2

02

0 0

9:0

01

0/1

5/2

02

0 1

4:0

8F

als

e

1,4

-Dio

xane

522

0.0

7F

S0

.11

ug

/L1

.04

74

35

38

Fin

ishe

d--

---

---

---

-

1

0/1

2/2

02

0 0

9:0

01

0/1

5/2

02

0 1

4:0

8T

rue

IS-T

etr

ahyd

rofu

ran-d

8522

N/A

CC

M9

02

87

ug

/L1

.04

74

76

59

---

---

---

50

- 1

50

10

09

02

87

1

0/1

2/2

02

0 1

1:3

01

0/1

5/2

02

0 1

6:2

4T

rue

SS

-1,4

-Dio

xane-d

8522

N/A

CC

M1

0.1

90

0ug

/L1

.04

74

76

59

---

---

---

70

- 1

30

10

21

0.0

1

0/1

2/2

02

0 1

1:3

01

0/1

5/2

02

0 1

6:2

4T

rue

1,4

-Dio

xane

522

0.0

7C

CM

1.0

73

0ug

/L1

.04

74

76

59

---

---

---

70

- 1

30

10

71

.0

10

/12

/20

20

11

:30

10

/15

/20

20

16

:24

Page 2

of

2E

EA

Run I

D 2

81027 /

EE

A R

eport

# 5

00223

Page 99 of 201

Eu

rofi

ns

Ea

ton

An

aly

tica

lR

un

Lo

gR

un ID

:281223

Meth

od:

522

Sam

ple

Sit

eS

am

ple

Id

Typ

eIn

str

um

en

t ID

Cali

bra

tio

n F

ile

An

aly

sis

Date

Matr

ix

CC

L4

75

43

57

DM

52

2-1

00

82

02

0-D

M.M

10

/21

/20

20

10

:20

OS

LR

B4

75

38

89

DM

52

2-1

00

82

02

0-D

M.M

10

/21

/20

20

10

:51

RW

FB

L4

75

38

90

DM

52

2-1

00

82

02

0-D

M.M

10

/21

/20

20

11

:22

RW

FB

H4

75

38

91

DM

52

2-1

00

82

02

0-D

M.M

10

/21

/20

20

11

:53

RW

CC

M4

75

43

58

DM

52

2-1

00

82

02

0-D

M.M

10

/21

/20

20

18

:38

OS

CC

H4

75

43

59

DM

52

2-1

00

82

02

0-D

M.M

10

/22

/20

20

02

:51

OS

0.0

0

Page 1

of

2E

EA

Run I

D 2

81223 /

EE

A R

eport

# 5

00223

Page 100 of 201

QC

Su

mm

ary

Re

po

rt

EE

AID

#R

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

eth

od

An

aly

teS

am

ple

Typ

eD

ilF

ac

tor

RP

DL

imit

Re

co

ve

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

gM

RL

Ex

tra

cte

dA

na

lyze

d

Tru

e

IS-T

etr

ahyd

rofu

ran-d

8522

N/A

CC

L9

41

65

ug

/L1

.04

75

43

57

---

---

---

50

- 1

50

10

09

41

65

1

0/2

0/2

02

0 1

2:4

91

0/2

1/2

02

0 1

0:2

0T

rue

SS

-1,4

-Dio

xane-d

8522

N/A

CC

L9

.89

00

ug

/L1

.04

75

43

57

---

---

---

70

- 1

30

99

10

.0

10

/20

/20

20

12

:49

10

/21

/20

20

10

:20

Tru

e

1,4

-Dio

xane

522

0.0

7C

CL

0.0

77

0ug

/L1

.04

75

43

57

---

---

---

50

- 1

50

11

00

.07

1

0/2

0/2

02

0 1

2:4

91

0/2

1/2

02

0 1

0:2

0F

als

e

IS-T

etr

ahyd

rofu

ran-d

8522

N/A

LR

B9

66

64

ug

/L1

.04

75

38

89

---

---

---

50

- 1

50

10

39

41

65

1

0/2

0/2

02

0 0

8:0

51

0/2

1/2

02

0 1

0:5

1F

als

e

SS

-1,4

-Dio

xane-d

8522

N/A

LR

B8

.67

00

ug

/L1

.04

75

38

89

---

---

---

70

- 1

30

87

10

.0

10

/20

/20

20

08

:05

10

/21

/20

20

10

:51

Fals

e

1,4

-Dio

xane

522

0.0

7L

RB

0.0

7ug

/L1

.04

75

38

89

---

---

---

---

---

<

10

/20

/20

20

08

:05

10

/21

/20

20

10

:51

Tru

e

IS-T

etr

ahyd

rofu

ran-d

8522

N/A

FB

L9

26

28

ug

/L1

.04

75

38

90

---

---

---

50

- 1

50

98

94

16

5

10

/20

/20

20

08

:05

10

/21

/20

20

11

:22

Tru

e

SS

-1,4

-Dio

xane-d

8522

N/A

FB

L8

.45

00

ug

/L1

.04

75

38

90

---

---

---

70

- 1

30

84

10

.0

10

/20

/20

20

08

:05

10

/21

/20

20

11

:22

Tru

e

1,4

-Dio

xane

522

0.0

7F

BL

0.0

79

0ug

/L1

.04

75

38

90

---

---

---

50

- 1

50

11

30

.07

1

0/2

0/2

02

0 0

8:0

51

0/2

1/2

02

0 1

1:2

2F

als

e

IS-T

etr

ahyd

rofu

ran-d

8522

N/A

FB

H9

67

87

ug

/L1

.04

75

38

91

---

---

---

50

- 1

50

10

39

41

65

1

0/2

0/2

02

0 0

8:0

51

0/2

1/2

02

0 1

1:5

3F

als

e

SS

-1,4

-Dio

xane-d

8522

N/A

FB

H8

.64

00

ug

/L1

.04

75

38

91

---

---

---

70

- 1

30

86

10

.0

10

/20

/20

20

08

:05

10

/21

/20

20

11

:53

Fals

e

1,4

-Dio

xane

522

0.0

7F

BH

8.9

77

0ug

/L1

.04

75

38

91

---

---

---

70

- 1

30

90

10

.0

10

/20

/20

20

08

:05

10

/21

/20

20

11

:53

Tru

e

IS-T

etr

ahyd

rofu

ran-d

8522

N/A

CC

M9

28

53

ug

/L1

.04

75

43

58

---

---

---

50

- 1

50

10

09

28

53

1

0/2

0/2

02

0 1

2:4

91

0/2

1/2

02

0 1

8:3

8T

rue

SS

-1,4

-Dio

xane-d

8522

N/A

CC

M1

0.5

50

0ug

/L1

.04

75

43

58

---

---

---

70

- 1

30

10

61

0.0

1

0/2

0/2

02

0 1

2:4

91

0/2

1/2

02

0 1

8:3

8T

rue

1,4

-Dio

xane

522

0.0

7C

CM

1.0

10

0ug

/L1

.04

75

43

58

---

---

---

70

- 1

30

10

11

.0

10

/20

/20

20

12

:49

10

/21

/20

20

18

:38

Fals

e

IS-T

etr

ahyd

rofu

ran-d

8522

N/A

CC

H9

83

80

ug

/L1

.04

75

43

59

---

---

---

50

- 1

50

10

09

83

80

1

0/2

0/2

02

0 1

2:4

91

0/2

2/2

02

0 0

2:5

1F

als

e

SS

-1,4

-Dio

xane-d

8522

N/A

CC

H1

0.2

50

0ug

/L1

.04

75

43

59

---

---

---

70

- 1

30

10

21

0.0

1

0/2

0/2

02

0 1

2:4

91

0/2

2/2

02

0 0

2:5

1F

als

e

1,4

-Dio

xane

522

0.0

7C

CH

9.9

72

0ug

/L1

.04

75

43

59

---

---

---

70

- 1

30

10

01

0.0

1

0/2

0/2

02

0 1

2:4

91

0/2

2/2

02

0 0

2:5

1

Page 2

of

2E

EA

Run I

D 2

81223 /

EE

A R

eport

# 5

00223

Page 101 of 201

Eu

rofi

ns

Ea

ton

An

aly

tica

lR

un

Lo

gR

un ID

:281343

Meth

od:

524.2

Sam

ple

Sit

eS

am

ple

Id

Typ

eIn

str

um

en

t ID

Cali

bra

tio

n F

ile

An

aly

sis

Date

Matr

ix

CC

C4

74

83

57

GE

M 5

24

GE

09

28

20

20

Ext

Mix

10

/13

/20

20

14

:04

RW

LM

B4

74

83

59

GE

M 5

24

GE

09

28

20

20

Ext

Mix

10

/13

/20

20

14

:59

RW

FS

47

43

54

8F

inis

he

dG

EM

52

4 G

E 0

92

82

02

0 E

xtM

ix1

0/1

3/2

02

0 1

6:1

1D

W

CC

C4

74

83

58

GE

M 5

24

GE

09

28

20

20

Ext

Mix

10

/13

/20

20

19

:38

RW

0.0

0

Page 1

of

3E

EA

Run I

D 2

81343 /

EE

A R

eport

# 5

00223

Page 102 of 201

QC

Su

mm

ary

Re

po

rt

EE

AID

#R

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

eth

od

An

aly

teS

am

ple

Typ

eD

ilF

ac

tor

RP

DL

imit

Re

co

ve

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

gM

RL

Ex

tra

cte

dA

na

lyze

d

Fals

e

SS

-Bro

mofluoro

be

nze

ne

524.2

N/A

CC

C4

.94

10

ug

/L1

.04

74

83

57

---

---

---

70

- 1

30

99

5.0

--

-1

0/1

3/2

02

0 1

4:0

4F

als

e

SS

-1,2

-Dic

hlo

robenze

ne-d

4524.2

N/A

CC

C9

.49

70

ug

/L1

.04

74

83

57

---

---

---

70

- 1

30

95

10

.0

---

10

/13

/20

20

14

:04

Fals

e

SS

-1,2

-Dic

hlo

roeth

ane-d

4524.2

N/A

CC

C1

0.2

02

0ug

/L1

.04

74

83

57

---

---

---

70

- 1

30

10

21

0.0

--

-1

0/1

3/2

02

0 1

4:0

4F

als

e

SS

-Tolu

ene-d

8524.2

N/A

CC

C9

.90

30

ug

/L1

.04

74

83

57

---

---

---

70

- 1

30

99

10

.0

---

10

/13

/20

20

14

:04

Fals

e

tert

-Am

yl M

eth

yl e

ther

524.2

3.0

CC

C9

.59

70

ug

/L1

.04

74

83

57

---

---

---

70

- 1

30

96

10

.0

---

10

/13

/20

20

14

:04

Fals

e

Benzy

l ch

lori

de

524.2

0.5

CC

C1

3.8

74

0ug

/L1

.04

74

83

57

---

---

---

40

- 1

50

13

91

0.0

--

-1

0/1

3/2

02

0 1

4:0

4F

als

e

1,3

-Buta

die

ne

524.2

5.0

CC

C1

1.9

84

0ug

/L1

.04

74

83

57

---

---

---

70

- 1

30

12

01

0.0

--

-1

0/1

3/2

02

0 1

4:0

4F

als

e

n-B

uty

l acr

ylate

524.2

1.0

CC

C1

1.5

63

0ug

/L1

.04

74

83

57

---

---

---

50

- 1

50

11

61

0.0

--

-1

0/1

3/2

02

0 1

4:0

4F

als

e

Chlo

ropre

ne

524.2

5.0

CC

C1

0.0

34

0ug

/L1

.04

74

83

57

---

---

---

70

- 1

30

10

01

0.0

--

-1

0/1

3/2

02

0 1

4:0

4F

als

e

Cyc

lohexa

no

ne

524.2

5.0

CC

C1

0.4

40

0ug

/L1

.04

74

83

57

---

---

---

31

- 1

49

10

41

0.0

--

-1

0/1

3/2

02

0 1

4:0

4F

als

e

Diis

opro

pyl

eth

er

524.2

0.5

CC

C1

0.3

67

0ug

/L1

.04

74

83

57

---

---

---

70

- 1

30

10

41

0.0

--

-1

0/1

3/2

02

0 1

4:0

4F

als

e

1,4

-Dio

xane

524.2

5.0

CC

C9

.87

60

ug

/L1

.04

74

83

57

---

---

---

50

- 1

50

99

10

.0

---

10

/13

/20

20

14

:04

Fals

e

Epic

hlo

rohyd

rin

524.2

1.0

CC

C6

.94

00

ug

/L1

.04

74

83

57

---

---

---

35

- 1

70

69

10

.0

---

10

/13

/20

20

14

:04

Fals

e

Eth

yl a

cryl

ate

524.2

1.0

CC

C1

0.6

16

0ug

/L1

.04

74

83

57

---

---

---

70

- 1

30

10

61

0.0

--

-1

0/1

3/2

02

0 1

4:0

4F

als

e

Eth

yl tert

-buty

l e

ther

524.2

3.0

CC

C9

.24

80

ug

/L1

.04

74

83

57

---

---

---

70

- 1

30

92

10

.0

---

10

/13

/20

20

14

:04

Fals

e

tert

-Buty

l alc

ohol

524.2

2.0

CC

C1

1.1

40

0ug

/L1

.04

74

83

57

---

---

---

60

- 1

30

11

11

0.0

--

-1

0/1

3/2

02

0 1

4:0

4F

als

e

Vin

yl a

ceta

te524.2

5.0

CC

C1

0.1

17

0ug

/L1

.04

74

83

57

---

---

---

45

- 1

60

10

11

0.0

--

-1

0/1

3/2

02

0 1

4:0

4T

rue

SS

-Bro

mofluoro

be

nze

ne

524.2

N/A

LM

B4

.75

70

ug

/L1

.04

74

83

59

---

---

---

70

- 1

30

95

5.0

--

-1

0/1

3/2

02

0 1

4:5

9T

rue

SS

-1,2

-Dic

hlo

robenze

ne-d

4524.2

N/A

LM

B9

.29

80

ug

/L1

.04

74

83

59

---

---

---

70

- 1

30

93

10

.0

---

10

/13

/20

20

14

:59

Tru

e

SS

-1,2

-Dic

hlo

roeth

ane-d

4524.2

N/A

LM

B9

.90

70

ug

/L1

.04

74

83

59

---

---

---

70

- 1

30

99

10

.0

---

10

/13

/20

20

14

:59

Tru

e

SS

-Tolu

ene-d

8524.2

N/A

LM

B9

.95

80

ug

/L1

.04

74

83

59

---

---

---

70

- 1

30

10

01

0.0

--

-1

0/1

3/2

02

0 1

4:5

9T

rue

tert

-Am

yl M

eth

yl e

ther

524.2

3.0

LM

B3

.0ug

/L1

.04

74

83

59

---

---

---

---

---

<

---

10

/13

/20

20

14

:59

Tru

e

Benzy

l ch

lori

de

524.2

0.5

LM

B0

.5ug

/L1

.04

74

83

59

---

---

---

---

---

<

---

10

/13

/20

20

14

:59

Tru

e

1,3

-Buta

die

ne

524.2

5.0

LM

B5

.0ug

/L1

.04

74

83

59

---

---

---

---

---

<

---

10

/13

/20

20

14

:59

Tru

e

n-B

uty

l acr

ylate

524.2

1.0

LM

B1

.0ug

/L1

.04

74

83

59

---

---

---

---

---

<

---

10

/13

/20

20

14

:59

Tru

e

Chlo

ropre

ne

524.2

5.0

LM

B5

.0ug

/L1

.04

74

83

59

---

---

---

---

---

<

---

10

/13

/20

20

14

:59

Tru

e

Cyc

lohexa

no

ne

524.2

5.0

LM

B5

.0ug

/L1

.04

74

83

59

---

---

---

---

---

<

---

10

/13

/20

20

14

:59

Tru

e

Diis

opro

pyl

eth

er

524.2

0.5

LM

B0

.5ug

/L1

.04

74

83

59

---

---

---

---

---

<

---

10

/13

/20

20

14

:59

Tru

e

1,4

-Dio

xane

524.2

5.0

LM

B5

.0ug

/L1

.04

74

83

59

---

---

---

---

---

<

---

10

/13

/20

20

14

:59

Tru

e

Epic

hlo

rohyd

rin

524.2

1.0

LM

B1

.0ug

/L1

.04

74

83

59

---

---

---

---

---

<

---

10

/13

/20

20

14

:59

Tru

e

Eth

yl a

cryl

ate

524.2

1.0

LM

B1

.0ug

/L1

.04

74

83

59

---

---

---

---

---

<

---

10

/13

/20

20

14

:59

Tru

e

Eth

yl tert

-buty

l e

ther

524.2

3.0

LM

B3

.0ug

/L1

.04

74

83

59

---

---

---

---

---

<

---

10

/13

/20

20

14

:59

Tru

e

tert

-Buty

l alc

ohol

524.2

2.0

LM

B2

.0ug

/L1

.04

74

83

59

---

---

---

---

---

<

---

10

/13

/20

20

14

:59

Tru

e

Vin

yl a

ceta

te524.2

5.0

LM

B5

.0ug

/L1

.04

74

83

59

---

---

---

---

---

<

---

10

/13

/20

20

14

:59

Fals

e

SS

-Bro

mofluoro

be

nze

ne

524.2

N/A

FS

4.8

11

0ug

/L1

.04

74

35

48

Fin

ishe

d--

---

-7

0 -

13

09

65

.0

---

10

/13

/20

20

16

:11

Fals

e

SS

-1,2

-Dic

hlo

robenze

ne-d

4524.2

N/A

FS

9.4

80

0ug

/L1

.04

74

35

48

Fin

ishe

d--

---

-7

0 -

13

09

51

0.0

--

-1

0/1

3/2

02

0 1

6:1

1F

als

e

SS

-1,2

-Dic

hlo

roeth

ane-d

4524.2

N/A

FS

10

.21

20

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

-7

0 -

13

01

02

10

.0

---

10

/13

/20

20

16

:11

Fals

e

SS

-Tolu

ene-d

8524.2

N/A

FS

10

.03

40

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

-7

0 -

13

01

00

10

.0

---

10

/13

/20

20

16

:11

Fals

e

tert

-Am

yl M

eth

yl e

ther

524.2

3.0

FS

3.0

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

3/2

02

0 1

6:1

1F

als

e

Benzy

l ch

lori

de

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

3/2

02

0 1

6:1

1

Page 2

of

3E

EA

Run I

D 2

81343 /

EE

A R

eport

# 5

00223

Page 103 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Fals

e

1,3

-Buta

die

ne

524.2

5.0

FS

5.0

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

3/2

02

0 1

6:1

1F

als

e

n-B

uty

l acr

ylate

524.2

1.0

FS

1.0

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

3/2

02

0 1

6:1

1F

als

e

Chlo

ropre

ne

524.2

5.0

FS

5.0

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

3/2

02

0 1

6:1

1F

als

e

Cyc

lohexa

no

ne

524.2

5.0

FS

5.0

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

3/2

02

0 1

6:1

1F

als

e

Diis

opro

pyl

eth

er

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

3/2

02

0 1

6:1

1F

als

e

1,4

-Dio

xane

524.2

5.0

FS

5.0

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

3/2

02

0 1

6:1

1F

als

e

Epic

hlo

rohyd

rin

524.2

1.0

FS

1.0

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

3/2

02

0 1

6:1

1F

als

e

Eth

yl a

cryl

ate

524.2

1.0

FS

1.0

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

3/2

02

0 1

6:1

1F

als

e

Eth

yl tert

-buty

l e

ther

524.2

3.0

FS

3.0

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

3/2

02

0 1

6:1

1F

als

e

tert

-Buty

l alc

ohol

524.2

2.0

FS

2.0

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

3/2

02

0 1

6:1

1F

als

e

Vin

yl a

ceta

te524.2

5.0

FS

5.0

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

3/2

02

0 1

6:1

1T

rue

SS

-Bro

mofluoro

be

nze

ne

524.2

N/A

CC

C4

.98

10

ug

/L1

.04

74

83

58

---

---

---

70

- 1

30

10

05

.0

---

10

/13

/20

20

19

:38

Tru

e

SS

-1,2

-Dic

hlo

robenze

ne-d

4524.2

N/A

CC

C9

.80

20

ug

/L1

.04

74

83

58

---

---

---

70

- 1

30

98

10

.0

---

10

/13

/20

20

19

:38

Tru

e

SS

-1,2

-Dic

hlo

roeth

ane-d

4524.2

N/A

CC

C1

0.5

38

0ug

/L1

.04

74

83

58

---

---

---

70

- 1

30

10

51

0.0

--

-1

0/1

3/2

02

0 1

9:3

8T

rue

SS

-Tolu

ene-d

8524.2

N/A

CC

C1

0.1

22

0ug

/L1

.04

74

83

58

---

---

---

70

- 1

30

10

11

0.0

--

-1

0/1

3/2

02

0 1

9:3

8T

rue

tert

-Am

yl M

eth

yl e

ther

524.2

3.0

CC

C5

.06

80

ug

/L1

.04

74

83

58

---

---

---

70

- 1

30

10

15

.0

---

10

/13

/20

20

19

:38

Tru

e

Benzy

l ch

lori

de

524.2

0.5

CC

C6

.54

10

ug

/L1

.04

74

83

58

---

---

---

40

- 1

50

13

15

.0

---

10

/13

/20

20

19

:38

Tru

e

1,3

-Buta

die

ne

524.2

5.0

CC

C5

.74

40

ug

/L1

.04

74

83

58

---

---

---

70

- 1

30

11

55

.0

---

10

/13

/20

20

19

:38

Tru

e

n-B

uty

l acr

ylate

524.2

1.0

CC

C5

.19

40

ug

/L1

.04

74

83

58

---

---

---

50

- 1

50

10

45

.0

---

10

/13

/20

20

19

:38

Tru

e

Chlo

ropre

ne

524.2

5.0

CC

C5

.57

80

ug

/L1

.04

74

83

58

---

---

---

70

- 1

30

11

25

.0

---

10

/13

/20

20

19

:38

Tru

e

Cyc

lohexa

no

ne

524.2

5.0

CC

C5

.20

30

ug

/L1

.04

74

83

58

---

---

---

31

- 1

49

10

45

.0

---

10

/13

/20

20

19

:38

Tru

e

Diis

opro

pyl

eth

er

524.2

0.5

CC

C5

.48

10

ug

/L1

.04

74

83

58

---

---

---

70

- 1

30

11

05

.0

---

10

/13

/20

20

19

:38

Tru

e

1,4

-Dio

xane

524.2

5.0

CC

C6

.45

10

ug

/L1

.04

74

83

58

---

---

---

50

- 1

50

12

95

.0

---

10

/13

/20

20

19

:38

Tru

e

Epic

hlo

rohyd

rin

524.2

1.0

CC

C6

.13

50

ug

/L1

.04

74

83

58

---

---

---

35

- 1

70

12

35

.0

---

10

/13

/20

20

19

:38

Tru

e

Eth

yl a

cryl

ate

524.2

1.0

CC

C5

.20

00

ug

/L1

.04

74

83

58

---

---

---

70

- 1

30

10

45

.0

---

10

/13

/20

20

19

:38

Tru

e

Eth

yl tert

-buty

l e

ther

524.2

3.0

CC

C5

.22

40

ug

/L1

.04

74

83

58

---

---

---

70

- 1

30

10

45

.0

---

10

/13

/20

20

19

:38

Tru

e

tert

-Buty

l alc

ohol

524.2

2.0

CC

C5

.35

20

ug

/L1

.04

74

83

58

---

---

---

60

- 1

30

10

75

.0

---

10

/13

/20

20

19

:38

Tru

e

Vin

yl a

ceta

te524.2

5.0

CC

C5

.80

20

ug

/L1

.04

74

83

58

---

---

---

45

- 1

60

11

65

.0

---

10

/13

/20

20

19

:38

Page 3

of

3E

EA

Run I

D 2

81343 /

EE

A R

eport

# 5

00223

Page 104 of 201

Eu

rofi

ns

Ea

ton

An

aly

tica

lR

un

Lo

gR

un ID

:281347

Meth

od:

524.2

Sam

ple

Sit

eS

am

ple

Id

Typ

eIn

str

um

en

t ID

Cali

bra

tio

n F

ile

An

aly

sis

Date

Matr

ix

CC

C4

75

25

74

GE

M 5

24

GE

10

14

20

20

10

/16

/20

20

15

:24

RW

LM

B4

75

25

79

GE

M 5

24

GE

10

14

20

20

10

/16

/20

20

15

:47

RW

FS

47

43

54

8F

inis

he

dG

EM

52

4 G

E 1

01

42

02

01

0/1

6/2

02

0 1

7:3

6D

W

CC

C4

75

28

31

GE

M 5

24

GE

10

14

20

20

10

/16

/20

20

22

:14

RW

0.0

0

Page 1

of

2E

EA

Run I

D 2

81347 /

EE

A R

eport

# 5

00223

Page 105 of 201

QC

Su

mm

ary

Re

po

rt

EE

AID

#R

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

eth

od

An

aly

teS

am

ple

Typ

eD

ilF

ac

tor

RP

DL

imit

Re

co

ve

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

gM

RL

Ex

tra

cte

dA

na

lyze

d

Tru

e

Ace

tone

524.2

5.0

CC

C5

.85

40

ug

/L1

.04

75

25

74

---

---

---

70

- 1

30

11

75

.0

---

10

/16

/20

20

15

:24

Fals

e

Ace

tone

524.2

5.0

LM

B5

.0ug

/L1

.04

75

25

79

---

---

---

---

---

<

---

10

/16

/20

20

15

:47

Tru

e

Ace

tone

524.2

5.0

FS

5.0

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

6/2

02

0 1

7:3

6F

als

e

Ace

tone

524.2

5.0

CC

C1

1.3

43

0ug

/L1

.04

75

28

31

---

---

---

70

- 1

30

11

31

0.0

--

-1

0/1

6/2

02

0 2

2:1

4

Page 2

of

2E

EA

Run I

D 2

81347 /

EE

A R

eport

# 5

00223

Page 106 of 201

Eu

rofi

ns

Ea

ton

An

aly

tica

lR

un

Lo

gR

un ID

:281544

Meth

od:

524.2

Sam

ple

Sit

eS

am

ple

Id

Typ

eIn

str

um

en

t ID

Cali

bra

tio

n F

ile

An

aly

sis

Date

Matr

ix

CC

C4

75

29

20

B5

24

2-1

00

62

0B

-up

2-S

C.m

th1

0/1

9/2

02

0 1

0:1

5R

W

CC

L4

75

29

49

B5

24

2-1

00

62

0B

-up

2-S

C.m

th1

0/1

9/2

02

0 1

1:4

0R

W

LM

B4

75

29

41

B5

24

2-1

00

62

0B

-up

2-S

C.m

th1

0/1

9/2

02

0 1

2:2

8R

W

LT

B4

74

35

50

VO

C L

TB

B5

24

2-1

00

62

0B

-up

2-S

C.m

th1

0/1

9/2

02

0 1

4:0

5R

W

FS

47

43

54

8F

inis

he

dB

52

4 2

-10

06

20

B-u

p2

-SC

.mth

10

/19

/20

20

14

:38

DW

CC

C4

75

29

21

B5

24

2-1

00

62

0B

-up

2-S

C.m

th1

0/1

9/2

02

0 1

5:1

4R

W

0.0

0

Page 1

of

13

EE

A R

un I

D 2

81544 /

EE

A R

eport

# 5

00223

Page 107 of 201

QC

Su

mm

ary

Re

po

rt

EE

AID

#R

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

eth

od

An

aly

teS

am

ple

Typ

eD

ilF

ac

tor

RP

DL

imit

Re

co

ve

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

gM

RL

Ex

tra

cte

dA

na

lyze

d

Fals

e

IS-1

,4-D

iflu

oro

benze

ne

524.2

N/A

CC

C2

00

17

7ug

/L1

.04

75

29

20

---

---

---

50

- 1

50

10

02

00

17

7

---

10

/19

/20

20

10

:15

Fals

e

SS

-Bro

mofluoro

be

nze

ne

524.2

N/A

CC

C5

.46

90

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

10

95

.0

---

10

/19

/20

20

10

:15

Fals

e

SS

-1,2

-Dic

hlo

robenze

ne-d

4524.2

N/A

CC

C1

0.7

61

0ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

10

81

0.0

--

-1

0/1

9/2

02

0 1

0:1

5F

als

e

SS

-1,2

-Dic

hlo

roeth

ane-d

4524.2

N/A

CC

C9

.93

00

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

99

10

.0

---

10

/19

/20

20

10

:15

Fals

e

SS

-Tolu

ene-d

8524.2

N/A

CC

C9

.67

50

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

97

10

.0

---

10

/19

/20

20

10

:15

Fals

e

Acr

ylonitri

le524.2

1.0

CC

C5

.34

00

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

10

75

.0

---

10

/19

/20

20

10

:15

Fals

e

Ally

l ch

lori

de

524.2

5.0

CC

C5

.68

30

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

11

45

.0

---

10

/19

/20

20

10

:15

Fals

e

Benze

ne

524.2

0.5

CC

C5

.50

50

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

11

05

.0

---

10

/19

/20

20

10

:15

Fals

e

Bro

mobenze

ne

524.2

0.5

CC

C5

.66

20

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

11

35

.0

---

10

/19

/20

20

10

:15

Fals

e

Bro

moch

loro

meth

ane

524.2

0.5

CC

C5

.52

40

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

11

05

.0

---

10

/19

/20

20

10

:15

Fals

e

Bro

modic

hlo

rom

eth

ane

524.2

0.5

CC

C5

.57

30

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

11

15

.0

---

10

/19

/20

20

10

:15

Fals

e

Bro

mofo

rm524.2

0.5

CC

C5

.70

00

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

11

45

.0

---

10

/19

/20

20

10

:15

Fals

e

Bro

mom

eth

ane

524.2

0.5

CC

C6

.38

90

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

12

85

.0

---

10

/19

/20

20

10

:15

Fals

e

2-B

uta

none (

ME

K)

524.2

5.0

CC

C4

.55

50

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

91

5.0

--

-1

0/1

9/2

02

0 1

0:1

5F

als

e

n-B

uty

lbenze

ne

524.2

0.5

CC

C5

.50

80

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

11

05

.0

---

10

/19

/20

20

10

:15

Fals

e

sec-

Buty

lbenze

ne

524.2

0.5

CC

C5

.48

60

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

11

05

.0

---

10

/19

/20

20

10

:15

Fals

e

tert

-Buty

lbenze

ne

524.2

0.5

CC

C5

.63

10

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

11

35

.0

---

10

/19

/20

20

10

:15

Fals

e

Carb

on d

isulfid

e524.2

5.0

CC

C5

.75

90

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

11

55

.0

---

10

/19

/20

20

10

:15

Fals

e

Carb

on tetr

ach

lori

de

524.2

0.5

CC

C5

.38

70

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

10

85

.0

---

10

/19

/20

20

10

:15

Fals

e

Chlo

roace

tonitri

le524.2

5.0

CC

C6

.42

20

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

12

85

.0

---

10

/19

/20

20

10

:15

Fals

e

Chlo

robenze

ne

524.2

0.5

CC

C5

.79

70

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

11

65

.0

---

10

/19

/20

20

10

:15

Fals

e

1-C

hlo

robuta

ne

524.2

5.0

CC

C5

.62

40

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

11

25

.0

---

10

/19

/20

20

10

:15

Fals

e

Chlo

roeth

ane

524.2

0.5

CC

C5

.43

50

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

10

95

.0

---

10

/19

/20

20

10

:15

Fals

e

Chlo

rofo

rm524.2

0.5

CC

C5

.38

70

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

10

85

.0

---

10

/19

/20

20

10

:15

Fals

e

Chlo

rom

eth

ane

524.2

0.5

CC

C5

.49

50

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

11

05

.0

---

10

/19

/20

20

10

:15

Fals

e

2-C

hlo

roto

luene

524.2

0.5

CC

C5

.54

40

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

11

15

.0

---

10

/19

/20

20

10

:15

Fals

e

4-C

hlo

roto

luene

524.2

0.5

CC

C5

.62

20

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

11

25

.0

---

10

/19

/20

20

10

:15

Fals

e

Dib

rom

och

loro

meth

ane

524.2

0.5

CC

C4

.91

20

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

98

5.0

--

-1

0/1

9/2

02

0 1

0:1

5F

als

e

1,2

-Dib

rom

o-3

-chlo

ropro

pane (

DB

CP

)524.2

0.2

CC

C5

.86

40

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

11

75

.0

---

10

/19

/20

20

10

:15

Fals

e

1,2

-Dib

rom

oeth

ane (

ED

B)

524.2

0.2

CC

C5

.69

30

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

11

45

.0

---

10

/19

/20

20

10

:15

Fals

e

Dib

rom

om

eth

ane

524.2

0.5

CC

C5

.63

20

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

11

35

.0

---

10

/19

/20

20

10

:15

Fals

e

1,2

-Dic

hlo

robenze

ne

524.2

0.5

CC

C6

.04

30

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

12

15

.0

---

10

/19

/20

20

10

:15

Fals

e

1,3

-Dic

hlo

robenze

ne

524.2

0.5

CC

C5

.70

00

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

11

45

.0

---

10

/19

/20

20

10

:15

Fals

e

1,4

-Dic

hlo

robenze

ne

524.2

0.5

CC

C5

.75

10

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

11

55

.0

---

10

/19

/20

20

10

:15

Fals

e

trans-

1,4

-Dic

hlo

ro-2

-buty

lene

524.2

5.0

CC

C5

.71

10

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

11

45

.0

---

10

/19

/20

20

10

:15

Fals

e

Dic

hlo

rodiflu

oro

meth

ane

524.2

0.5

CC

C4

.86

30

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

97

5.0

--

-1

0/1

9/2

02

0 1

0:1

5F

als

e

1,1

-Dic

hlo

roeth

ane

524.2

0.5

CC

C5

.37

10

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

10

75

.0

---

10

/19

/20

20

10

:15

Fals

e

1,2

-Dic

hlo

roeth

ane

524.2

0.5

CC

C5

.58

30

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

11

25

.0

---

10

/19

/20

20

10

:15

Fals

e

1,1

-Dic

hlo

roeth

ylene

524.2

0.5

CC

C5

.52

70

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

11

15

.0

---

10

/19

/20

20

10

:15

Fals

e

cis-

1,2

-Dic

hlo

roeth

ylene

524.2

0.5

CC

C5

.51

60

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

11

05

.0

---

10

/19

/20

20

10

:15

Page 2

of

13

EE

A R

un I

D 2

81544 /

EE

A R

eport

# 5

00223

Page 108 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Fals

e

trans-

1,2

-Dic

hlo

roe

thyl

ene

524.2

0.5

CC

C5

.55

80

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

11

15

.0

---

10

/19

/20

20

10

:15

Fals

e

Dic

hlo

rom

eth

ane

524.2

0.5

CC

C4

.48

30

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

90

5.0

--

-1

0/1

9/2

02

0 1

0:1

5F

als

e

1,2

-Dic

hlo

ropro

pane

524.2

0.5

CC

C5

.33

10

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

10

75

.0

---

10

/19

/20

20

10

:15

Fals

e

1,3

-Dic

hlo

ropro

pane

524.2

0.5

CC

C5

.52

20

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

11

05

.0

---

10

/19

/20

20

10

:15

Fals

e

2,2

-Dic

hlo

ropro

pane

524.2

0.5

CC

C5

.90

20

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

11

85

.0

---

10

/19

/20

20

10

:15

Fals

e

1,1

-Dic

hlo

ropro

panone

524.2

5.0

CC

C6

.11

50

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

12

25

.0

---

10

/19

/20

20

10

:15

Fals

e

1,1

-Dic

hlo

ropro

pyl

ene

524.2

0.5

CC

C5

.51

60

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

11

05

.0

---

10

/19

/20

20

10

:15

Fals

e

cis-

1,3

-Dic

hlo

ropro

pyl

ene

524.2

0.5

CC

C5

.59

30

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

11

25

.0

---

10

/19

/20

20

10

:15

Fals

e

trans-

1,3

-Dic

hlo

rop

ropyl

ene

524.2

0.5

CC

C5

.60

90

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

11

25

.0

---

10

/19

/20

20

10

:15

Fals

e

Eth

yl E

ther

524.2

2.0

CC

C3

.61

80

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

72

5.0

--

-1

0/1

9/2

02

0 1

0:1

5F

als

e

Eth

yl m

eth

acr

ylate

524.2

1.0

CC

C5

.87

70

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

11

85

.0

---

10

/19

/20

20

10

:15

Fals

e

Eth

ylbenze

ne

524.2

0.5

CC

C5

.61

10

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

11

25

.0

---

10

/19

/20

20

10

:15

Fals

e

Hexa

chlo

robuta

die

ne

524.2

0.5

CC

C5

.67

30

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

11

35

.0

---

10

/19

/20

20

10

:15

Fals

e

Hexa

chlo

roeth

ane

524.2

2.0

CC

C5

.56

80

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

11

15

.0

---

10

/19

/20

20

10

:15

Fals

e

2-H

exa

none

524.2

5.0

CC

C6

.07

50

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

12

25

.0

---

10

/19

/20

20

10

:15

Fals

e

Isopro

pyl

benze

ne

524.2

0.5

CC

C5

.60

40

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

11

25

.0

---

10

/19

/20

20

10

:15

Fals

e

4-I

sopro

pyl

tolu

ene

524.2

0.5

CC

C5

.44

90

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

10

95

.0

---

10

/19

/20

20

10

:15

Fals

e

Meth

acr

ylonitri

le524.2

5.0

CC

C5

.46

10

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

10

95

.0

---

10

/19

/20

20

10

:15

Fals

e

Meth

ylacr

yla

te524.2

1.0

CC

C5

.91

10

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

11

85

.0

---

10

/19

/20

20

10

:15

Fals

e

Meth

yl iodid

e524.2

2.0

CC

C4

.60

90

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

92

5.0

--

-1

0/1

9/2

02

0 1

0:1

5F

als

e

Meth

ylm

eth

acr

ylate

524.2

1.0

CC

C5

.94

30

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

11

95

.0

---

10

/19

/20

20

10

:15

Fals

e

4-M

eth

yl-2

-penta

none (

MIB

K)

524.2

2.0

CC

C6

.34

80

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

12

75

.0

---

10

/19

/20

20

10

:15

Fals

e

Meth

yl-t

-buty

l eth

er

(MT

BE

)524.2

0.5

CC

C5

.55

80

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

11

15

.0

---

10

/19

/20

20

10

:15

Fals

e

Naphth

ale

ne

524.2

0.5

CC

C5

.99

30

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

12

05

.0

---

10

/19

/20

20

10

:15

Fals

e

Nitro

benze

ne

524.2

5.0

CC

C3

.94

20

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

79

5.0

--

-1

0/1

9/2

02

0 1

0:1

5F

als

e

2-N

itro

pro

pane

524.2

2.0

CC

C6

.01

00

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

12

05

.0

---

10

/19

/20

20

10

:15

Fals

e

Penta

chlo

roeth

ane

524.2

2.0

CC

C5

.38

80

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

10

85

.0

---

10

/19

/20

20

10

:15

Fals

e

Pro

pio

nitri

le524.2

5.0

CC

C5

.62

70

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

11

35

.0

---

10

/19

/20

20

10

:15

Fals

e

n-P

ropyl

benze

ne

524.2

0.5

CC

C5

.53

80

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

11

15

.0

---

10

/19

/20

20

10

:15

Fals

e

Sty

rene

524.2

0.5

CC

C5

.56

40

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

11

15

.0

---

10

/19

/20

20

10

:15

Fals

e

1,1

,1,2

-Tetr

ach

loro

eth

ane

524.2

0.5

CC

C5

.27

60

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

10

65

.0

---

10

/19

/20

20

10

:15

Fals

e

1,1

,2,2

-Tetr

ach

loro

eth

ane

524.2

0.5

CC

C6

.02

30

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

12

05

.0

---

10

/19

/20

20

10

:15

Fals

e

Tetr

ach

loro

eth

ylene

524.2

0.5

CC

C5

.94

50

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

11

95

.0

---

10

/19

/20

20

10

:15

Fals

e

Tetr

ahyd

rofu

ran

524.2

5.0

CC

C6

.20

20

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

12

45

.0

---

10

/19

/20

20

10

:15

Fals

e

Tolu

ene

524.2

0.5

CC

C5

.50

50

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

11

05

.0

---

10

/19

/20

20

10

:15

Fals

e

1,2

,3-T

rich

loro

be

nze

ne

524.2

0.5

CC

C5

.56

30

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

11

15

.0

---

10

/19

/20

20

10

:15

Fals

e

1,2

,4-T

rich

loro

be

nze

ne

524.2

0.5

CC

C5

.66

20

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

11

35

.0

---

10

/19

/20

20

10

:15

Fals

e

1,1

,1-T

rich

loro

eth

ane

524.2

0.5

CC

C5

.59

70

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

11

25

.0

---

10

/19

/20

20

10

:15

Fals

e

1,1

,2-T

rich

loro

eth

ane

524.2

0.5

CC

C5

.82

40

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

11

65

.0

---

10

/19

/20

20

10

:15

Fals

e

Tri

chlo

roeth

yle

ne

524.2

0.5

CC

C5

.70

60

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

11

45

.0

---

10

/19

/20

20

10

:15

Fals

e

Tri

chlo

rofluoro

meth

ane

524.2

0.5

CC

C5

.81

90

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

11

65

.0

---

10

/19

/20

20

10

:15

Page 3

of

13

EE

A R

un I

D 2

81544 /

EE

A R

eport

# 5

00223

Page 109 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Fals

e

1,2

,3-T

rich

loro

pro

pane

524.2

0.5

CC

C5

.79

80

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

11

65

.0

---

10

/19

/20

20

10

:15

Fals

e

1,1

,2-T

rich

loro

-1,2

,2-t

rifluoro

eth

ane

524.2

0.5

CC

C5

.63

90

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

11

35

.0

---

10

/19

/20

20

10

:15

Fals

e

1,2

,3-T

rim

eth

ylbenze

ne

524.2

0.5

CC

C5

.39

40

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

10

85

.0

---

10

/19

/20

20

10

:15

Fals

e

1,2

,4-T

rim

eth

ylbenze

ne

524.2

0.5

CC

C5

.58

30

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

11

25

.0

---

10

/19

/20

20

10

:15

Fals

e

1,3

,5-T

rim

eth

ylbenze

ne

524.2

0.5

CC

C5

.40

90

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

10

85

.0

---

10

/19

/20

20

10

:15

Fals

e

Vin

yl c

hlo

ride

524.2

0.2

CC

C5

.84

10

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

11

75

.0

---

10

/19

/20

20

10

:15

Fals

e

1,2

-Xyl

ene

524.2

0.5

CC

C5

.58

70

ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

11

25

.0

---

10

/19

/20

20

10

:15

Fals

e

1,3

+ 1

,4-X

yle

ne

524.2

0.5

CC

C1

0.9

66

0ug

/L1

.04

75

29

20

---

---

---

70

- 1

30

11

01

0.0

--

-1

0/1

9/2

02

0 1

0:1

5T

rue

IS-1

,4-D

iflu

oro

benze

ne

524.2

N/A

CC

L2

06

95

0ug

/L1

.04

75

29

49

---

---

---

50

- 1

50

10

02

06

95

0

---

10

/19

/20

20

11

:40

Tru

e

SS

-Bro

mofluoro

be

nze

ne

524.2

N/A

CC

L5

.05

80

ug

/L1

.04

75

29

49

---

---

---

70

- 1

30

10

15

.0

---

10

/19

/20

20

11

:40

Tru

e

SS

-1,2

-Dic

hlo

robenze

ne-d

4524.2

N/A

CC

L1

0.0

12

0ug

/L1

.04

75

29

49

---

---

---

70

- 1

30

10

01

0.0

--

-1

0/1

9/2

02

0 1

1:4

0T

rue

SS

-1,2

-Dic

hlo

roeth

ane-d

4524.2

N/A

CC

L9

.93

40

ug

/L1

.04

75

29

49

---

---

---

70

- 1

30

99

10

.0

---

10

/19

/20

20

11

:40

Tru

e

SS

-Tolu

ene-d

8524.2

N/A

CC

L9

.93

30

ug

/L1

.04

75

29

49

---

---

---

70

- 1

30

99

10

.0

---

10

/19

/20

20

11

:40

Tru

e

Benze

ne

524.2

0.5

CC

L0

.45

10

ug

/L1

.04

75

29

49

---

---

---

50

- 1

50

90

0.5

--

-1

0/1

9/2

02

0 1

1:4

0T

rue

Bro

modic

hlo

rom

eth

ane

524.2

0.5

CC

L0

.48

80

ug

/L1

.04

75

29

49

---

---

---

50

- 1

50

98

0.5

--

-1

0/1

9/2

02

0 1

1:4

0T

rue

Bro

mofo

rm524.2

0.5

CC

L0

.45

30

ug

/L1

.04

75

29

49

---

---

---

50

- 1

50

91

0.5

--

-1

0/1

9/2

02

0 1

1:4

0T

rue

Carb

on tetr

ach

lori

de

524.2

0.5

CC

L0

.61

50

ug

/L1

.04

75

29

49

---

---

---

50

- 1

50

12

30

.5

---

10

/19

/20

20

11

:40

Tru

e

Chlo

robenze

ne

524.2

0.5

CC

L0

.65

20

ug

/L1

.04

75

29

49

---

---

---

50

- 1

50

13

00

.5

---

10

/19

/20

20

11

:40

Tru

e

Chlo

rofo

rm524.2

0.5

CC

L0

.61

90

ug

/L1

.04

75

29

49

---

---

---

50

- 1

50

12

40

.5

---

10

/19

/20

20

11

:40

Tru

e

Dib

rom

och

loro

meth

ane

524.2

0.5

CC

L0

.60

40

ug

/L1

.04

75

29

49

---

---

---

50

- 1

50

12

10

.5

---

10

/19

/20

20

11

:40

Tru

e

1,2

-Dic

hlo

robenze

ne

524.2

0.5

CC

L0

.57

60

ug

/L1

.04

75

29

49

---

---

---

50

- 1

50

11

50

.5

---

10

/19

/20

20

11

:40

Tru

e

1,4

-Dic

hlo

robenze

ne

524.2

0.5

CC

L0

.60

70

ug

/L1

.04

75

29

49

---

---

---

50

- 1

50

12

10

.5

---

10

/19

/20

20

11

:40

Tru

e

1,2

-Dic

hlo

roeth

ane

524.2

0.5

CC

L0

.67

40

ug

/L1

.04

75

29

49

---

---

---

50

- 1

50

13

50

.5

---

10

/19

/20

20

11

:40

Tru

e

1,1

-Dic

hlo

roeth

ylene

524.2

0.5

CC

L0

.56

20

ug

/L1

.04

75

29

49

---

---

---

50

- 1

50

11

20

.5

---

10

/19

/20

20

11

:40

Tru

e

cis-

1,2

-Dic

hlo

roeth

ylene

524.2

0.5

CC

L0

.62

40

ug

/L1

.04

75

29

49

---

---

---

50

- 1

50

12

50

.5

---

10

/19

/20

20

11

:40

Tru

e

trans-

1,2

-Dic

hlo

roe

thyl

ene

524.2

0.5

CC

L0

.62

10

ug

/L1

.04

75

29

49

---

---

---

50

- 1

50

12

40

.5

---

10

/19

/20

20

11

:40

Tru

e

Dic

hlo

rom

eth

ane

524.2

0.5

CC

L0

.39

50

ug

/L1

.04

75

29

49

---

---

---

50

- 1

50

79

0.5

--

-1

0/1

9/2

02

0 1

1:4

0T

rue

1,2

-Dic

hlo

ropro

pane

524.2

0.5

CC

L0

.65

80

ug

/L1

.04

75

29

49

---

---

---

50

- 1

50

13

20

.5

---

10

/19

/20

20

11

:40

Tru

e

Eth

ylbenze

ne

524.2

0.5

CC

L0

.59

60

ug

/L1

.04

75

29

49

---

---

---

50

- 1

50

11

90

.5

---

10

/19

/20

20

11

:40

Tru

e

Sty

rene

524.2

0.5

CC

L0

.62

00

ug

/L1

.04

75

29

49

---

---

---

50

- 1

50

12

40

.5

---

10

/19

/20

20

11

:40

Tru

e

Tetr

ach

loro

eth

ylene

524.2

0.5

CC

L0

.62

70

ug

/L1

.04

75

29

49

---

---

---

50

- 1

50

12

50

.5

---

10

/19

/20

20

11

:40

Tru

e

Tolu

ene

524.2

0.5

CC

L0

.58

20

ug

/L1

.04

75

29

49

---

---

---

50

- 1

50

11

60

.5

---

10

/19

/20

20

11

:40

Tru

e

1,2

,4-T

rich

loro

be

nze

ne

524.2

0.5

CC

L0

.55

00

ug

/L1

.04

75

29

49

---

---

---

50

- 1

50

11

00

.5

---

10

/19

/20

20

11

:40

Tru

e

1,1

,1-T

rich

loro

eth

ane

524.2

0.5

CC

L0

.54

20

ug

/L1

.04

75

29

49

---

---

---

50

- 1

50

10

80

.5

---

10

/19

/20

20

11

:40

Tru

e

1,1

,2-T

rich

loro

eth

ane

524.2

0.5

CC

L0

.59

50

ug

/L1

.04

75

29

49

---

---

---

50

- 1

50

11

90

.5

---

10

/19

/20

20

11

:40

Tru

e

Tri

chlo

roeth

yle

ne

524.2

0.5

CC

L0

.51

90

ug

/L1

.04

75

29

49

---

---

---

50

- 1

50

10

40

.5

---

10

/19

/20

20

11

:40

Tru

e

Vin

yl c

hlo

ride

524.2

0.2

CC

L0

.59

90

ug

/L1

.04

75

29

49

---

---

---

50

- 1

50

12

00

.5

---

10

/19

/20

20

11

:40

Tru

e

1,2

-Xyl

ene

524.2

0.5

CC

L0

.41

10

ug

/L1

.04

75

29

49

---

---

---

50

- 1

50

82

0.5

--

-1

0/1

9/2

02

0 1

1:4

0T

rue

1,3

+ 1

,4-X

yle

ne

524.2

0.5

CC

L1

.22

90

ug

/L1

.04

75

29

49

---

---

---

50

- 1

50

12

31

.0

---

10

/19

/20

20

11

:40

Fals

e

IS-1

,4-D

iflu

oro

benze

ne

524.2

N/A

LM

B2

01

35

3ug

/L1

.04

75

29

41

---

---

---

70

- 1

30

97

20

69

50

--

-1

0/1

9/2

02

0 1

2:2

8F

als

e

SS

-Bro

mofluoro

be

nze

ne

524.2

N/A

LM

B5

.05

60

ug

/L1

.04

75

29

41

---

---

---

70

- 1

30

10

15

.0

---

10

/19

/20

20

12

:28

Page 4

of

13

EE

A R

un I

D 2

81544 /

EE

A R

eport

# 5

00223

Page 110 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Fals

e

SS

-1,2

-Dic

hlo

robenze

ne-d

4524.2

N/A

LM

B1

0.1

34

0ug

/L1

.04

75

29

41

---

---

---

70

- 1

30

10

11

0.0

--

-1

0/1

9/2

02

0 1

2:2

8F

als

e

SS

-1,2

-Dic

hlo

roeth

ane-d

4524.2

N/A

LM

B9

.99

30

ug

/L1

.04

75

29

41

---

---

---

70

- 1

30

10

01

0.0

--

-1

0/1

9/2

02

0 1

2:2

8F

als

e

SS

-Tolu

ene-d

8524.2

N/A

LM

B1

0.1

31

0ug

/L1

.04

75

29

41

---

---

---

70

- 1

30

10

11

0.0

--

-1

0/1

9/2

02

0 1

2:2

8F

als

e

Acr

ylonitri

le524.2

1.0

LM

B1

.0ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

Ally

l ch

lori

de

524.2

5.0

LM

B5

.0ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

Benze

ne

524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

Bro

mobenze

ne

524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

Bro

moch

loro

meth

ane

524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

Bro

modic

hlo

rom

eth

ane

524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

Bro

mofo

rm524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

Bro

mom

eth

ane

524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

2-B

uta

none (

ME

K)

524.2

5.0

LM

B5

.0ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

n-B

uty

lbenze

ne

524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

sec-

Buty

lbenze

ne

524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

tert

-Buty

lbenze

ne

524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

Carb

on d

isulfid

e524.2

5.0

LM

B5

.0ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

Carb

on tetr

ach

lori

de

524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

Chlo

roace

tonitri

le524.2

5.0

LM

B5

.0ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

Chlo

robenze

ne

524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

1-C

hlo

robuta

ne

524.2

5.0

LM

B5

.0ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

Chlo

roeth

ane

524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

Chlo

rofo

rm524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

Chlo

rom

eth

ane

524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

2-C

hlo

roto

luene

524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

4-C

hlo

roto

luene

524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

Dib

rom

och

loro

meth

ane

524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

1,2

-Dib

rom

o-3

-chlo

ropro

pane (

DB

CP

)524.2

0.2

LM

B0

.2ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

1,2

-Dib

rom

oeth

ane (

ED

B)

524.2

0.2

LM

B0

.2ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

Dib

rom

om

eth

ane

524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

1,2

-Dic

hlo

robenze

ne

524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

1,3

-Dic

hlo

robenze

ne

524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

1,4

-Dic

hlo

robenze

ne

524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

trans-

1,4

-Dic

hlo

ro-2

-buty

lene

524.2

5.0

LM

B5

.0ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

Dic

hlo

rodiflu

oro

meth

ane

524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

1,1

-Dic

hlo

roeth

ane

524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

1,2

-Dic

hlo

roeth

ane

524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

1,1

-Dic

hlo

roeth

ylene

524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

cis-

1,2

-Dic

hlo

roeth

ylene

524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

trans-

1,2

-Dic

hlo

roe

thyl

ene

524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

Dic

hlo

rom

eth

ane

524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

1,2

-Dic

hlo

ropro

pane

524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Page 5

of

13

EE

A R

un I

D 2

81544 /

EE

A R

eport

# 5

00223

Page 111 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Fals

e

1,3

-Dic

hlo

ropro

pane

524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

2,2

-Dic

hlo

ropro

pane

524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

1,1

-Dic

hlo

ropro

panone

524.2

5.0

LM

B5

.0ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

1,1

-Dic

hlo

ropro

pyl

ene

524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

cis-

1,3

-Dic

hlo

ropro

pyl

ene

524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

trans-

1,3

-Dic

hlo

rop

ropyl

ene

524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

Eth

yl E

ther

524.2

2.0

LM

B2

.0ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

Eth

yl m

eth

acr

ylate

524.2

1.0

LM

B1

.0ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

Eth

ylbenze

ne

524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

Hexa

chlo

robuta

die

ne

524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

Hexa

chlo

roeth

ane

524.2

2.0

LM

B2

.0ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

2-H

exa

none

524.2

5.0

LM

B5

.0ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

Isopro

pyl

benze

ne

524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

4-I

sopro

pyl

tolu

ene

524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

Meth

acr

ylonitri

le524.2

5.0

LM

B5

.0ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

Meth

ylacr

yla

te524.2

1.0

LM

B1

.0ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

Meth

yl iodid

e524.2

2.0

LM

B2

.0ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

Meth

ylm

eth

acr

ylate

524.2

1.0

LM

B1

.0ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

4-M

eth

yl-2

-penta

none (

MIB

K)

524.2

2.0

LM

B2

.0ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

Meth

yl-t

-buty

l eth

er

(MT

BE

)524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

Naphth

ale

ne

524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

Nitro

benze

ne

524.2

5.0

LM

B5

.0ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

2-N

itro

pro

pane

524.2

2.0

LM

B2

.0ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

Penta

chlo

roeth

ane

524.2

2.0

LM

B2

.0ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

Pro

pio

nitri

le524.2

5.0

LM

B5

.0ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

n-P

ropyl

benze

ne

524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

Sty

rene

524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

1,1

,1,2

-Tetr

ach

loro

eth

ane

524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

1,1

,2,2

-Tetr

ach

loro

eth

ane

524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

Tetr

ach

loro

eth

ylene

524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

Tetr

ahyd

rofu

ran

524.2

5.0

LM

B5

.0ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

Tolu

ene

524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

1,2

,3-T

rich

loro

be

nze

ne

524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

1,2

,4-T

rich

loro

be

nze

ne

524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

1,1

,1-T

rich

loro

eth

ane

524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

1,1

,2-T

rich

loro

eth

ane

524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

Tri

chlo

roeth

yle

ne

524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

Tri

chlo

rofluoro

meth

ane

524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

1,2

,3-T

rich

loro

pro

pane

524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

1,1

,2-T

rich

loro

-1,2

,2-t

rifluoro

eth

ane

524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

1,2

,3-T

rim

eth

ylbenze

ne

524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Page 6

of

13

EE

A R

un I

D 2

81544 /

EE

A R

eport

# 5

00223

Page 112 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Fals

e

1,2

,4-T

rim

eth

ylbenze

ne

524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

1,3

,5-T

rim

eth

ylbenze

ne

524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

Vin

yl c

hlo

ride

524.2

0.2

LM

B0

.2ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

1,2

-Xyl

ene

524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Fals

e

1,3

+ 1

,4-X

yle

ne

524.2

0.5

LM

B0

.5ug

/L1

.04

75

29

41

---

---

---

---

---

<

---

10

/19

/20

20

12

:28

Tru

e

IS-1

,4-D

iflu

oro

benze

ne

524.2

N/A

LT

B1

97

64

1ug

/L1

.04

74

35

50

VO

C L

TB

---

---

70

- 1

30

96

20

69

50

--

-1

0/1

9/2

02

0 1

4:0

5T

rue

SS

-Bro

mofluoro

be

nze

ne

524.2

N/A

LT

B4

.91

40

ug

/L1

.04

74

35

50

VO

C L

TB

---

---

70

- 1

30

98

5.0

--

-1

0/1

9/2

02

0 1

4:0

5T

rue

SS

-1,2

-Dic

hlo

robenze

ne-d

4524.2

N/A

LT

B1

0.2

76

0ug

/L1

.04

74

35

50

VO

C L

TB

---

---

70

- 1

30

10

31

0.0

--

-1

0/1

9/2

02

0 1

4:0

5T

rue

SS

-1,2

-Dic

hlo

roeth

ane-d

4524.2

N/A

LT

B1

0.0

08

0ug

/L1

.04

74

35

50

VO

C L

TB

---

---

70

- 1

30

10

01

0.0

--

-1

0/1

9/2

02

0 1

4:0

5T

rue

SS

-Tolu

ene-d

8524.2

N/A

LT

B9

.86

30

ug

/L1

.04

74

35

50

VO

C L

TB

---

---

70

- 1

30

99

10

.0

---

10

/19

/20

20

14

:05

Tru

e

Acr

ylonitri

le524.2

1.0

LT

B1

.0ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

Ally

l ch

lori

de

524.2

5.0

LT

B5

.0ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

Benze

ne

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

Bro

mobenze

ne

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

Bro

moch

loro

meth

ane

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

Bro

modic

hlo

rom

eth

ane

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

Bro

mofo

rm524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

Bro

mom

eth

ane

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

2-B

uta

none (

ME

K)

524.2

5.0

LT

B5

.0ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

n-B

uty

lbenze

ne

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

sec-

Buty

lbenze

ne

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

tert

-Buty

lbenze

ne

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

Carb

on d

isulfid

e524.2

5.0

LT

B5

.0ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

Carb

on tetr

ach

lori

de

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

Chlo

roace

tonitri

le524.2

5.0

LT

B5

.0ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

Chlo

robenze

ne

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

1-C

hlo

robuta

ne

524.2

5.0

LT

B5

.0ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

Chlo

roeth

ane

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

Chlo

rofo

rm524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

Chlo

rom

eth

ane

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

2-C

hlo

roto

luene

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

4-C

hlo

roto

luene

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

Dib

rom

och

loro

meth

ane

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

1,2

-Dib

rom

o-3

-chlo

ropro

pane (

DB

CP

)524.2

0.2

LT

B0

.2ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

1,2

-Dib

rom

oeth

ane (

ED

B)

524.2

0.2

LT

B0

.2ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

Dib

rom

om

eth

ane

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

1,2

-Dic

hlo

robenze

ne

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

1,3

-Dic

hlo

robenze

ne

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

1,4

-Dic

hlo

robenze

ne

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

Tota

l D

ichlo

robenze

ne

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

trans-

1,4

-Dic

hlo

ro-2

-buty

lene

524.2

5.0

LT

B5

.0ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Page 7

of

13

EE

A R

un I

D 2

81544 /

EE

A R

eport

# 5

00223

Page 113 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Tru

e

Dic

hlo

rodiflu

oro

meth

ane

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

1,1

-Dic

hlo

roeth

ane

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

1,2

-Dic

hlo

roeth

ane

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

1,1

-Dic

hlo

roeth

ylene

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

cis-

1,2

-Dic

hlo

roeth

ylene

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

trans-

1,2

-Dic

hlo

roe

thyl

ene

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

Dic

hlo

rom

eth

ane

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

1,2

-Dic

hlo

ropro

pane

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

1,3

-Dic

hlo

ropro

pane

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

2,2

-Dic

hlo

ropro

pane

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

1,1

-Dic

hlo

ropro

panone

524.2

5.0

LT

B5

.0ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

1,1

-Dic

hlo

ropro

pyl

ene

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

1,3

-Dic

hlo

ropro

pyl

ene,

cis

& t

rans

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

cis-

1,3

-Dic

hlo

ropro

pyl

ene

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

trans-

1,3

-Dic

hlo

rop

ropyl

ene

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

Eth

yl E

ther

524.2

2.0

LT

B2

.0ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

Eth

yl m

eth

acr

ylate

524.2

1.0

LT

B1

.0ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

Eth

ylbenze

ne

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

Hexa

chlo

robuta

die

ne

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

Hexa

chlo

roeth

ane

524.2

2.0

LT

B2

.0ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

2-H

exa

none

524.2

5.0

LT

B5

.0ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

Isopro

pyl

benze

ne

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

4-I

sopro

pyl

tolu

ene

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

Meth

acr

ylonitri

le524.2

5.0

LT

B5

.0ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

Meth

ylacr

yla

te524.2

1.0

LT

B1

.0ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

Meth

yl iodid

e524.2

2.0

LT

B2

.0ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

Meth

ylm

eth

acr

ylate

524.2

1.0

LT

B1

.0ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

4-M

eth

yl-2

-penta

none (

MIB

K)

524.2

2.0

LT

B2

.0ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

Meth

yl-t

-buty

l eth

er

(MT

BE

)524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

Naphth

ale

ne

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

Nitro

benze

ne

524.2

5.0

LT

B5

.0ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

2-N

itro

pro

pane

524.2

2.0

LT

B2

.0ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

Penta

chlo

roeth

ane

524.2

2.0

LT

B2

.0ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

Pro

pio

nitri

le524.2

5.0

LT

B5

.0ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

n-P

ropyl

benze

ne

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

Sty

rene

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

1,1

,1,2

-Tetr

ach

loro

eth

ane

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

1,1

,2,2

-Tetr

ach

loro

eth

ane

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

Tetr

ach

loro

eth

ylene

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

Tetr

ahyd

rofu

ran

524.2

5.0

LT

B5

.0ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

Tolu

ene

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Page 8

of

13

EE

A R

un I

D 2

81544 /

EE

A R

eport

# 5

00223

Page 114 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Tru

e

Tota

l T

rihalo

meth

anes

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

1,2

,3-T

rich

loro

be

nze

ne

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

1,2

,4-T

rich

loro

be

nze

ne

524.2

0.5

LT

B0

.6ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

---

10

/19

/20

20

14

:05

Tru

e

1,1

,1-T

rich

loro

eth

ane

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

1,1

,2-T

rich

loro

eth

ane

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

Tri

chlo

roeth

yle

ne

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

Tri

chlo

rofluoro

meth

ane

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

1,2

,3-T

rich

loro

pro

pane

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

1,1

,2-T

rich

loro

-1,2

,2-t

rifluoro

eth

ane

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

1,2

,3-T

rim

eth

ylbenze

ne

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

1,2

,4-T

rim

eth

ylbenze

ne

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

1,3

,5-T

rim

eth

ylbenze

ne

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

Vin

yl c

hlo

ride

524.2

0.2

LT

B0

.2ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

1,2

-Xyl

ene

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

1,3

+ 1

,4-X

yle

ne

524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Tru

e

Xyl

enes,

Tota

l524.2

0.5

LT

B0

.5ug

/L1

.04

74

35

50

VO

C L

TB

---

---

---

---

<

---

10

/19

/20

20

14

:05

Fals

e

IS-1

,4-D

iflu

oro

benze

ne

524.2

N/A

FS

19

83

81

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

-7

0 -

13

09

62

06

95

0

---

10

/19

/20

20

14

:38

Fals

e

Acr

ylonitri

le524.2

1.0

FS

1.0

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

Ally

l ch

lori

de

524.2

5.0

FS

5.0

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

Benze

ne

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

Bro

mobenze

ne

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

Bro

moch

loro

meth

ane

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

Bro

modic

hlo

rom

eth

ane

524.2

0.5

FS

5.2

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

Bro

mofo

rm524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

Bro

mom

eth

ane

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

2-B

uta

none (

ME

K)

524.2

5.0

FS

5.0

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

n-B

uty

lbenze

ne

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

sec-

Buty

lbenze

ne

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

tert

-Buty

lbenze

ne

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

Carb

on d

isulfid

e524.2

5.0

FS

5.0

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

Carb

on tetr

ach

lori

de

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

Chlo

roace

tonitri

le524.2

5.0

FS

5.0

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

Chlo

robenze

ne

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

1-C

hlo

robuta

ne

524.2

5.0

FS

5.0

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

Chlo

roeth

ane

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

Chlo

rofo

rm524.2

0.5

FS

7.1

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

Chlo

rom

eth

ane

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

2-C

hlo

roto

luene

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

4-C

hlo

roto

luene

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

Dib

rom

och

loro

meth

ane

524.2

0.5

FS

1.9

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

1,2

-Dib

rom

o-3

-chlo

ropro

pane (

DB

CP

)524.2

0.2

FS

0.2

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8

Page 9

of

13

EE

A R

un I

D 2

81544 /

EE

A R

eport

# 5

00223

Page 115 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Fals

e

1,2

-Dib

rom

oeth

ane (

ED

B)

524.2

0.2

FS

0.2

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

Dib

rom

om

eth

ane

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

1,2

-Dic

hlo

robenze

ne

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

1,3

-Dic

hlo

robenze

ne

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

1,4

-Dic

hlo

robenze

ne

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

Tota

l D

ichlo

robenze

ne

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

trans-

1,4

-Dic

hlo

ro-2

-buty

lene

524.2

5.0

FS

5.0

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

Dic

hlo

rodiflu

oro

meth

ane

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

1,1

-Dic

hlo

roeth

ane

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

1,2

-Dic

hlo

roeth

ane

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

1,1

-Dic

hlo

roeth

ylene

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

cis-

1,2

-Dic

hlo

roeth

ylene

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

trans-

1,2

-Dic

hlo

roe

thyl

ene

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

Dic

hlo

rom

eth

ane

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

1,2

-Dic

hlo

ropro

pane

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

1,3

-Dic

hlo

ropro

pane

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

2,2

-Dic

hlo

ropro

pane

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

1,1

-Dic

hlo

ropro

panone

524.2

5.0

FS

5.0

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

1,1

-Dic

hlo

ropro

pyl

ene

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

1,3

-Dic

hlo

ropro

pyl

ene,

cis

& t

rans

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

cis-

1,3

-Dic

hlo

ropro

pyl

ene

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

trans-

1,3

-Dic

hlo

rop

ropyl

ene

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

Eth

yl E

ther

524.2

2.0

FS

2.0

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

Eth

yl m

eth

acr

ylate

524.2

1.0

FS

1.0

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

Eth

ylbenze

ne

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

Hexa

chlo

robuta

die

ne

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

Hexa

chlo

roeth

ane

524.2

2.0

FS

2.0

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

2-H

exa

none

524.2

5.0

FS

5.0

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

Isopro

pyl

benze

ne

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

4-I

sopro

pyl

tolu

ene

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

Meth

acr

ylonitri

le524.2

5.0

FS

5.0

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

Meth

ylacr

yla

te524.2

1.0

FS

1.0

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

Meth

yl iodid

e524.2

2.0

FS

2.0

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

Meth

ylm

eth

acr

ylate

524.2

1.0

FS

1.0

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

4-M

eth

yl-2

-penta

none (

MIB

K)

524.2

2.0

FS

2.0

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

Meth

yl-t

-buty

l eth

er

(MT

BE

)524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

Naphth

ale

ne

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

Nitro

benze

ne

524.2

5.0

FS

5.0

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

2-N

itro

pro

pane

524.2

2.0

FS

2.0

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

Penta

chlo

roeth

ane

524.2

2.0

FS

2.0

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

Pro

pio

nitri

le524.2

5.0

FS

5.0

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8

Page 1

0 o

f 13

EE

A R

un I

D 2

81544 /

EE

A R

eport

# 5

00223

Page 116 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Fals

e

n-P

ropyl

benze

ne

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

Sty

rene

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

1,1

,1,2

-Tetr

ach

loro

eth

ane

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

1,1

,2,2

-Tetr

ach

loro

eth

ane

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

Tetr

ach

loro

eth

ylene

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

Tetr

ahyd

rofu

ran

524.2

5.0

FS

5.0

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

Tolu

ene

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

Tota

l T

rihalo

meth

anes

524.2

0.5

FS

14

.2ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

1,2

,3-T

rich

loro

be

nze

ne

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

1,2

,4-T

rich

loro

be

nze

ne

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

1,1

,1-T

rich

loro

eth

ane

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

1,1

,2-T

rich

loro

eth

ane

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

Tri

chlo

roeth

yle

ne

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

Tri

chlo

rofluoro

meth

ane

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

1,2

,3-T

rich

loro

pro

pane

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

1,1

,2-T

rich

loro

-1,2

,2-t

rifluoro

eth

ane

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

1,2

,3-T

rim

eth

ylbenze

ne

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

1,2

,4-T

rim

eth

ylbenze

ne

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

1,3

,5-T

rim

eth

ylbenze

ne

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

Vin

yl c

hlo

ride

524.2

0.2

FS

0.2

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

1,2

-Xyl

ene

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

1,3

+ 1

,4-X

yle

ne

524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8F

als

e

Xyl

enes,

Tota

l524.2

0.5

FS

0.5

ug

/L1

.04

74

35

48

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

9/2

02

0 1

4:3

8T

rue

IS-1

,4-D

iflu

oro

benze

ne

524.2

N/A

CC

C1

96

63

6ug

/L1

.04

75

29

21

---

---

---

50

- 1

50

10

01

96

63

6

---

10

/19

/20

20

15

:14

Tru

e

SS

-Bro

mofluoro

be

nze

ne

524.2

N/A

CC

C5

.25

70

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

10

55

.0

---

10

/19

/20

20

15

:14

Tru

e

SS

-1,2

-Dic

hlo

robenze

ne-d

4524.2

N/A

CC

C1

0.8

62

0ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

10

91

0.0

--

-1

0/1

9/2

02

0 1

5:1

4T

rue

SS

-1,2

-Dic

hlo

roeth

ane-d

4524.2

N/A

CC

C9

.98

20

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

10

01

0.0

--

-1

0/1

9/2

02

0 1

5:1

4T

rue

SS

-Tolu

ene-d

8524.2

N/A

CC

C1

0.0

55

0ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

10

11

0.0

--

-1

0/1

9/2

02

0 1

5:1

4T

rue

Acr

ylonitri

le524.2

1.0

CC

C8

.30

60

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

17

.5

---

10

/19

/20

20

15

:14

Tru

e

Ally

l ch

lori

de

524.2

5.0

CC

C8

.63

20

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

57

.5

---

10

/19

/20

20

15

:14

Tru

e

Benze

ne

524.2

0.5

CC

C8

.41

50

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

27

.5

---

10

/19

/20

20

15

:14

Tru

e

Bro

mobenze

ne

524.2

0.5

CC

C8

.53

00

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

47

.5

---

10

/19

/20

20

15

:14

Tru

e

Bro

moch

loro

meth

ane

524.2

0.5

CC

C8

.36

50

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

27

.5

---

10

/19

/20

20

15

:14

Tru

e

Bro

modic

hlo

rom

eth

ane

524.2

0.5

CC

C8

.35

50

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

17

.5

---

10

/19

/20

20

15

:14

Tru

e

Bro

mofo

rm524.2

0.5

CC

C8

.83

10

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

87

.5

---

10

/19

/20

20

15

:14

Tru

e

Bro

mom

eth

ane

524.2

0.5

CC

C9

.06

30

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

12

17

.5

---

10

/19

/20

20

15

:14

Tru

e

2-B

uta

none (

ME

K)

524.2

5.0

CC

C8

.81

40

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

87

.5

---

10

/19

/20

20

15

:14

Tru

e

n-B

uty

lbenze

ne

524.2

0.5

CC

C8

.72

40

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

67

.5

---

10

/19

/20

20

15

:14

Tru

e

sec-

Buty

lbenze

ne

524.2

0.5

CC

C8

.54

20

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

47

.5

---

10

/19

/20

20

15

:14

Tru

e

tert

-Buty

lbenze

ne

524.2

0.5

CC

C8

.44

00

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

37

.5

---

10

/19

/20

20

15

:14

Tru

e

Carb

on d

isulfid

e524.2

5.0

CC

C8

.53

80

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

47

.5

---

10

/19

/20

20

15

:14

Page 1

1 o

f 13

EE

A R

un I

D 2

81544 /

EE

A R

eport

# 5

00223

Page 117 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Tru

e

Carb

on tetr

ach

lori

de

524.2

0.5

CC

C8

.01

70

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

10

77

.5

---

10

/19

/20

20

15

:14

Tru

e

Chlo

roace

tonitri

le524.2

5.0

CC

C8

.29

10

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

17

.5

---

10

/19

/20

20

15

:14

Tru

e

Chlo

robenze

ne

524.2

0.5

CC

C8

.60

90

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

57

.5

---

10

/19

/20

20

15

:14

Tru

e

1-C

hlo

robuta

ne

524.2

5.0

CC

C8

.33

40

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

17

.5

---

10

/19

/20

20

15

:14

Tru

e

Chlo

roeth

ane

524.2

0.5

CC

C7

.77

80

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

10

47

.5

---

10

/19

/20

20

15

:14

Tru

e

Chlo

rofo

rm524.2

0.5

CC

C8

.34

60

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

17

.5

---

10

/19

/20

20

15

:14

Tru

e

Chlo

rom

eth

ane

524.2

0.5

CC

C8

.52

00

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

47

.5

---

10

/19

/20

20

15

:14

Tru

e

2-C

hlo

roto

luene

524.2

0.5

CC

C8

.40

50

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

27

.5

---

10

/19

/20

20

15

:14

Tru

e

4-C

hlo

roto

luene

524.2

0.5

CC

C8

.57

80

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

47

.5

---

10

/19

/20

20

15

:14

Tru

e

Dib

rom

och

loro

meth

ane

524.2

0.5

CC

C7

.83

10

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

10

47

.5

---

10

/19

/20

20

15

:14

Tru

e

1,2

-Dib

rom

o-3

-chlo

ropro

pane (

DB

CP

)524.2

0.2

CC

C8

.62

40

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

57

.5

---

10

/19

/20

20

15

:14

Tru

e

1,2

-Dib

rom

oeth

ane (

ED

B)

524.2

0.2

CC

C8

.56

70

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

47

.5

---

10

/19

/20

20

15

:14

Tru

e

Dib

rom

om

eth

ane

524.2

0.5

CC

C8

.51

60

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

47

.5

---

10

/19

/20

20

15

:14

Tru

e

1,2

-Dic

hlo

robenze

ne

524.2

0.5

CC

C8

.62

80

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

57

.5

---

10

/19

/20

20

15

:14

Tru

e

1,3

-Dic

hlo

robenze

ne

524.2

0.5

CC

C8

.64

00

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

57

.5

---

10

/19

/20

20

15

:14

Tru

e

1,4

-Dic

hlo

robenze

ne

524.2

0.5

CC

C8

.58

80

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

57

.5

---

10

/19

/20

20

15

:14

Tru

e

trans-

1,4

-Dic

hlo

ro-2

-buty

lene

524.2

5.0

CC

C8

.27

50

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

07

.5

---

10

/19

/20

20

15

:14

Tru

e

Dic

hlo

rodiflu

oro

meth

ane

524.2

0.5

CC

C7

.20

00

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

96

7.5

--

-1

0/1

9/2

02

0 1

5:1

4T

rue

1,1

-Dic

hlo

roeth

ane

524.2

0.5

CC

C8

.31

00

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

17

.5

---

10

/19

/20

20

15

:14

Tru

e

1,2

-Dic

hlo

roeth

ane

524.2

0.5

CC

C8

.69

50

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

67

.5

---

10

/19

/20

20

15

:14

Tru

e

1,1

-Dic

hlo

roeth

ylene

524.2

0.5

CC

C8

.25

40

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

07

.5

---

10

/19

/20

20

15

:14

Tru

e

cis-

1,2

-Dic

hlo

roeth

ylene

524.2

0.5

CC

C8

.67

70

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

67

.5

---

10

/19

/20

20

15

:14

Tru

e

trans-

1,2

-Dic

hlo

roe

thyl

ene

524.2

0.5

CC

C8

.36

30

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

27

.5

---

10

/19

/20

20

15

:14

Tru

e

Dic

hlo

rom

eth

ane

524.2

0.5

CC

C7

.83

40

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

10

47

.5

---

10

/19

/20

20

15

:14

Tru

e

1,2

-Dic

hlo

ropro

pane

524.2

0.5

CC

C7

.99

70

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

10

77

.5

---

10

/19

/20

20

15

:14

Tru

e

1,3

-Dic

hlo

ropro

pane

524.2

0.5

CC

C8

.17

60

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

10

97

.5

---

10

/19

/20

20

15

:14

Tru

e

2,2

-Dic

hlo

ropro

pane

524.2

0.5

CC

C9

.60

50

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

12

87

.5

---

10

/19

/20

20

15

:14

Tru

e

1,1

-Dic

hlo

ropro

panone

524.2

5.0

CC

C8

.70

80

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

67

.5

---

10

/19

/20

20

15

:14

Tru

e

1,1

-Dic

hlo

ropro

pyl

ene

524.2

0.5

CC

C8

.17

40

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

10

97

.5

---

10

/19

/20

20

15

:14

Tru

e

cis-

1,3

-Dic

hlo

ropro

pyl

ene

524.2

0.5

CC

C8

.37

60

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

27

.5

---

10

/19

/20

20

15

:14

Tru

e

trans-

1,3

-Dic

hlo

rop

ropyl

ene

524.2

0.5

CC

C8

.74

50

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

77

.5

---

10

/19

/20

20

15

:14

Tru

e

Eth

yl E

ther

524.2

2.0

CC

C8

.75

90

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

77

.5

---

10

/19

/20

20

15

:14

Tru

e

Eth

yl m

eth

acr

ylate

524.2

1.0

CC

C8

.94

90

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

97

.5

---

10

/19

/20

20

15

:14

Tru

e

Eth

ylbenze

ne

524.2

0.5

CC

C8

.43

50

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

27

.5

---

10

/19

/20

20

15

:14

Tru

e

Hexa

chlo

robuta

die

ne

524.2

0.5

CC

C8

.62

90

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

57

.5

---

10

/19

/20

20

15

:14

Tru

e

Hexa

chlo

roeth

ane

524.2

2.0

CC

C8

.34

20

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

17

.5

---

10

/19

/20

20

15

:14

Tru

e

2-H

exa

none

524.2

5.0

CC

C9

.18

10

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

12

27

.5

---

10

/19

/20

20

15

:14

Tru

e

Isopro

pyl

benze

ne

524.2

0.5

CC

C8

.53

80

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

47

.5

---

10

/19

/20

20

15

:14

Tru

e

4-I

sopro

pyl

tolu

ene

524.2

0.5

CC

C8

.58

70

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

47

.5

---

10

/19

/20

20

15

:14

Tru

e

Meth

acr

ylonitri

le524.2

5.0

CC

C9

.01

20

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

12

07

.5

---

10

/19

/20

20

15

:14

Tru

e

Meth

ylacr

yla

te524.2

1.0

CC

C8

.35

40

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

17

.5

---

10

/19

/20

20

15

:14

Page 1

2 o

f 13

EE

A R

un I

D 2

81544 /

EE

A R

eport

# 5

00223

Page 118 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Tru

e

Meth

yl iodid

e524.2

2.0

CC

C6

.88

50

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

92

7.5

--

-1

0/1

9/2

02

0 1

5:1

4T

rue

Meth

ylm

eth

acr

ylate

524.2

1.0

CC

C8

.96

00

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

97

.5

---

10

/19

/20

20

15

:14

Tru

e

4-M

eth

yl-2

-penta

none (

MIB

K)

524.2

2.0

CC

C9

.51

20

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

12

77

.5

---

10

/19

/20

20

15

:14

Tru

e

Meth

yl-t

-buty

l eth

er

(MT

BE

)524.2

0.5

CC

C8

.35

10

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

17

.5

---

10

/19

/20

20

15

:14

Tru

e

Naphth

ale

ne

524.2

0.5

CC

C8

.79

50

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

77

.5

---

10

/19

/20

20

15

:14

Tru

e

Nitro

benze

ne

524.2

5.0

CC

C5

.50

30

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

73

7.5

--

-1

0/1

9/2

02

0 1

5:1

4T

rue

2-N

itro

pro

pane

524.2

2.0

CC

C8

.32

10

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

17

.5

---

10

/19

/20

20

15

:14

Tru

e

Penta

chlo

roeth

ane

524.2

2.0

CC

C8

.09

30

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

10

87

.5

---

10

/19

/20

20

15

:14

Tru

e

Pro

pio

nitri

le524.2

5.0

CC

C9

.02

30

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

12

07

.5

---

10

/19

/20

20

15

:14

Tru

e

n-P

ropyl

benze

ne

524.2

0.5

CC

C8

.61

70

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

57

.5

---

10

/19

/20

20

15

:14

Tru

e

Sty

rene

524.2

0.5

CC

C8

.36

80

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

27

.5

---

10

/19

/20

20

15

:14

Tru

e

1,1

,1,2

-Tetr

ach

loro

eth

ane

524.2

0.5

CC

C8

.14

30

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

10

97

.5

---

10

/19

/20

20

15

:14

Tru

e

1,1

,2,2

-Tetr

ach

loro

eth

ane

524.2

0.5

CC

C9

.24

90

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

12

37

.5

---

10

/19

/20

20

15

:14

Tru

e

Tetr

ach

loro

eth

ylene

524.2

0.5

CC

C8

.92

70

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

97

.5

---

10

/19

/20

20

15

:14

Tru

e

Tetr

ahyd

rofu

ran

524.2

5.0

CC

C9

.58

40

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

12

87

.5

---

10

/19

/20

20

15

:14

Tru

e

Tolu

ene

524.2

0.5

CC

C8

.27

30

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

07

.5

---

10

/19

/20

20

15

:14

Tru

e

1,2

,3-T

rich

loro

be

nze

ne

524.2

0.5

CC

C8

.45

90

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

37

.5

---

10

/19

/20

20

15

:14

Tru

e

1,2

,4-T

rich

loro

be

nze

ne

524.2

0.5

CC

C8

.77

20

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

77

.5

---

10

/19

/20

20

15

:14

Tru

e

1,1

,1-T

rich

loro

eth

ane

524.2

0.5

CC

C8

.33

00

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

17

.5

---

10

/19

/20

20

15

:14

Tru

e

1,1

,2-T

rich

loro

eth

ane

524.2

0.5

CC

C8

.73

40

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

67

.5

---

10

/19

/20

20

15

:14

Tru

e

Tri

chlo

roeth

yle

ne

524.2

0.5

CC

C8

.41

80

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

27

.5

---

10

/19

/20

20

15

:14

Tru

e

Tri

chlo

rofluoro

meth

ane

524.2

0.5

CC

C8

.99

30

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

12

07

.5

---

10

/19

/20

20

15

:14

Tru

e

1,2

,3-T

rich

loro

pro

pane

524.2

0.5

CC

C8

.42

30

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

27

.5

---

10

/19

/20

20

15

:14

Tru

e

1,1

,2-T

rich

loro

-1,2

,2-t

rifluoro

eth

ane

524.2

0.5

CC

C8

.90

00

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

97

.5

---

10

/19

/20

20

15

:14

Tru

e

1,2

,3-T

rim

eth

ylbenze

ne

524.2

0.5

CC

C8

.28

90

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

17

.5

---

10

/19

/20

20

15

:14

Tru

e

1,2

,4-T

rim

eth

ylbenze

ne

524.2

0.5

CC

C8

.36

10

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

17

.5

---

10

/19

/20

20

15

:14

Tru

e

1,3

,5-T

rim

eth

ylbenze

ne

524.2

0.5

CC

C8

.30

70

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

17

.5

---

10

/19

/20

20

15

:14

Tru

e

Vin

yl c

hlo

ride

524.2

0.2

CC

C9

.36

30

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

12

57

.5

---

10

/19

/20

20

15

:14

Tru

e

1,2

-Xyl

ene

524.2

0.5

CC

C8

.75

60

ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

77

.5

---

10

/19

/20

20

15

:14

Tru

e

1,3

+ 1

,4-X

yle

ne

524.2

0.5

CC

C1

6.9

27

0ug

/L1

.04

75

29

21

---

---

---

70

- 1

30

11

31

5.0

--

-1

0/1

9/2

02

0 1

5:1

4

Page 1

3 o

f 13

EE

A R

un I

D 2

81544 /

EE

A R

eport

# 5

00223

Page 119 of 201

Eu

rofi

ns

Ea

ton

An

aly

tica

lR

un

Lo

gR

un ID

:280992

Meth

od:

525.2

Sam

ple

Sit

eS

am

ple

Id

Typ

eIn

str

um

en

t ID

Cali

bra

tio

n F

ile

An

aly

sis

Date

Matr

ix

CC

C4

74

86

11

DO

52

5 2

-DO

-11

21

19

a.m

th1

0/1

4/2

02

0 0

8:5

8O

S

CC

C4

74

86

12

DO

52

5 2

-DO

-11

21

19

a.m

th1

0/1

4/2

02

0 0

9:4

0O

S

CC

C4

74

86

13

DO

52

5 2

-DO

-11

21

19

a.m

th1

0/1

4/2

02

0 1

0:2

2O

S

LF

B4

74

86

06

DO

52

5 2

-DO

-11

21

19

a.m

th1

0/1

4/2

02

0 1

1:0

4R

W

LF

B4

74

86

07

DO

52

5 2

-DO

-11

21

19

a.m

th1

0/1

4/2

02

0 1

1:4

6R

W

LF

B4

74

86

08

DO

52

5 2

-DO

-11

21

19

a.m

th1

0/1

4/2

02

0 1

2:2

8R

W

LM

B4

74

86

05

DO

52

5 2

-DO

-11

21

19

a.m

th1

0/1

4/2

02

0 1

3:1

0R

W

FS

47

43

53

6F

inis

he

dD

O5

25

2-D

O-1

12

11

9a

.mth

10

/14

/20

20

16

:40

DW

FD

47

48

60

9F

inis

he

dD

O5

25

2-D

O-1

12

11

9a

.mth

10

/14

/20

20

17

:22

DW

CC

C4

74

88

74

DO

52

5 2

-DO

-11

21

19

a.m

th1

0/1

4/2

02

0 2

0:5

5O

S

CC

C4

74

88

75

DO

52

5 2

-DO

-11

21

19

a.m

th1

0/1

4/2

02

0 2

1:3

7O

S

CC

C4

74

88

76

DO

52

5 2

-DO

-11

21

19

a.m

th1

0/1

4/2

02

0 2

2:1

9O

S

LF

B4

74

86

06

DO

52

5 2

-DO

-11

21

19

a.m

th1

0/1

4/2

02

0 2

3:0

1R

W

0.0

0

Page 1

of

32

EE

A R

un I

D 2

80992 /

EE

A R

eport

# 5

00223

Page 120 of 201

QC

Su

mm

ary

Re

po

rt

EE

AID

#R

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

eth

od

An

aly

teS

am

ple

Typ

eD

ilF

ac

tor

RP

DL

imit

Re

co

ve

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

gM

RL

Ex

tra

cte

dA

na

lyze

d

Tru

e

IS-C

hry

sene-d

12

525.2

N/A

CC

C5

51

84

4ug

/L1

.04

74

86

11

---

---

---

50

- 1

50

10

05

51

84

4

10

/13

/20

20

08

:06

10

/14

/20

20

08

:58

Tru

e

IS-P

henanth

rene-d

10

525.2

N/A

CC

C7

43

96

1ug

/L1

.04

74

86

11

---

---

---

50

- 1

50

10

07

43

96

1

10

/13

/20

20

08

:06

10

/14

/20

20

08

:58

Tru

e

IS-P

yrene-d

10

525.2

N/A

CC

C6

07

34

7ug

/L1

.04

74

86

11

---

---

---

50

- 1

50

10

06

07

34

7

10

/13

/20

20

08

:06

10

/14

/20

20

08

:58

Tru

e

SS

-4,4

'-D

ichlo

robip

henyl

525.2

N/A

CC

C4

.24

60

ug

/L1

.04

74

86

11

---

---

---

70

- 1

30

85

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 0

8:5

8T

rue

SS

-2,4

,5,6

-Tetr

ach

loro

-m-x

ylene

525.2

N/A

CC

C4

.68

70

ug

/L1

.04

74

86

11

---

---

---

70

- 1

30

94

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 0

8:5

8T

rue

SS

-Tri

phenyl

phosp

hate

525.2

N/A

CC

C5

.69

40

ug

/L1

.04

74

86

11

---

---

---

70

- 1

30

11

45

.0

10

/13

/20

20

08

:06

10

/14

/20

20

08

:58

Tru

e

Ace

naphth

ene

525.2

0.1

CC

C4

.45

60

ug

/L1

.04

74

86

11

---

---

---

65

- 1

30

89

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 0

8:5

8T

rue

Ace

naphth

ylene

525.2

0.1

CC

C4

.96

70

ug

/L1

.04

74

86

11

---

---

---

70

- 1

30

99

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 0

8:5

8T

rue

Anth

race

ne

525.2

0.1

CC

C4

.66

20

ug

/L1

.04

74

86

11

---

---

---

70

- 1

30

93

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 0

8:5

8T

rue

Azi

nphos-

eth

yl525.2

0.5

CC

C5

.10

90

ug

/L1

.04

74

86

11

---

---

---

70

- 1

45

10

25

.0

10

/13

/20

20

08

:06

10

/14

/20

20

08

:58

Tru

e

Bendio

carb

525.2

0.5

CC

C5

.35

60

ug

/L1

.04

74

86

11

---

---

---

65

- 1

59

10

75

.0

10

/13

/20

20

08

:06

10

/14

/20

20

08

:58

Tru

e

Benzo

(a)a

nth

race

ne

525.2

0.1

CC

C5

.45

20

ug

/L1

.04

74

86

11

---

---

---

70

- 1

30

10

95

.0

10

/13

/20

20

08

:06

10

/14

/20

20

08

:58

Tru

e

Benzo

(b)f

luora

nth

ene

525.2

0.1

CC

C5

.45

60

ug

/L1

.04

74

86

11

---

---

---

70

- 1

30

10

95

.0

10

/13

/20

20

08

:06

10

/14

/20

20

08

:58

Tru

e

Benzo

(k)f

luora

nth

ene

525.2

0.1

CC

C5

.36

90

ug

/L1

.04

74

86

11

---

---

---

70

- 1

30

10

75

.0

10

/13

/20

20

08

:06

10

/14

/20

20

08

:58

Tru

e

Benzo

(g,h

,i)p

ery

lene

525.2

0.1

CC

C4

.75

50

ug

/L1

.04

74

86

11

---

---

---

70

- 1

30

95

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 0

8:5

8T

rue

Buty

lbenzy

lphth

ala

te525.2

1.0

CC

C5

.78

10

ug

/L1

.04

74

86

11

---

---

---

70

- 1

30

11

65

.0

10

/13

/20

20

08

:06

10

/14

/20

20

08

:58

Tru

e

Carb

ophenoth

ion

525.2

0.5

CC

C5

.31

00

ug

/L1

.04

74

86

11

---

---

---

70

- 1

30

10

65

.0

10

/13

/20

20

08

:06

10

/14

/20

20

08

:58

Tru

e

Chlo

rfenvi

nphos

525.2

5.0

CC

C4

.67

40

ug

/L1

.04

74

86

11

---

---

---

70

- 1

30

10

64

.42

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 0

8:5

8T

rue

2-C

hlo

robip

he

nyl

525.2

0.1

CC

C4

.85

90

ug

/L1

.04

74

86

11

---

---

---

70

- 1

30

97

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 0

8:5

8T

rue

Chlo

rpyr

ifos

me

thyl

525.2

0.5

CC

C5

.26

30

ug

/L1

.04

74

86

11

---

---

---

70

- 1

30

10

55

.0

10

/13

/20

20

08

:06

10

/14

/20

20

08

:58

Tru

e

Chry

sene

525.2

0.1

CC

C5

.24

40

ug

/L1

.04

74

86

11

---

---

---

70

- 1

30

10

55

.0

10

/13

/20

20

08

:06

10

/14

/20

20

08

:58

Tru

e

Clo

pyr

alid

525.2

10

CC

C7

.17

80

ug

/L1

.04

74

86

11

---

---

---

1 -

10

97

21

0.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 0

8:5

8T

rue

Cro

toxy

phos

525.2

0.5

CC

C4

.67

50

ug

/L1

.04

74

86

11

---

---

---

70

- 1

73

94

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 0

8:5

8T

rue

Dib

enzo

(a,h

)anth

race

ne

525.2

0.1

CC

C5

.17

00

ug

/L1

.04

74

86

11

---

---

---

70

- 1

30

10

35

.0

10

/13

/20

20

08

:06

10

/14

/20

20

08

:58

Tru

e

Di-

n-b

uty

lphth

ala

te525.2

2.0

CC

C5

.57

30

ug

/L1

.04

74

86

11

---

---

---

70

- 1

30

11

15

.0

10

/13

/20

20

08

:06

10

/14

/20

20

08

:58

Tru

e

2,3

-Dic

hlo

robip

henyl

525.2

0.1

CC

C5

.00

30

ug

/L1

.04

74

86

11

---

---

---

70

- 1

30

10

05

.0

10

/13

/20

20

08

:06

10

/14

/20

20

08

:58

Tru

e

Dic

roto

phos

525.2

0.5

CC

C5

.18

10

ug

/L1

.04

74

86

11

---

---

---

70

- 1

91

10

45

.0

10

/13

/20

20

08

:06

10

/14

/20

20

08

:58

Tru

e

Die

thyl

phth

ala

te525.2

1.0

CC

C4

.78

60

ug

/L1

.04

74

86

11

---

---

---

70

- 1

30

96

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 0

8:5

8T

rue

Dim

eth

ylphth

ala

te525.2

1.0

CC

C4

.94

50

ug

/L1

.04

74

86

11

---

---

---

70

- 1

30

99

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 0

8:5

8T

rue

Di-

n-o

ctyl

phth

ala

te525.2

2.0

CC

C5

.74

40

ug

/L1

.04

74

86

11

---

---

---

48

- 1

73

11

55

.0

10

/13

/20

20

08

:06

10

/14

/20

20

08

:58

Tru

e

Dio

xath

ion A

525.2

0.5

CC

C4

.33

40

ug

/L1

.04

74

86

11

---

---

---

34

- 2

09

14

23

.06

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 0

8:5

8T

rue

Dio

xath

ion B

525.2

0.5

CC

C2

.57

50

ug

/L1

.04

74

86

11

---

---

---

14

- 4

98

13

61

.89

5

10

/13

/20

20

08

:06

10

/14

/20

20

08

:58

Tru

e

Dis

ulfoto

n s

ulfo

xide

525.2

10

CC

C1

0.8

78

0ug

/L1

.04

74

86

11

---

---

---

69

- 1

30

10

91

0.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 0

8:5

8T

rue

EP

N525.2

0.5

CC

C5

.60

00

ug

/L1

.04

74

86

11

---

---

---

70

- 1

47

11

25

.0

10

/13

/20

20

08

:06

10

/14

/20

20

08

:58

Tru

e

Eru

cyla

mid

e525.2

5.0

CC

C9

.35

70

ug

/L1

.04

74

86

11

---

---

---

43

- 2

51

94

10

.0

10

/13

/20

20

08

:06

10

/14

/20

20

08

:58

Tru

e

Esf

enva

lera

te525.2

0.5

CC

C5

.92

40

ug

/L1

.04

74

86

11

---

---

---

70

- 1

30

11

85

.0

10

/13

/20

20

08

:06

10

/14

/20

20

08

:58

Tru

e

Fenari

mol

525.2

1.0

CC

C5

.20

00

ug

/L1

.04

74

86

11

---

---

---

70

- 1

30

10

45

.0

10

/13

/20

20

08

:06

10

/14

/20

20

08

:58

Tru

e

Fenitro

thio

n525.2

0.5

CC

C5

.48

70

ug

/L1

.04

74

86

11

---

---

---

70

- 1

30

11

05

.0

10

/13

/20

20

08

:06

10

/14

/20

20

08

:58

Tru

e

Fenoxa

pro

p-e

thyl

525.2

1.0

CC

C5

.22

30

ug

/L1

.04

74

86

11

---

---

---

70

- 1

40

10

45

.0

10

/13

/20

20

08

:06

10

/14

/20

20

08

:58

Tru

e

Fensu

lfoth

ion

525.2

0.5

CC

C5

.91

20

ug

/L1

.04

74

86

11

---

---

---

70

- 1

91

11

85

.0

10

/13

/20

20

08

:06

10

/14

/20

20

08

:58

Page 2

of

32

EE

A R

un I

D 2

80992 /

EE

A R

eport

# 5

00223

Page 121 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Tru

e

Flu

ore

ne

525.2

0.1

CC

C5

.04

00

ug

/L1

.04

74

86

11

---

---

---

70

- 1

30

10

15

.0

10

/13

/20

20

08

:06

10

/14

/20

20

08

:58

Tru

e

Flu

ridone

525.2

1.0

CC

C4

.69

20

ug

/L1

.04

74

86

11

---

---

---

70

- 1

30

94

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 0

8:5

8T

rue

2,2

',3,3

',4,4

',6-H

epta

chlo

robip

henyl

525.2

0.5

CC

C4

.99

00

ug

/L1

.04

74

86

11

---

---

---

70

- 1

30

10

05

.0

10

/13

/20

20

08

:06

10

/14

/20

20

08

:58

Tru

e

2,2

',4,4

',5,6

'-H

exa

chlo

robip

henyl

525.2

0.1

CC

C5

.47

10

ug

/L1

.04

74

86

11

---

---

---

70

- 1

30

10

95

.0

10

/13

/20

20

08

:06

10

/14

/20

20

08

:58

Tru

e

Indeno(1

,2,3

-cd)p

yrene

525.2

0.1

CC

C5

.00

10

ug

/L1

.04

74

86

11

---

---

---

70

- 1

30

10

05

.0

10

/13

/20

20

08

:06

10

/14

/20

20

08

:58

Tru

e

Ipro

dio

ne

525.2

0.5

CC

C6

.74

10

ug

/L1

.04

74

86

11

---

---

---

70

- 2

07

13

55

.0

10

/13

/20

20

08

:06

10

/14

/20

20

08

:58

Tru

e

Isofe

nphos

525.2

0.5

CC

C5

.11

30

ug

/L1

.04

74

86

11

---

---

---

70

- 1

45

10

25

.0

10

/13

/20

20

08

:06

10

/14

/20

20

08

:58

Tru

e

Lepto

phos

525.2

0.5

CC

C5

.27

20

ug

/L1

.04

74

86

11

---

---

---

70

- 1

30

10

55

.0

10

/13

/20

20

08

:06

10

/14

/20

20

08

:58

Tru

e

Meta

laxy

l525.2

0.5

CC

C5

.25

40

ug

/L1

.04

74

86

11

---

---

---

70

- 1

43

10

55

.0

10

/13

/20

20

08

:06

10

/14

/20

20

08

:58

Tru

e

Meth

yl p

ara

thio

n525.2

0.5

CC

C7

.26

40

ug

/L1

.04

74

86

11

---

---

---

70

- 2

06

14

55

.0

10

/13

/20

20

08

:06

10

/14

/20

20

08

:58

Tru

e

Mets

ulfuro

n-m

eth

yl525.2

10

CC

C1

0.6

85

0ug

/L1

.04

74

86

11

---

---

---

70

- 1

70

10

71

0.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 0

8:5

8T

rue

Mir

ex

525.2

0.5

CC

C4

.60

00

ug

/L1

.04

74

86

11

---

---

---

61

- 1

30

92

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 0

8:5

8T

rue

Monocr

oto

phos

525.2

0.5

CC

C5

.46

90

ug

/L1

.04

74

86

11

---

---

---

70

- 1

85

10

95

.0

10

/13

/20

20

08

:06

10

/14

/20

20

08

:58

Tru

e

Nale

d525.2

0.5

CC

C3

.67

10

ug

/L1

.04

74

86

11

---

---

---

29

- 1

60

73

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 0

8:5

8T

rue

cis-

Nonach

lor

525.2

0.1

CC

C5

.97

30

ug

/L1

.04

74

86

11

---

---

---

70

- 1

30

11

95

.0

10

/13

/20

20

08

:06

10

/14

/20

20

08

:58

Tru

e

Norf

lura

zon

525.2

1.0

CC

C5

.14

10

ug

/L1

.04

74

86

11

---

---

---

70

- 1

30

10

35

.0

10

/13

/20

20

08

:06

10

/14

/20

20

08

:58

Tru

e

2,2

',3,3

',4,5

',6,6

'-O

ctach

loro

bip

henyl

525.2

0.5

CC

C5

.22

80

ug

/L1

.04

74

86

11

---

---

---

70

- 1

30

10

55

.0

10

/13

/20

20

08

:06

10

/14

/20

20

08

:58

Tru

e

Ory

zalin

525.2

10

CC

C8

.40

30

ug

/L1

.04

74

86

11

---

---

---

1 -

38

91

68

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 0

8:5

8T

rue

Oxy

chlo

rdane

525.2

0.1

CC

C5

.61

90

ug

/L1

.04

74

86

11

---

---

---

70

- 1

30

11

25

.0

10

/13

/20

20

08

:06

10

/14

/20

20

08

:58

Tru

e

Oxy

fluorf

en

525.2

0.5

CC

C5

.00

50

ug

/L1

.04

74

86

11

---

---

---

70

- 1

30

10

05

.0

10

/13

/20

20

08

:06

10

/14

/20

20

08

:58

Tru

e

Para

thio

n525.2

0.5

CC

C5

.17

10

ug

/L1

.04

74

86

11

---

---

---

63

- 1

45

10

35

.0

10

/13

/20

20

08

:06

10

/14

/20

20

08

:58

Tru

e

Penta

chlo

robenze

ne

525.2

0.5

CC

C4

.61

80

ug

/L1

.04

74

86

11

---

---

---

61

- 1

30

92

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 0

8:5

8T

rue

2,2

',3',4

,6-P

enta

chlo

robip

henyl

525.2

0.1

CC

C5

.72

00

ug

/L1

.04

74

86

11

---

---

---

70

- 1

30

11

45

.0

10

/13

/20

20

08

:06

10

/14

/20

20

08

:58

Tru

e

Phenanth

rene

525.2

0.1

CC

C5

.04

00

ug

/L1

.04

74

86

11

---

---

---

70

- 1

30

10

15

.0

10

/13

/20

20

08

:06

10

/14

/20

20

08

:58

Tru

e

Phosm

et

525.2

0.5

CC

C4

.78

80

ug

/L1

.04

74

86

11

---

---

---

70

- 1

30

96

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 0

8:5

8T

rue

E-P

hosp

ham

idon

525.2

0.5

CC

C1

.38

00

ug

/L1

.04

74

86

11

---

---

---

70

- 3

02

99

1.3

9

10

/13

/20

20

08

:06

10

/14

/20

20

08

:58

Tru

e

Z-P

hosp

ham

idon

525.2

0.5

CC

C3

.62

50

ug

/L1

.04

74

86

11

---

---

---

70

- 1

89

10

33

.51

5

10

/13

/20

20

08

:06

10

/14

/20

20

08

:58

Tru

e

Pro

pic

onazo

le iso

mer

a525.2

5.0

CC

C2

.12

40

ug

/L1

.04

74

86

11

---

---

---

1 -

27

89

52

.24

5

10

/13

/20

20

08

:06

10

/14

/20

20

08

:58

Tru

e

Pro

pic

onazo

le iso

mer

b525.2

5.0

CC

C2

.83

80

ug

/L1

.04

74

86

11

---

---

---

61

- 1

30

10

32

.75

5

10

/13

/20

20

08

:06

10

/14

/20

20

08

:58

Tru

e

Pro

thio

fos

525.2

0.5

CC

C5

.08

80

ug

/L1

.04

74

86

11

---

---

---

70

- 1

35

10

25

.0

10

/13

/20

20

08

:06

10

/14

/20

20

08

:58

Tru

e

Pyr

ene

525.2

0.1

CC

C5

.55

80

ug

/L1

.04

74

86

11

---

---

---

70

- 1

30

11

15

.0

10

/13

/20

20

08

:06

10

/14

/20

20

08

:58

Tru

e

Sulfote

p525.2

0.5

CC

C4

.28

60

ug

/L1

.04

74

86

11

---

---

---

70

- 1

30

86

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 0

8:5

8T

rue

Tebuth

iuro

n525.2

10

CC

C1

0.6

06

0ug

/L1

.04

74

86

11

---

---

---

70

- 1

30

10

61

0.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 0

8:5

8T

rue

TE

PP

525.2

1.0

CC

C4

.94

40

ug

/L1

.04

74

86

11

---

---

---

1 -

26

79

95

.0

10

/13

/20

20

08

:06

10

/14

/20

20

08

:58

Tru

e

1,2

,4,5

-Tetr

ach

loro

benze

ne

525.2

0.5

CC

C4

.42

90

ug

/L1

.04

74

86

11

---

---

---

57

- 1

30

89

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 0

8:5

8T

rue

2,2

',4,4

'-T

etr

ach

loro

bip

henyl

525.2

0.1

CC

C5

.29

40

ug

/L1

.04

74

86

11

---

---

---

70

- 1

30

10

65

.0

10

/13

/20

20

08

:06

10

/14

/20

20

08

:58

Tru

e

Thia

bendazo

le525.2

10

CC

C4

.43

00

ug

/L1

.04

74

86

11

---

---

---

6 -

19

08

95

.0

10

/13

/20

20

08

:06

10

/14

/20

20

08

:58

Tru

e

Thio

nazi

n525.2

0.5

CC

C5

.29

70

ug

/L1

.04

74

86

11

---

---

---

62

- 1

37

10

65

.0

10

/13

/20

20

08

:06

10

/14

/20

20

08

:58

Tru

e

Tri

bufo

s525.2

0.1

CC

C4

.87

10

ug

/L1

.04

74

86

11

---

---

---

70

- 1

36

97

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 0

8:5

8T

rue

2,4

,5-T

rich

loro

bip

henyl

525.2

0.1

CC

C5

.28

20

ug

/L1

.04

74

86

11

---

---

---

70

- 1

30

10

65

.0

10

/13

/20

20

08

:06

10

/14

/20

20

08

:58

Tru

e

Tri

chlo

ronate

525.2

0.5

CC

C5

.38

80

ug

/L1

.04

74

86

11

---

---

---

70

- 1

30

10

85

.0

10

/13

/20

20

08

:06

10

/14

/20

20

08

:58

Page 3

of

32

EE

A R

un I

D 2

80992 /

EE

A R

eport

# 5

00223

Page 122 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Tru

e

Tri

cycl

azo

le525.2

1.0

CC

C4

.16

20

ug

/L1

.04

74

86

11

---

---

---

70

- 1

30

83

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 0

8:5

8T

rue

Vin

clozo

lin525.2

0.5

CC

C5

.18

80

ug

/L1

.04

74

86

11

---

---

---

70

- 1

37

10

45

.0

10

/13

/20

20

08

:06

10

/14

/20

20

08

:58

Fals

e

IS-C

hry

sene-d

12

525.2

N/A

CC

C5

17

39

4ug

/L1

.04

74

86

12

---

---

---

50

- 1

50

10

05

17

39

4

10

/13

/20

20

08

:06

10

/14

/20

20

09

:40

Fals

e

IS-P

henanth

rene-d

10

525.2

N/A

CC

C7

29

81

1ug

/L1

.04

74

86

12

---

---

---

50

- 1

50

10

07

29

81

1

10

/13

/20

20

08

:06

10

/14

/20

20

09

:40

Fals

e

IS-P

yrene-d

10

525.2

N/A

CC

C5

54

23

1ug

/L1

.04

74

86

12

---

---

---

50

- 1

50

10

05

54

23

1

10

/13

/20

20

08

:06

10

/14

/20

20

09

:40

Fals

e

SS

-4,4

'-D

ichlo

robip

henyl

525.2

N/A

CC

C4

.34

00

ug

/L1

.04

74

86

12

---

---

---

70

- 1

30

87

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 0

9:4

0F

als

e

SS

-2,4

,5,6

-Tetr

ach

loro

-m-x

ylene

525.2

N/A

CC

C4

.51

20

ug

/L1

.04

74

86

12

---

---

---

70

- 1

30

90

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 0

9:4

0F

als

e

SS

-Tri

phenyl

phosp

hate

525.2

N/A

CC

C5

.56

80

ug

/L1

.04

74

86

12

---

---

---

70

- 1

30

11

15

.0

10

/13

/20

20

08

:06

10

/14

/20

20

09

:40

Fals

e

Anila

zine

525.2

1.0

CC

C3

.66

80

ug

/L1

.04

74

86

12

---

---

---

41

- 1

30

73

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 0

9:4

0F

als

e

alp

ha-H

exa

chlo

rocy

clohexa

ne

525.2

0.1

CC

C5

.25

20

ug

/L1

.04

74

86

12

---

---

---

70

- 1

30

10

55

.0

10

/13

/20

20

08

:06

10

/14

/20

20

09

:40

Fals

e

beta

-BH

C525.2

0.1

CC

C5

.40

40

ug

/L1

.04

74

86

12

---

---

---

70

- 1

30

10

85

.0

10

/13

/20

20

08

:06

10

/14

/20

20

09

:40

Fals

e

delta-B

HC

525.2

0.1

CC

C5

.19

50

ug

/L1

.04

74

86

12

---

---

---

70

- 1

30

10

45

.0

10

/13

/20

20

08

:06

10

/14

/20

20

09

:40

Fals

e

Buty

late

525.2

0.1

CC

C4

.75

70

ug

/L1

.04

74

86

12

---

---

---

70

- 1

30

95

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 0

9:4

0F

als

e

Chlo

robenzi

late

525.2

0.1

CC

C5

.22

70

ug

/L1

.04

74

86

12

---

---

---

70

- 1

30

10

55

.0

10

/13

/20

20

08

:06

10

/14

/20

20

09

:40

Fals

e

Chlo

roneb

525.2

0.1

CC

C5

.14

20

ug

/L1

.04

74

86

12

---

---

---

70

- 1

30

10

35

.0

10

/13

/20

20

08

:06

10

/14

/20

20

09

:40

Fals

e

Cyc

loate

525.2

0.1

CC

C5

.08

70

ug

/L1

.04

74

86

12

---

---

---

70

- 1

30

10

25

.0

10

/13

/20

20

08

:06

10

/14

/20

20

09

:40

Fals

e

DC

PA

525.2

0.1

CC

C5

.55

10

ug

/L1

.04

74

86

12

---

---

---

70

- 1

30

11

15

.0

10

/13

/20

20

08

:06

10

/14

/20

20

09

:40

Fals

e

4,4

'-D

DD

525.2

0.1

CC

C4

.99

50

ug

/L1

.04

74

86

12

---

---

---

70

- 1

30

10

05

.0

10

/13

/20

20

08

:06

10

/14

/20

20

09

:40

Fals

e

4,4

'-D

DE

525.2

0.1

CC

C5

.35

30

ug

/L1

.04

74

86

12

---

---

---

70

- 1

30

10

75

.0

10

/13

/20

20

08

:06

10

/14

/20

20

09

:40

Fals

e

Dem

eto

n O

525.2

0.5

CC

C4

.96

20

ug

/L1

.04

74

86

12

---

---

---

70

- 1

74

99

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 0

9:4

0F

als

e

Dem

eto

n S

525.2

0.5

CC

C5

.85

30

ug

/L1

.04

74

86

12

---

---

---

67

- 2

15

11

75

.0

10

/13

/20

20

08

:06

10

/14

/20

20

09

:40

Fals

e

Dese

thyl

atr

azi

ne

525.2

1.0

CC

C4

.27

70

ug

/L1

.04

74

86

12

---

---

---

70

- 1

30

86

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 0

9:4

0F

als

e

Dia

zinon

525.2

0.1

CC

C5

.34

20

ug

/L1

.04

74

86

12

---

---

---

66

- 1

30

10

75

.0

10

/13

/20

20

08

:06

10

/14

/20

20

09

:40

Fals

e

Dic

hlo

fenth

ion

525.2

0.1

CC

C5

.30

50

ug

/L1

.04

74

86

12

---

---

---

70

- 1

30

10

65

.0

10

/13

/20

20

08

:06

10

/14

/20

20

09

:40

Fals

e

Dic

hlo

ran

525.2

0.5

CC

C5

.45

50

ug

/L1

.04

74

86

12

---

---

---

70

- 1

30

10

95

.0

10

/13

/20

20

08

:06

10

/14

/20

20

09

:40

Fals

e

Dic

hlo

rvos

525.2

0.1

CC

C4

.08

40

ug

/L1

.04

74

86

12

---

---

---

70

- 1

30

82

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 0

9:4

0F

als

e

Dis

ulfoto

n525.2

0.1

CC

C5

.91

40

ug

/L1

.04

74

86

12

---

---

---

61

- 1

56

11

85

.0

10

/13

/20

20

08

:06

10

/14

/20

20

09

:40

Fals

e

Endosu

lfan I

525.2

0.1

CC

C5

.44

60

ug

/L1

.04

74

86

12

---

---

---

70

- 1

30

10

95

.0

10

/13

/20

20

08

:06

10

/14

/20

20

09

:40

Fals

e

Endosu

lfan I

I525.2

0.1

CC

C6

.08

10

ug

/L1

.04

74

86

12

---

---

---

70

- 1

30

12

25

.0

10

/13

/20

20

08

:06

10

/14

/20

20

09

:40

Fals

e

Endosu

lfan s

ulfate

525.2

0.1

CC

C5

.17

40

ug

/L1

.04

74

86

12

---

---

---

70

- 1

30

10

35

.0

10

/13

/20

20

08

:06

10

/14

/20

20

09

:40

Fals

e

Endri

n a

ldehyd

e525.2

0.5

CC

C5

.39

00

ug

/L1

.04

74

86

12

---

---

---

70

- 1

30

10

85

.0

10

/13

/20

20

08

:06

10

/14

/20

20

09

:40

Fals

e

EP

TC

525.2

0.1

CC

C4

.42

60

ug

/L1

.04

74

86

12

---

---

---

70

- 1

30

89

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 0

9:4

0F

als

e

Fenth

ion

525.2

0.1

CC

C5

.14

50

ug

/L1

.04

74

86

12

---

---

---

63

- 1

37

10

35

.0

10

/13

/20

20

08

:06

10

/14

/20

20

09

:40

Fals

e

Flu

chlo

ralin

525.2

0.1

CC

C5

.34

90

ug

/L1

.04

74

86

12

---

---

---

70

- 1

30

10

75

.0

10

/13

/20

20

08

:06

10

/14

/20

20

09

:40

Fals

e

Flu

ora

nth

ene

525.2

0.1

CC

C5

.57

30

ug

/L1

.04

74

86

12

---

---

---

65

- 1

30

11

15

.0

10

/13

/20

20

08

:06

10

/14

/20

20

09

:40

Fals

e

Fonofo

s525.2

0.1

CC

C5

.54

70

ug

/L1

.04

74

86

12

---

---

---

70

- 1

30

11

15

.0

10

/13

/20

20

08

:06

10

/14

/20

20

09

:40

Fals

e

2-M

eth

ylnaphth

ale

ne

525.2

0.1

CC

C5

.19

00

ug

/L1

.04

74

86

12

---

---

---

70

- 1

30

10

45

.0

10

/13

/20

20

08

:06

10

/14

/20

20

09

:40

Fals

e

MG

K 2

64 iso

mer

a525.2

0.1

CC

C3

.41

10

ug

/L1

.04

74

86

12

---

---

---

70

- 1

30

97

3.5

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 0

9:4

0F

als

e

MG

K 2

64 iso

mer

b525.2

0.1

CC

C2

.12

70

ug

/L1

.04

74

86

12

---

---

---

70

- 1

30

142

1.5

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 0

9:4

0F

als

e

MG

K 3

26

525.2

0.1

CC

C5

.76

00

ug

/L1

.04

74

86

12

---

---

---

70

- 1

31

11

55

.0

10

/13

/20

20

08

:06

10

/14

/20

20

09

:40

Fals

e

Molin

ate

525.2

0.1

CC

C5

.07

80

ug

/L1

.04

74

86

12

---

---

---

70

- 1

30

10

25

.0

10

/13

/20

20

08

:06

10

/14

/20

20

09

:40

Page 4

of

32

EE

A R

un I

D 2

80992 /

EE

A R

eport

# 5

00223

Page 123 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Fals

e

Pebula

te525.2

0.1

CC

C4

.49

50

ug

/L1

.04

74

86

12

---

---

---

70

- 1

30

90

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 0

9:4

0F

als

e

Pendim

eth

alin

525.2

0.1

CC

C5

.80

10

ug

/L1

.04

74

86

12

---

---

---

70

- 1

32

11

65

.0

10

/13

/20

20

08

:06

10

/14

/20

20

09

:40

Fals

e

cis-

Perm

eth

rin

525.2

0.1

CC

C5

.22

30

ug

/L1

.04

74

86

12

---

---

---

70

- 1

30

10

45

.0

10

/13

/20

20

08

:06

10

/14

/20

20

09

:40

Fals

e

trans-

Perm

eth

rin

525.2

0.1

CC

C6

.29

00

ug

/L1

.04

74

86

12

---

---

---

70

- 1

30

12

65

.0

10

/13

/20

20

08

:06

10

/14

/20

20

09

:40

Fals

e

Pro

flura

lin525.2

0.1

CC

C5

.30

20

ug

/L1

.04

74

86

12

---

---

---

70

- 1

30

10

65

.0

10

/13

/20

20

08

:06

10

/14

/20

20

09

:40

Fals

e

Pro

metr

yn525.2

0.1

CC

C5

.72

20

ug

/L1

.04

74

86

12

---

---

---

70

- 1

30

11

45

.0

10

/13

/20

20

08

:06

10

/14

/20

20

09

:40

Fals

e

Sim

etr

yn525.2

0.1

CC

C5

.73

00

ug

/L1

.04

74

86

12

---

---

---

70

- 1

30

11

55

.0

10

/13

/20

20

08

:06

10

/14

/20

20

09

:40

Fals

e

Terb

utr

yn525.2

0.1

CC

C5

.66

70

ug

/L1

.04

74

86

12

---

---

---

70

- 1

30

11

35

.0

10

/13

/20

20

08

:06

10

/14

/20

20

09

:40

Fals

e

Tri

adim

efo

n525.2

0.5

CC

C5

.55

50

ug

/L1

.04

74

86

12

---

---

---

70

- 1

30

11

15

.0

10

/13

/20

20

08

:06

10

/14

/20

20

09

:40

Tru

e

IS-C

hry

sene-d

12

525.2

N/A

CC

C5

72

58

4ug

/L1

.04

74

86

13

---

---

---

50

- 1

50

10

05

72

58

4

10

/13

/20

20

08

:06

10

/14

/20

20

10

:22

Tru

e

IS-P

henanth

rene-d

10

525.2

N/A

CC

C7

61

49

7ug

/L1

.04

74

86

13

---

---

---

50

- 1

50

10

07

61

49

7

10

/13

/20

20

08

:06

10

/14

/20

20

10

:22

Tru

e

IS-P

yrene-d

10

525.2

N/A

CC

C5

95

50

4ug

/L1

.04

74

86

13

---

---

---

50

- 1

50

10

05

95

50

4

10

/13

/20

20

08

:06

10

/14

/20

20

10

:22

Tru

e

SS

-4,4

'-D

ichlo

robip

henyl

525.2

N/A

CC

C4

.99

30

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

10

05

.0

10

/13

/20

20

08

:06

10

/14

/20

20

10

:22

Tru

e

SS

-2,4

,5,6

-Tetr

ach

loro

-m-x

ylene

525.2

N/A

CC

C5

.16

60

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

10

35

.0

10

/13

/20

20

08

:06

10

/14

/20

20

10

:22

Tru

e

SS

-Tri

phenyl

phosp

hate

525.2

N/A

CC

C5

.50

40

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

11

05

.0

10

/13

/20

20

08

:06

10

/14

/20

20

10

:22

Tru

e

Ace

toch

lor

525.2

0.1

CC

C5

.23

10

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

10

55

.0

10

/13

/20

20

08

:06

10

/14

/20

20

10

:22

Tru

e

Ala

chlo

r525.2

0.1

CC

C5

.13

80

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

10

35

.0

10

/13

/20

20

08

:06

10

/14

/20

20

10

:22

Tru

e

Ald

rin

525.2

0.1

CC

C5

.37

60

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

10

85

.0

10

/13

/20

20

08

:06

10

/14

/20

20

10

:22

Tru

e

Am

etr

yn525.2

0.1

CC

C5

.77

00

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

11

55

.0

10

/13

/20

20

08

:06

10

/14

/20

20

10

:22

Tru

e

Asp

on

525.2

0.1

CC

C5

.04

30

ug

/L1

.04

74

86

13

---

---

---

69

- 1

30

10

15

.0

10

/13

/20

20

08

:06

10

/14

/20

20

10

:22

Tru

e

Atr

ato

n525.2

0.1

CC

C5

.02

00

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

10

05

.0

10

/13

/20

20

08

:06

10

/14

/20

20

10

:22

Tru

e

Atr

azi

ne

525.2

0.1

CC

C4

.69

80

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

94

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

0:2

2T

rue

Azi

nphos-

meth

yl525.2

0.5

CC

C3

.89

60

ug

/L1

.04

74

86

13

---

---

---

70

- 1

51

78

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

0:2

2T

rue

Benflura

lin525.2

0.1

CC

C5

.41

50

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

10

85

.0

10

/13

/20

20

08

:06

10

/14

/20

20

10

:22

Tru

e

Benzo

(a)p

yrene

525.2

0.0

2C

CC

5.0

17

0ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

10

05

.0

10

/13

/20

20

08

:06

10

/14

/20

20

10

:22

Tru

e

gam

ma-B

HC

(Lin

dane)

525.2

0.0

2C

CC

4.4

95

0ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

90

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

0:2

2T

rue

Bols

tar

525.2

0.1

CC

C4

.85

20

ug

/L1

.04

74

86

13

---

---

---

70

- 1

32

97

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

0:2

2T

rue

Bro

maci

l525.2

0.1

CC

C5

.46

60

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

10

95

.0

10

/13

/20

20

08

:06

10

/14

/20

20

10

:22

Tru

e

Buta

chlo

r525.2

0.1

CC

C4

.93

80

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

99

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

0:2

2T

rue

Carb

oxi

n525.2

0.1

CC

C5

.12

90

ug

/L1

.04

74

86

13

---

---

---

60

- 1

82

10

35

.0

10

/13

/20

20

08

:06

10

/14

/20

20

10

:22

Tru

e

alp

ha-C

hlo

rda

ne

525.2

0.1

CC

C5

.44

90

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

10

95

.0

10

/13

/20

20

08

:06

10

/14

/20

20

10

:22

Tru

e

gam

ma-C

hlo

rdane

525.2

0.1

CC

C5

.60

60

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

11

25

.0

10

/13

/20

20

08

:06

10

/14

/20

20

10

:22

Tru

e

Chlo

ropro

pyl

ate

525.2

0.1

CC

C4

.80

40

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

96

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

0:2

2T

rue

Chlo

roth

alo

nil

525.2

0.1

CC

C5

.10

60

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

10

25

.0

10

/13

/20

20

08

:06

10

/14

/20

20

10

:22

Tru

e

Chlo

rpro

pham

525.2

0.1

CC

C5

.37

90

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

10

85

.0

10

/13

/20

20

08

:06

10

/14

/20

20

10

:22

Tru

e

Chlo

rpyr

ifos

525.2

0.1

CC

C5

.26

80

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

10

55

.0

10

/13

/20

20

08

:06

10

/14

/20

20

10

:22

Tru

e

Clo

mazo

ne

525.2

0.1

CC

C4

.86

90

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

97

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

0:2

2T

rue

Coum

aphos

525.2

0.1

CC

C4

.49

50

ug

/L1

.04

74

86

13

---

---

---

67

- 1

65

90

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

0:2

2T

rue

Cya

nazi

ne

525.2

0.1

CC

C4

.96

50

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

99

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

0:2

2T

rue

4,4

'-D

DT

525.2

0.1

CC

C4

.98

40

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

10

05

.0

10

/13

/20

20

08

:06

10

/14

/20

20

10

:22

Tru

e

Desi

sopro

pyl

atr

azi

ne

525.2

1.0

CC

C4

.26

20

ug

/L1

.04

74

86

13

---

---

---

62

- 1

30

85

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

0:2

2

Page 5

of

32

EE

A R

un I

D 2

80992 /

EE

A R

eport

# 5

00223

Page 124 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Tru

e

Dic

hlo

benil

525.2

0.1

CC

C4

.98

30

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

10

05

.0

10

/13

/20

20

08

:06

10

/14

/20

20

10

:22

Tru

e

Die

ldri

n525.2

0.1

CC

C4

.87

90

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

98

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

0:2

2T

rue

Di(

2-e

thyl

hexy

l)a

dip

ate

525.2

0.6

CC

C4

.79

80

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

96

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

0:2

2T

rue

Di(

2-e

thyl

hexy

l)phth

ala

te525.2

0.6

CC

C5

.01

30

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

10

05

.0

10

/13

/20

20

08

:06

10

/14

/20

20

10

:22

Tru

e

Dim

eth

oate

525.2

0.5

CC

C4

.62

80

ug

/L1

.04

74

86

13

---

---

---

62

- 1

31

93

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

0:2

2T

rue

2,4

-Din

itro

tolu

ene

525.2

0.5

CC

C5

.00

80

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

10

05

.0

10

/13

/20

20

08

:06

10

/14

/20

20

10

:22

Tru

e

2,6

-Din

itro

tolu

ene

525.2

0.5

CC

C4

.87

20

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

97

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

0:2

2T

rue

Dip

henam

id525.2

0.1

CC

C4

.95

50

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

99

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

0:2

2T

rue

Dis

ulfoto

n s

ulfone

525.2

0.1

CC

C4

.96

00

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

99

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

0:2

2T

rue

Endri

n525.2

0.0

1C

CC

5.0

44

0ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

10

15

.0

10

/13

/20

20

08

:06

10

/14

/20

20

10

:22

Tru

e

Eth

alflu

ralin

525.2

0.1

CC

C5

.24

70

ug

/L1

.04

74

86

13

---

---

---

70

- 1

36

10

55

.0

10

/13

/20

20

08

:06

10

/14

/20

20

10

:22

Tru

e

Eth

ion

525.2

5.0

CC

C4

.93

40

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

99

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

0:2

2T

rue

Eth

ofu

mesa

te525.2

0.5

CC

C5

.12

00

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

10

25

.0

10

/13

/20

20

08

:06

10

/14

/20

20

10

:22

Tru

e

Eth

opro

p525.2

0.1

CC

C4

.94

20

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

99

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

0:2

2T

rue

Etr

idia

zole

525.2

0.1

CC

C4

.43

80

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

89

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

0:2

2T

rue

Fam

phur

525.2

0.1

CC

C4

.79

10

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

96

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

0:2

2T

rue

Fenam

iphos

525.2

0.1

CC

C5

.01

00

ug

/L1

.04

74

86

13

---

---

---

61

- 2

34

10

05

.0

10

/13

/20

20

08

:06

10

/14

/20

20

10

:22

Tru

e

Flu

azi

fop-b

uty

l525.2

0.1

CC

C4

.78

30

ug

/L1

.04

74

86

13

---

---

---

66

- 1

40

96

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

0:2

2T

rue

Flu

om

etu

ron

525.2

0.5

CC

C3

.41

50

ug

/L1

.04

74

86

13

---

---

---

42

- 1

59

68

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

0:2

2T

rue

Hepta

chlo

r525.2

0.0

4C

CC

4.6

22

0ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

92

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

0:2

2T

rue

Hepta

chlo

r epo

xide

525.2

0.0

2C

CC

5.2

65

0ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

10

55

.0

10

/13

/20

20

08

:06

10

/14

/20

20

10

:22

Tru

e

Hexa

chlo

robenze

ne

525.2

0.1

CC

C5

.52

10

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

11

05

.0

10

/13

/20

20

08

:06

10

/14

/20

20

10

:22

Tru

e

Hexa

chlo

rocy

clope

nta

die

ne

525.2

0.1

CC

C4

.05

20

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

81

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

0:2

2T

rue

Hexa

zinone

525.2

0.1

CC

C5

.28

70

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

10

65

.0

10

/13

/20

20

08

:06

10

/14

/20

20

10

:22

Tru

e

Isophoro

ne

525.2

0.1

CC

C5

.23

00

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

10

55

.0

10

/13

/20

20

08

:06

10

/14

/20

20

10

:22

Tru

e

Mala

thio

n525.2

0.1

CC

C4

.98

40

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

10

05

.0

10

/13

/20

20

08

:06

10

/14

/20

20

10

:22

Tru

e

Meth

oxy

chlo

r525.2

0.1

CC

C5

.17

50

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

10

45

.0

10

/13

/20

20

08

:06

10

/14

/20

20

10

:22

Tru

e

1-M

eth

ylnaphth

ale

ne

525.2

0.1

CC

C5

.13

80

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

10

35

.0

10

/13

/20

20

08

:06

10

/14

/20

20

10

:22

Tru

e

Meth

yl p

ara

oxo

n525.2

0.5

CC

C4

.75

00

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

95

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

0:2

2T

rue

Meto

lach

lor

525.2

0.1

CC

C5

.14

50

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

10

35

.0

10

/13

/20

20

08

:06

10

/14

/20

20

10

:22

Tru

e

Metr

ibuzi

n525.2

0.1

CC

C5

.39

40

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

10

85

.0

10

/13

/20

20

08

:06

10

/14

/20

20

10

:22

Tru

e

Mevi

nphos

525.2

0.1

CC

C5

.71

30

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

11

45

.0

10

/13

/20

20

08

:06

10

/14

/20

20

10

:22

Tru

e

Naphth

ale

ne

525.2

0.1

CC

C5

.28

80

ug

/L1

.04

74

86

13

---

---

---

68

- 1

30

10

65

.0

10

/13

/20

20

08

:06

10

/14

/20

20

10

:22

Tru

e

Napro

pam

ide

525.2

0.1

CC

C4

.83

70

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

97

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

0:2

2T

rue

trans-

Nonach

lor

525.2

0.1

CC

C5

.67

70

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

11

45

.0

10

/13

/20

20

08

:06

10

/14

/20

20

10

:22

Tru

e

Oxa

dia

zon

525.2

0.1

CC

C4

.91

10

ug

/L1

.04

74

86

13

---

---

---

58

- 1

30

98

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

0:2

2T

rue

Penta

chlo

ronitro

be

nze

ne

525.2

0.5

CC

C5

.27

50

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

10

65

.0

10

/13

/20

20

08

:06

10

/14

/20

20

10

:22

Tru

e

Phora

te525.2

0.1

CC

C4

.82

20

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

96

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

0:2

2T

rue

Pro

meto

n525.2

1.0

CC

C5

.33

70

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

10

75

.0

10

/13

/20

20

08

:06

10

/14

/20

20

10

:22

Tru

e

Pro

nam

ide

525.2

0.1

CC

C5

.20

40

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

10

45

.0

10

/13

/20

20

08

:06

10

/14

/20

20

10

:22

Tru

e

Pro

pach

lor

525.2

0.1

CC

C5

.11

70

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

10

25

.0

10

/13

/20

20

08

:06

10

/14

/20

20

10

:22

Page 6

of

32

EE

A R

un I

D 2

80992 /

EE

A R

eport

# 5

00223

Page 125 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Tru

e

Pro

panil

525.2

0.5

CC

C4

.89

10

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

98

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

0:2

2T

rue

Pro

pazi

ne

525.2

0.1

CC

C4

.53

10

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

91

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

0:2

2T

rue

Sim

azi

ne

525.2

0.0

7C

CC

4.4

68

0ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

89

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

0:2

2T

rue

Stiro

fos

525.2

0.1

CC

C5

.10

90

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

10

25

.0

10

/13

/20

20

08

:06

10

/14

/20

20

10

:22

Tru

e

Terb

aci

l525.2

0.1

CC

C4

.89

30

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

98

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

0:2

2T

rue

Terb

ufo

s525.2

0.5

CC

C5

.18

80

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

10

45

.0

10

/13

/20

20

08

:06

10

/14

/20

20

10

:22

Tru

e

Thio

benca

rb525.2

0.1

CC

C5

.00

30

ug

/L1

.04

74

86

13

---

---

---

63

- 1

30

10

05

.0

10

/13

/20

20

08

:06

10

/14

/20

20

10

:22

Tru

e

Tri

flura

lin525.2

0.1

CC

C5

.70

20

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

11

45

.0

10

/13

/20

20

08

:06

10

/14

/20

20

10

:22

Tru

e

Vern

ola

te525.2

0.1

CC

C4

.19

80

ug

/L1

.04

74

86

13

---

---

---

70

- 1

30

84

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

0:2

2F

als

e

IS-C

hry

sene-d

12

525.2

N/A

LF

B5

34

74

5ug

/L1

.04

74

86

06

---

---

---

70

- 1

30

93

57

25

84

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

1:0

4F

als

e

IS-P

henanth

rene-d

10

525.2

N/A

LF

B7

59

94

6ug

/L1

.04

74

86

06

---

---

---

70

- 1

30

73

76

14

97

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

1:0

4F

als

e

IS-P

yrene-d

10

525.2

N/A

LF

B6

00

95

4ug

/L1

.04

74

86

06

---

---

---

70

- 1

30

10

15

95

50

4

10

/13

/20

20

08

:06

10

/14

/20

20

11

:04

Fals

e

SS

-4,4

'-D

ichlo

robip

henyl

525.2

N/A

LF

B4

.42

90

ug

/L1

.04

74

86

06

---

---

---

70

- 1

30

89

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

1:0

4F

als

e

SS

-2,4

,5,6

-Tetr

ach

loro

-m-x

ylene

525.2

N/A

LF

B4

.30

10

ug

/L1

.04

74

86

06

---

---

---

70

- 1

30

86

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

1:0

4F

als

e

SS

-Tri

phenyl

phosp

hate

525.2

N/A

LF

B5

.81

30

ug

/L1

.04

74

86

06

---

---

---

70

- 1

30

11

65

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:04

Fals

e

Anila

zine

525.2

1.0

LF

B3

.91

50

ug

/L1

.04

74

86

06

---

---

---

51

- 1

30

78

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

1:0

4F

als

e

alp

ha-H

exa

chlo

rocy

clohexa

ne

525.2

0.1

LF

B5

.15

90

ug

/L1

.04

74

86

06

---

---

---

70

- 1

30

10

35

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:04

Fals

e

beta

-BH

C525.2

0.1

LF

B5

.59

60

ug

/L1

.04

74

86

06

---

---

---

70

- 1

30

11

25

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:04

Fals

e

delta-B

HC

525.2

0.1

LF

B5

.32

80

ug

/L1

.04

74

86

06

---

---

---

70

- 1

30

10

75

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:04

Fals

e

Buty

late

525.2

0.1

LF

B4

.33

40

ug

/L1

.04

74

86

06

---

---

---

70

- 1

30

87

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

1:0

4F

als

e

Chlo

robenzi

late

525.2

0.1

LF

B5

.06

80

ug

/L1

.04

74

86

06

---

---

---

70

- 1

30

10

15

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:04

Fals

e

Chlo

roneb

525.2

0.1

LF

B5

.10

20

ug

/L1

.04

74

86

06

---

---

---

70

- 1

30

10

25

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:04

Fals

e

Cyc

loate

525.2

0.1

LF

B4

.97

40

ug

/L1

.04

74

86

06

---

---

---

70

- 1

30

99

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

1:0

4F

als

e

DC

PA

525.2

0.1

LF

B5

.74

70

ug

/L1

.04

74

86

06

---

---

---

70

- 1

30

11

55

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:04

Fals

e

4,4

'-D

DD

525.2

0.1

LF

B5

.32

20

ug

/L1

.04

74

86

06

---

---

---

70

- 1

30

10

65

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:04

Fals

e

4,4

'-D

DE

525.2

0.1

LF

B5

.40

60

ug

/L1

.04

74

86

06

---

---

---

70

- 1

30

10

85

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:04

Fals

e

Dem

eto

n O

525.2

0.5

LF

B4

.12

10

ug

/L1

.04

74

86

06

---

---

---

3 -

21

28

25

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:04

Fals

e

Dem

eto

n S

525.2

0.5

LF

B5

.80

20

ug

/L1

.04

74

86

06

---

---

---

1 -

24

21

16

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

1:0

4F

als

e

Dese

thyl

atr

azi

ne

525.2

1.0

LF

B1

.71

80

ug

/L1

.04

74

86

06

---

---

---

18

- 1

30

34

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

1:0

4F

als

e

Dia

zinon

525.2

0.1

LF

B4

.40

50

ug

/L1

.04

74

86

06

---

---

---

55

- 1

30

88

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

1:0

4F

als

e

Dic

hlo

fenth

ion

525.2

0.1

LF

B5

.13

50

ug

/L1

.04

74

86

06

---

---

---

70

- 1

32

10

35

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:04

Fals

e

Dic

hlo

ran

525.2

0.5

LF

B5

.18

80

ug

/L1

.04

74

86

06

---

---

---

70

- 1

30

10

45

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:04

Fals

e

Dic

hlo

rvos

525.2

0.1

LF

B3

.90

40

ug

/L1

.04

74

86

06

---

---

---

70

- 1

30

78

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

1:0

4F

als

e

Dis

ulfoto

n525.2

0.1

LF

B5

.68

40

ug

/L1

.04

74

86

06

---

---

---

1 -

18

01

14

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

1:0

4F

als

e

Endosu

lfan I

525.2

0.1

LF

B5

.57

10

ug

/L1

.04

74

86

06

---

---

---

70

- 1

30

11

15

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:04

Fals

e

Endosu

lfan I

I525.2

0.1

LF

B6

.52

30

ug

/L1

.04

74

86

06

---

---

---

70

- 1

30

13

05

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:04

Fals

e

Endosu

lfan s

ulfate

525.2

0.1

LF

B5

.40

30

ug

/L1

.04

74

86

06

---

---

---

70

- 1

30

10

85

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:04

Fals

e

Endri

n a

ldehyd

e525.2

0.5

LF

B5

.63

40

ug

/L1

.04

74

86

06

---

---

---

70

- 1

30

11

35

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:04

Fals

e

EP

TC

525.2

0.1

LF

B4

.40

70

ug

/L1

.04

74

86

06

---

---

---

70

- 1

30

88

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

1:0

4F

als

e

Fenth

ion

525.2

0.1

LF

B5

.50

80

ug

/L1

.04

74

86

06

---

---

---

67

- 1

37

11

05

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:04

Fals

e

Flu

chlo

ralin

525.2

0.1

LF

B5

.23

30

ug

/L1

.04

74

86

06

---

---

---

70

- 1

32

10

55

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:04

Page 7

of

32

EE

A R

un I

D 2

80992 /

EE

A R

eport

# 5

00223

Page 126 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Fals

e

Flu

ora

nth

ene

525.2

0.1

LF

B5

.42

60

ug

/L1

.04

74

86

06

---

---

---

64

- 1

39

10

95

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:04

Fals

e

Fonofo

s525.2

0.1

LF

B5

.45

80

ug

/L1

.04

74

86

06

---

---

---

70

- 1

30

10

95

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:04

Fals

e

2-M

eth

ylnaphth

ale

ne

525.2

0.1

LF

B4

.61

40

ug

/L1

.04

74

86

06

---

---

---

70

- 1

30

92

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

1:0

4F

als

e

MG

K 2

64 iso

mer

a525.2

0.1

LF

B3

.42

70

ug

/L1

.04

74

86

06

---

---

---

70

- 1

30

98

3.5

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

1:0

4F

als

e

MG

K 3

26

525.2

0.1

LF

B5

.89

90

ug

/L1

.04

74

86

06

---

---

---

70

- 1

36

11

85

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:04

Fals

e

Molin

ate

525.2

0.1

LF

B4

.91

70

ug

/L1

.04

74

86

06

---

---

---

70

- 1

30

98

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

1:0

4F

als

e

Pebula

te525.2

0.1

LF

B4

.45

70

ug

/L1

.04

74

86

06

---

---

---

70

- 1

30

89

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

1:0

4F

als

e

Pendim

eth

alin

525.2

0.1

LF

B5

.99

20

ug

/L1

.04

74

86

06

---

---

---

70

- 1

41

12

05

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:04

Fals

e

cis-

Perm

eth

rin

525.2

0.1

LF

B5

.21

20

ug

/L1

.04

74

86

06

---

---

---

70

- 1

30

10

45

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:04

Fals

e

trans-

Perm

eth

rin

525.2

0.1

LF

B6

.24

50

ug

/L1

.04

74

86

06

---

---

---

70

- 1

30

12

55

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:04

Fals

e

Pro

flura

lin525.2

0.1

LF

B5

.36

70

ug

/L1

.04

74

86

06

---

---

---

70

- 1

30

10

75

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:04

Fals

e

Pro

metr

yn525.2

0.1

LF

B5

.34

50

ug

/L1

.04

74

86

06

---

---

---

70

- 1

30

10

75

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:04

Fals

e

Sim

etr

yn525.2

0.1

LF

B5

.00

30

ug

/L1

.04

74

86

06

---

---

---

70

- 1

30

10

05

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:04

Fals

e

Terb

utr

yn525.2

0.1

LF

B5

.44

90

ug

/L1

.04

74

86

06

---

---

---

70

- 1

30

10

95

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:04

Fals

e

Tri

adim

efo

n525.2

0.5

LF

B5

.92

90

ug

/L1

.04

74

86

06

---

---

---

70

- 1

30

11

95

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:04

Tru

e

IS-C

hry

sene-d

12

525.2

N/A

LF

B4

93

02

2ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

86

57

25

84

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

1:4

6T

rue

IS-P

henanth

rene-d

10

525.2

N/A

LF

B6

19

19

5ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

81

76

14

97

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

1:4

6T

rue

IS-P

yrene-d

10

525.2

N/A

LF

B5

45

48

9ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

92

59

55

04

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

1:4

6T

rue

SS

-4,4

'-D

ichlo

robip

henyl

525.2

N/A

LF

B5

.32

70

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

10

75

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:46

Tru

e

SS

-2,4

,5,6

-Tetr

ach

loro

-m-x

ylene

525.2

N/A

LF

B4

.87

90

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

98

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

1:4

6T

rue

SS

-Tri

phenyl

phosp

hate

525.2

N/A

LF

B5

.57

70

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

11

25

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:46

Tru

e

Ace

toch

lor

525.2

0.1

LF

B5

.40

10

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

10

85

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:46

Tru

e

Ala

chlo

r525.2

0.1

LF

B5

.39

80

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

10

85

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:46

Tru

e

Ald

rin

525.2

0.1

LF

B5

.45

90

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

10

95

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:46

Tru

e

Am

etr

yn525.2

0.1

LF

B5

.40

70

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

10

85

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:46

Tru

e

Asp

on

525.2

0.1

LF

B5

.29

80

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

10

65

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:46

Tru

e

Atr

ato

n525.2

0.1

LF

B3

.04

10

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

61

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

1:4

6T

rue

Atr

azi

ne

525.2

0.1

LF

B5

.37

20

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

10

75

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:46

Tru

e

Azi

nphos-

meth

yl525.2

0.5

LF

B4

.28

80

ug

/L1

.04

74

86

07

---

---

---

70

- 1

66

86

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

1:4

6T

rue

Benflura

lin525.2

0.1

LF

B5

.27

30

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

10

55

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:46

Tru

e

Benzo

(a)p

yrene

525.2

0.0

2L

FB

4.5

29

0ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

91

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

1:4

6T

rue

gam

ma-B

HC

(Lin

dane)

525.2

0.0

2L

FB

4.7

21

0ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

94

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

1:4

6T

rue

Bols

tar

525.2

0.1

LF

B4

.95

60

ug

/L1

.04

74

86

07

---

---

---

55

- 1

40

99

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

1:4

6T

rue

Bro

maci

l525.2

0.1

LF

B6

.02

60

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

12

15

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:46

Tru

e

Buta

chlo

r525.2

0.1

LF

B5

.00

00

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

10

05

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:46

Tru

e

Carb

oxi

n525.2

0.1

LF

B4

.07

30

ug

/L1

.04

74

86

07

---

---

---

1 -

17

48

15

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:46

Tru

e

alp

ha-C

hlo

rda

ne

525.2

0.1

LF

B5

.85

70

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

11

75

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:46

Tru

e

gam

ma-C

hlo

rdane

525.2

0.1

LF

B5

.91

10

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

11

85

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:46

Tru

e

Chlo

ropro

pyl

ate

525.2

0.1

LF

B4

.74

00

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

95

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

1:4

6T

rue

Chlo

roth

alo

nil

525.2

0.1

LF

B5

.66

30

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

11

35

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:46

Tru

e

Chlo

rpro

pham

525.2

0.1

LF

B5

.49

20

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

11

05

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:46

Page 8

of

32

EE

A R

un I

D 2

80992 /

EE

A R

eport

# 5

00223

Page 127 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Tru

e

Chlo

rpyr

ifos

525.2

0.1

LF

B5

.30

20

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

10

65

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:46

Tru

e

Clo

mazo

ne

525.2

0.1

LF

B5

.14

90

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

10

35

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:46

Tru

e

Coum

aphos

525.2

0.1

LF

B4

.95

70

ug

/L1

.04

74

86

07

---

---

---

70

- 1

81

99

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

1:4

6T

rue

Cya

nazi

ne

525.2

0.1

LF

B5

.26

40

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

10

55

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:46

Tru

e

4,4

'-D

DT

525.2

0.1

LF

B5

.04

50

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

10

15

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:46

Tru

e

Desi

sopro

pyl

atr

azi

ne

525.2

1.0

LF

B1

.06

60

ug

/L1

.04

74

86

07

---

---

---

3 -

13

02

15

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:46

Tru

e

Dic

hlo

benil

525.2

0.1

LF

B4

.64

50

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

93

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

1:4

6T

rue

Die

ldri

n525.2

0.1

LF

B5

.00

70

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

10

05

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:46

Tru

e

Di(

2-e

thyl

hexy

l)a

dip

ate

525.2

0.6

LF

B4

.92

30

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

98

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

1:4

6T

rue

Di(

2-e

thyl

hexy

l)phth

ala

te525.2

0.6

LF

B5

.35

70

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

10

75

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:46

Tru

e

Dim

eth

oate

525.2

0.5

LF

B2

.88

70

ug

/L1

.04

74

86

07

---

---

---

17

- 1

30

58

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

1:4

6T

rue

2,4

-Din

itro

tolu

ene

525.2

0.5

LF

B4

.15

90

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

83

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

1:4

6T

rue

2,6

-Din

itro

tolu

ene

525.2

0.5

LF

B4

.31

30

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

86

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

1:4

6T

rue

Dip

henam

id525.2

0.1

LF

B5

.45

20

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

10

95

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:46

Tru

e

Dis

ulfoto

n s

ulfone

525.2

0.1

LF

B5

.26

10

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

10

55

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:46

Tru

e

Endri

n525.2

0.0

1L

FB

4.8

72

0ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

97

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

1:4

6T

rue

Eth

alflu

ralin

525.2

0.1

LF

B5

.50

40

ug

/L1

.04

74

86

07

---

---

---

70

- 1

37

11

05

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:46

Tru

e

Eth

ion

525.2

5.0

LF

B4

.77

90

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

96

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

1:4

6T

rue

Eth

ofu

mesa

te525.2

0.5

LF

B5

.36

80

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

10

75

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:46

Tru

e

Eth

opro

p525.2

0.1

LF

B4

.88

70

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

98

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

1:4

6T

rue

Etr

idia

zole

525.2

0.1

LF

B4

.74

00

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

95

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

1:4

6T

rue

Fam

phur

525.2

0.1

LF

B4

.90

70

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

98

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

1:4

6T

rue

Fenam

iphos

525.2

0.1

LF

B5

.34

00

ug

/L1

.04

74

86

07

---

---

---

42

- 2

45

10

75

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:46

Tru

e

Flu

azi

fop-b

uty

l525.2

0.1

LF

B4

.89

30

ug

/L1

.04

74

86

07

---

---

---

70

- 1

46

98

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

1:4

6T

rue

Flu

om

etu

ron

525.2

0.5

LF

B3

.64

40

ug

/L1

.04

74

86

07

---

---

---

34

- 1

61

73

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

1:4

6T

rue

Hepta

chlo

r525.2

0.0

4L

FB

4.7

32

0ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

95

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

1:4

6T

rue

Hepta

chlo

r epo

xide

525.2

0.0

2L

FB

5.3

37

0ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

10

75

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:46

Tru

e

Hexa

chlo

robenze

ne

525.2

0.1

LF

B5

.24

40

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

10

55

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:46

Tru

e

Hexa

chlo

rocy

clope

nta

die

ne

525.2

0.1

LF

B3

.78

30

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

76

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

1:4

6T

rue

Hexa

zinone

525.2

0.1

LF

B5

.48

60

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

11

05

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:46

Tru

e

Isophoro

ne

525.2

0.1

LF

B5

.17

30

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

10

35

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:46

Tru

e

Mala

thio

n525.2

0.1

LF

B5

.28

70

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

10

65

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:46

Tru

e

Meth

oxy

chlo

r525.2

0.1

LF

B5

.45

90

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

10

95

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:46

Tru

e

1-M

eth

ylnaphth

ale

ne

525.2

0.1

LF

B4

.81

10

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

96

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

1:4

6T

rue

Meth

yl p

ara

oxo

n525.2

0.5

LF

B4

.80

40

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

96

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

1:4

6T

rue

Meto

lach

lor

525.2

0.1

LF

B5

.67

80

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

11

45

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:46

Tru

e

Metr

ibuzi

n525.2

0.1

LF

B5

.60

00

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

11

25

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:46

Tru

e

Mevi

nphos

525.2

0.1

LF

B5

.49

60

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

11

05

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:46

Tru

e

Naphth

ale

ne

525.2

0.1

LF

B4

.68

70

ug

/L1

.04

74

86

07

---

---

---

69

- 1

30

94

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

1:4

6T

rue

Napro

pam

ide

525.2

0.1

LF

B4

.82

40

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

96

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

1:4

6T

rue

trans-

Nonach

lor

525.2

0.1

LF

B5

.93

90

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

11

95

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:46

Page 9

of

32

EE

A R

un I

D 2

80992 /

EE

A R

eport

# 5

00223

Page 128 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Tru

e

Oxa

dia

zon

525.2

0.1

LF

B5

.35

10

ug

/L1

.04

74

86

07

---

---

---

64

- 1

31

10

75

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:46

Tru

e

Penta

chlo

ronitro

be

nze

ne

525.2

0.5

LF

B5

.28

40

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

10

65

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:46

Tru

e

Phora

te525.2

0.1

LF

B4

.91

50

ug

/L1

.04

74

86

07

---

---

---

66

- 1

30

98

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

1:4

6T

rue

Pro

meto

n525.2

1.0

LF

B3

.35

90

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

67

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

1:4

6T

rue

Pro

nam

ide

525.2

0.1

LF

B5

.49

70

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

11

05

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:46

Tru

e

Pro

pach

lor

525.2

0.1

LF

B5

.17

20

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

10

35

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:46

Tru

e

Pro

panil

525.2

0.5

LF

B5

.11

80

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

10

25

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:46

Tru

e

Pro

pazi

ne

525.2

0.1

LF

B5

.06

60

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

10

15

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:46

Tru

e

Sim

azi

ne

525.2

0.0

7L

FB

4.7

36

0ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

95

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

1:4

6T

rue

Stiro

fos

525.2

0.1

LF

B5

.19

60

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

10

45

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:46

Tru

e

Terb

aci

l525.2

0.1

LF

B5

.16

30

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

10

35

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:46

Tru

e

Terb

ufo

s525.2

0.5

LF

B5

.26

30

ug

/L1

.04

74

86

07

---

---

---

69

- 1

30

10

55

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:46

Tru

e

Thio

benca

rb525.2

0.1

LF

B5

.36

40

ug

/L1

.04

74

86

07

---

---

---

64

- 1

40

10

75

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:46

Tru

e

Tri

flura

lin525.2

0.1

LF

B5

.39

70

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

10

85

.0

10

/13

/20

20

08

:06

10

/14

/20

20

11

:46

Tru

e

Vern

ola

te525.2

0.1

LF

B4

.40

80

ug

/L1

.04

74

86

07

---

---

---

70

- 1

30

88

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

1:4

6F

als

e

IS-C

hry

sene-d

12

525.2

N/A

LF

B6

46

15

5ug

/L1

.04

74

86

08

---

---

---

70

- 1

30

11

35

72

58

4

10

/13

/20

20

08

:06

10

/14

/20

20

12

:28

Fals

e

IS-P

henanth

rene-d

10

525.2

N/A

LF

B8

32

79

2ug

/L1

.04

74

86

08

---

---

---

70

- 1

30

10

97

61

49

7

10

/13

/20

20

08

:06

10

/14

/20

20

12

:28

Fals

e

IS-P

yrene-d

10

525.2

N/A

LF

B6

98

07

2ug

/L1

.04

74

86

08

---

---

---

70

- 1

30

11

75

95

50

4

10

/13

/20

20

08

:06

10

/14

/20

20

12

:28

Fals

e

SS

-4,4

'-D

ichlo

robip

henyl

525.2

N/A

LF

B4

.13

20

ug

/L1

.04

74

86

08

---

---

---

70

- 1

30

83

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

2:2

8F

als

e

SS

-2,4

,5,6

-Tetr

ach

loro

-m-x

ylene

525.2

N/A

LF

B4

.91

30

ug

/L1

.04

74

86

08

---

---

---

70

- 1

30

98

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

2:2

8F

als

e

SS

-Tri

phenyl

phosp

hate

525.2

N/A

LF

B5

.54

80

ug

/L1

.04

74

86

08

---

---

---

70

- 1

30

11

15

.0

10

/13

/20

20

08

:06

10

/14

/20

20

12

:28

Fals

e

Ace

naphth

ene

525.2

0.1

LF

B4

.39

90

ug

/L1

.04

74

86

08

---

---

---

57

- 1

30

88

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

2:2

8F

als

e

Ace

naphth

ylene

525.2

0.1

LF

B4

.73

20

ug

/L1

.04

74

86

08

---

---

---

70

- 1

30

95

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

2:2

8F

als

e

Anth

race

ne

525.2

0.1

LF

B3

.98

10

ug

/L1

.04

74

86

08

---

---

---

70

- 1

30

80

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

2:2

8F

als

e

Azi

nphos-

eth

yl525.2

0.5

LF

B5

.09

80

ug

/L1

.04

74

86

08

---

---

---

70

- 1

53

10

25

.0

10

/13

/20

20

08

:06

10

/14

/20

20

12

:28

Fals

e

Bendio

carb

525.2

0.5

LF

B5

.60

40

ug

/L1

.04

74

86

08

---

---

---

70

- 1

70

11

25

.0

10

/13

/20

20

08

:06

10

/14

/20

20

12

:28

Fals

e

Benzo

(a)a

nth

race

ne

525.2

0.1

LF

B5

.31

70

ug

/L1

.04

74

86

08

---

---

---

70

- 1

30

10

65

.0

10

/13

/20

20

08

:06

10

/14

/20

20

12

:28

Fals

e

Benzo

(b)f

luora

nth

ene

525.2

0.1

LF

B5

.33

70

ug

/L1

.04

74

86

08

---

---

---

70

- 1

30

10

75

.0

10

/13

/20

20

08

:06

10

/14

/20

20

12

:28

Fals

e

Benzo

(k)f

luora

nth

ene

525.2

0.1

LF

B5

.28

30

ug

/L1

.04

74

86

08

---

---

---

70

- 1

30

10

65

.0

10

/13

/20

20

08

:06

10

/14

/20

20

12

:28

Fals

e

Benzo

(g,h

,i)p

ery

lene

525.2

0.1

LF

B4

.84

40

ug

/L1

.04

74

86

08

---

---

---

70

- 1

30

97

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

2:2

8F

als

e

Buty

lbenzy

lphth

ala

te525.2

1.0

LF

B5

.63

70

ug

/L1

.04

74

86

08

---

---

---

70

- 1

30

11

35

.0

10

/13

/20

20

08

:06

10

/14

/20

20

12

:28

Fals

e

Carb

ophenoth

ion

525.2

0.5

LF

B5

.16

20

ug

/L1

.04

74

86

08

---

---

---

70

- 1

31

10

35

.0

10

/13

/20

20

08

:06

10

/14

/20

20

12

:28

Fals

e

Chlo

rfenvi

nphos

525.2

5.0

LF

B4

.56

00

ug

/L1

.04

74

86

08

---

---

---

70

- 1

30

10

34

.42

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

2:2

8F

als

e

2-C

hlo

robip

he

nyl

525.2

0.1

LF

B4

.75

60

ug

/L1

.04

74

86

08

---

---

---

70

- 1

30

95

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

2:2

8F

als

e

Chlo

rpyr

ifos

me

thyl

525.2

0.5

LF

B5

.89

70

ug

/L1

.04

74

86

08

---

---

---

70

- 1

35

11

85

.0

10

/13

/20

20

08

:06

10

/14

/20

20

12

:28

Fals

e

Chry

sene

525.2

0.1

LF

B4

.98

40

ug

/L1

.04

74

86

08

---

---

---

70

- 1

30

10

05

.0

10

/13

/20

20

08

:06

10

/14

/20

20

12

:28

Fals

e

Clo

pyr

alid

525.2

10

LF

B1

1.4

16

0ug

/L1

.04

74

86

08

---

---

---

12

- 1

30

11

41

0.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

2:2

8F

als

e

Cro

toxy

phos

525.2

0.5

LF

B5

.04

40

ug

/L1

.04

74

86

08

---

---

---

70

- 1

93

10

15

.0

10

/13

/20

20

08

:06

10

/14

/20

20

12

:28

Fals

e

Dib

enzo

(a,h

)anth

race

ne

525.2

0.1

LF

B5

.32

90

ug

/L1

.04

74

86

08

---

---

---

70

- 1

30

10

75

.0

10

/13

/20

20

08

:06

10

/14

/20

20

12

:28

Fals

e

Di-

n-b

uty

lphth

ala

te525.2

2.0

LF

B5

.87

90

ug

/L1

.04

74

86

08

---

---

---

70

- 1

30

11

85

.0

10

/13

/20

20

08

:06

10

/14

/20

20

12

:28

Fals

e

2,3

-Dic

hlo

robip

henyl

525.2

0.1

LF

B5

.18

10

ug

/L1

.04

74

86

08

---

---

---

70

- 1

30

10

45

.0

10

/13

/20

20

08

:06

10

/14

/20

20

12

:28

Page 1

0 o

f 32

EE

A R

un I

D 2

80992 /

EE

A R

eport

# 5

00223

Page 129 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Fals

e

Dic

roto

phos

525.2

0.5

LF

B4

.81

90

ug

/L1

.04

74

86

08

---

---

---

70

- 1

98

96

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

2:2

8F

als

e

Die

thyl

phth

ala

te525.2

1.0

LF

B4

.80

20

ug

/L1

.04

74

86

08

---

---

---

70

- 1

30

96

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

2:2

8F

als

e

Dim

eth

ylphth

ala

te525.2

1.0

LF

B5

.06

00

ug

/L1

.04

74

86

08

---

---

---

70

- 1

30

10

15

.0

10

/13

/20

20

08

:06

10

/14

/20

20

12

:28

Fals

e

Di-

n-o

ctyl

phth

ala

te525.2

2.0

LF

B5

.43

60

ug

/L1

.04

74

86

08

---

---

---

43

- 1

97

10

95

.0

10

/13

/20

20

08

:06

10

/14

/20

20

12

:28

Fals

e

Dio

xath

ion A

525.2

0.5

LF

B4

.07

00

ug

/L1

.04

74

86

08

---

---

---

29

- 2

22

13

33

.06

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

2:2

8F

als

e

Dio

xath

ion B

525.2

0.5

LF

B2

.47

00

ug

/L1

.04

74

86

08

---

---

---

25

- 5

14

13

01

.89

5

10

/13

/20

20

08

:06

10

/14

/20

20

12

:28

Fals

e

Dis

ulfoto

n s

ulfo

xide

525.2

10

LF

B1

1.2

08

0ug

/L1

.04

74

86

08

---

---

---

69

- 1

38

11

21

0.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

2:2

8F

als

e

EP

N525.2

0.5

LF

B5

.38

30

ug

/L1

.04

74

86

08

---

---

---

70

- 1

54

10

85

.0

10

/13

/20

20

08

:06

10

/14

/20

20

12

:28

Fals

e

Eru

cyla

mid

e525.2

5.0

LF

B9

.63

10

ug

/L1

.04

74

86

08

---

---

---

70

- 2

34

96

10

.0

10

/13

/20

20

08

:06

10

/14

/20

20

12

:28

Fals

e

Esf

enva

lera

te525.2

0.5

LF

B5

.72

00

ug

/L1

.04

74

86

08

---

---

---

70

- 1

30

11

45

.0

10

/13

/20

20

08

:06

10

/14

/20

20

12

:28

Fals

e

Fenari

mol

525.2

1.0

LF

B4

.88

00

ug

/L1

.04

74

86

08

---

---

---

70

- 1

30

98

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

2:2

8F

als

e

Fenitro

thio

n525.2

0.5

LF

B5

.54

00

ug

/L1

.04

74

86

08

---

---

---

70

- 1

43

11

15

.0

10

/13

/20

20

08

:06

10

/14

/20

20

12

:28

Fals

e

Fenoxa

pro

p-e

thyl

525.2

1.0

LF

B3

.50

60

ug

/L1

.04

74

86

08

---

---

---

66

- 1

30

70

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

2:2

8F

als

e

Fensu

lfoth

ion

525.2

0.5

LF

B5

.69

60

ug

/L1

.04

74

86

08

---

---

---

70

- 2

03

11

45

.0

10

/13

/20

20

08

:06

10

/14

/20

20

12

:28

Fals

e

Flu

ore

ne

525.2

0.1

LF

B4

.97

50

ug

/L1

.04

74

86

08

---

---

---

70

- 1

30

10

05

.0

10

/13

/20

20

08

:06

10

/14

/20

20

12

:28

Fals

e

Flu

ridone

525.2

1.0

LF

B5

.05

90

ug

/L1

.04

74

86

08

---

---

---

70

- 1

30

10

15

.0

10

/13

/20

20

08

:06

10

/14

/20

20

12

:28

Fals

e

2,2

',3,3

',4,4

',6-H

epta

chlo

robip

henyl

525.2

0.5

LF

B4

.94

20

ug

/L1

.04

74

86

08

---

---

---

70

- 1

30

99

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

2:2

8F

als

e

2,2

',4,4

',5,6

'-H

exa

chlo

robip

henyl

525.2

0.1

LF

B5

.21

90

ug

/L1

.04

74

86

08

---

---

---

70

- 1

30

10

45

.0

10

/13

/20

20

08

:06

10

/14

/20

20

12

:28

Fals

e

Indeno(1

,2,3

-cd)p

yrene

525.2

0.1

LF

B5

.09

70

ug

/L1

.04

74

86

08

---

---

---

70

- 1

30

10

25

.0

10

/13

/20

20

08

:06

10

/14

/20

20

12

:28

Fals

e

Ipro

dio

ne

525.2

0.5

LF

B6

.08

40

ug

/L1

.04

74

86

08

---

---

---

70

- 2

16

12

25

.0

10

/13

/20

20

08

:06

10

/14

/20

20

12

:28

Fals

e

Isofe

nphos

525.2

0.5

LF

B5

.17

00

ug

/L1

.04

74

86

08

---

---

---

70

- 1

54

10

35

.0

10

/13

/20

20

08

:06

10

/14

/20

20

12

:28

Fals

e

Lepto

phos

525.2

0.5

LF

B5

.01

10

ug

/L1

.04

74

86

08

---

---

---

70

- 1

30

10

05

.0

10

/13

/20

20

08

:06

10

/14

/20

20

12

:28

Fals

e

Meta

laxy

l525.2

0.5

LF

B5

.49

50

ug

/L1

.04

74

86

08

---

---

---

70

- 1

54

11

05

.0

10

/13

/20

20

08

:06

10

/14

/20

20

12

:28

Fals

e

Meth

yl p

ara

thio

n525.2

0.5

LF

B7

.42

00

ug

/L1

.04

74

86

08

---

---

---

70

- 2

13

14

85

.0

10

/13

/20

20

08

:06

10

/14

/20

20

12

:28

Fals

e

Mets

ulfuro

n-m

eth

yl525.2

10

LF

B1

1.2

29

0ug

/L1

.04

74

86

08

---

---

---

70

- 1

77

11

21

0.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

2:2

8F

als

e

Mir

ex

525.2

0.5

LF

B4

.52

20

ug

/L1

.04

74

86

08

---

---

---

65

- 1

30

90

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

2:2

8F

als

e

Monocr

oto

phos

525.2

0.5

LF

B2

.94

90

ug

/L1

.04

74

86

08

---

---

---

28

- 1

59

59

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

2:2

8F

als

e

Nale

d525.2

0.5

LF

B4

.03

60

ug

/L1

.04

74

86

08

---

---

---

49

- 1

47

81

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

2:2

8F

als

e

cis-

Nonach

lor

525.2

0.1

LF

B6

.09

70

ug

/L1

.04

74

86

08

---

---

---

70

- 1

30

12

25

.0

10

/13

/20

20

08

:06

10

/14

/20

20

12

:28

Fals

e

Norf

lura

zon

525.2

1.0

LF

B5

.08

00

ug

/L1

.04

74

86

08

---

---

---

70

- 1

30

10

25

.0

10

/13

/20

20

08

:06

10

/14

/20

20

12

:28

Fals

e

2,2

',3,3

',4,5

',6,6

'-O

ctach

loro

bip

henyl

525.2

0.5

LF

B5

.29

10

ug

/L1

.04

74

86

08

---

---

---

70

- 1

30

10

65

.0

10

/13

/20

20

08

:06

10

/14

/20

20

12

:28

Fals

e

Ory

zalin

525.2

10

LF

B8

.79

20

ug

/L1

.04

74

86

08

---

---

---

1 -

39

91

76

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

2:2

8F

als

e

Oxy

chlo

rdane

525.2

0.1

LF

B5

.39

90

ug

/L1

.04

74

86

08

---

---

---

70

- 1

30

10

85

.0

10

/13

/20

20

08

:06

10

/14

/20

20

12

:28

Fals

e

Oxy

fluorf

en

525.2

0.5

LF

B5

.01

90

ug

/L1

.04

74

86

08

---

---

---

70

- 1

42

10

05

.0

10

/13

/20

20

08

:06

10

/14

/20

20

12

:28

Fals

e

Para

thio

n525.2

0.5

LF

B5

.30

80

ug

/L1

.04

74

86

08

---

---

---

68

- 1

64

10

65

.0

10

/13

/20

20

08

:06

10

/14

/20

20

12

:28

Fals

e

Penta

chlo

robenze

ne

525.2

0.5

LF

B4

.23

50

ug

/L1

.04

74

86

08

---

---

---

59

- 1

30

85

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

2:2

8F

als

e

2,2

',3',4

,6-P

enta

chlo

robip

henyl

525.2

0.1

LF

B5

.52

90

ug

/L1

.04

74

86

08

---

---

---

70

- 1

30

11

15

.0

10

/13

/20

20

08

:06

10

/14

/20

20

12

:28

Fals

e

Penta

chlo

rophenol

525.2

1.0

LF

B3

.54

40

ug

/L1

.04

74

86

08

---

---

---

70

- 1

30

71

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

2:2

8F

als

e

Phenanth

rene

525.2

0.1

LF

B5

.03

50

ug

/L1

.04

74

86

08

---

---

---

70

- 1

30

10

15

.0

10

/13

/20

20

08

:06

10

/14

/20

20

12

:28

Fals

e

Phosm

et

525.2

0.5

LF

B4

.69

60

ug

/L1

.04

74

86

08

---

---

---

70

- 1

30

94

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

2:2

8F

als

e

E-P

hosp

ham

idon

525.2

0.5

LF

B1

.58

40

ug

/L1

.04

74

86

08

---

---

---

70

- 3

01

11

41

.39

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

2:2

8

Page 1

1 o

f 32

EE

A R

un I

D 2

80992 /

EE

A R

eport

# 5

00223

Page 130 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Fals

e

Z-P

hosp

ham

idon

525.2

0.5

LF

B3

.77

30

ug

/L1

.04

74

86

08

---

---

---

70

- 1

93

10

73

.51

5

10

/13

/20

20

08

:06

10

/14

/20

20

12

:28

Fals

e

Pro

pic

onazo

le iso

mer

a525.2

5.0

LF

B2

.16

90

ug

/L1

.04

74

86

08

---

---

---

1 -

27

69

72

.24

5

10

/13

/20

20

08

:06

10

/14

/20

20

12

:28

Fals

e

Pro

pic

onazo

le iso

mer

b525.2

5.0

LF

B2

.56

80

ug

/L1

.04

74

86

08

---

---

---

64

- 1

30

93

2.7

55

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

2:2

8F

als

e

Pro

thio

fos

525.2

0.5

LF

B5

.26

10

ug

/L1

.04

74

86

08

---

---

---

70

- 1

44

10

55

.0

10

/13

/20

20

08

:06

10

/14

/20

20

12

:28

Fals

e

Pyr

ene

525.2

0.1

LF

B5

.74

80

ug

/L1

.04

74

86

08

---

---

---

70

- 1

30

11

55

.0

10

/13

/20

20

08

:06

10

/14

/20

20

12

:28

Fals

e

Sulfote

p525.2

0.5

LF

B4

.50

10

ug

/L1

.04

74

86

08

---

---

---

70

- 1

30

90

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

2:2

8F

als

e

Tebuth

iuro

n525.2

10

LF

B1

0.0

69

0ug

/L1

.04

74

86

08

---

---

---

70

- 1

30

10

11

0.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

2:2

8F

als

e

TE

PP

525.2

1.0

LF

B3

.39

90

ug

/L1

.04

74

86

08

---

---

---

1 -

22

26

85

.0

10

/13

/20

20

08

:06

10

/14

/20

20

12

:28

Fals

e

1,2

,4,5

-Tetr

ach

loro

benze

ne

525.2

0.5

LF

B4

.31

60

ug

/L1

.04

74

86

08

---

---

---

56

- 1

30

86

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

2:2

8F

als

e

2,2

',4,4

'-T

etr

ach

loro

bip

henyl

525.2

0.1

LF

B5

.26

40

ug

/L1

.04

74

86

08

---

---

---

70

- 1

30

10

55

.0

10

/13

/20

20

08

:06

10

/14

/20

20

12

:28

Fals

e

Thia

bendazo

le525.2

10

LF

B0

.76

50

ug

/L1

.04

74

86

08

---

---

---

3 -

13

01

55

.0

10

/13

/20

20

08

:06

10

/14

/20

20

12

:28

Fals

e

Thio

nazi

n525.2

0.5

LF

B5

.40

00

ug

/L1

.04

74

86

08

---

---

---

60

- 1

47

10

85

.0

10

/13

/20

20

08

:06

10

/14

/20

20

12

:28

Fals

e

Tri

bufo

s525.2

0.1

LF

B4

.67

50

ug

/L1

.04

74

86

08

---

---

---

70

- 1

45

94

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

2:2

8F

als

e

2,4

,5-T

rich

loro

bip

henyl

525.2

0.1

LF

B5

.44

10

ug

/L1

.04

74

86

08

---

---

---

70

- 1

30

10

95

.0

10

/13

/20

20

08

:06

10

/14

/20

20

12

:28

Fals

e

Tri

chlo

ronate

525.2

0.5

LF

B5

.38

40

ug

/L1

.04

74

86

08

---

---

---

70

- 1

30

10

85

.0

10

/13

/20

20

08

:06

10

/14

/20

20

12

:28

Fals

e

Tri

cycl

azo

le525.2

1.0

LF

B4

.20

10

ug

/L1

.04

74

86

08

---

---

---

70

- 1

30

84

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

2:2

8F

als

e

Vin

clozo

lin525.2

0.5

LF

B5

.17

80

ug

/L1

.04

74

86

08

---

---

---

70

- 1

45

10

45

.0

10

/13

/20

20

08

:06

10

/14

/20

20

12

:28

Tru

e

IS-C

hry

sene-d

12

525.2

N/A

LM

B5

56

65

5ug

/L1

.01

47

48

60

5--

---

---

-7

0 -

13

09

75

72

58

4

10

/13

/20

20

08

:06

10

/14

/20

20

13

:10

Tru

e

IS-P

henanth

rene-d

10

525.2

N/A

LM

B7

66

00

6ug

/L1

.01

47

48

60

5--

---

---

-7

0 -

13

01

01

76

14

97

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

IS-P

yrene-d

10

525.2

N/A

LM

B6

21

53

0ug

/L1

.01

47

48

60

5--

---

---

-7

0 -

13

01

04

59

55

04

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

SS

-4,4

'-D

ichlo

robip

henyl

525.2

N/A

LM

B5

.21

90

ug

/L1

.01

47

48

60

5--

---

---

-7

0 -

13

01

03

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

SS

-2,4

,5,6

-Tetr

ach

loro

-m-x

ylene

525.2

N/A

LM

B5

.02

90

ug

/L1

.01

47

48

60

5--

---

---

-7

0 -

13

01

00

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

SS

-Tri

phenyl

phosp

hate

525.2

N/A

LM

B5

.52

90

ug

/L1

.01

47

48

60

5--

---

---

-7

0 -

13

01

09

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Ace

naphth

ene

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Ace

naphth

ylene

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Ace

toch

lor

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Ala

chlo

r525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Ald

rin

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Am

etr

yn525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Anila

zine

525.2

1.0

LM

B1

.0ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Anth

race

ne

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Asp

on

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Atr

ato

n525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Atr

azi

ne

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Azi

nphos-

eth

yl525.2

0.5

LM

B0

.5ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Azi

nphos-

meth

yl525.2

0.5

LM

B0

.5ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Bendio

carb

525.2

0.5

LM

B0

.5ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Benflura

lin525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Benzo

(a)a

nth

race

ne

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Benzo

(b)f

luora

nth

ene

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Benzo

(k)f

luora

nth

ene

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0

Page 1

2 o

f 32

EE

A R

un I

D 2

80992 /

EE

A R

eport

# 5

00223

Page 131 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Tru

e

Benzo

(g,h

,i)p

ery

lene

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Benzo

(a)p

yrene

525.2

0.0

2L

MB

0.0

2ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

alp

ha-H

exa

chlo

rocy

clohexa

ne

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

beta

-BH

C525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

delta-B

HC

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

gam

ma-B

HC

(Lin

dane)

525.2

0.0

2L

MB

0.0

2ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Bols

tar

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Bro

maci

l525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Buta

chlo

r525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Buty

late

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Buty

lbenzy

lphth

ala

te525.2

1.0

LM

B1

.0ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Carb

ophenoth

ion

525.2

0.5

LM

B0

.5ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Carb

oxi

n525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

alp

ha-C

hlo

rda

ne

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

gam

ma-C

hlo

rdane

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Chlo

rfenvi

nphos

525.2

5.0

LM

B5

.0ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Chlo

robenzi

late

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

2-C

hlo

robip

he

nyl

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Chlo

roneb

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Chlo

ropro

pyl

ate

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Chlo

roth

alo

nil

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Chlo

rpro

pham

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Chlo

rpyr

ifos

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Chlo

rpyr

ifos

me

thyl

525.2

0.5

LM

B0

.5ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Chry

sene

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Clo

mazo

ne

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Clo

pyr

alid

525.2

10

LM

B1

0ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Coum

aphos

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Cro

toxy

phos

525.2

0.5

LM

B0

.5ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Cya

nazi

ne

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Cyc

loate

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

DC

PA

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

4,4

'-D

DD

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

4,4

'-D

DE

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

4,4

'-D

DT

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Dem

eto

n O

525.2

0.5

LM

B0

.5ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Dem

eto

n S

525.2

0.5

LM

B0

.5ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Dese

thyl

atr

azi

ne

525.2

1.0

LM

B1

.0ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Desi

sopro

pyl

atr

azi

ne

525.2

1.0

LM

B1

.0ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Dia

zinon

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Dib

enzo

(a,h

)anth

race

ne

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0

Page 1

3 o

f 32

EE

A R

un I

D 2

80992 /

EE

A R

eport

# 5

00223

Page 132 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Tru

e

Di-

n-b

uty

lphth

ala

te525.2

2.0

LM

B2

.0ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Dic

hlo

benil

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Dic

hlo

fenth

ion

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Dic

hlo

ran

525.2

0.5

LM

B0

.5ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

2,3

-Dic

hlo

robip

henyl

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Dic

hlo

rvos

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Dic

roto

phos

525.2

0.5

LM

B0

.5ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Die

ldri

n525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Di(

2-e

thyl

hexy

l)a

dip

ate

525.2

0.6

LM

B0

.6ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Di(

2-e

thyl

hexy

l)phth

ala

te525.2

0.6

LM

B0

.6ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Die

thyl

phth

ala

te525.2

1.0

LM

B1

.0ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Dim

eth

oate

525.2

0.5

LM

B0

.5ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Dim

eth

ylphth

ala

te525.2

1.0

LM

B1

.0ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

2,4

-Din

itro

tolu

ene

525.2

0.5

LM

B0

.5ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

2,6

-Din

itro

tolu

ene

525.2

0.5

LM

B0

.5ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Di-

n-o

ctyl

phth

ala

te525.2

2.0

LM

B2

.0ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Dio

xath

ion A

525.2

0.5

LM

B0

.5ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Dio

xath

ion B

525.2

0.5

LM

B0

.5ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Dip

henam

id525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Dis

ulfoto

n525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Dis

ulfoto

n s

ulfone

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Dis

ulfoto

n s

ulfo

xide

525.2

10

LM

B1

0ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Endosu

lfan I

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Endosu

lfan I

I525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Endosu

lfan s

ulfate

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Endri

n525.2

0.0

1L

MB

0.0

1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Endri

n a

ldehyd

e525.2

0.5

LM

B0

.5ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

EP

N525.2

0.5

LM

B0

.5ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

EP

TC

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Eru

cyla

mid

e525.2

5.0

LM

B5

.0ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Esf

enva

lera

te525.2

0.5

LM

B0

.5ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Eth

alflu

ralin

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Eth

ion

525.2

5.0

LM

B5

.0ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Eth

ofu

mesa

te525.2

0.5

LM

B0

.5ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Eth

opro

p525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Etr

idia

zole

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Fam

phur

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Fenam

iphos

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Fenari

mol

525.2

1.0

LM

B1

.0ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Fenitro

thio

n525.2

0.5

LM

B0

.5ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Fenoxa

pro

p-e

thyl

525.2

1.0

LM

B1

.0ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0

Page 1

4 o

f 32

EE

A R

un I

D 2

80992 /

EE

A R

eport

# 5

00223

Page 133 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Tru

e

Fensu

lfoth

ion

525.2

0.5

LM

B0

.5ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Fenth

ion

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Flu

azi

fop-b

uty

l525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Flu

chlo

ralin

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Flu

om

etu

ron

525.2

0.5

LM

B0

.5ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Flu

ora

nth

ene

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Flu

ore

ne

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Flu

ridone

525.2

1.0

LM

B1

.0ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Fonofo

s525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Hepta

chlo

r525.2

0.0

4L

MB

0.0

4ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Hepta

chlo

r epo

xide

525.2

0.0

2L

MB

0.0

2ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

2,2

',3,3

',4,4

',6-H

epta

chlo

robip

henyl

525.2

0.5

LM

B0

.5ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Hexa

chlo

robenze

ne

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

2,2

',4,4

',5,6

'-H

exa

chlo

robip

henyl

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Hexa

chlo

rocy

clope

nta

die

ne

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Hexa

zinone

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Indeno(1

,2,3

-cd)p

yrene

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Ipro

dio

ne

525.2

0.5

LM

B0

.5ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Isofe

nphos

525.2

0.5

LM

B0

.5ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Isophoro

ne

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Lepto

phos

525.2

0.5

LM

B0

.5ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Mala

thio

n525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Meta

laxy

l525.2

0.5

LM

B0

.5ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Meth

oxy

chlo

r525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

1-M

eth

ylnaphth

ale

ne

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

2-M

eth

ylnaphth

ale

ne

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Meth

yl p

ara

oxo

n525.2

0.5

LM

B0

.5ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Meth

yl p

ara

thio

n525.2

0.5

LM

B0

.5ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Meto

lach

lor

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Metr

ibuzi

n525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Mets

ulfuro

n-m

eth

yl525.2

10

LM

B1

0ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Mevi

nphos

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

MG

K 2

64 iso

mer

a525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

MG

K 2

64 iso

mer

b525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

MG

K 3

26

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Mir

ex

525.2

0.5

LM

B0

.5ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Molin

ate

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Monocr

oto

phos

525.2

0.5

LM

B0

.5ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Nale

d525.2

0.5

LM

B0

.5ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Naphth

ale

ne

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Napro

pam

ide

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0

Page 1

5 o

f 32

EE

A R

un I

D 2

80992 /

EE

A R

eport

# 5

00223

Page 134 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Tru

e

cis-

Nonach

lor

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

trans-

Nonach

lor

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Norf

lura

zon

525.2

1.0

LM

B1

.0ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

2,2

',3,3

',4,5

',6,6

'-O

ctach

loro

bip

henyl

525.2

0.5

LM

B0

.5ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Ory

zalin

525.2

10

LM

B1

0ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Oxa

dia

zon

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Oxy

chlo

rdane

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Oxy

fluorf

en

525.2

0.5

LM

B0

.5ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Para

thio

n525.2

0.5

LM

B0

.5ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Pebula

te525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Pendim

eth

alin

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Penta

chlo

robenze

ne

525.2

0.5

LM

B0

.5ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

2,2

',3',4

,6-P

enta

chlo

robip

henyl

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Penta

chlo

ronitro

be

nze

ne

525.2

0.5

LM

B0

.5ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Penta

chlo

rophenol

525.2

1.0

LM

B1

.0ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

cis-

Perm

eth

rin

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

trans-

Perm

eth

rin

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Phenanth

rene

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Phora

te525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Phosm

et

525.2

0.5

LM

B0

.5ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

E-P

hosp

ham

idon

525.2

0.5

LM

B0

.5ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Z-P

hosp

ham

idon

525.2

0.5

LM

B0

.5ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Pro

flura

lin525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Pro

meto

n525.2

1.0

LM

B1

.0ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Pro

metr

yn525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Pro

nam

ide

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Pro

pach

lor

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Pro

panil

525.2

0.5

LM

B0

.5ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Pro

pazi

ne

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Pro

pic

onazo

le iso

mer

a525.2

5.0

LM

B5

.0ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Pro

pic

onazo

le iso

mer

b525.2

5.0

LM

B5

.0ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Pro

thio

fos

525.2

0.5

LM

B0

.5ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Pyr

ene

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Sim

azi

ne

525.2

0.0

7L

MB

0.0

7ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Sim

etr

yn525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Stiro

fos

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Sulfote

p525.2

0.5

LM

B0

.5ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Tebuth

iuro

n525.2

10

LM

B1

0ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

TE

PP

525.2

1.0

LM

B1

.0ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Terb

aci

l525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Terb

ufo

s525.2

0.5

LM

B0

.5ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0

Page 1

6 o

f 32

EE

A R

un I

D 2

80992 /

EE

A R

eport

# 5

00223

Page 135 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Tru

e

Terb

utr

yn525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

1,2

,4,5

-Tetr

ach

loro

benze

ne

525.2

0.5

LM

B0

.5ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

2,2

',4,4

'-T

etr

ach

loro

bip

henyl

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Thia

bendazo

le525.2

10

LM

B1

0ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Thio

benca

rb525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Thio

nazi

n525.2

0.5

LM

B0

.5ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Tri

adim

efo

n525.2

0.5

LM

B0

.5ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Tri

bufo

s525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

2,4

,5-T

rich

loro

bip

henyl

525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Tri

chlo

ronate

525.2

0.5

LM

B0

.5ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Tri

cycl

azo

le525.2

1.0

LM

B1

.0ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Tri

flura

lin525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Vern

ola

te525.2

0.1

LM

B0

.1ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0T

rue

Vin

clozo

lin525.2

0.5

LM

B0

.5ug

/L1

.01

47

48

60

5--

---

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

3:1

0F

als

e

IS-C

hry

sene-d

12

525.2

N/A

FS

60

66

08

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

-7

0 -

13

01

06

57

25

84

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

IS-P

henanth

rene-d

10

525.2

N/A

FS

88

14

39

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

-7

0 -

13

01

16

76

14

97

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

IS-P

yrene-d

10

525.2

N/A

FS

68

95

17

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

-7

0 -

13

01

16

59

55

04

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

SS

-4,4

'-D

ichlo

robip

henyl

525.2

N/A

FS

4.8

99

0ug

/L0

.97

47

43

53

6F

inis

he

d--

---

-7

0 -

13

01

01

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

SS

-2,4

,5,6

-Tetr

ach

loro

-m-x

ylene

525.2

N/A

FS

4.5

18

0ug

/L0

.97

47

43

53

6F

inis

he

d--

---

-7

0 -

13

09

35

.0

10

/13

/20

20

08

:06

10

/14

/20

20

16

:40

Fals

e

SS

-Tri

phenyl

phosp

hate

525.2

N/A

FS

5.7

40

0ug

/L0

.97

47

43

53

6F

inis

he

d--

---

-7

0 -

13

01

18

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Ace

naphth

ene

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Ace

naphth

ylene

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Ace

toch

lor

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Ala

chlo

r525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Ald

rin

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Am

etr

yn525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Anila

zine

525.2

1.0

FS

1.0

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Anth

race

ne

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Asp

on

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Atr

ato

n525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Atr

azi

ne

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Azi

nphos-

eth

yl525.2

0.5

FS

0.5

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Azi

nphos-

meth

yl525.2

0.5

FS

0.5

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Bendio

carb

525.2

0.5

FS

0.5

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Benflura

lin525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Benzo

(a)a

nth

race

ne

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Benzo

(b)f

luora

nth

ene

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Benzo

(k)f

luora

nth

ene

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Benzo

(g,h

,i)p

ery

lene

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Benzo

(a)p

yrene

525.2

0.0

2F

S0

.02

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

alp

ha-H

exa

chlo

rocy

clohexa

ne

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0

Page 1

7 o

f 32

EE

A R

un I

D 2

80992 /

EE

A R

eport

# 5

00223

Page 136 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Fals

e

beta

-BH

C525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

delta-B

HC

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

gam

ma-B

HC

(Lin

dane)

525.2

0.0

2F

S0

.02

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Bols

tar

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Bro

maci

l525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Buta

chlo

r525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Buty

late

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Buty

lbenzy

lphth

ala

te525.2

1.0

FS

1.0

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Carb

ophenoth

ion

525.2

0.5

FS

0.5

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Carb

oxi

n525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

alp

ha-C

hlo

rda

ne

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

gam

ma-C

hlo

rdane

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Chlo

rfenvi

nphos

525.2

5.0

FS

5.0

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Chlo

robenzi

late

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

2-C

hlo

robip

he

nyl

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Chlo

roneb

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Chlo

ropro

pyl

ate

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Chlo

roth

alo

nil

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Chlo

rpro

pham

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Chlo

rpyr

ifos

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Chlo

rpyr

ifos

me

thyl

525.2

0.5

FS

0.5

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Chry

sene

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Clo

mazo

ne

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Clo

pyr

alid

525.2

10

FS

10

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Coum

aphos

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Cro

toxy

phos

525.2

0.5

FS

0.5

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Cya

nazi

ne

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Cyc

loate

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

DC

PA

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

4,4

'-D

DD

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

4,4

'-D

DE

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

4,4

'-D

DT

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Dem

eto

n O

525.2

0.5

FS

0.5

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Dem

eto

n S

525.2

0.5

FS

0.5

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Dese

thyl

atr

azi

ne

525.2

1.0

FS

1.0

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Desi

sopro

pyl

atr

azi

ne

525.2

1.0

FS

1.0

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Dia

zinon

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Dib

enzo

(a,h

)anth

race

ne

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Di-

n-b

uty

lphth

ala

te525.2

2.0

FS

2.0

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Dic

hlo

benil

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Dic

hlo

fenth

ion

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0

Page 1

8 o

f 32

EE

A R

un I

D 2

80992 /

EE

A R

eport

# 5

00223

Page 137 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Fals

e

Dic

hlo

ran

525.2

0.5

FS

0.5

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

2,3

-Dic

hlo

robip

henyl

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Dic

hlo

rvos

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Dic

roto

phos

525.2

0.5

FS

0.5

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Die

ldri

n525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Di(

2-e

thyl

hexy

l)a

dip

ate

525.2

0.6

FS

0.6

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Di(

2-e

thyl

hexy

l)phth

ala

te525.2

0.6

FS

0.6

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Die

thyl

phth

ala

te525.2

1.0

FS

1.0

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Dim

eth

oate

525.2

0.5

FS

0.5

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Dim

eth

ylphth

ala

te525.2

1.0

FS

1.0

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

2,4

-Din

itro

tolu

ene

525.2

0.5

FS

0.5

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

2,6

-Din

itro

tolu

ene

525.2

0.5

FS

0.5

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Di-

n-o

ctyl

phth

ala

te525.2

2.0

FS

2.0

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Dio

xath

ion A

525.2

0.5

FS

0.5

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Dio

xath

ion B

525.2

0.5

FS

0.5

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Dip

henam

id525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Dis

ulfoto

n525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Dis

ulfoto

n s

ulfone

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Dis

ulfoto

n s

ulfo

xide

525.2

10

FS

10

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Endosu

lfan I

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Endosu

lfan I

I525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Endosu

lfan s

ulfate

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Endri

n525.2

0.0

1F

S0

.01

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Endri

n a

ldehyd

e525.2

0.5

FS

0.5

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

EP

N525.2

0.5

FS

0.5

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

EP

TC

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Eru

cyla

mid

e525.2

5.0

FS

5.0

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Esf

enva

lera

te525.2

0.5

FS

0.5

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Eth

alflu

ralin

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Eth

ion

525.2

5.0

FS

5.0

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Eth

ofu

mesa

te525.2

0.5

FS

0.5

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Eth

opro

p525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Etr

idia

zole

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Fam

phur

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Fenam

iphos

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Fenari

mol

525.2

1.0

FS

1.0

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Fenitro

thio

n525.2

0.5

FS

0.5

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Fenoxa

pro

p-e

thyl

525.2

1.0

FS

1.0

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Fensu

lfoth

ion

525.2

0.5

FS

0.5

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Fenth

ion

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Flu

azi

fop-b

uty

l525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0

Page 1

9 o

f 32

EE

A R

un I

D 2

80992 /

EE

A R

eport

# 5

00223

Page 138 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Fals

e

Flu

chlo

ralin

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Flu

om

etu

ron

525.2

0.5

FS

0.5

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Flu

ora

nth

ene

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Flu

ore

ne

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Flu

ridone

525.2

1.0

FS

1.0

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Fonofo

s525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Hepta

chlo

r525.2

0.0

4F

S0

.04

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Hepta

chlo

r epo

xide

525.2

0.0

2F

S0

.02

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

2,2

',3,3

',4,4

',6-H

epta

chlo

robip

henyl

525.2

0.5

FS

0.5

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Hexa

chlo

robenze

ne

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

2,2

',4,4

',5,6

'-H

exa

chlo

robip

henyl

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Hexa

chlo

rocy

clope

nta

die

ne

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Hexa

zinone

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Indeno(1

,2,3

-cd)p

yrene

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Ipro

dio

ne

525.2

0.5

FS

0.5

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Isofe

nphos

525.2

0.5

FS

0.5

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Isophoro

ne

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Lepto

phos

525.2

0.5

FS

0.5

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Mala

thio

n525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Meta

laxy

l525.2

0.5

FS

0.5

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Meth

oxy

chlo

r525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

1-M

eth

ylnaphth

ale

ne

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

2-M

eth

ylnaphth

ale

ne

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Meth

yl p

ara

oxo

n525.2

0.5

FS

0.5

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Meth

yl p

ara

thio

n525.2

0.5

FS

0.5

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Meto

lach

lor

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Metr

ibuzi

n525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Mets

ulfuro

n-m

eth

yl525.2

10

FS

10

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Mevi

nphos

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

MG

K 2

64 iso

mer

a525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

MG

K 2

64 iso

mer

b525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

MG

K 3

26

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Mir

ex

525.2

0.5

FS

0.5

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Molin

ate

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Monocr

oto

phos

525.2

0.5

FS

0.5

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Nale

d525.2

0.5

FS

0.5

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Naphth

ale

ne

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Napro

pam

ide

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

cis-

Nonach

lor

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

trans-

Nonach

lor

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Norf

lura

zon

525.2

1.0

FS

1.0

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0

Page 2

0 o

f 32

EE

A R

un I

D 2

80992 /

EE

A R

eport

# 5

00223

Page 139 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Fals

e

2,2

',3,3

',4,5

',6,6

'-O

ctach

loro

bip

henyl

525.2

0.5

FS

0.5

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Ory

zalin

525.2

10

FS

10

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Oxa

dia

zon

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Oxy

chlo

rdane

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Oxy

fluorf

en

525.2

0.5

FS

0.5

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Para

thio

n525.2

0.5

FS

0.5

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Pebula

te525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Pendim

eth

alin

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Penta

chlo

robenze

ne

525.2

0.5

FS

0.5

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

2,2

',3',4

,6-P

enta

chlo

robip

henyl

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Penta

chlo

ronitro

be

nze

ne

525.2

0.5

FS

0.5

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

cis-

Perm

eth

rin

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

trans-

Perm

eth

rin

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Perm

eth

rin, ci

s &

tra

ns

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Phenanth

rene

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Phora

te525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Phosm

et

525.2

0.5

FS

0.5

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

E-P

hosp

ham

idon

525.2

0.5

FS

0.5

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Z-P

hosp

ham

idon

525.2

0.5

FS

0.5

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Pro

flura

lin525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Pro

meto

n525.2

1.0

FS

1.0

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Pro

metr

yn525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Pro

nam

ide

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Pro

pach

lor

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Pro

panil

525.2

0.5

FS

0.5

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Pro

pazi

ne

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Pro

pic

onazo

le iso

mer

a525.2

5.0

FS

5.0

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Pro

pic

onazo

le iso

mer

b525.2

5.0

FS

5.0

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Pro

thio

fos

525.2

0.5

FS

0.5

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Pyr

ene

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Sim

azi

ne

525.2

0.0

7F

S0

.07

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Sim

etr

yn525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Stiro

fos

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Sulfote

p525.2

0.5

FS

0.5

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Tebuth

iuro

n525.2

10

FS

10

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

TE

PP

525.2

1.0

FS

1.0

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Terb

aci

l525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Terb

ufo

s525.2

0.5

FS

0.5

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Terb

utr

yn525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

1,2

,4,5

-Tetr

ach

loro

benze

ne

525.2

0.5

FS

0.5

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

2,2

',4,4

'-T

etr

ach

loro

bip

henyl

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0

Page 2

1 o

f 32

EE

A R

un I

D 2

80992 /

EE

A R

eport

# 5

00223

Page 140 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Fals

e

Thia

bendazo

le525.2

10

FS

10

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Thio

benca

rb525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Thio

nazi

n525.2

0.5

FS

0.5

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Tri

adim

efo

n525.2

0.5

FS

0.5

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Tri

bufo

s525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

2,4

,5-T

rich

loro

bip

henyl

525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Tri

chlo

ronate

525.2

0.5

FS

0.5

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Tri

cycl

azo

le525.2

1.0

FS

1.0

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Tri

flura

lin525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Vern

ola

te525.2

0.1

FS

0.1

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0F

als

e

Vin

clozo

lin525.2

0.5

FS

0.5

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

6:4

0T

rue

IS-C

hry

sene-d

12

525.2

N/A

FD

68

14

25

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

-7

0 -

13

01

19

57

25

84

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

IS-P

henanth

rene-d

10

525.2

N/A

FD

89

83

49

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

-7

0 -

13

01

18

76

14

97

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

IS-P

yrene-d

10

525.2

N/A

FD

74

53

01

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

-7

0 -

13

01

25

59

55

04

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

SS

-4,4

'-D

ichlo

robip

henyl

525.2

N/A

FD

4.8

03

0ug

/L0

.97

47

48

60

9F

inis

he

d--

---

-7

0 -

13

09

95

.0

10

/13

/20

20

08

:06

10

/14

/20

20

17

:22

Tru

e

SS

-2,4

,5,6

-Tetr

ach

loro

-m-x

ylene

525.2

N/A

FD

4.4

75

0ug

/L0

.97

47

48

60

9F

inis

he

d--

---

-7

0 -

13

09

25

.0

10

/13

/20

20

08

:06

10

/14

/20

20

17

:22

Tru

e

SS

-Tri

phenyl

phosp

hate

525.2

N/A

FD

5.6

85

0ug

/L0

.97

47

48

60

9F

inis

he

d--

---

-7

0 -

13

01

17

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Ace

naphth

ene

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Ace

naphth

ylene

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Ace

toch

lor

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Ala

chlo

r525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Ald

rin

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Am

etr

yn525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Anila

zine

525.2

1.0

FD

1.0

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Anth

race

ne

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Asp

on

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Atr

ato

n525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Atr

azi

ne

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Azi

nphos-

eth

yl525.2

0.5

FD

0.5

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Azi

nphos-

meth

yl525.2

0.5

FD

0.5

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Bendio

carb

525.2

0.5

FD

0.5

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Benflura

lin525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Benzo

(a)a

nth

race

ne

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Benzo

(b)f

luora

nth

ene

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Benzo

(k)f

luora

nth

ene

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Benzo

(g,h

,i)p

ery

lene

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Benzo

(a)p

yrene

525.2

0.0

2F

D0

.02

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

alp

ha-H

exa

chlo

rocy

clohexa

ne

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

beta

-BH

C525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

delta-B

HC

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

gam

ma-B

HC

(Lin

dane)

525.2

0.0

2F

D0

.02

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2

Page 2

2 o

f 32

EE

A R

un I

D 2

80992 /

EE

A R

eport

# 5

00223

Page 141 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Tru

e

Bols

tar

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Bro

maci

l525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Buta

chlo

r525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Buty

late

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Buty

lbenzy

lphth

ala

te525.2

1.0

FD

1.0

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Carb

ophenoth

ion

525.2

0.5

FD

0.5

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Carb

oxi

n525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

alp

ha-C

hlo

rda

ne

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

gam

ma-C

hlo

rdane

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Chlo

rfenvi

nphos

525.2

5.0

FD

5.0

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Chlo

robenzi

late

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

2-C

hlo

robip

he

nyl

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Chlo

roneb

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Chlo

ropro

pyl

ate

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Chlo

roth

alo

nil

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Chlo

rpro

pham

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Chlo

rpyr

ifos

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Chlo

rpyr

ifos

me

thyl

525.2

0.5

FD

0.5

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Chry

sene

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Clo

mazo

ne

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Clo

pyr

alid

525.2

10

FD

10

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Coum

aphos

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Cro

toxy

phos

525.2

0.5

FD

0.5

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Cya

nazi

ne

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Cyc

loate

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

DC

PA

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

4,4

'-D

DD

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

4,4

'-D

DE

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

4,4

'-D

DT

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Dem

eto

n O

525.2

0.5

FD

0.5

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Dem

eto

n S

525.2

0.5

FD

0.5

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Dese

thyl

atr

azi

ne

525.2

1.0

FD

1.0

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Desi

sopro

pyl

atr

azi

ne

525.2

1.0

FD

1.0

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Dia

zinon

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Dib

enzo

(a,h

)anth

race

ne

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Di-

n-b

uty

lphth

ala

te525.2

2.0

FD

2.0

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Dic

hlo

benil

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Dic

hlo

fenth

ion

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Dic

hlo

ran

525.2

0.5

FD

0.5

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

2,3

-Dic

hlo

robip

henyl

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Dic

hlo

rvos

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2

Page 2

3 o

f 32

EE

A R

un I

D 2

80992 /

EE

A R

eport

# 5

00223

Page 142 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Tru

e

Dic

roto

phos

525.2

0.5

FD

0.5

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Die

ldri

n525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Di(

2-e

thyl

hexy

l)a

dip

ate

525.2

0.6

FD

0.6

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Di(

2-e

thyl

hexy

l)phth

ala

te525.2

0.6

FD

0.6

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Die

thyl

phth

ala

te525.2

1.0

FD

1.0

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Dim

eth

oate

525.2

0.5

FD

0.5

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Dim

eth

ylphth

ala

te525.2

1.0

FD

1.0

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

2,4

-Din

itro

tolu

ene

525.2

0.5

FD

0.5

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

2,6

-Din

itro

tolu

ene

525.2

0.5

FD

0.5

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Di-

n-o

ctyl

phth

ala

te525.2

2.0

FD

2.0

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Dio

xath

ion A

525.2

0.5

FD

0.5

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Dio

xath

ion B

525.2

0.5

FD

0.5

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Dip

henam

id525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Dis

ulfoto

n525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Dis

ulfoto

n s

ulfone

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Dis

ulfoto

n s

ulfo

xide

525.2

10

FD

10

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Endosu

lfan I

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Endosu

lfan I

I525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Endosu

lfan s

ulfate

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Endri

n525.2

0.0

1F

D0

.01

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Endri

n a

ldehyd

e525.2

0.5

FD

0.5

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

EP

N525.2

0.5

FD

0.5

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

EP

TC

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Eru

cyla

mid

e525.2

5.0

FD

5.0

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Esf

enva

lera

te525.2

0.5

FD

0.5

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Eth

alflu

ralin

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Eth

ion

525.2

5.0

FD

5.0

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Eth

ofu

mesa

te525.2

0.5

FD

0.5

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Eth

opro

p525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Etr

idia

zole

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Fam

phur

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Fenam

iphos

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Fenari

mol

525.2

1.0

FD

1.0

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Fenitro

thio

n525.2

0.5

FD

0.5

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Fenoxa

pro

p-e

thyl

525.2

1.0

FD

1.0

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Fensu

lfoth

ion

525.2

0.5

FD

0.5

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Fenth

ion

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Flu

azi

fop-b

uty

l525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Flu

chlo

ralin

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Flu

om

etu

ron

525.2

0.5

FD

0.5

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Flu

ora

nth

ene

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2

Page 2

4 o

f 32

EE

A R

un I

D 2

80992 /

EE

A R

eport

# 5

00223

Page 143 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Tru

e

Flu

ore

ne

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Flu

ridone

525.2

1.0

FD

1.0

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Fonofo

s525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Hepta

chlo

r525.2

0.0

4F

D0

.04

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Hepta

chlo

r epo

xide

525.2

0.0

2F

D0

.02

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

2,2

',3,3

',4,4

',6-H

epta

chlo

robip

henyl

525.2

0.5

FD

0.5

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Hexa

chlo

robenze

ne

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

2,2

',4,4

',5,6

'-H

exa

chlo

robip

henyl

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Hexa

chlo

rocy

clope

nta

die

ne

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Hexa

zinone

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Indeno(1

,2,3

-cd)p

yrene

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Ipro

dio

ne

525.2

0.5

FD

0.5

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Isofe

nphos

525.2

0.5

FD

0.5

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Isophoro

ne

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Lepto

phos

525.2

0.5

FD

0.5

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Mala

thio

n525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Meta

laxy

l525.2

0.5

FD

0.5

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Meth

oxy

chlo

r525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

1-M

eth

ylnaphth

ale

ne

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

2-M

eth

ylnaphth

ale

ne

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Meth

yl p

ara

oxo

n525.2

0.5

FD

0.5

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Meth

yl p

ara

thio

n525.2

0.5

FD

0.5

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Meto

lach

lor

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Metr

ibuzi

n525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Mets

ulfuro

n-m

eth

yl525.2

10

FD

10

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Mevi

nphos

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

MG

K 2

64 iso

mer

a525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

MG

K 2

64 iso

mer

b525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

MG

K 3

26

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Mir

ex

525.2

0.5

FD

0.5

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Molin

ate

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Monocr

oto

phos

525.2

0.5

FD

0.5

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Nale

d525.2

0.5

FD

0.5

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Naphth

ale

ne

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Napro

pam

ide

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

cis-

Nonach

lor

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

trans-

Nonach

lor

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Norf

lura

zon

525.2

1.0

FD

1.0

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

2,2

',3,3

',4,5

',6,6

'-O

ctach

loro

bip

henyl

525.2

0.5

FD

0.5

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Ory

zalin

525.2

10

FD

10

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Oxa

dia

zon

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2

Page 2

5 o

f 32

EE

A R

un I

D 2

80992 /

EE

A R

eport

# 5

00223

Page 144 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Tru

e

Oxy

chlo

rdane

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Oxy

fluorf

en

525.2

0.5

FD

0.5

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Para

thio

n525.2

0.5

FD

0.5

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Pebula

te525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Pendim

eth

alin

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Penta

chlo

robenze

ne

525.2

0.5

FD

0.5

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

2,2

',3',4

,6-P

enta

chlo

robip

henyl

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Penta

chlo

ronitro

be

nze

ne

525.2

0.5

FD

0.5

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

cis-

Perm

eth

rin

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

trans-

Perm

eth

rin

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Phenanth

rene

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Phora

te525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Phosm

et

525.2

0.5

FD

0.5

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

E-P

hosp

ham

idon

525.2

0.5

FD

0.5

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Z-P

hosp

ham

idon

525.2

0.5

FD

0.5

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Pro

flura

lin525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Pro

meto

n525.2

1.0

FD

1.0

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Pro

metr

yn525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Pro

nam

ide

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Pro

pach

lor

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Pro

panil

525.2

0.5

FD

0.5

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Pro

pazi

ne

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Pro

pic

onazo

le iso

mer

a525.2

5.0

FD

5.0

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Pro

pic

onazo

le iso

mer

b525.2

5.0

FD

5.0

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Pro

thio

fos

525.2

0.5

FD

0.5

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Pyr

ene

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Sim

azi

ne

525.2

0.0

7F

D0

.07

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Sim

etr

yn525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Stiro

fos

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Sulfote

p525.2

0.5

FD

0.5

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Tebuth

iuro

n525.2

10

FD

10

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

TE

PP

525.2

1.0

FD

1.0

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Terb

aci

l525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Terb

ufo

s525.2

0.5

FD

0.5

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Terb

utr

yn525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

1,2

,4,5

-Tetr

ach

loro

benze

ne

525.2

0.5

FD

0.5

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

2,2

',4,4

'-T

etr

ach

loro

bip

henyl

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Thia

bendazo

le525.2

10

FD

10

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Thio

benca

rb525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Thio

nazi

n525.2

0.5

FD

0.5

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Tri

adim

efo

n525.2

0.5

FD

0.5

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2

Page 2

6 o

f 32

EE

A R

un I

D 2

80992 /

EE

A R

eport

# 5

00223

Page 145 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Tru

e

Tri

bufo

s525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

2,4

,5-T

rich

loro

bip

henyl

525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Tri

chlo

ronate

525.2

0.5

FD

0.5

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Tri

cycl

azo

le525.2

1.0

FD

1.0

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Tri

flura

lin525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Vern

ola

te525.2

0.1

FD

0.1

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2T

rue

Vin

clozo

lin525.2

0.5

FD

0.5

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 1

7:2

2F

als

e

IS-C

hry

sene-d

12

525.2

N/A

CC

C7

57

68

1ug

/L1

.04

74

88

74

---

---

---

50

- 1

50

10

07

57

68

1

10

/13

/20

20

08

:06

10

/14

/20

20

20

:55

Fals

e

IS-P

henanth

rene-d

10

525.2

N/A

CC

C1

06

60

00

ug

/L1

.04

74

88

74

---

---

---

50

- 1

50

10

01

06

60

00

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

0:5

5F

als

e

IS-P

yrene-d

10

525.2

N/A

CC

C7

94

39

7ug

/L1

.04

74

88

74

---

---

---

50

- 1

50

10

07

94

39

7

10

/13

/20

20

08

:06

10

/14

/20

20

20

:55

Fals

e

SS

-4,4

'-D

ichlo

robip

henyl

525.2

N/A

CC

C3

.83

50

ug

/L1

.04

74

88

74

---

---

---

70

- 1

30

77

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

0:5

5F

als

e

SS

-2,4

,5,6

-Tetr

ach

loro

-m-x

ylene

525.2

N/A

CC

C4

.99

30

ug

/L1

.04

74

88

74

---

---

---

70

- 1

30

10

05

.0

10

/13

/20

20

08

:06

10

/14

/20

20

20

:55

Fals

e

SS

-Tri

phenyl

phosp

hate

525.2

N/A

CC

C5

.02

60

ug

/L1

.04

74

88

74

---

---

---

70

- 1

30

10

15

.0

10

/13

/20

20

08

:06

10

/14

/20

20

20

:55

Fals

e

Ace

naphth

ene

525.2

0.1

CC

C4

.65

00

ug

/L1

.04

74

88

74

---

---

---

65

- 1

30

93

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

0:5

5F

als

e

Ace

naphth

ylene

525.2

0.1

CC

C5

.15

10

ug

/L1

.04

74

88

74

---

---

---

70

- 1

30

10

35

.0

10

/13

/20

20

08

:06

10

/14

/20

20

20

:55

Fals

e

Anth

race

ne

525.2

0.1

CC

C4

.73

00

ug

/L1

.04

74

88

74

---

---

---

70

- 1

30

95

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

0:5

5F

als

e

Azi

nphos-

eth

yl525.2

0.5

CC

C4

.63

60

ug

/L1

.04

74

88

74

---

---

---

70

- 1

45

93

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

0:5

5F

als

e

Bendio

carb

525.2

0.5

CC

C5

.53

90

ug

/L1

.04

74

88

74

---

---

---

65

- 1

59

11

15

.0

10

/13

/20

20

08

:06

10

/14

/20

20

20

:55

Fals

e

Benzo

(a)a

nth

race

ne

525.2

0.1

CC

C5

.10

80

ug

/L1

.04

74

88

74

---

---

---

70

- 1

30

10

25

.0

10

/13

/20

20

08

:06

10

/14

/20

20

20

:55

Fals

e

Benzo

(b)f

luora

nth

ene

525.2

0.1

CC

C5

.10

30

ug

/L1

.04

74

88

74

---

---

---

70

- 1

30

10

25

.0

10

/13

/20

20

08

:06

10

/14

/20

20

20

:55

Fals

e

Benzo

(k)f

luora

nth

ene

525.2

0.1

CC

C5

.17

70

ug

/L1

.04

74

88

74

---

---

---

70

- 1

30

10

45

.0

10

/13

/20

20

08

:06

10

/14

/20

20

20

:55

Fals

e

Benzo

(g,h

,i)p

ery

lene

525.2

0.1

CC

C4

.54

70

ug

/L1

.04

74

88

74

---

---

---

70

- 1

30

91

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

0:5

5F

als

e

Buty

lbenzy

lphth

ala

te525.2

1.0

CC

C5

.37

40

ug

/L1

.04

74

88

74

---

---

---

70

- 1

30

10

75

.0

10

/13

/20

20

08

:06

10

/14

/20

20

20

:55

Fals

e

Carb

ophenoth

ion

525.2

0.5

CC

C5

.03

00

ug

/L1

.04

74

88

74

---

---

---

70

- 1

30

10

15

.0

10

/13

/20

20

08

:06

10

/14

/20

20

20

:55

Fals

e

Chlo

rfenvi

nphos

525.2

5.0

CC

C4

.07

40

ug

/L1

.04

74

88

74

---

---

---

70

- 1

30

92

4.4

2

10

/13

/20

20

08

:06

10

/14

/20

20

20

:55

Fals

e

2-C

hlo

robip

he

nyl

525.2

0.1

CC

C5

.05

80

ug

/L1

.04

74

88

74

---

---

---

70

- 1

30

10

15

.0

10

/13

/20

20

08

:06

10

/14

/20

20

20

:55

Fals

e

Chlo

rpyr

ifos

me

thyl

525.2

0.5

CC

C5

.46

50

ug

/L1

.04

74

88

74

---

---

---

70

- 1

30

10

95

.0

10

/13

/20

20

08

:06

10

/14

/20

20

20

:55

Fals

e

Chry

sene

525.2

0.1

CC

C4

.82

10

ug

/L1

.04

74

88

74

---

---

---

70

- 1

30

96

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

0:5

5F

als

e

Clo

pyr

alid

525.2

10

CC

C6

.88

70

ug

/L1

.04

74

88

74

---

---

---

1 -

10

96

91

0.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

0:5

5F

als

e

Cro

toxy

phos

525.2

0.5

CC

C4

.11

80

ug

/L1

.04

74

88

74

---

---

---

70

- 1

73

82

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

0:5

5F

als

e

Dib

enzo

(a,h

)anth

race

ne

525.2

0.1

CC

C5

.06

70

ug

/L1

.04

74

88

74

---

---

---

70

- 1

30

10

15

.0

10

/13

/20

20

08

:06

10

/14

/20

20

20

:55

Fals

e

Di-

n-b

uty

lphth

ala

te525.2

2.0

CC

C5

.14

30

ug

/L1

.04

74

88

74

---

---

---

70

- 1

30

10

35

.0

10

/13

/20

20

08

:06

10

/14

/20

20

20

:55

Fals

e

2,3

-Dic

hlo

robip

henyl

525.2

0.1

CC

C4

.87

00

ug

/L1

.04

74

88

74

---

---

---

70

- 1

30

97

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

0:5

5F

als

e

Dic

roto

phos

525.2

0.5

CC

C4

.79

90

ug

/L1

.04

74

88

74

---

---

---

70

- 1

91

96

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

0:5

5F

als

e

Die

thyl

phth

ala

te525.2

1.0

CC

C4

.82

00

ug

/L1

.04

74

88

74

---

---

---

70

- 1

30

96

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

0:5

5F

als

e

Dim

eth

ylphth

ala

te525.2

1.0

CC

C5

.30

40

ug

/L1

.04

74

88

74

---

---

---

70

- 1

30

10

65

.0

10

/13

/20

20

08

:06

10

/14

/20

20

20

:55

Fals

e

Di-

n-o

ctyl

phth

ala

te525.2

2.0

CC

C5

.09

60

ug

/L1

.04

74

88

74

---

---

---

48

- 1

73

10

25

.0

10

/13

/20

20

08

:06

10

/14

/20

20

20

:55

Fals

e

Dio

xath

ion A

525.2

0.5

CC

C3

.93

50

ug

/L1

.04

74

88

74

---

---

---

34

- 2

09

12

93

.06

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

0:5

5F

als

e

Dio

xath

ion B

525.2

0.5

CC

C2

.29

90

ug

/L1

.04

74

88

74

---

---

---

14

- 4

98

12

11

.89

5

10

/13

/20

20

08

:06

10

/14

/20

20

20

:55

Fals

e

Dis

ulfoto

n s

ulfo

xide

525.2

10

CC

C9

.65

90

ug

/L1

.04

74

88

74

---

---

---

69

- 1

30

97

10

.0

10

/13

/20

20

08

:06

10

/14

/20

20

20

:55

Fals

e

EP

N525.2

0.5

CC

C4

.91

00

ug

/L1

.04

74

88

74

---

---

---

70

- 1

47

98

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

0:5

5

Page 2

7 o

f 32

EE

A R

un I

D 2

80992 /

EE

A R

eport

# 5

00223

Page 146 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Fals

e

Eru

cyla

mid

e525.2

5.0

CC

C8

.46

90

ug

/L1

.04

74

88

74

---

---

---

43

- 2

51

85

10

.0

10

/13

/20

20

08

:06

10

/14

/20

20

20

:55

Fals

e

Esf

enva

lera

te525.2

0.5

CC

C5

.28

80

ug

/L1

.04

74

88

74

---

---

---

70

- 1

30

10

65

.0

10

/13

/20

20

08

:06

10

/14

/20

20

20

:55

Fals

e

Fenari

mol

525.2

1.0

CC

C4

.72

60

ug

/L1

.04

74

88

74

---

---

---

70

- 1

30

95

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

0:5

5F

als

e

Fenitro

thio

n525.2

0.5

CC

C5

.06

50

ug

/L1

.04

74

88

74

---

---

---

70

- 1

30

10

15

.0

10

/13

/20

20

08

:06

10

/14

/20

20

20

:55

Fals

e

Fenoxa

pro

p-e

thyl

525.2

1.0

CC

C5

.04

10

ug

/L1

.04

74

88

74

---

---

---

70

- 1

40

10

15

.0

10

/13

/20

20

08

:06

10

/14

/20

20

20

:55

Fals

e

Fensu

lfoth

ion

525.2

0.5

CC

C5

.49

20

ug

/L1

.04

74

88

74

---

---

---

70

- 1

91

11

05

.0

10

/13

/20

20

08

:06

10

/14

/20

20

20

:55

Fals

e

Flu

ore

ne

525.2

0.1

CC

C4

.97

70

ug

/L1

.04

74

88

74

---

---

---

70

- 1

30

10

05

.0

10

/13

/20

20

08

:06

10

/14

/20

20

20

:55

Fals

e

Flu

ridone

525.2

1.0

CC

C4

.46

80

ug

/L1

.04

74

88

74

---

---

---

70

- 1

30

89

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

0:5

5F

als

e

2,2

',3,3

',4,4

',6-H

epta

chlo

robip

henyl

525.2

0.5

CC

C4

.40

80

ug

/L1

.04

74

88

74

---

---

---

70

- 1

30

88

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

0:5

5F

als

e

2,2

',4,4

',5,6

'-H

exa

chlo

robip

henyl

525.2

0.1

CC

C4

.92

60

ug

/L1

.04

74

88

74

---

---

---

70

- 1

30

99

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

0:5

5F

als

e

Indeno(1

,2,3

-cd)p

yrene

525.2

0.1

CC

C4

.73

00

ug

/L1

.04

74

88

74

---

---

---

70

- 1

30

95

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

0:5

5F

als

e

Ipro

dio

ne

525.2

0.5

CC

C6

.01

50

ug

/L1

.04

74

88

74

---

---

---

70

- 2

07

12

05

.0

10

/13

/20

20

08

:06

10

/14

/20

20

20

:55

Fals

e

Isofe

nphos

525.2

0.5

CC

C4

.51

60

ug

/L1

.04

74

88

74

---

---

---

70

- 1

45

90

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

0:5

5F

als

e

Lepto

phos

525.2

0.5

CC

C4

.53

40

ug

/L1

.04

74

88

74

---

---

---

70

- 1

30

91

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

0:5

5F

als

e

Meta

laxy

l525.2

0.5

CC

C4

.73

90

ug

/L1

.04

74

88

74

---

---

---

70

- 1

43

95

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

0:5

5F

als

e

Meth

yl p

ara

thio

n525.2

0.5

CC

C6

.67

80

ug

/L1

.04

74

88

74

---

---

---

70

- 2

06

13

45

.0

10

/13

/20

20

08

:06

10

/14

/20

20

20

:55

Fals

e

Mets

ulfuro

n-m

eth

yl525.2

10

CC

C8

.80

90

ug

/L1

.04

74

88

74

---

---

---

70

- 1

70

88

10

.0

10

/13

/20

20

08

:06

10

/14

/20

20

20

:55

Fals

e

Mir

ex

525.2

0.5

CC

C4

.18

50

ug

/L1

.04

74

88

74

---

---

---

61

- 1

30

84

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

0:5

5F

als

e

Monocr

oto

phos

525.2

0.5

CC

C4

.77

90

ug

/L1

.04

74

88

74

---

---

---

70

- 1

85

96

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

0:5

5F

als

e

Nale

d525.2

0.5

CC

C4

.16

70

ug

/L1

.04

74

88

74

---

---

---

29

- 1

60

83

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

0:5

5F

als

e

cis-

Nonach

lor

525.2

0.1

CC

C5

.74

40

ug

/L1

.04

74

88

74

---

---

---

70

- 1

30

11

55

.0

10

/13

/20

20

08

:06

10

/14

/20

20

20

:55

Fals

e

Norf

lura

zon

525.2

1.0

CC

C4

.72

10

ug

/L1

.04

74

88

74

---

---

---

70

- 1

30

94

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

0:5

5F

als

e

2,2

',3,3

',4,5

',6,6

'-O

ctach

loro

bip

henyl

525.2

0.5

CC

C4

.95

50

ug

/L1

.04

74

88

74

---

---

---

70

- 1

30

99

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

0:5

5F

als

e

Ory

zalin

525.2

10

CC

C6

.68

50

ug

/L1

.04

74

88

74

---

---

---

1 -

38

91

34

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

0:5

5F

als

e

Oxy

chlo

rdane

525.2

0.1

CC

C5

.28

30

ug

/L1

.04

74

88

74

---

---

---

70

- 1

30

10

65

.0

10

/13

/20

20

08

:06

10

/14

/20

20

20

:55

Fals

e

Oxy

fluorf

en

525.2

0.5

CC

C4

.78

50

ug

/L1

.04

74

88

74

---

---

---

70

- 1

30

96

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

0:5

5F

als

e

Para

thio

n525.2

0.5

CC

C4

.67

00

ug

/L1

.04

74

88

74

---

---

---

63

- 1

45

93

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

0:5

5F

als

e

Penta

chlo

robenze

ne

525.2

0.5

CC

C4

.95

70

ug

/L1

.04

74

88

74

---

---

---

61

- 1

30

99

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

0:5

5F

als

e

2,2

',3',4

,6-P

enta

chlo

robip

henyl

525.2

0.1

CC

C5

.10

90

ug

/L1

.04

74

88

74

---

---

---

70

- 1

30

10

25

.0

10

/13

/20

20

08

:06

10

/14

/20

20

20

:55

Fals

e

Phenanth

rene

525.2

0.1

CC

C4

.94

90

ug

/L1

.04

74

88

74

---

---

---

70

- 1

30

99

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

0:5

5F

als

e

Phosm

et

525.2

0.5

CC

C4

.07

70

ug

/L1

.04

74

88

74

---

---

---

70

- 1

30

82

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

0:5

5F

als

e

E-P

hosp

ham

idon

525.2

0.5

CC

C1

.40

20

ug

/L1

.04

74

88

74

---

---

---

70

- 3

02

10

11

.39

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

0:5

5F

als

e

Z-P

hosp

ham

idon

525.2

0.5

CC

C3

.32

80

ug

/L1

.04

74

88

74

---

---

---

70

- 1

89

95

3.5

15

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

0:5

5F

als

e

Pro

pic

onazo

le iso

mer

a525.2

5.0

CC

C1

.96

40

ug

/L1

.04

74

88

74

---

---

---

1 -

27

88

72

.24

5

10

/13

/20

20

08

:06

10

/14

/20

20

20

:55

Fals

e

Pro

pic

onazo

le iso

mer

b525.2

5.0

CC

C2

.55

00

ug

/L1

.04

74

88

74

---

---

---

61

- 1

30

93

2.7

55

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

0:5

5F

als

e

Pro

thio

fos

525.2

0.5

CC

C4

.79

00

ug

/L1

.04

74

88

74

---

---

---

70

- 1

35

96

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

0:5

5F

als

e

Pyr

ene

525.2

0.1

CC

C5

.06

30

ug

/L1

.04

74

88

74

---

---

---

70

- 1

30

10

15

.0

10

/13

/20

20

08

:06

10

/14

/20

20

20

:55

Fals

e

Sulfote

p525.2

0.5

CC

C4

.46

10

ug

/L1

.04

74

88

74

---

---

---

70

- 1

30

89

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

0:5

5F

als

e

Tebuth

iuro

n525.2

10

CC

C8

.54

20

ug

/L1

.04

74

88

74

---

---

---

70

- 1

30

85

10

.0

10

/13

/20

20

08

:06

10

/14

/20

20

20

:55

Fals

e

TE

PP

525.2

1.0

CC

C4

.85

50

ug

/L1

.04

74

88

74

---

---

---

1 -

26

79

75

.0

10

/13

/20

20

08

:06

10

/14

/20

20

20

:55

Fals

e

1,2

,4,5

-Tetr

ach

loro

benze

ne

525.2

0.5

CC

C4

.90

40

ug

/L1

.04

74

88

74

---

---

---

57

- 1

30

98

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

0:5

5

Page 2

8 o

f 32

EE

A R

un I

D 2

80992 /

EE

A R

eport

# 5

00223

Page 147 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Fals

e

2,2

',4,4

'-T

etr

ach

loro

bip

henyl

525.2

0.1

CC

C4

.87

40

ug

/L1

.04

74

88

74

---

---

---

70

- 1

30

97

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

0:5

5F

als

e

Thia

bendazo

le525.2

10

CC

C4

.80

40

ug

/L1

.04

74

88

74

---

---

---

6 -

19

09

65

.0

10

/13

/20

20

08

:06

10

/14

/20

20

20

:55

Fals

e

Thio

nazi

n525.2

0.5

CC

C5

.18

90

ug

/L1

.04

74

88

74

---

---

---

62

- 1

37

10

45

.0

10

/13

/20

20

08

:06

10

/14

/20

20

20

:55

Fals

e

Tri

bufo

s525.2

0.1

CC

C4

.61

00

ug

/L1

.04

74

88

74

---

---

---

70

- 1

36

92

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

0:5

5F

als

e

2,4

,5-T

rich

loro

bip

henyl

525.2

0.1

CC

C5

.22

60

ug

/L1

.04

74

88

74

---

---

---

70

- 1

30

10

55

.0

10

/13

/20

20

08

:06

10

/14

/20

20

20

:55

Fals

e

Tri

chlo

ronate

525.2

0.5

CC

C5

.04

40

ug

/L1

.04

74

88

74

---

---

---

70

- 1

30

10

15

.0

10

/13

/20

20

08

:06

10

/14

/20

20

20

:55

Fals

e

Tri

cycl

azo

le525.2

1.0

CC

C3

.93

40

ug

/L1

.04

74

88

74

---

---

---

70

- 1

30

79

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

0:5

5F

als

e

Vin

clozo

lin525.2

0.5

CC

C5

.06

80

ug

/L1

.04

74

88

74

---

---

---

70

- 1

37

10

15

.0

10

/13

/20

20

08

:06

10

/14

/20

20

20

:55

Tru

e

IS-C

hry

sene-d

12

525.2

N/A

CC

C7

19

15

4ug

/L1

.04

74

88

75

---

---

---

50

- 1

50

10

07

19

15

4

10

/13

/20

20

08

:06

10

/14

/20

20

21

:37

Tru

e

IS-P

henanth

rene-d

10

525.2

N/A

CC

C1

09

40

00

ug

/L1

.04

74

88

75

---

---

---

50

- 1

50

10

01

09

40

00

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

1:3

7T

rue

IS-P

yrene-d

10

525.2

N/A

CC

C7

39

36

9ug

/L1

.04

74

88

75

---

---

---

50

- 1

50

10

07

39

36

9

10

/13

/20

20

08

:06

10

/14

/20

20

21

:37

Tru

e

SS

-4,4

'-D

ichlo

robip

henyl

525.2

N/A

CC

C3

.89

80

ug

/L1

.04

74

88

75

---

---

---

70

- 1

30

78

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

1:3

7T

rue

SS

-2,4

,5,6

-Tetr

ach

loro

-m-x

ylene

525.2

N/A

CC

C4

.17

90

ug

/L1

.04

74

88

75

---

---

---

70

- 1

30

84

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

1:3

7T

rue

SS

-Tri

phenyl

phosp

hate

525.2

N/A

CC

C5

.34

50

ug

/L1

.04

74

88

75

---

---

---

70

- 1

30

10

75

.0

10

/13

/20

20

08

:06

10

/14

/20

20

21

:37

Tru

e

Anila

zine

525.2

1.0

CC

C3

.60

80

ug

/L1

.04

74

88

75

---

---

---

41

- 1

30

72

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

1:3

7T

rue

alp

ha-H

exa

chlo

rocy

clohexa

ne

525.2

0.1

CC

C4

.97

20

ug

/L1

.04

74

88

75

---

---

---

70

- 1

30

99

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

1:3

7T

rue

beta

-BH

C525.2

0.1

CC

C5

.05

90

ug

/L1

.04

74

88

75

---

---

---

70

- 1

30

10

15

.0

10

/13

/20

20

08

:06

10

/14

/20

20

21

:37

Tru

e

delta-B

HC

525.2

0.1

CC

C4

.91

50

ug

/L1

.04

74

88

75

---

---

---

70

- 1

30

98

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

1:3

7T

rue

Buty

late

525.2

0.1

CC

C4

.64

00

ug

/L1

.04

74

88

75

---

---

---

70

- 1

30

93

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

1:3

7T

rue

Chlo

robenzi

late

525.2

0.1

CC

C4

.84

60

ug

/L1

.04

74

88

75

---

---

---

70

- 1

30

97

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

1:3

7T

rue

Chlo

roneb

525.2

0.1

CC

C4

.98

90

ug

/L1

.04

74

88

75

---

---

---

70

- 1

30

10

05

.0

10

/13

/20

20

08

:06

10

/14

/20

20

21

:37

Tru

e

Cyc

loate

525.2

0.1

CC

C4

.85

30

ug

/L1

.04

74

88

75

---

---

---

70

- 1

30

97

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

1:3

7T

rue

DC

PA

525.2

0.1

CC

C4

.85

30

ug

/L1

.04

74

88

75

---

---

---

70

- 1

30

97

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

1:3

7T

rue

4,4

'-D

DD

525.2

0.1

CC

C4

.88

60

ug

/L1

.04

74

88

75

---

---

---

70

- 1

30

98

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

1:3

7T

rue

4,4

'-D

DE

525.2

0.1

CC

C5

.26

90

ug

/L1

.04

74

88

75

---

---

---

70

- 1

30

10

55

.0

10

/13

/20

20

08

:06

10

/14

/20

20

21

:37

Tru

e

Dem

eto

n O

525.2

0.5

CC

C4

.89

00

ug

/L1

.04

74

88

75

---

---

---

70

- 1

74

98

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

1:3

7T

rue

Dem

eto

n S

525.2

0.5

CC

C5

.53

80

ug

/L1

.04

74

88

75

---

---

---

67

- 2

15

11

15

.0

10

/13

/20

20

08

:06

10

/14

/20

20

21

:37

Tru

e

Dese

thyl

atr

azi

ne

525.2

1.0

CC

C4

.05

70

ug

/L1

.04

74

88

75

---

---

---

70

- 1

30

81

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

1:3

7T

rue

Dia

zinon

525.2

0.1

CC

C4

.92

60

ug

/L1

.04

74

88

75

---

---

---

66

- 1

30

99

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

1:3

7T

rue

Dic

hlo

fenth

ion

525.2

0.1

CC

C4

.91

70

ug

/L1

.04

74

88

75

---

---

---

70

- 1

30

98

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

1:3

7T

rue

Dic

hlo

ran

525.2

0.5

CC

C5

.24

90

ug

/L1

.04

74

88

75

---

---

---

70

- 1

30

10

55

.0

10

/13

/20

20

08

:06

10

/14

/20

20

21

:37

Tru

e

Dic

hlo

rvos

525.2

0.1

CC

C4

.07

60

ug

/L1

.04

74

88

75

---

---

---

70

- 1

30

82

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

1:3

7T

rue

Dis

ulfoto

n525.2

0.1

CC

C5

.11

20

ug

/L1

.04

74

88

75

---

---

---

61

- 1

56

10

25

.0

10

/13

/20

20

08

:06

10

/14

/20

20

21

:37

Tru

e

Endosu

lfan I

525.2

0.1

CC

C4

.94

20

ug

/L1

.04

74

88

75

---

---

---

70

- 1

30

99

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

1:3

7T

rue

Endosu

lfan I

I525.2

0.1

CC

C5

.61

50

ug

/L1

.04

74

88

75

---

---

---

70

- 1

30

11

25

.0

10

/13

/20

20

08

:06

10

/14

/20

20

21

:37

Tru

e

Endosu

lfan s

ulfate

525.2

0.1

CC

C4

.60

20

ug

/L1

.04

74

88

75

---

---

---

70

- 1

30

92

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

1:3

7T

rue

Endri

n a

ldehyd

e525.2

0.5

CC

C5

.15

00

ug

/L1

.04

74

88

75

---

---

---

70

- 1

30

10

35

.0

10

/13

/20

20

08

:06

10

/14

/20

20

21

:37

Tru

e

EP

TC

525.2

0.1

CC

C4

.48

50

ug

/L1

.04

74

88

75

---

---

---

70

- 1

30

90

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

1:3

7T

rue

Fenth

ion

525.2

0.1

CC

C5

.07

60

ug

/L1

.04

74

88

75

---

---

---

63

- 1

37

10

25

.0

10

/13

/20

20

08

:06

10

/14

/20

20

21

:37

Tru

e

Flu

chlo

ralin

525.2

0.1

CC

C5

.01

20

ug

/L1

.04

74

88

75

---

---

---

70

- 1

30

10

05

.0

10

/13

/20

20

08

:06

10

/14

/20

20

21

:37

Tru

e

Flu

ora

nth

ene

525.2

0.1

CC

C5

.08

30

ug

/L1

.04

74

88

75

---

---

---

65

- 1

30

10

25

.0

10

/13

/20

20

08

:06

10

/14

/20

20

21

:37

Page 2

9 o

f 32

EE

A R

un I

D 2

80992 /

EE

A R

eport

# 5

00223

Page 148 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Tru

e

Fonofo

s525.2

0.1

CC

C5

.19

80

ug

/L1

.04

74

88

75

---

---

---

70

- 1

30

10

45

.0

10

/13

/20

20

08

:06

10

/14

/20

20

21

:37

Tru

e

2-M

eth

ylnaphth

ale

ne

525.2

0.1

CC

C4

.91

80

ug

/L1

.04

74

88

75

---

---

---

70

- 1

30

98

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

1:3

7T

rue

MG

K 2

64 iso

mer

a525.2

0.1

CC

C3

.00

40

ug

/L1

.04

74

88

75

---

---

---

70

- 1

30

86

3.5

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

1:3

7T

rue

MG

K 2

64 iso

mer

b525.2

0.1

CC

C1

.82

20

ug

/L1

.04

74

88

75

---

---

---

70

- 1

30

12

11

.5

10

/13

/20

20

08

:06

10

/14

/20

20

21

:37

Tru

e

MG

K 3

26

525.2

0.1

CC

C5

.23

50

ug

/L1

.04

74

88

75

---

---

---

70

- 1

31

10

55

.0

10

/13

/20

20

08

:06

10

/14

/20

20

21

:37

Tru

e

Molin

ate

525.2

0.1

CC

C5

.11

40

ug

/L1

.04

74

88

75

---

---

---

70

- 1

30

10

25

.0

10

/13

/20

20

08

:06

10

/14

/20

20

21

:37

Tru

e

Pebula

te525.2

0.1

CC

C4

.44

60

ug

/L1

.04

74

88

75

---

---

---

70

- 1

30

89

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

1:3

7T

rue

Pendim

eth

alin

525.2

0.1

CC

C5

.19

90

ug

/L1

.04

74

88

75

---

---

---

70

- 1

32

10

45

.0

10

/13

/20

20

08

:06

10

/14

/20

20

21

:37

Tru

e

cis-

Perm

eth

rin

525.2

0.1

CC

C4

.89

00

ug

/L1

.04

74

88

75

---

---

---

70

- 1

30

98

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

1:3

7T

rue

trans-

Perm

eth

rin

525.2

0.1

CC

C5

.83

40

ug

/L1

.04

74

88

75

---

---

---

70

- 1

30

11

75

.0

10

/13

/20

20

08

:06

10

/14

/20

20

21

:37

Tru

e

Pro

flura

lin525.2

0.1

CC

C4

.87

70

ug

/L1

.04

74

88

75

---

---

---

70

- 1

30

98

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

1:3

7T

rue

Pro

metr

yn525.2

0.1

CC

C5

.17

60

ug

/L1

.04

74

88

75

---

---

---

70

- 1

30

10

45

.0

10

/13

/20

20

08

:06

10

/14

/20

20

21

:37

Tru

e

Sim

etr

yn525.2

0.1

CC

C5

.15

70

ug

/L1

.04

74

88

75

---

---

---

70

- 1

30

10

35

.0

10

/13

/20

20

08

:06

10

/14

/20

20

21

:37

Tru

e

Terb

utr

yn525.2

0.1

CC

C5

.21

90

ug

/L1

.04

74

88

75

---

---

---

70

- 1

30

10

45

.0

10

/13

/20

20

08

:06

10

/14

/20

20

21

:37

Tru

e

Tri

adim

efo

n525.2

0.5

CC

C4

.91

40

ug

/L1

.04

74

88

75

---

---

---

70

- 1

30

98

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

1:3

7F

als

e

IS-C

hry

sene-d

12

525.2

N/A

CC

C7

00

44

8ug

/L1

.04

74

88

76

---

---

---

50

- 1

50

10

07

00

44

8

10

/13

/20

20

08

:06

10

/14

/20

20

22

:19

Fals

e

IS-P

henanth

rene-d

10

525.2

N/A

CC

C1

04

30

00

ug

/L1

.04

74

88

76

---

---

---

50

- 1

50

10

01

04

30

00

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

IS-P

yrene-d

10

525.2

N/A

CC

C7

32

27

4ug

/L1

.04

74

88

76

---

---

---

50

- 1

50

10

07

32

27

4

10

/13

/20

20

08

:06

10

/14

/20

20

22

:19

Fals

e

SS

-4,4

'-D

ichlo

robip

henyl

525.2

N/A

CC

C4

.85

70

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

97

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

SS

-2,4

,5,6

-Tetr

ach

loro

-m-x

ylene

525.2

N/A

CC

C4

.70

30

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

94

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

SS

-Tri

phenyl

phosp

hate

525.2

N/A

CC

C5

.34

90

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

10

75

.0

10

/13

/20

20

08

:06

10

/14

/20

20

22

:19

Fals

e

Ace

toch

lor

525.2

0.1

CC

C4

.50

10

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

90

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Ala

chlo

r525.2

0.1

CC

C4

.44

80

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

89

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Ald

rin

525.2

0.1

CC

C4

.70

70

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

94

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Am

etr

yn525.2

0.1

CC

C4

.80

40

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

96

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Asp

on

525.2

0.1

CC

C4

.37

10

ug

/L1

.04

74

88

76

---

---

---

69

- 1

30

87

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Atr

ato

n525.2

0.1

CC

C4

.70

60

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

94

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Atr

azi

ne

525.2

0.1

CC

C4

.54

90

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

91

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Azi

nphos-

meth

yl525.2

0.5

CC

C3

.65

70

ug

/L1

.04

74

88

76

---

---

---

70

- 1

51

73

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Benflura

lin525.2

0.1

CC

C5

.14

10

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

10

35

.0

10

/13

/20

20

08

:06

10

/14

/20

20

22

:19

Fals

e

Benzo

(a)p

yrene

525.2

0.0

2C

CC

4.9

70

0ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

99

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

gam

ma-B

HC

(Lin

dane)

525.2

0.0

2C

CC

4.0

51

0ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

81

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Bols

tar

525.2

0.1

CC

C4

.60

00

ug

/L1

.04

74

88

76

---

---

---

70

- 1

32

92

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Bro

maci

l525.2

0.1

CC

C4

.74

30

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

95

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Buta

chlo

r525.2

0.1

CC

C4

.73

00

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

95

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Carb

oxi

n525.2

0.1

CC

C4

.99

30

ug

/L1

.04

74

88

76

---

---

---

60

- 1

82

10

05

.0

10

/13

/20

20

08

:06

10

/14

/20

20

22

:19

Fals

e

alp

ha-C

hlo

rda

ne

525.2

0.1

CC

C4

.92

10

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

98

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

gam

ma-C

hlo

rdane

525.2

0.1

CC

C4

.83

20

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

97

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Chlo

ropro

pyl

ate

525.2

0.1

CC

C4

.49

80

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

90

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Chlo

roth

alo

nil

525.2

0.1

CC

C4

.78

70

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

96

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Chlo

rpro

pham

525.2

0.1

CC

C5

.21

20

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

10

45

.0

10

/13

/20

20

08

:06

10

/14

/20

20

22

:19

Page 3

0 o

f 32

EE

A R

un I

D 2

80992 /

EE

A R

eport

# 5

00223

Page 149 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Fals

e

Chlo

rpyr

ifos

525.2

0.1

CC

C4

.57

50

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

92

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Clo

mazo

ne

525.2

0.1

CC

C4

.53

60

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

91

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Coum

aphos

525.2

0.1

CC

C4

.20

90

ug

/L1

.04

74

88

76

---

---

---

67

- 1

65

84

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Cya

nazi

ne

525.2

0.1

CC

C4

.36

80

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

87

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

4,4

'-D

DT

525.2

0.1

CC

C4

.85

00

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

97

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Desi

sopro

pyl

atr

azi

ne

525.2

1.0

CC

C4

.04

00

ug

/L1

.04

74

88

76

---

---

---

62

- 1

30

81

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Dic

hlo

benil

525.2

0.1

CC

C4

.50

30

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

90

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Die

ldri

n525.2

0.1

CC

C4

.91

50

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

98

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Di(

2-e

thyl

hexy

l)a

dip

ate

525.2

0.6

CC

C4

.66

00

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

93

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Di(

2-e

thyl

hexy

l)phth

ala

te525.2

0.6

CC

C4

.78

80

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

96

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Dim

eth

oate

525.2

0.5

CC

C4

.36

40

ug

/L1

.04

74

88

76

---

---

---

62

- 1

31

87

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

2,4

-Din

itro

tolu

ene

525.2

0.5

CC

C4

.73

70

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

95

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

2,6

-Din

itro

tolu

ene

525.2

0.5

CC

C4

.63

40

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

93

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Dip

henam

id525.2

0.1

CC

C4

.49

90

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

90

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Dis

ulfoto

n s

ulfone

525.2

0.1

CC

C4

.46

70

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

89

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Endri

n525.2

0.0

1C

CC

5.0

48

0ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

10

15

.0

10

/13

/20

20

08

:06

10

/14

/20

20

22

:19

Fals

e

Eth

alflu

ralin

525.2

0.1

CC

C4

.72

20

ug

/L1

.04

74

88

76

---

---

---

70

- 1

36

94

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Eth

ion

525.2

5.0

CC

C4

.67

70

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

94

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Eth

ofu

mesa

te525.2

0.5

CC

C4

.34

20

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

87

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Eth

opro

p525.2

0.1

CC

C3

.96

70

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

79

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Etr

idia

zole

525.2

0.1

CC

C4

.83

00

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

97

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Fam

phur

525.2

0.1

CC

C4

.18

20

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

84

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Fenam

iphos

525.2

0.1

CC

C4

.68

90

ug

/L1

.04

74

88

76

---

---

---

61

- 2

34

94

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Flu

azi

fop-b

uty

l525.2

0.1

CC

C4

.76

00

ug

/L1

.04

74

88

76

---

---

---

66

- 1

40

95

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Flu

om

etu

ron

525.2

0.5

CC

C2

.90

20

ug

/L1

.04

74

88

76

---

---

---

42

- 1

59

58

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Hepta

chlo

r525.2

0.0

4C

CC

3.6

86

0ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

74

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Hepta

chlo

r epo

xide

525.2

0.0

2C

CC

4.5

38

0ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

91

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Hexa

chlo

robenze

ne

525.2

0.1

CC

C4

.94

50

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

99

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Hexa

chlo

rocy

clope

nta

die

ne

525.2

0.1

CC

C4

.59

90

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

92

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Hexa

zinone

525.2

0.1

CC

C4

.96

80

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

99

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Isophoro

ne

525.2

0.1

CC

C4

.37

80

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

88

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Mala

thio

n525.2

0.1

CC

C4

.07

80

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

82

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Meth

oxy

chlo

r525.2

0.1

CC

C4

.94

20

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

99

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

1-M

eth

ylnaphth

ale

ne

525.2

0.1

CC

C5

.10

80

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

10

25

.0

10

/13

/20

20

08

:06

10

/14

/20

20

22

:19

Fals

e

Meth

yl p

ara

oxo

n525.2

0.5

CC

C4

.20

60

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

84

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Meto

lach

lor

525.2

0.1

CC

C4

.58

30

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

92

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Metr

ibuzi

n525.2

0.1

CC

C4

.65

70

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

93

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Mevi

nphos

525.2

0.1

CC

C4

.96

30

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

99

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Naphth

ale

ne

525.2

0.1

CC

C4

.82

70

ug

/L1

.04

74

88

76

---

---

---

68

- 1

30

97

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Napro

pam

ide

525.2

0.1

CC

C4

.58

30

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

92

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

trans-

Nonach

lor

525.2

0.1

CC

C5

.03

00

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

10

15

.0

10

/13

/20

20

08

:06

10

/14

/20

20

22

:19

Page 3

1 o

f 32

EE

A R

un I

D 2

80992 /

EE

A R

eport

# 5

00223

Page 150 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Fals

e

Oxa

dia

zon

525.2

0.1

CC

C4

.95

10

ug

/L1

.04

74

88

76

---

---

---

58

- 1

30

99

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Penta

chlo

ronitro

be

nze

ne

525.2

0.5

CC

C5

.07

40

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

10

15

.0

10

/13

/20

20

08

:06

10

/14

/20

20

22

:19

Fals

e

Phora

te525.2

0.1

CC

C4

.64

30

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

93

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Pro

meto

n525.2

1.0

CC

C4

.75

10

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

95

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Pro

nam

ide

525.2

0.1

CC

C4

.55

50

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

91

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Pro

pach

lor

525.2

0.1

CC

C4

.80

20

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

96

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Pro

panil

525.2

0.5

CC

C4

.43

70

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

89

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Pro

pazi

ne

525.2

0.1

CC

C4

.28

40

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

86

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Sim

azi

ne

525.2

0.0

7C

CC

3.9

99

0ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

80

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Stiro

fos

525.2

0.1

CC

C4

.73

40

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

95

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Terb

aci

l525.2

0.1

CC

C4

.25

00

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

85

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Terb

ufo

s525.2

0.5

CC

C5

.25

50

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

10

55

.0

10

/13

/20

20

08

:06

10

/14

/20

20

22

:19

Fals

e

Thio

benca

rb525.2

0.1

CC

C4

.45

90

ug

/L1

.04

74

88

76

---

---

---

63

- 1

30

89

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9F

als

e

Tri

flura

lin525.2

0.1

CC

C5

.10

00

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

10

25

.0

10

/13

/20

20

08

:06

10

/14

/20

20

22

:19

Fals

e

Vern

ola

te525.2

0.1

CC

C4

.45

50

ug

/L1

.04

74

88

76

---

---

---

70

- 1

30

89

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

4/2

02

0 2

2:1

9T

rue

MG

K 2

64 iso

mer

b525.2

0.1

LF

B1

.93

60

ug

/L1

.04

74

86

06

---

---

---

70

- 1

30

12

91

.5

10

/13

/20

20

08

:06

10

/14

/20

20

23

:01

Page 3

2 o

f 32

EE

A R

un I

D 2

80992 /

EE

A R

eport

# 5

00223

Page 151 of 201

Eu

rofi

ns

Ea

ton

An

aly

tica

lR

un

Lo

gR

un ID

:281054

Meth

od:

525.2

Sam

ple

Sit

eS

am

ple

Id

Typ

eIn

str

um

en

t ID

Cali

bra

tio

n F

ile

An

aly

sis

Date

Matr

ix

CC

C4

75

03

40

DO

52

5 2

-DO

-11

21

19

a.m

th1

0/1

5/2

02

0 0

9:2

7O

S

FS

47

43

53

6F

inis

he

dD

O5

25

2-D

O-1

12

11

9a

.mth

10

/15

/20

20

10

:51

DW

FD

47

48

60

9F

inis

he

dD

O5

25

2-D

O-1

12

11

9a

.mth

10

/15

/20

20

11

:33

DW

0.0

0

Page 1

of

2E

EA

Run I

D 2

81054 /

EE

A R

eport

# 5

00223

Page 152 of 201

QC

Su

mm

ary

Re

po

rt

EE

AID

#R

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

eth

od

An

aly

teS

am

ple

Typ

eD

ilF

ac

tor

RP

DL

imit

Re

co

ve

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

gM

RL

Ex

tra

cte

dA

na

lyze

d

Tru

e

Penta

chlo

rophenol

525.2

1.0

CC

C3

.79

30

ug

/L1

.04

75

03

40

---

---

---

70

- 1

30

76

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

5/2

02

0 0

9:2

7F

als

e

Penta

chlo

rophenol

525.2

1.0

FS

1.0

ug

/L0

.97

47

43

53

6F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

5/2

02

0 1

0:5

1T

rue

IS-C

hry

sene-d

12

525.2

N/A

FD

76

80

75

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

-7

0 -

13

01

07

71

97

89

1

0/1

3/2

02

0 0

8:0

61

0/1

5/2

02

0 1

1:3

3T

rue

IS-P

henanth

rene-d

10

525.2

N/A

FD

10

66

00

0ug

/L0

.97

47

48

60

9F

inis

he

d--

---

-7

0 -

13

01

05

10

14

00

0

10

/13

/20

20

08

:06

10

/15

/20

20

11

:33

Tru

e

IS-P

yrene-d

10

525.2

N/A

FD

87

43

59

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

-7

0 -

13

01

13

77

37

15

1

0/1

3/2

02

0 0

8:0

61

0/1

5/2

02

0 1

1:3

3T

rue

SS

-4,4

'-D

ichlo

robip

henyl

525.2

N/A

FD

4.8

05

0ug

/L0

.97

47

48

60

9F

inis

he

d--

---

-7

0 -

13

09

95

.0

10

/13

/20

20

08

:06

10

/15

/20

20

11

:33

Tru

e

SS

-2,4

,5,6

-Tetr

ach

loro

-m-x

ylene

525.2

N/A

FD

4.6

40

0ug

/L0

.97

47

48

60

9F

inis

he

d--

---

-7

0 -

13

09

65

.0

10

/13

/20

20

08

:06

10

/15

/20

20

11

:33

Tru

e

SS

-Tri

phenyl

phosp

hate

525.2

N/A

FD

5.3

39

0ug

/L0

.97

47

48

60

9F

inis

he

d--

---

-7

0 -

13

01

10

5.0

1

0/1

3/2

02

0 0

8:0

61

0/1

5/2

02

0 1

1:3

3T

rue

Penta

chlo

rophenol

525.2

1.0

FD

1.0

ug

/L0

.97

47

48

60

9F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:0

61

0/1

5/2

02

0 1

1:3

3

Page 2

of

2E

EA

Run I

D 2

81054 /

EE

A R

eport

# 5

00223

Page 153 of 201

Eu

rofi

ns

Ea

ton

An

aly

tica

lR

un

Lo

gR

un ID

:281380

Meth

od:

531.2

LL

Sam

ple

Sit

eS

am

ple

Id

Typ

eIn

str

um

en

t ID

Cali

bra

tio

n F

ile

An

aly

sis

Date

Matr

ix

CC

L4

75

82

51

DR

LL

_5

31

_2

_1

02

32

0D

R1

0/2

3/2

02

0 1

5:5

2R

W

LM

B4

75

82

49

DR

LL

_5

31

_2

_1

02

32

0D

R1

0/2

3/2

02

0 1

6:2

3R

W

FS

47

43

54

5F

inis

he

dD

RL

L_

53

1_

2_

10

23

20

DR

10

/23

/20

20

16

:54

DW

MS

47

58

24

7F

inis

he

dD

RL

L_

53

1_

2_

10

23

20

DR

10

/23

/20

20

17

:25

DW

MS

D4

75

82

48

Fin

ish

ed

DR

LL

_5

31

_2

_1

02

32

0D

R1

0/2

3/2

02

0 1

7:5

6D

W

CC

M4

75

82

52

DR

LL

_5

31

_2

_1

02

32

0D

R1

0/2

3/2

02

0 1

8:2

7R

W

0.0

0

Page 1

of

3E

EA

Run I

D 2

81380 /

EE

A R

eport

# 5

00223

Page 154 of 201

QC

Su

mm

ary

Re

po

rt

EE

AID

#R

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

eth

od

An

aly

teS

am

ple

Typ

eD

ilF

ac

tor

RP

DL

imit

Re

co

ve

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

gM

RL

Ex

tra

cte

dA

na

lyze

d

Tru

e

SS

-BD

MC

531.2

LL

N/A

CC

L1

.69

90

ug

/L1

.04

75

82

51

---

---

---

70

- 1

30

85

2.0

1

0/2

2/2

02

0 0

9:1

01

0/2

3/2

02

0 1

5:5

2T

rue

Ald

icarb

531.2

LL

0.1

CC

L0

.11

00

ug

/L1

.04

75

82

51

---

---

---

50

- 1

50

11

00

.1

10

/22

/20

20

09

:10

10

/23

/20

20

15

:52

Tru

e

Ald

icarb

sulfone

531.2

LL

0.1

CC

L0

.11

40

ug

/L1

.04

75

82

51

---

---

---

50

- 1

50

11

40

.1

10

/22

/20

20

09

:10

10

/23

/20

20

15

:52

Tru

e

Ald

icarb

sulfoxi

de

531.2

LL

0.1

CC

L0

.12

80

ug

/L1

.04

75

82

51

---

---

---

50

- 1

50

12

80

.1

10

/22

/20

20

09

:10

10

/23

/20

20

15

:52

Tru

e

Bayg

on

531.2

LL

0.1

CC

L0

.11

10

ug

/L1

.04

75

82

51

---

---

---

50

- 1

50

11

10

.1

10

/22

/20

20

09

:10

10

/23

/20

20

15

:52

Tru

e

Carb

ary

l531.2

LL

0.1

CC

L0

.12

00

ug

/L1

.04

75

82

51

---

---

---

50

- 1

50

12

00

.1

10

/22

/20

20

09

:10

10

/23

/20

20

15

:52

Tru

e

Carb

ofu

ran

531.2

LL

0.1

CC

L0

.11

90

ug

/L1

.04

75

82

51

---

---

---

50

- 1

50

11

90

.1

10

/22

/20

20

09

:10

10

/23

/20

20

15

:52

Tru

e

3-H

ydro

xyca

rbofu

ran

531.2

LL

0.1

CC

L0

.09

90

ug

/L1

.04

75

82

51

---

---

---

50

- 1

50

99

0.1

1

0/2

2/2

02

0 0

9:1

01

0/2

3/2

02

0 1

5:5

2T

rue

Meth

ioca

rb531.2

LL

1.0

CC

L0

.10

80

ug

/L1

.04

75

82

51

---

---

---

50

- 1

50

10

80

.1

10

/22

/20

20

09

:10

10

/23

/20

20

15

:52

Tru

e

Meth

om

yl531.2

LL

0.1

CC

L0

.11

40

ug

/L1

.04

75

82

51

---

---

---

50

- 1

50

11

40

.1

10

/22

/20

20

09

:10

10

/23

/20

20

15

:52

Tru

e

1-N

aphth

ol

531.2

LL

1.0

CC

L0

.07

00

ug

/L1

.04

75

82

51

---

---

---

50

- 1

50

70

0.1

1

0/2

2/2

02

0 0

9:1

01

0/2

3/2

02

0 1

5:5

2T

rue

Oxa

myl

531.2

LL

0.1

CC

L0

.09

70

ug

/L1

.04

75

82

51

---

---

---

50

- 1

50

97

0.1

1

0/2

2/2

02

0 0

9:1

01

0/2

3/2

02

0 1

5:5

2F

als

e

SS

-BD

MC

531.2

LL

N/A

LM

B1

.73

50

ug

/L1

.04

75

82

49

---

---

---

70

- 1

30

87

2.0

1

0/2

2/2

02

0 0

9:1

01

0/2

3/2

02

0 1

6:2

3F

als

e

Ald

icarb

531.2

LL

0.1

LM

B0

.1ug

/L1

.04

75

82

49

---

---

---

---

---

<

10

/22

/20

20

09

:10

10

/23

/20

20

16

:23

Fals

e

Ald

icarb

sulfone

531.2

LL

0.1

LM

B0

.1ug

/L1

.04

75

82

49

---

---

---

---

---

<

10

/22

/20

20

09

:10

10

/23

/20

20

16

:23

Fals

e

Ald

icarb

sulfoxi

de

531.2

LL

0.1

LM

B0

.1ug

/L1

.04

75

82

49

---

---

---

---

---

<

10

/22

/20

20

09

:10

10

/23

/20

20

16

:23

Fals

e

Bayg

on

531.2

LL

0.1

LM

B0

.1ug

/L1

.04

75

82

49

---

---

---

---

---

<

10

/22

/20

20

09

:10

10

/23

/20

20

16

:23

Fals

e

Carb

ary

l531.2

LL

0.1

LM

B0

.1ug

/L1

.04

75

82

49

---

---

---

---

---

<

10

/22

/20

20

09

:10

10

/23

/20

20

16

:23

Fals

e

Carb

ofu

ran

531.2

LL

0.1

LM

B0

.1ug

/L1

.04

75

82

49

---

---

---

---

---

<

10

/22

/20

20

09

:10

10

/23

/20

20

16

:23

Fals

e

3-H

ydro

xyca

rbofu

ran

531.2

LL

0.1

LM

B0

.1ug

/L1

.04

75

82

49

---

---

---

---

---

<

10

/22

/20

20

09

:10

10

/23

/20

20

16

:23

Fals

e

Meth

ioca

rb531.2

LL

1.0

LM

B1

.0ug

/L1

.04

75

82

49

---

---

---

---

---

<

10

/22

/20

20

09

:10

10

/23

/20

20

16

:23

Fals

e

Meth

om

yl531.2

LL

0.1

LM

B0

.1ug

/L1

.04

75

82

49

---

---

---

---

---

<

10

/22

/20

20

09

:10

10

/23

/20

20

16

:23

Fals

e

1-N

aphth

ol

531.2

LL

1.0

LM

B1

.0ug

/L1

.04

75

82

49

---

---

---

---

---

<

10

/22

/20

20

09

:10

10

/23

/20

20

16

:23

Fals

e

Oxa

myl

531.2

LL

0.1

LM

B0

.1ug

/L1

.04

75

82

49

---

---

---

---

---

<

10

/22

/20

20

09

:10

10

/23

/20

20

16

:23

Tru

e

SS

-BD

MC

531.2

LL

N/A

FS

1.7

67

0ug

/L1

.04

74

35

45

Fin

ishe

d--

---

-7

0 -

13

08

82

.0

10

/22

/20

20

09

:10

10

/23

/20

20

16

:54

Tru

e

Ald

icarb

531.2

LL

0.1

FS

0.1

ug

/L1

.04

74

35

45

Fin

ishe

d--

---

---

---

-

<1

0/2

2/2

02

0 0

9:1

01

0/2

3/2

02

0 1

6:5

4T

rue

Ald

icarb

sulfone

531.2

LL

0.1

FS

0.1

ug

/L1

.04

74

35

45

Fin

ishe

d--

---

---

---

-

<1

0/2

2/2

02

0 0

9:1

01

0/2

3/2

02

0 1

6:5

4T

rue

Ald

icarb

sulfoxi

de

531.2

LL

0.1

FS

0.1

ug

/L1

.04

74

35

45

Fin

ishe

d--

---

---

---

-

<1

0/2

2/2

02

0 0

9:1

01

0/2

3/2

02

0 1

6:5

4T

rue

Bayg

on

531.2

LL

0.1

FS

0.1

ug

/L1

.04

74

35

45

Fin

ishe

d--

---

---

---

-

<1

0/2

2/2

02

0 0

9:1

01

0/2

3/2

02

0 1

6:5

4T

rue

Carb

ary

l531.2

LL

0.1

FS

0.1

ug

/L1

.04

74

35

45

Fin

ishe

d--

---

---

---

-

<1

0/2

2/2

02

0 0

9:1

01

0/2

3/2

02

0 1

6:5

4T

rue

Carb

ofu

ran

531.2

LL

0.1

FS

0.1

ug

/L1

.04

74

35

45

Fin

ishe

d--

---

---

---

-

<1

0/2

2/2

02

0 0

9:1

01

0/2

3/2

02

0 1

6:5

4T

rue

3-H

ydro

xyca

rbofu

ran

531.2

LL

0.1

FS

0.1

ug

/L1

.04

74

35

45

Fin

ishe

d--

---

---

---

-

<1

0/2

2/2

02

0 0

9:1

01

0/2

3/2

02

0 1

6:5

4T

rue

Meth

ioca

rb531.2

LL

1.0

FS

1.0

ug

/L1

.04

74

35

45

Fin

ishe

d--

---

---

---

-

<1

0/2

2/2

02

0 0

9:1

01

0/2

3/2

02

0 1

6:5

4T

rue

Meth

om

yl531.2

LL

0.1

FS

0.1

ug

/L1

.04

74

35

45

Fin

ishe

d--

---

---

---

-

<1

0/2

2/2

02

0 0

9:1

01

0/2

3/2

02

0 1

6:5

4T

rue

1-N

aphth

ol

531.2

LL

1.0

FS

1.0

ug

/L1

.04

74

35

45

Fin

ishe

d--

---

---

---

-

<1

0/2

2/2

02

0 0

9:1

01

0/2

3/2

02

0 1

6:5

4T

rue

Oxa

myl

531.2

LL

0.1

FS

0.1

ug

/L1

.04

74

35

45

Fin

ishe

d--

---

---

---

-

<1

0/2

2/2

02

0 0

9:1

01

0/2

3/2

02

0 1

6:5

4F

als

e

SS

-BD

MC

531.2

LL

N/A

MS

1.7

98

0ug

/L1

.04

75

82

47

Fin

ishe

d--

---

-7

0 -

13

09

02

.0

10

/22

/20

20

09

:10

10

/23

/20

20

17

:25

Fals

e

Ald

icarb

531.2

LL

0.1

MS

2.3

44

0ug

/L1

.04

75

82

47

Fin

ishe

d--

---

-7

0 -

13

01

17

2.0

1

0/2

2/2

02

0 0

9:1

01

0/2

3/2

02

0 1

7:2

5F

als

e

Ald

icarb

sulfone

531.2

LL

0.1

MS

2.3

09

0ug

/L1

.04

75

82

47

Fin

ishe

d--

---

-7

0 -

13

01

15

2.0

1

0/2

2/2

02

0 0

9:1

01

0/2

3/2

02

0 1

7:2

5F

als

e

Ald

icarb

sulfoxi

de

531.2

LL

0.1

MS

2.2

91

0ug

/L1

.04

75

82

47

Fin

ishe

d--

---

-7

0 -

13

01

15

2.0

1

0/2

2/2

02

0 0

9:1

01

0/2

3/2

02

0 1

7:2

5

Page 2

of

3E

EA

Run I

D 2

81380 /

EE

A R

eport

# 5

00223

Page 155 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Fals

e

Bayg

on

531.2

LL

0.1

MS

2.3

56

0ug

/L1

.04

75

82

47

Fin

ishe

d--

---

-7

0 -

13

01

18

2.0

1

0/2

2/2

02

0 0

9:1

01

0/2

3/2

02

0 1

7:2

5F

als

e

Carb

ary

l531.2

LL

0.1

MS

2.3

42

0ug

/L1

.04

75

82

47

Fin

ishe

d--

---

-7

0 -

13

01

17

2.0

1

0/2

2/2

02

0 0

9:1

01

0/2

3/2

02

0 1

7:2

5F

als

e

Carb

ofu

ran

531.2

LL

0.1

MS

2.3

53

0ug

/L1

.04

75

82

47

Fin

ishe

d--

---

-7

0 -

13

01

18

2.0

1

0/2

2/2

02

0 0

9:1

01

0/2

3/2

02

0 1

7:2

5F

als

e

3-H

ydro

xyca

rbofu

ran

531.2

LL

0.1

MS

2.2

92

0ug

/L1

.04

75

82

47

Fin

ishe

d--

---

-7

0 -

13

01

15

2.0

1

0/2

2/2

02

0 0

9:1

01

0/2

3/2

02

0 1

7:2

5F

als

e

Meth

ioca

rb531.2

LL

1.0

MS

2.3

27

0ug

/L1

.04

75

82

47

Fin

ishe

d--

---

-7

0 -

13

01

16

2.0

1

0/2

2/2

02

0 0

9:1

01

0/2

3/2

02

0 1

7:2

5F

als

e

Meth

om

yl531.2

LL

0.1

MS

2.3

32

0ug

/L1

.04

75

82

47

Fin

ishe

d--

---

-7

0 -

13

01

17

2.0

1

0/2

2/2

02

0 0

9:1

01

0/2

3/2

02

0 1

7:2

5F

als

e

1-N

aphth

ol

531.2

LL

1.0

MS

2.3

96

0ug

/L1

.04

75

82

47

Fin

ishe

d--

---

-7

0 -

13

01

20

2.0

1

0/2

2/2

02

0 0

9:1

01

0/2

3/2

02

0 1

7:2

5F

als

e

Oxa

myl

531.2

LL

0.1

MS

2.2

73

0ug

/L1

.04

75

82

47

Fin

ishe

d--

---

-7

0 -

13

01

14

2.0

1

0/2

2/2

02

0 0

9:1

01

0/2

3/2

02

0 1

7:2

5T

rue

SS

-BD

MC

531.2

LL

N/A

MS

D1

.78

70

ug

/L1

.04

75

82

48

Fin

ishe

d--

---

-7

0 -

13

08

92

.0

10

/22

/20

20

09

:10

10

/23

/20

20

17

:56

Tru

e

Ald

icarb

531.2

LL

0.1

MS

D2

.32

50

ug

/L1

.04

75

82

48

Fin

ishe

d3

00

.87

0 -

13

01

16

2.0

1

0/2

2/2

02

0 0

9:1

01

0/2

3/2

02

0 1

7:5

6T

rue

Ald

icarb

sulfone

531.2

LL

0.1

MS

D2

.28

80

ug

/L1

.04

75

82

48

Fin

ishe

d3

00

.97

0 -

13

01

14

2.0

1

0/2

2/2

02

0 0

9:1

01

0/2

3/2

02

0 1

7:5

6T

rue

Ald

icarb

sulfoxi

de

531.2

LL

0.1

MS

D2

.28

10

ug

/L1

.04

75

82

48

Fin

ishe

d3

00

.47

0 -

13

01

14

2.0

1

0/2

2/2

02

0 0

9:1

01

0/2

3/2

02

0 1

7:5

6T

rue

Bayg

on

531.2

LL

0.1

MS

D2

.34

20

ug

/L1

.04

75

82

48

Fin

ishe

d3

00

.67

0 -

13

01

17

2.0

1

0/2

2/2

02

0 0

9:1

01

0/2

3/2

02

0 1

7:5

6T

rue

Carb

ary

l531.2

LL

0.1

MS

D2

.32

50

ug

/L1

.04

75

82

48

Fin

ishe

d3

00

.77

0 -

13

01

16

2.0

1

0/2

2/2

02

0 0

9:1

01

0/2

3/2

02

0 1

7:5

6T

rue

Carb

ofu

ran

531.2

LL

0.1

MS

D2

.32

80

ug

/L1

.04

75

82

48

Fin

ishe

d3

01

.17

0 -

13

01

16

2.0

1

0/2

2/2

02

0 0

9:1

01

0/2

3/2

02

0 1

7:5

6T

rue

3-H

ydro

xyca

rbofu

ran

531.2

LL

0.1

MS

D2

.29

80

ug

/L1

.04

75

82

48

Fin

ishe

d3

00

.37

0 -

13

01

15

2.0

1

0/2

2/2

02

0 0

9:1

01

0/2

3/2

02

0 1

7:5

6T

rue

Meth

ioca

rb531.2

LL

1.0

MS

D2

.30

60

ug

/L1

.04

75

82

48

Fin

ishe

d3

00

.97

0 -

13

01

15

2.0

1

0/2

2/2

02

0 0

9:1

01

0/2

3/2

02

0 1

7:5

6T

rue

Meth

om

yl531.2

LL

0.1

MS

D2

.32

10

ug

/L1

.04

75

82

48

Fin

ishe

d3

00

.57

0 -

13

01

16

2.0

1

0/2

2/2

02

0 0

9:1

01

0/2

3/2

02

0 1

7:5

6T

rue

1-N

aphth

ol

531.2

LL

1.0

MS

D2

.37

60

ug

/L1

.04

75

82

48

Fin

ishe

d3

00

.87

0 -

13

01

19

2.0

1

0/2

2/2

02

0 0

9:1

01

0/2

3/2

02

0 1

7:5

6T

rue

Oxa

myl

531.2

LL

0.1

MS

D2

.26

20

ug

/L1

.04

75

82

48

Fin

ishe

d3

00

.57

0 -

13

01

13

2.0

1

0/2

2/2

02

0 0

9:1

01

0/2

3/2

02

0 1

7:5

6F

als

e

SS

-BD

MC

531.2

LL

N/A

CC

M1

.76

30

ug

/L1

.04

75

82

52

---

---

---

70

- 1

30

88

2.0

1

0/2

2/2

02

0 0

9:1

01

0/2

3/2

02

0 1

8:2

7F

als

e

Ald

icarb

531.2

LL

0.1

CC

M2

.24

30

ug

/L1

.04

75

82

52

---

---

---

70

- 1

30

11

22

.0

10

/22

/20

20

09

:10

10

/23

/20

20

18

:27

Fals

e

Ald

icarb

sulfone

531.2

LL

0.1

CC

M2

.24

60

ug

/L1

.04

75

82

52

---

---

---

70

- 1

30

11

22

.0

10

/22

/20

20

09

:10

10

/23

/20

20

18

:27

Fals

e

Ald

icarb

sulfoxi

de

531.2

LL

0.1

CC

M2

.24

80

ug

/L1

.04

75

82

52

---

---

---

70

- 1

30

11

22

.0

10

/22

/20

20

09

:10

10

/23

/20

20

18

:27

Fals

e

Bayg

on

531.2

LL

0.1

CC

M2

.27

50

ug

/L1

.04

75

82

52

---

---

---

70

- 1

30

11

42

.0

10

/22

/20

20

09

:10

10

/23

/20

20

18

:27

Fals

e

Carb

ary

l531.2

LL

0.1

CC

M2

.26

80

ug

/L1

.04

75

82

52

---

---

---

70

- 1

30

11

32

.0

10

/22

/20

20

09

:10

10

/23

/20

20

18

:27

Fals

e

Carb

ofu

ran

531.2

LL

0.1

CC

M2

.29

70

ug

/L1

.04

75

82

52

---

---

---

70

- 1

30

11

52

.0

10

/22

/20

20

09

:10

10

/23

/20

20

18

:27

Fals

e

3-H

ydro

xyca

rbofu

ran

531.2

LL

0.1

CC

M2

.26

90

ug

/L1

.04

75

82

52

---

---

---

70

- 1

30

11

32

.0

10

/22

/20

20

09

:10

10

/23

/20

20

18

:27

Fals

e

Meth

ioca

rb531.2

LL

1.0

CC

M2

.28

10

ug

/L1

.04

75

82

52

---

---

---

70

- 1

30

11

42

.0

10

/22

/20

20

09

:10

10

/23

/20

20

18

:27

Fals

e

Meth

om

yl531.2

LL

0.1

CC

M2

.26

60

ug

/L1

.04

75

82

52

---

---

---

70

- 1

30

11

32

.0

10

/22

/20

20

09

:10

10

/23

/20

20

18

:27

Fals

e

1-N

aphth

ol

531.2

LL

1.0

CC

M2

.27

50

ug

/L1

.04

75

82

52

---

---

---

70

- 1

30

11

42

.0

10

/22

/20

20

09

:10

10

/23

/20

20

18

:27

Fals

e

Oxa

myl

531.2

LL

0.1

CC

M2

.23

90

ug

/L1

.04

75

82

52

---

---

---

70

- 1

30

11

22

.0

10

/22

/20

20

09

:10

10

/23

/20

20

18

:27

Page 3

of

3E

EA

Run I

D 2

81380 /

EE

A R

eport

# 5

00223

Page 156 of 201

Eu

rofi

ns

Ea

ton

An

aly

tica

lR

un

Lo

gR

un ID

:281025

Meth

od:

544

Sam

ple

Sit

eS

am

ple

Id

Typ

eIn

str

um

en

t ID

Cali

bra

tio

n F

ile

An

aly

sis

Date

Matr

ix

CC

L4

75

20

30

FL

10

16

20

M5

44

a.m

db

10

/16

/20

20

17

:29

OS

LR

B4

75

20

18

FL

10

16

20

M5

44

a.m

db

10

/16

/20

20

17

:59

RW

FB

L4

75

20

19

FL

10

16

20

M5

44

a.m

db

10

/16

/20

20

18

:15

RW

FS

47

43

53

1F

inis

he

dF

L1

01

62

0M

54

4a

.md

b1

0/1

6/2

02

0 1

9:1

6D

W

CC

M4

75

20

31

FL

10

16

20

M5

44

a.m

db

10

/16

/20

20

20

:33

OS

0.0

0

Page 1

of

3E

EA

Run I

D 2

81025 /

EE

A R

eport

# 5

00223

Page 157 of 201

QC

Su

mm

ary

Re

po

rt

EE

AID

#R

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

eth

od

An

aly

teS

am

ple

Typ

eD

ilF

ac

tor

RP

DL

imit

Re

co

ve

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

gM

RL

Ex

tra

cte

dA

na

lyze

d

Fals

e

SS

-C2D

5-M

C-L

R544

N/A

CC

L0

.09

75

ug

/L1

.04

75

20

30

---

---

---

70

- 1

30

97

0.1

1

0/1

6/2

02

0 1

0:5

81

0/1

6/2

02

0 1

7:2

9F

als

e

Mic

rocy

stin

-LA

544

0.0

08

CC

L0

.00

93

ug

/L1

.04

75

20

30

---

---

---

50

- 1

50

11

70

.00

8

10

/16

/20

20

10

:58

10

/16

/20

20

17

:29

Fals

e

Mic

rocy

stin

-LF

544

0.0

06

CC

L0

.00

66

ug

/L1

.04

75

20

30

---

---

---

50

- 1

50

10

90

.00

6

10

/16

/20

20

10

:58

10

/16

/20

20

17

:29

Fals

e

Mic

rocy

stin

-LR

544

0.0

20

CC

L0

.01

96

ug

/L1

.04

75

20

30

---

---

---

50

- 1

50

98

0.0

2

10

/16

/20

20

10

:58

10

/16

/20

20

17

:29

Fals

e

Mic

rocy

stin

-LY

544

0.0

09

CC

L0

.00

97

ug

/L1

.04

75

20

30

---

---

---

50

- 1

50

10

80

.00

9

10

/16

/20

20

10

:58

10

/16

/20

20

17

:29

Fals

e

Mic

rocy

stin

-RR

544

0.0

06

CC

L0

.00

54

ug

/L1

.04

75

20

30

---

---

---

50

- 1

50

90

0.0

06

1

0/1

6/2

02

0 1

0:5

81

0/1

6/2

02

0 1

7:2

9F

als

e

Mic

rocy

stin

-YR

544

0.0

20

CC

L0

.02

02

ug

/L1

.04

75

20

30

---

---

---

50

- 1

50

10

10

.02

1

0/1

6/2

02

0 1

0:5

81

0/1

6/2

02

0 1

7:2

9F

als

e

Nodula

rin

544

0.0

05

CC

L0

.00

52

ug

/L1

.04

75

20

30

---

---

---

50

- 1

50

10

50

.00

5

10

/16

/20

20

10

:58

10

/16

/20

20

17

:29

Tru

e

SS

-C2D

5-M

C-L

R544

N/A

LR

B0

.09

45

ug

/L1

.04

75

20

18

---

---

---

60

- 1

30

94

0.1

1

0/1

6/2

02

0 0

7:3

01

0/1

6/2

02

0 1

7:5

9T

rue

Mic

rocy

stin

-LA

544

0.0

08

LR

B0

.00

8ug

/L1

.04

75

20

18

---

---

---

---

---

<

10

/16

/20

20

07

:30

10

/16

/20

20

17

:59

Tru

e

Mic

rocy

stin

-LF

544

0.0

06

LR

B0

.00

6ug

/L1

.04

75

20

18

---

---

---

---

---

<

10

/16

/20

20

07

:30

10

/16

/20

20

17

:59

Tru

e

Mic

rocy

stin

-LR

544

0.0

20

LR

B0

.02

0ug

/L1

.04

75

20

18

---

---

---

---

---

<

10

/16

/20

20

07

:30

10

/16

/20

20

17

:59

Tru

e

Mic

rocy

stin

-LY

544

0.0

09

LR

B0

.00

9ug

/L1

.04

75

20

18

---

---

---

---

---

<

10

/16

/20

20

07

:30

10

/16

/20

20

17

:59

Tru

e

Mic

rocy

stin

-RR

544

0.0

06

LR

B0

.00

6ug

/L1

.04

75

20

18

---

---

---

---

---

<

10

/16

/20

20

07

:30

10

/16

/20

20

17

:59

Tru

e

Mic

rocy

stin

-YR

544

0.0

20

LR

B0

.02

0ug

/L1

.04

75

20

18

---

---

---

---

---

<

10

/16

/20

20

07

:30

10

/16

/20

20

17

:59

Tru

e

Nodula

rin

544

0.0

05

LR

B0

.00

5ug

/L1

.04

75

20

18

---

---

---

---

---

<

10

/16

/20

20

07

:30

10

/16

/20

20

17

:59

Fals

e

SS

-C2D

5-M

C-L

R544

N/A

FB

L0

.09

01

ug

/L1

.04

75

20

19

---

---

---

60

- 1

30

90

0.1

1

0/1

6/2

02

0 0

7:3

01

0/1

6/2

02

0 1

8:1

5F

als

e

Mic

rocy

stin

-LA

544

0.0

08

FB

L0

.00

89

ug

/L1

.04

75

20

19

---

---

---

50

- 1

50

11

20

.00

8

10

/16

/20

20

07

:30

10

/16

/20

20

18

:15

Fals

e

Mic

rocy

stin

-LF

544

0.0

06

FB

L0

.00

60

ug

/L1

.04

75

20

19

---

---

---

50

- 1

50

10

10

.00

6

10

/16

/20

20

07

:30

10

/16

/20

20

18

:15

Fals

e

Mic

rocy

stin

-LR

544

0.0

20

FB

L0

.01

81

ug

/L1

.04

75

20

19

---

---

---

50

- 1

50

91

0.0

2

10

/16

/20

20

07

:30

10

/16

/20

20

18

:15

Fals

e

Mic

rocy

stin

-LY

544

0.0

09

FB

L0

.00

97

ug

/L1

.04

75

20

19

---

---

---

50

- 1

50

10

80

.00

9

10

/16

/20

20

07

:30

10

/16

/20

20

18

:15

Fals

e

Mic

rocy

stin

-RR

544

0.0

06

FB

L0

.00

67

ug

/L1

.04

75

20

19

---

---

---

50

- 1

50

11

10

.00

6

10

/16

/20

20

07

:30

10

/16

/20

20

18

:15

Fals

e

Mic

rocy

stin

-YR

544

0.0

20

FB

L0

.01

81

ug

/L1

.04

75

20

19

---

---

---

50

- 1

50

91

0.0

2

10

/16

/20

20

07

:30

10

/16

/20

20

18

:15

Fals

e

Nodula

rin

544

0.0

05

FB

L0

.00

48

ug

/L1

.04

75

20

19

---

---

---

50

- 1

50

97

0.0

05

1

0/1

6/2

02

0 0

7:3

01

0/1

6/2

02

0 1

8:1

5T

rue

SS

-C2D

5-M

C-L

R544

N/A

FS

0.0

93

0ug

/L0

.93

47

43

53

1F

inis

he

d--

---

-6

0 -

13

01

00

0.1

1

0/1

6/2

02

0 0

7:3

01

0/1

6/2

02

0 1

9:1

6T

rue

Mic

rocy

stin

-LA

544

0.0

08

FS

0.0

08

ug

/L0

.93

47

43

53

1F

inis

he

d--

---

---

---

-

<1

0/1

6/2

02

0 0

7:3

01

0/1

6/2

02

0 1

9:1

6T

rue

Mic

rocy

stin

-LF

544

0.0

06

FS

0.0

06

ug

/L0

.93

47

43

53

1F

inis

he

d--

---

---

---

-

<1

0/1

6/2

02

0 0

7:3

01

0/1

6/2

02

0 1

9:1

6T

rue

Mic

rocy

stin

-LR

544

0.0

20

FS

0.0

20

ug

/L0

.93

47

43

53

1F

inis

he

d--

---

---

---

-

<1

0/1

6/2

02

0 0

7:3

01

0/1

6/2

02

0 1

9:1

6T

rue

Mic

rocy

stin

-LY

544

0.0

09

FS

0.0

09

ug

/L0

.93

47

43

53

1F

inis

he

d--

---

---

---

-

<1

0/1

6/2

02

0 0

7:3

01

0/1

6/2

02

0 1

9:1

6T

rue

Mic

rocy

stin

-RR

544

0.0

06

FS

0.0

06

ug

/L0

.93

47

43

53

1F

inis

he

d--

---

---

---

-

<1

0/1

6/2

02

0 0

7:3

01

0/1

6/2

02

0 1

9:1

6T

rue

Mic

rocy

stin

-YR

544

0.0

20

FS

0.0

20

ug

/L0

.93

47

43

53

1F

inis

he

d--

---

---

---

-

<1

0/1

6/2

02

0 0

7:3

01

0/1

6/2

02

0 1

9:1

6T

rue

Nodula

rin

544

0.0

05

FS

0.0

05

ug

/L0

.93

47

43

53

1F

inis

he

d--

---

---

---

-

<1

0/1

6/2

02

0 0

7:3

01

0/1

6/2

02

0 1

9:1

6F

als

e

SS

-C2D

5-M

C-L

R544

N/A

CC

M0

.11

15

ug

/L1

.04

75

20

31

---

---

---

70

- 1

30

11

10

.1

10

/16

/20

20

10

:58

10

/16

/20

20

20

:33

Fals

e

Mic

rocy

stin

-LA

544

0.0

08

CC

M0

.08

30

ug

/L1

.04

75

20

31

---

---

---

70

- 1

30

10

40

.08

1

0/1

6/2

02

0 1

0:5

81

0/1

6/2

02

0 2

0:3

3F

als

e

Mic

rocy

stin

-LF

544

0.0

06

CC

M0

.06

27

ug

/L1

.04

75

20

31

---

---

---

70

- 1

30

10

40

.06

1

0/1

6/2

02

0 1

0:5

81

0/1

6/2

02

0 2

0:3

3F

als

e

Mic

rocy

stin

-LR

544

0.0

20

CC

M0

.22

32

ug

/L1

.04

75

20

31

---

---

---

70

- 1

30

11

20

.2

10

/16

/20

20

10

:58

10

/16

/20

20

20

:33

Fals

e

Mic

rocy

stin

-LY

544

0.0

09

CC

M0

.09

30

ug

/L1

.04

75

20

31

---

---

---

70

- 1

30

10

30

.09

1

0/1

6/2

02

0 1

0:5

81

0/1

6/2

02

0 2

0:3

3F

als

e

Mic

rocy

stin

-RR

544

0.0

06

CC

M0

.07

39

ug

/L1

.04

75

20

31

---

---

---

70

- 1

30

12

30

.06

1

0/1

6/2

02

0 1

0:5

81

0/1

6/2

02

0 2

0:3

3F

als

e

Mic

rocy

stin

-YR

544

0.0

20

CC

M0

.23

00

ug

/L1

.04

75

20

31

---

---

---

70

- 1

30

11

50

.2

10

/16

/20

20

10

:58

10

/16

/20

20

20

:33

Fals

e

Nodula

rin

544

0.0

05

CC

M0

.05

14

ug

/L1

.04

75

20

31

---

---

---

70

- 1

30

10

30

.05

1

0/1

6/2

02

0 1

0:5

81

0/1

6/2

02

0 2

0:3

3

Page 2

of

3E

EA

Run I

D 2

81025 /

EE

A R

eport

# 5

00223

Page 158 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Page 3

of

3E

EA

Run I

D 2

81025 /

EE

A R

eport

# 5

00223

Page 159 of 201

Eu

rofi

ns

Ea

ton

An

aly

tica

lR

un

Lo

gR

un ID

:280802

Meth

od:

545

Sam

ple

Sit

eS

am

ple

Id

Typ

eIn

str

um

en

t ID

Cali

bra

tio

n F

ile

An

aly

sis

Date

Matr

ix

CC

L4

74

35

14

CY

10

09

20

M5

45

a-C

Y.m

db

10

/09

/20

20

01

:44

RW

LR

B4

74

35

16

CY

10

09

20

M5

45

a-C

Y.m

db

10

/09

/20

20

02

:14

RW

LR

B4

74

54

13

CY

10

09

20

M5

45

a-C

Y.m

db

10

/09

/20

20

02

:28

RW

FS

47

43

53

2F

inis

he

dC

Y1

00

92

0M

54

5a

-CY

.md

b1

0/0

9/2

02

0 0

5:1

0D

W

CC

M4

74

35

17

CY

10

09

20

M5

45

a-C

Y.m

db

10

/09

/20

20

05

:39

RW

0.0

0

Page 1

of

2E

EA

Run I

D 2

80802 /

EE

A R

eport

# 5

00223

Page 160 of 201

QC

Su

mm

ary

Re

po

rt

EE

AID

#R

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

eth

od

An

aly

teS

am

ple

Typ

eD

ilF

ac

tor

RP

DL

imit

Re

co

ve

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

gM

RL

Ex

tra

cte

dA

na

lyze

d

Fals

e

IS-L

-phenyl

ala

nin

e-d

5545

N/A

CC

L2

26

72

ug

/L1

.04

74

35

14

---

---

---

50

- 1

50

92

24

55

5

10

/07

/20

20

12

:54

10

/09

/20

20

01

:44

Fals

e

IS-U

raci

l-d4

545

N/A

CC

L1

50

44

ug

/L1

.04

74

35

14

---

---

---

50

- 1

50

92

16

39

6

10

/07

/20

20

12

:54

10

/09

/20

20

01

:44

Fals

e

Anato

xin-a

545

0.0

3C

CL

0.0

19

1ug

/L1

.04

74

35

14

---

---

---

50

- 1

50

64

0.0

3

10

/07

/20

20

12

:54

10

/09

/20

20

01

:44

Fals

e

Cyl

indro

sperm

opsi

n545

0.0

9C

CL

0.0

88

0ug

/L1

.04

74

35

14

---

---

---

50

- 1

50

98

0.0

9

10

/07

/20

20

12

:54

10

/09

/20

20

01

:44

Tru

e

IS-L

-phenyl

ala

nin

e-d

5545

N/A

LR

B2

31

51

ug

/L1

.04

74

35

16

---

---

---

50

- 1

50

94

24

55

5

10

/07

/20

20

13

:41

10

/09

/20

20

02

:14

Tru

e

IS-U

raci

l-d4

545

N/A

LR

B1

61

27

ug

/L1

.04

74

35

16

---

---

---

50

- 1

50

98

16

39

6

10

/07

/20

20

13

:41

10

/09

/20

20

02

:14

Tru

e

Anato

xin-a

545

0.0

3L

RB

0.0

3ug

/L1

.04

74

35

16

---

---

---

---

---

<

10

/07

/20

20

13

:41

10

/09

/20

20

02

:14

Tru

e

Cyl

indro

sperm

opsi

n545

0.0

9L

RB

0.0

9ug

/L1

.04

74

35

16

---

---

---

---

---

<

10

/07

/20

20

13

:41

10

/09

/20

20

02

:14

Fals

e

IS-L

-phenyl

ala

nin

e-d

5545

N/A

LR

B2

54

50

ug

/L1

.04

74

54

13

---

---

---

50

- 1

50

10

42

45

55

1

0/0

8/2

02

0 1

4:2

51

0/0

9/2

02

0 0

2:2

8F

als

e

IS-U

raci

l-d4

545

N/A

LR

B1

73

03

ug

/L1

.04

74

54

13

---

---

---

50

- 1

50

10

61

63

96

1

0/0

8/2

02

0 1

4:2

51

0/0

9/2

02

0 0

2:2

8F

als

e

Anato

xin-a

545

0.0

3L

RB

0.0

3ug

/L1

.04

74

54

13

---

---

---

---

---

<

10

/08

/20

20

14

:25

10

/09

/20

20

02

:28

Fals

e

Cyl

indro

sperm

opsi

n545

0.0

9L

RB

0.0

9ug

/L1

.04

74

54

13

---

---

---

---

---

<

10

/08

/20

20

14

:25

10

/09

/20

20

02

:28

Tru

e

IS-L

-phenyl

ala

nin

e-d

5545

N/A

FS

24

41

9ug

/L1

.04

74

35

32

Fin

ishe

d--

---

-5

0 -

15

09

92

45

55

1

0/0

8/2

02

0 1

4:2

51

0/0

9/2

02

0 0

5:1

0T

rue

IS-U

raci

l-d4

545

N/A

FS

12

56

9ug

/L1

.04

74

35

32

Fin

ishe

d--

---

-5

0 -

15

07

71

63

96

1

0/0

8/2

02

0 1

4:2

51

0/0

9/2

02

0 0

5:1

0T

rue

Anato

xin-a

545

0.0

3F

S0

.03

ug

/L1

.04

74

35

32

Fin

ishe

d--

---

---

---

-

<1

0/0

8/2

02

0 1

4:2

51

0/0

9/2

02

0 0

5:1

0T

rue

Cyl

indro

sperm

opsi

n545

0.0

9F

S0

.09

ug

/L1

.04

74

35

32

Fin

ishe

d--

---

---

---

-

<1

0/0

8/2

02

0 1

4:2

51

0/0

9/2

02

0 0

5:1

0F

als

e

IS-L

-phenyl

ala

nin

e-d

5545

N/A

CC

M2

43

63

ug

/L1

.04

74

35

17

---

---

---

50

- 1

50

99

24

55

5

10

/07

/20

20

12

:54

10

/09

/20

20

05

:39

Fals

e

IS-U

raci

l-d4

545

N/A

CC

M1

58

40

ug

/L1

.04

74

35

17

---

---

---

50

- 1

50

97

16

39

6

10

/07

/20

20

12

:54

10

/09

/20

20

05

:39

Fals

e

Anato

xin-a

545

0.0

3C

CM

0.5

01

3ug

/L1

.04

74

35

17

---

---

---

70

- 1

30

10

00

.5

10

/07

/20

20

12

:54

10

/09

/20

20

05

:39

Fals

e

Cyl

indro

sperm

opsi

n545

0.0

9C

CM

1.5

40

5ug

/L1

.04

74

35

17

---

---

---

70

- 1

30

10

31

.5

10

/07

/20

20

12

:54

10

/09

/20

20

05

:39

Page 2

of

2E

EA

Run I

D 2

80802 /

EE

A R

eport

# 5

00223

Page 161 of 201

Eu

rofi

ns

Ea

ton

An

aly

tica

lR

un

Lo

gR

un ID

:280867

Meth

od:

549.2

Sam

ple

Sit

eS

am

ple

Id

Typ

eIn

str

um

en

t ID

Cali

bra

tio

n F

ile

An

aly

sis

Date

Matr

ix

CC

C4

74

85

43

CL

54

9_

2-0

62

42

0C

L1

0/1

3/2

02

0 1

6:3

1R

W

LF

B4

74

83

82

CL

54

9_

2-0

62

42

0C

L1

0/1

3/2

02

0 1

6:3

8R

W

LM

B4

74

83

79

CL

54

9_

2-0

62

42

0C

L1

0/1

3/2

02

0 1

6:5

3R

W

FS

47

43

53

9F

inis

he

dC

L5

49

_2

-06

24

20

CL

10

/13

/20

20

17

:00

DW

CC

C4

74

85

44

CL

54

9_

2-0

62

42

0C

L1

0/1

3/2

02

0 1

9:4

6R

W

0.0

0

Page 1

of

2E

EA

Run I

D 2

80867 /

EE

A R

eport

# 5

00223

Page 162 of 201

QC

Su

mm

ary

Re

po

rt

EE

AID

#R

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

eth

od

An

aly

teS

am

ple

Typ

eD

ilF

ac

tor

RP

DL

imit

Re

co

ve

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

gM

RL

Ex

tra

cte

dA

na

lyze

d

Fals

e

Diq

uat

549.2

0.4

CC

C1

.97

33

ug

/L1

.04

74

85

43

---

---

---

80

- 1

20

99

2.0

0

9/2

4/2

02

0 0

8:3

01

0/1

3/2

02

0 1

6:3

1F

als

e

Para

quat

549.2

0.4

CC

C1

.94

76

ug

/L1

.04

74

85

43

---

---

---

80

- 1

20

97

2.0

0

9/2

4/2

02

0 0

8:3

01

0/1

3/2

02

0 1

6:3

1T

rue

Diq

uat

549.2

0.4

LF

B4

.02

07

ug

/L1

.04

74

83

82

---

---

---

70

- 1

30

80

5.0

1

0/1

3/2

02

0 0

8:2

01

0/1

3/2

02

0 1

6:3

8T

rue

Para

quat

549.2

0.4

LF

B4

.15

97

ug

/L1

.04

74

83

82

---

---

---

70

- 1

30

83

5.0

1

0/1

3/2

02

0 0

8:2

01

0/1

3/2

02

0 1

6:3

8F

als

e

Diq

uat

549.2

0.4

LM

B0

.4ug

/L1

.04

74

83

79

---

---

---

---

---

<

10

/13

/20

20

08

:20

10

/13

/20

20

16

:53

Fals

e

Para

quat

549.2

0.4

LM

B0

.4ug

/L1

.04

74

83

79

---

---

---

---

---

<

10

/13

/20

20

08

:20

10

/13

/20

20

16

:53

Tru

e

Diq

uat

549.2

0.4

FS

0.4

ug

/L1

.04

74

35

39

Fin

ishe

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:2

01

0/1

3/2

02

0 1

7:0

0T

rue

Para

quat

549.2

0.4

FS

0.4

ug

/L1

.04

74

35

39

Fin

ishe

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:2

01

0/1

3/2

02

0 1

7:0

0F

als

e

Diq

uat

549.2

0.4

CC

C4

.86

70

ug

/L1

.04

74

85

44

---

---

---

80

- 1

20

97

5.0

0

9/2

4/2

02

0 0

8:3

01

0/1

3/2

02

0 1

9:4

6F

als

e

Para

quat

549.2

0.4

CC

C4

.77

82

ug

/L1

.04

74

85

44

---

---

---

80

- 1

20

96

5.0

0

9/2

4/2

02

0 0

8:3

01

0/1

3/2

02

0 1

9:4

6

Page 2

of

2E

EA

Run I

D 2

80867 /

EE

A R

eport

# 5

00223

Page 163 of 201

Eu

rofi

ns

Ea

ton

An

aly

tica

lR

un

Lo

gR

un ID

:281134

Meth

od:

556

Sam

ple

Sit

eS

am

ple

Id

Typ

eIn

str

um

en

t ID

Cali

bra

tio

n F

ile

An

aly

sis

Date

Matr

ix

CC

L4

74

85

48

AY

m 5

56

10

15

20

AY

10

/15

/20

20

21

:09

RW

CC

M4

74

85

50

AY

m 5

56

10

15

20

AY

10

/15

/20

20

22

:14

RW

LM

B4

74

85

47

AY

m 5

56

10

15

20

AY

10

/15

/20

20

23

:19

RW

FS

47

43

53

4F

inis

he

dA

Ym

55

6 1

01

52

0A

Y1

0/1

6/2

02

0 0

2:3

4D

W

MS

47

48

54

5F

inis

he

dA

Ym

55

6 1

01

52

0A

Y1

0/1

6/2

02

0 0

3:3

9D

W

MS

D4

74

85

46

Fin

ish

ed

AY

m 5

56

10

15

20

AY

10

/16

/20

20

04

:44

DW

LT

B4

74

35

35

LT

B 0

7/1

6/2

02

0A

Ym

55

6 1

01

52

0A

Y1

0/1

6/2

02

0 0

5:4

9R

W

CC

L4

74

85

49

AY

m 5

56

10

15

20

AY

10

/16

/20

20

07

:59

RW

0.0

0

Page 1

of

5E

EA

Run I

D 2

81134 /

EE

A R

eport

# 5

00223

Page 164 of 201

QC

Su

mm

ary

Re

po

rt

EE

AID

#R

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

eth

od

An

aly

teS

am

ple

Typ

eD

ilF

ac

tor

RP

DL

imit

Re

co

ve

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

gM

RL

Ex

tra

cte

dA

na

lyze

d

Fals

e

Ace

tald

ehyd

e556

5.0

CC

L4

.61

21

ug

/L1

.04

74

85

48

---

---

---

50

- 1

50

92

5.0

1

0/1

3/2

02

0 0

8:3

81

0/1

5/2

02

0 2

1:0

9F

als

e

Benza

ldehyd

e556

5.0

CC

L4

.91

90

ug

/L1

.04

74

85

48

---

---

---

50

- 1

50

98

5.0

1

0/1

3/2

02

0 0

8:3

81

0/1

5/2

02

0 2

1:0

9F

als

e

Buta

nal

556

5.0

CC

L6

.09

86

ug

/L1

.04

74

85

48

---

---

---

50

- 1

50

12

25

.0

10

/13

/20

20

08

:38

10

/15

/20

20

21

:09

Fals

e

Cro

tonald

ehyd

e556

5.0

CC

L4

.69

23

ug

/L1

.04

74

85

48

---

---

---

50

- 1

50

94

5.0

1

0/1

3/2

02

0 0

8:3

81

0/1

5/2

02

0 2

1:0

9F

als

e

Cyc

lohexa

no

ne

556

5.0

CC

L4

.73

11

ug

/L1

.04

74

85

48

---

---

---

50

- 1

50

95

5.0

1

0/1

3/2

02

0 0

8:3

81

0/1

5/2

02

0 2

1:0

9F

als

e

Deca

nal

556

5.0

CC

L5

.28

13

ug

/L1

.04

74

85

48

---

---

---

50

- 1

50

10

65

.0

10

/13

/20

20

08

:38

10

/15

/20

20

21

:09

Fals

e

1,2

-Dib

rom

opro

pane

556

N/A

CC

L5

51

ug

/L1

.04

74

85

48

---

---

---

70

- 1

30

10

45

32

1

0/1

3/2

02

0 0

8:3

81

0/1

5/2

02

0 2

1:0

9F

als

e

Form

ald

ehyd

e556

5.0

CC

L3

.22

06

ug

/L1

.04

74

85

48

---

---

---

50

- 1

50

64

5.0

1

0/1

3/2

02

0 0

8:3

81

0/1

5/2

02

0 2

1:0

9F

als

e

Gly

oxa

l556

5.0

CC

L4

.55

63

ug

/L1

.04

74

85

48

---

---

---

50

- 1

50

91

5.0

1

0/1

3/2

02

0 0

8:3

81

0/1

5/2

02

0 2

1:0

9F

als

e

Hepta

nal

556

5.0

CC

L6

.37

13

ug

/L1

.04

74

85

48

---

---

---

50

- 1

50

12

75

.0

10

/13

/20

20

08

:38

10

/15

/20

20

21

:09

Fals

e

Hexa

nal

556

5.0

CC

L5

.22

00

ug

/L1

.04

74

85

48

---

---

---

50

- 1

50

10

45

.0

10

/13

/20

20

08

:38

10

/15

/20

20

21

:09

Fals

e

Meth

yl g

lyoxa

l556

5.0

CC

L7

.33

04

ug

/L1

.04

74

85

48

---

---

---

50

- 1

50

14

75

.0

10

/13

/20

20

08

:38

10

/15

/20

20

21

:09

Fals

e

Nonanal

556

5.0

CC

L5

.87

74

ug

/L1

.04

74

85

48

---

---

---

50

- 1

50

11

85

.0

10

/13

/20

20

08

:38

10

/15

/20

20

21

:09

Fals

e

Oct

anal

556

5.0

CC

L4

.89

68

ug

/L1

.04

74

85

48

---

---

---

50

- 1

50

98

5.0

1

0/1

3/2

02

0 0

8:3

81

0/1

5/2

02

0 2

1:0

9F

als

e

Penta

nal

556

5.0

CC

L4

.89

65

ug

/L1

.04

74

85

48

---

---

---

50

- 1

50

98

5.0

1

0/1

3/2

02

0 0

8:3

81

0/1

5/2

02

0 2

1:0

9F

als

e

Pro

panal

556

5.0

CC

L6

.21

67

ug

/L1

.04

74

85

48

---

---

---

50

- 1

50

12

45

.0

10

/13

/20

20

08

:38

10

/15

/20

20

21

:09

Fals

e

2,4

,5-T

rifluoro

ace

tophenone

556

N/A

CC

L2

3.4

63

2ug

/L1

.04

74

85

48

---

---

---

70

- 1

30

94

25

.0

10

/13

/20

20

08

:38

10

/15

/20

20

21

:09

Tru

e

Ace

tald

ehyd

e556

5.0

CC

M1

9.6

62

5ug

/L1

.04

74

85

50

---

---

---

70

- 1

30

98

20

.0

10

/13

/20

20

08

:38

10

/15

/20

20

22

:14

Tru

e

Benza

ldehyd

e556

5.0

CC

M1

9.2

76

1ug

/L1

.04

74

85

50

---

---

---

70

- 1

30

96

20

.0

10

/13

/20

20

08

:38

10

/15

/20

20

22

:14

Tru

e

Buta

nal

556

5.0

CC

M2

0.8

68

8ug

/L1

.04

74

85

50

---

---

---

70

- 1

30

10

42

0.0

1

0/1

3/2

02

0 0

8:3

81

0/1

5/2

02

0 2

2:1

4T

rue

Cro

tonald

ehyd

e556

5.0

CC

M2

1.2

94

5ug

/L1

.04

74

85

50

---

---

---

70

- 1

30

10

62

0.0

1

0/1

3/2

02

0 0

8:3

81

0/1

5/2

02

0 2

2:1

4T

rue

Cyc

lohexa

no

ne

556

5.0

CC

M1

8.7

94

2ug

/L1

.04

74

85

50

---

---

---

70

- 1

30

94

20

.0

10

/13

/20

20

08

:38

10

/15

/20

20

22

:14

Tru

e

Deca

nal

556

5.0

CC

M2

0.0

66

4ug

/L1

.04

74

85

50

---

---

---

70

- 1

30

10

02

0.0

1

0/1

3/2

02

0 0

8:3

81

0/1

5/2

02

0 2

2:1

4T

rue

1,2

-Dib

rom

opro

pane

556

N/A

CC

M5

41

ug

/L1

.04

74

85

50

---

---

---

70

- 1

30

10

25

32

1

0/1

3/2

02

0 0

8:3

81

0/1

5/2

02

0 2

2:1

4T

rue

Form

ald

ehyd

e556

5.0

CC

M2

0.4

78

8ug

/L1

.04

74

85

50

---

---

---

70

- 1

30

10

22

0.0

1

0/1

3/2

02

0 0

8:3

81

0/1

5/2

02

0 2

2:1

4T

rue

Gly

oxa

l556

5.0

CC

M2

2.5

68

0ug

/L1

.04

74

85

50

---

---

---

70

- 1

30

11

32

0.0

1

0/1

3/2

02

0 0

8:3

81

0/1

5/2

02

0 2

2:1

4T

rue

Hepta

nal

556

5.0

CC

M2

0.3

66

3ug

/L1

.04

74

85

50

---

---

---

70

- 1

30

10

22

0.0

1

0/1

3/2

02

0 0

8:3

81

0/1

5/2

02

0 2

2:1

4T

rue

Hexa

nal

556

5.0

CC

M1

9.9

20

9ug

/L1

.04

74

85

50

---

---

---

70

- 1

30

10

02

0.0

1

0/1

3/2

02

0 0

8:3

81

0/1

5/2

02

0 2

2:1

4T

rue

Meth

yl g

lyoxa

l556

5.0

CC

M1

7.9

00

7ug

/L1

.04

74

85

50

---

---

---

70

- 1

30

90

20

.0

10

/13

/20

20

08

:38

10

/15

/20

20

22

:14

Tru

e

Nonanal

556

5.0

CC

M1

9.5

53

7ug

/L1

.04

74

85

50

---

---

---

70

- 1

30

98

20

.0

10

/13

/20

20

08

:38

10

/15

/20

20

22

:14

Tru

e

Oct

anal

556

5.0

CC

M1

8.4

14

6ug

/L1

.04

74

85

50

---

---

---

70

- 1

30

92

20

.0

10

/13

/20

20

08

:38

10

/15

/20

20

22

:14

Tru

e

Penta

nal

556

5.0

CC

M1

8.5

99

8ug

/L1

.04

74

85

50

---

---

---

70

- 1

30

93

20

.0

10

/13

/20

20

08

:38

10

/15

/20

20

22

:14

Tru

e

Pro

panal

556

5.0

CC

M1

9.3

12

7ug

/L1

.04

74

85

50

---

---

---

70

- 1

30

97

20

.0

10

/13

/20

20

08

:38

10

/15

/20

20

22

:14

Tru

e

2,4

,5-T

rifluoro

ace

tophenone

556

N/A

CC

M2

3.6

03

6ug

/L1

.04

74

85

50

---

---

---

70

- 1

30

94

25

.0

10

/13

/20

20

08

:38

10

/15

/20

20

22

:14

Fals

e

Ace

tald

ehyd

e556

5.0

LM

B5

.0ug

/L1

.04

74

85

47

---

---

---

---

---

<

10

/13

/20

20

08

:38

10

/15

/20

20

23

:19

Fals

e

Benza

ldehyd

e556

5.0

LM

B5

.0ug

/L1

.04

74

85

47

---

---

---

---

---

<

10

/13

/20

20

08

:38

10

/15

/20

20

23

:19

Fals

e

Buta

nal

556

5.0

LM

B5

.0ug

/L1

.04

74

85

47

---

---

---

---

---

<

10

/13

/20

20

08

:38

10

/15

/20

20

23

:19

Fals

e

Cro

tonald

ehyd

e556

5.0

LM

B5

.0ug

/L1

.04

74

85

47

---

---

---

---

---

<

10

/13

/20

20

08

:38

10

/15

/20

20

23

:19

Fals

e

Cyc

lohexa

no

ne

556

5.0

LM

B5

.0ug

/L1

.04

74

85

47

---

---

---

---

---

<

10

/13

/20

20

08

:38

10

/15

/20

20

23

:19

Fals

e

Deca

nal

556

5.0

LM

B5

.0ug

/L1

.04

74

85

47

---

---

---

---

---

<

10

/13

/20

20

08

:38

10

/15

/20

20

23

:19

Page 2

of

5E

EA

Run I

D 2

81134 /

EE

A R

eport

# 5

00223

Page 165 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Fals

e

1,2

-Dib

rom

opro

pane

556

N/A

LM

B5

54

ug

/L1

.04

74

85

47

---

---

---

70

- 1

30

10

45

32

1

0/1

3/2

02

0 0

8:3

81

0/1

5/2

02

0 2

3:1

9F

als

e

Form

ald

ehyd

e556

5.0

LM

B5

.0ug

/L1

.04

74

85

47

---

---

---

---

---

<

10

/13

/20

20

08

:38

10

/15

/20

20

23

:19

Fals

e

Gly

oxa

l556

5.0

LM

B5

.0ug

/L1

.04

74

85

47

---

---

---

---

---

<

10

/13

/20

20

08

:38

10

/15

/20

20

23

:19

Fals

e

Hepta

nal

556

5.0

LM

B5

.0ug

/L1

.04

74

85

47

---

---

---

---

---

<

10

/13

/20

20

08

:38

10

/15

/20

20

23

:19

Fals

e

Hexa

nal

556

5.0

LM

B5

.0ug

/L1

.04

74

85

47

---

---

---

---

---

<

10

/13

/20

20

08

:38

10

/15

/20

20

23

:19

Fals

e

Meth

yl g

lyoxa

l556

5.0

LM

B5

.0ug

/L1

.04

74

85

47

---

---

---

---

---

<

10

/13

/20

20

08

:38

10

/15

/20

20

23

:19

Fals

e

Nonanal

556

5.0

LM

B5

.0ug

/L1

.04

74

85

47

---

---

---

---

---

<

10

/13

/20

20

08

:38

10

/15

/20

20

23

:19

Fals

e

Oct

anal

556

5.0

LM

B5

.0ug

/L1

.04

74

85

47

---

---

---

---

---

<

10

/13

/20

20

08

:38

10

/15

/20

20

23

:19

Fals

e

Penta

nal

556

5.0

LM

B5

.0ug

/L1

.04

74

85

47

---

---

---

---

---

<

10

/13

/20

20

08

:38

10

/15

/20

20

23

:19

Fals

e

Pro

panal

556

5.0

LM

B5

.0ug

/L1

.04

74

85

47

---

---

---

---

---

<

10

/13

/20

20

08

:38

10

/15

/20

20

23

:19

Fals

e

2,4

,5-T

rifluoro

ace

tophenone

556

N/A

LM

B2

4.8

12

8ug

/L1

.04

74

85

47

---

---

---

70

- 1

30

99

25

.0

10

/13

/20

20

08

:38

10

/15

/20

20

23

:19

Tru

e

Ace

tald

ehyd

e556

5.0

FS

5.0

ug

/L0

.97

47

43

53

4F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:3

81

0/1

6/2

02

0 0

2:3

4T

rue

Benza

ldehyd

e556

5.0

FS

5.0

ug

/L0

.97

47

43

53

4F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:3

81

0/1

6/2

02

0 0

2:3

4T

rue

Buta

nal

556

5.0

FS

5.0

ug

/L0

.97

47

43

53

4F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:3

81

0/1

6/2

02

0 0

2:3

4T

rue

Cro

tonald

ehyd

e556

5.0

FS

5.0

ug

/L0

.97

47

43

53

4F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:3

81

0/1

6/2

02

0 0

2:3

4T

rue

Cyc

lohexa

no

ne

556

5.0

FS

5.0

ug

/L0

.97

47

43

53

4F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:3

81

0/1

6/2

02

0 0

2:3

4T

rue

Deca

nal

556

5.0

FS

5.0

ug

/L0

.97

47

43

53

4F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:3

81

0/1

6/2

02

0 0

2:3

4T

rue

1,2

-Dib

rom

opro

pane

556

N/A

FS

52

3ug

/L0

.97

47

43

53

4F

inis

he

d--

---

-7

0 -

13

09

85

32

1

0/1

3/2

02

0 0

8:3

81

0/1

6/2

02

0 0

2:3

4T

rue

Form

ald

ehyd

e556

5.0

FS

7.3

ug

/L0

.97

47

43

53

4F

inis

he

d--

---

---

---

-

1

0/1

3/2

02

0 0

8:3

81

0/1

6/2

02

0 0

2:3

4T

rue

Gly

oxa

l556

5.0

FS

5.0

ug

/L0

.97

47

43

53

4F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:3

81

0/1

6/2

02

0 0

2:3

4T

rue

Hepta

nal

556

5.0

FS

5.0

ug

/L0

.97

47

43

53

4F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:3

81

0/1

6/2

02

0 0

2:3

4T

rue

Hexa

nal

556

5.0

FS

5.0

ug

/L0

.97

47

43

53

4F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:3

81

0/1

6/2

02

0 0

2:3

4T

rue

Meth

yl g

lyoxa

l556

5.0

FS

5.0

ug

/L0

.97

47

43

53

4F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:3

81

0/1

6/2

02

0 0

2:3

4T

rue

Nonanal

556

5.0

FS

5.0

ug

/L0

.97

47

43

53

4F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:3

81

0/1

6/2

02

0 0

2:3

4T

rue

Oct

anal

556

5.0

FS

5.0

ug

/L0

.97

47

43

53

4F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:3

81

0/1

6/2

02

0 0

2:3

4T

rue

Penta

nal

556

5.0

FS

5.0

ug

/L0

.97

47

43

53

4F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:3

81

0/1

6/2

02

0 0

2:3

4T

rue

Pro

panal

556

5.0

FS

5.0

ug

/L0

.97

47

43

53

4F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

8:3

81

0/1

6/2

02

0 0

2:3

4T

rue

2,4

,5-T

rifluoro

ace

tophenone

556

N/A

FS

24

.37

29

ug

/L0

.97

47

43

53

4F

inis

he

d--

---

-7

0 -

13

09

72

5.0

1

0/1

3/2

02

0 0

8:3

81

0/1

6/2

02

0 0

2:3

4F

als

e

Ace

tald

ehyd

e556

5.0

MS

15

.59

43

ug

/L0

.95

47

48

54

5F

inis

he

d--

---

-7

0 -

13

08

22

0.0

1

0/1

3/2

02

0 0

8:3

81

0/1

6/2

02

0 0

3:3

9F

als

e

Benza

ldehyd

e556

5.0

MS

19

.28

40

ug

/L0

.95

47

48

54

5F

inis

he

d--

---

-7

0 -

13

01

01

20

.0

10

/13

/20

20

08

:38

10

/16

/20

20

03

:39

Fals

e

Buta

nal

556

5.0

MS

14

.31

90

ug

/L0

.95

47

48

54

5F

inis

he

d--

---

-7

0 -

13

07

52

0.0

1

0/1

3/2

02

0 0

8:3

81

0/1

6/2

02

0 0

3:3

9F

als

e

Cro

tonald

ehyd

e556

5.0

MS

20

.42

50

ug

/L0

.95

47

48

54

5F

inis

he

d--

---

-7

0 -

13

01

08

20

.0

10

/13

/20

20

08

:38

10

/16

/20

20

03

:39

Fals

e

Cyc

lohexa

no

ne

556

5.0

MS

14

.80

18

ug

/L0

.95

47

48

54

5F

inis

he

d--

---

-7

0 -

13

07

82

0.0

1

0/1

3/2

02

0 0

8:3

81

0/1

6/2

02

0 0

3:3

9F

als

e

Deca

nal

556

5.0

MS

15

.87

95

ug

/L0

.95

47

48

54

5F

inis

he

d--

---

-7

0 -

13

08

42

0.0

1

0/1

3/2

02

0 0

8:3

81

0/1

6/2

02

0 0

3:3

9F

als

e

1,2

-Dib

rom

opro

pane

556

N/A

MS

54

5ug

/L0

.95

47

48

54

5F

inis

he

d--

---

-7

0 -

13

01

02

53

2

10

/13

/20

20

08

:38

10

/16

/20

20

03

:39

Fals

e

Form

ald

ehyd

e556

5.0

MS

26

.02

47

ug

/L0

.95

47

48

54

5F

inis

he

d--

---

-7

0 -

13

09

82

7.3

21

1

10

/13

/20

20

08

:38

10

/16

/20

20

03

:39

Fals

e

Gly

oxa

l556

5.0

MS

18

.84

61

ug

/L0

.95

47

48

54

5F

inis

he

d--

---

-7

0 -

13

09

92

0.0

1

0/1

3/2

02

0 0

8:3

81

0/1

6/2

02

0 0

3:3

9F

als

e

Hepta

nal

556

5.0

MS

13

.27

72

ug

/L0

.95

47

48

54

5F

inis

he

d--

---

-7

0 -

13

07

02

0.0

1

0/1

3/2

02

0 0

8:3

81

0/1

6/2

02

0 0

3:3

9F

als

e

Hexa

nal

556

5.0

MS

15

.78

89

ug

/L0

.95

47

48

54

5F

inis

he

d--

---

-7

0 -

13

08

32

0.0

1

0/1

3/2

02

0 0

8:3

81

0/1

6/2

02

0 0

3:3

9F

als

e

Meth

yl g

lyoxa

l556

5.0

MS

18

.92

15

ug

/L0

.95

47

48

54

5F

inis

he

d--

---

-7

0 -

13

01

00

20

.0

10

/13

/20

20

08

:38

10

/16

/20

20

03

:39

Fals

e

Nonanal

556

5.0

MS

14

.49

16

ug

/L0

.95

47

48

54

5F

inis

he

d--

---

-7

0 -

13

07

62

0.0

1

0/1

3/2

02

0 0

8:3

81

0/1

6/2

02

0 0

3:3

9

Page 3

of

5E

EA

Run I

D 2

81134 /

EE

A R

eport

# 5

00223

Page 166 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Fals

e

Oct

anal

556

5.0

MS

17

.71

52

ug

/L0

.95

47

48

54

5F

inis

he

d--

---

-7

0 -

13

09

32

0.0

1

0/1

3/2

02

0 0

8:3

81

0/1

6/2

02

0 0

3:3

9F

als

e

Penta

nal

556

5.0

MS

15

.21

72

ug

/L0

.95

47

48

54

5F

inis

he

d--

---

-7

0 -

13

08

02

0.0

1

0/1

3/2

02

0 0

8:3

81

0/1

6/2

02

0 0

3:3

9F

als

e

Pro

panal

556

5.0

MS

14

.27

23

ug

/L0

.95

47

48

54

5F

inis

he

d--

---

-7

0 -

13

07

52

0.0

1

0/1

3/2

02

0 0

8:3

81

0/1

6/2

02

0 0

3:3

9F

als

e

2,4

,5-T

rifluoro

ace

tophenone

556

N/A

MS

23

.35

07

ug

/L0

.95

47

48

54

5F

inis

he

d--

---

-7

0 -

13

09

32

5.0

1

0/1

3/2

02

0 0

8:3

81

0/1

6/2

02

0 0

3:3

9T

rue

Ace

tald

ehyd

e556

5.0

MS

D1

7.5

16

8ug

/L1

.04

74

85

46

Fin

ishe

d3

01

27

0 -

13

08

82

0.0

1

0/1

3/2

02

0 0

8:3

81

0/1

6/2

02

0 0

4:4

4T

rue

Benza

ldehyd

e556

5.0

MS

D2

2.8

00

7ug

/L1

.04

74

85

46

Fin

ishe

d3

01

77

0 -

13

01

14

20

.0

10

/13

/20

20

08

:38

10

/16

/20

20

04

:44

Tru

e

Buta

nal

556

5.0

MS

D1

7.3

87

8ug

/L1

.04

74

85

46

Fin

ishe

d3

01

97

0 -

13

08

72

0.0

1

0/1

3/2

02

0 0

8:3

81

0/1

6/2

02

0 0

4:4

4T

rue

Cro

tonald

ehyd

e556

5.0

MS

D2

3.4

71

2ug

/L1

.04

74

85

46

Fin

ishe

d3

01

47

0 -

13

01

17

20

.0

10

/13

/20

20

08

:38

10

/16

/20

20

04

:44

Tru

e

Cyc

lohexa

no

ne

556

5.0

MS

D1

3.2

63

4ug

/L1

.04

74

85

46

Fin

ishe

d3

01

17

0 -

13

066

20

.0

10

/13

/20

20

08

:38

10

/16

/20

20

04

:44

Tru

e

Deca

nal

556

5.0

MS

D1

6.3

05

2ug

/L1

.04

74

85

46

Fin

ishe

d3

02

.67

0 -

13

08

22

0.0

1

0/1

3/2

02

0 0

8:3

81

0/1

6/2

02

0 0

4:4

4T

rue

1,2

-Dib

rom

opro

pane

556

N/A

MS

D5

06

ug

/L1

.04

74

85

46

Fin

ishe

d--

---

-7

0 -

13

09

55

32

1

0/1

3/2

02

0 0

8:3

81

0/1

6/2

02

0 0

4:4

4T

rue

Form

ald

ehyd

e556

5.0

MS

D3

4.7

05

0ug

/L1

.04

74

85

46

Fin

ishe

d3

02

97

0 -

13

0137

27

.32

11

1

0/1

3/2

02

0 0

8:3

81

0/1

6/2

02

0 0

4:4

4T

rue

Gly

oxa

l556

5.0

MS

D2

5.2

06

5ug

/L1

.04

74

85

46

Fin

ishe

d3

02

97

0 -

13

01

26

20

.0

10

/13

/20

20

08

:38

10

/16

/20

20

04

:44

Tru

e

Hepta

nal

556

5.0

MS

D1

3.8

30

3ug

/L1

.04

74

85

46

Fin

ishe

d3

04

.17

0 -

13

069

20

.0

10

/13

/20

20

08

:38

10

/16

/20

20

04

:44

Tru

e

Hexa

nal

556

5.0

MS

D1

7.3

98

4ug

/L1

.04

74

85

46

Fin

ishe

d3

09

.77

0 -

13

08

72

0.0

1

0/1

3/2

02

0 0

8:3

81

0/1

6/2

02

0 0

4:4

4T

rue

Meth

yl g

lyoxa

l556

5.0

MS

D2

1.6

69

0ug

/L1

.04

74

85

46

Fin

ishe

d3

01

47

0 -

13

01

08

20

.0

10

/13

/20

20

08

:38

10

/16

/20

20

04

:44

Tru

e

Nonanal

556

5.0

MS

D1

9.4

17

8ug

/L1

.04

74

85

46

Fin

ishe

d3

02

97

0 -

13

09

72

0.0

1

0/1

3/2

02

0 0

8:3

81

0/1

6/2

02

0 0

4:4

4T

rue

Oct

anal

556

5.0

MS

D2

1.2

51

2ug

/L1

.04

74

85

46

Fin

ishe

d3

01

87

0 -

13

01

06

20

.0

10

/13

/20

20

08

:38

10

/16

/20

20

04

:44

Tru

e

Penta

nal

556

5.0

MS

D1

8.2

56

6ug

/L1

.04

74

85

46

Fin

ishe

d3

01

87

0 -

13

09

12

0.0

1

0/1

3/2

02

0 0

8:3

81

0/1

6/2

02

0 0

4:4

4T

rue

Pro

panal

556

5.0

MS

D1

7.8

75

7ug

/L1

.04

74

85

46

Fin

ishe

d3

02

27

0 -

13

08

92

0.0

1

0/1

3/2

02

0 0

8:3

81

0/1

6/2

02

0 0

4:4

4T

rue

2,4

,5-T

rifluoro

ace

tophenone

556

N/A

MS

D2

6.2

75

9ug

/L1

.04

74

85

46

Fin

ishe

d--

---

-7

0 -

13

01

05

25

.0

10

/13

/20

20

08

:38

10

/16

/20

20

04

:44

Fals

e

Ace

tald

ehyd

e556

5.0

LT

B5

.0ug

/L0

.95

47

43

53

5L

TB

07

/16

/20

20

---

---

---

---

<

10

/13

/20

20

08

:38

10

/16

/20

20

05

:49

Fals

e

Benza

ldehyd

e556

5.0

LT

B5

.0ug

/L0

.95

47

43

53

5L

TB

07

/16

/20

20

---

---

---

---

<

10

/13

/20

20

08

:38

10

/16

/20

20

05

:49

Fals

e

Buta

nal

556

5.0

LT

B5

.0ug

/L0

.95

47

43

53

5L

TB

07

/16

/20

20

---

---

---

---

<

10

/13

/20

20

08

:38

10

/16

/20

20

05

:49

Fals

e

Cro

tonald

ehyd

e556

5.0

LT

B5

.0ug

/L0

.95

47

43

53

5L

TB

07

/16

/20

20

---

---

---

---

<

10

/13

/20

20

08

:38

10

/16

/20

20

05

:49

Fals

e

Cyc

lohexa

no

ne

556

5.0

LT

B5

.0ug

/L0

.95

47

43

53

5L

TB

07

/16

/20

20

---

---

---

---

<

10

/13

/20

20

08

:38

10

/16

/20

20

05

:49

Fals

e

Deca

nal

556

5.0

LT

B5

.0ug

/L0

.95

47

43

53

5L

TB

07

/16

/20

20

---

---

---

---

<

10

/13

/20

20

08

:38

10

/16

/20

20

05

:49

Fals

e

1,2

-Dib

rom

opro

pane

556

N/A

LT

B5

46

ug

/L0

.95

47

43

53

5L

TB

07

/16

/20

20

---

---

70

- 1

30

10

35

32

1

0/1

3/2

02

0 0

8:3

81

0/1

6/2

02

0 0

5:4

9F

als

e

Form

ald

ehyd

e556

5.0

LT

B5

.0ug

/L0

.95

47

43

53

5L

TB

07

/16

/20

20

---

---

---

---

<

10

/13

/20

20

08

:38

10

/16

/20

20

05

:49

Fals

e

Gly

oxa

l556

5.0

LT

B5

.0ug

/L0

.95

47

43

53

5L

TB

07

/16

/20

20

---

---

---

---

<

10

/13

/20

20

08

:38

10

/16

/20

20

05

:49

Fals

e

Hepta

nal

556

5.0

LT

B5

.0ug

/L0

.95

47

43

53

5L

TB

07

/16

/20

20

---

---

---

---

<

10

/13

/20

20

08

:38

10

/16

/20

20

05

:49

Fals

e

Hexa

nal

556

5.0

LT

B5

.0ug

/L0

.95

47

43

53

5L

TB

07

/16

/20

20

---

---

---

---

<

10

/13

/20

20

08

:38

10

/16

/20

20

05

:49

Fals

e

Meth

yl g

lyoxa

l556

5.0

LT

B5

.0ug

/L0

.95

47

43

53

5L

TB

07

/16

/20

20

---

---

---

---

<

10

/13

/20

20

08

:38

10

/16

/20

20

05

:49

Fals

e

Nonanal

556

5.0

LT

B5

.0ug

/L0

.95

47

43

53

5L

TB

07

/16

/20

20

---

---

---

---

<

10

/13

/20

20

08

:38

10

/16

/20

20

05

:49

Fals

e

Oct

anal

556

5.0

LT

B5

.0ug

/L0

.95

47

43

53

5L

TB

07

/16

/20

20

---

---

---

---

<

10

/13

/20

20

08

:38

10

/16

/20

20

05

:49

Fals

e

Penta

nal

556

5.0

LT

B5

.0ug

/L0

.95

47

43

53

5L

TB

07

/16

/20

20

---

---

---

---

<

10

/13

/20

20

08

:38

10

/16

/20

20

05

:49

Fals

e

Pro

panal

556

5.0

LT

B5

.0ug

/L0

.95

47

43

53

5L

TB

07

/16

/20

20

---

---

---

---

<

10

/13

/20

20

08

:38

10

/16

/20

20

05

:49

Fals

e

2,4

,5-T

rifluoro

ace

tophenone

556

N/A

LT

B2

3.4

57

8ug

/L0

.95

47

43

53

5L

TB

07

/16

/20

20

---

---

70

- 1

30

94

25

.0

10

/13

/20

20

08

:38

10

/16

/20

20

05

:49

Tru

e

Ace

tald

ehyd

e556

5.0

CC

L4

.28

45

ug

/L1

.04

74

85

49

---

---

---

50

- 1

50

86

5.0

1

0/1

3/2

02

0 0

8:3

81

0/1

6/2

02

0 0

7:5

9T

rue

Benza

ldehyd

e556

5.0

CC

L5

.27

04

ug

/L1

.04

74

85

49

---

---

---

50

- 1

50

10

55

.0

10

/13

/20

20

08

:38

10

/16

/20

20

07

:59

Tru

e

Buta

nal

556

5.0

CC

L4

.25

67

ug

/L1

.04

74

85

49

---

---

---

50

- 1

50

85

5.0

1

0/1

3/2

02

0 0

8:3

81

0/1

6/2

02

0 0

7:5

9

Page 4

of

5E

EA

Run I

D 2

81134 /

EE

A R

eport

# 5

00223

Page 167 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Tru

e

Cro

tonald

ehyd

e556

5.0

CC

L4

.18

60

ug

/L1

.04

74

85

49

---

---

---

50

- 1

50

84

5.0

1

0/1

3/2

02

0 0

8:3

81

0/1

6/2

02

0 0

7:5

9T

rue

Cyc

lohexa

no

ne

556

5.0

CC

L4

.01

83

ug

/L1

.04

74

85

49

---

---

---

50

- 1

50

80

5.0

1

0/1

3/2

02

0 0

8:3

81

0/1

6/2

02

0 0

7:5

9T

rue

Deca

nal

556

5.0

CC

L4

.79

21

ug

/L1

.04

74

85

49

---

---

---

50

- 1

50

96

5.0

1

0/1

3/2

02

0 0

8:3

81

0/1

6/2

02

0 0

7:5

9T

rue

1,2

-Dib

rom

opro

pane

556

N/A

CC

L5

70

ug

/L1

.04

74

85

49

---

---

---

70

- 1

30

10

75

32

1

0/1

3/2

02

0 0

8:3

81

0/1

6/2

02

0 0

7:5

9T

rue

Form

ald

ehyd

e556

5.0

CC

L2

.75

54

ug

/L1

.04

74

85

49

---

---

---

50

- 1

50

55

5.0

1

0/1

3/2

02

0 0

8:3

81

0/1

6/2

02

0 0

7:5

9T

rue

Gly

oxa

l556

5.0

CC

L3

.96

22

ug

/L1

.04

74

85

49

---

---

---

50

- 1

50

79

5.0

1

0/1

3/2

02

0 0

8:3

81

0/1

6/2

02

0 0

7:5

9T

rue

Hepta

nal

556

5.0

CC

L5

.18

77

ug

/L1

.04

74

85

49

---

---

---

50

- 1

50

10

45

.0

10

/13

/20

20

08

:38

10

/16

/20

20

07

:59

Tru

e

Hexa

nal

556

5.0

CC

L4

.80

97

ug

/L1

.04

74

85

49

---

---

---

50

- 1

50

96

5.0

1

0/1

3/2

02

0 0

8:3

81

0/1

6/2

02

0 0

7:5

9T

rue

Meth

yl g

lyoxa

l556

5.0

CC

L7

.21

80

ug

/L1

.04

74

85

49

---

---

---

50

- 1

50

14

45

.0

10

/13

/20

20

08

:38

10

/16

/20

20

07

:59

Tru

e

Nonanal

556

5.0

CC

L6

.18

33

ug

/L1

.04

74

85

49

---

---

---

50

- 1

50

12

45

.0

10

/13

/20

20

08

:38

10

/16

/20

20

07

:59

Tru

e

Oct

anal

556

5.0

CC

L4

.71

35

ug

/L1

.04

74

85

49

---

---

---

50

- 1

50

94

5.0

1

0/1

3/2

02

0 0

8:3

81

0/1

6/2

02

0 0

7:5

9T

rue

Penta

nal

556

5.0

CC

L3

.46

75

ug

/L1

.04

74

85

49

---

---

---

50

- 1

50

69

5.0

1

0/1

3/2

02

0 0

8:3

81

0/1

6/2

02

0 0

7:5

9T

rue

Pro

panal

556

5.0

CC

L5

.38

12

ug

/L1

.04

74

85

49

---

---

---

50

- 1

50

10

85

.0

10

/13

/20

20

08

:38

10

/16

/20

20

07

:59

Tru

e

2,4

,5-T

rifluoro

ace

tophenone

556

N/A

CC

L2

2.7

11

8ug

/L1

.04

74

85

49

---

---

---

70

- 1

30

91

25

.0

10

/13

/20

20

08

:38

10

/16

/20

20

07

:59

Page 5

of

5E

EA

Run I

D 2

81134 /

EE

A R

eport

# 5

00223

Page 168 of 201

Eu

rofi

ns

Ea

ton

An

aly

tica

lR

un

Lo

gR

un ID

:M

eth

od:

Sam

ple

Sit

eS

am

ple

Id

Typ

eIn

str

um

en

t ID

Cali

bra

tio

n F

ile

An

aly

sis

Date

Matr

ix

0.0

0

Page 1

of

2

Page 169 of 201

QC

Su

mm

ary

Re

po

rt

EE

AID

#R

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

eth

od

An

aly

teS

am

ple

Typ

eD

ilF

ac

tor

RP

DL

imit

Re

co

ve

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

Tru

e

Page 2

of

2

Page 170 of 201

Eu

rofi

ns

Ea

ton

An

aly

tica

lR

un

Lo

gR

un ID

:280793

Meth

od:

L306

Sam

ple

Sit

eS

am

ple

Id

Typ

eIn

str

um

en

t ID

Cali

bra

tio

n F

ile

An

aly

sis

Date

Matr

ix

ICL

47

46

48

7D

Q1

00

92

0L

30

6a

.md

b1

0/0

9/2

02

0 1

4:1

8R

W

ICS

47

46

48

8D

Q1

00

92

0L

30

6a

.md

b1

0/0

9/2

02

0 1

4:4

2R

W

ICS

47

46

48

9D

Q1

00

92

0L

30

6a

.md

b1

0/0

9/2

02

0 1

5:0

7R

W

ICS

47

46

49

0D

Q1

00

92

0L

30

6a

.md

b1

0/0

9/2

02

0 1

5:3

1R

W

ICS

47

46

49

1D

Q1

00

92

0L

30

6a

.md

b1

0/0

9/2

02

0 1

5:5

6R

W

ICS

47

46

49

2D

Q1

00

92

0L

30

6a

.md

b1

0/0

9/2

02

0 1

6:2

0R

W

ICS

47

46

49

3D

Q1

00

92

0L

30

6a

.md

b1

0/0

9/2

02

0 1

6:4

4R

W

LM

B4

74

64

95

DQ

10

09

20

L3

06

a.m

db

10

/09

/20

20

17

:33

RW

FS

47

43

54

6F

inis

he

dD

Q1

00

92

0L

30

6a

.md

b1

0/0

9/2

02

0 1

8:2

2D

W

MS

47

46

49

6F

inis

he

dD

Q1

00

92

0L

30

6a

.md

b1

0/0

9/2

02

0 1

8:4

6D

W

MS

D4

74

64

97

Fin

ish

ed

DQ

10

09

20

L3

06

a.m

db

10

/09

/20

20

19

:10

DW

CC

C4

74

64

98

DQ

10

09

20

L3

06

a.m

db

10

/09

/20

20

19

:35

RW

0.0

0

Page 1

of

12

EE

A R

un I

D 2

80793 /

EE

A R

eport

# 5

00223

Page 171 of 201

QC

Su

mm

ary

Re

po

rt

EE

AID

#R

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

eth

od

An

aly

teS

am

ple

Typ

eD

ilF

ac

tor

RP

DL

imit

Re

co

ve

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

gM

RL

Ex

tra

cte

dA

na

lyze

d

Tru

e

IS-L

inuro

n-d

6L306

N/A

ICL

30

09

9ug

/L1

.04

74

64

87

---

---

---

50

- 1

50

99

30

55

0

---

10

/09

/20

20

14

:18

Tru

e

Diu

ron

L306

N/A

ICL

0.0

50

7ug

/L1

.04

74

64

87

---

---

---

50

- 1

50

10

10

.05

--

-1

0/0

9/2

02

0 1

4:1

8T

rue

Diflu

benzu

ron

L306

N/A

ICL

0.0

48

9ug

/L1

.04

74

64

87

---

---

---

50

- 1

50

98

0.0

5

---

10

/09

/20

20

14

:18

Tru

e

Meth

om

ylL306

N/A

ICL

0.0

55

8ug

/L1

.04

74

64

87

---

---

---

50

- 1

50

11

20

.05

--

-1

0/0

9/2

02

0 1

4:1

8T

rue

Sid

uro

n, T

ota

lL306

N/A

ICL

0.0

50

1ug

/L1

.04

74

64

87

---

---

---

50

- 1

50

10

00

.05

--

-1

0/0

9/2

02

0 1

4:1

8T

rue

Neburo

nL306

N/A

ICL

0.0

48

4ug

/L1

.04

74

64

87

---

---

---

50

- 1

50

97

0.0

5

---

10

/09

/20

20

14

:18

Tru

e

IS-D

iuro

n-d

6L306

N/A

ICL

59

97

21

ug

/L1

.04

74

64

87

---

---

---

50

- 1

50

95

62

92

37

--

-1

0/0

9/2

02

0 1

4:1

8T

rue

Tebuth

iuro

nL306

N/A

ICL

0.0

49

9ug

/L1

.04

74

64

87

---

---

---

50

- 1

50

10

00

.05

--

-1

0/0

9/2

02

0 1

4:1

8T

rue

Pro

panil

L306

N/A

ICL

0.0

51

5ug

/L1

.04

74

64

87

---

---

---

50

- 1

50

10

30

.05

--

-1

0/0

9/2

02

0 1

4:1

8T

rue

Bensu

lide

L306

N/A

ICL

0.0

49

2ug

/L1

.04

74

64

87

---

---

---

50

- 1

50

98

0.0

5

---

10

/09

/20

20

14

:18

Tru

e

Bendio

carb

L306

N/A

ICL

0.0

49

6ug

/L1

.04

74

64

87

---

---

---

50

- 1

50

99

0.0

5

---

10

/09

/20

20

14

:18

Tru

e

Oxa

myl

L306

N/A

ICL

0.5

15

5ug

/L1

.04

74

64

87

---

---

---

50

- 1

50

10

30

.5

---

10

/09

/20

20

14

:18

Tru

e

3-H

ydro

xyca

rbofu

ran

L306

N/A

ICL

0.0

49

0ug

/L1

.04

74

64

87

---

---

---

50

- 1

50

98

0.0

5

---

10

/09

/20

20

14

:18

Tru

e

Fenuro

nL306

N/A

ICL

0.0

48

7ug

/L1

.04

74

64

87

---

---

---

50

- 1

50

97

0.0

5

---

10

/09

/20

20

14

:18

Tru

e

Ald

icarb

sulfone

L306

N/A

ICL

0.5

12

2ug

/L1

.04

74

64

87

---

---

---

50

- 1

50

10

20

.5

---

10

/09

/20

20

14

:18

Tru

e

Bayg

on

L306

N/A

ICL

0.0

49

5ug

/L1

.04

74

64

87

---

---

---

50

- 1

50

99

0.0

5

---

10

/09

/20

20

14

:18

Tru

e

Halo

fenozi

de

L306

N/A

ICL

0.0

48

9ug

/L1

.04

74

64

87

---

---

---

50

- 1

50

98

0.0

5

---

10

/09

/20

20

14

:18

Tru

e

Pacl

obutr

azo

lL306

N/A

ICL

0.0

48

1ug

/L1

.04

74

64

87

---

---

---

50

- 1

50

96

0.0

5

---

10

/09

/20

20

14

:18

Tru

e

Meta

laxy

l/M

eta

laxy

l-M

(M

efe

noxa

m)

L306

N/A

ICL

0.0

49

6ug

/L1

.04

74

64

87

---

---

---

50

- 1

50

99

0.0

5

---

10

/09

/20

20

14

:18

Tru

e

Ory

zalin

L306

N/A

ICL

0.4

81

6ug

/L1

.04

74

64

87

---

---

---

50

- 1

50

96

0.5

--

-1

0/0

9/2

02

0 1

4:1

8T

rue

Lin

uro

nL306

N/A

ICL

0.4

83

4ug

/L1

.04

74

64

87

---

---

---

50

- 1

50

97

0.5

--

-1

0/0

9/2

02

0 1

4:1

8T

rue

Pro

parg

ite

L306

N/A

ICL

0.0

41

1ug

/L1

.04

74

64

87

---

---

---

50

- 1

50

82

0.0

5

---

10

/09

/20

20

14

:18

Tru

e

Oxa

dia

zon

L306

N/A

ICL

0.0

49

7ug

/L1

.04

74

64

87

---

---

---

50

- 1

50

99

0.0

5

---

10

/09

/20

20

14

:18

Tru

e

Azo

xyst

robin

L306

N/A

ICL

0.4

88

2ug

/L1

.04

74

64

87

---

---

---

50

- 1

50

98

0.5

--

-1

0/0

9/2

02

0 1

4:1

8T

rue

Tri

adim

enol

L306

N/A

ICL

0.0

50

5ug

/L1

.04

74

64

87

---

---

---

50

- 1

50

10

10

.05

--

-1

0/0

9/2

02

0 1

4:1

8T

rue

Flu

om

etu

ron

L306

N/A

ICL

0.0

48

9ug

/L1

.04

74

64

87

---

---

---

50

- 1

50

98

0.0

5

---

10

/09

/20

20

14

:18

Tru

e

Ald

icarb

sulfoxi

de

L306

N/A

ICL

0.4

72

3ug

/L1

.04

74

64

87

---

---

---

50

- 1

50

94

0.5

--

-1

0/0

9/2

02

0 1

4:1

8T

rue

Clo

mazo

ne

L306

N/A

ICL

0.0

49

4ug

/L1

.04

74

64

87

---

---

---

50

- 1

50

99

0.0

5

---

10

/09

/20

20

14

:18

Tru

e

Monuro

nL306

N/A

ICL

0.0

47

6ug

/L1

.04

74

64

87

---

---

---

50

- 1

50

95

0.0

5

---

10

/09

/20

20

14

:18

Tru

e

Halo

sulfuro

n m

eth

ylL306

N/A

ICL

0.0

50

4ug

/L1

.04

74

64

87

---

---

---

50

- 1

50

10

10

.05

--

-1

0/0

9/2

02

0 1

4:1

8T

rue

Carb

ary

lL306

N/A

ICL

0.0

50

4ug

/L1

.04

74

64

87

---

---

---

50

- 1

50

10

10

.05

--

-1

0/0

9/2

02

0 1

4:1

8T

rue

Thid

iazu

ron

L306

N/A

ICL

0.0

47

4ug

/L1

.04

74

64

87

---

---

---

50

- 1

50

95

0.0

5

---

10

/09

/20

20

14

:18

Tru

e

Carb

ofu

ran

L306

N/A

ICL

0.0

46

8ug

/L1

.04

74

64

87

---

---

---

50

- 1

50

94

0.0

5

---

10

/09

/20

20

14

:18

Tru

e

Meth

ioca

rbL306

N/A

ICL

0.0

49

5ug

/L1

.04

74

64

87

---

---

---

50

- 1

50

99

0.0

5

---

10

/09

/20

20

14

:18

Tru

e

Imid

acl

opri

dL306

N/A

ICL

0.0

48

0ug

/L1

.04

74

64

87

---

---

---

50

- 1

50

96

0.0

5

---

10

/09

/20

20

14

:18

Tru

e

Tri

adim

efo

nL306

N/A

ICL

0.0

49

3ug

/L1

.04

74

64

87

---

---

---

50

- 1

50

99

0.0

5

---

10

/09

/20

20

14

:18

Fals

e

IS-L

inuro

n-d

6L306

N/A

ICS

30

41

1ug

/L1

.04

74

64

88

---

---

---

50

- 1

50

10

03

05

50

--

-1

0/0

9/2

02

0 1

4:4

2F

als

e

Diu

ron

L306

N/A

ICS

0.1

02

7ug

/L1

.04

74

64

88

---

---

---

70

- 1

30

10

30

.1

---

10

/09

/20

20

14

:42

Fals

e

Diflu

benzu

ron

L306

N/A

ICS

0.1

01

9ug

/L1

.04

74

64

88

---

---

---

70

- 1

30

10

20

.1

---

10

/09

/20

20

14

:42

Fals

e

Meth

om

ylL306

N/A

ICS

0.0

97

4ug

/L1

.04

74

64

88

---

---

---

70

- 1

30

97

0.1

--

-1

0/0

9/2

02

0 1

4:4

2

Page 2

of

12

EE

A R

un I

D 2

80793 /

EE

A R

eport

# 5

00223

Page 172 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Fals

e

Sid

uro

n, T

ota

lL306

N/A

ICS

0.1

06

0ug

/L1

.04

74

64

88

---

---

---

70

- 1

30

10

60

.1

---

10

/09

/20

20

14

:42

Fals

e

Neburo

nL306

N/A

ICS

0.1

01

9ug

/L1

.04

74

64

88

---

---

---

70

- 1

30

10

20

.1

---

10

/09

/20

20

14

:42

Fals

e

IS-D

iuro

n-d

6L306

N/A

ICS

62

16

61

ug

/L1

.04

74

64

88

---

---

---

50

- 1

50

99

62

92

37

--

-1

0/0

9/2

02

0 1

4:4

2F

als

e

Tebuth

iuro

nL306

N/A

ICS

0.1

02

0ug

/L1

.04

74

64

88

---

---

---

70

- 1

30

10

20

.1

---

10

/09

/20

20

14

:42

Fals

e

Pro

panil

L306

N/A

ICS

0.0

97

4ug

/L1

.04

74

64

88

---

---

---

70

- 1

30

97

0.1

--

-1

0/0

9/2

02

0 1

4:4

2F

als

e

Bensu

lide

L306

N/A

ICS

0.0

94

6ug

/L1

.04

74

64

88

---

---

---

70

- 1

30

95

0.1

--

-1

0/0

9/2

02

0 1

4:4

2F

als

e

Bendio

carb

L306

N/A

ICS

0.1

03

8ug

/L1

.04

74

64

88

---

---

---

70

- 1

30

10

40

.1

---

10

/09

/20

20

14

:42

Fals

e

Oxa

myl

L306

N/A

ICS

1.0

72

2ug

/L1

.04

74

64

88

---

---

---

70

- 1

30

10

71

.0

---

10

/09

/20

20

14

:42

Fals

e

3-H

ydro

xyca

rbofu

ran

L306

N/A

ICS

0.1

03

0ug

/L1

.04

74

64

88

---

---

---

70

- 1

30

10

30

.1

---

10

/09

/20

20

14

:42

Fals

e

Fenuro

nL306

N/A

ICS

0.1

03

4ug

/L1

.04

74

64

88

---

---

---

70

- 1

30

10

30

.1

---

10

/09

/20

20

14

:42

Fals

e

Ald

icarb

sulfone

L306

N/A

ICS

1.1

05

8ug

/L1

.04

74

64

88

---

---

---

70

- 1

30

11

11

.0

---

10

/09

/20

20

14

:42

Fals

e

Bayg

on

L306

N/A

ICS

0.1

04

8ug

/L1

.04

74

64

88

---

---

---

70

- 1

30

10

50

.1

---

10

/09

/20

20

14

:42

Fals

e

Halo

fenozi

de

L306

N/A

ICS

0.1

01

1ug

/L1

.04

74

64

88

---

---

---

70

- 1

30

10

10

.1

---

10

/09

/20

20

14

:42

Fals

e

Pacl

obutr

azo

lL306

N/A

ICS

0.1

04

7ug

/L1

.04

74

64

88

---

---

---

70

- 1

30

10

50

.1

---

10

/09

/20

20

14

:42

Fals

e

Meta

laxy

l/M

eta

laxy

l-M

(M

efe

noxa

m)

L306

N/A

ICS

0.1

03

8ug

/L1

.04

74

64

88

---

---

---

70

- 1

30

10

40

.1

---

10

/09

/20

20

14

:42

Fals

e

Ory

zalin

L306

N/A

ICS

1.0

41

5ug

/L1

.04

74

64

88

---

---

---

70

- 1

30

10

41

.0

---

10

/09

/20

20

14

:42

Fals

e

Lin

uro

nL306

N/A

ICS

0.8

64

4ug

/L1

.04

74

64

88

---

---

---

70

- 1

30

86

1.0

--

-1

0/0

9/2

02

0 1

4:4

2F

als

e

Pro

parg

ite

L306

N/A

ICS

0.1

01

6ug

/L1

.04

74

64

88

---

---

---

70

- 1

30

10

20

.1

---

10

/09

/20

20

14

:42

Fals

e

Oxa

dia

zon

L306

N/A

ICS

0.1

03

5ug

/L1

.04

74

64

88

---

---

---

70

- 1

30

10

40

.1

---

10

/09

/20

20

14

:42

Fals

e

Azo

xyst

robin

L306

N/A

ICS

1.0

70

4ug

/L1

.04

74

64

88

---

---

---

70

- 1

30

10

71

.0

---

10

/09

/20

20

14

:42

Fals

e

Tri

adim

enol

L306

N/A

ICS

0.0

98

6ug

/L1

.04

74

64

88

---

---

---

70

- 1

30

99

0.1

--

-1

0/0

9/2

02

0 1

4:4

2F

als

e

Flu

om

etu

ron

L306

N/A

ICS

0.1

02

5ug

/L1

.04

74

64

88

---

---

---

70

- 1

30

10

20

.1

---

10

/09

/20

20

14

:42

Fals

e

Ald

icarb

sulfoxi

de

L306

N/A

ICS

1.0

43

3ug

/L1

.04

74

64

88

---

---

---

70

- 1

30

10

41

.0

---

10

/09

/20

20

14

:42

Fals

e

Clo

mazo

ne

L306

N/A

ICS

0.1

01

4ug

/L1

.04

74

64

88

---

---

---

70

- 1

30

10

10

.1

---

10

/09

/20

20

14

:42

Fals

e

Monuro

nL306

N/A

ICS

0.1

04

1ug

/L1

.04

74

64

88

---

---

---

70

- 1

30

10

40

.1

---

10

/09

/20

20

14

:42

Fals

e

Halo

sulfuro

n m

eth

ylL306

N/A

ICS

0.0

94

9ug

/L1

.04

74

64

88

---

---

---

70

- 1

30

95

0.1

--

-1

0/0

9/2

02

0 1

4:4

2F

als

e

Carb

ary

lL306

N/A

ICS

0.1

00

0ug

/L1

.04

74

64

88

---

---

---

70

- 1

30

10

00

.1

---

10

/09

/20

20

14

:42

Fals

e

Thid

iazu

ron

L306

N/A

ICS

0.1

03

9ug

/L1

.04

74

64

88

---

---

---

70

- 1

30

10

40

.1

---

10

/09

/20

20

14

:42

Fals

e

Carb

ofu

ran

L306

N/A

ICS

0.1

08

3ug

/L1

.04

74

64

88

---

---

---

70

- 1

30

10

80

.1

---

10

/09

/20

20

14

:42

Fals

e

Meth

ioca

rbL306

N/A

ICS

0.1

03

1ug

/L1

.04

74

64

88

---

---

---

70

- 1

30

10

30

.1

---

10

/09

/20

20

14

:42

Fals

e

Imid

acl

opri

dL306

N/A

ICS

0.1

02

5ug

/L1

.04

74

64

88

---

---

---

70

- 1

30

10

30

.1

---

10

/09

/20

20

14

:42

Fals

e

Tri

adim

efo

nL306

N/A

ICS

0.1

00

0ug

/L1

.04

74

64

88

---

---

---

70

- 1

30

10

00

.1

---

10

/09

/20

20

14

:42

Tru

e

IS-L

inuro

n-d

6L306

N/A

ICS

30

41

8ug

/L1

.04

74

64

89

---

---

---

50

- 1

50

10

03

05

50

--

-1

0/0

9/2

02

0 1

5:0

7T

rue

Diu

ron

L306

N/A

ICS

0.1

94

7ug

/L1

.04

74

64

89

---

---

---

70

- 1

30

97

0.2

--

-1

0/0

9/2

02

0 1

5:0

7T

rue

Diflu

benzu

ron

L306

N/A

ICS

0.1

95

1ug

/L1

.04

74

64

89

---

---

---

70

- 1

30

98

0.2

--

-1

0/0

9/2

02

0 1

5:0

7T

rue

Meth

om

ylL306

N/A

ICS

0.1

95

5ug

/L1

.04

74

64

89

---

---

---

70

- 1

30

98

0.2

--

-1

0/0

9/2

02

0 1

5:0

7T

rue

Sid

uro

n, T

ota

lL306

N/A

ICS

0.1

90

3ug

/L1

.04

74

64

89

---

---

---

70

- 1

30

95

0.2

--

-1

0/0

9/2

02

0 1

5:0

7T

rue

Neburo

nL306

N/A

ICS

0.1

96

4ug

/L1

.04

74

64

89

---

---

---

70

- 1

30

98

0.2

--

-1

0/0

9/2

02

0 1

5:0

7T

rue

IS-D

iuro

n-d

6L306

N/A

ICS

63

61

11

ug

/L1

.04

74

64

89

---

---

---

50

- 1

50

10

16

29

23

7

---

10

/09

/20

20

15

:07

Tru

e

Tebuth

iuro

nL306

N/A

ICS

0.1

98

8ug

/L1

.04

74

64

89

---

---

---

70

- 1

30

99

0.2

--

-1

0/0

9/2

02

0 1

5:0

7T

rue

Pro

panil

L306

N/A

ICS

0.2

04

9ug

/L1

.04

74

64

89

---

---

---

70

- 1

30

10

20

.2

---

10

/09

/20

20

15

:07

Page 3

of

12

EE

A R

un I

D 2

80793 /

EE

A R

eport

# 5

00223

Page 173 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Tru

e

Bensu

lide

L306

N/A

ICS

0.1

99

5ug

/L1

.04

74

64

89

---

---

---

70

- 1

30

10

00

.2

---

10

/09

/20

20

15

:07

Tru

e

Bendio

carb

L306

N/A

ICS

0.1

96

7ug

/L1

.04

74

64

89

---

---

---

70

- 1

30

98

0.2

--

-1

0/0

9/2

02

0 1

5:0

7T

rue

Oxa

myl

L306

N/A

ICS

2.0

48

6ug

/L1

.04

74

64

89

---

---

---

70

- 1

30

10

22

.0

---

10

/09

/20

20

15

:07

Tru

e

3-H

ydro

xyca

rbofu

ran

L306

N/A

ICS

0.1

99

4ug

/L1

.04

74

64

89

---

---

---

70

- 1

30

10

00

.2

---

10

/09

/20

20

15

:07

Tru

e

Fenuro

nL306

N/A

ICS

0.1

98

3ug

/L1

.04

74

64

89

---

---

---

70

- 1

30

99

0.2

--

-1

0/0

9/2

02

0 1

5:0

7T

rue

Ald

icarb

sulfone

L306

N/A

ICS

2.1

27

9ug

/L1

.04

74

64

89

---

---

---

70

- 1

30

10

62

.0

---

10

/09

/20

20

15

:07

Tru

e

Bayg

on

L306

N/A

ICS

0.1

97

3ug

/L1

.04

74

64

89

---

---

---

70

- 1

30

99

0.2

--

-1

0/0

9/2

02

0 1

5:0

7T

rue

Halo

fenozi

de

L306

N/A

ICS

0.2

01

2ug

/L1

.04

74

64

89

---

---

---

70

- 1

30

10

10

.2

---

10

/09

/20

20

15

:07

Tru

e

Pacl

obutr

azo

lL306

N/A

ICS

0.1

97

7ug

/L1

.04

74

64

89

---

---

---

70

- 1

30

99

0.2

--

-1

0/0

9/2

02

0 1

5:0

7T

rue

Meta

laxy

l/M

eta

laxy

l-M

(M

efe

noxa

m)

L306

N/A

ICS

0.2

00

8ug

/L1

.04

74

64

89

---

---

---

70

- 1

30

10

00

.2

---

10

/09

/20

20

15

:07

Tru

e

Ory

zalin

L306

N/A

ICS

2.0

80

8ug

/L1

.04

74

64

89

---

---

---

70

- 1

30

10

42

.0

---

10

/09

/20

20

15

:07

Tru

e

Lin

uro

nL306

N/A

ICS

2.2

22

0ug

/L1

.04

74

64

89

---

---

---

70

- 1

30

11

12

.0

---

10

/09

/20

20

15

:07

Tru

e

Pro

parg

ite

L306

N/A

ICS

0.2

13

7ug

/L1

.04

74

64

89

---

---

---

70

- 1

30

10

70

.2

---

10

/09

/20

20

15

:07

Tru

e

Oxa

dia

zon

L306

N/A

ICS

0.1

98

2ug

/L1

.04

74

64

89

---

---

---

70

- 1

30

99

0.2

--

-1

0/0

9/2

02

0 1

5:0

7T

rue

Azo

xyst

robin

L306

N/A

ICS

2.0

15

5ug

/L1

.04

74

64

89

---

---

---

70

- 1

30

10

12

.0

---

10

/09

/20

20

15

:07

Tru

e

Tri

adim

enol

L306

N/A

ICS

0.1

97

6ug

/L1

.04

74

64

89

---

---

---

70

- 1

30

99

0.2

--

-1

0/0

9/2

02

0 1

5:0

7T

rue

Flu

om

etu

ron

L306

N/A

ICS

0.1

97

2ug

/L1

.04

74

64

89

---

---

---

70

- 1

30

99

0.2

--

-1

0/0

9/2

02

0 1

5:0

7T

rue

Ald

icarb

sulfoxi

de

L306

N/A

ICS

2.0

17

4ug

/L1

.04

74

64

89

---

---

---

70

- 1

30

10

12

.0

---

10

/09

/20

20

15

:07

Tru

e

Clo

mazo

ne

L306

N/A

ICS

0.2

03

1ug

/L1

.04

74

64

89

---

---

---

70

- 1

30

10

20

.2

---

10

/09

/20

20

15

:07

Tru

e

Monuro

nL306

N/A

ICS

0.1

97

6ug

/L1

.04

74

64

89

---

---

---

70

- 1

30

99

0.2

--

-1

0/0

9/2

02

0 1

5:0

7T

rue

Halo

sulfuro

n m

eth

ylL306

N/A

ICS

0.1

98

2ug

/L1

.04

74

64

89

---

---

---

70

- 1

30

99

0.2

--

-1

0/0

9/2

02

0 1

5:0

7T

rue

Carb

ary

lL306

N/A

ICS

0.1

98

5ug

/L1

.04

74

64

89

---

---

---

70

- 1

30

99

0.2

--

-1

0/0

9/2

02

0 1

5:0

7T

rue

Thid

iazu

ron

L306

N/A

ICS

0.1

95

1ug

/L1

.04

74

64

89

---

---

---

70

- 1

30

98

0.2

--

-1

0/0

9/2

02

0 1

5:0

7T

rue

Carb

ofu

ran

L306

N/A

ICS

0.1

97

1ug

/L1

.04

74

64

89

---

---

---

70

- 1

30

99

0.2

--

-1

0/0

9/2

02

0 1

5:0

7T

rue

Meth

ioca

rbL306

N/A

ICS

0.1

98

8ug

/L1

.04

74

64

89

---

---

---

70

- 1

30

99

0.2

--

-1

0/0

9/2

02

0 1

5:0

7T

rue

Imid

acl

opri

dL306

N/A

ICS

0.1

98

9ug

/L1

.04

74

64

89

---

---

---

70

- 1

30

99

0.2

--

-1

0/0

9/2

02

0 1

5:0

7T

rue

Tri

adim

efo

nL306

N/A

ICS

0.2

03

7ug

/L1

.04

74

64

89

---

---

---

70

- 1

30

10

20

.2

---

10

/09

/20

20

15

:07

Fals

e

IS-L

inuro

n-d

6L306

N/A

ICS

29

30

4ug

/L1

.04

74

64

90

---

---

---

50

- 1

50

96

30

55

0

---

10

/09

/20

20

15

:31

Fals

e

Diu

ron

L306

N/A

ICS

0.5

09

1ug

/L1

.04

74

64

90

---

---

---

70

- 1

30

10

20

.5

---

10

/09

/20

20

15

:31

Fals

e

Diflu

benzu

ron

L306

N/A

ICS

0.5

05

4ug

/L1

.04

74

64

90

---

---

---

70

- 1

30

10

10

.5

---

10

/09

/20

20

15

:31

Fals

e

Meth

om

ylL306

N/A

ICS

0.5

21

2ug

/L1

.04

74

64

90

---

---

---

70

- 1

30

10

40

.5

---

10

/09

/20

20

15

:31

Fals

e

Sid

uro

n, T

ota

lL306

N/A

ICS

0.5

06

1ug

/L1

.04

74

64

90

---

---

---

70

- 1

30

10

10

.5

---

10

/09

/20

20

15

:31

Fals

e

Neburo

nL306

N/A

ICS

0.5

05

5ug

/L1

.04

74

64

90

---

---

---

70

- 1

30

10

10

.5

---

10

/09

/20

20

15

:31

Fals

e

IS-D

iuro

n-d

6L306

N/A

ICS

63

18

42

ug

/L1

.04

74

64

90

---

---

---

50

- 1

50

10

06

29

23

7

---

10

/09

/20

20

15

:31

Fals

e

Tebuth

iuro

nL306

N/A

ICS

0.5

06

1ug

/L1

.04

74

64

90

---

---

---

70

- 1

30

10

10

.5

---

10

/09

/20

20

15

:31

Fals

e

Pro

panil

L306

N/A

ICS

0.5

34

3ug

/L1

.04

74

64

90

---

---

---

70

- 1

30

10

70

.5

---

10

/09

/20

20

15

:31

Fals

e

Bensu

lide

L306

N/A

ICS

0.4

86

6ug

/L1

.04

74

64

90

---

---

---

70

- 1

30

97

0.5

--

-1

0/0

9/2

02

0 1

5:3

1F

als

e

Bendio

carb

L306

N/A

ICS

0.5

10

1ug

/L1

.04

74

64

90

---

---

---

70

- 1

30

10

20

.5

---

10

/09

/20

20

15

:31

Fals

e

Oxa

myl

L306

N/A

ICS

5.0

71

0ug

/L1

.04

74

64

90

---

---

---

70

- 1

30

10

15

.0

---

10

/09

/20

20

15

:31

Fals

e

3-H

ydro

xyca

rbofu

ran

L306

N/A

ICS

0.5

08

3ug

/L1

.04

74

64

90

---

---

---

70

- 1

30

10

20

.5

---

10

/09

/20

20

15

:31

Fals

e

Fenuro

nL306

N/A

ICS

0.5

06

2ug

/L1

.04

74

64

90

---

---

---

70

- 1

30

10

10

.5

---

10

/09

/20

20

15

:31

Page 4

of

12

EE

A R

un I

D 2

80793 /

EE

A R

eport

# 5

00223

Page 174 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Fals

e

Ald

icarb

sulfone

L306

N/A

ICS

5.0

76

1ug

/L1

.04

74

64

90

---

---

---

70

- 1

30

10

25

.0

---

10

/09

/20

20

15

:31

Fals

e

Bayg

on

L306

N/A

ICS

0.5

12

0ug

/L1

.04

74

64

90

---

---

---

70

- 1

30

10

20

.5

---

10

/09

/20

20

15

:31

Fals

e

Halo

fenozi

de

L306

N/A

ICS

0.5

38

4ug

/L1

.04

74

64

90

---

---

---

70

- 1

30

10

80

.5

---

10

/09

/20

20

15

:31

Fals

e

Pacl

obutr

azo

lL306

N/A

ICS

0.5

03

9ug

/L1

.04

74

64

90

---

---

---

70

- 1

30

10

10

.5

---

10

/09

/20

20

15

:31

Fals

e

Meta

laxy

l/M

eta

laxy

l-M

(M

efe

noxa

m)

L306

N/A

ICS

0.5

07

0ug

/L1

.04

74

64

90

---

---

---

70

- 1

30

10

10

.5

---

10

/09

/20

20

15

:31

Fals

e

Ory

zalin

L306

N/A

ICS

5.3

95

0ug

/L1

.04

74

64

90

---

---

---

70

- 1

30

10

85

.0

---

10

/09

/20

20

15

:31

Fals

e

Lin

uro

nL306

N/A

ICS

5.7

72

7ug

/L1

.04

74

64

90

---

---

---

70

- 1

30

11

55

.0

---

10

/09

/20

20

15

:31

Fals

e

Pro

parg

ite

L306

N/A

ICS

0.4

84

4ug

/L1

.04

74

64

90

---

---

---

70

- 1

30

97

0.5

--

-1

0/0

9/2

02

0 1

5:3

1F

als

e

Oxa

dia

zon

L306

N/A

ICS

0.4

93

8ug

/L1

.04

74

64

90

---

---

---

70

- 1

30

99

0.5

--

-1

0/0

9/2

02

0 1

5:3

1F

als

e

Azo

xyst

robin

L306

N/A

ICS

5.1

82

4ug

/L1

.04

74

64

90

---

---

---

70

- 1

30

10

45

.0

---

10

/09

/20

20

15

:31

Fals

e

Tri

adim

enol

L306

N/A

ICS

0.5

18

4ug

/L1

.04

74

64

90

---

---

---

70

- 1

30

10

40

.5

---

10

/09

/20

20

15

:31

Fals

e

Flu

om

etu

ron

L306

N/A

ICS

0.5

07

3ug

/L1

.04

74

64

90

---

---

---

70

- 1

30

10

10

.5

---

10

/09

/20

20

15

:31

Fals

e

Ald

icarb

sulfoxi

de

L306

N/A

ICS

5.1

41

7ug

/L1

.04

74

64

90

---

---

---

70

- 1

30

10

35

.0

---

10

/09

/20

20

15

:31

Fals

e

Clo

mazo

ne

L306

N/A

ICS

0.5

11

1ug

/L1

.04

74

64

90

---

---

---

70

- 1

30

10

20

.5

---

10

/09

/20

20

15

:31

Fals

e

Monuro

nL306

N/A

ICS

0.5

13

0ug

/L1

.04

74

64

90

---

---

---

70

- 1

30

10

30

.5

---

10

/09

/20

20

15

:31

Fals

e

Halo

sulfuro

n m

eth

ylL306

N/A

ICS

0.5

05

8ug

/L1

.04

74

64

90

---

---

---

70

- 1

30

10

10

.5

---

10

/09

/20

20

15

:31

Fals

e

Carb

ary

lL306

N/A

ICS

0.5

12

1ug

/L1

.04

74

64

90

---

---

---

70

- 1

30

10

20

.5

---

10

/09

/20

20

15

:31

Fals

e

Thid

iazu

ron

L306

N/A

ICS

0.5

13

9ug

/L1

.04

74

64

90

---

---

---

70

- 1

30

10

30

.5

---

10

/09

/20

20

15

:31

Fals

e

Carb

ofu

ran

L306

N/A

ICS

0.5

18

6ug

/L1

.04

74

64

90

---

---

---

70

- 1

30

10

40

.5

---

10

/09

/20

20

15

:31

Fals

e

Meth

ioca

rbL306

N/A

ICS

0.5

12

6ug

/L1

.04

74

64

90

---

---

---

70

- 1

30

10

30

.5

---

10

/09

/20

20

15

:31

Fals

e

Imid

acl

opri

dL306

N/A

ICS

0.5

03

3ug

/L1

.04

74

64

90

---

---

---

70

- 1

30

10

10

.5

---

10

/09

/20

20

15

:31

Fals

e

Tri

adim

efo

nL306

N/A

ICS

0.5

01

3ug

/L1

.04

74

64

90

---

---

---

70

- 1

30

10

00

.5

---

10

/09

/20

20

15

:31

Tru

e

IS-L

inuro

n-d

6L306

N/A

ICS

32

55

0ug

/L1

.04

74

64

91

---

---

---

50

- 1

50

10

73

05

50

--

-1

0/0

9/2

02

0 1

5:5

6T

rue

Diu

ron

L306

N/A

ICS

0.9

98

0ug

/L1

.04

74

64

91

---

---

---

70

- 1

30

10

01

.0

---

10

/09

/20

20

15

:56

Tru

e

Diflu

benzu

ron

L306

N/A

ICS

0.9

98

9ug

/L1

.04

74

64

91

---

---

---

70

- 1

30

10

01

.0

---

10

/09

/20

20

15

:56

Tru

e

Meth

om

ylL306

N/A

ICS

0.9

82

2ug

/L1

.04

74

64

91

---

---

---

70

- 1

30

98

1.0

--

-1

0/0

9/2

02

0 1

5:5

6T

rue

Sid

uro

n, T

ota

lL306

N/A

ICS

1.0

02

5ug

/L1

.04

74

64

91

---

---

---

70

- 1

30

10

01

.0

---

10

/09

/20

20

15

:56

Tru

e

Neburo

nL306

N/A

ICS

1.0

01

1ug

/L1

.04

74

64

91

---

---

---

70

- 1

30

10

01

.0

---

10

/09

/20

20

15

:56

Tru

e

IS-D

iuro

n-d

6L306

N/A

ICS

65

16

91

ug

/L1

.04

74

64

91

---

---

---

50

- 1

50

10

46

29

23

7

---

10

/09

/20

20

15

:56

Tru

e

Tebuth

iuro

nL306

N/A

ICS

0.9

99

6ug

/L1

.04

74

64

91

---

---

---

70

- 1

30

10

01

.0

---

10

/09

/20

20

15

:56

Tru

e

Pro

panil

L306

N/A

ICS

0.9

69

0ug

/L1

.04

74

64

91

---

---

---

70

- 1

30

97

1.0

--

-1

0/0

9/2

02

0 1

5:5

6T

rue

Bensu

lide

L306

N/A

ICS

1.0

04

3ug

/L1

.04

74

64

91

---

---

---

70

- 1

30

10

01

.0

---

10

/09

/20

20

15

:56

Tru

e

Bendio

carb

L306

N/A

ICS

1.0

01

0ug

/L1

.04

74

64

91

---

---

---

70

- 1

30

10

01

.0

---

10

/09

/20

20

15

:56

Tru

e

Oxa

myl

L306

N/A

ICS

9.4

73

4ug

/L1

.04

74

64

91

---

---

---

70

- 1

30

95

10

.0

---

10

/09

/20

20

15

:56

Tru

e

3-H

ydro

xyca

rbofu

ran

L306

N/A

ICS

1.0

00

8ug

/L1

.04

74

64

91

---

---

---

70

- 1

30

10

01

.0

---

10

/09

/20

20

15

:56

Tru

e

Fenuro

nL306

N/A

ICS

1.0

01

7ug

/L1

.04

74

64

91

---

---

---

70

- 1

30

10

01

.0

---

10

/09

/20

20

15

:56

Tru

e

Ald

icarb

sulfone

L306

N/A

ICS

9.1

29

9ug

/L1

.04

74

64

91

---

---

---

70

- 1

30

91

10

.0

---

10

/09

/20

20

15

:56

Tru

e

Bayg

on

L306

N/A

ICS

0.9

92

9ug

/L1

.04

74

64

91

---

---

---

70

- 1

30

99

1.0

--

-1

0/0

9/2

02

0 1

5:5

6T

rue

Halo

fenozi

de

L306

N/A

ICS

0.9

83

4ug

/L1

.04

74

64

91

---

---

---

70

- 1

30

98

1.0

--

-1

0/0

9/2

02

0 1

5:5

6T

rue

Pacl

obutr

azo

lL306

N/A

ICS

1.0

09

3ug

/L1

.04

74

64

91

---

---

---

70

- 1

30

10

11

.0

---

10

/09

/20

20

15

:56

Tru

e

Meta

laxy

l/M

eta

laxy

l-M

(M

efe

noxa

m)

L306

N/A

ICS

0.9

92

6ug

/L1

.04

74

64

91

---

---

---

70

- 1

30

99

1.0

--

-1

0/0

9/2

02

0 1

5:5

6

Page 5

of

12

EE

A R

un I

D 2

80793 /

EE

A R

eport

# 5

00223

Page 175 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Tru

e

Ory

zalin

L306

N/A

ICS

9.6

02

4ug

/L1

.04

74

64

91

---

---

---

70

- 1

30

96

10

.0

---

10

/09

/20

20

15

:56

Tru

e

Lin

uro

nL306

N/A

ICS

9.9

38

9ug

/L1

.04

74

64

91

---

---

---

70

- 1

30

99

10

.0

---

10

/09

/20

20

15

:56

Tru

e

Pro

parg

ite

L306

N/A

ICS

0.9

89

1ug

/L1

.04

74

64

91

---

---

---

70

- 1

30

99

1.0

--

-1

0/0

9/2

02

0 1

5:5

6T

rue

Oxa

dia

zon

L306

N/A

ICS

1.0

05

2ug

/L1

.04

74

64

91

---

---

---

70

- 1

30

10

11

.0

---

10

/09

/20

20

15

:56

Tru

e

Azo

xyst

robin

L306

N/A

ICS

9.9

75

1ug

/L1

.04

74

64

91

---

---

---

70

- 1

30

10

01

0.0

--

-1

0/0

9/2

02

0 1

5:5

6T

rue

Tri

adim

enol

L306

N/A

ICS

0.9

89

9ug

/L1

.04

74

64

91

---

---

---

70

- 1

30

99

1.0

--

-1

0/0

9/2

02

0 1

5:5

6T

rue

Flu

om

etu

ron

L306

N/A

ICS

1.0

02

9ug

/L1

.04

74

64

91

---

---

---

70

- 1

30

10

01

.0

---

10

/09

/20

20

15

:56

Tru

e

Ald

icarb

sulfoxi

de

L306

N/A

ICS

9.6

56

4ug

/L1

.04

74

64

91

---

---

---

70

- 1

30

97

10

.0

---

10

/09

/20

20

15

:56

Tru

e

Clo

mazo

ne

L306

N/A

ICS

0.9

86

6ug

/L1

.04

74

64

91

---

---

---

70

- 1

30

99

1.0

--

-1

0/0

9/2

02

0 1

5:5

6T

rue

Monuro

nL306

N/A

ICS

0.9

95

8ug

/L1

.04

74

64

91

---

---

---

70

- 1

30

10

01

.0

---

10

/09

/20

20

15

:56

Tru

e

Halo

sulfuro

n m

eth

ylL306

N/A

ICS

0.9

96

0ug

/L1

.04

74

64

91

---

---

---

70

- 1

30

10

01

.0

---

10

/09

/20

20

15

:56

Tru

e

Carb

ary

lL306

N/A

ICS

0.9

96

0ug

/L1

.04

74

64

91

---

---

---

70

- 1

30

10

01

.0

---

10

/09

/20

20

15

:56

Tru

e

Thid

iazu

ron

L306

N/A

ICS

0.9

90

2ug

/L1

.04

74

64

91

---

---

---

70

- 1

30

99

1.0

--

-1

0/0

9/2

02

0 1

5:5

6T

rue

Carb

ofu

ran

L306

N/A

ICS

0.9

95

9ug

/L1

.04

74

64

91

---

---

---

70

- 1

30

10

01

.0

---

10

/09

/20

20

15

:56

Tru

e

Meth

ioca

rbL306

N/A

ICS

1.0

01

7ug

/L1

.04

74

64

91

---

---

---

70

- 1

30

10

01

.0

---

10

/09

/20

20

15

:56

Tru

e

Imid

acl

opri

dL306

N/A

ICS

1.0

02

8ug

/L1

.04

74

64

91

---

---

---

70

- 1

30

10

01

.0

---

10

/09

/20

20

15

:56

Tru

e

Tri

adim

efo

nL306

N/A

ICS

1.0

08

9ug

/L1

.04

74

64

91

---

---

---

70

- 1

30

10

11

.0

---

10

/09

/20

20

15

:56

Fals

e

IS-L

inuro

n-d

6L306

N/A

ICS

31

02

0ug

/L1

.04

74

64

92

---

---

---

50

- 1

50

10

23

05

50

--

-1

0/0

9/2

02

0 1

6:2

0F

als

e

Diu

ron

L306

N/A

ICS

1.9

91

8ug

/L1

.04

74

64

92

---

---

---

70

- 1

30

10

02

.0

---

10

/09

/20

20

16

:20

Fals

e

Diflu

benzu

ron

L306

N/A

ICS

2.0

00

1ug

/L1

.04

74

64

92

---

---

---

70

- 1

30

10

02

.0

---

10

/09

/20

20

16

:20

Fals

e

Meth

om

ylL306

N/A

ICS

1.9

92

2ug

/L1

.04

74

64

92

---

---

---

70

- 1

30

10

02

.0

---

10

/09

/20

20

16

:20

Fals

e

Sid

uro

n, T

ota

lL306

N/A

ICS

1.9

93

0ug

/L1

.04

74

64

92

---

---

---

70

- 1

30

10

02

.0

---

10

/09

/20

20

16

:20

Fals

e

Neburo

nL306

N/A

ICS

1.9

95

7ug

/L1

.04

74

64

92

---

---

---

70

- 1

30

10

02

.0

---

10

/09

/20

20

16

:20

Fals

e

IS-D

iuro

n-d

6L306

N/A

ICS

63

29

51

ug

/L1

.04

74

64

92

---

---

---

50

- 1

50

10

16

29

23

7

---

10

/09

/20

20

16

:20

Fals

e

Tebuth

iuro

nL306

N/A

ICS

1.9

89

7ug

/L1

.04

74

64

92

---

---

---

70

- 1

30

99

2.0

--

-1

0/0

9/2

02

0 1

6:2

0F

als

e

Pro

panil

L306

N/A

ICS

1.9

84

0ug

/L1

.04

74

64

92

---

---

---

70

- 1

30

99

2.0

--

-1

0/0

9/2

02

0 1

6:2

0F

als

e

Bensu

lide

L306

N/A

ICS

2.0

27

3ug

/L1

.04

74

64

92

---

---

---

70

- 1

30

10

12

.0

---

10

/09

/20

20

16

:20

Fals

e

Bendio

carb

L306

N/A

ICS

1.9

80

8ug

/L1

.04

74

64

92

---

---

---

70

- 1

30

99

2.0

--

-1

0/0

9/2

02

0 1

6:2

0F

als

e

Oxa

myl

L306

N/A

ICS

20

.66

85

ug

/L1

.04

74

64

92

---

---

---

70

- 1

30

10

32

0.0

--

-1

0/0

9/2

02

0 1

6:2

0F

als

e

3-H

ydro

xyca

rbofu

ran

L306

N/A

ICS

1.9

82

6ug

/L1

.04

74

64

92

---

---

---

70

- 1

30

99

2.0

--

-1

0/0

9/2

02

0 1

6:2

0F

als

e

Fenuro

nL306

N/A

ICS

1.9

86

7ug

/L1

.04

74

64

92

---

---

---

70

- 1

30

99

2.0

--

-1

0/0

9/2

02

0 1

6:2

0F

als

e

Ald

icarb

sulfone

L306

N/A

ICS

22

.34

79

ug

/L1

.04

74

64

92

---

---

---

70

- 1

30

11

22

0.0

--

-1

0/0

9/2

02

0 1

6:2

0F

als

e

Bayg

on

L306

N/A

ICS

1.9

87

3ug

/L1

.04

74

64

92

---

---

---

70

- 1

30

99

2.0

--

-1

0/0

9/2

02

0 1

6:2

0F

als

e

Halo

fenozi

de

L306

N/A

ICS

1.9

62

7ug

/L1

.04

74

64

92

---

---

---

70

- 1

30

98

2.0

--

-1

0/0

9/2

02

0 1

6:2

0F

als

e

Pacl

obutr

azo

lL306

N/A

ICS

1.9

80

9ug

/L1

.04

74

64

92

---

---

---

70

- 1

30

99

2.0

--

-1

0/0

9/2

02

0 1

6:2

0F

als

e

Meta

laxy

l/M

eta

laxy

l-M

(M

efe

noxa

m)

L306

N/A

ICS

1.9

92

3ug

/L1

.04

74

64

92

---

---

---

70

- 1

30

10

02

.0

---

10

/09

/20

20

16

:20

Fals

e

Ory

zalin

L306

N/A

ICS

19

.73

44

ug

/L1

.04

74

64

92

---

---

---

70

- 1

30

99

20

.0

---

10

/09

/20

20

16

:20

Fals

e

Lin

uro

nL306

N/A

ICS

18

.86

51

ug

/L1

.04

74

64

92

---

---

---

70

- 1

30

94

20

.0

---

10

/09

/20

20

16

:20

Fals

e

Pro

parg

ite

L306

N/A

ICS

2.0

31

2ug

/L1

.04

74

64

92

---

---

---

70

- 1

30

10

22

.0

---

10

/09

/20

20

16

:20

Fals

e

Oxa

dia

zon

L306

N/A

ICS

1.9

99

9ug

/L1

.04

74

64

92

---

---

---

70

- 1

30

10

02

.0

---

10

/09

/20

20

16

:20

Fals

e

Azo

xyst

robin

L306

N/A

ICS

19

.57

41

ug

/L1

.04

74

64

92

---

---

---

70

- 1

30

98

20

.0

---

10

/09

/20

20

16

:20

Page 6

of

12

EE

A R

un I

D 2

80793 /

EE

A R

eport

# 5

00223

Page 176 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Fals

e

Tri

adim

enol

L306

N/A

ICS

1.9

91

4ug

/L1

.04

74

64

92

---

---

---

70

- 1

30

10

02

.0

---

10

/09

/20

20

16

:20

Fals

e

Flu

om

etu

ron

L306

N/A

ICS

1.9

87

2ug

/L1

.04

74

64

92

---

---

---

70

- 1

30

99

2.0

--

-1

0/0

9/2

02

0 1

6:2

0F

als

e

Ald

icarb

sulfoxi

de

L306

N/A

ICS

20

.24

67

ug

/L1

.04

74

64

92

---

---

---

70

- 1

30

10

12

0.0

--

-1

0/0

9/2

02

0 1

6:2

0F

als

e

Clo

mazo

ne

L306

N/A

ICS

1.9

94

0ug

/L1

.04

74

64

92

---

---

---

70

- 1

30

10

02

.0

---

10

/09

/20

20

16

:20

Fals

e

Monuro

nL306

N/A

ICS

1.9

86

0ug

/L1

.04

74

64

92

---

---

---

70

- 1

30

99

2.0

--

-1

0/0

9/2

02

0 1

6:2

0F

als

e

Halo

sulfuro

n m

eth

ylL306

N/A

ICS

2.0

07

0ug

/L1

.04

74

64

92

---

---

---

70

- 1

30

10

02

.0

---

10

/09

/20

20

16

:20

Fals

e

Carb

ary

lL306

N/A

ICS

1.9

88

0ug

/L1

.04

74

64

92

---

---

---

70

- 1

30

99

2.0

--

-1

0/0

9/2

02

0 1

6:2

0F

als

e

Thid

iazu

ron

L306

N/A

ICS

1.9

97

9ug

/L1

.04

74

64

92

---

---

---

70

- 1

30

10

02

.0

---

10

/09

/20

20

16

:20

Fals

e

Carb

ofu

ran

L306

N/A

ICS

1.9

71

4ug

/L1

.04

74

64

92

---

---

---

70

- 1

30

99

2.0

--

-1

0/0

9/2

02

0 1

6:2

0F

als

e

Meth

ioca

rbL306

N/A

ICS

1.9

74

3ug

/L1

.04

74

64

92

---

---

---

70

- 1

30

99

2.0

--

-1

0/0

9/2

02

0 1

6:2

0F

als

e

Imid

acl

opri

dL306

N/A

ICS

1.9

92

1ug

/L1

.04

74

64

92

---

---

---

70

- 1

30

10

02

.0

---

10

/09

/20

20

16

:20

Fals

e

Tri

adim

efo

nL306

N/A

ICS

1.9

81

5ug

/L1

.04

74

64

92

---

---

---

70

- 1

30

99

2.0

--

-1

0/0

9/2

02

0 1

6:2

0T

rue

IS-L

inuro

n-d

6L306

N/A

ICS

30

05

3ug

/L1

.04

74

64

93

---

---

---

50

- 1

50

98

30

55

0

---

10

/09

/20

20

16

:44

Tru

e

Diu

ron

L306

N/A

ICS

5.0

03

0ug

/L1

.04

74

64

93

---

---

---

70

- 1

30

10

05

.0

---

10

/09

/20

20

16

:44

Tru

e

Diflu

benzu

ron

L306

N/A

ICS

4.9

99

8ug

/L1

.04

74

64

93

---

---

---

70

- 1

30

10

05

.0

---

10

/09

/20

20

16

:44

Tru

e

Meth

om

ylL306

N/A

ICS

5.0

06

0ug

/L1

.04

74

64

93

---

---

---

70

- 1

30

10

05

.0

---

10

/09

/20

20

16

:44

Tru

e

Sid

uro

n, T

ota

lL306

N/A

ICS

5.0

02

0ug

/L1

.04

74

64

93

---

---

---

70

- 1

30

10

05

.0

---

10

/09

/20

20

16

:44

Tru

e

Neburo

nL306

N/A

ICS

5.0

01

1ug

/L1

.04

74

64

93

---

---

---

70

- 1

30

10

05

.0

---

10

/09

/20

20

16

:44

Tru

e

IS-D

iuro

n-d

6L306

N/A

ICS

63

06

85

ug

/L1

.04

74

64

93

---

---

---

50

- 1

50

10

06

29

23

7

---

10

/09

/20

20

16

:44

Tru

e

Tebuth

iuro

nL306

N/A

ICS

5.0

03

9ug

/L1

.04

74

64

93

---

---

---

70

- 1

30

10

05

.0

---

10

/09

/20

20

16

:44

Tru

e

Pro

panil

L306

N/A

ICS

5.0

08

9ug

/L1

.04

74

64

93

---

---

---

70

- 1

30

10

05

.0

---

10

/09

/20

20

16

:44

Tru

e

Bensu

lide

L306

N/A

ICS

4.9

88

2ug

/L1

.04

74

64

93

---

---

---

70

- 1

30

10

05

.0

---

10

/09

/20

20

16

:44

Tru

e

Bendio

carb

L306

N/A

ICS

5.0

09

2ug

/L1

.04

74

64

93

---

---

---

70

- 1

30

10

05

.0

---

10

/09

/20

20

16

:44

Tru

e

3-H

ydro

xyca

rbofu

ran

L306

N/A

ICS

5.0

07

4ug

/L1

.04

74

64

93

---

---

---

70

- 1

30

10

05

.0

---

10

/09

/20

20

16

:44

Tru

e

Fenuro

nL306

N/A

ICS

5.0

05

1ug

/L1

.04

74

64

93

---

---

---

70

- 1

30

10

05

.0

---

10

/09

/20

20

16

:44

Tru

e

Bayg

on

L306

N/A

ICS

5.0

06

5ug

/L1

.04

74

64

93

---

---

---

70

- 1

30

10

05

.0

---

10

/09

/20

20

16

:44

Tru

e

Halo

fenozi

de

L306

N/A

ICS

5.0

14

4ug

/L1

.04

74

64

93

---

---

---

70

- 1

30

10

05

.0

---

10

/09

/20

20

16

:44

Tru

e

Pacl

obutr

azo

lL306

N/A

ICS

5.0

05

5ug

/L1

.04

74

64

93

---

---

---

70

- 1

30

10

05

.0

---

10

/09

/20

20

16

:44

Tru

e

Meta

laxy

l/M

eta

laxy

l-M

(M

efe

noxa

m)

L306

N/A

ICS

5.0

03

8ug

/L1

.04

74

64

93

---

---

---

70

- 1

30

10

05

.0

---

10

/09

/20

20

16

:44

Tru

e

Ory

zalin

L306

N/A

ICS

50

.17

37

ug

/L1

.04

74

64

93

---

---

---

70

- 1

30

10

05

0.0

--

-1

0/0

9/2

02

0 1

6:4

4T

rue

Lin

uro

nL306

N/A

ICS

50

.35

46

ug

/L1

.04

74

64

93

---

---

---

70

- 1

30

10

15

0.0

--

-1

0/0

9/2

02

0 1

6:4

4T

rue

Pro

parg

ite

L306

N/A

ICS

4.9

87

9ug

/L1

.04

74

64

93

---

---

---

70

- 1

30

10

05

.0

---

10

/09

/20

20

16

:44

Tru

e

Oxa

dia

zon

L306

N/A

ICS

4.9

99

6ug

/L1

.04

74

64

93

---

---

---

70

- 1

30

10

05

.0

---

10

/09

/20

20

16

:44

Tru

e

Azo

xyst

robin

L306

N/A

ICS

50

.22

94

ug

/L1

.04

74

64

93

---

---

---

70

- 1

30

10

05

0.0

--

-1

0/0

9/2

02

0 1

6:4

4T

rue

Tri

adim

enol

L306

N/A

ICS

5.0

03

8ug

/L1

.04

74

64

93

---

---

---

70

- 1

30

10

05

.0

---

10

/09

/20

20

16

:44

Tru

e

Flu

om

etu

ron

L306

N/A

ICS

5.0

04

0ug

/L1

.04

74

64

93

---

---

---

70

- 1

30

10

05

.0

---

10

/09

/20

20

16

:44

Tru

e

Clo

mazo

ne

L306

N/A

ICS

5.0

04

8ug

/L1

.04

74

64

93

---

---

---

70

- 1

30

10

05

.0

---

10

/09

/20

20

16

:44

Tru

e

Monuro

nL306

N/A

ICS

5.0

06

3ug

/L1

.04

74

64

93

---

---

---

70

- 1

30

10

05

.0

---

10

/09

/20

20

16

:44

Tru

e

Halo

sulfuro

n m

eth

ylL306

N/A

ICS

4.9

97

6ug

/L1

.04

74

64

93

---

---

---

70

- 1

30

10

05

.0

---

10

/09

/20

20

16

:44

Tru

e

Carb

ary

lL306

N/A

ICS

5.0

05

0ug

/L1

.04

74

64

93

---

---

---

70

- 1

30

10

05

.0

---

10

/09

/20

20

16

:44

Tru

e

Thid

iazu

ron

L306

N/A

ICS

5.0

01

6ug

/L1

.04

74

64

93

---

---

---

70

- 1

30

10

05

.0

---

10

/09

/20

20

16

:44

Page 7

of

12

EE

A R

un I

D 2

80793 /

EE

A R

eport

# 5

00223

Page 177 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Tru

e

Carb

ofu

ran

L306

N/A

ICS

5.0

12

5ug

/L1

.04

74

64

93

---

---

---

70

- 1

30

10

05

.0

---

10

/09

/20

20

16

:44

Tru

e

Meth

ioca

rbL306

N/A

ICS

5.0

10

4ug

/L1

.04

74

64

93

---

---

---

70

- 1

30

10

05

.0

---

10

/09

/20

20

16

:44

Tru

e

Imid

acl

opri

dL306

N/A

ICS

5.0

02

4ug

/L1

.04

74

64

93

---

---

---

70

- 1

30

10

05

.0

---

10

/09

/20

20

16

:44

Tru

e

Tri

adim

efo

nL306

N/A

ICS

5.0

05

2ug

/L1

.04

74

64

93

---

---

---

70

- 1

30

10

05

.0

---

10

/09

/20

20

16

:44

Fals

e

IS-L

inuro

n-d

6L306

N/A

LM

B3

08

59

ug

/L1

.04

74

64

95

---

---

---

50

- 1

50

10

13

05

50

--

-1

0/0

9/2

02

0 1

7:3

3F

als

e

Diu

ron

L306

0.0

5L

MB

0.0

5ug

/L1

.04

74

64

95

---

---

---

---

---

<

---

10

/09

/20

20

17

:33

Fals

e

Diflu

benzu

ron

L306

0.0

5L

MB

0.0

5ug

/L1

.04

74

64

95

---

---

---

---

---

<

---

10

/09

/20

20

17

:33

Fals

e

Meth

om

ylL306

0.0

5L

MB

0.0

5ug

/L1

.04

74

64

95

---

---

---

---

---

<

---

10

/09

/20

20

17

:33

Fals

e

Sid

uro

n, T

ota

lL306

0.0

5L

MB

0.0

5ug

/L1

.04

74

64

95

---

---

---

---

---

<

---

10

/09

/20

20

17

:33

Fals

e

Neburo

nL306

0.0

5L

MB

0.0

5ug

/L1

.04

74

64

95

---

---

---

---

---

<

---

10

/09

/20

20

17

:33

Fals

e

IS-D

iuro

n-d

6L306

N/A

LM

B6

47

52

1ug

/L1

.04

74

64

95

---

---

---

50

- 1

50

10

36

29

23

7

---

10

/09

/20

20

17

:33

Fals

e

Tebuth

iuro

nL306

0.0

5L

MB

0.0

5ug

/L1

.04

74

64

95

---

---

---

---

---

<

---

10

/09

/20

20

17

:33

Fals

e

Pro

panil

L306

0.0

5L

MB

0.0

5ug

/L1

.04

74

64

95

---

---

---

---

---

<

---

10

/09

/20

20

17

:33

Fals

e

Bensu

lide

L306

0.0

5L

MB

0.0

5ug

/L1

.04

74

64

95

---

---

---

---

---

<

---

10

/09

/20

20

17

:33

Fals

e

Bendio

carb

L306

0.0

5L

MB

0.0

5ug

/L1

.04

74

64

95

---

---

---

---

---

<

---

10

/09

/20

20

17

:33

Fals

e

Oxa

myl

L306

0.5

LM

B0

.5ug

/L1

.04

74

64

95

---

---

---

---

---

<

---

10

/09

/20

20

17

:33

Fals

e

3-H

ydro

xyca

rbofu

ran

L306

0.0

5L

MB

0.0

5ug

/L1

.04

74

64

95

---

---

---

---

---

<

---

10

/09

/20

20

17

:33

Fals

e

Fenuro

nL306

0.0

5L

MB

0.0

5ug

/L1

.04

74

64

95

---

---

---

---

---

<

---

10

/09

/20

20

17

:33

Fals

e

Ald

icarb

sulfone

L306

0.5

LM

B0

.5ug

/L1

.04

74

64

95

---

---

---

---

---

<

---

10

/09

/20

20

17

:33

Fals

e

Bayg

on

L306

0.0

5L

MB

0.0

5ug

/L1

.04

74

64

95

---

---

---

---

---

<

---

10

/09

/20

20

17

:33

Fals

e

Halo

fenozi

de

L306

0.0

5L

MB

0.0

5ug

/L1

.04

74

64

95

---

---

---

---

---

<

---

10

/09

/20

20

17

:33

Fals

e

Pacl

obutr

azo

lL306

0.0

5L

MB

0.0

5ug

/L1

.04

74

64

95

---

---

---

---

---

<

---

10

/09

/20

20

17

:33

Fals

e

Meta

laxy

l/M

eta

laxy

l-M

(M

efe

noxa

m)

L306

0.0

5L

MB

0.0

5ug

/L1

.04

74

64

95

---

---

---

---

---

<

---

10

/09

/20

20

17

:33

Fals

e

Ory

zalin

L306

0.5

LM

B0

.5ug

/L1

.04

74

64

95

---

---

---

---

---

<

---

10

/09

/20

20

17

:33

Fals

e

Lin

uro

nL306

0.5

LM

B0

.5ug

/L1

.04

74

64

95

---

---

---

---

---

<

---

10

/09

/20

20

17

:33

Fals

e

Pro

parg

ite

L306

0.0

5L

MB

0.0

5ug

/L1

.04

74

64

95

---

---

---

---

---

<

---

10

/09

/20

20

17

:33

Fals

e

Oxa

dia

zon

L306

0.0

5L

MB

0.0

5ug

/L1

.04

74

64

95

---

---

---

---

---

<

---

10

/09

/20

20

17

:33

Fals

e

Azo

xyst

robin

L306

0.5

LM

B0

.5ug

/L1

.04

74

64

95

---

---

---

---

---

<

---

10

/09

/20

20

17

:33

Fals

e

Tri

adim

enol

L306

0.0

5L

MB

0.0

5ug

/L1

.04

74

64

95

---

---

---

---

---

<

---

10

/09

/20

20

17

:33

Fals

e

Flu

om

etu

ron

L306

0.0

5L

MB

0.0

5ug

/L1

.04

74

64

95

---

---

---

---

---

<

---

10

/09

/20

20

17

:33

Fals

e

Ald

icarb

sulfoxi

de

L306

0.5

LM

B0

.5ug

/L1

.04

74

64

95

---

---

---

---

---

<

---

10

/09

/20

20

17

:33

Fals

e

Clo

mazo

ne

L306

0.0

5L

MB

0.0

5ug

/L1

.04

74

64

95

---

---

---

---

---

<

---

10

/09

/20

20

17

:33

Fals

e

Monuro

nL306

0.0

5L

MB

0.0

5ug

/L1

.04

74

64

95

---

---

---

---

---

<

---

10

/09

/20

20

17

:33

Fals

e

Halo

sulfuro

n m

eth

ylL306

0.0

5L

MB

0.0

5ug

/L1

.04

74

64

95

---

---

---

---

---

<

---

10

/09

/20

20

17

:33

Fals

e

Carb

ary

lL306

0.0

5L

MB

0.0

5ug

/L1

.04

74

64

95

---

---

---

---

---

<

---

10

/09

/20

20

17

:33

Fals

e

Thid

iazu

ron

L306

0.0

5L

MB

0.0

5ug

/L1

.04

74

64

95

---

---

---

---

---

<

---

10

/09

/20

20

17

:33

Fals

e

Carb

ofu

ran

L306

0.0

5L

MB

0.0

5ug

/L1

.04

74

64

95

---

---

---

---

---

<

---

10

/09

/20

20

17

:33

Fals

e

Meth

ioca

rbL306

0.0

5L

MB

0.0

5ug

/L1

.04

74

64

95

---

---

---

---

---

<

---

10

/09

/20

20

17

:33

Fals

e

Imid

acl

opri

dL306

0.0

5L

MB

0.0

5ug

/L1

.04

74

64

95

---

---

---

---

---

<

---

10

/09

/20

20

17

:33

Fals

e

Tri

adim

efo

nL306

0.0

5L

MB

0.0

5ug

/L1

.04

74

64

95

---

---

---

---

---

<

---

10

/09

/20

20

17

:33

Tru

e

IS-L

inuro

n-d

6L306

N/A

FS

29

39

9ug

/L1

.04

74

35

46

Fin

ishe

d--

---

-5

0 -

15

09

63

05

50

--

-1

0/0

9/2

02

0 1

8:2

2

Page 8

of

12

EE

A R

un I

D 2

80793 /

EE

A R

eport

# 5

00223

Page 178 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Tru

e

Diu

ron

L306

0.0

5F

S0

.07

ug

/L1

.04

74

35

46

Fin

ishe

d--

---

---

---

-

--

-1

0/0

9/2

02

0 1

8:2

2T

rue

Diflu

benzu

ron

L306

0.0

5F

S0

.05

ug

/L1

.04

74

35

46

Fin

ishe

d--

---

---

---

-

<--

-1

0/0

9/2

02

0 1

8:2

2T

rue

Meth

om

ylL306

0.0

5F

S0

.05

ug

/L1

.04

74

35

46

Fin

ishe

d--

---

---

---

-

<--

-1

0/0

9/2

02

0 1

8:2

2T

rue

Sid

uro

n, T

ota

lL306

0.0

5F

S0

.05

ug

/L1

.04

74

35

46

Fin

ishe

d--

---

---

---

-

<--

-1

0/0

9/2

02

0 1

8:2

2T

rue

Neburo

nL306

0.0

5F

S0

.05

ug

/L1

.04

74

35

46

Fin

ishe

d--

---

---

---

-

<--

-1

0/0

9/2

02

0 1

8:2

2T

rue

IS-D

iuro

n-d

6L306

N/A

FS

65

53

17

ug

/L1

.04

74

35

46

Fin

ishe

d--

---

-5

0 -

15

01

04

62

92

37

--

-1

0/0

9/2

02

0 1

8:2

2T

rue

Tebuth

iuro

nL306

0.0

5F

S0

.05

ug

/L1

.04

74

35

46

Fin

ishe

d--

---

---

---

-

<--

-1

0/0

9/2

02

0 1

8:2

2T

rue

Pro

panil

L306

0.0

5F

S0

.05

ug

/L1

.04

74

35

46

Fin

ishe

d--

---

---

---

-

<--

-1

0/0

9/2

02

0 1

8:2

2T

rue

Bensu

lide

L306

0.0

5F

S0

.05

ug

/L1

.04

74

35

46

Fin

ishe

d--

---

---

---

-

<--

-1

0/0

9/2

02

0 1

8:2

2T

rue

Bendio

carb

L306

0.0

5F

S0

.05

ug

/L1

.04

74

35

46

Fin

ishe

d--

---

---

---

-

<--

-1

0/0

9/2

02

0 1

8:2

2T

rue

Oxa

myl

L306

0.5

FS

0.5

ug

/L1

.04

74

35

46

Fin

ishe

d--

---

---

---

-

<--

-1

0/0

9/2

02

0 1

8:2

2T

rue

3-H

ydro

xyca

rbofu

ran

L306

0.0

5F

S0

.05

ug

/L1

.04

74

35

46

Fin

ishe

d--

---

---

---

-

<--

-1

0/0

9/2

02

0 1

8:2

2T

rue

Fenuro

nL306

0.0

5F

S0

.05

ug

/L1

.04

74

35

46

Fin

ishe

d--

---

---

---

-

<--

-1

0/0

9/2

02

0 1

8:2

2T

rue

Ald

icarb

sulfone

L306

0.5

FS

0.5

ug

/L1

.04

74

35

46

Fin

ishe

d--

---

---

---

-

<--

-1

0/0

9/2

02

0 1

8:2

2T

rue

Bayg

on

L306

0.0

5F

S0

.05

ug

/L1

.04

74

35

46

Fin

ishe

d--

---

---

---

-

<--

-1

0/0

9/2

02

0 1

8:2

2T

rue

Halo

fenozi

de

L306

0.0

5F

S0

.05

ug

/L1

.04

74

35

46

Fin

ishe

d--

---

---

---

-

<--

-1

0/0

9/2

02

0 1

8:2

2T

rue

Pacl

obutr

azo

lL306

0.0

5F

S0

.05

ug

/L1

.04

74

35

46

Fin

ishe

d--

---

---

---

-

<--

-1

0/0

9/2

02

0 1

8:2

2T

rue

Meta

laxy

l/M

eta

laxy

l-M

(M

efe

noxa

m)

L306

0.0

5F

S0

.05

ug

/L1

.04

74

35

46

Fin

ishe

d--

---

---

---

-

<--

-1

0/0

9/2

02

0 1

8:2

2T

rue

Ory

zalin

L306

0.5

FS

0.5

ug

/L1

.04

74

35

46

Fin

ishe

d--

---

---

---

-

<--

-1

0/0

9/2

02

0 1

8:2

2T

rue

Lin

uro

nL306

0.5

FS

0.5

ug

/L1

.04

74

35

46

Fin

ishe

d--

---

---

---

-

<--

-1

0/0

9/2

02

0 1

8:2

2T

rue

Pro

parg

ite

L306

0.0

5F

S0

.05

ug

/L1

.04

74

35

46

Fin

ishe

d--

---

---

---

-

<--

-1

0/0

9/2

02

0 1

8:2

2T

rue

Oxa

dia

zon

L306

0.0

5F

S0

.05

ug

/L1

.04

74

35

46

Fin

ishe

d--

---

---

---

-

<--

-1

0/0

9/2

02

0 1

8:2

2T

rue

Azo

xyst

robin

L306

0.5

FS

0.5

ug

/L1

.04

74

35

46

Fin

ishe

d--

---

---

---

-

<--

-1

0/0

9/2

02

0 1

8:2

2T

rue

Tri

adim

enol

L306

0.0

5F

S0

.05

ug

/L1

.04

74

35

46

Fin

ishe

d--

---

---

---

-

<--

-1

0/0

9/2

02

0 1

8:2

2T

rue

Flu

om

etu

ron

L306

0.0

5F

S0

.05

ug

/L1

.04

74

35

46

Fin

ishe

d--

---

---

---

-

<--

-1

0/0

9/2

02

0 1

8:2

2T

rue

Ald

icarb

sulfoxi

de

L306

0.5

FS

0.5

ug

/L1

.04

74

35

46

Fin

ishe

d--

---

---

---

-

<--

-1

0/0

9/2

02

0 1

8:2

2T

rue

Clo

mazo

ne

L306

0.0

5F

S0

.05

ug

/L1

.04

74

35

46

Fin

ishe

d--

---

---

---

-

<--

-1

0/0

9/2

02

0 1

8:2

2T

rue

Monuro

nL306

0.0

5F

S0

.05

ug

/L1

.04

74

35

46

Fin

ishe

d--

---

---

---

-

<--

-1

0/0

9/2

02

0 1

8:2

2T

rue

Halo

sulfuro

n m

eth

ylL306

0.0

5F

S0

.05

ug

/L1

.04

74

35

46

Fin

ishe

d--

---

---

---

-

<--

-1

0/0

9/2

02

0 1

8:2

2T

rue

Carb

ary

lL306

0.0

5F

S0

.05

ug

/L1

.04

74

35

46

Fin

ishe

d--

---

---

---

-

<--

-1

0/0

9/2

02

0 1

8:2

2T

rue

Thid

iazu

ron

L306

0.0

5F

S0

.05

ug

/L1

.04

74

35

46

Fin

ishe

d--

---

---

---

-

<--

-1

0/0

9/2

02

0 1

8:2

2T

rue

Carb

ofu

ran

L306

0.0

5F

S0

.05

ug

/L1

.04

74

35

46

Fin

ishe

d--

---

---

---

-

<--

-1

0/0

9/2

02

0 1

8:2

2T

rue

Meth

ioca

rbL306

0.0

5F

S0

.05

ug

/L1

.04

74

35

46

Fin

ishe

d--

---

---

---

-

<--

-1

0/0

9/2

02

0 1

8:2

2T

rue

Imid

acl

opri

dL306

0.0

5F

S0

.05

ug

/L1

.04

74

35

46

Fin

ishe

d--

---

---

---

-

<--

-1

0/0

9/2

02

0 1

8:2

2T

rue

Tri

adim

efo

nL306

0.0

5F

S0

.05

ug

/L1

.04

74

35

46

Fin

ishe

d--

---

---

---

-

<--

-1

0/0

9/2

02

0 1

8:2

2F

als

e

IS-L

inuro

n-d

6L306

N/A

MS

30

37

6ug

/L1

.04

74

64

96

Fin

ishe

d--

---

-5

0 -

15

09

93

05

50

--

-1

0/0

9/2

02

0 1

8:4

6F

als

e

Diu

ron

L306

0.0

5M

S1

.12

17

ug

/L1

.04

74

64

96

Fin

ishe

d--

---

-7

0 -

13

01

05

1.0

71

75

5

---

10

/09

/20

20

18

:46

Fals

e

Diflu

benzu

ron

L306

0.0

5M

S1

.06

27

ug

/L1

.04

74

64

96

Fin

ishe

d--

---

-7

0 -

13

01

06

1.0

--

-1

0/0

9/2

02

0 1

8:4

6F

als

e

Meth

om

ylL306

0.0

5M

S0

.93

49

ug

/L1

.04

74

64

96

Fin

ishe

d--

---

-7

0 -

13

09

31

.0

---

10

/09

/20

20

18

:46

Fals

e

Sid

uro

n, T

ota

lL306

0.0

5M

S1

.03

29

ug

/L1

.04

74

64

96

Fin

ishe

d--

---

-7

0 -

13

01

03

1.0

--

-1

0/0

9/2

02

0 1

8:4

6F

als

e

Neburo

nL306

0.0

5M

S1

.04

95

ug

/L1

.04

74

64

96

Fin

ishe

d--

---

-7

0 -

13

01

05

1.0

--

-1

0/0

9/2

02

0 1

8:4

6

Page 9

of

12

EE

A R

un I

D 2

80793 /

EE

A R

eport

# 5

00223

Page 179 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Fals

e

IS-D

iuro

n-d

6L306

N/A

MS

64

86

63

ug

/L1

.04

74

64

96

Fin

ishe

d--

---

-5

0 -

15

01

03

62

92

37

--

-1

0/0

9/2

02

0 1

8:4

6F

als

e

Tebuth

iuro

nL306

0.0

5M

S1

.01

75

ug

/L1

.04

74

64

96

Fin

ishe

d--

---

-7

0 -

13

01

02

1.0

--

-1

0/0

9/2

02

0 1

8:4

6F

als

e

Pro

panil

L306

0.0

5M

S1

.00

26

ug

/L1

.04

74

64

96

Fin

ishe

d--

---

-7

0 -

13

01

00

1.0

--

-1

0/0

9/2

02

0 1

8:4

6F

als

e

Bensu

lide

L306

0.0

5M

S1

.11

98

ug

/L1

.04

74

64

96

Fin

ishe

d--

---

-7

0 -

13

01

12

1.0

--

-1

0/0

9/2

02

0 1

8:4

6F

als

e

Bendio

carb

L306

0.0

5M

S1

.04

25

ug

/L1

.04

74

64

96

Fin

ishe

d--

---

-7

0 -

13

01

04

1.0

--

-1

0/0

9/2

02

0 1

8:4

6F

als

e

Oxa

myl

L306

0.5

MS

9.6

01

7ug

/L1

.04

74

64

96

Fin

ishe

d--

---

-7

0 -

13

09

61

0.0

--

-1

0/0

9/2

02

0 1

8:4

6F

als

e

3-H

ydro

xyca

rbofu

ran

L306

0.0

5M

S1

.03

91

ug

/L1

.04

74

64

96

Fin

ishe

d--

---

-7

0 -

13

01

04

1.0

--

-1

0/0

9/2

02

0 1

8:4

6F

als

e

Fenuro

nL306

0.0

5M

S0

.99

76

ug

/L1

.04

74

64

96

Fin

ishe

d--

---

-7

0 -

13

01

00

1.0

--

-1

0/0

9/2

02

0 1

8:4

6F

als

e

Ald

icarb

sulfone

L306

0.5

MS

9.5

46

1ug

/L1

.04

74

64

96

Fin

ishe

d--

---

-7

0 -

13

09

51

0.0

--

-1

0/0

9/2

02

0 1

8:4

6F

als

e

Bayg

on

L306

0.0

5M

S1

.05

77

ug

/L1

.04

74

64

96

Fin

ishe

d--

---

-7

0 -

13

01

06

1.0

--

-1

0/0

9/2

02

0 1

8:4

6F

als

e

Halo

fenozi

de

L306

0.0

5M

S1

.02

93

ug

/L1

.04

74

64

96

Fin

ishe

d--

---

-7

0 -

13

01

03

1.0

--

-1

0/0

9/2

02

0 1

8:4

6F

als

e

Pacl

obutr

azo

lL306

0.0

5M

S1

.07

62

ug

/L1

.04

74

64

96

Fin

ishe

d--

---

-7

0 -

13

01

08

1.0

--

-1

0/0

9/2

02

0 1

8:4

6F

als

e

Meta

laxy

l/M

eta

laxy

l-M

(M

efe

noxa

m)

L306

0.0

5M

S1

.02

76

ug

/L1

.04

74

64

96

Fin

ishe

d--

---

-7

0 -

13

01

03

1.0

--

-1

0/0

9/2

02

0 1

8:4

6F

als

e

Ory

zalin

L306

0.5

MS

9.7

41

9ug

/L1

.04

74

64

96

Fin

ishe

d--

---

-7

0 -

13

09

71

0.0

--

-1

0/0

9/2

02

0 1

8:4

6F

als

e

Lin

uro

nL306

0.5

MS

10

.01

55

ug

/L1

.04

74

64

96

Fin

ishe

d--

---

-7

0 -

13

01

00

10

.0

---

10

/09

/20

20

18

:46

Fals

e

Pro

parg

ite

L306

0.0

5M

S1

.02

98

ug

/L1

.04

74

64

96

Fin

ishe

d--

---

-7

0 -

13

01

03

1.0

--

-1

0/0

9/2

02

0 1

8:4

6F

als

e

Oxa

dia

zon

L306

0.0

5M

S1

.02

47

ug

/L1

.04

74

64

96

Fin

ishe

d--

---

-7

0 -

13

01

02

1.0

--

-1

0/0

9/2

02

0 1

8:4

6F

als

e

Azo

xyst

robin

L306

0.5

MS

10

.40

28

ug

/L1

.04

74

64

96

Fin

ishe

d--

---

-7

0 -

13

01

04

10

.0

---

10

/09

/20

20

18

:46

Fals

e

Tri

adim

enol

L306

0.0

5M

S1

.07

59

ug

/L1

.04

74

64

96

Fin

ishe

d--

---

-7

0 -

13

01

08

1.0

--

-1

0/0

9/2

02

0 1

8:4

6F

als

e

Flu

om

etu

ron

L306

0.0

5M

S1

.03

78

ug

/L1

.04

74

64

96

Fin

ishe

d--

---

-7

0 -

13

01

04

1.0

--

-1

0/0

9/2

02

0 1

8:4

6F

als

e

Ald

icarb

sulfoxi

de

L306

0.5

MS

9.6

80

2ug

/L1

.04

74

64

96

Fin

ishe

d--

---

-7

0 -

13

09

71

0.0

--

-1

0/0

9/2

02

0 1

8:4

6F

als

e

Clo

mazo

ne

L306

0.0

5M

S1

.01

53

ug

/L1

.04

74

64

96

Fin

ishe

d--

---

-7

0 -

13

01

02

1.0

--

-1

0/0

9/2

02

0 1

8:4

6F

als

e

Monuro

nL306

0.0

5M

S1

.05

84

ug

/L1

.04

74

64

96

Fin

ishe

d--

---

-7

0 -

13

01

06

1.0

--

-1

0/0

9/2

02

0 1

8:4

6F

als

e

Halo

sulfuro

n m

eth

ylL306

0.0

5M

S1

.03

67

ug

/L1

.04

74

64

96

Fin

ishe

d--

---

-7

0 -

13

01

04

1.0

--

-1

0/0

9/2

02

0 1

8:4

6F

als

e

Carb

ary

lL306

0.0

5M

S1

.06

43

ug

/L1

.04

74

64

96

Fin

ishe

d--

---

-7

0 -

13

01

06

1.0

--

-1

0/0

9/2

02

0 1

8:4

6F

als

e

Thid

iazu

ron

L306

0.0

5M

S1

.12

76

ug

/L1

.04

74

64

96

Fin

ishe

d--

---

-7

0 -

13

01

13

1.0

--

-1

0/0

9/2

02

0 1

8:4

6F

als

e

Carb

ofu

ran

L306

0.0

5M

S1

.04

82

ug

/L1

.04

74

64

96

Fin

ishe

d--

---

-7

0 -

13

01

05

1.0

--

-1

0/0

9/2

02

0 1

8:4

6F

als

e

Meth

ioca

rbL306

0.0

5M

S1

.06

44

ug

/L1

.04

74

64

96

Fin

ishe

d--

---

-7

0 -

13

01

06

1.0

--

-1

0/0

9/2

02

0 1

8:4

6F

als

e

Imid

acl

opri

dL306

0.0

5M

S1

.24

37

ug

/L1

.04

74

64

96

Fin

ishe

d--

---

-7

0 -

13

01

24

1.0

--

-1

0/0

9/2

02

0 1

8:4

6F

als

e

Tri

adim

efo

nL306

0.0

5M

S1

.06

75

ug

/L1

.04

74

64

96

Fin

ishe

d--

---

-7

0 -

13

01

07

1.0

--

-1

0/0

9/2

02

0 1

8:4

6T

rue

IS-L

inuro

n-d

6L306

N/A

MS

D3

00

94

ug

/L1

.04

74

64

97

Fin

ishe

d--

---

-5

0 -

15

09

93

05

50

--

-1

0/0

9/2

02

0 1

9:1

0T

rue

Diu

ron

L306

0.0

5M

SD

1.0

68

5ug

/L1

.04

74

64

97

Fin

ishe

d3

04

.97

0 -

13

01

00

1.0

71

75

5

---

10

/09

/20

20

19

:10

Tru

e

Diflu

benzu

ron

L306

0.0

5M

SD

1.0

39

1ug

/L1

.04

74

64

97

Fin

ishe

d3

02

.27

0 -

13

01

04

1.0

--

-1

0/0

9/2

02

0 1

9:1

0T

rue

Meth

om

ylL306

0.0

5M

SD

0.8

98

2ug

/L1

.04

74

64

97

Fin

ishe

d3

04

.07

0 -

13

09

01

.0

---

10

/09

/20

20

19

:10

Tru

e

Sid

uro

n, T

ota

lL306

0.0

5M

SD

1.0

11

5ug

/L1

.04

74

64

97

Fin

ishe

d3

02

.17

0 -

13

01

01

1.0

--

-1

0/0

9/2

02

0 1

9:1

0T

rue

Neburo

nL306

0.0

5M

SD

1.0

26

1ug

/L1

.04

74

64

97

Fin

ishe

d3

02

.37

0 -

13

01

03

1.0

--

-1

0/0

9/2

02

0 1

9:1

0T

rue

IS-D

iuro

n-d

6L306

N/A

MS

D6

60

23

3ug

/L1

.04

74

64

97

Fin

ishe

d--

---

-5

0 -

15

01

05

62

92

37

--

-1

0/0

9/2

02

0 1

9:1

0T

rue

Tebuth

iuro

nL306

0.0

5M

SD

0.9

86

7ug

/L1

.04

74

64

97

Fin

ishe

d3

03

.17

0 -

13

09

91

.0

---

10

/09

/20

20

19

:10

Tru

e

Pro

panil

L306

0.0

5M

SD

1.0

02

0ug

/L1

.04

74

64

97

Fin

ishe

d3

00

.17

0 -

13

01

00

1.0

--

-1

0/0

9/2

02

0 1

9:1

0T

rue

Bensu

lide

L306

0.0

5M

SD

0.9

51

0ug

/L1

.04

74

64

97

Fin

ishe

d3

01

67

0 -

13

09

51

.0

---

10

/09

/20

20

19

:10

Tru

e

Bendio

carb

L306

0.0

5M

SD

1.0

23

3ug

/L1

.04

74

64

97

Fin

ishe

d3

01

.97

0 -

13

01

02

1.0

--

-1

0/0

9/2

02

0 1

9:1

0

Page 1

0 o

f 12

EE

A R

un I

D 2

80793 /

EE

A R

eport

# 5

00223

Page 180 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Tru

e

Oxa

myl

L306

0.5

MS

D9

.16

53

ug

/L1

.04

74

64

97

Fin

ishe

d3

04

.77

0 -

13

09

21

0.0

--

-1

0/0

9/2

02

0 1

9:1

0T

rue

3-H

ydro

xyca

rbofu

ran

L306

0.0

5M

SD

1.0

22

0ug

/L1

.04

74

64

97

Fin

ishe

d3

01

.77

0 -

13

01

02

1.0

--

-1

0/0

9/2

02

0 1

9:1

0T

rue

Fenuro

nL306

0.0

5M

SD

0.9

74

3ug

/L1

.04

74

64

97

Fin

ishe

d3

02

.47

0 -

13

09

71

.0

---

10

/09

/20

20

19

:10

Tru

e

Ald

icarb

sulfone

L306

0.5

MS

D9

.05

97

ug

/L1

.04

74

64

97

Fin

ishe

d3

05

.27

0 -

13

09

11

0.0

--

-1

0/0

9/2

02

0 1

9:1

0T

rue

Bayg

on

L306

0.0

5M

SD

1.0

27

5ug

/L1

.04

74

64

97

Fin

ishe

d3

02

.97

0 -

13

01

03

1.0

--

-1

0/0

9/2

02

0 1

9:1

0T

rue

Halo

fenozi

de

L306

0.0

5M

SD

1.0

49

1ug

/L1

.04

74

64

97

Fin

ishe

d3

01

.97

0 -

13

01

05

1.0

--

-1

0/0

9/2

02

0 1

9:1

0T

rue

Pacl

obutr

azo

lL306

0.0

5M

SD

1.0

27

8ug

/L1

.04

74

64

97

Fin

ishe

d3

04

.67

0 -

13

01

03

1.0

--

-1

0/0

9/2

02

0 1

9:1

0T

rue

Meta

laxy

l/M

eta

laxy

l-M

(M

efe

noxa

m)

L306

0.0

5M

SD

1.0

15

2ug

/L1

.04

74

64

97

Fin

ishe

d3

01

.27

0 -

13

01

02

1.0

--

-1

0/0

9/2

02

0 1

9:1

0T

rue

Ory

zalin

L306

0.5

MS

D1

0.1

35

5ug

/L1

.04

74

64

97

Fin

ishe

d3

04

.07

0 -

13

01

01

10

.0

---

10

/09

/20

20

19

:10

Tru

e

Lin

uro

nL306

0.5

MS

D1

0.0

81

6ug

/L1

.04

74

64

97

Fin

ishe

d3

00

.77

0 -

13

01

01

10

.0

---

10

/09

/20

20

19

:10

Tru

e

Pro

parg

ite

L306

0.0

5M

SD

0.9

54

6ug

/L1

.04

74

64

97

Fin

ishe

d3

07

.67

0 -

13

09

51

.0

---

10

/09

/20

20

19

:10

Tru

e

Oxa

dia

zon

L306

0.0

5M

SD

0.9

99

8ug

/L1

.04

74

64

97

Fin

ishe

d3

02

.57

0 -

13

01

00

1.0

--

-1

0/0

9/2

02

0 1

9:1

0T

rue

Azo

xyst

robin

L306

0.5

MS

D1

0.1

07

6ug

/L1

.04

74

64

97

Fin

ishe

d3

02

.97

0 -

13

01

01

10

.0

---

10

/09

/20

20

19

:10

Tru

e

Tri

adim

enol

L306

0.0

5M

SD

1.0

33

7ug

/L1

.04

74

64

97

Fin

ishe

d3

04

.07

0 -

13

01

03

1.0

--

-1

0/0

9/2

02

0 1

9:1

0T

rue

Flu

om

etu

ron

L306

0.0

5M

SD

1.0

09

6ug

/L1

.04

74

64

97

Fin

ishe

d3

02

.87

0 -

13

01

01

1.0

--

-1

0/0

9/2

02

0 1

9:1

0T

rue

Ald

icarb

sulfoxi

de

L306

0.5

MS

D9

.18

47

ug

/L1

.04

74

64

97

Fin

ishe

d3

05

.37

0 -

13

09

21

0.0

--

-1

0/0

9/2

02

0 1

9:1

0T

rue

Clo

mazo

ne

L306

0.0

5M

SD

0.9

98

0ug

/L1

.04

74

64

97

Fin

ishe

d3

01

.77

0 -

13

01

00

1.0

--

-1

0/0

9/2

02

0 1

9:1

0T

rue

Monuro

nL306

0.0

5M

SD

1.0

54

2ug

/L1

.04

74

64

97

Fin

ishe

d3

00

.47

0 -

13

01

05

1.0

--

-1

0/0

9/2

02

0 1

9:1

0T

rue

Halo

sulfuro

n m

eth

ylL306

0.0

5M

SD

1.0

22

2ug

/L1

.04

74

64

97

Fin

ishe

d3

01

.47

0 -

13

01

02

1.0

--

-1

0/0

9/2

02

0 1

9:1

0T

rue

Carb

ary

lL306

0.0

5M

SD

1.0

15

2ug

/L1

.04

74

64

97

Fin

ishe

d3

04

.77

0 -

13

01

02

1.0

--

-1

0/0

9/2

02

0 1

9:1

0T

rue

Thid

iazu

ron

L306

0.0

5M

SD

1.0

90

0ug

/L1

.04

74

64

97

Fin

ishe

d3

03

.47

0 -

13

01

09

1.0

--

-1

0/0

9/2

02

0 1

9:1

0T

rue

Carb

ofu

ran

L306

0.0

5M

SD

1.0

27

5ug

/L1

.04

74

64

97

Fin

ishe

d3

02

.07

0 -

13

01

03

1.0

--

-1

0/0

9/2

02

0 1

9:1

0T

rue

Meth

ioca

rbL306

0.0

5M

SD

1.0

35

9ug

/L1

.04

74

64

97

Fin

ishe

d3

02

.77

0 -

13

01

04

1.0

--

-1

0/0

9/2

02

0 1

9:1

0T

rue

Imid

acl

opri

dL306

0.0

5M

SD

1.2

03

3ug

/L1

.04

74

64

97

Fin

ishe

d3

03

.37

0 -

13

01

20

1.0

--

-1

0/0

9/2

02

0 1

9:1

0T

rue

Tri

adim

efo

nL306

0.0

5M

SD

1.0

30

9ug

/L1

.04

74

64

97

Fin

ishe

d3

03

.57

0 -

13

01

03

1.0

--

-1

0/0

9/2

02

0 1

9:1

0F

als

e

IS-L

inuro

n-d

6L306

N/A

CC

C3

23

03

ug

/L1

.04

74

64

98

---

---

---

50

- 1

50

10

63

05

50

--

-1

0/0

9/2

02

0 1

9:3

5F

als

e

Diu

ron

L306

0.0

5C

CC

0.9

89

9ug

/L1

.04

74

64

98

---

---

---

70

- 1

30

99

1.0

--

-1

0/0

9/2

02

0 1

9:3

5F

als

e

Diflu

benzu

ron

L306

0.0

5C

CC

0.9

94

9ug

/L1

.04

74

64

98

---

---

---

70

- 1

30

99

1.0

--

-1

0/0

9/2

02

0 1

9:3

5F

als

e

Meth

om

ylL306

0.0

5C

CC

0.9

30

5ug

/L1

.04

74

64

98

---

---

---

70

- 1

30

93

1.0

--

-1

0/0

9/2

02

0 1

9:3

5F

als

e

Sid

uro

n, T

ota

lL306

0.0

5C

CC

0.9

85

5ug

/L1

.04

74

64

98

---

---

---

70

- 1

30

99

1.0

--

-1

0/0

9/2

02

0 1

9:3

5F

als

e

Neburo

nL306

0.0

5C

CC

1.0

14

3ug

/L1

.04

74

64

98

---

---

---

70

- 1

30

10

11

.0

---

10

/09

/20

20

19

:35

Fals

e

IS-D

iuro

n-d

6L306

N/A

CC

C7

14

37

6ug

/L1

.04

74

64

98

---

---

---

50

- 1

50

11

46

29

23

7

---

10

/09

/20

20

19

:35

Fals

e

Tebuth

iuro

nL306

0.0

5C

CC

0.9

74

4ug

/L1

.04

74

64

98

---

---

---

70

- 1

30

97

1.0

--

-1

0/0

9/2

02

0 1

9:3

5F

als

e

Pro

panil

L306

0.0

5C

CC

1.0

25

1ug

/L1

.04

74

64

98

---

---

---

70

- 1

30

10

31

.0

---

10

/09

/20

20

19

:35

Fals

e

Bensu

lide

L306

0.0

5C

CC

0.9

57

3ug

/L1

.04

74

64

98

---

---

---

70

- 1

30

96

1.0

--

-1

0/0

9/2

02

0 1

9:3

5F

als

e

Bendio

carb

L306

0.0

5C

CC

0.9

47

4ug

/L1

.04

74

64

98

---

---

---

70

- 1

30

95

1.0

--

-1

0/0

9/2

02

0 1

9:3

5F

als

e

Oxa

myl

L306

0.5

CC

C8

.54

48

ug

/L1

.04

74

64

98

---

---

---

70

- 1

30

85

10

.0

---

10

/09

/20

20

19

:35

Fals

e

3-H

ydro

xyca

rbofu

ran

L306

0.0

5C

CC

0.9

75

8ug

/L1

.04

74

64

98

---

---

---

70

- 1

30

98

1.0

--

-1

0/0

9/2

02

0 1

9:3

5F

als

e

Fenuro

nL306

0.0

5C

CC

0.9

53

7ug

/L1

.04

74

64

98

---

---

---

70

- 1

30

95

1.0

--

-1

0/0

9/2

02

0 1

9:3

5F

als

e

Ald

icarb

sulfone

L306

0.5

CC

C8

.38

52

ug

/L1

.04

74

64

98

---

---

---

70

- 1

30

84

10

.0

---

10

/09

/20

20

19

:35

Fals

e

Bayg

on

L306

0.0

5C

CC

0.9

34

6ug

/L1

.04

74

64

98

---

---

---

70

- 1

30

93

1.0

--

-1

0/0

9/2

02

0 1

9:3

5

Page 1

1 o

f 12

EE

A R

un I

D 2

80793 /

EE

A R

eport

# 5

00223

Page 181 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Fals

e

Halo

fenozi

de

L306

0.0

5C

CC

1.0

48

9ug

/L1

.04

74

64

98

---

---

---

70

- 1

30

10

51

.0

---

10

/09

/20

20

19

:35

Fals

e

Pacl

obutr

azo

lL306

0.0

5C

CC

1.0

55

7ug

/L1

.04

74

64

98

---

---

---

70

- 1

30

10

61

.0

---

10

/09

/20

20

19

:35

Fals

e

Meta

laxy

l/M

eta

laxy

l-M

(M

efe

noxa

m)

L306

0.0

5C

CC

0.9

56

4ug

/L1

.04

74

64

98

---

---

---

70

- 1

30

96

1.0

--

-1

0/0

9/2

02

0 1

9:3

5F

als

e

Ory

zalin

L306

0.5

CC

C1

0.6

65

0ug

/L1

.04

74

64

98

---

---

---

70

- 1

30

10

71

0.0

--

-1

0/0

9/2

02

0 1

9:3

5F

als

e

Lin

uro

nL306

0.5

CC

C1

0.3

55

0ug

/L1

.04

74

64

98

---

---

---

70

- 1

30

10

41

0.0

--

-1

0/0

9/2

02

0 1

9:3

5F

als

e

Pro

parg

ite

L306

0.0

5C

CC

0.9

33

9ug

/L1

.04

74

64

98

---

---

---

70

- 1

30

93

1.0

--

-1

0/0

9/2

02

0 1

9:3

5F

als

e

Oxa

dia

zon

L306

0.0

5C

CC

1.0

02

2ug

/L1

.04

74

64

98

---

---

---

70

- 1

30

10

01

.0

---

10

/09

/20

20

19

:35

Fals

e

Azo

xyst

robin

L306

0.5

CC

C9

.76

67

ug

/L1

.04

74

64

98

---

---

---

70

- 1

30

98

10

.0

---

10

/09

/20

20

19

:35

Fals

e

Tri

adim

enol

L306

0.0

5C

CC

0.9

46

0ug

/L1

.04

74

64

98

---

---

---

70

- 1

30

95

1.0

--

-1

0/0

9/2

02

0 1

9:3

5F

als

e

Flu

om

etu

ron

L306

0.0

5C

CC

0.9

84

4ug

/L1

.04

74

64

98

---

---

---

70

- 1

30

98

1.0

--

-1

0/0

9/2

02

0 1

9:3

5F

als

e

Ald

icarb

sulfoxi

de

L306

0.5

CC

C9

.06

89

ug

/L1

.04

74

64

98

---

---

---

70

- 1

30

91

10

.0

---

10

/09

/20

20

19

:35

Fals

e

Clo

mazo

ne

L306

0.0

5C

CC

0.9

71

9ug

/L1

.04

74

64

98

---

---

---

70

- 1

30

97

1.0

--

-1

0/0

9/2

02

0 1

9:3

5F

als

e

Monuro

nL306

0.0

5C

CC

0.9

95

0ug

/L1

.04

74

64

98

---

---

---

70

- 1

30

99

1.0

--

-1

0/0

9/2

02

0 1

9:3

5F

als

e

Halo

sulfuro

n m

eth

ylL306

0.0

5C

CC

0.9

89

3ug

/L1

.04

74

64

98

---

---

---

70

- 1

30

99

1.0

--

-1

0/0

9/2

02

0 1

9:3

5F

als

e

Carb

ary

lL306

0.0

5C

CC

0.9

37

5ug

/L1

.04

74

64

98

---

---

---

70

- 1

30

94

1.0

--

-1

0/0

9/2

02

0 1

9:3

5F

als

e

Thid

iazu

ron

L306

0.0

5C

CC

1.0

46

0ug

/L1

.04

74

64

98

---

---

---

70

- 1

30

10

51

.0

---

10

/09

/20

20

19

:35

Fals

e

Carb

ofu

ran

L306

0.0

5C

CC

0.9

75

3ug

/L1

.04

74

64

98

---

---

---

70

- 1

30

98

1.0

--

-1

0/0

9/2

02

0 1

9:3

5F

als

e

Meth

ioca

rbL306

0.0

5C

CC

0.9

29

9ug

/L1

.04

74

64

98

---

---

---

70

- 1

30

93

1.0

--

-1

0/0

9/2

02

0 1

9:3

5F

als

e

Imid

acl

opri

dL306

0.0

5C

CC

0.9

92

4ug

/L1

.04

74

64

98

---

---

---

70

- 1

30

99

1.0

--

-1

0/0

9/2

02

0 1

9:3

5F

als

e

Tri

adim

efo

nL306

0.0

5C

CC

1.0

25

1ug

/L1

.04

74

64

98

---

---

---

70

- 1

30

10

31

.0

---

10

/09

/20

20

19

:35

Page 1

2 o

f 12

EE

A R

un I

D 2

80793 /

EE

A R

eport

# 5

00223

Page 182 of 201

Eu

rofi

ns

Ea

ton

An

aly

tica

lR

un

Lo

gR

un ID

:281023

Meth

od:

L402

Sam

ple

Sit

eS

am

ple

Id

Typ

eIn

str

um

en

t ID

Cali

bra

tio

n F

ile

An

aly

sis

Date

Matr

ix

CC

L4

74

81

56

FL

10

13

20

L4

02

a2

-PF

CQ

ua

nt-

NT

A.m

db

10

/13

/20

20

22

:12

OS

LR

B4

74

81

43

FL

10

13

20

L4

02

a2

-PF

CQ

ua

nt-

NT

A.m

db

10

/13

/20

20

22

:38

RW

FB

L4

74

81

44

FL

10

13

20

L4

02

a2

-PF

CQ

ua

nt-

NT

A.m

db

10

/13

/20

20

23

:04

RW

CC

M4

74

81

60

FL

10

13

20

L4

02

a2

-PF

CQ

ua

nt-

NT

A.m

db

10

/14

/20

20

04

:47

OS

FS

47

43

54

0F

inis

he

dF

L1

01

32

0L

40

2a

2-P

FC

Qu

an

t-N

TA

.md

b1

0/1

4/2

02

0 0

6:3

2D

W

CC

H4

74

81

61

FL

10

13

20

L4

02

a2

-PF

CQ

ua

nt-

NT

A.m

db

10

/14

/20

20

06

:58

OS

0.0

0

Page 1

of

9E

EA

Run I

D 2

81023 /

EE

A R

eport

# 5

00223

Page 183 of 201

QC

Su

mm

ary

Re

po

rt

EE

AID

#R

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

eth

od

An

aly

teS

am

ple

Typ

eD

ilF

ac

tor

RP

DL

imit

Re

co

ve

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

gM

RL

Ex

tra

cte

dA

na

lyze

d

Fals

e

IS-4

:2-F

TS

-13C

2L402

N/A

CC

L6

56

92

1ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

10

06

60

16

1

10

/13

/20

20

10

:16

10

/13

/20

20

22

:12

Fals

e

IS-6

:2-F

TS

-13C

2L402

N/A

CC

L2

95

58

8ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

10

72

76

81

7

10

/13

/20

20

10

:16

10

/13

/20

20

22

:12

Fals

e

IS-8

:2-F

TS

-13C

2L402

N/A

CC

L8

30

13

8ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

11

17

44

87

0

10

/13

/20

20

10

:16

10

/13

/20

20

22

:12

Fals

e

IS-G

enX

-13C

3L402

N/A

CC

L3

01

28

ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

11

22

67

89

1

0/1

3/2

02

0 1

0:1

61

0/1

3/2

02

0 2

2:1

2F

als

e

IS-N

EtF

OS

AA

-d5

L402

N/A

CC

L1

11

32

60

ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

11

39

83

53

5

10

/13

/20

20

10

:16

10

/13

/20

20

22

:12

Fals

e

IS-N

EtF

OS

E-d

9L402

N/A

CC

L1

26

47

7ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

95

13

33

88

1

0/1

3/2

02

0 1

0:1

61

0/1

3/2

02

0 2

2:1

2F

als

e

IS-N

MeF

OS

AA

-d3

L402

N/A

CC

L1

24

55

80

ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

10

61

17

87

68

1

0/1

3/2

02

0 1

0:1

61

0/1

3/2

02

0 2

2:1

2F

als

e

IS-N

MeF

OS

A-d

3L402

N/A

CC

L1

11

63

10

ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

10

01

11

92

26

1

0/1

3/2

02

0 1

0:1

61

0/1

3/2

02

0 2

2:1

2F

als

e

IS-N

MeF

OS

E-d

7L402

N/A

CC

L1

37

06

7ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

96

14

30

02

1

0/1

3/2

02

0 1

0:1

61

0/1

3/2

02

0 2

2:1

2F

als

e

IS-P

FB

A-1

3C

4L402

N/A

CC

L4

46

73

70

ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

10

54

23

76

66

1

0/1

3/2

02

0 1

0:1

61

0/1

3/2

02

0 2

2:1

2F

als

e

IS-P

FB

S-1

3C

3L402

N/A

CC

L9

49

11

4ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

10

78

90

95

8

10

/13

/20

20

10

:16

10

/13

/20

20

22

:12

Fals

e

IS-P

FD

A-1

3C

2L402

N/A

CC

L5

51

94

00

ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

12

54

39

89

56

1

0/1

3/2

02

0 1

0:1

61

0/1

3/2

02

0 2

2:1

2F

als

e

IS-P

FD

oA

-13C

2L402

N/A

CC

L4

61

92

40

ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

97

47

85

14

8

10

/13

/20

20

10

:16

10

/13

/20

20

22

:12

Fals

e

IS-P

FH

pA

-13C

4L402

N/A

CC

L5

95

06

90

ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

11

35

24

62

83

1

0/1

3/2

02

0 1

0:1

61

0/1

3/2

02

0 2

2:1

2F

als

e

IS-P

FH

xA-1

3C

2L402

N/A

CC

L2

31

82

10

ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

10

72

16

22

10

1

0/1

3/2

02

0 1

0:1

61

0/1

3/2

02

0 2

2:1

2F

als

e

IS-P

FO

SA

-13C

8L402

N/A

CC

L3

30

53

90

ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

10

63

10

86

20

1

0/1

3/2

02

0 1

0:1

61

0/1

3/2

02

0 2

2:1

2F

als

e

IS-N

EtF

OS

A-d

5L402

N/A

CC

L9

37

88

6ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

10

09

37

15

4

10

/13

/20

20

10

:16

10

/13

/20

20

22

:12

Fals

e

IS-P

FH

xS-1

3C

3L402

N/A

CC

L1

27

47

90

ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

11

21

13

97

95

1

0/1

3/2

02

0 1

0:1

61

0/1

3/2

02

0 2

2:1

2F

als

e

IS-P

FN

A-1

3C

9L402

N/A

CC

L7

63

67

50

ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

11

56

63

10

95

1

0/1

3/2

02

0 1

0:1

61

0/1

3/2

02

0 2

2:1

2F

als

e

IS-P

FO

A-1

3C

2L402

N/A

CC

L6

45

93

60

ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

11

15

82

04

50

1

0/1

3/2

02

0 1

0:1

61

0/1

3/2

02

0 2

2:1

2F

als

e

IS-P

FO

S-1

3C

4L402

N/A

CC

L1

10

58

60

ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

10

81

02

51

60

1

0/1

3/2

02

0 1

0:1

61

0/1

3/2

02

0 2

2:1

2F

als

e

IS-P

FP

eA

-13C

5L402

N/A

CC

L1

86

36

20

ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

10

21

83

31

73

1

0/1

3/2

02

0 1

0:1

61

0/1

3/2

02

0 2

2:1

2F

als

e

IS-P

FT

eD

A-1

3C

2L402

N/A

CC

L1

15

88

90

ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

70

16

59

81

3

10

/13

/20

20

10

:16

10

/13

/20

20

22

:12

Fals

e

IS-P

FU

nA

-13C

7L402

N/A

CC

L5

54

63

70

ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

11

74

75

85

88

1

0/1

3/2

02

0 1

0:1

61

0/1

3/2

02

0 2

2:1

2F

als

e

10

:2 F

luo

rote

lom

er

sulfo

nic

aci

d (

10

:2 F

TS

)L402

2.0

CC

L2

.29

07

ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

11

52

.0

10

/13

/20

20

10

:16

10

/13

/20

20

22

:12

Fals

e

4:2

Flu

oro

telo

me

r su

lfo

nic

aci

d (

4:2

FT

S)

L402

2.0

CC

L2

.22

28

ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

11

12

.0

10

/13

/20

20

10

:16

10

/13

/20

20

22

:12

Fals

e

6:2

Flu

oro

telo

me

r su

lfo

nic

aci

d (

6:2

FT

S)

L402

2.0

CC

L2

.12

56

ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

10

62

.0

10

/13

/20

20

10

:16

10

/13

/20

20

22

:12

Fals

e

8:2

Flu

oro

telo

me

r su

lfo

nic

aci

d (

8:2

FT

S)

L402

2.0

CC

L2

.18

94

ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

10

92

.0

10

/13

/20

20

10

:16

10

/13

/20

20

22

:12

Fals

e

AD

ON

AL402

2.0

CC

L2

.11

25

ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

10

62

.0

10

/13

/20

20

10

:16

10

/13

/20

20

22

:12

Fals

e

9C

l-P

F3O

NS

/F-5

3B

Majo

rL402

2.0

CC

L1

.75

30

ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

88

2.0

1

0/1

3/2

02

0 1

0:1

61

0/1

3/2

02

0 2

2:1

2F

als

e

11C

l-P

F3O

UdS

/F-5

3B

Min

or

L402

2.0

CC

L1

.87

59

ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

94

2.0

1

0/1

3/2

02

0 1

0:1

61

0/1

3/2

02

0 2

2:1

2F

als

e

HF

PO

-DA

/GenX

L402

5.0

CC

L4

.74

29

ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

95

5.0

1

0/1

3/2

02

0 1

0:1

61

0/1

3/2

02

0 2

2:1

2F

als

e

N-e

thyl

pe

rflu

oro

oct

an

e s

ulfo

na

mid

e (

NE

tFO

SA

)L402

2.0

CC

L1

.89

75

ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

95

2.0

1

0/1

3/2

02

0 1

0:1

61

0/1

3/2

02

0 2

2:1

2F

als

e

N-e

thyl

pe

rflu

oro

oct

an

e s

ulfo

na

mid

oe

tha

no

lL402

2.0

CC

L1

.86

62

ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

93

2.0

1

0/1

3/2

02

0 1

0:1

61

0/1

3/2

02

0 2

2:1

2F

als

e

N-m

eth

ylp

erf

luo

roo

cta

ne

su

lfo

na

mid

e (

NM

eF

OS

A)

L402

2.0

CC

L1

.88

32

ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

94

2.0

1

0/1

3/2

02

0 1

0:1

61

0/1

3/2

02

0 2

2:1

2F

als

e

N-m

eth

ylp

erf

luo

roo

cta

ne

su

lfo

na

mid

oe

tha

no

lL402

2.0

CC

L1

.84

80

ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

92

2.0

1

0/1

3/2

02

0 1

0:1

61

0/1

3/2

02

0 2

2:1

2F

als

e

Perf

luoro

buta

nesu

lfonic

aci

d (

PF

BS

)L402

2.0

CC

L1

.79

00

ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

89

2.0

1

0/1

3/2

02

0 1

0:1

61

0/1

3/2

02

0 2

2:1

2F

als

e

Perf

luoro

buta

noic

aci

d (

PF

BA

)L402

5.0

CC

L4

.52

23

ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

90

5.0

1

0/1

3/2

02

0 1

0:1

61

0/1

3/2

02

0 2

2:1

2F

als

e

Perf

luoro

deca

noic

aci

d (

PF

DA

)L402

2.0

CC

L1

.84

20

ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

92

2.0

1

0/1

3/2

02

0 1

0:1

61

0/1

3/2

02

0 2

2:1

2F

als

e

Perf

luoro

hepta

noic

aci

d (

PF

HpA

)L402

2.0

CC

L1

.86

19

ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

93

2.0

1

0/1

3/2

02

0 1

0:1

61

0/1

3/2

02

0 2

2:1

2

Page 2

of

9E

EA

Run I

D 2

81023 /

EE

A R

eport

# 5

00223

Page 184 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Fals

e

Perf

luoro

hexa

nesu

lfonic

aci

d (

PF

HxS

)L402

2.0

CC

L1

.74

56

ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

87

2.0

1

0/1

3/2

02

0 1

0:1

61

0/1

3/2

02

0 2

2:1

2F

als

e

Perf

luoro

hexa

noic

aci

d (

PF

HxA

)L402

2.0

CC

L1

.90

42

ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

95

2.0

1

0/1

3/2

02

0 1

0:1

61

0/1

3/2

02

0 2

2:1

2F

als

e

Perf

luoro

dodeca

noic

aci

d (

PF

DoA

)L402

2.0

CC

L1

.92

86

ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

96

2.0

1

0/1

3/2

02

0 1

0:1

61

0/1

3/2

02

0 2

2:1

2F

als

e

Perf

luoro

nonanoic

aci

d (

PF

NA

)L402

2.0

CC

L1

.89

79

ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

95

2.0

1

0/1

3/2

02

0 1

0:1

61

0/1

3/2

02

0 2

2:1

2F

als

e

Perf

luoro

oct

anesu

lfonic

aci

d (

PF

OS

)L402

2.0

CC

L1

.93

69

ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

97

2.0

1

0/1

3/2

02

0 1

0:1

61

0/1

3/2

02

0 2

2:1

2F

als

e

N-e

thyl

Pe

rflu

oro

oct

an

esu

lfo

na

mid

oa

cetic

aci

dL402

2.0

CC

L1

.91

42

ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

96

2.0

1

0/1

3/2

02

0 1

0:1

61

0/1

3/2

02

0 2

2:1

2F

als

e

N-m

eth

yl P

erf

luo

roo

cta

ne

sulfo

na

mid

oa

cetic

aci

dL402

2.0

CC

L1

.81

11

ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

91

2.0

1

0/1

3/2

02

0 1

0:1

61

0/1

3/2

02

0 2

2:1

2F

als

e

Perf

luoro

oct

anoic

aci

d (

PF

OA

)L402

2.0

CC

L1

.93

74

ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

97

2.0

1

0/1

3/2

02

0 1

0:1

61

0/1

3/2

02

0 2

2:1

2F

als

e

Perf

luoro

trid

eca

noic

aci

d (

PF

TrD

A)

L402

2.0

CC

L2

.03

95

ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

10

22

.0

10

/13

/20

20

10

:16

10

/13

/20

20

22

:12

Fals

e

Perf

luoro

undeca

noic

aci

d (

PF

UnA

)L402

2.0

CC

L1

.90

07

ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

95

2.0

1

0/1

3/2

02

0 1

0:1

61

0/1

3/2

02

0 2

2:1

2F

als

e

Perf

luoro

dodeca

nesu

lfonic

aci

d (

PF

DoS

)L402

2.0

CC

L2

.26

17

ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

11

32

.0

10

/13

/20

20

10

:16

10

/13

/20

20

22

:12

Fals

e

Pe

rflu

oro

deca

nesu

lfonic

aci

d (

PF

DS

)L402

2.0

CC

L1

.95

96

ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

98

2.0

1

0/1

3/2

02

0 1

0:1

61

0/1

3/2

02

0 2

2:1

2F

als

e

Perf

luoro

hepta

nesu

lfonic

aci

d (

PF

HpS

)L402

2.0

CC

L1

.73

16

ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

87

2.0

1

0/1

3/2

02

0 1

0:1

61

0/1

3/2

02

0 2

2:1

2F

als

e

Perf

luoro

hexa

deca

noic

aci

d (

PF

HxD

A)

L402

2.0

CC

L2

.11

39

ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

10

62

.0

10

/13

/20

20

10

:16

10

/13

/20

20

22

:12

Fals

e

No

na

flu

oro

-3,6

-dio

xah

ep

tan

oic

aci

d (

NF

DH

A)

L402

5.0

CC

L5

.58

38

ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

11

25

.0

10

/13

/20

20

10

:16

10

/13

/20

20

22

:12

Fals

e

Perf

luoro

-4-i

sopro

poxy

buta

noic

aci

dL402

5.0

CC

L5

.75

24

ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

11

55

.0

10

/13

/20

20

10

:16

10

/13

/20

20

22

:12

Fals

e

Perf

luoro

-4-m

eth

oxy

buta

no

ic a

cid (

PF

MB

A)

L402

5.0

CC

L4

.44

64

ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

89

5.0

1

0/1

3/2

02

0 1

0:1

61

0/1

3/2

02

0 2

2:1

2F

als

e

Pe

rflu

oro

-3-m

eth

oxy

pro

pa

no

ic a

cid

(P

FM

PA

)L402

5.0

CC

L4

.61

46

ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

92

5.0

1

0/1

3/2

02

0 1

0:1

61

0/1

3/2

02

0 2

2:1

2F

als

e

Perf

luoro

nonanesu

lfonic

aci

d (

PF

NS

)L402

2.0

CC

L1

.70

96

ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

85

2.0

1

0/1

3/2

02

0 1

0:1

61

0/1

3/2

02

0 2

2:1

2F

als

e

Pe

rflu

oro

oct

ane s

ulfonam

ide (

PF

OS

A)

L402

2.0

CC

L1

.88

21

ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

94

2.0

1

0/1

3/2

02

0 1

0:1

61

0/1

3/2

02

0 2

2:1

2F

als

e

Perf

luoro

penta

noic

aci

d (

PF

PeA

)L402

2.0

CC

L1

.91

86

ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

96

2.0

1

0/1

3/2

02

0 1

0:1

61

0/1

3/2

02

0 2

2:1

2F

als

e

Pe

rflu

oro

penta

nesu

lfonic

aci

d (

PF

PeS

)L402

2.0

CC

L2

.14

91

ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

10

72

.0

10

/13

/20

20

10

:16

10

/13

/20

20

22

:12

Fals

e

Pe

rflu

oro

tetr

adeca

noic

aci

d (

PF

TeD

A)

L402

2.0

CC

L2

.03

72

ng

/L1

.04

74

81

56

---

---

---

50

- 1

50

10

22

.0

10

/13

/20

20

10

:16

10

/13

/20

20

22

:12

Tru

e

10

:2 F

luo

rote

lom

er

sulfo

nic

aci

d (

10

:2 F

TS

)L402

2.0

LR

B2

.0ng

/L1

.04

74

81

43

---

---

---

---

---

<

10

/13

/20

20

06

:30

10

/13

/20

20

22

:38

Tru

e

4:2

Flu

oro

telo

me

r su

lfo

nic

aci

d (

4:2

FT

S)

L402

2.0

LR

B2

.0ng

/L1

.04

74

81

43

---

---

---

---

---

<

10

/13

/20

20

06

:30

10

/13

/20

20

22

:38

Tru

e

6:2

Flu

oro

telo

me

r su

lfo

nic

aci

d (

6:2

FT

S)

L402

2.0

LR

B2

.0ng

/L1

.04

74

81

43

---

---

---

---

---

<

10

/13

/20

20

06

:30

10

/13

/20

20

22

:38

Tru

e

8:2

Flu

oro

telo

me

r su

lfo

nic

aci

d (

8:2

FT

S)

L402

2.0

LR

B2

.0ng

/L1

.04

74

81

43

---

---

---

---

---

<

10

/13

/20

20

06

:30

10

/13

/20

20

22

:38

Tru

e

AD

ON

AL402

2.0

LR

B2

.0ng

/L1

.04

74

81

43

---

---

---

---

---

<

10

/13

/20

20

06

:30

10

/13

/20

20

22

:38

Tru

e

9C

l-P

F3O

NS

/F-5

3B

Majo

rL402

2.0

LR

B2

.0ng

/L1

.04

74

81

43

---

---

---

---

---

<

10

/13

/20

20

06

:30

10

/13

/20

20

22

:38

Tru

e

11C

l-P

F3O

UdS

/F-5

3B

Min

or

L402

2.0

LR

B2

.0ng

/L1

.04

74

81

43

---

---

---

---

---

<

10

/13

/20

20

06

:30

10

/13

/20

20

22

:38

Tru

e

HF

PO

-DA

/GenX

L402

5.0

LR

B5

.0ng

/L1

.04

74

81

43

---

---

---

---

---

<

10

/13

/20

20

06

:30

10

/13

/20

20

22

:38

Tru

e

N-e

thyl

pe

rflu

oro

oct

an

e s

ulfo

na

mid

e (

NE

tFO

SA

)L402

2.0

LR

B2

.0ng

/L1

.04

74

81

43

---

---

---

---

---

<

10

/13

/20

20

06

:30

10

/13

/20

20

22

:38

Tru

e

N-e

thyl

pe

rflu

oro

oct

an

e s

ulfo

na

mid

oe

tha

no

lL402

2.0

LR

B2

.0ng

/L1

.04

74

81

43

---

---

---

---

---

<

10

/13

/20

20

06

:30

10

/13

/20

20

22

:38

Tru

e

N-m

eth

ylp

erf

luo

roo

cta

ne

su

lfo

na

mid

e (

NM

eF

OS

A)

L402

2.0

LR

B2

.0ng

/L1

.04

74

81

43

---

---

---

---

---

<

10

/13

/20

20

06

:30

10

/13

/20

20

22

:38

Tru

e

N-m

eth

ylp

erf

luo

roo

cta

ne

su

lfo

na

mid

oe

tha

no

lL402

2.0

LR

B2

.0ng

/L1

.04

74

81

43

---

---

---

---

---

<

10

/13

/20

20

06

:30

10

/13

/20

20

22

:38

Tru

e

Perf

luoro

buta

nesu

lfonic

aci

d (

PF

BS

)L402

2.0

LR

B2

.0ng

/L1

.04

74

81

43

---

---

---

---

---

<

10

/13

/20

20

06

:30

10

/13

/20

20

22

:38

Tru

e

Perf

luoro

buta

noic

aci

d (

PF

BA

)L402

5.0

LR

B5

.0ng

/L1

.04

74

81

43

---

---

---

---

---

<

10

/13

/20

20

06

:30

10

/13

/20

20

22

:38

Tru

e

Perf

luoro

deca

noic

aci

d (

PF

DA

)L402

2.0

LR

B2

.0ng

/L1

.04

74

81

43

---

---

---

---

---

<

10

/13

/20

20

06

:30

10

/13

/20

20

22

:38

Tru

e

Perf

luoro

hepta

noic

aci

d (

PF

HpA

)L402

2.0

LR

B2

.0ng

/L1

.04

74

81

43

---

---

---

---

---

<

10

/13

/20

20

06

:30

10

/13

/20

20

22

:38

Tru

e

Perf

luoro

hexa

nesu

lfonic

aci

d (

PF

HxS

)L402

2.0

LR

B2

.0ng

/L1

.04

74

81

43

---

---

---

---

---

<

10

/13

/20

20

06

:30

10

/13

/20

20

22

:38

Tru

e

Perf

luoro

hexa

noic

aci

d (

PF

HxA

)L402

2.0

LR

B2

.0ng

/L1

.04

74

81

43

---

---

---

---

---

<

10

/13

/20

20

06

:30

10

/13

/20

20

22

:38

Page 3

of

9E

EA

Run I

D 2

81023 /

EE

A R

eport

# 5

00223

Page 185 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Tru

e

Perf

luoro

dodeca

noic

aci

d (

PF

DoA

)L402

2.0

LR

B2

.0ng

/L1

.04

74

81

43

---

---

---

---

---

<

10

/13

/20

20

06

:30

10

/13

/20

20

22

:38

Tru

e

Perf

luoro

nonanoic

aci

d (

PF

NA

)L402

2.0

LR

B2

.0ng

/L1

.04

74

81

43

---

---

---

---

---

<

10

/13

/20

20

06

:30

10

/13

/20

20

22

:38

Tru

e

Perf

luoro

oct

anesu

lfonic

aci

d (

PF

OS

)L402

2.0

LR

B2

.0ng

/L1

.04

74

81

43

---

---

---

---

---

<

10

/13

/20

20

06

:30

10

/13

/20

20

22

:38

Tru

e

N-e

thyl

Pe

rflu

oro

oct

an

esu

lfo

na

mid

oa

cetic

aci

dL402

2.0

LR

B2

.0ng

/L1

.04

74

81

43

---

---

---

---

---

<

10

/13

/20

20

06

:30

10

/13

/20

20

22

:38

Tru

e

N-m

eth

yl P

erf

luo

roo

cta

ne

sulfo

na

mid

oa

cetic

aci

dL402

2.0

LR

B2

.0ng

/L1

.04

74

81

43

---

---

---

---

---

<

10

/13

/20

20

06

:30

10

/13

/20

20

22

:38

Tru

e

Perf

luoro

oct

anoic

aci

d (

PF

OA

)L402

2.0

LR

B2

.0ng

/L1

.04

74

81

43

---

---

---

---

---

<

10

/13

/20

20

06

:30

10

/13

/20

20

22

:38

Tru

e

Perf

luoro

trid

eca

noic

aci

d (

PF

TrD

A)

L402

2.0

LR

B2

.0ng

/L1

.04

74

81

43

---

---

---

---

---

<

10

/13

/20

20

06

:30

10

/13

/20

20

22

:38

Tru

e

Perf

luoro

undeca

noic

aci

d (

PF

UnA

)L402

2.0

LR

B2

.0ng

/L1

.04

74

81

43

---

---

---

---

---

<

10

/13

/20

20

06

:30

10

/13

/20

20

22

:38

Tru

e

Perf

luoro

dodeca

nesu

lfonic

aci

d (

PF

DoS

)L402

2.0

LR

B2

.0ng

/L1

.04

74

81

43

---

---

---

---

---

<

10

/13

/20

20

06

:30

10

/13

/20

20

22

:38

Tru

e

Pe

rflu

oro

deca

nesu

lfonic

aci

d (

PF

DS

)L402

2.0

LR

B2

.0ng

/L1

.04

74

81

43

---

---

---

---

---

<

10

/13

/20

20

06

:30

10

/13

/20

20

22

:38

Tru

e

Perf

luoro

hepta

nesu

lfonic

aci

d (

PF

HpS

)L402

2.0

LR

B2

.0ng

/L1

.04

74

81

43

---

---

---

---

---

<

10

/13

/20

20

06

:30

10

/13

/20

20

22

:38

Tru

e

Perf

luoro

hexa

deca

noic

aci

d (

PF

HxD

A)

L402

2.0

LR

B2

.0ng

/L1

.04

74

81

43

---

---

---

---

---

<

10

/13

/20

20

06

:30

10

/13

/20

20

22

:38

Tru

e

No

na

flu

oro

-3,6

-dio

xah

ep

tan

oic

aci

d (

NF

DH

A)

L402

5.0

LR

B5

.0ng

/L1

.04

74

81

43

---

---

---

---

---

<

10

/13

/20

20

06

:30

10

/13

/20

20

22

:38

Tru

e

Perf

luoro

-4-i

sopro

poxy

buta

noic

aci

dL402

5.0

LR

B5

.0ng

/L1

.04

74

81

43

---

---

---

---

---

<

10

/13

/20

20

06

:30

10

/13

/20

20

22

:38

Tru

e

Perf

luoro

-4-m

eth

oxy

buta

no

ic a

cid (

PF

MB

A)

L402

5.0

LR

B5

.0ng

/L1

.04

74

81

43

---

---

---

---

---

<

10

/13

/20

20

06

:30

10

/13

/20

20

22

:38

Tru

e

Pe

rflu

oro

-3-m

eth

oxy

pro

pa

no

ic a

cid

(P

FM

PA

)L402

5.0

LR

B5

.0ng

/L1

.04

74

81

43

---

---

---

---

---

<

10

/13

/20

20

06

:30

10

/13

/20

20

22

:38

Tru

e

Perf

luoro

nonanesu

lfonic

aci

d (

PF

NS

)L402

2.0

LR

B2

.0ng

/L1

.04

74

81

43

---

---

---

---

---

<

10

/13

/20

20

06

:30

10

/13

/20

20

22

:38

Tru

e

Pe

rflu

oro

oct

ane s

ulfonam

ide (

PF

OS

A)

L402

2.0

LR

B2

.0ng

/L1

.04

74

81

43

---

---

---

---

---

<

10

/13

/20

20

06

:30

10

/13

/20

20

22

:38

Tru

e

Perf

luoro

penta

noic

aci

d (

PF

PeA

)L402

2.0

LR

B2

.0ng

/L1

.04

74

81

43

---

---

---

---

---

<

10

/13

/20

20

06

:30

10

/13

/20

20

22

:38

Tru

e

Pe

rflu

oro

penta

nesu

lfonic

aci

d (

PF

PeS

)L402

2.0

LR

B2

.0ng

/L1

.04

74

81

43

---

---

---

---

---

<

10

/13

/20

20

06

:30

10

/13

/20

20

22

:38

Tru

e

Pe

rflu

oro

tetr

adeca

noic

aci

d (

PF

TeD

A)

L402

2.0

LR

B2

.0ng

/L1

.04

74

81

43

---

---

---

---

---

<

10

/13

/20

20

06

:30

10

/13

/20

20

22

:38

Fals

e

10

:2 F

luo

rote

lom

er

sulfo

nic

aci

d (

10

:2 F

TS

)L402

2.0

FB

L2

.64

63

ng

/L1

.04

74

81

44

---

---

---

50

- 1

50

13

22

.0

10

/13

/20

20

06

:30

10

/13

/20

20

23

:04

Fals

e

4:2

Flu

oro

telo

me

r su

lfo

nic

aci

d (

4:2

FT

S)

L402

2.0

FB

L2

.14

80

ng

/L1

.04

74

81

44

---

---

---

50

- 1

50

10

72

.0

10

/13

/20

20

06

:30

10

/13

/20

20

23

:04

Fals

e

6:2

Flu

oro

telo

me

r su

lfo

nic

aci

d (

6:2

FT

S)

L402

2.0

FB

L1

.94

05

ng

/L1

.04

74

81

44

---

---

---

50

- 1

50

97

2.0

1

0/1

3/2

02

0 0

6:3

01

0/1

3/2

02

0 2

3:0

4F

als

e

8:2

Flu

oro

telo

me

r su

lfo

nic

aci

d (

8:2

FT

S)

L402

2.0

FB

L2

.21

86

ng

/L1

.04

74

81

44

---

---

---

50

- 1

50

11

12

.0

10

/13

/20

20

06

:30

10

/13

/20

20

23

:04

Fals

e

AD

ON

AL402

2.0

FB

L1

.94

55

ng

/L1

.04

74

81

44

---

---

---

50

- 1

50

97

2.0

1

0/1

3/2

02

0 0

6:3

01

0/1

3/2

02

0 2

3:0

4F

als

e

9C

l-P

F3O

NS

/F-5

3B

Majo

rL402

2.0

FB

L1

.77

36

ng

/L1

.04

74

81

44

---

---

---

50

- 1

50

89

2.0

1

0/1

3/2

02

0 0

6:3

01

0/1

3/2

02

0 2

3:0

4F

als

e

11C

l-P

F3O

UdS

/F-5

3B

Min

or

L402

2.0

FB

L1

.57

63

ng

/L1

.04

74

81

44

---

---

---

50

- 1

50

79

2.0

1

0/1

3/2

02

0 0

6:3

01

0/1

3/2

02

0 2

3:0

4F

als

e

HF

PO

-DA

/GenX

L402

5.0

FB

L4

.34

06

ng

/L1

.04

74

81

44

---

---

---

50

- 1

50

87

5.0

1

0/1

3/2

02

0 0

6:3

01

0/1

3/2

02

0 2

3:0

4F

als

e

N-e

thyl

pe

rflu

oro

oct

an

e s

ulfo

na

mid

e (

NE

tFO

SA

)L402

2.0

FB

L1

.65

95

ng

/L1

.04

74

81

44

---

---

---

50

- 1

50

83

2.0

1

0/1

3/2

02

0 0

6:3

01

0/1

3/2

02

0 2

3:0

4F

als

e

N-e

thyl

pe

rflu

oro

oct

an

e s

ulfo

na

mid

oe

tha

no

lL402

2.0

FB

L2

.05

57

ng

/L1

.04

74

81

44

---

---

---

50

- 1

50

10

32

.0

10

/13

/20

20

06

:30

10

/13

/20

20

23

:04

Fals

e

N-m

eth

ylp

erf

luo

roo

cta

ne

su

lfo

na

mid

e (

NM

eF

OS

A)

L402

2.0

FB

L1

.97

81

ng

/L1

.04

74

81

44

---

---

---

50

- 1

50

99

2.0

1

0/1

3/2

02

0 0

6:3

01

0/1

3/2

02

0 2

3:0

4F

als

e

N-m

eth

ylp

erf

luo

roo

cta

ne

su

lfo

na

mid

oe

tha

no

lL402

2.0

FB

L1

.99

46

ng

/L1

.04

74

81

44

---

---

---

50

- 1

50

10

02

.0

10

/13

/20

20

06

:30

10

/13

/20

20

23

:04

Fals

e

Perf

luoro

buta

nesu

lfonic

aci

d (

PF

BS

)L402

2.0

FB

L1

.77

19

ng

/L1

.04

74

81

44

---

---

---

50

- 1

50

89

2.0

1

0/1

3/2

02

0 0

6:3

01

0/1

3/2

02

0 2

3:0

4F

als

e

Perf

luoro

buta

noic

aci

d (

PF

BA

)L402

5.0

FB

L4

.21

44

ng

/L1

.04

74

81

44

---

---

---

50

- 1

50

84

5.0

1

0/1

3/2

02

0 0

6:3

01

0/1

3/2

02

0 2

3:0

4F

als

e

Perf

luoro

deca

noic

aci

d (

PF

DA

)L402

2.0

FB

L1

.75

89

ng

/L1

.04

74

81

44

---

---

---

50

- 1

50

88

2.0

1

0/1

3/2

02

0 0

6:3

01

0/1

3/2

02

0 2

3:0

4F

als

e

Perf

luoro

hepta

noic

aci

d (

PF

HpA

)L402

2.0

FB

L1

.77

35

ng

/L1

.04

74

81

44

---

---

---

50

- 1

50

89

2.0

1

0/1

3/2

02

0 0

6:3

01

0/1

3/2

02

0 2

3:0

4F

als

e

Perf

luoro

hexa

nesu

lfonic

aci

d (

PF

HxS

)L402

2.0

FB

L1

.70

65

ng

/L1

.04

74

81

44

---

---

---

50

- 1

50

85

2.0

1

0/1

3/2

02

0 0

6:3

01

0/1

3/2

02

0 2

3:0

4F

als

e

Perf

luoro

hexa

noic

aci

d (

PF

HxA

)L402

2.0

FB

L1

.77

85

ng

/L1

.04

74

81

44

---

---

---

50

- 1

50

89

2.0

1

0/1

3/2

02

0 0

6:3

01

0/1

3/2

02

0 2

3:0

4F

als

e

Perf

luoro

dodeca

noic

aci

d (

PF

DoA

)L402

2.0

FB

L1

.84

00

ng

/L1

.04

74

81

44

---

---

---

50

- 1

50

92

2.0

1

0/1

3/2

02

0 0

6:3

01

0/1

3/2

02

0 2

3:0

4F

als

e

Perf

luoro

nonanoic

aci

d (

PF

NA

)L402

2.0

FB

L1

.81

41

ng

/L1

.04

74

81

44

---

---

---

50

- 1

50

91

2.0

1

0/1

3/2

02

0 0

6:3

01

0/1

3/2

02

0 2

3:0

4

Page 4

of

9E

EA

Run I

D 2

81023 /

EE

A R

eport

# 5

00223

Page 186 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Fals

e

Perf

luoro

oct

anesu

lfonic

aci

d (

PF

OS

)L402

2.0

FB

L1

.91

12

ng

/L1

.04

74

81

44

---

---

---

50

- 1

50

96

2.0

1

0/1

3/2

02

0 0

6:3

01

0/1

3/2

02

0 2

3:0

4F

als

e

N-e

thyl

Pe

rflu

oro

oct

an

esu

lfo

na

mid

oa

cetic

aci

dL402

2.0

FB

L1

.98

71

ng

/L1

.04

74

81

44

---

---

---

50

- 1

50

99

2.0

1

0/1

3/2

02

0 0

6:3

01

0/1

3/2

02

0 2

3:0

4F

als

e

N-m

eth

yl P

erf

luo

roo

cta

ne

sulfo

na

mid

oa

cetic

aci

dL402

2.0

FB

L1

.81

44

ng

/L1

.04

74

81

44

---

---

---

50

- 1

50

91

2.0

1

0/1

3/2

02

0 0

6:3

01

0/1

3/2

02

0 2

3:0

4F

als

e

Perf

luoro

oct

anoic

aci

d (

PF

OA

)L402

2.0

FB

L1

.94

39

ng

/L1

.04

74

81

44

---

---

---

50

- 1

50

97

2.0

1

0/1

3/2

02

0 0

6:3

01

0/1

3/2

02

0 2

3:0

4F

als

e

Perf

luoro

trid

eca

noic

aci

d (

PF

TrD

A)

L402

2.0

FB

L2

.05

38

ng

/L1

.04

74

81

44

---

---

---

40

- 1

60

10

32

.0

10

/13

/20

20

06

:30

10

/13

/20

20

23

:04

Fals

e

Perf

luoro

undeca

noic

aci

d (

PF

UnA

)L402

2.0

FB

L1

.79

06

ng

/L1

.04

74

81

44

---

---

---

50

- 1

50

90

2.0

1

0/1

3/2

02

0 0

6:3

01

0/1

3/2

02

0 2

3:0

4F

als

e

Perf

luoro

dodeca

nesu

lfonic

aci

d (

PF

DoS

)L402

2.0

FB

L1

.95

20

ng

/L1

.04

74

81

44

---

---

---

40

- 1

60

98

2.0

1

0/1

3/2

02

0 0

6:3

01

0/1

3/2

02

0 2

3:0

4F

als

e

Pe

rflu

oro

deca

nesu

lfonic

aci

d (

PF

DS

)L402

2.0

FB

L1

.95

77

ng

/L1

.04

74

81

44

---

---

---

50

- 1

50

98

2.0

1

0/1

3/2

02

0 0

6:3

01

0/1

3/2

02

0 2

3:0

4F

als

e

Perf

luoro

hepta

nesu

lfonic

aci

d (

PF

HpS

)L402

2.0

FB

L1

.33

36

ng

/L1

.04

74

81

44

---

---

---

50

- 1

50

67

2.0

1

0/1

3/2

02

0 0

6:3

01

0/1

3/2

02

0 2

3:0

4F

als

e

Perf

luoro

hexa

deca

noic

aci

d (

PF

HxD

A)

L402

2.0

FB

L1

.87

61

ng

/L1

.04

74

81

44

---

---

---

50

- 1

50

94

2.0

1

0/1

3/2

02

0 0

6:3

01

0/1

3/2

02

0 2

3:0

4F

als

e

No

na

flu

oro

-3,6

-dio

xah

ep

tan

oic

aci

d (

NF

DH

A)

L402

5.0

FB

L5

.00

04

ng

/L1

.04

74

81

44

---

---

---

50

- 1

50

10

05

.0

10

/13

/20

20

06

:30

10

/13

/20

20

23

:04

Fals

e

Perf

luoro

-4-i

sopro

poxy

buta

noic

aci

dL402

5.0

FB

L5

.27

37

ng

/L1

.04

74

81

44

---

---

---

50

- 1

50

10

55

.0

10

/13

/20

20

06

:30

10

/13

/20

20

23

:04

Fals

e

Perf

luoro

-4-m

eth

oxy

buta

no

ic a

cid (

PF

MB

A)

L402

5.0

FB

L4

.26

43

ng

/L1

.04

74

81

44

---

---

---

50

- 1

50

85

5.0

1

0/1

3/2

02

0 0

6:3

01

0/1

3/2

02

0 2

3:0

4F

als

e

Pe

rflu

oro

-3-m

eth

oxy

pro

pa

no

ic a

cid

(P

FM

PA

)L402

5.0

FB

L4

.27

19

ng

/L1

.04

74

81

44

---

---

---

50

- 1

50

85

5.0

1

0/1

3/2

02

0 0

6:3

01

0/1

3/2

02

0 2

3:0

4F

als

e

Perf

luoro

nonanesu

lfonic

aci

d (

PF

NS

)L402

2.0

FB

L2

.34

90

ng

/L1

.04

74

81

44

---

---

---

50

- 1

50

11

72

.0

10

/13

/20

20

06

:30

10

/13

/20

20

23

:04

Fals

e

Pe

rflu

oro

oct

ane s

ulfonam

ide (

PF

OS

A)

L402

2.0

FB

L1

.88

26

ng

/L1

.04

74

81

44

---

---

---

50

- 1

50

94

2.0

1

0/1

3/2

02

0 0

6:3

01

0/1

3/2

02

0 2

3:0

4F

als

e

Perf

luoro

penta

noic

aci

d (

PF

PeA

)L402

2.0

FB

L1

.78

93

ng

/L1

.04

74

81

44

---

---

---

50

- 1

50

89

2.0

1

0/1

3/2

02

0 0

6:3

01

0/1

3/2

02

0 2

3:0

4F

als

e

Pe

rflu

oro

penta

nesu

lfonic

aci

d (

PF

PeS

)L402

2.0

FB

L2

.04

12

ng

/L1

.04

74

81

44

---

---

---

50

- 1

50

10

22

.0

10

/13

/20

20

06

:30

10

/13

/20

20

23

:04

Fals

e

Pe

rflu

oro

tetr

adeca

noic

aci

d (

PF

TeD

A)

L402

2.0

FB

L1

.86

04

ng

/L1

.04

74

81

44

---

---

---

50

- 1

50

93

2.0

1

0/1

3/2

02

0 0

6:3

01

0/1

3/2

02

0 2

3:0

4T

rue

IS-4

:2-F

TS

-13C

2L402

N/A

CC

M5

28

24

8ng

/L1

.04

74

81

60

---

---

---

50

- 1

50

80

66

01

61

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

4:4

7T

rue

IS-6

:2-F

TS

-13C

2L402

N/A

CC

M2

23

30

3ng

/L1

.04

74

81

60

---

---

---

50

- 1

50

81

27

68

17

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

4:4

7T

rue

IS-8

:2-F

TS

-13C

2L402

N/A

CC

M6

15

45

9ng

/L1

.04

74

81

60

---

---

---

50

- 1

50

83

74

48

70

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

4:4

7T

rue

IS-G

enX

-13C

3L402

N/A

CC

M2

91

23

ng

/L1

.04

74

81

60

---

---

---

50

- 1

50

10

92

67

89

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

4:4

7T

rue

IS-N

EtF

OS

AA

-d5

L402

N/A

CC

M8

77

46

6ng

/L1

.04

74

81

60

---

---

---

50

- 1

50

89

98

35

35

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

4:4

7T

rue

IS-N

EtF

OS

E-d

9L402

N/A

CC

M1

24

53

0ng

/L1

.04

74

81

60

---

---

---

50

- 1

50

93

13

33

88

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

4:4

7T

rue

IS-N

MeF

OS

AA

-d3

L402

N/A

CC

M1

06

76

70

ng

/L1

.04

74

81

60

---

---

---

50

- 1

50

91

11

78

76

8

10

/13

/20

20

10

:16

10

/14

/20

20

04

:47

Tru

e

IS-N

MeF

OS

A-d

3L402

N/A

CC

M1

08

32

30

ng

/L1

.04

74

81

60

---

---

---

50

- 1

50

97

11

19

22

6

10

/13

/20

20

10

:16

10

/14

/20

20

04

:47

Tru

e

IS-N

MeF

OS

E-d

7L402

N/A

CC

M1

28

15

2ng

/L1

.04

74

81

60

---

---

---

50

- 1

50

90

14

30

02

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

4:4

7T

rue

IS-P

FB

A-1

3C

4L402

N/A

CC

M4

37

51

20

ng

/L1

.04

74

81

60

---

---

---

50

- 1

50

10

34

23

76

66

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

4:4

7T

rue

IS-P

FB

S-1

3C

3L402

N/A

CC

M8

19

39

7ng

/L1

.04

74

81

60

---

---

---

50

- 1

50

92

89

09

58

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

4:4

7T

rue

IS-P

FD

A-1

3C

2L402

N/A

CC

M4

11

51

80

ng

/L1

.04

74

81

60

---

---

---

50

- 1

50

94

43

98

95

6

10

/13

/20

20

10

:16

10

/14

/20

20

04

:47

Tru

e

IS-P

FD

oA

-13C

2L402

N/A

CC

M4

29

25

20

ng

/L1

.04

74

81

60

---

---

---

50

- 1

50

90

47

85

14

8

10

/13

/20

20

10

:16

10

/14

/20

20

04

:47

Tru

e

IS-P

FH

pA

-13C

4L402

N/A

CC

M5

15

38

80

ng

/L1

.04

74

81

60

---

---

---

50

- 1

50

98

52

46

28

3

10

/13

/20

20

10

:16

10

/14

/20

20

04

:47

Tru

e

IS-P

FH

xA-1

3C

2L402

N/A

CC

M2

16

34

00

ng

/L1

.04

74

81

60

---

---

---

50

- 1

50

10

02

16

22

10

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

4:4

7T

rue

IS-P

FO

SA

-13C

8L402

N/A

CC

M3

01

73

90

ng

/L1

.04

74

81

60

---

---

---

50

- 1

50

97

31

08

62

0

10

/13

/20

20

10

:16

10

/14

/20

20

04

:47

Tru

e

IS-N

EtF

OS

A-d

5L402

N/A

CC

M9

28

87

5ng

/L1

.04

74

81

60

---

---

---

50

- 1

50

99

93

71

54

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

4:4

7T

rue

IS-P

FH

xS-1

3C

3L402

N/A

CC

M1

11

29

60

ng

/L1

.04

74

81

60

---

---

---

50

- 1

50

98

11

39

79

5

10

/13

/20

20

10

:16

10

/14

/20

20

04

:47

Tru

e

IS-P

FN

A-1

3C

9L402

N/A

CC

M6

48

73

70

ng

/L1

.04

74

81

60

---

---

---

50

- 1

50

98

66

31

09

5

10

/13

/20

20

10

:16

10

/14

/20

20

04

:47

Tru

e

IS-P

FO

A-1

3C

2L402

N/A

CC

M5

60

52

10

ng

/L1

.04

74

81

60

---

---

---

50

- 1

50

96

58

20

45

0

10

/13

/20

20

10

:16

10

/14

/20

20

04

:47

Tru

e

IS-P

FO

S-1

3C

4L402

N/A

CC

M1

05

68

20

ng

/L1

.04

74

81

60

---

---

---

50

- 1

50

10

31

02

51

60

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

4:4

7T

rue

IS-P

FP

eA

-13C

5L402

N/A

CC

M1

72

74

80

ng

/L1

.04

74

81

60

---

---

---

50

- 1

50

94

18

33

17

3

10

/13

/20

20

10

:16

10

/14

/20

20

04

:47

Page 5

of

9E

EA

Run I

D 2

81023 /

EE

A R

eport

# 5

00223

Page 187 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Tru

e

IS-P

FT

eD

A-1

3C

2L402

N/A

CC

M1

31

94

60

ng

/L1

.04

74

81

60

---

---

---

50

- 1

50

79

16

59

81

3

10

/13

/20

20

10

:16

10

/14

/20

20

04

:47

Tru

e

IS-P

FU

nA

-13C

7L402

N/A

CC

M4

65

15

20

ng

/L1

.04

74

81

60

---

---

---

50

- 1

50

98

47

58

58

8

10

/13

/20

20

10

:16

10

/14

/20

20

04

:47

Tru

e

10

:2 F

luo

rote

lom

er

sulfo

nic

aci

d (

10

:2 F

TS

)L402

2.0

CC

M8

9.9

41

0ng

/L1

.04

74

81

60

---

---

---

70

- 1

30

90

10

0

10

/13

/20

20

10

:16

10

/14

/20

20

04

:47

Tru

e

4:2

Flu

oro

telo

me

r su

lfo

nic

aci

d (

4:2

FT

S)

L402

2.0

CC

M1

09

.46

90

ng

/L1

.04

74

81

60

---

---

---

70

- 1

30

10

91

00

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

4:4

7T

rue

6:2

Flu

oro

telo

me

r su

lfo

nic

aci

d (

6:2

FT

S)

L402

2.0

CC

M1

03

.68

20

ng

/L1

.04

74

81

60

---

---

---

70

- 1

30

10

41

00

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

4:4

7T

rue

8:2

Flu

oro

telo

me

r su

lfo

nic

aci

d (

8:2

FT

S)

L402

2.0

CC

M1

09

.28

30

ng

/L1

.04

74

81

60

---

---

---

70

- 1

30

10

91

00

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

4:4

7T

rue

AD

ON

AL402

2.0

CC

M1

07

.18

10

ng

/L1

.04

74

81

60

---

---

---

70

- 1

30

10

71

00

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

4:4

7T

rue

9C

l-P

F3O

NS

/F-5

3B

Majo

rL402

2.0

CC

M1

05

.44

60

ng

/L1

.04

74

81

60

---

---

---

70

- 1

30

10

51

00

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

4:4

7T

rue

11C

l-P

F3O

UdS

/F-5

3B

Min

or

L402

2.0

CC

M1

12

.06

70

ng

/L1

.04

74

81

60

---

---

---

70

- 1

30

11

21

00

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

4:4

7T

rue

HF

PO

-DA

/GenX

L402

5.0

CC

M2

48

.08

40

ng

/L1

.04

74

81

60

---

---

---

70

- 1

30

99

25

0

10

/13

/20

20

10

:16

10

/14

/20

20

04

:47

Tru

e

N-e

thyl

pe

rflu

oro

oct

an

e s

ulfo

na

mid

e (

NE

tFO

SA

)L402

2.0

CC

M1

01

.63

50

ng

/L1

.04

74

81

60

---

---

---

70

- 1

30

10

21

00

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

4:4

7T

rue

N-e

thyl

pe

rflu

oro

oct

an

e s

ulfo

na

mid

oe

tha

no

lL402

2.0

CC

M9

9.2

00

9ng

/L1

.04

74

81

60

---

---

---

70

- 1

30

99

10

0

10

/13

/20

20

10

:16

10

/14

/20

20

04

:47

Tru

e

N-m

eth

ylp

erf

luo

roo

cta

ne

su

lfo

na

mid

e (

NM

eF

OS

A)

L402

2.0

CC

M9

9.5

46

8ng

/L1

.04

74

81

60

---

---

---

70

- 1

30

10

01

00

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

4:4

7T

rue

N-m

eth

ylp

erf

luo

roo

cta

ne

su

lfo

na

mid

oe

tha

no

lL402

2.0

CC

M1

01

.42

70

ng

/L1

.04

74

81

60

---

---

---

70

- 1

30

10

11

00

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

4:4

7T

rue

Perf

luoro

buta

nesu

lfonic

aci

d (

PF

BS

)L402

2.0

CC

M1

01

.67

30

ng

/L1

.04

74

81

60

---

---

---

70

- 1

30

10

21

00

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

4:4

7T

rue

Perf

luoro

buta

noic

aci

d (

PF

BA

)L402

5.0

CC

M2

53

.35

80

ng

/L1

.04

74

81

60

---

---

---

70

- 1

30

10

12

50

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

4:4

7T

rue

Perf

luoro

deca

noic

aci

d (

PF

DA

)L402

2.0

CC

M9

9.3

95

1ng

/L1

.04

74

81

60

---

---

---

70

- 1

30

99

10

0

10

/13

/20

20

10

:16

10

/14

/20

20

04

:47

Tru

e

Perf

luoro

hepta

noic

aci

d (

PF

HpA

)L402

2.0

CC

M1

01

.50

50

ng

/L1

.04

74

81

60

---

---

---

70

- 1

30

10

21

00

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

4:4

7T

rue

Perf

luoro

hexa

nesu

lfonic

aci

d (

PF

HxS

)L402

2.0

CC

M9

9.8

09

9ng

/L1

.04

74

81

60

---

---

---

70

- 1

30

10

01

00

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

4:4

7T

rue

Perf

luoro

hexa

noic

aci

d (

PF

HxA

)L402

2.0

CC

M1

01

.27

20

ng

/L1

.04

74

81

60

---

---

---

70

- 1

30

10

11

00

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

4:4

7T

rue

Perf

luoro

dodeca

noic

aci

d (

PF

DoA

)L402

2.0

CC

M1

01

.13

50

ng

/L1

.04

74

81

60

---

---

---

70

- 1

30

10

11

00

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

4:4

7T

rue

Perf

luoro

nonanoic

aci

d (

PF

NA

)L402

2.0

CC

M1

03

.04

90

ng

/L1

.04

74

81

60

---

---

---

70

- 1

30

10

31

00

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

4:4

7T

rue

Perf

luoro

oct

anesu

lfonic

aci

d (

PF

OS

)L402

2.0

CC

M9

7.8

85

8ng

/L1

.04

74

81

60

---

---

---

70

- 1

30

98

10

0

10

/13

/20

20

10

:16

10

/14

/20

20

04

:47

Tru

e

N-e

thyl

Pe

rflu

oro

oct

an

esu

lfo

na

mid

oa

cetic

aci

dL402

2.0

CC

M1

04

.67

10

ng

/L1

.04

74

81

60

---

---

---

70

- 1

30

10

51

00

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

4:4

7T

rue

N-m

eth

yl P

erf

luo

roo

cta

ne

sulfo

na

mid

oa

cetic

aci

dL402

2.0

CC

M1

02

.05

10

ng

/L1

.04

74

81

60

---

---

---

70

- 1

30

10

21

00

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

4:4

7T

rue

Perf

luoro

oct

anoic

aci

d (

PF

OA

)L402

2.0

CC

M1

03

.81

50

ng

/L1

.04

74

81

60

---

---

---

70

- 1

30

10

41

00

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

4:4

7T

rue

Perf

luoro

trid

eca

noic

aci

d (

PF

TrD

A)

L402

2.0

CC

M9

4.3

76

5ng

/L1

.04

74

81

60

---

---

---

70

- 1

30

94

10

0

10

/13

/20

20

10

:16

10

/14

/20

20

04

:47

Tru

e

Perf

luoro

undeca

noic

aci

d (

PF

UnA

)L402

2.0

CC

M9

9.7

91

2ng

/L1

.04

74

81

60

---

---

---

70

- 1

30

10

01

00

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

4:4

7T

rue

Perf

luoro

dodeca

nesu

lfonic

aci

d (

PF

DoS

)L402

2.0

CC

M1

13

.73

90

ng

/L1

.04

74

81

60

---

---

---

70

- 1

30

11

41

00

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

4:4

7T

rue

Pe

rflu

oro

deca

nesu

lfonic

aci

d (

PF

DS

)L402

2.0

CC

M1

15

.50

50

ng

/L1

.04

74

81

60

---

---

---

70

- 1

30

11

61

00

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

4:4

7T

rue

Perf

luoro

hepta

nesu

lfonic

aci

d (

PF

HpS

)L402

2.0

CC

M1

02

.40

70

ng

/L1

.04

74

81

60

---

---

---

70

- 1

30

10

21

00

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

4:4

7T

rue

Perf

luoro

hexa

deca

noic

aci

d (

PF

HxD

A)

L402

2.0

CC

M1

00

.00

00

ng

/L1

.04

74

81

60

---

---

---

70

- 1

30

10

01

00

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

4:4

7T

rue

No

na

flu

oro

-3,6

-dio

xah

ep

tan

oic

aci

d (

NF

DH

A)

L402

5.0

CC

M2

84

.13

50

ng

/L1

.04

74

81

60

---

---

---

70

- 1

30

11

42

50

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

4:4

7T

rue

Perf

luoro

-4-i

sopro

poxy

buta

noic

aci

dL402

5.0

CC

M2

69

.17

70

ng

/L1

.04

74

81

60

---

---

---

70

- 1

30

10

82

50

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

4:4

7T

rue

Perf

luoro

-4-m

eth

oxy

buta

no

ic a

cid (

PF

MB

A)

L402

5.0

CC

M2

62

.02

40

ng

/L1

.04

74

81

60

---

---

---

70

- 1

30

10

52

50

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

4:4

7T

rue

Pe

rflu

oro

-3-m

eth

oxy

pro

pa

no

ic a

cid

(P

FM

PA

)L402

5.0

CC

M2

53

.21

60

ng

/L1

.04

74

81

60

---

---

---

70

- 1

30

10

12

50

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

4:4

7T

rue

Perf

luoro

nonanesu

lfonic

aci

d (

PF

NS

)L402

2.0

CC

M1

09

.33

60

ng

/L1

.04

74

81

60

---

---

---

70

- 1

30

10

91

00

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

4:4

7T

rue

Pe

rflu

oro

oct

ane s

ulfonam

ide (

PF

OS

A)

L402

2.0

CC

M1

01

.41

80

ng

/L1

.04

74

81

60

---

---

---

70

- 1

30

10

11

00

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

4:4

7T

rue

Perf

luoro

penta

noic

aci

d (

PF

PeA

)L402

2.0

CC

M1

03

.29

80

ng

/L1

.04

74

81

60

---

---

---

70

- 1

30

10

31

00

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

4:4

7T

rue

Pe

rflu

oro

penta

nesu

lfonic

aci

d (

PF

PeS

)L402

2.0

CC

M1

15

.20

10

ng

/L1

.04

74

81

60

---

---

---

70

- 1

30

11

51

00

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

4:4

7T

rue

Pe

rflu

oro

tetr

adeca

noic

aci

d (

PF

TeD

A)

L402

2.0

CC

M9

7.8

32

4ng

/L1

.04

74

81

60

---

---

---

70

- 1

30

98

10

0

10

/13

/20

20

10

:16

10

/14

/20

20

04

:47

Page 6

of

9E

EA

Run I

D 2

81023 /

EE

A R

eport

# 5

00223

Page 188 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Fals

e

10

:2 F

luo

rote

lom

er

sulfo

nic

aci

d (

10

:2 F

TS

)L402

2.0

FS

2.0

ng

/L0

.95

47

43

54

0F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

6:3

01

0/1

4/2

02

0 0

6:3

2F

als

e

4:2

Flu

oro

telo

me

r su

lfo

nic

aci

d (

4:2

FT

S)

L402

2.0

FS

2.0

ng

/L0

.95

47

43

54

0F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

6:3

01

0/1

4/2

02

0 0

6:3

2F

als

e

6:2

Flu

oro

telo

me

r su

lfo

nic

aci

d (

6:2

FT

S)

L402

2.0

FS

2.0

ng

/L0

.95

47

43

54

0F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

6:3

01

0/1

4/2

02

0 0

6:3

2F

als

e

8:2

Flu

oro

telo

me

r su

lfo

nic

aci

d (

8:2

FT

S)

L402

2.0

FS

2.0

ng

/L0

.95

47

43

54

0F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

6:3

01

0/1

4/2

02

0 0

6:3

2F

als

e

AD

ON

AL402

2.0

FS

2.0

ng

/L0

.95

47

43

54

0F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

6:3

01

0/1

4/2

02

0 0

6:3

2F

als

e

9C

l-P

F3O

NS

/F-5

3B

Majo

rL402

2.0

FS

2.0

ng

/L0

.95

47

43

54

0F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

6:3

01

0/1

4/2

02

0 0

6:3

2F

als

e

11C

l-P

F3O

UdS

/F-5

3B

Min

or

L402

2.0

FS

2.0

ng

/L0

.95

47

43

54

0F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

6:3

01

0/1

4/2

02

0 0

6:3

2F

als

e

HF

PO

-DA

/GenX

L402

5.0

FS

5.0

ng

/L0

.95

47

43

54

0F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

6:3

01

0/1

4/2

02

0 0

6:3

2F

als

e

N-e

thyl

pe

rflu

oro

oct

an

e s

ulfo

na

mid

e (

NE

tFO

SA

)L402

2.0

FS

2.0

ng

/L0

.95

47

43

54

0F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

6:3

01

0/1

4/2

02

0 0

6:3

2F

als

e

N-e

thyl

pe

rflu

oro

oct

an

e s

ulfo

na

mid

oe

tha

no

lL402

2.0

FS

2.0

ng

/L0

.95

47

43

54

0F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

6:3

01

0/1

4/2

02

0 0

6:3

2F

als

e

N-m

eth

ylp

erf

luo

roo

cta

ne

su

lfo

na

mid

e (

NM

eF

OS

A)

L402

2.0

FS

2.0

ng

/L0

.95

47

43

54

0F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

6:3

01

0/1

4/2

02

0 0

6:3

2F

als

e

N-m

eth

ylp

erf

luo

roo

cta

ne

su

lfo

na

mid

oe

tha

no

lL402

2.0

FS

2.0

ng

/L0

.95

47

43

54

0F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

6:3

01

0/1

4/2

02

0 0

6:3

2F

als

e

Perf

luoro

buta

nesu

lfonic

aci

d (

PF

BS

)L402

2.0

FS

2.9

ng

/L0

.95

47

43

54

0F

inis

he

d--

---

---

---

-

1

0/1

3/2

02

0 0

6:3

01

0/1

4/2

02

0 0

6:3

2F

als

e

Perf

luoro

buta

noic

aci

d (

PF

BA

)L402

5.0

FS

8.0

ng

/L0

.95

47

43

54

0F

inis

he

d--

---

---

---

-

1

0/1

3/2

02

0 0

6:3

01

0/1

4/2

02

0 0

6:3

2F

als

e

Perf

luoro

deca

noic

aci

d (

PF

DA

)L402

2.0

FS

2.0

ng

/L0

.95

47

43

54

0F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

6:3

01

0/1

4/2

02

0 0

6:3

2F

als

e

Perf

luoro

hepta

noic

aci

d (

PF

HpA

)L402

2.0

FS

2.6

ng

/L0

.95

47

43

54

0F

inis

he

d--

---

---

---

-

1

0/1

3/2

02

0 0

6:3

01

0/1

4/2

02

0 0

6:3

2F

als

e

Perf

luoro

hexa

nesu

lfonic

aci

d (

PF

HxS

)L402

2.0

FS

2.7

ng

/L0

.95

47

43

54

0F

inis

he

d--

---

---

---

-

1

0/1

3/2

02

0 0

6:3

01

0/1

4/2

02

0 0

6:3

2F

als

e

Perf

luoro

hexa

noic

aci

d (

PF

HxA

)L402

2.0

FS

4.9

ng

/L0

.95

47

43

54

0F

inis

he

d--

---

---

---

-

1

0/1

3/2

02

0 0

6:3

01

0/1

4/2

02

0 0

6:3

2F

als

e

Perf

luoro

dodeca

noic

aci

d (

PF

DoA

)L402

2.0

FS

2.0

ng

/L0

.95

47

43

54

0F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

6:3

01

0/1

4/2

02

0 0

6:3

2F

als

e

Perf

luoro

nonanoic

aci

d (

PF

NA

)L402

2.0

FS

2.0

ng

/L0

.95

47

43

54

0F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

6:3

01

0/1

4/2

02

0 0

6:3

2F

als

e

Perf

luoro

oct

anesu

lfonic

aci

d (

PF

OS

)L402

2.0

FS

7.5

ng

/L0

.95

47

43

54

0F

inis

he

d--

---

---

---

-

1

0/1

3/2

02

0 0

6:3

01

0/1

4/2

02

0 0

6:3

2F

als

e

N-e

thyl

Pe

rflu

oro

oct

an

esu

lfo

na

mid

oa

cetic

aci

dL402

2.0

FS

2.0

ng

/L0

.95

47

43

54

0F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

6:3

01

0/1

4/2

02

0 0

6:3

2F

als

e

N-m

eth

yl P

erf

luo

roo

cta

ne

sulfo

na

mid

oa

cetic

aci

dL402

2.0

FS

2.0

ng

/L0

.95

47

43

54

0F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

6:3

01

0/1

4/2

02

0 0

6:3

2F

als

e

Perf

luoro

oct

anoic

aci

d (

PF

OA

)L402

2.0

FS

4.3

ng

/L0

.95

47

43

54

0F

inis

he

d--

---

---

---

-

1

0/1

3/2

02

0 0

6:3

01

0/1

4/2

02

0 0

6:3

2F

als

e

Perf

luoro

trid

eca

noic

aci

d (

PF

TrD

A)

L402

2.0

FS

2.0

ng

/L0

.95

47

43

54

0F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

6:3

01

0/1

4/2

02

0 0

6:3

2F

als

e

Perf

luoro

undeca

noic

aci

d (

PF

UnA

)L402

2.0

FS

2.0

ng

/L0

.95

47

43

54

0F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

6:3

01

0/1

4/2

02

0 0

6:3

2F

als

e

Perf

luoro

dodeca

nesu

lfonic

aci

d (

PF

DoS

)L402

2.0

FS

2.0

ng

/L0

.95

47

43

54

0F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

6:3

01

0/1

4/2

02

0 0

6:3

2F

als

e

Pe

rflu

oro

deca

nesu

lfonic

aci

d (

PF

DS

)L402

2.0

FS

2.0

ng

/L0

.95

47

43

54

0F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

6:3

01

0/1

4/2

02

0 0

6:3

2F

als

e

Perf

luoro

hepta

nesu

lfonic

aci

d (

PF

HpS

)L402

2.0

FS

2.0

ng

/L0

.95

47

43

54

0F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

6:3

01

0/1

4/2

02

0 0

6:3

2F

als

e

Perf

luoro

hexa

deca

noic

aci

d (

PF

HxD

A)

L402

2.0

FS

2.0

ng

/L0

.95

47

43

54

0F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

6:3

01

0/1

4/2

02

0 0

6:3

2F

als

e

No

na

flu

oro

-3,6

-dio

xah

ep

tan

oic

aci

d (

NF

DH

A)

L402

5.0

FS

5.0

ng

/L0

.95

47

43

54

0F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

6:3

01

0/1

4/2

02

0 0

6:3

2F

als

e

Perf

luoro

-4-i

sopro

poxy

buta

noic

aci

dL402

5.0

FS

5.0

ng

/L0

.95

47

43

54

0F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

6:3

01

0/1

4/2

02

0 0

6:3

2F

als

e

Perf

luoro

-4-m

eth

oxy

buta

no

ic a

cid (

PF

MB

A)

L402

5.0

FS

5.0

ng

/L0

.95

47

43

54

0F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

6:3

01

0/1

4/2

02

0 0

6:3

2F

als

e

Pe

rflu

oro

-3-m

eth

oxy

pro

pa

no

ic a

cid

(P

FM

PA

)L402

5.0

FS

5.0

ng

/L0

.95

47

43

54

0F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

6:3

01

0/1

4/2

02

0 0

6:3

2F

als

e

Perf

luoro

nonanesu

lfonic

aci

d (

PF

NS

)L402

2.0

FS

2.0

ng

/L0

.95

47

43

54

0F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

6:3

01

0/1

4/2

02

0 0

6:3

2F

als

e

Pe

rflu

oro

oct

ane s

ulfonam

ide (

PF

OS

A)

L402

2.0

FS

2.0

ng

/L0

.95

47

43

54

0F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

6:3

01

0/1

4/2

02

0 0

6:3

2F

als

e

Perf

luoro

penta

noic

aci

d (

PF

PeA

)L402

2.0

FS

5.5

ng

/L0

.95

47

43

54

0F

inis

he

d--

---

---

---

-

1

0/1

3/2

02

0 0

6:3

01

0/1

4/2

02

0 0

6:3

2F

als

e

Pe

rflu

oro

penta

nesu

lfonic

aci

d (

PF

PeS

)L402

2.0

FS

2.0

ng

/L0

.95

47

43

54

0F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

6:3

01

0/1

4/2

02

0 0

6:3

2F

als

e

Pe

rflu

oro

tetr

adeca

noic

aci

d (

PF

TeD

A)

L402

2.0

FS

2.0

ng

/L0

.95

47

43

54

0F

inis

he

d--

---

---

---

-

<1

0/1

3/2

02

0 0

6:3

01

0/1

4/2

02

0 0

6:3

2T

rue

IS-4

:2-F

TS

-13C

2L402

N/A

CC

H5

55

63

0ng

/L1

.04

74

81

61

---

---

---

50

- 1

50

84

66

01

61

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

6:5

8T

rue

IS-6

:2-F

TS

-13C

2L402

N/A

CC

H2

21

84

8ng

/L1

.04

74

81

61

---

---

---

50

- 1

50

80

27

68

17

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

6:5

8

Page 7

of

9E

EA

Run I

D 2

81023 /

EE

A R

eport

# 5

00223

Page 189 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Tru

e

IS-8

:2-F

TS

-13C

2L402

N/A

CC

H5

95

71

1ng

/L1

.04

74

81

61

---

---

---

50

- 1

50

80

74

48

70

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

6:5

8T

rue

IS-G

enX

-13C

3L402

N/A

CC

H2

53

86

ng

/L1

.04

74

81

61

---

---

---

50

- 1

50

95

26

78

9

10

/13

/20

20

10

:16

10

/14

/20

20

06

:58

Tru

e

IS-N

EtF

OS

AA

-d5

L402

N/A

CC

H8

11

61

1ng

/L1

.04

74

81

61

---

---

---

50

- 1

50

83

98

35

35

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

6:5

8T

rue

IS-N

EtF

OS

E-d

9L402

N/A

CC

H1

12

48

8ng

/L1

.04

74

81

61

---

---

---

50

- 1

50

84

13

33

88

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

6:5

8T

rue

IS-N

MeF

OS

AA

-d3

L402

N/A

CC

H1

06

38

30

ng

/L1

.04

74

81

61

---

---

---

50

- 1

50

90

11

78

76

8

10

/13

/20

20

10

:16

10

/14

/20

20

06

:58

Tru

e

IS-N

MeF

OS

A-d

3L402

N/A

CC

H8

45

20

3ng

/L1

.04

74

81

61

---

---

---

50

- 1

50

76

11

19

22

6

10

/13

/20

20

10

:16

10

/14

/20

20

06

:58

Tru

e

IS-N

MeF

OS

E-d

7L402

N/A

CC

H1

20

39

2ng

/L1

.04

74

81

61

---

---

---

50

- 1

50

84

14

30

02

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

6:5

8T

rue

IS-P

FB

A-1

3C

4L402

N/A

CC

H4

35

67

00

ng

/L1

.04

74

81

61

---

---

---

50

- 1

50

10

34

23

76

66

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

6:5

8T

rue

IS-P

FB

S-1

3C

3L402

N/A

CC

H8

29

65

6ng

/L1

.04

74

81

61

---

---

---

50

- 1

50

93

89

09

58

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

6:5

8T

rue

IS-P

FD

A-1

3C

2L402

N/A

CC

H3

57

30

60

ng

/L1

.04

74

81

61

---

---

---

50

- 1

50

81

43

98

95

6

10

/13

/20

20

10

:16

10

/14

/20

20

06

:58

Tru

e

IS-P

FD

oA

-13C

2L402

N/A

CC

H4

11

60

50

ng

/L1

.04

74

81

61

---

---

---

50

- 1

50

86

47

85

14

8

10

/13

/20

20

10

:16

10

/14

/20

20

06

:58

Tru

e

IS-P

FH

pA

-13C

4L402

N/A

CC

H4

76

84

00

ng

/L1

.04

74

81

61

---

---

---

50

- 1

50

91

52

46

28

3

10

/13

/20

20

10

:16

10

/14

/20

20

06

:58

Tru

e

IS-P

FH

xA-1

3C

2L402

N/A

CC

H2

10

70

90

ng

/L1

.04

74

81

61

---

---

---

50

- 1

50

97

21

62

21

0

10

/13

/20

20

10

:16

10

/14

/20

20

06

:58

Tru

e

IS-P

FO

SA

-13C

8L402

N/A

CC

H2

85

98

50

ng

/L1

.04

74

81

61

---

---

---

50

- 1

50

92

31

08

62

0

10

/13

/20

20

10

:16

10

/14

/20

20

06

:58

Tru

e

IS-N

EtF

OS

A-d

5L402

N/A

CC

H6

57

74

7ng

/L1

.04

74

81

61

---

---

---

50

- 1

50

70

93

71

54

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

6:5

8T

rue

IS-P

FH

xS-1

3C

3L402

N/A

CC

H1

03

79

30

ng

/L1

.04

74

81

61

---

---

---

50

- 1

50

91

11

39

79

5

10

/13

/20

20

10

:16

10

/14

/20

20

06

:58

Tru

e

IS-P

FN

A-1

3C

9L402

N/A

CC

H5

98

60

20

ng

/L1

.04

74

81

61

---

---

---

50

- 1

50

90

66

31

09

5

10

/13

/20

20

10

:16

10

/14

/20

20

06

:58

Tru

e

IS-P

FO

A-1

3C

2L402

N/A

CC

H5

19

32

40

ng

/L1

.04

74

81

61

---

---

---

50

- 1

50

89

58

20

45

0

10

/13

/20

20

10

:16

10

/14

/20

20

06

:58

Tru

e

IS-P

FO

S-1

3C

4L402

N/A

CC

H1

03

90

80

ng

/L1

.04

74

81

61

---

---

---

50

- 1

50

10

11

02

51

60

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

6:5

8T

rue

IS-P

FP

eA

-13C

5L402

N/A

CC

H1

76

49

00

ng

/L1

.04

74

81

61

---

---

---

50

- 1

50

96

18

33

17

3

10

/13

/20

20

10

:16

10

/14

/20

20

06

:58

Tru

e

IS-P

FT

eD

A-1

3C

2L402

N/A

CC

H1

44

08

90

ng

/L1

.04

74

81

61

---

---

---

50

- 1

50

87

16

59

81

3

10

/13

/20

20

10

:16

10

/14

/20

20

06

:58

Tru

e

IS-P

FU

nA

-13C

7L402

N/A

CC

H4

09

17

10

ng

/L1

.04

74

81

61

---

---

---

50

- 1

50

86

47

58

58

8

10

/13

/20

20

10

:16

10

/14

/20

20

06

:58

Tru

e

10

:2 F

luo

rote

lom

er

sulfo

nic

aci

d (

10

:2 F

TS

)L402

2.0

CC

H1

67

.37

50

ng

/L1

.04

74

81

61

---

---

---

70

- 1

30

84

20

0

10

/13

/20

20

10

:16

10

/14

/20

20

06

:58

Tru

e

4:2

Flu

oro

telo

me

r su

lfo

nic

aci

d (

4:2

FT

S)

L402

2.0

CC

H1

99

.27

70

ng

/L1

.04

74

81

61

---

---

---

70

- 1

30

10

02

00

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

6:5

8T

rue

6:2

Flu

oro

telo

me

r su

lfo

nic

aci

d (

6:2

FT

S)

L402

2.0

CC

H2

03

.01

90

ng

/L1

.04

74

81

61

---

---

---

70

- 1

30

10

22

00

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

6:5

8T

rue

8:2

Flu

oro

telo

me

r su

lfo

nic

aci

d (

8:2

FT

S)

L402

2.0

CC

H1

97

.95

30

ng

/L1

.04

74

81

61

---

---

---

70

- 1

30

99

20

0

10

/13

/20

20

10

:16

10

/14

/20

20

06

:58

Tru

e

AD

ON

AL402

2.0

CC

H1

98

.59

50

ng

/L1

.04

74

81

61

---

---

---

70

- 1

30

99

20

0

10

/13

/20

20

10

:16

10

/14

/20

20

06

:58

Tru

e

9C

l-P

F3O

NS

/F-5

3B

Majo

rL402

2.0

CC

H2

04

.97

00

ng

/L1

.04

74

81

61

---

---

---

70

- 1

30

10

22

00

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

6:5

8T

rue

11C

l-P

F3O

UdS

/F-5

3B

Min

or

L402

2.0

CC

H2

21

.54

00

ng

/L1

.04

74

81

61

---

---

---

70

- 1

30

11

12

00

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

6:5

8T

rue

HF

PO

-DA

/GenX

L402

5.0

CC

H5

12

.63

90

ng

/L1

.04

74

81

61

---

---

---

70

- 1

30

10

35

00

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

6:5

8T

rue

N-e

thyl

pe

rflu

oro

oct

an

e s

ulfo

na

mid

e (

NE

tFO

SA

)L402

2.0

CC

H1

82

.58

10

ng

/L1

.04

74

81

61

---

---

---

70

- 1

30

91

20

0

10

/13

/20

20

10

:16

10

/14

/20

20

06

:58

Tru

e

N-e

thyl

pe

rflu

oro

oct

an

e s

ulfo

na

mid

oe

tha

no

lL402

2.0

CC

H1

95

.67

30

ng

/L1

.04

74

81

61

---

---

---

70

- 1

30

98

20

0

10

/13

/20

20

10

:16

10

/14

/20

20

06

:58

Tru

e

N-m

eth

ylp

erf

luo

roo

cta

ne

su

lfo

na

mid

e (

NM

eF

OS

A)

L402

2.0

CC

H1

97

.45

40

ng

/L1

.04

74

81

61

---

---

---

70

- 1

30

99

20

0

10

/13

/20

20

10

:16

10

/14

/20

20

06

:58

Tru

e

N-m

eth

ylp

erf

luo

roo

cta

ne

su

lfo

na

mid

oe

tha

no

lL402

2.0

CC

H2

00

.09

30

ng

/L1

.04

74

81

61

---

---

---

70

- 1

30

10

02

00

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

6:5

8T

rue

Perf

luoro

buta

nesu

lfonic

aci

d (

PF

BS

)L402

2.0

CC

H1

99

.61

50

ng

/L1

.04

74

81

61

---

---

---

70

- 1

30

10

02

00

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

6:5

8T

rue

Perf

luoro

buta

noic

aci

d (

PF

BA

)L402

5.0

CC

H4

98

.86

40

ng

/L1

.04

74

81

61

---

---

---

70

- 1

30

10

05

00

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

6:5

8T

rue

Perf

luoro

deca

noic

aci

d (

PF

DA

)L402

2.0

CC

H1

98

.85

50

ng

/L1

.04

74

81

61

---

---

---

70

- 1

30

99

20

0

10

/13

/20

20

10

:16

10

/14

/20

20

06

:58

Tru

e

Perf

luoro

hepta

noic

aci

d (

PF

HpA

)L402

2.0

CC

H2

00

.89

30

ng

/L1

.04

74

81

61

---

---

---

70

- 1

30

10

02

00

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

6:5

8T

rue

Perf

luoro

hexa

nesu

lfonic

aci

d (

PF

HxS

)L402

2.0

CC

H1

98

.21

10

ng

/L1

.04

74

81

61

---

---

---

70

- 1

30

99

20

0

10

/13

/20

20

10

:16

10

/14

/20

20

06

:58

Tru

e

Perf

luoro

hexa

noic

aci

d (

PF

HxA

)L402

2.0

CC

H1

99

.71

00

ng

/L1

.04

74

81

61

---

---

---

70

- 1

30

10

02

00

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

6:5

8T

rue

Perf

luoro

dodeca

noic

aci

d (

PF

DoA

)L402

2.0

CC

H2

00

.89

20

ng

/L1

.04

74

81

61

---

---

---

70

- 1

30

10

02

00

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

6:5

8

Page 8

of

9E

EA

Run I

D 2

81023 /

EE

A R

eport

# 5

00223

Page 190 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Tru

e

Perf

luoro

nonanoic

aci

d (

PF

NA

)L402

2.0

CC

H2

02

.10

70

ng

/L1

.04

74

81

61

---

---

---

70

- 1

30

10

12

00

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

6:5

8T

rue

Perf

luoro

oct

anesu

lfonic

aci

d (

PF

OS

)L402

2.0

CC

H1

97

.27

70

ng

/L1

.04

74

81

61

---

---

---

70

- 1

30

99

20

0

10

/13

/20

20

10

:16

10

/14

/20

20

06

:58

Tru

e

N-e

thyl

Pe

rflu

oro

oct

an

esu

lfo

na

mid

oa

cetic

aci

dL402

2.0

CC

H2

05

.42

60

ng

/L1

.04

74

81

61

---

---

---

70

- 1

30

10

32

00

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

6:5

8T

rue

N-m

eth

yl P

erf

luo

roo

cta

ne

sulfo

na

mid

oa

cetic

aci

dL402

2.0

CC

H2

00

.59

90

ng

/L1

.04

74

81

61

---

---

---

70

- 1

30

10

02

00

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

6:5

8T

rue

Perf

luoro

oct

anoic

aci

d (

PF

OA

)L402

2.0

CC

H2

02

.45

90

ng

/L1

.04

74

81

61

---

---

---

70

- 1

30

10

12

00

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

6:5

8T

rue

Perf

luoro

trid

eca

noic

aci

d (

PF

TrD

A)

L402

2.0

CC

H1

94

.08

90

ng

/L1

.04

74

81

61

---

---

---

70

- 1

30

97

20

0

10

/13

/20

20

10

:16

10

/14

/20

20

06

:58

Tru

e

Perf

luoro

undeca

noic

aci

d (

PF

UnA

)L402

2.0

CC

H1

97

.78

40

ng

/L1

.04

74

81

61

---

---

---

70

- 1

30

99

20

0

10

/13

/20

20

10

:16

10

/14

/20

20

06

:58

Tru

e

Perf

luoro

dodeca

nesu

lfonic

aci

d (

PF

DoS

)L402

2.0

CC

H2

20

.89

20

ng

/L1

.04

74

81

61

---

---

---

70

- 1

30

11

02

00

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

6:5

8T

rue

Pe

rflu

oro

deca

nesu

lfonic

aci

d (

PF

DS

)L402

2.0

CC

H2

25

.17

70

ng

/L1

.04

74

81

61

---

---

---

70

- 1

30

11

32

00

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

6:5

8T

rue

Perf

luoro

hepta

nesu

lfonic

aci

d (

PF

HpS

)L402

2.0

CC

H2

03

.52

70

ng

/L1

.04

74

81

61

---

---

---

70

- 1

30

10

22

00

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

6:5

8T

rue

Perf

luoro

hexa

deca

noic

aci

d (

PF

HxD

A)

L402

2.0

CC

H1

93

.39

20

ng

/L1

.04

74

81

61

---

---

---

70

- 1

30

97

20

0

10

/13

/20

20

10

:16

10

/14

/20

20

06

:58

Tru

e

No

na

flu

oro

-3,6

-dio

xah

ep

tan

oic

aci

d (

NF

DH

A)

L402

5.0

CC

H5

29

.07

10

ng

/L1

.04

74

81

61

---

---

---

70

- 1

30

10

65

00

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

6:5

8T

rue

Perf

luoro

-4-i

sopro

poxy

buta

noic

aci

dL402

5.0

CC

H4

91

.94

80

ng

/L1

.04

74

81

61

---

---

---

70

- 1

30

98

50

0

10

/13

/20

20

10

:16

10

/14

/20

20

06

:58

Tru

e

Perf

luoro

-4-m

eth

oxy

buta

no

ic a

cid (

PF

MB

A)

L402

5.0

CC

H5

10

.73

30

ng

/L1

.04

74

81

61

---

---

---

70

- 1

30

10

25

00

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

6:5

8T

rue

Pe

rflu

oro

-3-m

eth

oxy

pro

pa

no

ic a

cid

(P

FM

PA

)L402

5.0

CC

H4

99

.83

50

ng

/L1

.04

74

81

61

---

---

---

70

- 1

30

10

05

00

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

6:5

8T

rue

Perf

luoro

nonanesu

lfonic

aci

d (

PF

NS

)L402

2.0

CC

H2

20

.75

50

ng

/L1

.04

74

81

61

---

---

---

70

- 1

30

11

02

00

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

6:5

8T

rue

Pe

rflu

oro

oct

ane s

ulfonam

ide (

PF

OS

A)

L402

2.0

CC

H2

00

.66

50

ng

/L1

.04

74

81

61

---

---

---

70

- 1

30

10

02

00

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

6:5

8T

rue

Perf

luoro

penta

noic

aci

d (

PF

PeA

)L402

2.0

CC

H2

01

.80

40

ng

/L1

.04

74

81

61

---

---

---

70

- 1

30

10

12

00

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

6:5

8T

rue

Pe

rflu

oro

penta

nesu

lfonic

aci

d (

PF

PeS

)L402

2.0

CC

H2

06

.67

50

ng

/L1

.04

74

81

61

---

---

---

70

- 1

30

10

32

00

1

0/1

3/2

02

0 1

0:1

61

0/1

4/2

02

0 0

6:5

8T

rue

Pe

rflu

oro

tetr

adeca

noic

aci

d (

PF

TeD

A)

L402

2.0

CC

H1

87

.95

90

ng

/L1

.04

74

81

61

---

---

---

70

- 1

30

94

20

0

10

/13

/20

20

10

:16

10

/14

/20

20

06

:58

Page 9

of

9E

EA

Run I

D 2

81023 /

EE

A R

eport

# 5

00223

Page 191 of 201

Eu

rofi

ns

Ea

ton

An

aly

tica

lR

un

Lo

gR

un ID

:280778

Meth

od:

L520

Sam

ple

Sit

eS

am

ple

Id

Typ

eIn

str

um

en

t ID

Cali

bra

tio

n F

ile

An

aly

sis

Date

Matr

ix

ICL

47

46

68

3C

Y1

00

92

0L

52

0a

.md

b1

0/0

9/2

02

0 1

7:4

1R

W

ICS

47

46

68

5C

Y1

00

92

0L

52

0a

.md

b1

0/0

9/2

02

0 1

7:5

5R

W

ICS

47

46

68

6C

Y1

00

92

0L

52

0a

.md

b1

0/0

9/2

02

0 1

8:0

8R

W

ICS

47

46

68

7C

Y1

00

92

0L

52

0a

.md

b1

0/0

9/2

02

0 1

8:2

1R

W

ICS

47

46

68

8C

Y1

00

92

0L

52

0a

.md

b1

0/0

9/2

02

0 1

8:3

4R

W

ICS

47

46

68

9C

Y1

00

92

0L

52

0a

.md

b1

0/0

9/2

02

0 1

8:4

7R

W

LM

B4

74

66

93

CY

10

09

20

L5

20

a.m

db

10

/09

/20

20

19

:14

RW

FS

47

43

53

3F

inis

he

dC

Y1

00

92

0L

52

0a

.md

b1

0/0

9/2

02

0 2

0:1

9D

W

CC

C4

74

66

98

CY

10

09

20

L5

20

a.m

db

10

/09

/20

20

21

:25

RW

0.0

0

Page 1

of

2E

EA

Run I

D 2

80778 /

EE

A R

eport

# 5

00223

Page 192 of 201

QC

Su

mm

ary

Re

po

rt

EE

AID

#R

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

eth

od

An

aly

teS

am

ple

Typ

eD

ilF

ac

tor

RP

DL

imit

Re

co

ve

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

gM

RL

Ex

tra

cte

dA

na

lyze

d

Tru

e

Acr

ylam

ide

L520

N/A

ICL

0.3

99

3ug

/L1

.04

74

66

83

---

---

---

50

- 1

50

80

0.5

--

-1

0/0

9/2

02

0 1

7:4

1T

rue

Anili

ne

L520

N/A

ICL

0.4

11

8ug

/L1

.04

74

66

83

---

---

---

50

- 1

50

82

0.5

--

-1

0/0

9/2

02

0 1

7:4

1T

rue

Ure

thane

L520

N/A

ICL

0.8

48

2ug

/L1

.04

74

66

83

---

---

---

50

- 1

50

85

1.0

--

-1

0/0

9/2

02

0 1

7:4

1F

als

e

Acr

ylam

ide

L520

N/A

ICS

1.1

50

2ug

/L1

.04

74

66

85

---

---

---

70

- 1

30

11

51

.0

---

10

/09

/20

20

17

:55

Fals

e

Anili

ne

L520

N/A

ICS

1.0

96

5ug

/L1

.04

74

66

85

---

---

---

70

- 1

30

11

01

.0

---

10

/09

/20

20

17

:55

Fals

e

Ure

thane

L520

N/A

ICS

2.0

86

2ug

/L1

.04

74

66

85

---

---

---

70

- 1

30

10

42

.0

---

10

/09

/20

20

17

:55

Tru

e

Acr

ylam

ide

L520

N/A

ICS

2.2

55

1ug

/L1

.04

74

66

86

---

---

---

70

- 1

30

11

32

.0

---

10

/09

/20

20

18

:08

Tru

e

Anili

ne

L520

N/A

ICS

2.3

15

1ug

/L1

.04

74

66

86

---

---

---

70

- 1

30

11

62

.0

---

10

/09

/20

20

18

:08

Tru

e

Ure

thane

L520

N/A

ICS

4.7

39

0ug

/L1

.04

74

66

86

---

---

---

70

- 1

30

11

84

.0

---

10

/09

/20

20

18

:08

Fals

e

Acr

ylam

ide

L520

N/A

ICS

4.5

55

5ug

/L1

.04

74

66

87

---

---

---

70

- 1

30

91

5.0

--

-1

0/0

9/2

02

0 1

8:2

1F

als

e

Anili

ne

L520

N/A

ICS

4.5

76

2ug

/L1

.04

74

66

87

---

---

---

70

- 1

30

92

5.0

--

-1

0/0

9/2

02

0 1

8:2

1F

als

e

Ure

thane

L520

N/A

ICS

9.2

57

0ug

/L1

.04

74

66

87

---

---

---

70

- 1

30

93

10

.0

---

10

/09

/20

20

18

:21

Tru

e

Acr

ylam

ide

L520

N/A

ICS

10

.11

48

ug

/L1

.04

74

66

88

---

---

---

70

- 1

30

10

11

0.0

--

-1

0/0

9/2

02

0 1

8:3

4T

rue

Anili

ne

L520

N/A

ICS

10

.04

91

ug

/L1

.04

74

66

88

---

---

---

70

- 1

30

10

01

0.0

--

-1

0/0

9/2

02

0 1

8:3

4T

rue

Ure

thane

L520

N/A

ICS

19

.87

81

ug

/L1

.04

74

66

88

---

---

---

70

- 1

30

99

20

.0

---

10

/09

/20

20

18

:34

Fals

e

Acr

ylam

ide

L520

N/A

ICS

20

.02

60

ug

/L1

.04

74

66

89

---

---

---

70

- 1

30

10

02

0.0

--

-1

0/0

9/2

02

0 1

8:4

7F

als

e

Anili

ne

L520

N/A

ICS

20

.05

31

ug

/L1

.04

74

66

89

---

---

---

70

- 1

30

10

02

0.0

--

-1

0/0

9/2

02

0 1

8:4

7F

als

e

Ure

thane

L520

N/A

ICS

40

.20

08

ug

/L1

.04

74

66

89

---

---

---

70

- 1

30

10

14

0.0

--

-1

0/0

9/2

02

0 1

8:4

7T

rue

Acr

ylam

ide

L520

0.5

LM

B0

.5ug

/L1

.04

74

66

93

---

---

---

---

---

<

---

10

/09

/20

20

19

:14

Tru

e

Anili

ne

L520

0.5

LM

B0

.5ug

/L1

.04

74

66

93

---

---

---

---

---

<

---

10

/09

/20

20

19

:14

Tru

e

Ure

thane

L520

1.0

LM

B1

.0ug

/L1

.04

74

66

93

---

---

---

---

---

<

---

10

/09

/20

20

19

:14

Fals

e

Acr

ylam

ide

L520

0.5

FS

0.5

ug

/L1

.04

74

35

33

Fin

ishe

d--

---

---

---

-

<--

-1

0/0

9/2

02

0 2

0:1

9F

als

e

Anili

ne

L520

0.5

FS

0.5

ug

/L1

.04

74

35

33

Fin

ishe

d--

---

---

---

-

<--

-1

0/0

9/2

02

0 2

0:1

9F

als

e

Ure

thane

L520

1.0

FS

1.0

ug

/L1

.04

74

35

33

Fin

ishe

d--

---

---

---

-

<--

-1

0/0

9/2

02

0 2

0:1

9T

rue

Acr

ylam

ide

L520

0.5

CC

C4

.69

05

ug

/L1

.04

74

66

98

---

---

---

70

- 1

30

94

5.0

--

-1

0/0

9/2

02

0 2

1:2

5T

rue

Anili

ne

L520

0.5

CC

C4

.70

05

ug

/L1

.04

74

66

98

---

---

---

70

- 1

30

94

5.0

--

-1

0/0

9/2

02

0 2

1:2

5T

rue

Ure

thane

L520

1.0

CC

C8

.79

67

ug

/L1

.04

74

66

98

---

---

---

70

- 1

30

88

10

.0

---

10

/09

/20

20

21

:25

Page 2

of

2E

EA

Run I

D 2

80778 /

EE

A R

eport

# 5

00223

Page 193 of 201

Eu

rofi

ns

Ea

ton

An

aly

tica

lR

un

Lo

gR

un ID

:0

Meth

od:

8330A

Sam

ple

Sit

eS

am

ple

Id

Typ

eIn

str

um

en

t ID

Cali

bra

tio

n F

ile

An

aly

sis

Date

Matr

ix

FS

47

43

53

0F

inis

he

d1

0/2

4/2

02

0 1

7:2

7D

W

FS

47

43

54

4F

inis

he

d1

1/0

3/2

02

0 2

1:5

1D

W

0.0

0

Page 1

of

4E

EA

Run I

D 0

/ E

EA

Report

# 5

00223

Page 194 of 201

QC

Su

mm

ary

Re

po

rt

EE

AID

#R

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

eth

od

An

aly

teS

am

ple

Typ

eD

ilF

ac

tor

RP

DL

imit

Re

co

ve

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

gM

RL

Ex

tra

cte

dA

na

lyze

d

Tru

e

2-A

min

o-4

,6-d

initro

tolu

ene

8330A

0.6

FS

ug

/L1

.04

74

35

30

Fin

ishe

d--

---

---

---

-

--

-1

0/2

4/2

02

0 1

7:2

7T

rue

4-A

min

o-2

,6-d

initro

tolu

ene

8330A

0.6

FS

ug

/L1

.04

74

35

30

Fin

ishe

d--

---

---

---

-

--

-1

0/2

4/2

02

0 1

7:2

7T

rue

1,3

-Din

itro

benze

ne

8330A

0.6

FS

ug

/L1

.04

74

35

30

Fin

ishe

d--

---

---

---

-

--

-1

0/2

4/2

02

0 1

7:2

7T

rue

2,4

-Din

itro

tolu

ene

8330A

2.0

FS

ug

/L1

.04

74

35

30

Fin

ishe

d--

---

---

---

-

--

-1

0/2

4/2

02

0 1

7:2

7T

rue

2,6

-Din

itro

tolu

ene

8330A

1.3

FS

ug

/L1

.04

74

35

30

Fin

ishe

d--

---

---

---

-

--

-1

0/2

4/2

02

0 1

7:2

7T

rue

HM

X (

Oct

ah

ydro

-1,3

,5,7

-te

tra

nitr

o-1

,3,5

,7-t

etr

azo

cin

8330A

2.0

FS

ug

/L1

.04

74

35

30

Fin

ishe

d--

---

---

---

-

--

-1

0/2

4/2

02

0 1

7:2

7T

rue

Nitro

benze

ne

8330A

0.6

FS

ug

/L1

.04

74

35

30

Fin

ishe

d--

---

---

---

-

--

-1

0/2

4/2

02

0 1

7:2

7T

rue

Nitro

gly

ceri

n8330A

15

FS

ug

/L1

.04

74

35

30

Fin

ishe

d--

---

---

---

-

--

-1

0/2

4/2

02

0 1

7:2

7T

rue

2-N

itro

tolu

ene

8330A

0.7

5F

Sug

/L1

.04

74

35

30

Fin

ishe

d--

---

---

---

-

--

-1

0/2

4/2

02

0 1

7:2

7T

rue

3-N

itro

tolu

ene

8330A

1.2

FS

ug

/L1

.04

74

35

30

Fin

ishe

d--

---

---

---

-

--

-1

0/2

4/2

02

0 1

7:2

7T

rue

4-N

itro

tolu

ene

8330A

1.2

FS

ug

/L1

.04

74

35

30

Fin

ishe

d--

---

---

---

-

--

-1

0/2

4/2

02

0 1

7:2

7T

rue

PE

TN

(P

enta

ery

thri

tol te

tranitra

te)

8330A

18

FS

ug

/L1

.04

74

35

30

Fin

ishe

d--

---

---

---

-

--

-1

0/2

4/2

02

0 1

7:2

7T

rue

RD

X (

He

xah

ydro

-1,3

,5-t

rin

itro

-1,3

,5-t

ria

zin

e)

8330A

0.5

FS

ug

/L1

.04

74

35

30

Fin

ishe

d--

---

---

---

-

--

-1

0/2

4/2

02

0 1

7:2

7T

rue

Te

tryl

(2

,4,6

-Trin

itro

ph

en

ylm

eth

yln

itra

min

e)

8330A

0.8

FS

ug

/L1

.04

74

35

30

Fin

ishe

d--

---

---

---

-

--

-1

0/2

4/2

02

0 1

7:2

7T

rue

1,3

,5-T

rinitro

benze

ne

8330A

0.6

FS

ug

/L1

.04

74

35

30

Fin

ishe

d--

---

---

---

-

--

-1

0/2

4/2

02

0 1

7:2

7T

rue

2,4

,6-T

rinitro

tolu

ene

8330A

0.6

FS

ug

/L1

.04

74

35

30

Fin

ishe

d--

---

---

---

-

--

-1

0/2

4/2

02

0 1

7:2

7F

als

e

Ace

sulfam

e-K

LC

/MS

/MS

20

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Ace

tam

inophen

LC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Alb

ute

rol

LC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Am

oxi

cilli

nLC

/MS

/MS

20

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

4-A

ndro

stene-3

,17-d

ione

LC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Ate

nolo

lLC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Atr

azi

ne

LC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Bendro

flum

eth

iazi

de

LC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Beza

fibra

teLC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Bis

phenol A

LC

/MS

/MS

10

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Bro

maci

lLC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Buta

lbital

LC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Buty

lpara

ben

LC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Caffein

eLC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Carb

adox

LC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Carb

am

aze

pin

eLC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Cari

sopro

dol

LC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Chlo

ram

phenic

ol

LC

/MS

/MS

10

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Chlo

ridazo

nLC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Chlo

roto

luro

nLC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Cim

etidin

eLC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Clo

fibri

c aci

dLC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Cotinin

eLC

/MS

/MS

10

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Cya

nazi

ne

LC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1

Page 2

of

4E

EA

Run I

D 0

/ E

EA

Report

# 5

00223

Page 195 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Fals

e

2,4

-DLC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

DE

ET

LC

/MS

/MS

10

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Dehyd

ronifedip

ine

LC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Dese

thyl

atr

azi

ne

LC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Desi

sopro

pyl

atr

azi

ne

LC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Dia

min

och

loro

tria

zine

LC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Dia

zepam

LC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Dic

lofe

nac

LC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Dila

ntin

LC

/MS

/MS

20

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Dilt

iaze

mLC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

1,7

-Dim

eth

ylxa

nth

ine

LC

/MS

/MS

10

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Diu

ron

LC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Ery

thro

myc

inLC

/MS

/MS

10

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

17beta

-Est

rad

iol

LC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Est

rone

LC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Eth

ylpara

ben

LC

/MS

/MS

20

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

17alp

ha-E

thyn

yl e

stra

dio

lLC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Flu

mequin

eLC

/MS

/MS

10

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Flu

oxe

tine (

Pro

zac)

LC

/MS

/MS

10

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Gem

fibro

zil

LC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Ibupro

fen

LC

/MS

/MS

10

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Iohexa

lLC

/MS

/MS

10

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Iopro

mid

eLC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Isobuty

lpara

ben

LC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Isopro

turo

nLC

/MS

/MS

100

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Keto

pro

fen

LC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Keto

rola

cLC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Lid

oca

ine

LC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Lin

com

ycin

LC

/MS

/MS

10

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Lin

uro

nLC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Lopre

ssor

LC

/MS

/MS

20

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Mecl

ofe

nam

ic a

cid

LC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Mepro

bam

ate

LC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Meta

zoch

lor

LC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Meth

ylpara

be

nLC

/MS

/MS

20

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Meto

lach

lor

LC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Napro

xen

LC

/MS

/MS

10

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Nifedip

ine

LC

/MS

/MS

20

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

4-N

onyl

phenol

LC

/MS

/MS

100

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Nore

this

tero

ne

LC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

4-t

ert

-Oct

ylphenol

LC

/MS

/MS

50

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1

Page 3

of

4E

EA

Run I

D 0

/ E

EA

Report

# 5

00223

Page 196 of 201

Sa

mp

leT

yp

eE

EA

ID #

An

aly

zed

Ex

tra

cte

dR

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

RL

Me

tho

dA

na

lyte

Dil

Fa

cto

rR

PD

Lim

itR

ec

ove

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

g

QC

Su

mm

ary

Rep

ort

(co

nt.

)

Fals

e

Oxo

linic

aci

dLC

/MS

/MS

10

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Pento

xify

lline

LC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Pri

mid

one

LC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Pro

gest

ero

ne

LC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Pro

pazi

ne

LC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Pro

pyl

para

be

nLC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Quin

olin

eLC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Sim

azi

ne

LC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Sucr

alo

seLC

/MS

/MS

100

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Sulfach

loro

pyr

idazi

ne

LC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Sulfadia

zine

LC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Sulfadim

eth

oxi

ne

LC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Sulfam

era

zine

LC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Sulfam

eth

azi

ne

LC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Sulfam

eth

izo

leLC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Sulfam

eth

oxa

zole

LC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Sulfath

iazo

leLC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Test

ost

ero

ne

LC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Theobro

min

eLC

/MS

/MS

10

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Theophyl

line

LC

/MS

/MS

20

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Thia

bendazo

leLC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Tri

cloca

rban

LC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Tri

closa

nLC

/MS

/MS

10

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Tri

meth

opri

mLC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Tri

s(1,3

-dic

hlo

ro-2

-pro

pyl)

phosp

hate

LC

/MS

/MS

100

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Warf

ari

nLC

/MS

/MS

5.0

FS

ng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1F

als

e

Metform

inLC

/MS

/MS

5.0

0F

Sng

/L1

.04

74

35

44

Fin

ishe

d--

---

---

---

-

--

-1

1/0

3/2

02

0 2

1:5

1

Page 4

of

4E

EA

Run I

D 0

/ E

EA

Report

# 5

00223

Page 197 of 201

Eu

rofi

ns

Ea

ton

An

aly

tica

lR

un

Lo

gR

un ID

:281398

Meth

od:

SR

L 5

24M

-TC

P

Sam

ple

Sit

eS

am

ple

Id

Typ

eIn

str

um

en

t ID

Cali

bra

tio

n F

ile

An

aly

sis

Date

Matr

ix

LF

B4

75

14

21

ET

CD

HS

-10

15

20

a-E

T.m

10

/15

/20

20

21

:24

RW

LR

B4

75

14

23

ET

CD

HS

-10

15

20

a-E

T.m

10

/15

/20

20

22

:32

RW

FS

47

43

54

7F

inis

he

dE

TC

DH

S-1

01

52

0a

-ET

.m1

0/1

5/2

02

0 2

3:0

6D

W

FD

47

51

43

3F

inis

he

dE

TC

DH

S-1

01

52

0a

-ET

.m1

0/1

6/2

02

0 0

0:1

4D

W

CC

C4

75

14

26

ET

CD

HS

-10

15

20

a-E

T.m

10

/16

/20

20

01

:23

RW

0.0

0

Page 1

of

2E

EA

Run I

D 2

81398 /

EE

A R

eport

# 5

00223

Page 198 of 201

QC

Su

mm

ary

Re

po

rt

EE

AID

#R

PD

Un

its

Ta

rge

tA

mo

un

tC

lie

nt

IDM

eth

od

An

aly

teS

am

ple

Typ

eD

ilF

ac

tor

RP

DL

imit

Re

co

ve

ryL

imit

s%

R

ec

ove

ryR

es

ult

Fla

gM

RL

Ex

tra

cte

dA

na

lyze

d

Fals

e

1,2

,3-T

rich

loro

pro

pane

SR

L 5

24M

-TC

P5.0

LF

B1

0.0

21

0ng

/L1

.04

75

14

21

---

---

---

80

- 1

20

10

01

0.0

--

-1

0/1

5/2

02

0 2

1:2

4T

rue

1,2

,3-T

rich

loro

pro

pane

SR

L 5

24M

-TC

P5.0

LR

B5

.0ng

/L1

.04

75

14

23

---

---

---

---

---

<

---

10

/15

/20

20

22

:32

Fals

e

1,2

,3-T

rich

loro

pro

pane

SR

L 5

24M

-TC

P5.0

FS

5.0

ng

/L1

.04

74

35

47

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

5/2

02

0 2

3:0

6T

rue

1,2

,3-T

rich

loro

pro

pane

SR

L 5

24M

-TC

P5.0

FD

5.0

ng

/L1

.04

75

14

33

Fin

ishe

d--

---

---

---

-

<--

-1

0/1

6/2

02

0 0

0:1

4F

als

e

1,2

,3-T

rich

loro

pro

pane

SR

L 5

24M

-TC

P5.0

CC

C4

9.0

67

0ng

/L1

.04

75

14

26

---

---

---

80

- 1

20

98

50

.0

---

10

/16

/20

20

01

:23

Page 2

of

2E

EA

Run I

D 2

81398 /

EE

A R

eport

# 5

00223

Page 199 of 201

Sa

mp

le T

yp

e K

ey

Typ

e (

Ab

br.

)S

am

ple

Typ

eT

yp

e (

Ab

br.

)S

am

ple

Typ

e

CC

VC

ontin

uin

g C

ali.

Verificatio

n

CC

BC

ontin

uin

g C

alib

ratio

n B

lank

CC

CC

ontin

uin

g C

alib

ratio

n C

heck

CC

HC

ontin

uin

g C

alib

ratio

n H

igh

CC

LC

ontin

uin

g C

alib

ratio

n L

ow

CC

MC

ontin

uin

g C

alib

ratio

n M

id

FD

Fie

ld D

uplic

ate

FS

Fie

ld S

am

ple

FB

HF

ort

ifie

d B

lank H

igh

FB

LF

ort

ifie

d B

lank L

ow

FB

MF

ort

ifie

d B

lank M

id

ICV

Initi

al C

ali.

Verificatio

n

ICB

Initi

al C

alib

ratio

n B

lank

ICL

Initi

al C

alib

ratio

n L

ow

ICS

Initi

al C

alib

ratio

n S

am

ple

IPC

Instr

um

ent

Perf

orm

ance C

heck

LF

BLabora

tory

Fort

ifie

d B

lank

LM

BLabora

tory

Meth

od B

lank

LR

BLabora

tory

Reagent

Bla

nk

LT

BLabora

tory

Trip B

lank

MS

Matr

ix S

pik

e

MS

DM

atr

ix S

pik

e D

uplic

ate

MS

MM

atr

ix S

pik

e M

id

QC

SQ

ualit

y C

ontr

ol S

am

ple

SD

MS

pik

e D

uplic

ate

Mid

1.0

0

Page 200 of 201

END OF REPORT

Page 201 of 201

Documents

LABORATORY REPORT - Charleston Water